data_2my9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2my9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.545 0.761 0 CA-C-O 118.834 -0.603 . . . . 1.0 109.445 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.4 143.56 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.708 2.939 . . . . 1.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -125.0 160.41 54.54 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.61 1.964 . . . . 1.0 111.849 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.77 129.31 11.74 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 124.082 3.188 . . . . 1.0 112.786 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.5 -11.3 72.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.323 1.44 . . . . 1.0 114.924 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.77 137.64 57.91 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.125 1.463 . . . . 1.0 112.958 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.15 118.2 24.57 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.558 1.143 . . . . 1.0 108.348 171.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mm -93.95 127.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -108.29 117.14 33.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.246 2.219 . . . . 1.0 107.611 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mt -115.1 129.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.386 1.474 . . . . 1.0 109.052 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.442 1.497 . . . . 1.0 109.843 -179.316 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.605 ' CD2' ' HG ' ' A' ' 113' ' ' CYS . 10.9 t-80 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 119.669 -0.205 . . . . 1.0 111.512 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -136.54 154.95 50.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.422 1.267 . . . . 1.0 114.422 -173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.29 159.63 43.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.495 1.518 . . . . 1.0 112.744 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.43 114.88 29.5 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.076 1.75 . . . . 1.0 108.709 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -82.67 131.69 35.2 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.062 -1.024 . . . . 1.0 112.183 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 pt -112.86 -0.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -170.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.28 165.61 27.62 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 124.602 1.096 . . . . 1.0 113.164 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.3 t70 60.51 20.47 10.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.834 1.654 . . . . 1.0 114.079 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.54 0.27 79.47 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.637 1.589 . . . . 1.0 114.624 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.98 152.45 18.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.751 . . . . 1.0 114.16 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.3 155.09 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.664 1.586 . . . . 1.0 111.111 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.3 137.33 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.54 1.536 . . . . 1.0 107.219 169.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -153.07 159.34 42.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.143 0.977 . . . . 1.0 111.313 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -95.6 127.34 41.55 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 117.639 -1.172 . . . . 1.0 109.202 171.44 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -146.41 138.32 24.86 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.832 -0.542 . . . . 1.0 110.292 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -77.6 129.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.29 161.49 35.65 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.728 1.611 . . . . 1.0 112.004 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -117.4 129.47 55.87 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.104 1.762 . . . . 1.0 110.281 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -148.37 173.9 12.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.656 1.183 . . . . 1.0 111.291 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.79 142.66 49.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.624 0.77 . . . . 1.0 110.661 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.34 -51.0 61.2 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.389 1.076 . . . . 1.0 111.826 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.06 -48.01 71.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.168 0.987 . . . . 1.0 110.988 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.86 -39.21 93.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.982 0.513 . . . . 1.0 111.877 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.57 -46.44 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.432 1.093 . . . . 1.0 112.065 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.71 -35.36 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.389 0.995 . . . . 1.0 113.05 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.33 -124.14 35.01 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.421 1.009 . . . . 1.0 111.797 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.02 -7.2 84.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.383 0.992 . . . . 1.0 114.812 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.07 148.44 41.9 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 1.0 111.634 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -76.54 161.94 28.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.738 0.815 . . . . 1.0 110.978 171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -157.19 160.45 38.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -144.01 163.51 33.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.769 2.028 . . . . 1.0 110.844 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.99 129.94 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 168.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -147.85 83.69 1.52 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.91 0.862 . . . . 1.0 111.914 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -80.81 54.65 2.2 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.998 1.319 . . . . 1.0 112.66 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.1 m -60.54 -31.89 70.96 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.734 -1.229 . . . . 1.0 113.271 -171.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -68.57 -11.37 59.89 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.932 1.086 . . . . 1.0 113.932 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.07 -28.06 67.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.999 0.818 . . . . 1.0 112.968 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -80.35 -14.56 58.25 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.244 1.418 . . . . 1.0 112.185 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -101.33 -46.83 4.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.396 1.478 . . . . 1.0 111.863 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.02 167.09 13.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.499 1.519 . . . . 1.0 113.464 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -66.23 161.63 55.21 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.682 1.193 . . . . 1.0 111.87 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.9 87.96 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.174 2.582 . . . . 1.0 110.761 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.59 151.15 96.76 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.681 1.192 . . . . 1.0 111.428 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.37 116.42 4.69 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.567 2.845 . . . . 1.0 110.093 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.28 -31.81 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.34 -36.07 77.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.065 0.395 . . . . 1.0 112.065 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.0 t -76.57 -32.19 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.323 0.649 . . . . 1.0 111.211 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.91 -46.43 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 119.265 0.939 . . . . 1.0 110.155 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.15 -38.01 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 1.0 111.531 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.0 m -64.9 -38.28 90.45 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.92 0.782 . . . . 1.0 111.14 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.0 m -63.73 -43.71 95.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.941 0.897 . . . . 1.0 111.306 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.04 -50.41 72.81 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.294 0.637 . . . . 1.0 110.662 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.78 -40.7 96.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.219 1.008 . . . . 1.0 112.903 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -66.55 -32.97 74.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.855 0.862 . . . . 1.0 112.388 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.6 -39.21 64.78 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.187 -0.911 . . . . 1.0 112.595 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.2 127.24 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.674 1.125 . . . . 1.0 111.406 172.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.13 63.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.927 1.727 . . . . 1.0 114.017 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -84.89 143.3 29.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.024 1.412 . . . . 1.0 111.306 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -97.32 159.01 15.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.618 1.567 . . . . 1.0 113.501 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.476 0.861 0 C-N-CA 126.657 1.983 . . . . 1.0 110.347 172.426 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 115.723 1.749 . . . . 1.0 115.723 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.605 ' HG ' ' CD2' ' A' ' 23' ' ' HIS . 25.4 p -68.97 -38.75 79.56 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 121.199 1.818 . . . . 1.0 112.912 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -43.61 93.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.608 0.763 . . . . 1.0 111.018 170.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -61.37 -39.55 91.05 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.427 -0.796 . . . . 1.0 111.77 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.1 -59.78 4.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.196 0.999 . . . . 1.0 110.797 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.28 -21.19 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 119.769 1.168 . . . . 1.0 113.425 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.5 m -64.0 -49.69 71.47 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.818 1.247 . . . . 1.0 111.038 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -61.35 -25.2 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.521 0.728 . . . . 1.0 112.74 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.43 -35.16 80.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.996 0.816 . . . . 1.0 113.076 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -94.03 -40.77 9.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.117 0.967 . . . . 1.0 112.297 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.47 -44.65 78.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.894 0.877 . . . . 1.0 112.29 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.078 0 C-N-CA 126.229 1.871 . . . . 1.0 113.639 -179.51 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 118.855 -0.593 . . . . 1.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.02 153.23 22.03 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.828 3.019 . . . . 1.0 113.003 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.91 162.94 50.64 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.331 1.852 . . . . 1.0 112.841 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -45.36 128.51 10.14 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 124.387 3.392 . . . . 1.0 113.509 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 -3.74 85.66 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.232 1.396 . . . . 1.0 115.204 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -70.04 143.43 52.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.636 . . . . 1.0 113.382 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.57 127.48 34.91 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.612 1.165 . . . . 1.0 108.594 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mt -117.07 127.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.722 0.809 . . . . 1.0 109.523 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -89.46 134.24 34.18 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.936 1.294 . . . . 1.0 108.169 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.66 119.49 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.877 1.271 . . . . 1.0 108.375 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 125.009 1.324 . . . . 1.0 110.985 -171.667 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.3 m80 . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -133.86 148.63 51.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.313 -0.867 . . . . 1.0 112.841 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.36 151.49 40.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.235 1.014 . . . . 1.0 112.93 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.16 116.97 32.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.562 1.945 . . . . 1.0 108.306 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.3 133.04 35.22 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.135 -0.978 . . . . 1.0 112.356 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 pt -114.74 2.79 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 115.147 1.536 . . . . 1.0 115.147 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 166.63 32.86 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.353 0.978 . . . . 1.0 112.807 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.64 17.73 9.96 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.921 1.688 . . . . 1.0 114.143 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.57 80.95 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 125.11 1.338 . . . . 1.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -95.11 153.85 17.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.641 1.721 . . . . 1.0 114.672 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.59 158.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.031 1.732 . . . . 1.0 111.125 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.89 137.85 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 126.051 1.74 . . . . 1.0 106.718 168.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -154.38 149.31 26.72 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.215 -0.928 . . . . 1.0 111.625 -168.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.0 tp -86.12 130.1 34.64 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.505 1.122 . . . . 1.0 110.47 -175.694 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -132.36 140.98 48.73 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.433 -0.792 . . . . 1.0 110.813 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.12 126.89 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 170.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -132.66 163.28 29.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.38 1.472 . . . . 1.0 112.003 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -121.29 137.86 54.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.209 1.804 . . . . 1.0 110.393 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -163.46 178.69 7.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.079 1.351 . . . . 1.0 110.977 171.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.9 142.08 51.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.9 0.88 . . . . 1.0 111.115 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 tp -52.07 -52.0 54.02 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.371 1.068 . . . . 1.0 111.778 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -54.65 -47.92 72.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.074 0.95 . . . . 1.0 110.788 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.54 -39.21 93.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.985 0.514 . . . . 1.0 111.985 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.3 t -69.25 -44.99 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.724 1.21 . . . . 1.0 111.956 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.79 -36.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.48 1.036 . . . . 1.0 112.829 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.62 -119.55 18.72 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 119.499 1.045 . . . . 1.0 111.622 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.22 -3.86 86.9 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.543 1.068 . . . . 1.0 114.867 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.4 m -76.41 147.24 38.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.828 1.314 . . . . 1.0 111.429 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -78.84 166.28 22.6 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.175 0.59 . . . . 1.0 110.15 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -160.22 164.1 33.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.023 1.119 . . . . 1.0 114.023 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -156.38 158.54 37.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.956 1.303 . . . . 1.0 112.115 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.0 t -81.04 139.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.488 1.115 . . . . 1.0 108.657 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -150.88 80.55 1.33 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.22 1.008 . . . . 1.0 111.111 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.78 68.44 3.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.388 1.075 . . . . 1.0 111.124 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.3 p -64.65 -36.02 82.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.691 1.197 . . . . 1.0 113.331 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.57 -10.16 56.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.925 1.084 . . . . 1.0 113.925 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.15 -32.65 55.85 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.537 1.135 . . . . 1.0 112.181 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.13 -16.11 58.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.382 1.473 . . . . 1.0 112.877 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -103.79 -45.9 4.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.398 1.479 . . . . 1.0 112.185 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -128.67 162.55 27.08 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.133 1.373 . . . . 1.0 113.211 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -71.33 156.17 91.99 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.613 -0.68 . . . . 1.0 111.03 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -51.04 133.63 41.28 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.182 3.255 . . . . 1.0 113.508 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -98.66 153.8 37.76 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.359 1.464 . . . . 1.0 110.352 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.37 110.99 3.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.207 2.605 . . . . 1.0 110.749 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.42 -33.55 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.323 1.231 . . . . 1.0 114.323 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -37.98 84.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.134 0.425 . . . . 1.0 111.517 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.83 -36.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.523 0.729 . . . . 1.0 110.907 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -60.01 -48.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.589 0.631 . . . . 1.0 110.12 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.7 -39.47 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.083 0.953 . . . . 1.0 111.742 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -63.51 -38.28 90.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.567 1.076 . . . . 1.0 112.196 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -62.7 -45.6 92.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.501 -0.75 . . . . 1.0 111.021 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.26 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.434 0.693 . . . . 1.0 110.951 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.59 -39.48 91.35 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.925 0.89 . . . . 1.0 113.224 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.93 -34.01 77.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.785 0.834 . . . . 1.0 112.232 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.9 mmm -73.29 -40.64 64.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.349 -0.834 . . . . 1.0 112.649 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.07 128.36 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.483 1.038 . . . . 1.0 111.586 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.7 -14.06 63.38 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.569 1.556 . . . . 1.0 113.219 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -83.75 142.3 30.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.171 1.485 . . . . 1.0 111.242 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -95.32 147.2 23.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.164 1.385 . . . . 1.0 112.269 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 N--CA 1.472 0.628 0 C-N-CA 126.434 1.894 . . . . 1.0 110.237 179.446 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.6 t30 . . . . . 0 CA--C 1.552 1.03 0 N-CA-C 113.893 1.072 . . . . 1.0 113.893 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.3 m -59.59 -30.29 68.56 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.576 -1.328 . . . . 1.0 112.661 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -58.72 -56.76 17.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.462 0.573 . . . . 1.0 109.834 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -56.06 -32.21 63.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.756 0.822 . . . . 1.0 112.698 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -63.27 -57.84 9.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.64 -0.662 . . . . 1.0 110.491 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.74 -29.09 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.0 p -67.72 -41.98 82.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.656 1.116 . . . . 1.0 111.884 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -63.09 -23.26 67.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.987 0.915 . . . . 1.0 112.933 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.54 -30.21 71.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.399 0.999 . . . . 1.0 112.342 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -92.37 -53.72 4.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.27 1.428 . . . . 1.0 111.446 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -69.02 -35.3 76.48 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.881 1.067 . . . . 1.0 113.881 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.189 0 C-N-CA 126.142 1.829 . . . . 1.0 113.755 -177.627 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 118.677 -0.678 . . . . 1.0 109.929 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.45 147.97 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.634 2.889 . . . . 1.0 111.927 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -122.68 162.44 38.48 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.191 1.796 . . . . 1.0 111.728 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.57 127.09 11.23 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.822 3.014 . . . . 1.0 113.254 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.16 -8.51 77.62 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-O 118.495 -1.169 . . . . 1.0 115.303 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.28 143.38 57.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.326 1.563 . . . . 1.0 113.468 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.32 125.22 34.57 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.207 1.403 . . . . 1.0 109.341 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.3 mm -102.86 131.67 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.489 -1.3 . . . . 1.0 107.489 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -108.88 129.63 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.832 1.653 . . . . 1.0 108.231 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mt -126.81 118.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.9 1.28 . . . . 1.0 109.339 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 125.391 1.476 . . . . 1.0 110.539 -177.363 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -141.5 164.18 30.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.755 0.822 . . . . 1.0 112.537 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.98 154.45 35.0 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.74 115.19 27.51 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.029 1.732 . . . . 1.0 107.158 169.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -81.43 128.68 34.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.304 -0.873 . . . . 1.0 111.868 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.68 4.64 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.617 1.34 . . . . 1.0 114.617 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.71 169.82 40.15 Favored Glycine 0 N--CA 1.475 1.266 0 C-N-CA 124.292 0.949 . . . . 1.0 112.393 -173.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.78 16.14 8.77 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.004 1.722 . . . . 1.0 114.075 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 2.97 83.17 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.282 1.42 . . . . 1.0 114.205 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -98.66 154.34 18.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.749 1.775 . . . . 1.0 114.236 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.92 155.71 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.643 1.577 . . . . 1.0 111.309 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.5 mt -115.72 137.83 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.734 1.614 . . . . 1.0 107.327 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.34 147.41 24.64 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.982 -1.074 . . . . 1.0 111.636 -168.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.0 tp -87.48 128.55 35.23 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.392 -0.966 . . . . 1.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 124.721 1.208 . . . . 1.0 110.878 -170.374 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 119.512 -0.28 . . . . 1.0 110.837 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.7 139.04 54.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.499 1.12 . . . . 1.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.53 125.9 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.827 0.739 . . . . 1.0 109.013 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.98 162.93 29.52 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.93 1.692 . . . . 1.0 111.807 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.65 140.81 50.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.722 1.609 . . . . 1.0 110.227 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -162.09 179.7 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.018 1.327 . . . . 1.0 111.076 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.9 145.21 48.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.947 0.899 . . . . 1.0 111.413 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -52.16 -53.56 41.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.631 1.172 . . . . 1.0 111.227 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.1 -43.77 74.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.471 1.109 . . . . 1.0 111.627 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -44.04 91.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.317 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.56 -42.6 72.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.38 1.072 . . . . 1.0 112.207 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.27 -3.02 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.74 128.93 48.1 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.493 1.044 . . . . 1.0 113.555 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.04 1.23 79.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.864 1.221 . . . . 1.0 114.839 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.3 m -125.66 158.14 35.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.026 1.73 . . . . 1.0 111.561 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.9 m -86.08 156.17 20.5 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -158.97 164.52 35.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.565 1.321 . . . . 1.0 114.565 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -161.3 163.35 30.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.37 1.468 . . . . 1.0 112.169 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.0 t -82.11 135.47 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 107.329 -1.36 . . . . 1.0 107.329 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -146.97 74.79 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.269 1.033 . . . . 1.0 111.215 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -77.94 57.97 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.543 1.537 . . . . 1.0 111.486 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 t -60.78 -40.32 92.12 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.515 -1.366 . . . . 1.0 112.498 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.5 mt -70.82 -10.28 59.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.56 -28.74 70.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.273 0.942 . . . . 1.0 112.58 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -84.08 -4.82 59.04 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.313 1.445 . . . . 1.0 111.825 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -103.67 -47.29 4.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.379 1.472 . . . . 1.0 111.698 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -129.49 150.68 50.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.101 1.36 . . . . 1.0 113.497 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -65.32 152.29 92.27 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.346 1.058 . . . . 1.0 111.382 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.94 133.69 23.93 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.039 2.493 . . . . 1.0 112.784 -170.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -83.74 160.62 58.17 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.555 . . . . 1.0 112.024 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.6 115.52 3.77 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.691 2.928 . . . . 1.0 110.045 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.96 -30.49 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -169.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.74 -35.08 77.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.201 0.601 . . . . 1.0 112.112 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.81 -37.88 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.65 -0.656 . . . . 1.0 110.576 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.3 mt -64.07 -48.67 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.397 0.679 . . . . 1.0 110.235 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -71.68 -41.02 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.32 1.048 . . . . 1.0 112.27 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.4 p -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.878 1.217 . . . . 1.0 111.81 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.2 m -61.39 -45.0 96.19 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.683 -0.636 . . . . 1.0 111.767 169.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.31 -48.71 78.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.797 0.726 . . . . 1.0 110.585 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.16 -40.46 96.07 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.082 0.953 . . . . 1.0 112.972 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.59 -32.34 73.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.678 0.791 . . . . 1.0 112.475 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.8 mmm -73.7 -37.95 65.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.835 0.854 . . . . 1.0 112.89 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.5 t -47.21 126.96 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.594 1.088 . . . . 1.0 111.372 170.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.56 61.24 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.895 1.712 . . . . 1.0 113.929 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.6 162.97 17.7 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.034 1.417 . . . . 1.0 111.403 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.63 160.85 27.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.373 1.469 . . . . 1.0 113.046 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.9 mtt . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 125.278 1.431 . . . . 1.0 112.182 178.372 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 CA--C 1.546 0.8 0 N-CA-C 114.392 1.256 . . . . 1.0 114.392 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.25 -38.26 75.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.301 0.955 . . . . 1.0 113.352 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.63 -54.83 41.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 1.0 109.609 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -60.31 -29.08 68.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.643 0.777 . . . . 1.0 113.018 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.38 -59.88 3.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.39 -0.819 . . . . 1.0 109.928 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.63 -30.43 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.9 p -67.87 -44.48 76.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.577 1.081 . . . . 1.0 112.127 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.05 -25.16 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.068 0.947 . . . . 1.0 112.945 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.26 -29.14 67.34 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.216 0.916 . . . . 1.0 112.807 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -96.97 -53.71 3.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.629 1.172 . . . . 1.0 111.708 169.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -64.77 -28.85 69.86 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.207 1.188 . . . . 1.0 114.207 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.329 0 C-N-CA 123.944 0.783 . . . . 1.0 114.328 176.84 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.85 147.12 26.93 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.989 3.126 . . . . 1.0 111.376 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -127.29 156.11 75.33 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.187 1.795 . . . . 1.0 112.731 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.83 124.26 5.54 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.2 3.266 . . . . 1.0 113.677 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.11 -0.03 89.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.068 -1.407 . . . . 1.0 115.897 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.1 159.17 32.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.102 1.951 . . . . 1.0 114.241 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 124.67 34.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.615 1.166 . . . . 1.0 108.943 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.5 mt -100.34 124.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -88.68 116.33 26.86 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.52 129.86 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.165 0.986 . . . . 1.0 108.859 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 125.782 1.633 . . . . 1.0 108.997 179.041 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 110.108 -0.33 . . . . 1.0 110.108 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 144.87 25.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.818 -1.176 . . . . 1.0 110.48 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.5 154.0 44.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.423 1.489 . . . . 1.0 112.064 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.18 112.39 24.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.36 1.464 . . . . 1.0 108.426 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -83.67 133.86 34.8 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.007 -1.058 . . . . 1.0 112.091 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 38.7 pt -110.04 15.55 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -170.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -27.34 10.66 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 116.388 1.315 . . . . 1.0 116.388 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.44 13.13 26.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.359 1.063 . . . . 1.0 113.691 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.82 -4.6 83.5 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.704 1.145 . . . . 1.0 112.483 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -96.66 155.46 16.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.58 1.552 . . . . 1.0 112.906 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.82 152.69 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.601 1.56 . . . . 1.0 110.26 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.7 mt -117.83 138.11 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.14 1.376 . . . . 1.0 108.048 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -161.62 168.76 22.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.024 0.929 . . . . 1.0 110.463 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.3 tp -89.69 150.87 22.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 C-N-CA 124.871 1.268 . . . . 1.0 108.662 173.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.26 143.29 49.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.293 0.951 . . . . 1.0 111.646 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.49 124.21 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.65 157.42 42.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.13 1.372 . . . . 1.0 112.742 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -117.81 134.37 54.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.306 1.842 . . . . 1.0 110.215 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -159.38 174.89 14.05 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.993 0.917 . . . . 1.0 110.406 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.2 mtp85 -64.68 145.07 56.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.74 0.816 . . . . 1.0 110.893 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt -51.54 -52.31 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.032 0.933 . . . . 1.0 110.675 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -50.6 -50.56 53.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.004 1.322 . . . . 1.0 111.601 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.48 -43.79 89.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.256 0.623 . . . . 1.0 112.052 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.84 -40.89 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.248 1.019 . . . . 1.0 112.142 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 p -80.46 -35.29 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.947 0.794 . . . . 1.0 112.846 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.77 -130.37 47.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.877 0.762 . . . . 1.0 112.406 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.8 5.14 83.62 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.88 1.229 . . . . 1.0 114.734 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.2 m -79.19 160.13 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.611 1.206 . . . . 1.0 112.16 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.83 155.66 27.74 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.079 0.952 . . . . 1.0 111.124 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.02 163.67 33.84 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.319 1.229 . . . . 1.0 114.319 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -158.66 158.51 33.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.818 1.647 . . . . 1.0 111.283 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.4 t -86.13 134.45 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.193 0.997 . . . . 1.0 108.503 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -163.06 93.52 0.8 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.838 0.855 . . . . 1.0 111.804 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.33 109.05 10.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.37 0.668 . . . . 1.0 110.793 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.6 p -76.54 -51.5 11.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.545 1.138 . . . . 1.0 111.939 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.76 -14.18 62.86 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.463 1.105 . . . . 1.0 113.906 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.56 -30.1 62.74 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.285 1.034 . . . . 1.0 112.197 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -89.49 -6.34 56.52 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.09 1.356 . . . . 1.0 112.534 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -100.43 -49.27 4.28 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.367 1.467 . . . . 1.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.0 170.26 14.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.817 1.647 . . . . 1.0 112.505 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.64 139.75 83.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 121.317 -0.865 . . . . 1.0 108.861 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.27 143.45 77.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.473 2.782 . . . . 1.0 112.427 -170.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -86.0 162.09 47.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.368 0.667 . . . . 1.0 111.121 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.49 117.87 4.82 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.465 2.777 . . . . 1.0 111.535 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.77 -33.13 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.332 0.864 . . . . 1.0 113.332 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.06 -37.68 85.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.961 0.504 . . . . 1.0 111.37 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -34.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.535 0.734 . . . . 1.0 110.929 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.96 -43.06 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.362 0.983 . . . . 1.0 110.862 174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.48 -36.83 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.885 -1.134 . . . . 1.0 111.599 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 t -69.58 -39.86 77.09 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.455 -0.778 . . . . 1.0 111.391 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.8 p -65.53 -40.23 92.69 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.89 0.876 . . . . 1.0 111.25 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.22 -53.5 57.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 1.0 110.808 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.75 -41.23 90.54 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.561 0.744 . . . . 1.0 112.847 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -65.9 -35.36 80.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.022 0.929 . . . . 1.0 112.559 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.76 -29.72 51.15 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.042 -0.98 . . . . 1.0 113.347 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.5 t -48.03 125.41 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.477 1.489 . . . . 1.0 111.17 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.64 -13.28 62.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.448 1.499 . . . . 1.0 114.318 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -75.81 155.88 35.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.197 1.499 . . . . 1.0 110.896 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.97 148.13 45.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.868 1.267 . . . . 1.0 112.604 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.471 0.582 0 C-N-CA 126.87 2.068 . . . . 1.0 110.499 179.042 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.4 p30 . . . . . 0 CA--C 1.554 1.099 0 N-CA-C 115.274 1.583 . . . . 1.0 115.274 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.0 m -59.25 -35.0 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.718 -1.239 . . . . 1.0 114.334 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -49.19 13.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.149 1.379 . . . . 1.0 111.184 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -55.26 -35.04 64.58 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.244 1.017 . . . . 1.0 112.399 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -51.81 -51.5 55.99 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.641 -0.662 . . . . 1.0 112.494 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.35 -22.76 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.833 1.197 . . . . 1.0 113.557 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.5 p -74.79 -39.33 61.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.296 0.953 . . . . 1.0 110.922 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.97 -26.03 67.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.894 0.878 . . . . 1.0 113.127 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.05 -32.68 71.15 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 120.017 1.281 . . . . 1.0 113.247 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -89.62 -51.36 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.681 1.193 . . . . 1.0 110.978 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.21 -38.24 84.97 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.38 0.882 . . . . 1.0 113.38 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 126.962 2.22 . . . . 1.0 112.476 176.044 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 CA--C 1.545 0.781 0 CA-C-O 118.758 -0.639 . . . . 1.0 109.778 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.24 143.3 22.25 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.55 2.834 . . . . 1.0 111.387 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -115.27 160.07 35.63 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.939 1.696 . . . . 1.0 112.003 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -56.47 131.18 44.17 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.694 1.596 . . . . 1.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.97 -3.41 80.79 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.977 1.275 . . . . 1.0 114.348 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.29 149.83 38.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.101 1.45 . . . . 1.0 112.949 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.68 124.62 35.23 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.596 1.159 . . . . 1.0 109.379 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.57 130.5 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -110.66 129.5 55.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.389 2.276 . . . . 1.0 107.961 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.9 mt -125.26 120.34 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.1 1.36 . . . . 1.0 109.466 -169.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 125.377 1.471 . . . . 1.0 109.669 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 111.272 0.101 . . . . 1.0 111.272 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -141.71 153.66 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.257 -0.902 . . . . 1.0 113.286 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.07 154.87 39.9 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.751 1.22 . . . . 1.0 112.627 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.08 118.83 35.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.555 1.942 . . . . 1.0 108.443 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -82.06 130.56 35.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.186 -0.947 . . . . 1.0 112.156 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 pt -104.41 6.32 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 114.618 1.34 . . . . 1.0 114.618 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.99 -17.17 56.51 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 116.649 1.42 . . . . 1.0 116.649 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.13 13.67 26.49 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.813 1.245 . . . . 1.0 113.532 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -5.84 84.42 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.114 1.34 . . . . 1.0 112.305 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.61 156.53 16.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.867 1.667 . . . . 1.0 112.517 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -126.51 155.14 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.996 1.718 . . . . 1.0 109.888 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.54 138.47 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 168.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -159.86 175.55 12.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.324 1.05 . . . . 1.0 110.773 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.22 153.46 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.325 0.65 . . . . 1.0 109.263 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 168.721 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -141.78 142.57 33.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.014 0.926 . . . . 1.0 110.86 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.12 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -137.92 162.07 34.99 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.171 1.388 . . . . 1.0 112.595 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.6 ttp85 -112.69 136.44 52.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.287 1.835 . . . . 1.0 110.029 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.58 173.85 16.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.502 1.121 . . . . 1.0 110.557 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -66.17 143.62 57.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.763 1.625 . . . . 1.0 110.441 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 tt -52.8 -55.83 20.15 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.165 0.986 . . . . 1.0 110.478 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -52.58 -47.53 66.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.606 1.163 . . . . 1.0 111.635 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.77 -41.5 99.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.862 0.465 . . . . 1.0 111.687 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.49 -44.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.109 0.963 . . . . 1.0 112.356 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -74.6 -32.73 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 119.402 1.001 . . . . 1.0 112.768 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.54 -134.21 52.49 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.142 0.877 . . . . 1.0 112.904 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.47 0.99 87.25 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.78 1.181 . . . . 1.0 114.47 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.5 m -81.92 148.1 28.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.916 1.286 . . . . 1.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.82 156.18 39.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.387 0.675 . . . . 1.0 110.962 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -156.98 162.6 39.6 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.533 1.309 . . . . 1.0 114.533 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -160.12 165.58 31.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.262 1.825 . . . . 1.0 111.414 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.0 t -84.56 140.14 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.174 0.99 . . . . 1.0 108.836 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -146.24 74.21 1.36 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.423 1.089 . . . . 1.0 111.762 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -76.04 70.25 2.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.487 1.115 . . . . 1.0 111.312 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -60.37 -33.72 72.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.859 -1.151 . . . . 1.0 113.376 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.6 mt -71.47 -9.74 58.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.28 -34.56 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.467 1.107 . . . . 1.0 112.181 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.274 1.43 . . . . 1.0 112.741 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -104.43 -47.82 4.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.263 1.425 . . . . 1.0 112.576 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -131.15 156.33 45.46 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.899 1.28 . . . . 1.0 113.532 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.62 155.37 92.53 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.192 -0.909 . . . . 1.0 110.021 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.63 129.76 36.69 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.763 2.976 . . . . 1.0 114.926 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 159.33 85.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.48 1.112 . . . . 1.0 111.704 169.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.43 109.91 2.96 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.462 2.775 . . . . 1.0 110.151 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 p -52.89 -37.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.176 1.547 . . . . 1.0 115.176 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.524 0.602 . . . . 1.0 111.598 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 t -75.85 -31.67 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.706 0.802 . . . . 1.0 110.931 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.1 mt -64.46 -49.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.732 1.151 . . . . 1.0 109.976 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.44 -40.27 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.373 1.069 . . . . 1.0 110.667 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.2 m -68.56 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.523 -0.736 . . . . 1.0 111.981 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.4 m -63.26 -44.08 96.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.696 1.198 . . . . 1.0 110.763 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.64 77.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.433 0.693 . . . . 1.0 111.051 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -61.84 -38.36 87.91 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.147 -0.971 . . . . 1.0 113.173 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -66.09 -34.16 77.43 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.609 0.764 . . . . 1.0 112.307 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.4 mmm -74.83 -37.9 62.16 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.316 -0.85 . . . . 1.0 112.872 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.7 t -47.09 129.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.711 1.142 . . . . 1.0 111.684 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -16.43 60.57 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.934 1.73 . . . . 1.0 114.068 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -83.01 148.88 27.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.047 1.424 . . . . 1.0 111.267 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.1 156.61 17.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.151 1.38 . . . . 1.0 113.372 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.477 0.898 0 C-N-CA 125.934 1.694 . . . . 1.0 111.974 179.857 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 112.474 0.546 . . . . 1.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.8 m -69.56 -39.19 77.55 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.501 1.046 . . . . 1.0 112.85 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -57.57 -56.92 15.65 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.718 0.69 . . . . 1.0 109.255 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -58.61 -30.12 66.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.798 0.839 . . . . 1.0 113.128 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -67.23 -56.41 9.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.214 -0.928 . . . . 1.0 111.039 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.51 -26.12 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 -172.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.4 p -65.87 -44.65 84.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.703 1.138 . . . . 1.0 110.76 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.39 -24.57 66.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.339 0.866 . . . . 1.0 113.339 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.8 mt -61.77 -30.42 70.78 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.203 1.365 . . . . 1.0 112.835 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -94.06 -56.37 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.319 1.447 . . . . 1.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -65.98 -39.06 90.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.764 -1.21 . . . . 1.0 113.359 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.101 0 C-N-CA 126.404 1.954 . . . . 1.0 113.42 -179.269 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 CA--C 1.546 0.801 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.75 150.28 27.23 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.185 2.59 . . . . 1.0 112.441 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -126.44 158.92 65.62 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.138 1.775 . . . . 1.0 112.31 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -46.37 127.75 11.58 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.332 3.354 . . . . 1.0 113.083 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.56 -8.21 77.08 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.987 1.28 . . . . 1.0 115.126 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -67.55 143.55 56.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.251 1.525 . . . . 1.0 113.573 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.62 127.25 34.42 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.976 1.31 . . . . 1.0 108.155 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mt -112.63 131.19 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -102.85 138.77 39.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.558 1.143 . . . . 1.0 109.082 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.24 134.9 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.557 1.943 . . . . 1.0 108.396 -169.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.283 . . . . 1.0 109.243 -175.491 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -138.92 160.49 39.61 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.676 -1.265 . . . . 1.0 112.252 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.95 152.83 33.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.729 0.812 . . . . 1.0 112.756 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.9 116.06 31.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.672 1.989 . . . . 1.0 106.995 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -82.24 129.67 34.9 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.59 -0.694 . . . . 1.0 111.91 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.92 4.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 -170.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.01 163.73 31.11 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 124.598 1.094 . . . . 1.0 113.08 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 t70 60.8 20.06 10.22 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.02 1.728 . . . . 1.0 114.312 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.7 71.68 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.551 1.548 . . . . 1.0 114.625 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.42 153.8 18.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.585 1.693 . . . . 1.0 113.951 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.4 157.76 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.58 1.552 . . . . 1.0 111.58 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.8 mt -121.0 141.07 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.754 1.622 . . . . 1.0 108.183 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -154.52 163.19 40.57 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.063 -1.023 . . . . 1.0 110.92 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.8 tp -104.92 119.41 38.95 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 1.0 108.752 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 118.174 -0.917 . . . . 1.0 110.11 -175.455 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 110.37 -0.233 . . . . 1.0 110.37 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.39 138.49 34.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.823 0.849 . . . . 1.0 111.412 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.74 129.03 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -134.98 156.46 49.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.675 1.59 . . . . 1.0 112.025 -173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -117.8 140.11 50.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.062 1.745 . . . . 1.0 110.331 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -164.59 -179.97 6.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.561 1.144 . . . . 1.0 110.846 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.06 143.97 52.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.295 1.038 . . . . 1.0 110.476 170.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.7 tt -49.8 -56.87 8.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.912 1.285 . . . . 1.0 110.831 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.05 -49.17 63.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.509 1.124 . . . . 1.0 111.256 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.07 -34.05 76.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.33 0.652 . . . . 1.0 112.69 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.73 -45.58 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.903 0.881 . . . . 1.0 111.951 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -81.5 -32.97 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.516 1.053 . . . . 1.0 113.832 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.67 -123.64 32.37 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.54 1.063 . . . . 1.0 111.256 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.73 2.07 85.76 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.646 1.117 . . . . 1.0 114.719 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.12 147.49 34.6 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.723 1.261 . . . . 1.0 111.755 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 23.9 t -75.16 156.97 35.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.68 0.792 . . . . 1.0 110.952 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.93 161.82 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -161.06 160.17 30.16 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.708 1.603 . . . . 1.0 111.862 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.3 t -79.68 139.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.941 0.897 . . . . 1.0 109.334 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -149.26 79.06 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.439 1.096 . . . . 1.0 111.401 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.22 72.29 4.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.58 1.152 . . . . 1.0 110.89 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.9 p -67.85 -46.18 72.49 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.591 1.156 . . . . 1.0 112.79 -172.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.8 mt -75.58 -8.35 56.54 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -174.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.86 -27.46 68.14 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.96 0.886 . . . . 1.0 113.128 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -79.39 -15.4 57.91 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.429 1.492 . . . . 1.0 112.288 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -102.03 -39.93 7.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.556 1.543 . . . . 1.0 112.237 -174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -126.98 160.7 30.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.732 1.613 . . . . 1.0 113.159 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -66.06 159.19 72.52 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.545 1.138 . . . . 1.0 111.342 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.43 127.03 19.79 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.667 2.245 . . . . 1.0 110.796 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -95.34 157.38 36.4 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.134 1.374 . . . . 1.0 110.181 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.51 111.2 2.9 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.86 2.373 . . . . 1.0 110.674 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.93 -32.52 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.612 1.165 . . . . 1.0 112.815 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.18 -36.81 75.97 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.049 0.54 . . . . 1.0 112.237 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.58 -37.81 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.817 0.847 . . . . 1.0 110.776 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.83 -48.69 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 1.0 110.156 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.7 mt -68.33 -39.27 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.258 1.023 . . . . 1.0 111.836 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -61.17 -42.87 99.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.419 1.009 . . . . 1.0 111.42 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 -43.67 98.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 1.0 111.756 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.11 73.93 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.328 -0.857 . . . . 1.0 110.746 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.13 -38.29 88.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.311 1.044 . . . . 1.0 113.203 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.97 -36.34 83.06 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.585 0.754 . . . . 1.0 112.117 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.0 mmm -73.22 -38.36 66.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.881 0.873 . . . . 1.0 112.752 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.95 129.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.167 0.894 . . . . 1.0 111.606 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.52 66.51 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.711 1.624 . . . . 1.0 113.479 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -87.14 145.38 26.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.961 1.38 . . . . 1.0 111.477 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -95.32 148.27 22.61 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.761 1.224 . . . . 1.0 112.399 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.476 0.863 0 C-N-CA 125.522 1.529 . . . . 1.0 112.001 -173.429 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.6 t30 . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 120.51 0.195 . . . . 1.0 111.391 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.99 -40.04 60.91 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.914 1.079 . . . . 1.0 113.914 -169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -49.56 76.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.196 0.453 . . . . 1.0 110.18 170.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -61.52 -36.59 80.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.958 0.903 . . . . 1.0 111.814 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.05 -57.22 13.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.866 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.96 -28.13 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.828 1.194 . . . . 1.0 113.637 -173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.6 p -71.75 -39.72 69.82 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.846 1.203 . . . . 1.0 112.582 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -57.46 -26.62 61.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.812 0.845 . . . . 1.0 112.484 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.4 mt -62.31 -31.45 72.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.296 0.953 . . . . 1.0 112.719 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -88.75 -55.82 3.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.548 1.139 . . . . 1.0 111.18 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -65.37 -35.9 82.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -171.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 C-N-CA 126.923 2.201 . . . . 1.0 112.282 175.548 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -86.63 155.82 9.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.986 3.79 . . . . 1.0 112.471 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.09 168.3 17.24 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.812 2.045 . . . . 1.0 112.476 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -50.16 127.23 19.18 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.608 2.872 . . . . 1.0 113.402 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.5 -2.84 86.5 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.341 -1.255 . . . . 1.0 115.011 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -75.01 148.17 40.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.678 1.739 . . . . 1.0 113.011 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -93.96 129.89 40.26 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.203 1.401 . . . . 1.0 110.177 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.45 133.09 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.174 0.99 . . . . 1.0 108.94 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.49 128.34 52.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.683 1.593 . . . . 1.0 108.69 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.4 mt -130.29 124.17 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.65 1.18 . . . . 1.0 110.257 -169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 125.172 1.389 . . . . 1.0 108.6 173.417 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 . . . . . 0 CA--C 1.546 0.81 0 CA-C-O 120.523 0.201 . . . . 1.0 110.61 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -140.24 148.94 42.25 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.301 -0.874 . . . . 1.0 111.811 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.66 149.79 36.28 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.532 0.938 . . . . 1.0 113.532 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.28 119.2 38.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.524 2.33 . . . . 1.0 107.484 169.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -82.58 132.81 35.19 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.058 -1.026 . . . . 1.0 112.137 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.69 2.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.102 1.519 . . . . 1.0 115.102 -170.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 169.86 38.81 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.265 0.936 . . . . 1.0 112.756 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.99 16.04 7.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.204 1.802 . . . . 1.0 114.031 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.02 2.99 73.85 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 124.997 1.284 . . . . 1.0 114.717 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -101.89 154.32 19.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.812 1.806 . . . . 1.0 114.454 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.65 153.76 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.588 1.555 . . . . 1.0 111.36 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.64 138.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 168.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -153.53 176.3 12.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.615 1.166 . . . . 1.0 109.85 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -126.53 122.0 33.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.119 0.872 . . . . 1.0 108.78 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 118.075 -0.964 . . . . 1.0 109.775 -173.434 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -150.08 139.99 21.9 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.417 -0.802 . . . . 1.0 111.376 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.71 124.63 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.83 159.16 39.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.073 1.749 . . . . 1.0 112.77 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ttm105 -112.71 143.56 43.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.684 1.594 . . . . 1.0 110.245 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.86 176.77 9.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.351 1.46 . . . . 1.0 109.564 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -71.67 143.61 49.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.575 1.55 . . . . 1.0 110.008 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.91 -56.82 7.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.891 1.276 . . . . 1.0 110.275 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -53.56 -45.6 69.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.6 1.16 . . . . 1.0 111.812 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.99 -45.1 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.746 0.418 . . . . 1.0 111.297 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.63 -43.17 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.841 0.856 . . . . 1.0 111.745 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.47 -0.5 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.69 121.62 25.57 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.177 0.894 . . . . 1.0 111.306 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 10.99 85.92 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.294 0.95 . . . . 1.0 114.343 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 m -125.52 165.63 18.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.653 1.581 . . . . 1.0 112.413 -173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.6 m -111.98 150.94 29.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.193 1.397 . . . . 1.0 108.183 168.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.9 153.18 30.7 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.291 1.96 . . . . 1.0 116.291 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -132.31 151.51 51.81 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.379 2.271 . . . . 1.0 109.734 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.92 133.52 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.945 1.298 . . . . 1.0 107.625 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.94 85.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.058 0.932 . . . . 1.0 113.262 -169.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -79.11 46.99 0.75 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.203 1.401 . . . . 1.0 112.18 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.2 m -62.0 -24.43 67.04 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.593 -1.317 . . . . 1.0 113.293 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -61.99 -14.88 39.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.47 -33.81 46.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.917 1.287 . . . . 1.0 112.417 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -97.05 5.67 49.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.898 0.879 . . . . 1.0 113.222 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.32 -49.97 3.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.398 1.479 . . . . 1.0 111.204 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -126.52 167.46 15.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.802 1.641 . . . . 1.0 112.877 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -71.0 155.12 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 121.434 -0.791 . . . . 1.0 111.13 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.71 135.89 71.64 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.852 3.034 . . . . 1.0 113.075 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -113.39 148.28 39.29 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.27 1.428 . . . . 1.0 109.753 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.66 122.26 7.24 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.41 2.74 . . . . 1.0 111.536 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.28 -32.61 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.717 1.207 . . . . 1.0 113.198 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.39 -36.22 79.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.749 0.704 . . . . 1.0 112.061 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.27 -34.17 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.227 0.611 . . . . 1.0 111.065 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -64.66 -47.6 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.541 0.61 . . . . 1.0 110.049 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.02 -38.34 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.126 0.971 . . . . 1.0 111.399 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -41.38 96.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.928 0.786 . . . . 1.0 111.842 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.5 t -64.21 -42.36 96.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.738 0.815 . . . . 1.0 111.197 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.7 -48.39 77.81 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.212 -0.93 . . . . 1.0 110.855 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.91 -22.21 65.96 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.434 1.494 . . . . 1.0 114.529 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.5 -40.06 30.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.449 1.1 . . . . 1.0 111.621 170.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.6 mmm -75.45 -38.13 59.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.336 1.055 . . . . 1.0 112.688 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.71 135.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.186 0.81 . . . . 1.0 113.186 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.44 -16.17 61.68 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.806 1.67 . . . . 1.0 113.826 -174.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -84.04 146.9 27.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.154 1.477 . . . . 1.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.49 156.67 16.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.521 1.529 . . . . 1.0 112.271 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 125.264 1.426 . . . . 1.0 112.376 176.003 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 112.275 0.472 . . . . 1.0 112.275 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.3 m -55.26 -43.92 75.09 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.397 1.629 . . . . 1.0 115.397 -169.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.36 -41.2 96.85 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.552 0.614 . . . . 1.0 111.685 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -69.44 -37.05 77.2 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.257 -0.902 . . . . 1.0 110.851 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.11 -58.2 9.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.429 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.74 -25.35 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.914 1.234 . . . . 1.0 112.263 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -63.85 -48.76 75.46 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.157 0.983 . . . . 1.0 111.461 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -61.6 -27.59 68.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.583 1.153 . . . . 1.0 112.986 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.2 -34.41 72.13 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.598 1.09 . . . . 1.0 112.946 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.9 ttm105 -94.36 -51.15 4.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.605 1.162 . . . . 1.0 111.717 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.43 -29.96 70.21 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.115 -0.991 . . . . 1.0 113.665 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 C-N-CA 124.945 1.26 . . . . 1.0 114.3 176.062 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 118.753 -0.641 . . . . 1.0 110.042 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.84 148.3 25.16 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.072 2.514 . . . . 1.0 112.269 -177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -121.12 161.05 42.68 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.302 1.841 . . . . 1.0 111.346 171.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.59 132.07 49.91 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.431 2.088 . . . . 1.0 110.815 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.09 -1.39 73.76 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.322 -1.266 . . . . 1.0 114.835 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -76.53 149.38 36.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.442 1.621 . . . . 1.0 113.283 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.59 128.72 37.53 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.58 1.152 . . . . 1.0 108.93 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.4 mt -109.16 131.14 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -99.62 133.79 43.45 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.904 1.681 . . . . 1.0 108.231 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.8 mt -122.11 120.33 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.732 1.613 . . . . 1.0 108.322 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 125.152 1.381 . . . . 1.0 109.793 -179.421 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 119.637 -0.22 . . . . 1.0 111.492 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.12 158.3 44.27 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 154.89 39.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.973 1.309 . . . . 1.0 112.694 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.77 120.61 36.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.172 1.789 . . . . 1.0 108.135 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -82.97 134.92 35.04 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.903 -1.123 . . . . 1.0 112.229 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.1 pt -118.73 4.33 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 -171.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 168.34 37.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.348 0.975 . . . . 1.0 112.861 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t70 62.91 16.1 8.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.125 1.77 . . . . 1.0 113.899 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 -0.98 81.07 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.121 1.343 . . . . 1.0 114.478 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -96.43 154.56 17.2 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.396 1.598 . . . . 1.0 114.366 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.86 159.5 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.104 1.762 . . . . 1.0 111.02 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -120.18 137.4 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 106.651 -1.611 . . . . 1.0 106.651 168.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.57 174.95 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.214 1.006 . . . . 1.0 110.552 -169.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.14 151.92 20.78 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.965 -0.459 . . . . 1.0 110.033 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 168.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 120.352 0.12 . . . . 1.0 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.87 145.15 49.39 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.765 0.826 . . . . 1.0 110.973 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -75.72 127.93 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -137.62 161.69 35.79 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.669 1.188 . . . . 1.0 112.711 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -115.51 138.89 50.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.814 2.046 . . . . 1.0 110.138 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.09 176.93 8.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.991 1.316 . . . . 1.0 110.361 170.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -67.64 142.11 56.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.086 1.754 . . . . 1.0 110.377 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.7 tp -51.9 -52.54 49.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.975 0.91 . . . . 1.0 111.711 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -55.36 -47.51 75.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.165 0.986 . . . . 1.0 111.153 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.38 -39.61 94.99 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.783 0.433 . . . . 1.0 111.94 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.69 -45.39 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.545 1.138 . . . . 1.0 111.583 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.37 -35.36 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.716 1.144 . . . . 1.0 112.834 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.78 -124.16 32.13 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.331 0.969 . . . . 1.0 111.533 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.08 -0.19 87.25 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.601 1.096 . . . . 1.0 114.623 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.52 148.61 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.648 1.179 . . . . 1.0 110.974 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.95 165.92 23.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.438 0.695 . . . . 1.0 111.318 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -161.45 164.95 29.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -160.34 161.0 33.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.535 1.534 . . . . 1.0 112.015 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.03 131.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -140.68 60.3 1.53 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.744 1.259 . . . . 1.0 109.842 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.65 67.55 8.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.311 1.445 . . . . 1.0 111.577 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 p -68.48 -21.31 64.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.314 1.445 . . . . 1.0 114.463 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.1 mt -65.78 -14.07 60.65 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.674 0.99 . . . . 1.0 113.674 -172.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -33.33 53.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 1.0 112.255 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.17 -17.48 49.58 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.32 1.448 . . . . 1.0 112.622 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -98.19 -47.2 5.56 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.035 1.334 . . . . 1.0 111.996 -170.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -128.43 162.38 27.28 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.103 1.361 . . . . 1.0 113.458 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -69.97 159.77 82.94 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 118.377 -0.82 . . . . 1.0 110.358 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.45 156.5 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.285 3.323 . . . . 1.0 115.559 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 154.95 71.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.513 1.525 . . . . 1.0 112.182 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.24 123.27 5.5 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.046 3.164 . . . . 1.0 111.992 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.07 -35.42 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.454 1.102 . . . . 1.0 113.934 -170.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.9 -37.37 79.21 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.765 0.826 . . . . 1.0 111.788 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.94 -34.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.455 -0.778 . . . . 1.0 110.664 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mt -64.35 -48.21 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 118.813 0.733 . . . . 1.0 109.997 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -39.79 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.572 1.149 . . . . 1.0 111.108 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -66.18 -43.35 87.13 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.282 -0.886 . . . . 1.0 111.947 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.16 -44.44 92.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.598 1.159 . . . . 1.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.919 0.781 . . . . 1.0 110.672 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.16 -39.6 90.73 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.245 -0.91 . . . . 1.0 113.161 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.75 -34.22 77.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.79 0.836 . . . . 1.0 112.29 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.4 mmm -74.9 -36.07 62.23 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.383 -0.818 . . . . 1.0 112.934 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.4 t -46.33 129.67 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 1.0 112.008 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.54 -16.05 61.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.951 1.739 . . . . 1.0 114.041 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -84.47 143.69 29.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.081 1.441 . . . . 1.0 111.401 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -94.33 146.61 23.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.919 1.288 . . . . 1.0 112.393 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 125.591 1.556 . . . . 1.0 112.088 -170.331 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 113.78 1.029 . . . . 1.0 113.78 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.9 p -60.84 -61.22 2.74 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.333 1.453 . . . . 1.0 113.563 172.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.98 -46.71 87.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.772 0.829 . . . . 1.0 111.126 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -59.25 -46.53 88.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.107 0.412 . . . . 1.0 111.288 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -55.31 -59.21 5.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.493 0.717 . . . . 1.0 111.308 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.18 -26.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.997 0.817 . . . . 1.0 112.372 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.0 m -66.02 -49.45 67.7 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.344 1.057 . . . . 1.0 111.237 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.51 -29.77 68.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.904 0.882 . . . . 1.0 112.509 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.81 -33.82 74.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.295 0.85 . . . . 1.0 113.295 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -98.29 -42.78 7.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.777 1.231 . . . . 1.0 112.374 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -67.07 -50.82 60.46 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.856 -1.152 . . . . 1.0 112.092 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.199 0 C-N-CA 126.412 1.958 . . . . 1.0 114.222 -174.56 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 118.742 -0.647 . . . . 1.0 109.807 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.06 153.47 16.74 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.526 2.817 . . . . 1.0 112.728 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -128.61 162.65 49.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.54 1.936 . . . . 1.0 112.431 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -43.99 127.12 6.55 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 124.396 3.397 . . . . 1.0 113.093 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 2.33 87.95 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 118.354 -1.248 . . . . 1.0 115.422 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.71 146.14 42.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.739 1.77 . . . . 1.0 112.947 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.07 122.61 33.21 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.387 -1.338 . . . . 1.0 107.387 169.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -101.98 132.24 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -109.91 132.1 54.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.799 2.04 . . . . 1.0 107.951 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mt -127.42 123.77 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.78 1.232 . . . . 1.0 109.195 -169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 124.829 1.252 . . . . 1.0 110.172 174.801 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 119.701 -0.19 . . . . 1.0 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -138.56 155.32 48.47 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.088 -1.007 . . . . 1.0 113.206 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.1 153.4 40.65 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.424 1.489 . . . . 1.0 112.309 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.55 118.26 34.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.049 1.74 . . . . 1.0 108.205 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -84.19 130.9 34.81 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.449 1.022 . . . . 1.0 112.545 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -113.43 0.79 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 114.87 1.433 . . . . 1.0 114.87 -170.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.17 168.04 34.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.357 0.979 . . . . 1.0 112.881 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.74 16.3 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.212 1.805 . . . . 1.0 114.082 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.56 6.49 77.08 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.133 1.349 . . . . 1.0 114.274 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -103.83 154.5 19.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.352 1.576 . . . . 1.0 113.94 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.67 161.52 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.381 1.873 . . . . 1.0 111.229 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.59 137.61 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -161.98 169.96 20.18 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.208 -0.933 . . . . 1.0 110.537 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.9 mt -88.15 151.59 22.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.874 -0.516 . . . . 1.0 109.745 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.82 0 C-N-CA 125.685 1.594 . . . . 1.0 109.88 171.53 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 119.794 -0.146 . . . . 1.0 110.725 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.07 138.59 36.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.192 0.997 . . . . 1.0 110.595 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.1 t -77.63 123.2 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -127.38 155.01 44.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.417 1.487 . . . . 1.0 112.395 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -104.03 128.79 51.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.858 1.663 . . . . 1.0 108.291 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -157.24 166.07 34.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.45 0.568 . . . . 1.0 111.552 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -76.06 137.62 40.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.82 1.648 . . . . 1.0 110.743 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.32 -55.55 17.8 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.891 1.277 . . . . 1.0 110.952 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -55.01 -44.61 74.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.391 1.076 . . . . 1.0 111.721 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.14 -42.3 93.96 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.451 0.3 . . . . 1.0 111.521 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.92 -39.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.8 1.24 . . . . 1.0 112.244 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.6 m -85.58 -0.74 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.471 1.108 . . . . 1.0 113.776 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.28 126.72 36.51 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.322 0.963 . . . . 1.0 112.082 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.37 6.29 79.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.294 0.949 . . . . 1.0 114.194 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.9 m -122.52 -179.51 4.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.686 1.994 . . . . 1.0 110.783 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.07 156.99 39.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.392 1.477 . . . . 1.0 108.119 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -155.01 164.89 38.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.403 1.631 . . . . 1.0 115.403 -171.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -158.56 160.27 36.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.758 2.023 . . . . 1.0 110.944 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -88.14 129.05 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 168.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -131.66 54.58 1.92 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.502 1.144 . . . . 1.0 110.165 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.28 71.46 7.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.896 1.279 . . . . 1.0 111.329 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.2 p -73.56 -43.47 59.78 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.835 1.254 . . . . 1.0 113.681 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.79 -17.17 63.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.29 -28.13 51.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.126 1.37 . . . . 1.0 112.898 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -91.44 -20.44 21.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.375 1.47 . . . . 1.0 112.536 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -86.99 -36.24 18.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.412 1.085 . . . . 1.0 112.516 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -120.25 170.42 9.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.319 1.448 . . . . 1.0 112.355 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -66.35 144.8 98.86 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.437 -0.79 . . . . 1.0 109.557 171.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.41 134.16 46.81 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.86 2.373 . . . . 1.0 111.653 -169.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -93.81 151.65 40.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.069 1.348 . . . . 1.0 110.676 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.17 111.41 3.07 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.5 2.8 . . . . 1.0 110.858 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.72 -32.66 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.179 1.177 . . . . 1.0 114.179 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.73 -35.72 75.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.268 0.627 . . . . 1.0 112.16 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.6 -40.55 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.884 0.874 . . . . 1.0 110.722 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.3 mt -59.8 -46.74 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.762 0.71 . . . . 1.0 110.26 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.7 mt -69.18 -35.36 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.3 1.04 . . . . 1.0 111.627 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.3 m -64.34 -43.48 94.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.278 -0.889 . . . . 1.0 111.615 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.7 m -59.8 -43.77 94.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.303 1.041 . . . . 1.0 111.508 172.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.35 73.58 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.188 -0.945 . . . . 1.0 111.358 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -62.38 -38.11 88.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.301 1.041 . . . . 1.0 112.953 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.6 -35.3 79.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.84 0.856 . . . . 1.0 112.07 173.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.5 mmm -74.0 -37.54 64.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.376 -0.821 . . . . 1.0 112.85 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.9 t -46.68 130.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 119.359 0.981 . . . . 1.0 111.678 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.35 -14.04 65.73 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.567 1.556 . . . . 1.0 114.095 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -87.27 158.8 19.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.9 1.35 . . . . 1.0 111.413 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -120.25 148.61 43.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.148 1.379 . . . . 1.0 112.334 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 78.7 mtm . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 124.863 1.265 . . . . 1.0 112.161 179.777 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.3 m120 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.6 m -65.19 -40.68 94.54 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.31 0.959 . . . . 1.0 112.741 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -59.64 -53.11 61.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.111 0.964 . . . . 1.0 109.888 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.38 -45.75 87.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.813 0.445 . . . . 1.0 111.566 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -52.21 -60.09 3.61 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.861 0.865 . . . . 1.0 111.004 172.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -32.65 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.33 0.968 . . . . 1.0 113.017 -172.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -71.17 -38.87 72.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.647 0.779 . . . . 1.0 112.254 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -60.62 -26.55 67.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.997 0.817 . . . . 1.0 112.813 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.75 -26.54 68.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.868 1.213 . . . . 1.0 112.592 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -93.71 -53.31 4.08 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.657 1.583 . . . . 1.0 111.798 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -73.21 -38.94 65.92 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 C-N-CA 125.229 1.395 . . . . 1.0 112.292 175.524 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 118.588 -0.72 . . . . 1.0 110.089 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.23 144.58 26.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.562 2.841 . . . . 1.0 112.088 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -129.48 160.57 63.71 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.861 1.664 . . . . 1.0 112.846 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -47.59 129.03 16.3 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.815 3.01 . . . . 1.0 112.822 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -8.84 73.79 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.074 1.321 . . . . 1.0 114.172 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -68.59 139.34 55.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.968 1.384 . . . . 1.0 112.541 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.55 126.95 35.8 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.879 1.272 . . . . 1.0 108.905 170.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.3 131.93 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.44 138.45 39.34 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.187 1.395 . . . . 1.0 108.784 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mt -133.14 113.99 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.226 1.01 . . . . 1.0 109.174 -173.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 125.474 1.51 . . . . 1.0 111.205 -169.58 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.034 0.445 . . . . 1.0 110.472 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -137.37 150.19 47.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.204 1.001 . . . . 1.0 110.546 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 152.1 44.37 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.312 1.045 . . . . 1.0 112.598 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.33 116.86 33.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.197 1.799 . . . . 1.0 107.921 170.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -79.89 132.24 36.04 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.326 -0.859 . . . . 1.0 111.716 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.2 pt -114.89 -3.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -171.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.57 166.31 24.48 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 124.717 1.151 . . . . 1.0 113.008 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 62.69 18.37 10.54 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.082 1.753 . . . . 1.0 113.867 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.75 85.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.446 1.498 . . . . 1.0 114.281 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -94.2 153.12 18.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.425 1.613 . . . . 1.0 114.252 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -133.54 157.87 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.004 1.721 . . . . 1.0 111.006 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -115.58 138.68 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.396 1.478 . . . . 1.0 107.13 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -155.43 150.95 27.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.723 0.809 . . . . 1.0 111.75 -168.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -84.38 121.49 27.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 124.492 1.117 . . . . 1.0 112.239 -169.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 110.579 -0.156 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.12 137.49 54.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.94 0.896 . . . . 1.0 109.989 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.77 124.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -132.05 163.81 27.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.414 1.486 . . . . 1.0 111.999 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -117.51 137.11 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.007 1.723 . . . . 1.0 110.077 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.05 177.74 10.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.822 1.249 . . . . 1.0 111.214 171.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.0 141.62 49.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.123 0.969 . . . . 1.0 111.604 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 tp -51.19 -52.82 40.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.308 1.043 . . . . 1.0 112.19 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.84 -48.22 73.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.086 0.954 . . . . 1.0 111.287 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.53 -35.02 79.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.083 0.553 . . . . 1.0 112.083 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.84 -45.23 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.17 0.988 . . . . 1.0 112.293 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.43 -34.47 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 119.585 1.084 . . . . 1.0 112.818 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.27 -131.11 49.68 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 119.151 0.887 . . . . 1.0 112.192 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.88 -3.73 85.38 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.652 1.12 . . . . 1.0 114.481 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.0 m -74.99 149.59 39.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.166 1.387 . . . . 1.0 111.433 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.5 t -72.05 154.43 41.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.007 0.523 . . . . 1.0 110.78 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -158.85 163.59 36.5 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.688 0.995 . . . . 1.0 113.688 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -159.81 157.46 29.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.83 1.252 . . . . 1.0 113.371 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.8 t -82.47 138.06 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.446 -1.316 . . . . 1.0 107.446 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -152.65 84.77 1.24 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 1.0 111.394 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.04 53.54 2.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.759 1.224 . . . . 1.0 111.847 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 p -58.73 -34.65 71.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.985 1.314 . . . . 1.0 113.159 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.65 -17.85 65.06 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.253 -0.905 . . . . 1.0 112.899 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.82 -25.9 68.38 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.126 0.876 . . . . 1.0 112.631 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.64 12.9 36.42 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.532 1.133 . . . . 1.0 111.949 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -109.8 -44.35 3.84 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.589 1.555 . . . . 1.0 111.754 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -131.41 168.32 17.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.593 1.557 . . . . 1.0 113.609 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -66.78 160.13 70.64 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.308 1.043 . . . . 1.0 112.471 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.77 152.33 35.71 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.405 3.403 . . . . 1.0 113.489 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -129.14 153.99 80.44 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.83 1.652 . . . . 1.0 111.042 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.75 111.45 3.25 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.205 2.604 . . . . 1.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.94 -31.86 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.193 0.997 . . . . 1.0 113.086 -169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.36 -36.98 76.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.731 0.696 . . . . 1.0 112.1 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 t -71.56 -34.41 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.057 0.943 . . . . 1.0 110.7 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.1 mt -66.13 -48.32 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.536 0.735 . . . . 1.0 109.982 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -42.62 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.702 1.201 . . . . 1.0 110.853 173.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -65.26 -40.92 94.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 1.0 111.384 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.8 m -63.48 -42.5 98.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.06 0.944 . . . . 1.0 111.804 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.4 77.98 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.559 -0.713 . . . . 1.0 110.29 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.47 -39.83 92.31 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.15 -0.969 . . . . 1.0 113.149 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.64 -32.9 74.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.905 0.882 . . . . 1.0 112.631 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -74.34 -37.25 63.6 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.33 -0.843 . . . . 1.0 112.815 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.8 t -47.57 127.54 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.726 1.148 . . . . 1.0 111.373 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.75 -16.47 59.58 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.006 1.765 . . . . 1.0 113.818 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -85.04 157.58 20.69 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.741 1.271 . . . . 1.0 111.067 176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.27 153.99 36.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.867 1.267 . . . . 1.0 113.214 -172.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.2 mtt . . . . . 0 N--CA 1.474 0.775 0 C-N-CA 126.243 1.817 . . . . 1.0 111.77 -178.814 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.7 t30 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -63.52 -36.71 84.68 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.325 -1.484 . . . . 1.0 113.022 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.46 -58.8 6.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.576 0.75 . . . . 1.0 109.963 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -52.83 -32.57 45.02 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.814 1.245 . . . . 1.0 113.419 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.91 -57.54 10.46 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.093 -1.004 . . . . 1.0 110.786 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.37 -28.29 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.902 1.075 . . . . 1.0 113.902 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.79 -42.5 90.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.539 1.063 . . . . 1.0 111.872 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -58.01 -29.37 65.25 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 1.0 112.813 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.21 -32.04 70.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.793 0.837 . . . . 1.0 112.652 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -94.42 -51.37 4.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 1.0 111.43 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -62.88 -32.07 73.25 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 -169.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.245 0 C-N-CA 123.883 0.754 . . . . 1.0 114.272 -179.543 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 CA--C 1.545 0.75 0 CA-C-O 118.668 -0.682 . . . . 1.0 109.638 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.22 146.53 17.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.817 3.012 . . . . 1.0 111.614 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.97 161.02 62.29 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.637 1.575 . . . . 1.0 112.583 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -46.74 128.58 13.33 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.942 3.095 . . . . 1.0 112.99 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.81 -7.88 80.59 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.265 -1.297 . . . . 1.0 115.18 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.05 143.91 54.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.666 1.733 . . . . 1.0 113.761 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.42 128.11 33.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.52 1.528 . . . . 1.0 107.922 169.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.56 129.38 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.629 1.171 . . . . 1.0 108.162 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -100.15 125.08 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.316 1.447 . . . . 1.0 107.676 170.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.3 mt -120.92 119.9 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.559 1.143 . . . . 1.0 109.167 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 125.741 1.616 . . . . 1.0 110.514 -175.888 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -136.39 145.2 45.07 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.738 0.815 . . . . 1.0 111.508 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 156.81 45.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.303 1.041 . . . . 1.0 112.515 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.95 116.32 32.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.538 1.935 . . . . 1.0 107.713 172.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -81.91 130.73 35.16 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.335 -0.853 . . . . 1.0 111.845 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.85 3.66 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.5 167.48 35.3 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.529 1.062 . . . . 1.0 112.584 -174.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 61.38 20.02 10.75 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.952 1.701 . . . . 1.0 113.813 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.99 -1.04 87.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.585 1.564 . . . . 1.0 114.458 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -91.68 151.72 20.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.595 1.698 . . . . 1.0 114.492 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.53 154.23 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.402 1.481 . . . . 1.0 111.155 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.8 mt -112.23 136.02 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -155.16 150.09 26.71 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.138 -0.977 . . . . 1.0 111.866 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.07 133.05 33.92 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.666 0 C-N-CA 125.114 1.366 . . . . 1.0 110.491 -175.97 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 119.552 -0.261 . . . . 1.0 110.675 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.23 139.44 53.78 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.272 1.029 . . . . 1.0 110.76 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.11 125.85 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.21 162.3 30.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.149 1.779 . . . . 1.0 111.986 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -120.69 126.28 49.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.819 1.648 . . . . 1.0 110.672 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -147.98 174.14 12.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.173 1.389 . . . . 1.0 110.681 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.74 137.37 38.43 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.109 -0.994 . . . . 1.0 110.744 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.79 -42.75 84.81 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.228 -0.92 . . . . 1.0 111.643 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.04 -46.42 75.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.774 . . . . 1.0 111.402 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.97 -42.94 80.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.671 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.15 -42.58 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 1.0 111.664 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.55 -2.31 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.813 1.245 . . . . 1.0 113.831 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.76 123.78 33.21 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.048 -1.033 . . . . 1.0 111.797 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.99 5.51 86.93 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.66 1.124 . . . . 1.0 114.757 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -126.31 -160.86 1.01 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.512 2.325 . . . . 1.0 110.436 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.2 t -148.87 171.8 15.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.266 1.826 . . . . 1.0 109.349 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -152.76 158.91 42.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.743 1.386 . . . . 1.0 114.743 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.98 150.29 39.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.362 1.865 . . . . 1.0 110.483 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.1 t -82.65 134.6 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -148.63 67.23 1.06 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.797 0.839 . . . . 1.0 112.197 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -72.61 82.62 1.12 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.37 1.068 . . . . 1.0 111.643 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -69.6 -38.33 77.25 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.148 0.795 . . . . 1.0 113.148 -170.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.7 mt -81.63 -8.89 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -172.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.56 -31.53 68.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 1.0 112.758 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -90.42 -5.71 55.79 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.925 1.29 . . . . 1.0 112.382 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -97.35 -47.76 5.58 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.033 1.333 . . . . 1.0 112.19 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -127.1 169.88 12.95 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.976 1.31 . . . . 1.0 113.717 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -66.21 148.59 98.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 110.067 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.38 144.72 62.84 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.364 2.709 . . . . 1.0 113.001 -170.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.92 151.72 37.94 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.45 1.5 . . . . 1.0 112.299 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.09 114.95 4.16 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.859 3.04 . . . . 1.0 110.991 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.81 -35.42 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.943 1.297 . . . . 1.0 114.154 -170.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.91 -35.4 78.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.827 0.451 . . . . 1.0 112.191 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.38 -36.71 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.468 0.707 . . . . 1.0 110.915 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.08 -49.5 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.472 0.578 . . . . 1.0 109.769 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.8 mt -67.68 -38.43 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.912 0.885 . . . . 1.0 111.904 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.9 m -62.42 -41.55 98.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.348 0.976 . . . . 1.0 111.71 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -62.46 -44.34 96.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.697 0.799 . . . . 1.0 111.079 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.63 72.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.618 0.767 . . . . 1.0 110.903 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.26 -40.36 93.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.234 1.014 . . . . 1.0 112.803 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.83 -33.47 75.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.565 0.746 . . . . 1.0 112.096 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.2 mmm -74.92 -38.24 61.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.195 -0.907 . . . . 1.0 112.975 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.54 127.95 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 120.017 1.281 . . . . 1.0 111.299 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.71 -15.42 62.72 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.722 1.629 . . . . 1.0 113.593 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -84.64 160.13 20.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.001 1.4 . . . . 1.0 111.314 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -123.86 157.81 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.368 1.467 . . . . 1.0 112.561 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.56 1.544 . . . . 1.0 110.283 177.772 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 . . . . . 0 CA--C 1.558 1.255 0 N-CA-C 117.072 2.249 . . . . 1.0 117.072 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 29.9 m -62.86 -29.94 71.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.024 1.329 . . . . 1.0 113.942 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.55 93.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.868 0.758 . . . . 1.0 111.674 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -58.68 -45.96 88.27 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.305 -0.872 . . . . 1.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -54.11 -57.1 12.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.569 -0.707 . . . . 1.0 111.349 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.47 -28.07 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.358 0.981 . . . . 1.0 113.489 -173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.4 p -72.47 -38.46 68.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.349 0.977 . . . . 1.0 112.276 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -57.6 -30.54 65.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.777 0.831 . . . . 1.0 112.53 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.26 -32.58 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.023 0.829 . . . . 1.0 112.928 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -93.58 -37.8 11.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 112.19 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -72.16 -46.27 57.1 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.605 -1.309 . . . . 1.0 112.908 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.059 0 C-N-CA 126.316 1.913 . . . . 1.0 114.006 -176.499 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 118.848 -0.596 . . . . 1.0 110.242 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.0 157.54 23.77 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.809 3.006 . . . . 1.0 113.263 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -124.82 162.56 42.44 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 127.188 2.195 . . . . 1.0 112.165 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.73 129.48 14.31 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.037 3.158 . . . . 1.0 113.059 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.78 -3.46 86.85 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.541 -1.144 . . . . 1.0 115.192 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.09 139.91 58.76 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.343 1.572 . . . . 1.0 113.027 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.69 120.95 26.98 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.88 124.75 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.401 -0.963 . . . . 1.0 108.401 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -87.57 135.31 33.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mt -124.57 116.6 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.899 1.28 . . . . 1.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.328 -0.363 0 C-N-CA 124.42 1.088 . . . . 1.0 109.678 -173.471 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.8 m80 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -135.99 145.16 45.82 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.108 0.963 . . . . 1.0 112.58 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 151.86 44.18 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 1.0 112.928 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.61 116.17 29.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.466 1.906 . . . . 1.0 109.223 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -83.03 129.89 35.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.14 -0.975 . . . . 1.0 112.502 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.0 pt -106.57 4.11 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.84 30.6 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 116.118 1.207 . . . . 1.0 116.118 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -88.36 9.11 24.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.747 1.219 . . . . 1.0 113.641 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.1 83.9 Favored Glycine 0 N--CA 1.476 1.355 0 C-N-CA 124.811 1.196 . . . . 1.0 112.142 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -95.09 157.03 16.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.913 1.685 . . . . 1.0 112.569 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.88 155.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.298 1.439 . . . . 1.0 110.105 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.2 mt -111.43 135.91 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -153.91 151.12 29.08 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.411 -0.805 . . . . 1.0 111.803 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -85.96 133.62 33.92 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 124.922 1.289 . . . . 1.0 110.254 -175.745 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 110.323 -0.251 . . . . 1.0 110.323 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -116.54 140.13 49.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.369 1.068 . . . . 1.0 110.195 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.79 125.39 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 169.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.69 163.13 27.89 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.412 1.485 . . . . 1.0 112.199 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -123.86 133.39 53.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.925 1.69 . . . . 1.0 110.058 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -158.14 174.65 14.87 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.063 0.945 . . . . 1.0 111.116 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.64 142.67 56.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.384 1.074 . . . . 1.0 111.453 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 tp -52.19 -53.96 36.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.764 0.826 . . . . 1.0 111.821 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.38 -48.59 71.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.213 1.005 . . . . 1.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.26 -36.18 83.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.222 0.609 . . . . 1.0 112.302 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.84 -42.54 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.228 1.011 . . . . 1.0 112.303 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.1 m -71.53 -36.76 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.031 1.287 . . . . 1.0 112.508 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.58 -130.84 46.48 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 119.033 0.833 . . . . 1.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.2 -6.79 87.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.415 1.007 . . . . 1.0 114.328 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -75.9 148.74 38.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.303 1.441 . . . . 1.0 111.35 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.8 t -73.35 160.44 31.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.051 0.54 . . . . 1.0 110.878 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -158.67 160.25 36.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.088 1.144 . . . . 1.0 114.088 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -160.89 158.69 28.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.26 1.424 . . . . 1.0 112.02 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.73 138.86 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -152.71 85.24 1.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 1.0 110.69 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.66 59.28 2.45 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.599 1.16 . . . . 1.0 112.141 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -65.01 -33.41 75.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.253 1.421 . . . . 1.0 113.56 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.94 -11.99 58.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.193 0.997 . . . . 1.0 113.58 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.73 -34.56 65.27 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.924 1.289 . . . . 1.0 112.136 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -79.2 -18.58 52.73 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.996 1.318 . . . . 1.0 112.306 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -94.74 -43.49 8.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.762 1.225 . . . . 1.0 112.097 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -134.41 146.94 50.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.98 1.312 . . . . 1.0 112.709 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -65.82 159.66 67.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.395 1.078 . . . . 1.0 111.329 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -54.59 151.58 30.66 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.491 3.461 . . . . 1.0 116.241 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 160.11 48.84 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.307 1.843 . . . . 1.0 111.109 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.11 126.02 10.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.987 3.125 . . . . 1.0 112.161 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.43 -33.51 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 113.239 0.829 . . . . 1.0 113.239 -174.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.44 -37.96 82.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.188 0.595 . . . . 1.0 111.909 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.77 -38.16 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 1.0 110.431 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.8 mt -61.55 -46.49 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.212 0.915 . . . . 1.0 110.518 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.35 -37.17 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.112 0.965 . . . . 1.0 111.764 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -63.6 -45.08 91.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.893 0.77 . . . . 1.0 111.363 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.6 m -58.68 -44.09 90.13 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.568 1.147 . . . . 1.0 111.746 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.01 63.09 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.533 0.733 . . . . 1.0 110.782 173.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.78 -39.74 85.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.018 0.927 . . . . 1.0 112.991 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -67.75 -33.92 75.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.112 0.965 . . . . 1.0 112.473 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 96.5 mtp -77.76 -33.21 52.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.845 -1.074 . . . . 1.0 112.857 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.8 t -48.62 128.83 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 120.33 1.423 . . . . 1.0 111.004 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.06 -15.3 62.74 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.628 1.585 . . . . 1.0 113.804 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -87.18 163.27 17.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.94 1.37 . . . . 1.0 111.494 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -125.57 157.7 36.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.393 1.477 . . . . 1.0 112.952 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.7 mtt . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 126.097 1.759 . . . . 1.0 110.258 177.951 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 . . . . . 0 CA--C 1.547 0.856 0 N-CA-C 113.073 0.768 . . . . 1.0 113.073 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.9 -37.31 72.97 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 1.0 112.024 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -61.38 -52.09 66.09 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.447 0.699 . . . . 1.0 109.977 170.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -58.46 -37.67 75.95 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.816 -0.553 . . . . 1.0 111.881 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -59.82 -61.36 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.174 -0.917 . . . . 1.0 111.128 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.64 -24.81 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.799 1.181 . . . . 1.0 112.875 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -63.44 -49.36 73.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.449 1.1 . . . . 1.0 111.295 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -59.8 -28.24 67.28 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.425 0.69 . . . . 1.0 112.688 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -63.42 -36.11 82.63 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.107 0.78 . . . . 1.0 113.107 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -93.75 -44.04 8.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.812 0.845 . . . . 1.0 111.741 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.97 -46.24 88.66 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.001 -1.062 . . . . 1.0 112.349 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.018 0 C-N-CA 126.566 2.031 . . . . 1.0 114.315 -176.821 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 118.659 -0.686 . . . . 1.0 109.482 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.08 143.16 22.5 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.35 2.7 . . . . 1.0 111.493 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -117.02 164.31 19.38 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.397 1.879 . . . . 1.0 111.323 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.64 128.46 10.72 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.855 3.036 . . . . 1.0 112.674 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.28 -3.4 87.25 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.368 -1.24 . . . . 1.0 115.429 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.3 142.24 57.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.647 1.723 . . . . 1.0 113.041 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.2 mt -89.22 118.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.039 -0.982 . . . . 1.0 108.984 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.89 127.64 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.614 -1.624 . . . . 1.0 106.614 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -108.5 122.71 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.411 . . . . 1.0 107.696 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.9 mt -120.28 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 124.893 1.277 . . . . 1.0 109.254 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 125.537 1.535 . . . . 1.0 111.132 -176.859 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 120.357 0.122 . . . . 1.0 110.928 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -137.46 149.31 46.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.079 0.951 . . . . 1.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.58 151.65 38.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.196 0.998 . . . . 1.0 112.949 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -94.13 113.54 25.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.151 1.78 . . . . 1.0 108.778 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -82.32 129.56 34.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.086 -1.009 . . . . 1.0 112.425 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.7 pt -106.14 10.18 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.58 -35.48 4.48 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 124.665 1.126 . . . . 1.0 115.801 169.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.46 17.12 3.98 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.459 1.104 . . . . 1.0 113.706 -172.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 -4.89 85.43 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.905 1.241 . . . . 1.0 112.803 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -92.92 155.39 17.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.171 1.388 . . . . 1.0 113.131 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -126.94 151.31 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.247 1.419 . . . . 1.0 110.481 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.04 134.49 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 106.842 -1.54 . . . . 1.0 106.842 169.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -154.53 162.86 40.93 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.26 -0.9 . . . . 1.0 111.502 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -101.43 132.49 47.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.52 1.128 . . . . 1.0 109.156 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 124.161 0.985 . . . . 1.0 112.676 -174.911 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.64 135.64 35.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.823 1.249 . . . . 1.0 109.233 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.94 131.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.847 0.749 . . . . 1.0 109.268 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -135.05 162.19 33.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.58 1.552 . . . . 1.0 112.594 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -118.33 123.61 45.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.837 1.655 . . . . 1.0 109.946 171.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -145.52 172.08 13.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.715 1.206 . . . . 1.0 110.39 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -75.53 143.39 42.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.105 -0.997 . . . . 1.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.12 -51.92 64.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.172 -0.918 . . . . 1.0 111.702 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -54.33 -49.31 70.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.418 0.687 . . . . 1.0 111.299 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.64 -38.53 83.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.286 0.634 . . . . 1.0 111.846 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -44.79 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.405 1.082 . . . . 1.0 112.056 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -87.98 -7.58 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 114.354 1.242 . . . . 1.0 114.354 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.24 133.83 52.21 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.405 1.003 . . . . 1.0 113.192 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.08 80.87 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.822 1.201 . . . . 1.0 114.723 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.8 m -120.58 150.07 41.45 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.795 1.638 . . . . 1.0 111.204 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.8 m -81.41 158.87 24.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -161.18 168.02 25.02 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.429 . . . . 1.0 114.857 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -159.78 167.83 27.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.882 1.673 . . . . 1.0 112.205 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -87.25 126.57 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 168.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -131.67 57.66 1.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.336 1.065 . . . . 1.0 110.68 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.86 57.7 3.55 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.388 1.475 . . . . 1.0 111.667 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 p -78.64 -14.23 59.42 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.523 1.529 . . . . 1.0 114.72 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 mt -67.79 -11.83 59.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.135 1.161 . . . . 1.0 114.135 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.26 -26.69 67.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.946 0.794 . . . . 1.0 112.422 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -87.51 -5.37 58.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.123 1.369 . . . . 1.0 111.694 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -100.54 -47.24 4.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.549 1.54 . . . . 1.0 111.122 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -130.81 146.67 52.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.857 1.663 . . . . 1.0 112.338 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -64.52 155.13 82.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 1.0 111.864 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -48.78 141.23 21.46 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.569 3.513 . . . . 1.0 115.688 -170.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -121.21 146.45 44.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.724 1.61 . . . . 1.0 110.857 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.56 114.92 4.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.494 2.796 . . . . 1.0 110.398 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.06 -29.9 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 114.452 1.278 . . . . 1.0 114.452 -169.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.1 -35.72 75.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.926 0.49 . . . . 1.0 111.878 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.22 -32.61 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.254 0.622 . . . . 1.0 110.89 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.88 -49.24 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.289 0.949 . . . . 1.0 110.338 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.06 -38.6 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.086 0.954 . . . . 1.0 111.253 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.4 m -63.12 -41.77 99.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 1.0 112.127 173.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t -61.68 -44.45 96.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.101 0.96 . . . . 1.0 110.968 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.5 -52.42 65.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.164 0.986 . . . . 1.0 110.517 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.81 -39.09 87.64 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.138 0.975 . . . . 1.0 113.057 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.55 -34.71 77.63 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.921 0.888 . . . . 1.0 112.363 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 97.5 mtp -78.61 -31.64 47.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.711 -1.137 . . . . 1.0 113.305 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.6 t -47.61 126.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 120.264 1.393 . . . . 1.0 110.607 169.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.11 -12.43 65.43 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.741 1.639 . . . . 1.0 114.274 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.24 158.37 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.109 1.455 . . . . 1.0 111.45 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -118.53 159.54 23.35 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.338 1.455 . . . . 1.0 113.895 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 125.965 1.706 . . . . 1.0 112.091 -178.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -69.6 -35.16 75.05 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.324 -0.86 . . . . 1.0 112.71 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.74 -51.79 66.89 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.729 0.812 . . . . 1.0 110.593 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -63.49 -34.63 78.2 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.254 -0.904 . . . . 1.0 111.261 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.38 -60.02 4.47 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.125 -0.985 . . . . 1.0 110.917 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.8 m -64.9 -22.76 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 120.634 1.561 . . . . 1.0 113.338 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.1 m -65.55 -52.87 49.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.788 1.235 . . . . 1.0 110.984 169.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -66.55 -24.96 66.44 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.391 0.885 . . . . 1.0 113.391 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.2 -37.55 75.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.911 0.884 . . . . 1.0 112.986 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -93.88 -46.74 7.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.118 0.967 . . . . 1.0 112.133 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -62.08 -44.68 96.15 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.153 -0.967 . . . . 1.0 111.747 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.045 0 C-N-CA 126.424 1.964 . . . . 1.0 113.652 179.148 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -86.33 158.62 9.63 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.68 3.587 . . . . 1.0 111.998 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -129.97 162.53 53.19 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.805 1.642 . . . . 1.0 112.027 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.77 128.01 8.51 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.253 3.302 . . . . 1.0 113.091 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.81 -9.42 76.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.999 1.285 . . . . 1.0 115.108 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.82 151.27 44.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.103 1.452 . . . . 1.0 113.71 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.31 125.45 35.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.087 0.955 . . . . 1.0 109.976 171.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.0 mm -95.0 132.93 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 106.757 -1.572 . . . . 1.0 106.757 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -111.68 130.88 55.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.776 1.63 . . . . 1.0 108.851 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.06 129.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.732 1.613 . . . . 1.0 109.355 -169.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 125.61 1.564 . . . . 1.0 109.274 178.694 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 111.944 0.35 . . . . 1.0 111.944 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -142.14 155.54 45.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.118 0.785 . . . . 1.0 113.118 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.12 153.33 42.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.462 1.105 . . . . 1.0 112.115 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.47 118.15 30.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.999 1.319 . . . . 1.0 108.52 171.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -83.39 132.55 34.98 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.236 -0.915 . . . . 1.0 112.156 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 pt -117.44 2.45 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 -170.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.43 163.71 27.33 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.742 1.163 . . . . 1.0 113.427 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 61.71 19.03 10.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.146 1.778 . . . . 1.0 114.116 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.78 2.93 81.0 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.602 1.572 . . . . 1.0 114.107 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -95.14 152.53 18.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.74 . . . . 1.0 114.151 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.8 160.53 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.034 1.733 . . . . 1.0 110.737 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.51 132.07 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.761 -1.57 . . . . 1.0 106.761 168.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.194 -0.941 . . . . 1.0 111.062 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.25 111.14 16.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 171.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 123.914 0.886 . . . . 1.0 111.326 -169.533 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.17 140.35 52.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.81 0.844 . . . . 1.0 109.837 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.36 123.32 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.3 153.71 51.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.987 1.315 . . . . 1.0 112.091 -175.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -100.96 125.11 47.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.967 1.707 . . . . 1.0 109.713 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -149.62 174.81 12.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.782 1.233 . . . . 1.0 110.372 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -75.54 144.57 41.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.008 -1.058 . . . . 1.0 111.71 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -48.99 -52.16 26.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.0 1.32 . . . . 1.0 110.942 173.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.66 -53.6 18.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.325 1.85 . . . . 1.0 111.248 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.32 -34.73 75.11 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.466 0.543 . . . . 1.0 112.466 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.8 t -71.25 -43.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.571 1.148 . . . . 1.0 112.303 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.2 m -73.87 -39.18 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 119.459 1.027 . . . . 1.0 112.697 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.39 -127.38 45.02 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.968 0.804 . . . . 1.0 112.191 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.01 3.16 84.54 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.102 1.334 . . . . 1.0 114.903 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.1 m -78.73 155.95 29.12 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.782 1.291 . . . . 1.0 111.579 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.59 150.91 37.94 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.659 0.384 . . . . 1.0 110.097 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -161.0 164.55 30.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -160.84 160.11 30.68 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.652 1.581 . . . . 1.0 111.556 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.11 133.38 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -155.87 87.3 1.07 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.596 0.758 . . . . 1.0 111.288 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.5 58.84 1.8 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.999 1.32 . . . . 1.0 112.353 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -61.19 -35.61 77.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.866 1.266 . . . . 1.0 112.988 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.47 -14.03 62.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.621 1.168 . . . . 1.0 113.487 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.97 -23.08 67.2 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.634 -0.666 . . . . 1.0 112.762 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.73 -2.67 55.81 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.141 1.376 . . . . 1.0 111.589 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -98.71 -46.2 5.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.633 1.573 . . . . 1.0 111.554 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -125.73 168.98 13.03 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.418 1.487 . . . . 1.0 114.079 -172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -65.93 161.15 57.27 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.588 1.155 . . . . 1.0 111.204 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.78 131.82 28.66 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.867 2.378 . . . . 1.0 110.807 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -113.21 152.19 44.89 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.056 1.343 . . . . 1.0 110.989 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 118.07 5.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.404 2.736 . . . . 1.0 111.348 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.75 -36.6 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.899 1.28 . . . . 1.0 114.174 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.37 -35.53 79.43 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.944 0.498 . . . . 1.0 111.908 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.22 -37.92 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.334 0.654 . . . . 1.0 110.651 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -62.73 -47.13 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 118.95 0.796 . . . . 1.0 110.465 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.33 -36.84 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.821 0.849 . . . . 1.0 111.749 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -62.1 -44.13 97.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.146 0.885 . . . . 1.0 111.252 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 m -58.43 -44.73 89.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 1.0 111.72 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.66 -50.38 73.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.305 0.957 . . . . 1.0 110.89 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.54 -38.33 89.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.531 1.132 . . . . 1.0 113.322 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -69.32 -32.1 70.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.116 0.966 . . . . 1.0 112.155 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.36 -35.23 54.74 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.385 -0.817 . . . . 1.0 112.933 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -45.65 126.46 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.484 1.038 . . . . 1.0 111.359 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.14 59.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.22 1.867 . . . . 1.0 113.972 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -87.71 149.43 24.24 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.027 1.414 . . . . 1.0 111.078 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -106.4 153.15 22.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.397 1.479 . . . . 1.0 113.892 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.8 mtt . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 126.922 2.089 . . . . 1.0 110.811 174.111 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.9 m120 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 27.3 p -58.43 -34.78 71.19 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.06 -1.025 . . . . 1.0 113.702 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -68.24 -55.28 12.76 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.74 1.616 . . . . 1.0 110.591 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -65.37 -33.19 75.38 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.164 -0.96 . . . . 1.0 111.415 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -56.75 -59.02 5.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.338 -0.839 . . . . 1.0 111.129 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.84 -24.38 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.729 1.15 . . . . 1.0 112.31 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -65.4 -48.35 73.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.036 0.934 . . . . 1.0 111.336 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -62.06 -26.47 68.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.267 1.027 . . . . 1.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.03 -32.87 74.33 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.339 0.972 . . . . 1.0 112.949 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -90.39 -48.87 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.275 1.03 . . . . 1.0 111.557 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.76 -30.45 68.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.074 0 C-N-CA 126.147 1.832 . . . . 1.0 114.52 -179.832 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 CA--C 1.55 0.972 0 CA-C-O 118.739 -0.648 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.07 144.96 12.16 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.663 2.908 . . . . 1.0 112.165 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -130.51 162.64 53.48 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.747 2.019 . . . . 1.0 111.678 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.15 129.23 15.19 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.559 2.839 . . . . 1.0 113.412 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.21 85.12 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.29 -1.284 . . . . 1.0 114.841 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.86 137.44 58.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.585 1.693 . . . . 1.0 112.758 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.39 117.88 24.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.785 1.234 . . . . 1.0 108.419 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.4 mm -99.67 121.81 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.46 1.504 . . . . 1.0 107.85 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.74 119.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.491 1.116 . . . . 1.0 109.505 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 125.192 1.397 . . . . 1.0 110.078 -179.51 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 120.634 0.254 . . . . 1.0 110.854 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -139.69 153.32 47.23 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.267 1.027 . . . . 1.0 112.668 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 152.18 38.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.635 0.774 . . . . 1.0 112.693 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.27 115.43 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.084 1.754 . . . . 1.0 108.323 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -80.32 129.12 34.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.956 0.798 . . . . 1.0 112.099 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.5 pt -105.94 10.62 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 115.06 1.504 . . . . 1.0 115.06 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.86 -34.8 5.08 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.53 1.062 . . . . 1.0 115.743 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.96 16.59 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.371 1.068 . . . . 1.0 113.838 -172.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 -7.46 80.79 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.121 1.343 . . . . 1.0 113.202 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -91.89 156.64 17.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.051 1.341 . . . . 1.0 112.819 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -127.61 152.63 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.405 1.482 . . . . 1.0 110.309 172.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -110.91 135.03 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.061 1.345 . . . . 1.0 107.976 169.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -153.8 151.97 30.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.048 0.939 . . . . 1.0 112.294 -168.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.86 126.56 36.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.566 0.747 . . . . 1.0 109.406 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 117.841 -1.076 . . . . 1.0 109.518 173.681 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -136.96 137.46 39.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.541 0.736 . . . . 1.0 110.129 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.3 t -80.08 125.13 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.04 161.43 31.0 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.218 1.807 . . . . 1.0 111.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -120.52 124.59 45.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.753 1.621 . . . . 1.0 110.405 172.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -147.27 178.38 8.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.415 1.486 . . . . 1.0 110.219 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.02 143.19 32.69 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.952 -1.092 . . . . 1.0 111.78 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.77 -61.27 2.13 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.153 1.381 . . . . 1.0 111.319 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -56.19 -43.95 78.96 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.268 1.027 . . . . 1.0 111.36 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.39 -43.03 91.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.3 t -69.79 -42.1 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.451 1.1 . . . . 1.0 112.15 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -79.22 -5.47 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.91 132.96 51.21 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.616 1.103 . . . . 1.0 113.041 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.71 69.71 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.691 1.138 . . . . 1.0 114.785 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 m -126.04 154.22 43.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.307 1.843 . . . . 1.0 111.244 -175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.0 t -82.64 153.52 25.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 168.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -160.48 163.67 32.76 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -161.04 159.55 29.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.206 1.403 . . . . 1.0 112.813 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.2 t -82.75 133.06 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -153.77 80.47 1.15 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.885 0.85 . . . . 1.0 112.153 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.15 51.12 1.71 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.138 1.375 . . . . 1.0 113.049 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.8 m -59.0 -30.43 67.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.684 -1.26 . . . . 1.0 113.411 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.54 -16.07 63.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.88 1.067 . . . . 1.0 113.88 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.0 -20.66 65.5 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.038 0.755 . . . . 1.0 113.038 170.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -97.58 -3.2 40.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.596 1.558 . . . . 1.0 111.815 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -97.58 -48.11 5.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.657 1.583 . . . . 1.0 110.98 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.38 167.59 12.61 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.005 1.722 . . . . 1.0 112.795 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -67.45 163.36 48.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.756 0.822 . . . . 1.0 111.701 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.13 128.01 28.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.396 2.73 . . . . 1.0 111.527 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -113.26 152.65 45.32 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.318 1.447 . . . . 1.0 110.43 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.39 113.78 3.81 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.461 2.774 . . . . 1.0 110.783 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.19 -29.23 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -37.0 78.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.493 . . . . 1.0 111.887 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.02 -33.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.526 0.73 . . . . 1.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.17 -47.82 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.938 0.79 . . . . 1.0 110.121 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.81 -38.97 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.253 1.021 . . . . 1.0 111.729 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 t -63.03 -43.17 99.44 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.439 -0.788 . . . . 1.0 111.567 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.5 m -61.63 -42.38 98.8 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.342 1.057 . . . . 1.0 111.671 173.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 72.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.496 0.719 . . . . 1.0 110.456 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -60.95 -40.62 94.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.153 0.981 . . . . 1.0 112.865 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.79 -33.72 76.52 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.838 0.855 . . . . 1.0 112.554 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.5 mmm -73.48 -38.63 65.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.834 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.9 t -47.33 128.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.88 1.218 . . . . 1.0 111.507 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.76 62.95 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.788 1.661 . . . . 1.0 113.703 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -82.76 145.11 29.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 118.965 1.383 . . . . 1.0 111.19 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -114.9 147.38 40.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.83 1.652 . . . . 1.0 112.732 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 N--CA 1.472 0.669 0 C-N-CA 125.979 1.712 . . . . 1.0 110.237 -178.732 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 CA--C 1.546 0.809 0 N-CA-C 115.933 1.827 . . . . 1.0 115.933 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.13 -43.91 81.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 121.446 1.93 . . . . 1.0 113.33 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -43.91 85.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.138 0.975 . . . . 1.0 110.88 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.23 -41.58 93.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.451 -0.781 . . . . 1.0 111.362 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -58.02 -58.92 6.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.139 0.976 . . . . 1.0 110.891 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.38 -22.52 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.61 1.095 . . . . 1.0 112.76 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 83.5 m -65.7 -49.91 66.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.615 1.166 . . . . 1.0 111.476 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.97 -29.02 64.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.555 1.142 . . . . 1.0 112.468 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.5 -34.54 77.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.219 0.822 . . . . 1.0 113.219 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -93.75 -47.86 6.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.164 0.986 . . . . 1.0 111.307 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.57 -30.48 71.5 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.547 1.139 . . . . 1.0 113.546 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.219 0 C-N-CA 124.599 1.095 . . . . 1.0 114.435 177.823 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 CA--C 1.547 0.83 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 148.26 26.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.589 2.859 . . . . 1.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.88 164.27 41.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.246 1.818 . . . . 1.0 112.177 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.91 126.68 11.37 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.656 2.904 . . . . 1.0 113.235 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.66 -10.03 75.91 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.744 1.164 . . . . 1.0 115.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -66.87 137.78 56.83 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.457 1.628 . . . . 1.0 112.911 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.27 118.41 26.68 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.276 1.43 . . . . 1.0 108.45 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.3 mt -101.28 130.93 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -103.06 131.78 49.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.301 1.44 . . . . 1.0 108.364 170.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.5 mt -124.43 118.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.632 1.573 . . . . 1.0 108.431 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 1.0 112.034 -169.929 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 120.576 0.226 . . . . 1.0 110.433 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -141.41 154.43 45.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.091 0.557 . . . . 1.0 112.048 -175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.73 147.73 31.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.695 0.798 . . . . 1.0 112.356 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.35 118.72 32.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.091 1.756 . . . . 1.0 107.976 169.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.35 132.89 35.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.043 -1.035 . . . . 1.0 112.4 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.86 0.86 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 115.092 1.515 . . . . 1.0 115.092 -169.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.06 169.29 33.45 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.389 0.995 . . . . 1.0 112.917 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 64.1 15.49 9.32 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.239 1.816 . . . . 1.0 114.202 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.57 83.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.35 1.453 . . . . 1.0 114.059 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -101.53 154.52 18.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.21 1.505 . . . . 1.0 114.006 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.72 165.0 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.473 1.909 . . . . 1.0 110.769 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -121.91 135.53 61.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 168.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -154.81 166.02 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.073 -1.017 . . . . 1.0 110.808 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.3 tp -86.57 139.0 31.25 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 124.836 1.254 . . . . 1.0 109.371 -177.582 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -129.44 142.68 50.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.386 0.674 . . . . 1.0 111.195 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.0 t -75.41 125.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 169.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.94 151.48 51.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.709 1.204 . . . . 1.0 112.765 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -97.04 129.14 44.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.883 1.673 . . . . 1.0 108.394 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.15 163.06 37.93 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.029 0.532 . . . . 1.0 110.941 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -72.48 141.26 48.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.47 1.108 . . . . 1.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.69 -58.99 3.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.154 1.382 . . . . 1.0 111.167 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -55.77 -45.54 78.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.432 1.093 . . . . 1.0 111.393 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.42 -41.08 98.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.884 0.474 . . . . 1.0 111.671 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.23 -44.49 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.33 1.052 . . . . 1.0 112.325 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.94 -1.76 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 114.044 1.127 . . . . 1.0 114.044 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.27 50.81 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.377 0.989 . . . . 1.0 113.615 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 1.66 76.45 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.933 1.254 . . . . 1.0 114.56 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.4 m -126.27 155.75 41.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.148 1.779 . . . . 1.0 111.418 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.1 t -85.25 154.77 21.73 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -157.13 150.4 23.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.055 -1.028 . . . . 1.0 113.741 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -150.75 163.79 37.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.219 1.808 . . . . 1.0 110.58 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.6 t -83.64 137.46 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.085 0.954 . . . . 1.0 108.878 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -145.0 77.77 1.54 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.291 1.436 . . . . 1.0 110.845 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.08 62.69 2.89 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.929 1.292 . . . . 1.0 111.418 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.3 p -64.24 -40.18 95.5 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.806 1.242 . . . . 1.0 113.378 -170.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -71.48 -9.67 58.56 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.814 1.042 . . . . 1.0 113.814 -175.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.56 -27.06 68.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.873 0.844 . . . . 1.0 113.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -80.58 -14.73 57.96 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.295 1.438 . . . . 1.0 112.184 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -102.49 -39.89 6.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.654 1.581 . . . . 1.0 112.241 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -129.92 161.5 30.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.631 1.572 . . . . 1.0 113.11 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -65.85 159.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.413 1.085 . . . . 1.0 111.288 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.1 124.47 14.45 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.726 2.284 . . . . 1.0 110.817 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -94.23 154.94 40.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.076 1.35 . . . . 1.0 110.343 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.91 113.19 3.32 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.562 . . . . 1.0 110.89 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.45 -32.61 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.55 -36.29 78.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.875 0.47 . . . . 1.0 112.019 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.3 t -71.96 -36.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.912 0.885 . . . . 1.0 111.008 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.27 -47.72 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.858 0.754 . . . . 1.0 110.197 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.95 -38.81 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.945 0.898 . . . . 1.0 111.604 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -61.92 -41.52 98.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.305 0.957 . . . . 1.0 111.706 172.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -61.24 -45.3 95.1 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.2 -0.938 . . . . 1.0 111.055 173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.94 73.36 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.394 -0.817 . . . . 1.0 110.717 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.69 -37.12 85.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.292 1.037 . . . . 1.0 113.43 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.76 -33.49 73.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.714 0.806 . . . . 1.0 112.507 173.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.9 mmm -74.65 -37.39 62.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.919 0.888 . . . . 1.0 112.654 176.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.9 t -46.11 128.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.268 0.94 . . . . 1.0 111.754 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.94 64.92 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.789 1.661 . . . . 1.0 113.56 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -84.06 146.05 28.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.004 1.402 . . . . 1.0 110.89 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -100.19 151.72 21.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.396 1.478 . . . . 1.0 112.56 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 125.586 1.554 . . . . 1.0 112.802 -175.448 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 117.457 2.391 . . . . 1.0 117.457 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 90.7 m -63.14 -41.53 99.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.463 1.938 . . . . 1.0 114.171 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.41 -47.05 77.61 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.754 -0.591 . . . . 1.0 110.881 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -59.54 -30.98 69.0 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.61 -0.681 . . . . 1.0 112.436 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.19 -61.16 2.55 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.376 -0.828 . . . . 1.0 111.01 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.41 -28.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 p -67.28 -39.08 85.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.959 0.904 . . . . 1.0 112.469 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -59.35 -24.41 63.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.804 0.842 . . . . 1.0 113.036 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -66.19 -35.7 81.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.091 0.86 . . . . 1.0 112.637 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -87.08 -42.79 12.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.064 0.946 . . . . 1.0 111.846 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -68.09 -30.86 70.14 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.244 0 C-N-CA 124.652 1.12 . . . . 1.0 113.298 179.678 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 119.105 -0.474 . . . . 1.0 110.736 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.03 156.74 13.27 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.515 2.81 . . . . 1.0 113.197 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -126.85 162.14 49.2 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.587 1.955 . . . . 1.0 111.706 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -45.8 129.06 11.64 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.061 3.174 . . . . 1.0 113.289 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -7.36 73.94 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.251 1.405 . . . . 1.0 114.887 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -71.48 142.23 50.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.28 1.54 . . . . 1.0 113.839 -175.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.05 124.57 31.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.296 1.438 . . . . 1.0 108.814 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -105.25 128.47 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.124 -1.436 . . . . 1.0 107.124 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -109.6 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.364 1.466 . . . . 1.0 108.048 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mt -127.89 140.64 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.959 1.704 . . . . 1.0 108.911 -169.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 1.0 110.375 -179.559 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 110.89 -0.041 . . . . 1.0 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -144.34 157.88 44.03 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.023 -1.048 . . . . 1.0 113.407 -173.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.91 40.11 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.781 1.232 . . . . 1.0 112.824 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.37 118.64 37.31 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.971 1.708 . . . . 1.0 108.37 171.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.092 -1.005 . . . . 1.0 112.496 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.06 2.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 115.155 1.539 . . . . 1.0 115.155 -170.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.15 166.84 31.5 Favored Glycine 0 N--CA 1.479 1.513 0 C-N-CA 124.593 1.092 . . . . 1.0 112.984 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 65.12 1.17 1.44 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.39 2.276 . . . . 1.0 114.321 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 6.09 59.31 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.112 1.339 . . . . 1.0 113.932 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -90.49 152.22 21.04 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.167 1.984 . . . . 1.0 113.573 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.68 154.76 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.695 1.598 . . . . 1.0 110.734 171.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -114.51 137.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.837 -1.542 . . . . 1.0 106.837 168.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -155.77 164.17 38.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 120.951 -1.093 . . . . 1.0 110.344 -170.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.7 tp -85.92 143.19 28.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.747 -1.205 . . . . 1.0 107.747 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 124.897 1.279 . . . . 1.0 110.692 -176.695 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 119.164 -0.446 . . . . 1.0 110.608 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -113.39 141.6 46.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.64 0.776 . . . . 1.0 110.81 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.31 127.72 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 170.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.52 160.15 40.51 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.557 1.543 . . . . 1.0 112.636 -173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -101.88 134.33 45.25 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.01 1.324 . . . . 1.0 110.059 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.49 172.9 12.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.505 1.522 . . . . 1.0 109.922 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -81.26 143.93 31.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.979 -1.076 . . . . 1.0 112.124 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 tp -50.85 -53.55 31.33 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.816 1.246 . . . . 1.0 111.226 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.77 -47.94 73.27 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 1.0 111.042 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.71 -36.53 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.5 -47.25 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.862 1.265 . . . . 1.0 112.292 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 m -79.78 -1.25 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 114.353 1.242 . . . . 1.0 114.353 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.32 127.42 44.86 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.974 0.797 . . . . 1.0 112.768 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 2.92 81.23 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.922 1.248 . . . . 1.0 114.781 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.2 m -125.38 160.46 29.32 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 1.0 111.909 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.9 m -89.18 157.8 18.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.806 0.842 . . . . 1.0 109.033 168.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.24 162.9 36.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -158.95 162.05 36.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.836 1.655 . . . . 1.0 112.001 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.1 t -83.23 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -148.5 74.8 1.29 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.278 1.037 . . . . 1.0 111.426 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -77.92 58.65 1.96 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.104 1.362 . . . . 1.0 111.555 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.5 p -63.56 -45.88 88.48 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.615 -1.303 . . . . 1.0 112.896 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 mt -72.49 -10.23 59.54 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.94 -25.36 57.57 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.708 0.803 . . . . 1.0 112.299 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.34 -4.61 53.64 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.45 1.5 . . . . 1.0 113.253 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -84.17 -65.44 1.01 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.431 1.093 . . . . 1.0 111.114 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -109.72 174.68 5.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.068 2.147 . . . . 1.0 113.148 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -66.48 140.21 96.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 121.271 -0.893 . . . . 1.0 110.791 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.21 148.37 91.17 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.887 3.058 . . . . 1.0 113.711 -169.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -99.26 153.83 37.59 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.832 1.253 . . . . 1.0 112.248 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.66 118.46 5.47 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.591 2.861 . . . . 1.0 110.341 170.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 t -55.8 -38.4 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.372 1.469 . . . . 1.0 112.851 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.01 -36.57 70.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.64 0.776 . . . . 1.0 111.616 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.29 -34.46 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.497 -0.764 . . . . 1.0 111.081 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.72 -46.66 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.535 1.062 . . . . 1.0 110.186 171.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.07 -36.68 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.48 1.112 . . . . 1.0 111.414 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 t -63.07 -44.39 95.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.061 0.846 . . . . 1.0 111.111 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.8 m -58.32 -44.44 88.64 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.483 1.113 . . . . 1.0 111.817 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.71 72.74 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.416 1.007 . . . . 1.0 111.135 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.368 1.067 . . . . 1.0 112.957 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.85 -32.89 74.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.978 0.911 . . . . 1.0 112.371 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 80.9 mmm -74.95 -36.35 62.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.703 -1.141 . . . . 1.0 113.086 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.8 t -46.42 125.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 120.277 1.398 . . . . 1.0 111.015 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.72 -17.13 57.9 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.151 1.834 . . . . 1.0 114.182 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -85.77 165.65 16.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.912 1.356 . . . . 1.0 110.961 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.6 156.32 44.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.4 mtt . . . . . 0 N--CA 1.48 1.033 0 C-N-CA 126.797 2.039 . . . . 1.0 112.598 -177.559 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 113.581 0.956 . . . . 1.0 113.581 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.7 m -69.95 -36.64 75.42 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.075 -1.016 . . . . 1.0 113.366 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.4 -56.86 14.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.461 0.573 . . . . 1.0 109.942 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -55.58 -34.0 64.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 1.0 112.751 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -60.0 -59.73 4.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.074 -0.489 . . . . 1.0 110.737 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.22 -32.27 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 -170.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.75 -42.71 90.62 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.393 0.997 . . . . 1.0 111.553 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -61.41 -24.27 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.612 1.165 . . . . 1.0 112.773 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.95 -31.84 73.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.51 1.05 . . . . 1.0 112.846 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -94.89 -49.87 5.38 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.805 1.242 . . . . 1.0 111.352 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -62.26 -46.94 86.56 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.922 -1.111 . . . . 1.0 112.51 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 C-N-CA 126.837 2.16 . . . . 1.0 112.969 178.688 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.38 147.77 18.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.223 2.615 . . . . 1.0 112.722 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -129.81 159.48 69.64 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.219 1.807 . . . . 1.0 112.744 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -46.61 129.24 13.76 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 124.086 3.191 . . . . 1.0 112.907 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.99 79.05 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.584 -1.12 . . . . 1.0 114.863 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -64.85 144.12 57.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.323 1.561 . . . . 1.0 113.143 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -94.12 125.24 38.64 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.421 1.488 . . . . 1.0 108.523 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.57 132.35 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -103.89 133.75 48.33 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.578 1.551 . . . . 1.0 108.863 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.2 mt -127.81 119.92 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.929 1.692 . . . . 1.0 108.132 -171.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 125.899 1.679 . . . . 1.0 113.168 -168.65 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.0 m170 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 121.028 0.442 . . . . 1.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.95 154.29 51.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.406 1.083 . . . . 1.0 111.259 174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.8 146.84 28.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.16 115.41 27.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.972 1.709 . . . . 1.0 107.846 170.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -81.14 131.89 35.32 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.565 -0.71 . . . . 1.0 111.95 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.67 2.31 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.6 165.23 29.43 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 124.726 1.155 . . . . 1.0 112.759 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.58 17.31 9.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.109 1.764 . . . . 1.0 113.958 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 0.05 81.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.665 1.602 . . . . 1.0 114.195 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.83 154.2 17.37 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.448 1.624 . . . . 1.0 114.057 -175.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 m -137.25 158.38 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.98 1.712 . . . . 1.0 111.662 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.42 139.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.807 1.643 . . . . 1.0 108.326 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -156.43 150.02 24.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 1.0 111.661 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -97.06 124.79 41.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.863 0.865 . . . . 1.0 109.512 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.832 0 CA-C-O 117.406 -1.283 . . . . 1.0 110.322 -179.627 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 111.347 0.128 . . . . 1.0 111.347 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -133.56 137.41 45.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.979 0.912 . . . . 1.0 109.98 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.45 127.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -132.27 160.98 34.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.984 1.714 . . . . 1.0 111.804 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -121.14 139.92 52.69 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.906 1.682 . . . . 1.0 109.84 172.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -164.86 -179.52 5.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.772 1.229 . . . . 1.0 111.076 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -70.09 142.92 52.56 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.943 0.897 . . . . 1.0 111.02 172.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.5 tp -51.57 -56.77 11.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.288 1.035 . . . . 1.0 112.152 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.51 -41.18 80.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.502 0.592 . . . . 1.0 111.187 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.37 -39.0 81.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.08 0.552 . . . . 1.0 112.137 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.0 -38.48 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.49 1.116 . . . . 1.0 111.972 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.56 -49.47 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.024 1.33 . . . . 1.0 111.056 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.38 -121.94 27.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.713 0.673 . . . . 1.0 111.677 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.31 -0.68 86.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.953 1.263 . . . . 1.0 114.854 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.6 m -79.43 175.27 10.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.076 1.35 . . . . 1.0 111.591 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 95.6 m -110.19 168.34 9.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.379 1.471 . . . . 1.0 108.884 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -158.05 162.56 38.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -149.39 155.15 40.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.024 1.73 . . . . 1.0 111.272 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.26 135.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -153.86 84.86 1.16 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.818 0.818 . . . . 1.0 111.866 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -81.11 50.13 1.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.187 1.395 . . . . 1.0 112.926 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 m -59.19 -33.46 70.98 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.501 -1.374 . . . . 1.0 113.144 -171.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.48 -12.37 60.13 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -26.69 68.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.962 0.801 . . . . 1.0 112.946 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -88.98 -5.1 58.2 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.893 1.277 . . . . 1.0 112.057 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -99.34 -50.26 4.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.17 1.388 . . . . 1.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -128.2 147.64 50.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.203 1.401 . . . . 1.0 112.774 -174.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -65.56 153.25 90.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 118.44 -0.79 . . . . 1.0 111.57 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.81 127.98 27.28 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.149 3.233 . . . . 1.0 114.765 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.32 155.62 46.45 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.003 1.321 . . . . 1.0 111.536 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.16 117.9 5.36 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.707 2.938 . . . . 1.0 110.063 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -57.3 -34.92 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.42 1.088 . . . . 1.0 113.017 -170.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.2 -36.37 75.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.953 0.501 . . . . 1.0 112.188 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.11 -36.1 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.97 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mt -59.99 -46.39 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 119.662 1.119 . . . . 1.0 110.337 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.44 -36.1 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.021 0.928 . . . . 1.0 111.288 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.7 m -64.56 -43.2 94.67 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.453 -0.779 . . . . 1.0 111.404 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.7 m -60.41 -43.97 96.17 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.658 1.183 . . . . 1.0 111.445 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.64 73.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.66 0.784 . . . . 1.0 110.458 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -60.92 -40.63 93.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.196 0.999 . . . . 1.0 113.002 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -65.25 -34.12 77.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.923 0.889 . . . . 1.0 112.334 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 75.3 mmm -73.73 -39.64 64.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.321 -0.847 . . . . 1.0 112.789 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -47.65 129.49 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.674 1.124 . . . . 1.0 111.707 172.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.37 -14.68 64.03 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.539 1.542 . . . . 1.0 113.464 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -82.69 143.2 31.09 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.122 1.461 . . . . 1.0 111.186 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.75 146.57 27.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.179 1.392 . . . . 1.0 111.633 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.3 mmt . . . . . 0 N--CA 1.469 0.504 0 C-N-CA 125.809 1.643 . . . . 1.0 110.628 -178.031 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 111.867 0.321 . . . . 1.0 111.867 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 6.9 t -85.04 -38.39 19.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.533 1.133 . . . . 1.0 113.504 -169.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -44.97 92.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.141 0.977 . . . . 1.0 110.385 169.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.31 -43.63 64.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.492 1.917 . . . . 1.0 111.381 170.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -64.12 -59.47 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.818 -0.611 . . . . 1.0 111.714 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.55 -22.36 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.481 1.037 . . . . 1.0 113.032 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 m -60.81 -51.41 69.42 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.791 1.236 . . . . 1.0 111.426 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -64.46 -26.51 68.47 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.979 0.733 . . . . 1.0 112.979 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.75 -34.97 76.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.035 0.834 . . . . 1.0 112.917 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -91.87 -49.71 6.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.23 1.012 . . . . 1.0 111.482 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -61.27 -45.86 92.73 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.257 -0.902 . . . . 1.0 112.288 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 126.38 1.943 . . . . 1.0 112.315 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.16 143.08 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.265 2.643 . . . . 1.0 111.591 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -129.48 163.44 46.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.094 1.757 . . . . 1.0 112.201 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -45.54 126.62 8.81 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 124.196 3.264 . . . . 1.0 113.095 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.75 82.6 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.44 1.495 . . . . 1.0 115.348 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.25 145.71 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.658 1.729 . . . . 1.0 113.782 -175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.94 123.05 30.06 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.54 1.136 . . . . 1.0 108.068 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.81 131.19 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.416 -1.328 . . . . 1.0 107.416 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.45 129.06 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.244 1.818 . . . . 1.0 108.27 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.75 128.95 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.005 1.722 . . . . 1.0 108.297 -170.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 CA--C 1.533 0.321 0 C-N-CA 125.384 1.474 . . . . 1.0 111.451 -174.471 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 111.315 0.117 . . . . 1.0 111.315 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -139.51 156.87 46.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.179 -0.951 . . . . 1.0 113.251 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.41 40.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.214 . . . . 1.0 112.546 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.08 119.08 38.21 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.901 1.681 . . . . 1.0 108.145 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -82.78 130.36 35.12 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.241 -0.912 . . . . 1.0 111.965 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 pt -113.05 3.3 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 114.744 1.387 . . . . 1.0 114.744 -170.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.37 168.05 35.63 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.4 1.0 . . . . 1.0 112.671 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.12 17.78 9.46 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.906 1.682 . . . . 1.0 113.999 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.63 85.37 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.002 1.287 . . . . 1.0 114.379 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.5 154.44 17.27 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.554 1.677 . . . . 1.0 114.204 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.27 157.11 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.283 1.833 . . . . 1.0 111.2 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.53 136.27 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.33 -1.73 . . . . 1.0 106.33 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -158.8 175.28 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.305 1.042 . . . . 1.0 110.32 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.6 mt -90.12 153.18 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.633 -0.667 . . . . 1.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.911 0 C-N-CA 126.566 1.946 . . . . 1.0 107.86 169.386 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 119.255 -0.403 . . . . 1.0 110.13 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -98.24 138.77 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.093 0.861 . . . . 1.0 110.42 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.11 127.32 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 169.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -138.07 162.02 35.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.442 1.497 . . . . 1.0 112.276 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -109.22 140.28 43.05 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.227 1.811 . . . . 1.0 110.345 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.17 176.61 9.08 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.771 1.228 . . . . 1.0 110.909 172.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -74.28 142.07 45.27 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.705 1.202 . . . . 1.0 111.529 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.85 -51.94 64.34 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.977 -1.011 . . . . 1.0 111.844 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.19 -47.01 72.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.727 0.694 . . . . 1.0 111.22 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.74 -39.71 84.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.549 0.739 . . . . 1.0 112.025 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.55 -42.05 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.404 1.081 . . . . 1.0 112.401 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -0.63 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.536 1.535 . . . . 1.0 113.9 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.91 52.29 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.404 1.002 . . . . 1.0 112.993 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.48 1.87 77.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.725 1.155 . . . . 1.0 114.622 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 24.5 m -120.44 161.26 21.53 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.243 1.817 . . . . 1.0 111.127 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.1 t -97.14 163.19 13.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.015 0.926 . . . . 1.0 109.204 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -157.39 163.32 38.7 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.13 151.72 28.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 109.67 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.23 129.5 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -132.39 68.76 1.49 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.068 0.947 . . . . 1.0 111.531 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -75.58 73.2 2.59 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.873 1.269 . . . . 1.0 111.729 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 m -70.37 -38.76 74.82 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.124 -0.985 . . . . 1.0 113.305 -170.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -75.55 -10.47 59.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.473 1.286 . . . . 1.0 114.473 -169.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.95 -30.59 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.065 0.946 . . . . 1.0 112.693 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -79.21 -16.46 56.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.602 1.561 . . . . 1.0 112.538 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -100.0 -41.33 7.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.486 1.515 . . . . 1.0 112.365 -172.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -130.1 160.27 34.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.202 1.401 . . . . 1.0 113.299 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -66.08 162.86 42.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.706 1.203 . . . . 1.0 111.803 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.32 146.14 7.38 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 125.124 3.883 . . . . 1.0 115.255 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 151.71 63.0 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.486 1.514 . . . . 1.0 112.296 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.88 120.09 4.56 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.853 3.035 . . . . 1.0 112.446 -169.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.9 p -55.58 -33.25 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.208 1.188 . . . . 1.0 114.208 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.66 -35.4 79.51 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.677 0.391 . . . . 1.0 112.041 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.53 -35.47 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.202 0.601 . . . . 1.0 110.815 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.3 mt -62.52 -49.39 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.837 0.744 . . . . 1.0 110.059 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -68.65 -37.64 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.031 0.932 . . . . 1.0 111.709 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.1 m -62.11 -42.02 98.82 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.238 -0.914 . . . . 1.0 111.86 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 t -60.23 -45.44 93.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.559 0.744 . . . . 1.0 111.06 173.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.84 75.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.351 0.66 . . . . 1.0 110.95 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.55 -38.67 90.93 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.14 -0.975 . . . . 1.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.3 -35.58 80.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.766 0.827 . . . . 1.0 112.092 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mmm -73.75 -36.24 65.12 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 1.0 112.975 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.62 126.89 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.744 1.156 . . . . 1.0 111.417 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.27 -17.68 58.72 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.154 1.835 . . . . 1.0 113.981 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -88.14 158.07 18.65 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.872 1.336 . . . . 1.0 110.709 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.79 141.81 43.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.618 1.167 . . . . 1.0 112.335 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 126.381 1.872 . . . . 1.0 110.51 -175.52 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t30 . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.0 m -74.79 -15.31 60.75 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.229 -1.544 . . . . 1.0 114.558 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -46.53 55.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.825 0.739 . . . . 1.0 110.391 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -53.12 -27.98 23.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.608 1.163 . . . . 1.0 113.654 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -65.07 -53.97 37.42 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.183 -0.948 . . . . 1.0 111.173 169.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.43 -26.6 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -64.56 -41.72 96.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.479 1.036 . . . . 1.0 111.815 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.6 -24.23 66.55 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.537 1.135 . . . . 1.0 112.923 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.16 -31.36 72.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.954 0.797 . . . . 1.0 112.557 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -94.16 -43.73 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.618 1.167 . . . . 1.0 111.723 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -67.81 -33.81 75.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.616 0.969 . . . . 1.0 113.616 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 C-N-CA 125.8 1.667 . . . . 1.0 114.323 179.791 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 CA--C 1.547 0.835 0 CA-C-O 118.68 -0.676 . . . . 1.0 110.717 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.37 148.6 16.55 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.689 2.926 . . . . 1.0 112.181 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -130.0 161.26 60.9 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.386 1.874 . . . . 1.0 112.915 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.43 128.17 12.16 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.182 3.255 . . . . 1.0 113.114 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.91 -7.64 78.86 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.122 1.344 . . . . 1.0 114.9 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.41 142.48 53.86 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.316 1.558 . . . . 1.0 113.689 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.85 123.96 31.8 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.132 1.373 . . . . 1.0 108.733 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 mm -105.64 127.17 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.783 -1.192 . . . . 1.0 107.783 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -102.49 125.67 49.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.498 1.519 . . . . 1.0 108.272 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.75 119.06 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.137 1.375 . . . . 1.0 109.317 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 C--N 1.327 -0.393 0 C-N-CA 125.444 1.498 . . . . 1.0 110.514 -179.677 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 120.73 0.3 . . . . 1.0 111.023 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -138.0 150.08 46.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.035 0.934 . . . . 1.0 112.868 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.28 155.82 42.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.468 1.107 . . . . 1.0 112.469 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.35 116.22 32.29 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.924 1.689 . . . . 1.0 107.733 172.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -82.29 131.09 35.23 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.241 -0.912 . . . . 1.0 111.872 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.2 pt -114.26 2.5 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.806 1.41 . . . . 1.0 114.806 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.73 168.67 36.73 Favored Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.448 1.023 . . . . 1.0 112.772 -175.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.74 17.8 9.07 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.983 1.713 . . . . 1.0 113.8 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.16 -0.35 85.79 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.143 1.354 . . . . 1.0 114.445 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -92.94 153.41 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.788 1.794 . . . . 1.0 114.646 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.85 156.52 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.274 1.83 . . . . 1.0 110.865 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.0 mt -115.09 134.84 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.659 1.584 . . . . 1.0 107.101 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.32 145.39 22.75 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.326 -0.859 . . . . 1.0 112.402 -168.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.71 93.31 8.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.491 0.716 . . . . 1.0 109.861 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 124.494 1.117 . . . . 1.0 111.374 -176.74 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 119.48 -0.295 . . . . 1.0 110.514 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.25 135.34 52.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.223 1.009 . . . . 1.0 110.929 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.44 122.35 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 170.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -128.04 161.03 30.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.536 1.534 . . . . 1.0 111.799 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -117.38 120.27 37.64 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.143 1.777 . . . . 1.0 109.994 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -147.19 177.53 9.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.694 1.198 . . . . 1.0 110.852 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.52 139.68 38.62 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.147 -0.97 . . . . 1.0 111.394 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.48 -49.97 68.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.063 0.945 . . . . 1.0 111.609 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.76 -46.21 74.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.426 0.69 . . . . 1.0 111.316 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -44.9 76.37 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.785 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.55 -41.56 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.825 1.25 . . . . 1.0 112.144 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.37 -2.08 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.502 1.521 . . . . 1.0 113.71 -171.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.1 128.65 47.91 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.228 0.918 . . . . 1.0 112.924 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.46 -1.17 83.08 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.942 1.258 . . . . 1.0 114.726 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 m -117.67 150.26 39.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.78 1.632 . . . . 1.0 111.283 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.74 159.64 20.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -160.71 168.46 24.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.484 1.29 . . . . 1.0 114.484 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -159.97 162.2 34.31 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.507 1.523 . . . . 1.0 112.098 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.02 134.31 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 107.146 -1.427 . . . . 1.0 107.146 168.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -145.25 75.64 1.45 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.087 0.946 . . . . 1.0 111.075 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.11 64.64 3.32 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.974 1.309 . . . . 1.0 110.71 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -62.89 -42.4 99.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.736 1.215 . . . . 1.0 113.036 -170.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.67 -7.43 50.37 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.53 -27.95 68.04 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.767 0.794 . . . . 1.0 112.841 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.33 -14.7 59.3 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.205 1.402 . . . . 1.0 112.391 175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -104.21 -40.42 6.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.544 1.538 . . . . 1.0 112.112 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -129.4 156.76 43.55 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.109 1.764 . . . . 1.0 112.75 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -65.95 160.3 63.88 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.951 0.9 . . . . 1.0 111.828 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.34 125.51 17.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.635 2.89 . . . . 1.0 112.28 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -96.99 154.49 38.19 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.955 1.302 . . . . 1.0 110.137 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.11 112.41 3.3 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.032 2.488 . . . . 1.0 111.061 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.67 -33.06 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 124.549 1.139 . . . . 1.0 113.133 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.83 -37.38 79.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.267 0.485 . . . . 1.0 112.034 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.4 -38.76 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.67 0.788 . . . . 1.0 110.646 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.0 mt -60.07 -50.26 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.7 0.682 . . . . 1.0 109.858 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.6 mt -66.67 -36.46 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.248 1.019 . . . . 1.0 112.077 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 t -63.77 -41.78 97.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.948 0.795 . . . . 1.0 110.745 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.4 p -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.67 0.788 . . . . 1.0 111.858 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.83 76.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.888 0.875 . . . . 1.0 110.469 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.59 -39.21 90.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.223 1.009 . . . . 1.0 112.974 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.99 -34.86 79.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.564 0.746 . . . . 1.0 112.358 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.5 mmm -74.63 -36.83 62.91 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.322 -0.847 . . . . 1.0 113.162 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.96 127.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.528 1.058 . . . . 1.0 111.389 170.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.18 -13.53 61.72 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.857 1.694 . . . . 1.0 113.782 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -88.16 155.89 19.53 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.062 1.431 . . . . 1.0 111.245 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.16 143.63 46.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.263 1.425 . . . . 1.0 113.187 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 126.385 1.874 . . . . 1.0 111.172 -172.45 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.2 t30 . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 115.268 1.581 . . . . 1.0 115.268 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.34 -32.04 62.21 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.695 -1.253 . . . . 1.0 113.945 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.49 -50.94 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.789 1.177 . . . . 1.0 110.876 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -64.1 -28.87 70.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.637 0.775 . . . . 1.0 112.488 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.31 -56.11 19.15 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.746 -0.596 . . . . 1.0 110.112 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.64 -30.34 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.0 p -66.43 -41.24 89.49 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.809 1.186 . . . . 1.0 112.344 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -63.22 -21.87 66.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.134 0.974 . . . . 1.0 112.806 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.0 mt -65.14 -32.93 74.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.515 1.052 . . . . 1.0 112.14 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -84.26 -55.05 4.38 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.58 0.752 . . . . 1.0 111.055 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.95 -34.71 77.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 -170.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.085 0 C-N-CA 126.2 1.857 . . . . 1.0 114.184 -178.141 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 111.795 0.295 . . . . 1.0 111.795 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.31 162.39 28.46 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.162 0.985 . . . . 1.0 112.397 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -66.79 143.05 97.86 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.674 0.79 . . . . 1.0 112.678 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.23 -21.77 10.26 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.309 2.672 . . . . 1.0 113.538 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -128.94 162.87 26.56 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.606 1.562 . . . . 1.0 110.998 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -79.06 156.56 28.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.506 0.722 . . . . 1.0 111.389 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -134.75 131.3 20.07 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.7 1.2 . . . . 1.0 109.445 169.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.4 143.56 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.708 2.939 . . . . 1.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -125.0 160.41 54.54 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.61 1.964 . . . . 1.0 111.849 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.77 129.31 11.74 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 124.082 3.188 . . . . 1.0 112.786 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.5 -11.3 72.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.323 1.44 . . . . 1.0 114.924 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.77 137.64 57.91 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.125 1.463 . . . . 1.0 112.958 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.15 118.2 24.57 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.558 1.143 . . . . 1.0 108.348 171.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mm -93.95 127.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -108.29 117.14 33.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.246 2.219 . . . . 1.0 107.611 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mt -115.1 129.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.386 1.474 . . . . 1.0 109.052 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.82 105.0 14.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.442 1.497 . . . . 1.0 109.843 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -85.61 -178.88 6.77 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.59 1.556 . . . . 1.0 110.474 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -70.81 102.3 2.31 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.297 -0.877 . . . . 1.0 110.182 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.26 3.29 90.6 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.972 1.273 . . . . 1.0 115.837 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -150.77 160.83 43.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.645 1.578 . . . . 1.0 112.545 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -116.78 157.49 25.44 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.26 1.024 . . . . 1.0 111.669 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.605 ' CD2' ' HG ' ' A' ' 113' ' ' CYS . 10.9 t-80 -147.66 161.31 41.43 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.075 1.35 . . . . 1.0 111.512 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -136.54 154.95 50.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.422 1.267 . . . . 1.0 114.422 -173.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.29 159.63 43.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.495 1.518 . . . . 1.0 112.744 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.43 114.88 29.5 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.076 1.75 . . . . 1.0 108.709 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -82.67 131.69 35.2 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.062 -1.024 . . . . 1.0 112.183 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 pt -112.86 -0.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -170.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.28 165.61 27.62 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 124.602 1.096 . . . . 1.0 113.164 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.3 t70 60.51 20.47 10.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.834 1.654 . . . . 1.0 114.079 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.54 0.27 79.47 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.637 1.589 . . . . 1.0 114.624 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.98 152.45 18.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.751 . . . . 1.0 114.16 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.3 155.09 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.664 1.586 . . . . 1.0 111.111 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.3 137.33 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.54 1.536 . . . . 1.0 107.219 169.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -153.07 159.34 42.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.143 0.977 . . . . 1.0 111.313 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -95.6 127.34 41.55 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.41 129.54 74.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 117.639 -1.172 . . . . 1.0 109.202 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.12 148.79 45.09 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.763 2.309 . . . . 1.0 111.944 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -89.52 -167.98 0.3 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.355 3.37 . . . . 1.0 111.622 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.9 t -148.4 -176.39 5.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.744 1.218 . . . . 1.0 112.002 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.47 7.46 44.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.682 1.993 . . . . 1.0 112.567 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . 0.333 1.8 t80 -37.29 -50.64 2.42 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 119.905 3.298 . . . . 1.0 119.905 -168.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.65 -14.59 42.44 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.226 2.617 . . . . 1.0 114.14 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.78 22.84 9.76 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.9 1.714 . . . . 1.0 113.099 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.3 146.41 23.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.529 1.165 . . . . 1.0 111.985 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.16 129.36 45.76 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.945 0.783 . . . . 1.0 113.794 -169.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t 76.78 -2.07 2.75 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.989 2.116 . . . . 1.0 113.441 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -123.08 174.09 7.44 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.614 1.566 . . . . 1.0 112.731 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -154.11 -174.17 4.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 1.0 110.395 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.39 -21.53 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.738 1.385 . . . . 1.0 114.738 -171.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -85.48 -21.54 28.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.619 1.167 . . . . 1.0 113.363 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 p -121.2 -13.27 8.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.683 1.593 . . . . 1.0 114.295 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.67 144.03 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.169 1.788 . . . . 1.0 109.881 170.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.6 mt -80.4 174.48 11.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.229 1.014 . . . . 1.0 112.811 -173.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.5 p -85.0 178.29 7.63 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.364 1.066 . . . . 1.0 113.713 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -148.73 176.09 10.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.692 1.597 . . . . 1.0 110.602 172.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.3 p -162.72 163.47 26.85 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.958 -1.089 . . . . 1.0 112.74 171.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.58 153.41 21.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.449 1.099 . . . . 1.0 109.445 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -146.41 138.32 24.86 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.832 -0.542 . . . . 1.0 110.292 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -77.6 129.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.29 161.49 35.65 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.728 1.611 . . . . 1.0 112.004 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -117.4 129.47 55.87 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.104 1.762 . . . . 1.0 110.281 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -148.37 173.9 12.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.656 1.183 . . . . 1.0 111.291 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.79 142.66 49.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.624 0.77 . . . . 1.0 110.661 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.34 -51.0 61.2 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.389 1.076 . . . . 1.0 111.826 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.06 -48.01 71.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.168 0.987 . . . . 1.0 110.988 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.86 -39.21 93.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.982 0.513 . . . . 1.0 111.877 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.57 -46.44 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.432 1.093 . . . . 1.0 112.065 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.71 -35.36 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.389 0.995 . . . . 1.0 113.05 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.33 -124.14 35.01 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.421 1.009 . . . . 1.0 111.797 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.02 -7.2 84.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.383 0.992 . . . . 1.0 114.812 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.07 148.44 41.9 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 1.0 111.634 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -76.54 161.94 28.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.738 0.815 . . . . 1.0 110.978 171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -157.19 160.45 38.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -144.01 163.51 33.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.769 2.028 . . . . 1.0 110.844 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.99 129.94 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 168.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -147.85 83.69 1.52 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.91 0.862 . . . . 1.0 111.914 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -80.81 54.65 2.2 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.998 1.319 . . . . 1.0 112.66 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.1 m -60.54 -31.89 70.96 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.734 -1.229 . . . . 1.0 113.271 -171.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -68.57 -11.37 59.89 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.932 1.086 . . . . 1.0 113.932 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.07 -28.06 67.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.999 0.818 . . . . 1.0 112.968 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -80.35 -14.56 58.25 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.244 1.418 . . . . 1.0 112.185 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -101.33 -46.83 4.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.396 1.478 . . . . 1.0 111.863 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.02 167.09 13.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.499 1.519 . . . . 1.0 113.464 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -66.23 161.63 55.21 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.682 1.193 . . . . 1.0 111.87 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.9 87.96 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.174 2.582 . . . . 1.0 110.761 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.59 151.15 96.76 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.681 1.192 . . . . 1.0 111.428 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.37 116.42 4.69 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.567 2.845 . . . . 1.0 110.093 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.28 -31.81 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.34 -36.07 77.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.065 0.395 . . . . 1.0 112.065 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.0 t -76.57 -32.19 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.323 0.649 . . . . 1.0 111.211 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.91 -46.43 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 119.265 0.939 . . . . 1.0 110.155 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.15 -38.01 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 1.0 111.531 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.0 m -64.9 -38.28 90.45 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.92 0.782 . . . . 1.0 111.14 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.0 m -63.73 -43.71 95.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.941 0.897 . . . . 1.0 111.306 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.04 -50.41 72.81 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.294 0.637 . . . . 1.0 110.662 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.78 -40.7 96.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.219 1.008 . . . . 1.0 112.903 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -66.55 -32.97 74.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.855 0.862 . . . . 1.0 112.388 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.6 -39.21 64.78 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.187 -0.911 . . . . 1.0 112.595 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.2 127.24 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.674 1.125 . . . . 1.0 111.406 172.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.13 63.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.927 1.727 . . . . 1.0 114.017 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -84.89 143.3 29.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.024 1.412 . . . . 1.0 111.306 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -97.32 159.01 15.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.618 1.567 . . . . 1.0 113.501 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.4 mtt -137.85 164.88 27.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.657 1.983 . . . . 1.0 110.347 172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.29 -174.46 0.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 116.065 1.876 . . . . 1.0 116.065 -169.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -68.06 -172.37 0.29 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.627 1.971 . . . . 1.0 113.674 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.8 p -32.24 -42.18 0.06 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 127.091 2.156 . . . . 1.0 115.235 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 pp -56.07 -11.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 115.758 1.762 . . . . 1.0 115.758 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.3 m -67.22 -21.88 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 120.073 1.306 . . . . 1.0 112.443 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.8 t 57.32 -144.41 0.64 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.324 1.449 . . . . 1.0 111.743 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -60.84 112.59 2.1 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.84 -1.163 . . . . 1.0 109.728 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -142.57 -17.5 0.7 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.723 1.749 . . . . 1.0 115.723 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.605 ' HG ' ' CD2' ' A' ' 23' ' ' HIS . 25.4 p -68.97 -38.75 79.56 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 121.199 1.818 . . . . 1.0 112.912 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -43.61 93.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.608 0.763 . . . . 1.0 111.018 170.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -61.37 -39.55 91.05 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.427 -0.796 . . . . 1.0 111.77 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.1 -59.78 4.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.196 0.999 . . . . 1.0 110.797 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.28 -21.19 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 119.769 1.168 . . . . 1.0 113.425 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.5 m -64.0 -49.69 71.47 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.818 1.247 . . . . 1.0 111.038 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -61.35 -25.2 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.521 0.728 . . . . 1.0 112.74 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.43 -35.16 80.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.996 0.816 . . . . 1.0 113.076 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -94.03 -40.77 9.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.117 0.967 . . . . 1.0 112.297 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.47 -44.65 78.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.894 0.877 . . . . 1.0 112.29 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.9 32.33 6.45 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.229 1.871 . . . . 1.0 113.639 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.32 -48.62 71.14 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.528 1.131 . . . . 1.0 112.372 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.378 1.871 . . . . 1.0 113.09 -177.799 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 110.772 -0.085 . . . . 1.0 110.772 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.57 164.49 26.58 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.213 1.005 . . . . 1.0 113.14 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.9 m -65.45 147.93 98.35 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.116 0.966 . . . . 1.0 112.605 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.53 133.17 33.48 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.971 2.448 . . . . 1.0 110.726 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.54 -7.2 59.57 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.047 0.758 . . . . 1.0 113.047 -175.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -157.25 137.83 13.07 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.364 1.866 . . . . 1.0 109.121 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.12 138.57 27.75 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.484 1.113 . . . . 1.0 110.626 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.02 153.23 22.03 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.828 3.019 . . . . 1.0 113.003 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.91 162.94 50.64 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.331 1.852 . . . . 1.0 112.841 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -45.36 128.51 10.14 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 124.387 3.392 . . . . 1.0 113.509 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 -3.74 85.66 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.232 1.396 . . . . 1.0 115.204 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -70.04 143.43 52.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.636 . . . . 1.0 113.382 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.57 127.48 34.91 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.612 1.165 . . . . 1.0 108.594 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mt -117.07 127.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.722 0.809 . . . . 1.0 109.523 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -89.46 134.24 34.18 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.936 1.294 . . . . 1.0 108.169 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.66 119.49 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.877 1.271 . . . . 1.0 108.375 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -90.55 59.83 4.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.009 1.324 . . . . 1.0 110.985 -171.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -67.02 156.46 35.98 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.535 1.134 . . . . 1.0 111.396 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.0 tp -56.88 138.48 53.62 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.851 1.26 . . . . 1.0 111.565 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.42 -54.2 4.93 Favored Glycine 0 N--CA 1.473 1.144 0 C-N-CA 125.21 1.386 . . . . 1.0 112.996 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -147.28 142.63 27.38 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.724 1.61 . . . . 1.0 112.445 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.22 148.58 44.27 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.702 0.801 . . . . 1.0 110.99 170.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.462 ' CE1' ' HG ' ' A' ' 110' ' ' SER . 8.3 m80 -124.18 165.42 17.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.169 1.788 . . . . 1.0 109.14 175.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -133.86 148.63 51.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.313 -0.867 . . . . 1.0 112.841 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.36 151.49 40.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.235 1.014 . . . . 1.0 112.93 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.16 116.97 32.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.562 1.945 . . . . 1.0 108.306 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.3 133.04 35.22 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.135 -0.978 . . . . 1.0 112.356 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 pt -114.74 2.79 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 115.147 1.536 . . . . 1.0 115.147 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 166.63 32.86 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.353 0.978 . . . . 1.0 112.807 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.64 17.73 9.96 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.921 1.688 . . . . 1.0 114.143 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.57 80.95 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 125.11 1.338 . . . . 1.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -95.11 153.85 17.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.641 1.721 . . . . 1.0 114.672 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.59 158.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.031 1.732 . . . . 1.0 111.125 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.89 137.85 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 126.051 1.74 . . . . 1.0 106.718 168.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -154.38 149.31 26.72 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.215 -0.928 . . . . 1.0 111.625 -168.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.0 tp -86.12 130.1 34.64 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.69 119.57 47.45 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 124.505 1.122 . . . . 1.0 110.47 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -60.28 168.72 5.92 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.151 3.234 . . . . 1.0 113.108 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.11 133.57 58.88 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.908 3.072 . . . . 1.0 112.588 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 p -83.63 -20.63 33.32 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.491 0.922 . . . . 1.0 113.491 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.6 159.61 3.62 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.604 2.362 . . . . 1.0 109.578 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -64.18 139.19 97.63 Favored Pre-proline 0 CA--C 1.559 1.29 0 O-C-N 121.401 -0.812 . . . . 1.0 112.135 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -60.42 -42.5 40.69 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.478 2.785 . . . . 1.0 115.303 -173.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.15 -176.48 31.78 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 124.166 0.889 . . . . 1.0 113.519 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.53 60.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.645 0.609 . . . . 1.0 112.645 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.01 -141.52 15.63 Favored Glycine 0 C--N 1.344 1.023 0 C-N-CA 125.206 1.384 . . . . 1.0 112.421 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -63.31 -16.21 59.66 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.589 1.329 . . . . 1.0 114.589 -173.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -74.84 -27.46 60.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.134 0.974 . . . . 1.0 113.188 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.6 p -107.15 -50.04 3.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.609 1.164 . . . . 1.0 112.8 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t 73.09 -46.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 129.063 2.945 . . . . 1.0 112.426 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -72.55 -36.48 68.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.92 1.288 . . . . 1.0 113.666 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.8 p -87.16 1.0 54.4 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.517 1.302 . . . . 1.0 114.517 -170.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 m -68.25 147.13 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.147 0.979 . . . . 1.0 112.081 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.23 166.51 24.33 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.595 1.558 . . . . 1.0 110.929 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 m -68.91 148.04 50.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.865 0.866 . . . . 1.0 113.051 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -82.57 159.88 22.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.954 0.901 . . . . 1.0 112.135 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.9 p -158.28 151.0 22.35 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.314 1.046 . . . . 1.0 112.763 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -100.0 160.93 13.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.423 1.489 . . . . 1.0 110.06 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -132.36 140.98 48.73 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.433 -0.792 . . . . 1.0 110.813 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.12 126.89 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 170.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -132.66 163.28 29.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.38 1.472 . . . . 1.0 112.003 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -121.29 137.86 54.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.209 1.804 . . . . 1.0 110.393 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -163.46 178.69 7.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.079 1.351 . . . . 1.0 110.977 171.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.9 142.08 51.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.9 0.88 . . . . 1.0 111.115 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 tp -52.07 -52.0 54.02 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.371 1.068 . . . . 1.0 111.778 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -54.65 -47.92 72.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.074 0.95 . . . . 1.0 110.788 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.54 -39.21 93.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.985 0.514 . . . . 1.0 111.985 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.3 t -69.25 -44.99 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.724 1.21 . . . . 1.0 111.956 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.79 -36.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.48 1.036 . . . . 1.0 112.829 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.62 -119.55 18.72 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 119.499 1.045 . . . . 1.0 111.622 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.22 -3.86 86.9 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.543 1.068 . . . . 1.0 114.867 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.4 m -76.41 147.24 38.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.828 1.314 . . . . 1.0 111.429 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -78.84 166.28 22.6 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.175 0.59 . . . . 1.0 110.15 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -160.22 164.1 33.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.023 1.119 . . . . 1.0 114.023 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -156.38 158.54 37.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.956 1.303 . . . . 1.0 112.115 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.0 t -81.04 139.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.488 1.115 . . . . 1.0 108.657 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -150.88 80.55 1.33 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.22 1.008 . . . . 1.0 111.111 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.78 68.44 3.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.388 1.075 . . . . 1.0 111.124 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.3 p -64.65 -36.02 82.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.691 1.197 . . . . 1.0 113.331 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.57 -10.16 56.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.925 1.084 . . . . 1.0 113.925 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.15 -32.65 55.85 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.537 1.135 . . . . 1.0 112.181 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.13 -16.11 58.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.382 1.473 . . . . 1.0 112.877 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -103.79 -45.9 4.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.398 1.479 . . . . 1.0 112.185 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -128.67 162.55 27.08 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.133 1.373 . . . . 1.0 113.211 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -71.33 156.17 91.99 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.613 -0.68 . . . . 1.0 111.03 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -51.04 133.63 41.28 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.182 3.255 . . . . 1.0 113.508 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -98.66 153.8 37.76 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.359 1.464 . . . . 1.0 110.352 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.37 110.99 3.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.207 2.605 . . . . 1.0 110.749 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.42 -33.55 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.323 1.231 . . . . 1.0 114.323 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -37.98 84.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.134 0.425 . . . . 1.0 111.517 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.83 -36.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.523 0.729 . . . . 1.0 110.907 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -60.01 -48.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.589 0.631 . . . . 1.0 110.12 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.7 -39.47 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.083 0.953 . . . . 1.0 111.742 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -63.51 -38.28 90.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.567 1.076 . . . . 1.0 112.196 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -62.7 -45.6 92.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.501 -0.75 . . . . 1.0 111.021 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.26 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.434 0.693 . . . . 1.0 110.951 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.59 -39.48 91.35 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.925 0.89 . . . . 1.0 113.224 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.93 -34.01 77.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.785 0.834 . . . . 1.0 112.232 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.9 mmm -73.29 -40.64 64.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.349 -0.834 . . . . 1.0 112.649 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.07 128.36 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.483 1.038 . . . . 1.0 111.586 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.7 -14.06 63.38 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.569 1.556 . . . . 1.0 113.219 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -83.75 142.3 30.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.171 1.485 . . . . 1.0 111.242 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -95.32 147.2 23.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.164 1.385 . . . . 1.0 112.269 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 21.5 mmt -126.2 152.42 46.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.434 1.894 . . . . 1.0 110.237 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -61.77 157.76 17.25 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.709 -0.619 . . . . 1.0 112.668 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -61.61 135.62 57.71 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.469 -0.769 . . . . 1.0 112.258 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.6 m -106.93 -0.15 23.39 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -171.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.269 18.9 pt 58.1 -31.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 130.422 3.489 . . . . 1.0 116.382 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.18 150.43 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.942 2.497 . . . . 1.0 109.382 170.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.462 ' HG ' ' CE1' ' A' ' 23' ' ' HIS . 49.5 m -71.79 -7.79 50.34 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 -172.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -53.52 -28.55 31.86 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -60.54 -18.48 52.64 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 113.893 1.072 . . . . 1.0 113.893 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.3 m -59.59 -30.29 68.56 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.576 -1.328 . . . . 1.0 112.661 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -58.72 -56.76 17.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.462 0.573 . . . . 1.0 109.834 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -56.06 -32.21 63.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.756 0.822 . . . . 1.0 112.698 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -63.27 -57.84 9.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.64 -0.662 . . . . 1.0 110.491 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.74 -29.09 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.0 p -67.72 -41.98 82.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.656 1.116 . . . . 1.0 111.884 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -63.09 -23.26 67.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.987 0.915 . . . . 1.0 112.933 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.54 -30.21 71.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.399 0.999 . . . . 1.0 112.342 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -92.37 -53.72 4.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.27 1.428 . . . . 1.0 111.446 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -69.02 -35.3 76.48 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.881 1.067 . . . . 1.0 113.881 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.23 23.22 37.2 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.142 1.829 . . . . 1.0 113.755 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.86 150.41 13.17 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 118.311 1.056 . . . . 1.0 112.719 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.512 1.925 . . . . 1.0 114.904 -175.115 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 119.024 -0.513 . . . . 1.0 110.993 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.64 167.62 29.91 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.459 1.503 . . . . 1.0 112.009 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 t -159.13 146.66 13.22 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.154 1.382 . . . . 1.0 111.101 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.02 150.25 65.76 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.554 2.836 . . . . 1.0 113.576 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -87.07 156.5 19.71 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.937 0.895 . . . . 1.0 112.37 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.24 140.96 56.05 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.194 -0.941 . . . . 1.0 110.528 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.75 133.04 20.88 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.331 1.053 . . . . 1.0 109.929 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.45 147.97 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.634 2.889 . . . . 1.0 111.927 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -122.68 162.44 38.48 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.191 1.796 . . . . 1.0 111.728 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.57 127.09 11.23 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.822 3.014 . . . . 1.0 113.254 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.16 -8.51 77.62 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-O 118.495 -1.169 . . . . 1.0 115.303 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.28 143.38 57.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.326 1.563 . . . . 1.0 113.468 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.32 125.22 34.57 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.207 1.403 . . . . 1.0 109.341 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.3 mm -102.86 131.67 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.489 -1.3 . . . . 1.0 107.489 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -108.88 129.63 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.832 1.653 . . . . 1.0 108.231 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mt -126.81 118.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.9 1.28 . . . . 1.0 109.339 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -88.7 64.68 7.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.391 1.476 . . . . 1.0 110.539 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -62.78 151.67 38.05 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.749 0.82 . . . . 1.0 110.488 169.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.4 tp -55.55 129.65 39.76 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.215 1.006 . . . . 1.0 110.729 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.17 -123.58 6.2 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -169.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -65.6 137.76 57.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.278 1.031 . . . . 1.0 112.852 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.67 161.17 18.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.702 0.801 . . . . 1.0 111.271 170.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.91 165.22 22.51 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.93 1.692 . . . . 1.0 109.668 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -141.5 164.18 30.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.755 0.822 . . . . 1.0 112.537 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.98 154.45 35.0 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.74 115.19 27.51 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.029 1.732 . . . . 1.0 107.158 169.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -81.43 128.68 34.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.304 -0.873 . . . . 1.0 111.868 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.68 4.64 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.617 1.34 . . . . 1.0 114.617 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.71 169.82 40.15 Favored Glycine 0 N--CA 1.475 1.266 0 C-N-CA 124.292 0.949 . . . . 1.0 112.393 -173.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.78 16.14 8.77 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.004 1.722 . . . . 1.0 114.075 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 2.97 83.17 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.282 1.42 . . . . 1.0 114.205 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -98.66 154.34 18.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.749 1.775 . . . . 1.0 114.236 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.92 155.71 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.643 1.577 . . . . 1.0 111.309 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.5 mt -115.72 137.83 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.734 1.614 . . . . 1.0 107.327 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.34 147.41 24.64 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.982 -1.074 . . . . 1.0 111.636 -168.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.0 tp -87.48 128.55 35.23 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.392 -0.966 . . . . 1.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.36 139.92 23.78 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.721 1.208 . . . . 1.0 110.878 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.13 161.06 45.74 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.07 2.514 . . . . 1.0 111.267 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.21 137.77 48.99 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.583 2.855 . . . . 1.0 111.416 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 p -82.92 -9.09 59.47 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -174.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -158.45 144.27 16.86 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.503 1.921 . . . . 1.0 109.253 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . 0.267 49.4 m-85 86.71 -9.82 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.264 0 N-CA-C 118.972 2.952 . . . . 1.0 118.972 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -70.28 148.85 62.58 Favored 'Trans proline' 0 C--N 1.362 1.258 0 CA-C-N 124.87 2.775 . . . . 1.0 110.961 176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.15 7.57 87.6 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.042 -0.865 . . . . 1.0 114.105 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.93 163.55 14.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.68 1.192 . . . . 1.0 113.12 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.7 -157.32 22.28 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.906 1.241 . . . . 1.0 112.645 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.5 m -74.33 -17.05 60.89 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.571 0.952 . . . . 1.0 113.571 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -86.11 -163.81 0.94 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.084 1.754 . . . . 1.0 112.298 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.9 t -147.79 176.7 9.91 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.325 -1.485 . . . . 1.0 111.215 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.5 m -59.57 -26.44 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.021 -1.049 . . . . 1.0 113.274 -173.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -75.59 -28.13 58.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.218 1.007 . . . . 1.0 112.713 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 p -107.42 -14.16 14.93 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.791 1.237 . . . . 1.0 114.114 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.25 149.46 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.921 1.288 . . . . 1.0 111.456 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.1 mt -124.88 151.84 44.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.744 1.218 . . . . 1.0 110.124 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.2 p -163.46 156.02 18.18 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.892 0.877 . . . . 1.0 112.099 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 78.77 157.0 0.16 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 128.133 2.573 . . . . 1.0 111.955 -172.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -77.41 149.01 35.18 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.429 1.27 . . . . 1.0 114.429 -171.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.1 153.43 19.37 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.738 1.615 . . . . 1.0 110.837 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.7 139.04 54.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.499 1.12 . . . . 1.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.53 125.9 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.827 0.739 . . . . 1.0 109.013 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.98 162.93 29.52 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.93 1.692 . . . . 1.0 111.807 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.65 140.81 50.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.722 1.609 . . . . 1.0 110.227 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -162.09 179.7 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.018 1.327 . . . . 1.0 111.076 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.9 145.21 48.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.947 0.899 . . . . 1.0 111.413 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -52.16 -53.56 41.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.631 1.172 . . . . 1.0 111.227 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.1 -43.77 74.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.471 1.109 . . . . 1.0 111.627 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -44.04 91.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.317 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.56 -42.6 72.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.38 1.072 . . . . 1.0 112.207 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.27 -3.02 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.74 128.93 48.1 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.493 1.044 . . . . 1.0 113.555 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.04 1.23 79.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.864 1.221 . . . . 1.0 114.839 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.3 m -125.66 158.14 35.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.026 1.73 . . . . 1.0 111.561 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.9 m -86.08 156.17 20.5 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -158.97 164.52 35.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.565 1.321 . . . . 1.0 114.565 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -161.3 163.35 30.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.37 1.468 . . . . 1.0 112.169 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.0 t -82.11 135.47 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 107.329 -1.36 . . . . 1.0 107.329 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -146.97 74.79 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.269 1.033 . . . . 1.0 111.215 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -77.94 57.97 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.543 1.537 . . . . 1.0 111.486 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 t -60.78 -40.32 92.12 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.515 -1.366 . . . . 1.0 112.498 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.5 mt -70.82 -10.28 59.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.56 -28.74 70.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.273 0.942 . . . . 1.0 112.58 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -84.08 -4.82 59.04 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.313 1.445 . . . . 1.0 111.825 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -103.67 -47.29 4.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.379 1.472 . . . . 1.0 111.698 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -129.49 150.68 50.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.101 1.36 . . . . 1.0 113.497 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -65.32 152.29 92.27 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.346 1.058 . . . . 1.0 111.382 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.94 133.69 23.93 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.039 2.493 . . . . 1.0 112.784 -170.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -83.74 160.62 58.17 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.555 . . . . 1.0 112.024 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.6 115.52 3.77 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.691 2.928 . . . . 1.0 110.045 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.96 -30.49 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -169.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.74 -35.08 77.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.201 0.601 . . . . 1.0 112.112 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.81 -37.88 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.65 -0.656 . . . . 1.0 110.576 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.3 mt -64.07 -48.67 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.397 0.679 . . . . 1.0 110.235 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -71.68 -41.02 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.32 1.048 . . . . 1.0 112.27 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.4 p -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.878 1.217 . . . . 1.0 111.81 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.2 m -61.39 -45.0 96.19 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.683 -0.636 . . . . 1.0 111.767 169.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.31 -48.71 78.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.797 0.726 . . . . 1.0 110.585 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.16 -40.46 96.07 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.082 0.953 . . . . 1.0 112.972 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.59 -32.34 73.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.678 0.791 . . . . 1.0 112.475 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.8 mmm -73.7 -37.95 65.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.835 0.854 . . . . 1.0 112.89 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.5 t -47.21 126.96 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.594 1.088 . . . . 1.0 111.372 170.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.56 61.24 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.895 1.712 . . . . 1.0 113.929 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.6 162.97 17.7 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.034 1.417 . . . . 1.0 111.403 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.63 160.85 27.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.373 1.469 . . . . 1.0 113.046 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.9 mtt -134.58 143.04 47.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.278 1.431 . . . . 1.0 112.182 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -77.71 166.79 22.54 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.894 1.277 . . . . 1.0 113.013 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -106.7 163.77 12.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.918 1.687 . . . . 1.0 112.718 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.6 m 71.01 -31.12 0.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 127.955 2.502 . . . . 1.0 114.071 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.6 tt -56.26 -34.9 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.771 2.028 . . . . 1.0 113.874 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.75 156.44 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 126.775 2.03 . . . . 1.0 109.723 172.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.7 p -83.39 -68.48 0.71 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.178 0.991 . . . . 1.0 112.758 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -83.31 51.87 2.08 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.629 1.572 . . . . 1.0 111.701 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -51.81 -40.0 59.69 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.641 1.576 . . . . 1.0 114.392 -170.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.25 -38.26 75.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.301 0.955 . . . . 1.0 113.352 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.63 -54.83 41.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 1.0 109.609 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -60.31 -29.08 68.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.643 0.777 . . . . 1.0 113.018 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.38 -59.88 3.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.39 -0.819 . . . . 1.0 109.928 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.63 -30.43 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.9 p -67.87 -44.48 76.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.577 1.081 . . . . 1.0 112.127 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.05 -25.16 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.068 0.947 . . . . 1.0 112.945 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.26 -29.14 67.34 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.216 0.916 . . . . 1.0 112.807 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -96.97 -53.71 3.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.629 1.172 . . . . 1.0 111.708 169.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -64.77 -28.85 69.86 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.207 1.188 . . . . 1.0 114.207 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.44 -4.21 86.96 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.944 0.783 . . . . 1.0 114.328 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -109.16 169.14 8.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.513 1.925 . . . . 1.0 111.859 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.389 1.876 . . . . 1.0 111.593 179.303 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 120.401 0.143 . . . . 1.0 110.975 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.5 160.76 30.51 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.199 1.0 . . . . 1.0 112.84 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 p -76.51 154.49 83.78 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.761 1.225 . . . . 1.0 112.762 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.7 162.81 37.05 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.502 2.801 . . . . 1.0 111.795 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -157.66 161.96 38.63 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.95 1.3 . . . . 1.0 111.323 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -72.01 151.33 43.27 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.56 -0.712 . . . . 1.0 111.699 171.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -116.81 130.28 24.68 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.552 1.141 . . . . 1.0 109.051 169.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.85 147.12 26.93 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.989 3.126 . . . . 1.0 111.376 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -127.29 156.11 75.33 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.187 1.795 . . . . 1.0 112.731 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.83 124.26 5.54 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.2 3.266 . . . . 1.0 113.677 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.11 -0.03 89.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.068 -1.407 . . . . 1.0 115.897 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.1 159.17 32.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.102 1.951 . . . . 1.0 114.241 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 124.67 34.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.615 1.166 . . . . 1.0 108.943 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.5 mt -100.34 124.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -88.68 116.33 26.86 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.52 129.86 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.165 0.986 . . . . 1.0 108.859 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -114.03 99.52 7.71 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.782 1.633 . . . . 1.0 108.997 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -84.92 175.06 9.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.212 1.405 . . . . 1.0 110.329 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.71 104.51 1.06 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.603 0.761 . . . . 1.0 109.877 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -0.32 89.28 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.112 1.339 . . . . 1.0 116.001 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -150.44 137.28 19.16 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.518 1.659 . . . . 1.0 113.762 -173.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.37 139.01 37.62 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.128 1.771 . . . . 1.0 110.77 172.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.19 127.52 18.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.494 1.517 . . . . 1.0 110.108 174.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 144.87 25.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.818 -1.176 . . . . 1.0 110.48 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.5 154.0 44.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.423 1.489 . . . . 1.0 112.064 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.18 112.39 24.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.36 1.464 . . . . 1.0 108.426 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -83.67 133.86 34.8 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.007 -1.058 . . . . 1.0 112.091 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 38.7 pt -110.04 15.55 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -170.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -27.34 10.66 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 116.388 1.315 . . . . 1.0 116.388 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.44 13.13 26.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.359 1.063 . . . . 1.0 113.691 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.82 -4.6 83.5 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.704 1.145 . . . . 1.0 112.483 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -96.66 155.46 16.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.58 1.552 . . . . 1.0 112.906 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.82 152.69 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.601 1.56 . . . . 1.0 110.26 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.7 mt -117.83 138.11 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.14 1.376 . . . . 1.0 108.048 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -161.62 168.76 22.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.024 0.929 . . . . 1.0 110.463 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.3 tp -89.69 150.87 22.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.67 119.64 28.08 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.871 1.268 . . . . 1.0 108.662 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.47 159.97 28.88 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.042 2.494 . . . . 1.0 111.753 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.81 116.42 4.56 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.456 2.771 . . . . 1.0 110.382 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.3 p -83.65 -20.88 32.82 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -94.18 20.52 7.93 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.651 1.58 . . . . 1.0 112.159 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -55.8 132.04 72.75 Favored Pre-proline 0 CA--C 1.555 1.136 0 O-C-N 120.692 -1.255 . . . . 1.0 112.421 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.11 131.31 15.25 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.195 2.597 . . . . 1.0 111.459 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.58 7.58 24.28 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-O 118.91 -0.939 . . . . 1.0 115.252 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.62 128.98 38.07 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.879 1.339 . . . . 1.0 112.432 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.04 -40.22 10.68 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 123.907 0.765 . . . . 1.0 113.735 -170.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 p -68.26 -30.88 70.02 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.207 1.003 . . . . 1.0 113.416 -175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.6 p -93.15 -1.29 56.5 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.108 1.363 . . . . 1.0 113.13 172.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 m 66.59 8.26 5.71 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.657 1.983 . . . . 1.0 114.127 175.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.07 -12.58 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.665 -1.272 . . . . 1.0 114.325 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -67.58 -23.53 65.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.508 0.723 . . . . 1.0 111.997 169.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.3 p -121.83 -37.49 2.86 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.037 1.335 . . . . 1.0 113.74 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.52 155.75 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.512 1.051 . . . . 1.0 111.845 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.4 mt 66.44 -166.13 0.22 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.265 1.826 . . . . 1.0 111.724 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.6 p -166.75 165.2 16.5 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.265 1.426 . . . . 1.0 112.279 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -136.57 175.02 9.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.943 1.697 . . . . 1.0 110.595 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -105.88 130.99 53.73 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.945 -1.097 . . . . 1.0 113.822 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.49 149.5 22.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.241 1.817 . . . . 1.0 109.036 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.26 143.29 49.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.293 0.951 . . . . 1.0 111.646 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.49 124.21 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.65 157.42 42.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.13 1.372 . . . . 1.0 112.742 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -117.81 134.37 54.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.306 1.842 . . . . 1.0 110.215 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -159.38 174.89 14.05 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.993 0.917 . . . . 1.0 110.406 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.2 mtp85 -64.68 145.07 56.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.74 0.816 . . . . 1.0 110.893 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt -51.54 -52.31 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.032 0.933 . . . . 1.0 110.675 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -50.6 -50.56 53.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.004 1.322 . . . . 1.0 111.601 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.48 -43.79 89.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.256 0.623 . . . . 1.0 112.052 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.84 -40.89 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.248 1.019 . . . . 1.0 112.142 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 p -80.46 -35.29 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.947 0.794 . . . . 1.0 112.846 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.77 -130.37 47.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.877 0.762 . . . . 1.0 112.406 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.8 5.14 83.62 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.88 1.229 . . . . 1.0 114.734 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.2 m -79.19 160.13 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.611 1.206 . . . . 1.0 112.16 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.83 155.66 27.74 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.079 0.952 . . . . 1.0 111.124 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.02 163.67 33.84 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.319 1.229 . . . . 1.0 114.319 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -158.66 158.51 33.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.818 1.647 . . . . 1.0 111.283 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.4 t -86.13 134.45 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.193 0.997 . . . . 1.0 108.503 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -163.06 93.52 0.8 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.838 0.855 . . . . 1.0 111.804 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.33 109.05 10.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.37 0.668 . . . . 1.0 110.793 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.6 p -76.54 -51.5 11.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.545 1.138 . . . . 1.0 111.939 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.76 -14.18 62.86 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.463 1.105 . . . . 1.0 113.906 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.56 -30.1 62.74 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.285 1.034 . . . . 1.0 112.197 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -89.49 -6.34 56.52 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.09 1.356 . . . . 1.0 112.534 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -100.43 -49.27 4.28 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.367 1.467 . . . . 1.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.0 170.26 14.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.817 1.647 . . . . 1.0 112.505 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.64 139.75 83.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 121.317 -0.865 . . . . 1.0 108.861 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.27 143.45 77.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.473 2.782 . . . . 1.0 112.427 -170.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -86.0 162.09 47.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.368 0.667 . . . . 1.0 111.121 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.49 117.87 4.82 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.465 2.777 . . . . 1.0 111.535 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.77 -33.13 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.332 0.864 . . . . 1.0 113.332 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.06 -37.68 85.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.961 0.504 . . . . 1.0 111.37 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -34.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.535 0.734 . . . . 1.0 110.929 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.96 -43.06 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.362 0.983 . . . . 1.0 110.862 174.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.48 -36.83 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.885 -1.134 . . . . 1.0 111.599 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 t -69.58 -39.86 77.09 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.455 -0.778 . . . . 1.0 111.391 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.8 p -65.53 -40.23 92.69 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.89 0.876 . . . . 1.0 111.25 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.22 -53.5 57.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 1.0 110.808 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.75 -41.23 90.54 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.561 0.744 . . . . 1.0 112.847 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -65.9 -35.36 80.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.022 0.929 . . . . 1.0 112.559 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.76 -29.72 51.15 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.042 -0.98 . . . . 1.0 113.347 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.5 t -48.03 125.41 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.477 1.489 . . . . 1.0 111.17 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.64 -13.28 62.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.448 1.499 . . . . 1.0 114.318 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -75.81 155.88 35.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.197 1.499 . . . . 1.0 110.896 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.97 148.13 45.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.868 1.267 . . . . 1.0 112.604 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.1 mmt -124.97 151.2 45.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.87 2.068 . . . . 1.0 110.499 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -72.73 153.04 41.34 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.591 -0.693 . . . . 1.0 111.435 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -151.82 136.74 17.24 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.753 1.221 . . . . 1.0 111.387 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.2 p -130.64 1.94 4.48 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.817 1.414 . . . . 1.0 114.817 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.27 16.9 pt 57.63 -31.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 130.004 3.321 . . . . 1.0 115.063 -169.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 99.2 t -67.81 -37.45 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.862 2.065 . . . . 1.0 110.377 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t -119.49 162.16 19.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.844 1.258 . . . . 1.0 111.511 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -146.15 145.59 30.54 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.651 1.58 . . . . 1.0 111.382 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -139.74 5.74 2.2 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 115.274 1.583 . . . . 1.0 115.274 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.0 m -59.25 -35.0 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.718 -1.239 . . . . 1.0 114.334 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.49 -49.19 13.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.149 1.379 . . . . 1.0 111.184 174.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -55.26 -35.04 64.58 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.244 1.017 . . . . 1.0 112.399 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -51.81 -51.5 55.99 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.641 -0.662 . . . . 1.0 112.494 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.35 -22.76 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.833 1.197 . . . . 1.0 113.557 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.5 p -74.79 -39.33 61.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.296 0.953 . . . . 1.0 110.922 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.97 -26.03 67.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.894 0.878 . . . . 1.0 113.127 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.05 -32.68 71.15 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 120.017 1.281 . . . . 1.0 113.247 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -89.62 -51.36 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.681 1.193 . . . . 1.0 110.978 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.21 -38.24 84.97 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.38 0.882 . . . . 1.0 113.38 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.74 38.54 3.27 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 126.962 2.22 . . . . 1.0 112.476 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.18 152.33 3.34 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.382 1.073 . . . . 1.0 112.877 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.905 1.682 . . . . 1.0 114.964 -172.765 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 120.24 0.067 . . . . 1.0 110.932 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.73 163.55 27.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.274 1.03 . . . . 1.0 112.922 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 m -66.2 148.25 98.53 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.998 0.919 . . . . 1.0 112.814 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.57 160.46 44.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.632 2.888 . . . . 1.0 111.677 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -76.92 -8.68 57.8 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.898 1.073 . . . . 1.0 113.898 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -158.5 146.44 18.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.954 1.702 . . . . 1.0 109.82 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.17 134.91 13.85 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.509 1.124 . . . . 1.0 109.778 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.24 143.3 22.25 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.55 2.834 . . . . 1.0 111.387 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -115.27 160.07 35.63 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.939 1.696 . . . . 1.0 112.003 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -56.47 131.18 44.17 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.694 1.596 . . . . 1.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.97 -3.41 80.79 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.977 1.275 . . . . 1.0 114.348 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.29 149.83 38.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.101 1.45 . . . . 1.0 112.949 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.68 124.62 35.23 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.596 1.159 . . . . 1.0 109.379 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.57 130.5 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -110.66 129.5 55.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.389 2.276 . . . . 1.0 107.961 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.9 mt -125.26 120.34 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.1 1.36 . . . . 1.0 109.466 -169.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -90.65 76.35 6.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.377 1.471 . . . . 1.0 109.669 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -76.72 168.42 20.11 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.219 1.008 . . . . 1.0 111.49 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.9 tp -61.44 133.46 55.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.902 0.881 . . . . 1.0 110.203 169.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.86 -132.25 11.08 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.599 -1.0 . . . . 1.0 110.599 -170.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -67.04 151.19 48.1 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.563 0.745 . . . . 1.0 112.937 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -67.12 165.99 14.82 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.994 1.318 . . . . 1.0 111.028 169.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -138.36 164.0 30.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.912 1.285 . . . . 1.0 111.272 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -141.71 153.66 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.257 -0.902 . . . . 1.0 113.286 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.07 154.87 39.9 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.751 1.22 . . . . 1.0 112.627 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.08 118.83 35.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.555 1.942 . . . . 1.0 108.443 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -82.06 130.56 35.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.186 -0.947 . . . . 1.0 112.156 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 pt -104.41 6.32 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 114.618 1.34 . . . . 1.0 114.618 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.99 -17.17 56.51 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 116.649 1.42 . . . . 1.0 116.649 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.13 13.67 26.49 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.813 1.245 . . . . 1.0 113.532 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -5.84 84.42 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.114 1.34 . . . . 1.0 112.305 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.61 156.53 16.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.867 1.667 . . . . 1.0 112.517 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -126.51 155.14 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.996 1.718 . . . . 1.0 109.888 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.54 138.47 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 168.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -159.86 175.55 12.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.324 1.05 . . . . 1.0 110.773 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.22 153.46 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.325 0.65 . . . . 1.0 109.263 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.68 113.23 66.01 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 168.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.15 148.96 56.58 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.619 2.879 . . . . 1.0 113.885 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.76 173.68 12.61 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.878 3.052 . . . . 1.0 112.257 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 t -149.25 167.6 25.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.536 1.535 . . . . 1.0 111.024 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.22 126.04 26.47 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.705 0.802 . . . . 1.0 111.16 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -68.25 141.39 93.73 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 112.683 0.623 . . . . 1.0 112.683 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -82.79 -171.12 1.06 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.495 3.464 . . . . 1.0 111.627 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.5 -15.08 60.36 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.124 1.345 . . . . 1.0 114.523 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.29 -31.29 58.14 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.323 1.049 . . . . 1.0 112.864 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.33 -155.01 16.02 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.025 1.774 . . . . 1.0 112.548 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.1 m -71.66 -26.74 62.66 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -78.78 143.42 36.11 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.559 1.144 . . . . 1.0 112.017 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.5 t -132.1 -172.84 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.119 1.367 . . . . 1.0 112.304 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.48 -20.59 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 120.607 -1.308 . . . . 1.0 113.115 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -81.62 -23.22 37.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.458 1.103 . . . . 1.0 112.404 171.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 m -79.08 -32.23 44.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.716 1.206 . . . . 1.0 111.585 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.8 p -148.62 112.2 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.409 1.084 . . . . 1.0 111.028 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.39 -35.05 21.59 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.689 0.796 . . . . 1.0 112.521 -171.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 t -76.8 111.72 12.63 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.658 -0.651 . . . . 1.0 110.301 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -128.36 -77.42 0.56 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.417 1.087 . . . . 1.0 109.864 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 p -70.84 168.62 16.41 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.4 1.08 . . . . 1.0 112.65 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.82 155.49 25.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.441 -0.787 . . . . 1.0 112.001 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -141.78 142.57 33.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.014 0.926 . . . . 1.0 110.86 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.12 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -137.92 162.07 34.99 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.171 1.388 . . . . 1.0 112.595 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.6 ttp85 -112.69 136.44 52.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.287 1.835 . . . . 1.0 110.029 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.58 173.85 16.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.502 1.121 . . . . 1.0 110.557 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -66.17 143.62 57.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.763 1.625 . . . . 1.0 110.441 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 tt -52.8 -55.83 20.15 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.165 0.986 . . . . 1.0 110.478 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -52.58 -47.53 66.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.606 1.163 . . . . 1.0 111.635 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.77 -41.5 99.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.862 0.465 . . . . 1.0 111.687 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.49 -44.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.109 0.963 . . . . 1.0 112.356 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -74.6 -32.73 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 119.402 1.001 . . . . 1.0 112.768 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.54 -134.21 52.49 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.142 0.877 . . . . 1.0 112.904 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.47 0.99 87.25 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.78 1.181 . . . . 1.0 114.47 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.5 m -81.92 148.1 28.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.916 1.286 . . . . 1.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.82 156.18 39.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.387 0.675 . . . . 1.0 110.962 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -156.98 162.6 39.6 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.533 1.309 . . . . 1.0 114.533 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -160.12 165.58 31.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.262 1.825 . . . . 1.0 111.414 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.0 t -84.56 140.14 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.174 0.99 . . . . 1.0 108.836 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -146.24 74.21 1.36 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.423 1.089 . . . . 1.0 111.762 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -76.04 70.25 2.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.487 1.115 . . . . 1.0 111.312 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -60.37 -33.72 72.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.859 -1.151 . . . . 1.0 113.376 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.6 mt -71.47 -9.74 58.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.28 -34.56 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.467 1.107 . . . . 1.0 112.181 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.274 1.43 . . . . 1.0 112.741 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -104.43 -47.82 4.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.263 1.425 . . . . 1.0 112.576 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -131.15 156.33 45.46 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.899 1.28 . . . . 1.0 113.532 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.62 155.37 92.53 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.192 -0.909 . . . . 1.0 110.021 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.63 129.76 36.69 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.763 2.976 . . . . 1.0 114.926 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 159.33 85.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.48 1.112 . . . . 1.0 111.704 169.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.43 109.91 2.96 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.462 2.775 . . . . 1.0 110.151 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 p -52.89 -37.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.176 1.547 . . . . 1.0 115.176 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.524 0.602 . . . . 1.0 111.598 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 t -75.85 -31.67 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.706 0.802 . . . . 1.0 110.931 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.1 mt -64.46 -49.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.732 1.151 . . . . 1.0 109.976 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.44 -40.27 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.373 1.069 . . . . 1.0 110.667 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.2 m -68.56 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.523 -0.736 . . . . 1.0 111.981 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.4 m -63.26 -44.08 96.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.696 1.198 . . . . 1.0 110.763 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.64 77.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.433 0.693 . . . . 1.0 111.051 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -61.84 -38.36 87.91 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.147 -0.971 . . . . 1.0 113.173 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -66.09 -34.16 77.43 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.609 0.764 . . . . 1.0 112.307 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.4 mmm -74.83 -37.9 62.16 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.316 -0.85 . . . . 1.0 112.872 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.7 t -47.09 129.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.711 1.142 . . . . 1.0 111.684 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -16.43 60.57 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.934 1.73 . . . . 1.0 114.068 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -83.01 148.88 27.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.047 1.424 . . . . 1.0 111.267 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.1 156.61 17.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.151 1.38 . . . . 1.0 113.372 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtt -140.23 167.73 21.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.934 1.694 . . . . 1.0 111.974 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -67.48 177.09 2.06 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.203 1.557 . . . . 1.0 115.203 -170.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.37 0.87 39.85 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.885 1.674 . . . . 1.0 115.114 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -55.89 120.88 8.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.779 1.232 . . . . 1.0 112.803 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.28 -10.65 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 116.051 1.871 . . . . 1.0 116.051 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 63.7 t -79.39 108.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 119.072 0.851 . . . . 1.0 109.083 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.3 m -63.73 -8.95 11.86 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.405 2.002 . . . . 1.0 116.405 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -60.56 -19.31 57.03 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.588 -1.32 . . . . 1.0 112.561 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -56.39 -28.47 59.37 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 120.354 -1.466 . . . . 1.0 112.474 169.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.8 m -69.56 -39.19 77.55 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.501 1.046 . . . . 1.0 112.85 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -57.57 -56.92 15.65 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.718 0.69 . . . . 1.0 109.255 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -58.61 -30.12 66.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.798 0.839 . . . . 1.0 113.128 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -67.23 -56.41 9.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.214 -0.928 . . . . 1.0 111.039 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.51 -26.12 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 -172.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.4 p -65.87 -44.65 84.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.703 1.138 . . . . 1.0 110.76 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.39 -24.57 66.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.339 0.866 . . . . 1.0 113.339 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.8 mt -61.77 -30.42 70.78 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.203 1.365 . . . . 1.0 112.835 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -94.06 -56.37 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.319 1.447 . . . . 1.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -65.98 -39.06 90.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.764 -1.21 . . . . 1.0 113.359 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.18 24.3 32.62 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.404 1.954 . . . . 1.0 113.42 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 150.04 5.02 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.26 1.024 . . . . 1.0 112.34 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.596 1.958 . . . . 1.0 115.459 -175.784 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 120.184 0.04 . . . . 1.0 111.003 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.59 164.83 26.12 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.107 0.963 . . . . 1.0 112.616 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.3 p -75.2 159.21 82.94 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.199 1.0 . . . . 1.0 112.893 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.76 145.81 94.77 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.763 2.975 . . . . 1.0 113.473 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -162.73 169.77 19.45 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.76 1.624 . . . . 1.0 110.851 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -75.57 148.05 39.17 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.25 -0.906 . . . . 1.0 112.287 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -137.61 126.69 14.93 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.206 1.402 . . . . 1.0 108.745 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.75 150.28 27.23 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.185 2.59 . . . . 1.0 112.441 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -126.44 158.92 65.62 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.138 1.775 . . . . 1.0 112.31 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -46.37 127.75 11.58 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.332 3.354 . . . . 1.0 113.083 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.56 -8.21 77.08 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.987 1.28 . . . . 1.0 115.126 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -67.55 143.55 56.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.251 1.525 . . . . 1.0 113.573 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.62 127.25 34.42 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.976 1.31 . . . . 1.0 108.155 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mt -112.63 131.19 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -102.85 138.77 39.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.558 1.143 . . . . 1.0 109.082 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.24 134.9 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.557 1.943 . . . . 1.0 108.396 -169.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -114.21 93.69 4.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.283 . . . . 1.0 109.243 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.2 mtt-85 -81.12 167.18 19.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.705 0.802 . . . . 1.0 110.463 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.15 105.4 0.59 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.635 0.774 . . . . 1.0 110.917 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.27 -3.27 84.06 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.232 1.396 . . . . 1.0 116.176 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -165.61 144.02 6.05 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.874 1.837 . . . . 1.0 114.941 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.18 159.73 24.53 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.652 1.581 . . . . 1.0 113.047 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -151.1 159.38 44.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.1 2.16 . . . . 1.0 109.034 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -138.92 160.49 39.61 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.676 -1.265 . . . . 1.0 112.252 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.95 152.83 33.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.729 0.812 . . . . 1.0 112.756 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.9 116.06 31.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.672 1.989 . . . . 1.0 106.995 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -82.24 129.67 34.9 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.59 -0.694 . . . . 1.0 111.91 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.92 4.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 -170.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.01 163.73 31.11 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 124.598 1.094 . . . . 1.0 113.08 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 t70 60.8 20.06 10.22 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.02 1.728 . . . . 1.0 114.312 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.7 71.68 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.551 1.548 . . . . 1.0 114.625 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.42 153.8 18.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.585 1.693 . . . . 1.0 113.951 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.4 157.76 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.58 1.552 . . . . 1.0 111.58 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.8 mt -121.0 141.07 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.754 1.622 . . . . 1.0 108.183 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -154.52 163.19 40.57 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.063 -1.023 . . . . 1.0 110.92 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.8 tp -104.92 119.41 38.95 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 1.0 108.752 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.78 135.59 30.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.174 -0.917 . . . . 1.0 110.11 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.56 161.47 44.0 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.933 2.422 . . . . 1.0 111.425 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.82 151.17 85.01 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.01 2.473 . . . . 1.0 113.244 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m -66.48 -24.34 66.4 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.375 0.88 . . . . 1.0 113.375 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -160.57 92.37 0.96 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.228 1.811 . . . . 1.0 108.954 171.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -65.76 159.98 64.91 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.402 1.481 . . . . 1.0 114.622 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.67 156.32 64.46 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.066 2.511 . . . . 1.0 110.843 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.38 86.5 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.093 -0.837 . . . . 1.0 114.921 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.27 -25.33 66.82 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 118.699 1.25 . . . . 1.0 112.851 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.19 18.99 40.66 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.847 1.213 . . . . 1.0 115.017 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -158.44 -111.88 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.438 1.119 . . . . 1.0 110.726 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 m -54.64 -19.52 6.26 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.686 1.594 . . . . 1.0 113.332 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.0 p -49.83 -36.51 26.89 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.569 1.548 . . . . 1.0 112.46 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.62 -17.35 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.555 1.07 . . . . 1.0 113.505 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -100.36 -43.78 6.13 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.789 1.235 . . . . 1.0 110.111 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.6 m -65.52 -17.37 64.51 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.937 1.088 . . . . 1.0 113.937 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -54.64 -22.61 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 120.396 1.453 . . . . 1.0 113.455 169.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.13 -12.21 59.99 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.41 1.084 . . . . 1.0 113.525 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 m -131.99 -35.81 1.21 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.857 1.428 . . . . 1.0 114.857 -169.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -74.57 150.27 39.78 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.261 0.937 . . . . 1.0 113.414 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.1 p -166.23 156.5 12.39 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.824 1.25 . . . . 1.0 111.992 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.13 145.83 24.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.151 0.98 . . . . 1.0 110.37 170.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.39 138.49 34.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.823 0.849 . . . . 1.0 111.412 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.74 129.03 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -134.98 156.46 49.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.675 1.59 . . . . 1.0 112.025 -173.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -117.8 140.11 50.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.062 1.745 . . . . 1.0 110.331 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -164.59 -179.97 6.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.561 1.144 . . . . 1.0 110.846 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.06 143.97 52.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.295 1.038 . . . . 1.0 110.476 170.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.7 tt -49.8 -56.87 8.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.912 1.285 . . . . 1.0 110.831 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.05 -49.17 63.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.509 1.124 . . . . 1.0 111.256 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.07 -34.05 76.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.33 0.652 . . . . 1.0 112.69 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.73 -45.58 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.903 0.881 . . . . 1.0 111.951 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -81.5 -32.97 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.516 1.053 . . . . 1.0 113.832 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.67 -123.64 32.37 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.54 1.063 . . . . 1.0 111.256 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.73 2.07 85.76 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.646 1.117 . . . . 1.0 114.719 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.12 147.49 34.6 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.723 1.261 . . . . 1.0 111.755 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 23.9 t -75.16 156.97 35.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.68 0.792 . . . . 1.0 110.952 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.93 161.82 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -161.06 160.17 30.16 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.708 1.603 . . . . 1.0 111.862 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.3 t -79.68 139.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.941 0.897 . . . . 1.0 109.334 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -149.26 79.06 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.439 1.096 . . . . 1.0 111.401 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.22 72.29 4.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.58 1.152 . . . . 1.0 110.89 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.9 p -67.85 -46.18 72.49 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.591 1.156 . . . . 1.0 112.79 -172.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.8 mt -75.58 -8.35 56.54 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -174.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.86 -27.46 68.14 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.96 0.886 . . . . 1.0 113.128 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -79.39 -15.4 57.91 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.429 1.492 . . . . 1.0 112.288 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -102.03 -39.93 7.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.556 1.543 . . . . 1.0 112.237 -174.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -126.98 160.7 30.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.732 1.613 . . . . 1.0 113.159 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -66.06 159.19 72.52 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.545 1.138 . . . . 1.0 111.342 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.43 127.03 19.79 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.667 2.245 . . . . 1.0 110.796 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -95.34 157.38 36.4 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.134 1.374 . . . . 1.0 110.181 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.51 111.2 2.9 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.86 2.373 . . . . 1.0 110.674 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.93 -32.52 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.612 1.165 . . . . 1.0 112.815 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.18 -36.81 75.97 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.049 0.54 . . . . 1.0 112.237 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.58 -37.81 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.817 0.847 . . . . 1.0 110.776 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.83 -48.69 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 1.0 110.156 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.7 mt -68.33 -39.27 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.258 1.023 . . . . 1.0 111.836 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -61.17 -42.87 99.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.419 1.009 . . . . 1.0 111.42 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 -43.67 98.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 1.0 111.756 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.11 73.93 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.328 -0.857 . . . . 1.0 110.746 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.13 -38.29 88.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.311 1.044 . . . . 1.0 113.203 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.97 -36.34 83.06 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.585 0.754 . . . . 1.0 112.117 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.0 mmm -73.22 -38.36 66.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.881 0.873 . . . . 1.0 112.752 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.95 129.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.167 0.894 . . . . 1.0 111.606 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.52 66.51 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.711 1.624 . . . . 1.0 113.479 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -87.14 145.38 26.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.961 1.38 . . . . 1.0 111.477 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -95.32 148.27 22.61 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.761 1.224 . . . . 1.0 112.399 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.8 mmt -128.48 176.26 7.88 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.522 1.529 . . . . 1.0 112.001 -173.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.94 162.97 8.29 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.601 1.161 . . . . 1.0 112.887 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -71.93 168.33 18.2 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.64 1.176 . . . . 1.0 113.94 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.3 t -148.21 140.14 23.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.828 1.251 . . . . 1.0 109.767 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.7 tt -118.57 43.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 125.866 1.666 . . . . 1.0 107.497 169.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 t 64.02 47.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.943 1.697 . . . . 1.0 108.042 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.2 p -120.09 12.44 11.9 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.564 1.546 . . . . 1.0 114.402 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 82.07 133.52 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 129.596 3.158 . . . . 1.0 111.551 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -177.57 -58.8 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.119 2.168 . . . . 1.0 111.391 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.99 -40.04 60.91 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.914 1.079 . . . . 1.0 113.914 -169.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -49.56 76.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.196 0.453 . . . . 1.0 110.18 170.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -61.52 -36.59 80.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.958 0.903 . . . . 1.0 111.814 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.05 -57.22 13.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.866 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.96 -28.13 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.828 1.194 . . . . 1.0 113.637 -173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.6 p -71.75 -39.72 69.82 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.846 1.203 . . . . 1.0 112.582 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -57.46 -26.62 61.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.812 0.845 . . . . 1.0 112.484 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.4 mt -62.31 -31.45 72.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.296 0.953 . . . . 1.0 112.719 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -88.75 -55.82 3.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.548 1.139 . . . . 1.0 111.18 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -65.37 -35.9 82.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -171.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.47 39.73 2.79 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.923 2.201 . . . . 1.0 112.282 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -42.93 -54.95 3.96 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.712 1.605 . . . . 1.0 115.171 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.253 1.271 0 C-N-CA 128.13 2.572 . . . . 1.0 114.584 -172.266 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 ttp . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 110.489 -0.189 . . . . 1.0 110.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.44 157.42 35.64 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.275 1.03 . . . . 1.0 112.966 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 p -80.96 152.29 71.48 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.355 1.062 . . . . 1.0 112.51 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.83 -23.4 5.64 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.28 2.653 . . . . 1.0 113.734 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -149.37 166.51 28.82 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.472 1.509 . . . . 1.0 111.501 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -70.82 127.38 32.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.292 1.437 . . . . 1.0 110.958 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.35 129.16 56.54 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 121.572 -0.705 . . . . 1.0 112.457 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -86.63 155.82 9.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.986 3.79 . . . . 1.0 112.471 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.09 168.3 17.24 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.812 2.045 . . . . 1.0 112.476 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -50.16 127.23 19.18 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.608 2.872 . . . . 1.0 113.402 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.5 -2.84 86.5 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.341 -1.255 . . . . 1.0 115.011 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -75.01 148.17 40.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.678 1.739 . . . . 1.0 113.011 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -93.96 129.89 40.26 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.203 1.401 . . . . 1.0 110.177 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.45 133.09 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.174 0.99 . . . . 1.0 108.94 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.49 128.34 52.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.683 1.593 . . . . 1.0 108.69 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.4 mt -130.29 124.17 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.65 1.18 . . . . 1.0 110.257 -169.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -90.59 89.11 7.4 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.172 1.389 . . . . 1.0 108.6 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -94.33 155.31 17.06 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.449 1.5 . . . . 1.0 111.037 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.47 118.05 5.17 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.914 0.886 . . . . 1.0 111.031 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.99 -9.89 72.75 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.029 -1.429 . . . . 1.0 115.568 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -170.51 142.89 2.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.648 1.724 . . . . 1.0 114.532 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.45 144.04 54.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.967 0.907 . . . . 1.0 110.024 169.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -141.79 152.53 43.81 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.577 1.151 . . . . 1.0 110.61 -172.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -140.24 148.94 42.25 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.301 -0.874 . . . . 1.0 111.811 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.66 149.79 36.28 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.532 0.938 . . . . 1.0 113.532 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.28 119.2 38.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.524 2.33 . . . . 1.0 107.484 169.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -82.58 132.81 35.19 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.058 -1.026 . . . . 1.0 112.137 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.69 2.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.102 1.519 . . . . 1.0 115.102 -170.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 169.86 38.81 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.265 0.936 . . . . 1.0 112.756 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.99 16.04 7.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.204 1.802 . . . . 1.0 114.031 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.02 2.99 73.85 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 124.997 1.284 . . . . 1.0 114.717 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -101.89 154.32 19.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.812 1.806 . . . . 1.0 114.454 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.65 153.76 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.588 1.555 . . . . 1.0 111.36 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.64 138.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 168.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -153.53 176.3 12.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.615 1.166 . . . . 1.0 109.85 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -126.53 122.0 33.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.119 0.872 . . . . 1.0 108.78 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.18 124.5 55.7 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 118.075 -0.964 . . . . 1.0 109.775 -173.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.91 158.28 34.47 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.272 2.648 . . . . 1.0 111.891 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.79 -31.41 95.07 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.532 2.821 . . . . 1.0 115.756 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.5 m 70.8 -22.2 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.23 2.212 . . . . 1.0 114.383 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -129.72 130.78 45.9 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.114 2.166 . . . . 1.0 107.909 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -125.99 157.35 69.65 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.37 1.068 . . . . 1.0 113.207 -169.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.46 164.5 28.55 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.705 2.936 . . . . 1.0 112.985 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.37 -107.5 1.16 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.917 1.246 . . . . 1.0 111.193 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.51 -13.43 62.32 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.54 -129.82 9.42 Favored Glycine 0 N--CA 1.47 0.904 0 C-N-CA 124.709 1.147 . . . . 1.0 112.04 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.6 p -60.11 -23.68 64.05 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.825 1.046 . . . . 1.0 113.825 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -68.52 -35.22 77.17 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.919 0.888 . . . . 1.0 112.994 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -105.15 -25.16 12.6 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.341 14.4 m 59.13 18.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 128.653 2.781 . . . . 1.0 114.206 -169.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -68.05 120.44 14.29 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.608 0.763 . . . . 1.0 110.069 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.0 m 70.07 -26.55 0.16 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 127.315 2.246 . . . . 1.0 115.136 170.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.75 -23.26 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 120.094 1.315 . . . . 1.0 113.357 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.89 -3.86 52.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.807 1.243 . . . . 1.0 113.101 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -135.48 -49.45 0.72 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -72.18 144.84 48.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -172.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 p -165.0 156.13 14.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.585 1.154 . . . . 1.0 112.2 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.08 150.8 21.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.899 0.88 . . . . 1.0 109.525 169.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -150.08 139.99 21.9 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.417 -0.802 . . . . 1.0 111.376 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.71 124.63 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.83 159.16 39.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.073 1.749 . . . . 1.0 112.77 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ttm105 -112.71 143.56 43.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.684 1.594 . . . . 1.0 110.245 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.86 176.77 9.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.351 1.46 . . . . 1.0 109.564 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -71.67 143.61 49.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.575 1.55 . . . . 1.0 110.008 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.91 -56.82 7.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.891 1.276 . . . . 1.0 110.275 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -53.56 -45.6 69.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.6 1.16 . . . . 1.0 111.812 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.99 -45.1 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.746 0.418 . . . . 1.0 111.297 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.63 -43.17 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.841 0.856 . . . . 1.0 111.745 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.47 -0.5 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.69 121.62 25.57 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.177 0.894 . . . . 1.0 111.306 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 10.99 85.92 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.294 0.95 . . . . 1.0 114.343 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 m -125.52 165.63 18.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.653 1.581 . . . . 1.0 112.413 -173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.6 m -111.98 150.94 29.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.193 1.397 . . . . 1.0 108.183 168.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.9 153.18 30.7 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.291 1.96 . . . . 1.0 116.291 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -132.31 151.51 51.81 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.379 2.271 . . . . 1.0 109.734 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.92 133.52 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.945 1.298 . . . . 1.0 107.625 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.94 85.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.058 0.932 . . . . 1.0 113.262 -169.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -79.11 46.99 0.75 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.203 1.401 . . . . 1.0 112.18 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.2 m -62.0 -24.43 67.04 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.593 -1.317 . . . . 1.0 113.293 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -61.99 -14.88 39.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.47 -33.81 46.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.917 1.287 . . . . 1.0 112.417 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -97.05 5.67 49.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.898 0.879 . . . . 1.0 113.222 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.32 -49.97 3.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.398 1.479 . . . . 1.0 111.204 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -126.52 167.46 15.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.802 1.641 . . . . 1.0 112.877 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -71.0 155.12 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 121.434 -0.791 . . . . 1.0 111.13 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.71 135.89 71.64 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.852 3.034 . . . . 1.0 113.075 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -113.39 148.28 39.29 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.27 1.428 . . . . 1.0 109.753 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.66 122.26 7.24 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.41 2.74 . . . . 1.0 111.536 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.28 -32.61 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.717 1.207 . . . . 1.0 113.198 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.39 -36.22 79.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.749 0.704 . . . . 1.0 112.061 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.27 -34.17 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.227 0.611 . . . . 1.0 111.065 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -64.66 -47.6 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.541 0.61 . . . . 1.0 110.049 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.02 -38.34 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.126 0.971 . . . . 1.0 111.399 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -41.38 96.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.928 0.786 . . . . 1.0 111.842 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.5 t -64.21 -42.36 96.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.738 0.815 . . . . 1.0 111.197 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.7 -48.39 77.81 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.212 -0.93 . . . . 1.0 110.855 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.91 -22.21 65.96 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.434 1.494 . . . . 1.0 114.529 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.5 -40.06 30.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.449 1.1 . . . . 1.0 111.621 170.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.6 mmm -75.45 -38.13 59.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.336 1.055 . . . . 1.0 112.688 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.71 135.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.186 0.81 . . . . 1.0 113.186 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.44 -16.17 61.68 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.806 1.67 . . . . 1.0 113.826 -174.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -84.04 146.9 27.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.154 1.477 . . . . 1.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.49 156.67 16.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.521 1.529 . . . . 1.0 112.271 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 47.0 mtt -144.06 164.93 29.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.264 1.426 . . . . 1.0 112.376 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -72.75 162.53 29.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.447 1.099 . . . . 1.0 112.431 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -130.09 14.62 5.71 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.61 1.564 . . . . 1.0 113.965 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.8 m -57.83 124.66 19.97 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.355 1.062 . . . . 1.0 111.759 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.37 21.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 116.822 2.156 . . . . 1.0 116.822 -169.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.99 -34.73 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.33 1.452 . . . . 1.0 111.187 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.8 t -162.85 157.56 21.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.339 1.456 . . . . 1.0 110.549 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -76.52 113.79 14.52 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.709 0.804 . . . . 1.0 110.592 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -66.88 -48.84 67.52 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.549 -0.72 . . . . 1.0 112.275 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.3 m -55.26 -43.92 75.09 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.397 1.629 . . . . 1.0 115.397 -169.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.36 -41.2 96.85 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.552 0.614 . . . . 1.0 111.685 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -69.44 -37.05 77.2 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.257 -0.902 . . . . 1.0 110.851 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.11 -58.2 9.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.429 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.74 -25.35 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.914 1.234 . . . . 1.0 112.263 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -63.85 -48.76 75.46 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.157 0.983 . . . . 1.0 111.461 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -61.6 -27.59 68.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.583 1.153 . . . . 1.0 112.986 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.2 -34.41 72.13 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.598 1.09 . . . . 1.0 112.946 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.9 ttm105 -94.36 -51.15 4.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.605 1.162 . . . . 1.0 111.717 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.43 -29.96 70.21 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.115 -0.991 . . . . 1.0 113.665 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.59 -2.44 85.07 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.945 1.26 . . . . 1.0 114.3 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -63.1 -48.34 78.99 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.979 1.389 . . . . 1.0 111.252 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 C--O 1.255 1.352 0 C-N-CA 126.916 2.087 . . . . 1.0 113.773 -174.347 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 120.282 0.087 . . . . 1.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.51 160.48 31.63 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.171 0.989 . . . . 1.0 112.394 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 t -162.1 143.25 8.11 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.307 1.043 . . . . 1.0 111.882 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.46 172.45 16.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.56 2.84 . . . . 1.0 111.79 174.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 67.28 14.23 9.64 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.788 1.635 . . . . 1.0 114.449 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -65.87 133.98 52.07 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.219 -0.926 . . . . 1.0 110.825 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -80.04 130.63 65.74 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.753 -0.641 . . . . 1.0 110.042 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.84 148.3 25.16 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.072 2.514 . . . . 1.0 112.269 -177.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -121.12 161.05 42.68 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.302 1.841 . . . . 1.0 111.346 171.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.59 132.07 49.91 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.431 2.088 . . . . 1.0 110.815 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.09 -1.39 73.76 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.322 -1.266 . . . . 1.0 114.835 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -76.53 149.38 36.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.442 1.621 . . . . 1.0 113.283 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.59 128.72 37.53 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.58 1.152 . . . . 1.0 108.93 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.4 mt -109.16 131.14 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -99.62 133.79 43.45 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.904 1.681 . . . . 1.0 108.231 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.8 mt -122.11 120.33 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.732 1.613 . . . . 1.0 108.322 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -93.45 81.26 4.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.152 1.381 . . . . 1.0 109.793 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.1 mtt-85 -77.24 168.27 20.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.192 0.597 . . . . 1.0 111.048 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.66 144.41 56.32 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.57 0.748 . . . . 1.0 110.749 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.28 -66.03 3.88 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.854 1.216 . . . . 1.0 112.563 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -146.94 153.61 40.3 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.368 1.867 . . . . 1.0 112.836 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -72.34 163.94 27.13 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.614 1.566 . . . . 1.0 112.72 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.409 ' CD2' ' HH ' ' A' ' 106' ' ' TYR . 5.6 t-80 -142.55 174.08 10.96 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.212 1.405 . . . . 1.0 111.492 170.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.12 158.3 44.27 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 154.89 39.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.973 1.309 . . . . 1.0 112.694 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.77 120.61 36.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.172 1.789 . . . . 1.0 108.135 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -82.97 134.92 35.04 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.903 -1.123 . . . . 1.0 112.229 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.1 pt -118.73 4.33 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 -171.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 168.34 37.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.348 0.975 . . . . 1.0 112.861 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t70 62.91 16.1 8.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.125 1.77 . . . . 1.0 113.899 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 -0.98 81.07 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.121 1.343 . . . . 1.0 114.478 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -96.43 154.56 17.2 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.396 1.598 . . . . 1.0 114.366 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.86 159.5 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.104 1.762 . . . . 1.0 111.02 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -120.18 137.4 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 106.651 -1.611 . . . . 1.0 106.651 168.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.57 174.95 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.214 1.006 . . . . 1.0 110.552 -169.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.14 151.92 20.78 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.965 -0.459 . . . . 1.0 110.033 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.93 106.86 58.67 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 168.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -59.69 162.01 16.58 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.712 2.941 . . . . 1.0 114.069 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.49 148.9 90.72 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.589 2.859 . . . . 1.0 111.972 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 p -78.56 -19.69 52.27 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.17 0.804 . . . . 1.0 113.17 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 74.26 -58.95 0.57 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.924 2.89 . . . . 1.0 110.838 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -117.83 99.36 52.13 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.959 1.703 . . . . 1.0 110.002 169.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.6 144.36 66.15 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.475 3.45 . . . . 1.0 113.043 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.02 -162.47 52.77 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.432 1.015 . . . . 1.0 115.214 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.65 11.86 35.6 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.446 1.498 . . . . 1.0 113.818 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.27 5.14 62.29 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.984 1.278 . . . . 1.0 114.403 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.9 t -80.0 -156.44 0.12 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.437 1.095 . . . . 1.0 110.994 170.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 m -51.22 -25.82 6.14 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.045 1.738 . . . . 1.0 115.208 -172.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 m -60.25 -19.44 54.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.988 1.315 . . . . 1.0 113.748 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 p -57.01 -23.62 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.168 1.387 . . . . 1.0 113.305 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -55.08 -31.31 61.09 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.395 1.078 . . . . 1.0 112.731 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.5 m -94.23 10.39 34.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.366 1.066 . . . . 1.0 113.762 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.8 t -54.73 125.8 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.567 1.147 . . . . 1.0 110.503 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.0 mt 65.14 -25.45 0.09 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.81 2.844 . . . . 1.0 114.634 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.5 m -73.88 -18.52 60.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.109 1.363 . . . . 1.0 113.657 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -64.72 156.41 30.52 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.291 1.436 . . . . 1.0 113.806 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -134.98 171.68 14.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.052 1.341 . . . . 1.0 112.223 -172.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.89 163.7 24.13 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.599 -0.688 . . . . 1.0 111.174 171.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.87 145.15 49.39 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.765 0.826 . . . . 1.0 110.973 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -75.72 127.93 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -137.62 161.69 35.79 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.669 1.188 . . . . 1.0 112.711 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -115.51 138.89 50.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.814 2.046 . . . . 1.0 110.138 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.09 176.93 8.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.991 1.316 . . . . 1.0 110.361 170.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -67.64 142.11 56.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.086 1.754 . . . . 1.0 110.377 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.7 tp -51.9 -52.54 49.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.975 0.91 . . . . 1.0 111.711 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -55.36 -47.51 75.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.165 0.986 . . . . 1.0 111.153 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.38 -39.61 94.99 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.783 0.433 . . . . 1.0 111.94 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.69 -45.39 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.545 1.138 . . . . 1.0 111.583 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.37 -35.36 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.716 1.144 . . . . 1.0 112.834 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.78 -124.16 32.13 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.331 0.969 . . . . 1.0 111.533 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.08 -0.19 87.25 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.601 1.096 . . . . 1.0 114.623 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.52 148.61 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.648 1.179 . . . . 1.0 110.974 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.95 165.92 23.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.438 0.695 . . . . 1.0 111.318 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -161.45 164.95 29.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -160.34 161.0 33.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.535 1.534 . . . . 1.0 112.015 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.03 131.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -140.68 60.3 1.53 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.744 1.259 . . . . 1.0 109.842 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.65 67.55 8.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.311 1.445 . . . . 1.0 111.577 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 p -68.48 -21.31 64.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.314 1.445 . . . . 1.0 114.463 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.1 mt -65.78 -14.07 60.65 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.674 0.99 . . . . 1.0 113.674 -172.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -33.33 53.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 1.0 112.255 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.17 -17.48 49.58 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.32 1.448 . . . . 1.0 112.622 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -98.19 -47.2 5.56 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.035 1.334 . . . . 1.0 111.996 -170.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -128.43 162.38 27.28 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.103 1.361 . . . . 1.0 113.458 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -69.97 159.77 82.94 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 118.377 -0.82 . . . . 1.0 110.358 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.45 156.5 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.285 3.323 . . . . 1.0 115.559 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 154.95 71.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.513 1.525 . . . . 1.0 112.182 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.24 123.27 5.5 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.046 3.164 . . . . 1.0 111.992 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.07 -35.42 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.454 1.102 . . . . 1.0 113.934 -170.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.9 -37.37 79.21 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.765 0.826 . . . . 1.0 111.788 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.94 -34.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.455 -0.778 . . . . 1.0 110.664 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mt -64.35 -48.21 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 118.813 0.733 . . . . 1.0 109.997 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -39.79 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.572 1.149 . . . . 1.0 111.108 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -66.18 -43.35 87.13 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.282 -0.886 . . . . 1.0 111.947 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.16 -44.44 92.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.598 1.159 . . . . 1.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.919 0.781 . . . . 1.0 110.672 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.16 -39.6 90.73 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.245 -0.91 . . . . 1.0 113.161 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.75 -34.22 77.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.79 0.836 . . . . 1.0 112.29 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.4 mmm -74.9 -36.07 62.23 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.383 -0.818 . . . . 1.0 112.934 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.4 t -46.33 129.67 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 1.0 112.008 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.54 -16.05 61.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.951 1.739 . . . . 1.0 114.041 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -84.47 143.69 29.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.081 1.441 . . . . 1.0 111.401 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -94.33 146.61 23.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.919 1.288 . . . . 1.0 112.393 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.7 mmt -134.83 141.54 46.42 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.591 1.556 . . . . 1.0 112.088 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -78.23 113.49 16.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.752 0.821 . . . . 1.0 109.544 170.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HH ' ' CD2' ' A' ' 23' ' ' HIS . 30.2 t80 -93.37 -27.84 16.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -169.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 t -83.1 92.78 7.48 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.6 0.714 . . . . 1.0 110.489 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.1 tp -163.77 130.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.51 1.524 . . . . 1.0 109.789 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.81 -24.43 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 113.976 1.102 . . . . 1.0 113.976 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.5 m -67.43 -5.28 14.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.199 1.4 . . . . 1.0 114.413 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 66.64 86.14 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.568 2.347 . . . . 1.0 111.22 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -54.53 -34.56 61.95 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.78 1.029 . . . . 1.0 113.78 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.9 p -60.84 -61.22 2.74 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.333 1.453 . . . . 1.0 113.563 172.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.98 -46.71 87.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.772 0.829 . . . . 1.0 111.126 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -59.25 -46.53 88.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.107 0.412 . . . . 1.0 111.288 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -55.31 -59.21 5.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.493 0.717 . . . . 1.0 111.308 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.18 -26.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.997 0.817 . . . . 1.0 112.372 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.0 m -66.02 -49.45 67.7 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.344 1.057 . . . . 1.0 111.237 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.51 -29.77 68.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.904 0.882 . . . . 1.0 112.509 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.81 -33.82 74.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.295 0.85 . . . . 1.0 113.295 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -98.29 -42.78 7.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.777 1.231 . . . . 1.0 112.374 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -67.07 -50.82 60.46 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.856 -1.152 . . . . 1.0 112.092 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.79 35.77 3.69 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.412 1.958 . . . . 1.0 114.222 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 157.42 4.03 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.53 1.132 . . . . 1.0 113.15 172.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.738 1.615 . . . . 1.0 114.212 -176.67 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.2 mtp . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.385 0.136 . . . . 1.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.98 161.54 29.98 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.893 0.877 . . . . 1.0 112.434 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -67.7 144.3 97.41 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.662 0.785 . . . . 1.0 112.787 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.48 164.78 28.19 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.654 2.903 . . . . 1.0 112.133 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 80.13 160.69 0.17 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 127.496 2.318 . . . . 1.0 113.996 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -78.7 154.03 30.43 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.253 -0.904 . . . . 1.0 110.839 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -130.74 129.11 22.6 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.423 1.089 . . . . 1.0 109.807 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.06 153.47 16.74 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.526 2.817 . . . . 1.0 112.728 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -128.61 162.65 49.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.54 1.936 . . . . 1.0 112.431 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -43.99 127.12 6.55 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 124.396 3.397 . . . . 1.0 113.093 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 2.33 87.95 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 118.354 -1.248 . . . . 1.0 115.422 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.71 146.14 42.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.739 1.77 . . . . 1.0 112.947 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.07 122.61 33.21 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.387 -1.338 . . . . 1.0 107.387 169.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -101.98 132.24 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -109.91 132.1 54.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.799 2.04 . . . . 1.0 107.951 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mt -127.42 123.77 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.78 1.232 . . . . 1.0 109.195 -169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -86.56 131.14 34.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.829 1.252 . . . . 1.0 110.172 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -137.31 173.52 11.59 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.519 1.928 . . . . 1.0 110.2 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.23 122.27 13.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.958 0.903 . . . . 1.0 109.229 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.0 -130.55 9.77 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.215 0.912 . . . . 1.0 111.17 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -76.05 152.53 36.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.573 1.149 . . . . 1.0 113.438 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.07 168.47 8.29 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.935 1.694 . . . . 1.0 112.941 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -137.26 164.08 29.4 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.044 1.738 . . . . 1.0 111.146 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -138.56 155.32 48.47 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.088 -1.007 . . . . 1.0 113.206 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.1 153.4 40.65 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.424 1.489 . . . . 1.0 112.309 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.55 118.26 34.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.049 1.74 . . . . 1.0 108.205 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -84.19 130.9 34.81 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.449 1.022 . . . . 1.0 112.545 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -113.43 0.79 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 114.87 1.433 . . . . 1.0 114.87 -170.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.17 168.04 34.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.357 0.979 . . . . 1.0 112.881 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.74 16.3 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.212 1.805 . . . . 1.0 114.082 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.56 6.49 77.08 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.133 1.349 . . . . 1.0 114.274 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -103.83 154.5 19.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.352 1.576 . . . . 1.0 113.94 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.67 161.52 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.381 1.873 . . . . 1.0 111.229 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.59 137.61 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -161.98 169.96 20.18 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.208 -0.933 . . . . 1.0 110.537 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.9 mt -88.15 151.59 22.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.874 -0.516 . . . . 1.0 109.745 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.47 114.59 27.23 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.685 1.594 . . . . 1.0 109.88 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.52 164.79 25.82 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.346 2.697 . . . . 1.0 111.453 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.9 -19.23 18.3 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.977 3.118 . . . . 1.0 113.359 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.0 m 72.07 -18.99 0.29 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.434 2.294 . . . . 1.0 115.0 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -135.45 134.3 39.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.162 1.785 . . . . 1.0 110.164 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -72.38 144.62 86.96 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.962 0.905 . . . . 1.0 111.701 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.27 160.26 35.73 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.737 2.958 . . . . 1.0 113.703 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.68 142.23 9.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.718 1.627 . . . . 1.0 111.787 -170.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.19 -25.02 60.62 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -173.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.17 -134.94 1.84 Allowed Glycine 0 N--CA 1.471 1.013 0 C-N-CA 125.727 1.632 . . . . 1.0 111.043 175.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.7 m -57.77 -19.69 29.88 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.884 0.874 . . . . 1.0 112.749 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 p -53.36 -14.73 0.81 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.257 1.823 . . . . 1.0 113.631 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -52.62 -30.47 31.54 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.225 1.41 . . . . 1.0 113.298 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.91 -18.8 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.287 0.847 . . . . 1.0 113.287 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -106.05 -46.47 4.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.475 1.51 . . . . 1.0 111.225 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.7 m -75.12 42.7 0.19 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.333 1.853 . . . . 1.0 113.163 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.2 m -66.62 143.36 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.647 1.579 . . . . 1.0 112.469 -176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.3 tp -165.47 145.46 6.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.605 1.562 . . . . 1.0 110.329 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -63.01 128.07 34.15 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.367 -0.833 . . . . 1.0 111.811 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -91.28 150.91 21.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.701 0.8 . . . . 1.0 111.184 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.7 p -142.26 146.55 35.25 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.179 0.992 . . . . 1.0 112.837 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.68 150.16 27.25 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.557 1.543 . . . . 1.0 110.725 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.07 138.59 36.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.192 0.997 . . . . 1.0 110.595 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.1 t -77.63 123.2 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -127.38 155.01 44.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.417 1.487 . . . . 1.0 112.395 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -104.03 128.79 51.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.858 1.663 . . . . 1.0 108.291 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -157.24 166.07 34.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.45 0.568 . . . . 1.0 111.552 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -76.06 137.62 40.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.82 1.648 . . . . 1.0 110.743 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.32 -55.55 17.8 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.891 1.277 . . . . 1.0 110.952 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -55.01 -44.61 74.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.391 1.076 . . . . 1.0 111.721 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.14 -42.3 93.96 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.451 0.3 . . . . 1.0 111.521 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.92 -39.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.8 1.24 . . . . 1.0 112.244 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.6 m -85.58 -0.74 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.471 1.108 . . . . 1.0 113.776 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.28 126.72 36.51 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.322 0.963 . . . . 1.0 112.082 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.37 6.29 79.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.294 0.949 . . . . 1.0 114.194 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.9 m -122.52 -179.51 4.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.686 1.994 . . . . 1.0 110.783 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.07 156.99 39.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.392 1.477 . . . . 1.0 108.119 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -155.01 164.89 38.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.403 1.631 . . . . 1.0 115.403 -171.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -158.56 160.27 36.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.758 2.023 . . . . 1.0 110.944 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -88.14 129.05 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 168.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -131.66 54.58 1.92 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.502 1.144 . . . . 1.0 110.165 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.28 71.46 7.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.896 1.279 . . . . 1.0 111.329 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.2 p -73.56 -43.47 59.78 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.835 1.254 . . . . 1.0 113.681 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.79 -17.17 63.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.29 -28.13 51.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.126 1.37 . . . . 1.0 112.898 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -91.44 -20.44 21.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.375 1.47 . . . . 1.0 112.536 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -86.99 -36.24 18.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.412 1.085 . . . . 1.0 112.516 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -120.25 170.42 9.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.319 1.448 . . . . 1.0 112.355 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -66.35 144.8 98.86 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.437 -0.79 . . . . 1.0 109.557 171.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.41 134.16 46.81 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.86 2.373 . . . . 1.0 111.653 -169.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -93.81 151.65 40.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.069 1.348 . . . . 1.0 110.676 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.17 111.41 3.07 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.5 2.8 . . . . 1.0 110.858 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.72 -32.66 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.179 1.177 . . . . 1.0 114.179 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.73 -35.72 75.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.268 0.627 . . . . 1.0 112.16 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.6 -40.55 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.884 0.874 . . . . 1.0 110.722 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.3 mt -59.8 -46.74 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.762 0.71 . . . . 1.0 110.26 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.7 mt -69.18 -35.36 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.3 1.04 . . . . 1.0 111.627 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.3 m -64.34 -43.48 94.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.278 -0.889 . . . . 1.0 111.615 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.7 m -59.8 -43.77 94.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.303 1.041 . . . . 1.0 111.508 172.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.35 73.58 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.188 -0.945 . . . . 1.0 111.358 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -62.38 -38.11 88.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.301 1.041 . . . . 1.0 112.953 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.6 -35.3 79.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.84 0.856 . . . . 1.0 112.07 173.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.5 mmm -74.0 -37.54 64.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.376 -0.821 . . . . 1.0 112.85 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.9 t -46.68 130.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 119.359 0.981 . . . . 1.0 111.678 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.35 -14.04 65.73 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.567 1.556 . . . . 1.0 114.095 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -87.27 158.8 19.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.9 1.35 . . . . 1.0 111.413 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -120.25 148.61 43.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.148 1.379 . . . . 1.0 112.334 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 78.7 mtm -142.35 152.62 43.08 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.863 1.265 . . . . 1.0 112.161 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -74.33 162.34 28.98 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.012 0.925 . . . . 1.0 112.578 170.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -155.29 163.3 40.33 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.323 1.231 . . . . 1.0 114.323 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.0 t -145.14 130.64 18.8 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.891 1.677 . . . . 1.0 108.542 169.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.9 pt -64.64 -20.7 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 114.786 1.402 . . . . 1.0 114.786 -169.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.65 -14.35 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.099 0.959 . . . . 1.0 113.414 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.0 m -96.53 -5.8 38.52 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.55 0.944 . . . . 1.0 113.55 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.7 mtm-85 58.04 39.87 25.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.904 1.682 . . . . 1.0 112.875 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -53.6 -33.33 54.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -171.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.6 m -65.19 -40.68 94.54 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.31 0.959 . . . . 1.0 112.741 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -59.64 -53.11 61.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.111 0.964 . . . . 1.0 109.888 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.38 -45.75 87.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.813 0.445 . . . . 1.0 111.566 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -52.21 -60.09 3.61 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.861 0.865 . . . . 1.0 111.004 172.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -32.65 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.33 0.968 . . . . 1.0 113.017 -172.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -71.17 -38.87 72.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.647 0.779 . . . . 1.0 112.254 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -60.62 -26.55 67.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.997 0.817 . . . . 1.0 112.813 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.75 -26.54 68.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.868 1.213 . . . . 1.0 112.592 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -93.71 -53.31 4.08 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.657 1.583 . . . . 1.0 111.798 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -73.21 -38.94 65.92 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.45 -41.19 5.82 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.229 1.395 . . . . 1.0 112.292 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . 0.335 0.1 OUTLIER 43.6 -144.85 0.1 Allowed 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.971 2.108 . . . . 1.0 113.858 177.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.9 p . . . . . 0 C--O 1.253 1.277 0 C-N-CA 124.975 1.31 . . . . 1.0 114.228 174.641 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 110.866 -0.05 . . . . 1.0 110.866 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.96 162.64 41.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.398 1.479 . . . . 1.0 111.702 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.9 p -78.45 154.91 79.16 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.398 1.079 . . . . 1.0 112.734 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.49 162.76 39.3 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.753 2.969 . . . . 1.0 111.639 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -156.26 154.5 30.8 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.586 1.155 . . . . 1.0 111.771 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -157.93 141.7 15.64 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.565 1.546 . . . . 1.0 109.445 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.86 133.74 17.8 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.934 1.294 . . . . 1.0 110.089 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.23 144.58 26.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.562 2.841 . . . . 1.0 112.088 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -129.48 160.57 63.71 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.861 1.664 . . . . 1.0 112.846 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -47.59 129.03 16.3 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.815 3.01 . . . . 1.0 112.822 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -8.84 73.79 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.074 1.321 . . . . 1.0 114.172 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -68.59 139.34 55.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.968 1.384 . . . . 1.0 112.541 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.55 126.95 35.8 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.879 1.272 . . . . 1.0 108.905 170.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.3 131.93 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.44 138.45 39.34 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.187 1.395 . . . . 1.0 108.784 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mt -133.14 113.99 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.226 1.01 . . . . 1.0 109.174 -173.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -92.76 61.46 3.6 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.474 1.51 . . . . 1.0 111.205 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -66.89 158.87 29.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.173 0.989 . . . . 1.0 112.176 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.73 135.67 57.84 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.091 0.957 . . . . 1.0 110.13 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.82 -130.52 10.29 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -71.88 133.46 45.45 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.742 0.782 . . . . 1.0 112.607 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -66.23 163.28 18.2 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.594 1.958 . . . . 1.0 110.947 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.48 160.5 32.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.731 1.212 . . . . 1.0 110.472 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -137.37 150.19 47.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.204 1.001 . . . . 1.0 110.546 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 152.1 44.37 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.312 1.045 . . . . 1.0 112.598 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.33 116.86 33.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.197 1.799 . . . . 1.0 107.921 170.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -79.89 132.24 36.04 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.326 -0.859 . . . . 1.0 111.716 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.2 pt -114.89 -3.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -171.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.57 166.31 24.48 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 124.717 1.151 . . . . 1.0 113.008 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 62.69 18.37 10.54 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.082 1.753 . . . . 1.0 113.867 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.75 85.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.446 1.498 . . . . 1.0 114.281 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -94.2 153.12 18.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.425 1.613 . . . . 1.0 114.252 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -133.54 157.87 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.004 1.721 . . . . 1.0 111.006 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -115.58 138.68 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.396 1.478 . . . . 1.0 107.13 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -155.43 150.95 27.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.723 0.809 . . . . 1.0 111.75 -168.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -84.38 121.49 27.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.64 144.05 27.44 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.492 1.117 . . . . 1.0 112.239 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.23 144.44 29.52 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.233 2.622 . . . . 1.0 111.899 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.48 165.8 12.3 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.275 3.316 . . . . 1.0 112.614 174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.3 m -71.57 140.3 49.76 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 169.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -59.88 -38.63 82.74 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -169.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -141.69 144.84 34.6 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.8 1.24 . . . . 1.0 112.241 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.76 -30.33 6.23 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.456 2.771 . . . . 1.0 112.41 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.23 -151.57 6.63 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.547 1.546 . . . . 1.0 112.732 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.57 159.28 17.97 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.482 1.113 . . . . 1.0 112.622 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.88 158.65 33.85 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.149 1.357 . . . . 1.0 114.018 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -76.17 -12.31 60.08 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.166 1.173 . . . . 1.0 114.166 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.2 p -90.79 -98.15 0.11 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.804 1.242 . . . . 1.0 109.459 169.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.6 t 65.9 -51.33 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 128.841 2.857 . . . . 1.0 115.759 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.98 -22.9 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.495 1.918 . . . . 1.0 114.756 -169.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.16 -13.72 62.58 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -171.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.2 p -85.75 -11.36 53.77 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.75 1.389 . . . . 1.0 114.75 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -157.47 143.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.294 0.952 . . . . 1.0 113.102 -169.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.1 tp -83.72 -13.33 54.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.17 1.388 . . . . 1.0 114.032 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 m -56.5 -25.23 50.82 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.746 1.388 . . . . 1.0 114.746 -173.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.11 41.05 0.16 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.062 1.745 . . . . 1.0 112.571 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.3 m -102.03 154.26 19.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.652 1.581 . . . . 1.0 111.47 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.49 147.11 42.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.012 0.925 . . . . 1.0 110.579 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.12 137.49 54.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.94 0.896 . . . . 1.0 109.989 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.77 124.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -132.05 163.81 27.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.414 1.486 . . . . 1.0 111.999 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -117.51 137.11 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.007 1.723 . . . . 1.0 110.077 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.05 177.74 10.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.822 1.249 . . . . 1.0 111.214 171.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.0 141.62 49.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.123 0.969 . . . . 1.0 111.604 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 tp -51.19 -52.82 40.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.308 1.043 . . . . 1.0 112.19 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.84 -48.22 73.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.086 0.954 . . . . 1.0 111.287 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.53 -35.02 79.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.083 0.553 . . . . 1.0 112.083 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.84 -45.23 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.17 0.988 . . . . 1.0 112.293 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.43 -34.47 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 119.585 1.084 . . . . 1.0 112.818 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.27 -131.11 49.68 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 119.151 0.887 . . . . 1.0 112.192 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.88 -3.73 85.38 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.652 1.12 . . . . 1.0 114.481 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.0 m -74.99 149.59 39.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.166 1.387 . . . . 1.0 111.433 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.5 t -72.05 154.43 41.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.007 0.523 . . . . 1.0 110.78 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -158.85 163.59 36.5 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.688 0.995 . . . . 1.0 113.688 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -159.81 157.46 29.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.83 1.252 . . . . 1.0 113.371 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.8 t -82.47 138.06 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.446 -1.316 . . . . 1.0 107.446 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -152.65 84.77 1.24 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 1.0 111.394 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.04 53.54 2.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.759 1.224 . . . . 1.0 111.847 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 p -58.73 -34.65 71.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.985 1.314 . . . . 1.0 113.159 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.65 -17.85 65.06 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.253 -0.905 . . . . 1.0 112.899 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.82 -25.9 68.38 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.126 0.876 . . . . 1.0 112.631 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.64 12.9 36.42 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.532 1.133 . . . . 1.0 111.949 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -109.8 -44.35 3.84 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.589 1.555 . . . . 1.0 111.754 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -131.41 168.32 17.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.593 1.557 . . . . 1.0 113.609 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -66.78 160.13 70.64 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.308 1.043 . . . . 1.0 112.471 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.77 152.33 35.71 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.405 3.403 . . . . 1.0 113.489 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -129.14 153.99 80.44 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.83 1.652 . . . . 1.0 111.042 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.75 111.45 3.25 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.205 2.604 . . . . 1.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.94 -31.86 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.193 0.997 . . . . 1.0 113.086 -169.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.36 -36.98 76.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.731 0.696 . . . . 1.0 112.1 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 t -71.56 -34.41 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.057 0.943 . . . . 1.0 110.7 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.1 mt -66.13 -48.32 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.536 0.735 . . . . 1.0 109.982 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -42.62 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.702 1.201 . . . . 1.0 110.853 173.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -65.26 -40.92 94.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 1.0 111.384 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.8 m -63.48 -42.5 98.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.06 0.944 . . . . 1.0 111.804 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.4 77.98 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.559 -0.713 . . . . 1.0 110.29 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.47 -39.83 92.31 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.15 -0.969 . . . . 1.0 113.149 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.64 -32.9 74.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.905 0.882 . . . . 1.0 112.631 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -74.34 -37.25 63.6 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.33 -0.843 . . . . 1.0 112.815 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.8 t -47.57 127.54 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.726 1.148 . . . . 1.0 111.373 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.75 -16.47 59.58 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.006 1.765 . . . . 1.0 113.818 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -85.04 157.58 20.69 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.741 1.271 . . . . 1.0 111.067 176.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.27 153.99 36.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.867 1.267 . . . . 1.0 113.214 -172.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.2 mtt -147.86 165.3 31.04 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.243 1.817 . . . . 1.0 111.77 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -69.89 142.17 53.04 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.494 -0.754 . . . . 1.0 109.949 169.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -78.75 164.37 24.61 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.251 -0.905 . . . . 1.0 113.065 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -55.73 140.94 40.1 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.627 1.171 . . . . 1.0 113.451 172.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.3 tt -167.06 97.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.189 1.795 . . . . 1.0 107.698 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 t 69.73 -61.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 127.498 2.319 . . . . 1.0 108.871 -169.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.6 m -82.56 143.13 31.26 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.687 1.595 . . . . 1.0 110.524 169.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -96.04 119.93 35.41 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.195 0.998 . . . . 1.0 110.791 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -91.06 -23.18 20.42 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -63.52 -36.71 84.68 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.325 -1.484 . . . . 1.0 113.022 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.46 -58.8 6.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.576 0.75 . . . . 1.0 109.963 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -52.83 -32.57 45.02 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.814 1.245 . . . . 1.0 113.419 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.91 -57.54 10.46 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.093 -1.004 . . . . 1.0 110.786 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.37 -28.29 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.902 1.075 . . . . 1.0 113.902 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.79 -42.5 90.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.539 1.063 . . . . 1.0 111.872 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -58.01 -29.37 65.25 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 1.0 112.813 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.21 -32.04 70.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.793 0.837 . . . . 1.0 112.652 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -94.42 -51.37 4.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 1.0 111.43 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -62.88 -32.07 73.25 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 -169.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.83 -9.02 87.46 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.883 0.754 . . . . 1.0 114.272 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -79.2 149.1 32.03 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.871 1.336 . . . . 1.0 112.211 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.618 1.567 . . . . 1.0 113.112 178.157 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 110.704 -0.109 . . . . 1.0 110.704 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.75 162.28 29.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.259 1.024 . . . . 1.0 113.11 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 m -66.37 149.06 98.29 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.787 0.835 . . . . 1.0 112.731 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.48 158.78 50.53 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.498 2.799 . . . . 1.0 111.834 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -160.25 146.79 15.73 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.87 1.268 . . . . 1.0 111.571 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -144.3 153.24 41.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.461 1.505 . . . . 1.0 110.049 175.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -136.1 129.72 18.1 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 124.539 1.136 . . . . 1.0 109.638 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.22 146.53 17.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.817 3.012 . . . . 1.0 111.614 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.97 161.02 62.29 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.637 1.575 . . . . 1.0 112.583 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -46.74 128.58 13.33 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.942 3.095 . . . . 1.0 112.99 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.81 -7.88 80.59 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.265 -1.297 . . . . 1.0 115.18 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.05 143.91 54.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.666 1.733 . . . . 1.0 113.761 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.42 128.11 33.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.52 1.528 . . . . 1.0 107.922 169.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.56 129.38 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.629 1.171 . . . . 1.0 108.162 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -100.15 125.08 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.316 1.447 . . . . 1.0 107.676 170.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.3 mt -120.92 119.9 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.559 1.143 . . . . 1.0 109.167 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -83.68 60.56 5.8 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.741 1.616 . . . . 1.0 110.514 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -65.85 147.16 53.81 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.355 1.062 . . . . 1.0 110.642 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.76 145.2 55.4 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.338 1.055 . . . . 1.0 111.428 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.43 -55.84 4.41 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.168 1.366 . . . . 1.0 112.678 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -147.41 132.1 17.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.308 1.843 . . . . 1.0 111.169 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.26 155.4 21.17 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.911 0.884 . . . . 1.0 111.423 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.3 166.9 20.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.979 1.712 . . . . 1.0 110.133 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -136.39 145.2 45.07 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.738 0.815 . . . . 1.0 111.508 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 156.81 45.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.303 1.041 . . . . 1.0 112.515 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.95 116.32 32.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.538 1.935 . . . . 1.0 107.713 172.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -81.91 130.73 35.16 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.335 -0.853 . . . . 1.0 111.845 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.85 3.66 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.5 167.48 35.3 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.529 1.062 . . . . 1.0 112.584 -174.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 61.38 20.02 10.75 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.952 1.701 . . . . 1.0 113.813 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.99 -1.04 87.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.585 1.564 . . . . 1.0 114.458 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -91.68 151.72 20.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.595 1.698 . . . . 1.0 114.492 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.53 154.23 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.402 1.481 . . . . 1.0 111.155 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.8 mt -112.23 136.02 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -155.16 150.09 26.71 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.138 -0.977 . . . . 1.0 111.866 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.07 133.05 33.92 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.26 130.69 23.74 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.114 1.366 . . . . 1.0 110.491 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.86 158.37 34.86 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.336 2.69 . . . . 1.0 112.343 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.41 171.85 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.424 3.416 . . . . 1.0 112.975 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.3 m -66.69 162.97 20.06 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.615 1.166 . . . . 1.0 113.064 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.93 -38.78 89.72 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.302 -0.874 . . . . 1.0 113.332 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -159.56 133.32 5.0 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.796 1.239 . . . . 1.0 112.143 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.18 157.12 26.33 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.515 2.81 . . . . 1.0 111.233 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.94 17.8 79.44 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 114.635 0.614 . . . . 1.0 114.635 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.1 64.06 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 118.332 1.066 . . . . 1.0 113.751 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.2 -158.72 34.95 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.406 1.479 . . . . 1.0 113.157 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.2 m -65.73 -27.59 68.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.6 m -77.5 54.63 1.19 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.459 1.503 . . . . 1.0 111.531 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.9 p -56.05 -33.06 64.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.74 1.616 . . . . 1.0 114.342 -169.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.9 m -55.8 -22.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.0 1.32 . . . . 1.0 113.855 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -63.63 -13.53 43.21 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.5 0.72 . . . . 1.0 112.899 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.7 m -56.64 -24.5 48.82 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.35 0.977 . . . . 1.0 113.232 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -71.29 -25.72 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.179 1.392 . . . . 1.0 112.595 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.37 156.75 27.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.835 1.254 . . . . 1.0 113.243 -169.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 p -84.23 167.71 16.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.682 1.193 . . . . 1.0 112.725 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -107.9 147.82 30.46 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.35 1.06 . . . . 1.0 112.374 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.1 m -145.62 140.1 27.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.452 1.101 . . . . 1.0 112.344 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.82 154.26 28.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.003 1.321 . . . . 1.0 110.675 169.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.23 139.44 53.78 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.272 1.029 . . . . 1.0 110.76 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.11 125.85 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.21 162.3 30.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.149 1.779 . . . . 1.0 111.986 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -120.69 126.28 49.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.819 1.648 . . . . 1.0 110.672 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -147.98 174.14 12.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.173 1.389 . . . . 1.0 110.681 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.74 137.37 38.43 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.109 -0.994 . . . . 1.0 110.744 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.79 -42.75 84.81 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.228 -0.92 . . . . 1.0 111.643 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.04 -46.42 75.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.774 . . . . 1.0 111.402 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.97 -42.94 80.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.671 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.15 -42.58 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 1.0 111.664 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.55 -2.31 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.813 1.245 . . . . 1.0 113.831 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.76 123.78 33.21 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.048 -1.033 . . . . 1.0 111.797 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.99 5.51 86.93 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.66 1.124 . . . . 1.0 114.757 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -126.31 -160.86 1.01 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.512 2.325 . . . . 1.0 110.436 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.2 t -148.87 171.8 15.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.266 1.826 . . . . 1.0 109.349 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -152.76 158.91 42.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.743 1.386 . . . . 1.0 114.743 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.98 150.29 39.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.362 1.865 . . . . 1.0 110.483 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.1 t -82.65 134.6 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -148.63 67.23 1.06 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.797 0.839 . . . . 1.0 112.197 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -72.61 82.62 1.12 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.37 1.068 . . . . 1.0 111.643 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -69.6 -38.33 77.25 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.148 0.795 . . . . 1.0 113.148 -170.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.7 mt -81.63 -8.89 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -172.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.56 -31.53 68.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 1.0 112.758 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -90.42 -5.71 55.79 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.925 1.29 . . . . 1.0 112.382 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -97.35 -47.76 5.58 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.033 1.333 . . . . 1.0 112.19 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -127.1 169.88 12.95 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.976 1.31 . . . . 1.0 113.717 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -66.21 148.59 98.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 110.067 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.38 144.72 62.84 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.364 2.709 . . . . 1.0 113.001 -170.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.92 151.72 37.94 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.45 1.5 . . . . 1.0 112.299 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.09 114.95 4.16 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.859 3.04 . . . . 1.0 110.991 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.81 -35.42 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.943 1.297 . . . . 1.0 114.154 -170.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.91 -35.4 78.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.827 0.451 . . . . 1.0 112.191 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.38 -36.71 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.468 0.707 . . . . 1.0 110.915 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.08 -49.5 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.472 0.578 . . . . 1.0 109.769 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.8 mt -67.68 -38.43 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.912 0.885 . . . . 1.0 111.904 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.9 m -62.42 -41.55 98.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.348 0.976 . . . . 1.0 111.71 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -62.46 -44.34 96.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.697 0.799 . . . . 1.0 111.079 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.63 72.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.618 0.767 . . . . 1.0 110.903 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.26 -40.36 93.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.234 1.014 . . . . 1.0 112.803 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.83 -33.47 75.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.565 0.746 . . . . 1.0 112.096 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.2 mmm -74.92 -38.24 61.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.195 -0.907 . . . . 1.0 112.975 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.54 127.95 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 120.017 1.281 . . . . 1.0 111.299 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.71 -15.42 62.72 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.722 1.629 . . . . 1.0 113.593 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -84.64 160.13 20.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.001 1.4 . . . . 1.0 111.314 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -123.86 157.81 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.368 1.467 . . . . 1.0 112.561 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.2 mtt -133.11 136.05 45.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.56 1.544 . . . . 1.0 110.283 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -59.09 133.88 56.49 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.775 -0.578 . . . . 1.0 110.936 174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -68.29 126.91 31.05 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.853 0.686 . . . . 1.0 112.853 -170.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.2 m -76.79 36.28 0.16 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.236 1.814 . . . . 1.0 113.192 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.1 pt 55.54 -14.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 130.755 3.622 . . . . 1.0 117.181 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.46 151.05 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 128.449 2.7 . . . . 1.0 109.038 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.2 m -59.56 168.03 1.77 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.196 1.399 . . . . 1.0 113.979 174.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 117.05 -20.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 131.328 3.851 . . . . 1.0 113.563 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -59.14 -6.96 1.0 Allowed 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 117.072 2.249 . . . . 1.0 117.072 -174.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 29.9 m -62.86 -29.94 71.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.024 1.329 . . . . 1.0 113.942 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.55 93.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.868 0.758 . . . . 1.0 111.674 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -58.68 -45.96 88.27 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.305 -0.872 . . . . 1.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -54.11 -57.1 12.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.569 -0.707 . . . . 1.0 111.349 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.47 -28.07 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.358 0.981 . . . . 1.0 113.489 -173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.4 p -72.47 -38.46 68.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.349 0.977 . . . . 1.0 112.276 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -57.6 -30.54 65.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.777 0.831 . . . . 1.0 112.53 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.26 -32.58 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.023 0.829 . . . . 1.0 112.928 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -93.58 -37.8 11.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 112.19 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -72.16 -46.27 57.1 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.605 -1.309 . . . . 1.0 112.908 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.53 30.71 8.77 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.316 1.913 . . . . 1.0 114.006 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.97 152.0 10.91 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.291 1.036 . . . . 1.0 112.458 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.271 1.829 . . . . 1.0 114.946 -175.277 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 110.542 -0.17 . . . . 1.0 110.542 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.43 158.24 31.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.962 0.905 . . . . 1.0 112.624 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 p -79.21 -31.67 0.72 Allowed Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 117.805 2.52 . . . . 1.0 117.805 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -81.5 156.82 19.1 Favored 'Trans proline' 0 C--N 1.357 1.023 0 CA-C-N 123.007 2.11 . . . . 1.0 112.136 -175.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -86.45 4.6 38.94 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.999 0.92 . . . . 1.0 112.722 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -153.66 140.92 19.56 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.037 1.735 . . . . 1.0 109.687 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -135.55 139.86 32.36 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.699 1.199 . . . . 1.0 110.242 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.0 157.54 23.77 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.809 3.006 . . . . 1.0 113.263 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -124.82 162.56 42.44 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 127.188 2.195 . . . . 1.0 112.165 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.73 129.48 14.31 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.037 3.158 . . . . 1.0 113.059 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.78 -3.46 86.85 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.541 -1.144 . . . . 1.0 115.192 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.09 139.91 58.76 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.343 1.572 . . . . 1.0 113.027 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.69 120.95 26.98 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.88 124.75 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.401 -0.963 . . . . 1.0 108.401 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -87.57 135.31 33.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mt -124.57 116.6 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.899 1.28 . . . . 1.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.28 85.97 4.1 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.42 1.088 . . . . 1.0 109.678 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -78.29 165.97 23.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.77 0.828 . . . . 1.0 110.485 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.13 112.44 1.9 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.88 0.872 . . . . 1.0 110.625 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.34 -5.27 60.46 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.25 1.405 . . . . 1.0 115.934 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -154.09 115.39 4.11 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.417 1.608 . . . . 1.0 113.881 -170.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -73.19 137.72 45.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.031 0.932 . . . . 1.0 110.234 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -125.01 170.01 11.56 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.365 1.866 . . . . 1.0 110.073 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -135.99 145.16 45.82 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.108 0.963 . . . . 1.0 112.58 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 151.86 44.18 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 1.0 112.928 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.61 116.17 29.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.466 1.906 . . . . 1.0 109.223 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -83.03 129.89 35.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.14 -0.975 . . . . 1.0 112.502 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.0 pt -106.57 4.11 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.84 30.6 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 116.118 1.207 . . . . 1.0 116.118 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -88.36 9.11 24.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.747 1.219 . . . . 1.0 113.641 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.1 83.9 Favored Glycine 0 N--CA 1.476 1.355 0 C-N-CA 124.811 1.196 . . . . 1.0 112.142 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -95.09 157.03 16.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.913 1.685 . . . . 1.0 112.569 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.88 155.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.298 1.439 . . . . 1.0 110.105 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.2 mt -111.43 135.91 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -153.91 151.12 29.08 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.411 -0.805 . . . . 1.0 111.803 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -85.96 133.62 33.92 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.57 121.71 35.39 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.922 1.289 . . . . 1.0 110.254 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.09 158.25 11.99 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 124.381 3.387 . . . . 1.0 113.667 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.25 152.9 77.5 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.221 3.281 . . . . 1.0 112.794 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.4 p -75.86 -19.91 58.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.265 1.209 . . . . 1.0 114.265 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -157.67 111.71 2.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.832 1.253 . . . . 1.0 111.143 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -81.98 136.2 47.57 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 118.642 -0.695 . . . . 1.0 110.567 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.98 122.97 11.44 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.083 2.522 . . . . 1.0 112.299 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.35 7.51 78.25 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.974 1.273 . . . . 1.0 116.135 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.18 86.68 2.42 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.978 1.389 . . . . 1.0 112.531 -177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.55 -111.17 3.96 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.133 0.873 . . . . 1.0 111.638 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.4 m -69.99 -17.46 63.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.989 0.916 . . . . 1.0 113.397 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.5 m -70.86 140.75 51.2 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.062 -1.024 . . . . 1.0 112.647 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.1 t -98.29 -147.2 0.32 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.315 1.446 . . . . 1.0 111.743 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.28 26.2 m 56.62 32.26 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 127.706 2.402 . . . . 1.0 114.288 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -42.13 -43.03 3.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.342 2.257 . . . . 1.0 114.349 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.6 m -82.66 -8.95 59.57 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.167 1.173 . . . . 1.0 114.167 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.77 120.03 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.655 1.182 . . . . 1.0 109.467 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.29 -18.76 26.33 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.709 1.003 . . . . 1.0 113.709 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.3 t -73.76 135.74 43.59 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.388 -0.82 . . . . 1.0 112.36 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.61 123.92 1.11 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.868 1.267 . . . . 1.0 110.715 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.0 m -146.9 142.36 27.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.035 0.754 . . . . 1.0 113.035 -169.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.28 152.16 26.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.83 1.252 . . . . 1.0 110.323 169.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -116.54 140.13 49.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.369 1.068 . . . . 1.0 110.195 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.79 125.39 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 169.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.69 163.13 27.89 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.412 1.485 . . . . 1.0 112.199 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -123.86 133.39 53.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.925 1.69 . . . . 1.0 110.058 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -158.14 174.65 14.87 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.063 0.945 . . . . 1.0 111.116 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.64 142.67 56.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.384 1.074 . . . . 1.0 111.453 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 tp -52.19 -53.96 36.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.764 0.826 . . . . 1.0 111.821 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.38 -48.59 71.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.213 1.005 . . . . 1.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.26 -36.18 83.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.222 0.609 . . . . 1.0 112.302 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.84 -42.54 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.228 1.011 . . . . 1.0 112.303 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.1 m -71.53 -36.76 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.031 1.287 . . . . 1.0 112.508 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.58 -130.84 46.48 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 119.033 0.833 . . . . 1.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.2 -6.79 87.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.415 1.007 . . . . 1.0 114.328 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -75.9 148.74 38.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.303 1.441 . . . . 1.0 111.35 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.8 t -73.35 160.44 31.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.051 0.54 . . . . 1.0 110.878 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -158.67 160.25 36.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.088 1.144 . . . . 1.0 114.088 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -160.89 158.69 28.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.26 1.424 . . . . 1.0 112.02 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.73 138.86 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -152.71 85.24 1.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 1.0 110.69 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.66 59.28 2.45 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.599 1.16 . . . . 1.0 112.141 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -65.01 -33.41 75.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.253 1.421 . . . . 1.0 113.56 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.94 -11.99 58.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.193 0.997 . . . . 1.0 113.58 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.73 -34.56 65.27 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.924 1.289 . . . . 1.0 112.136 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -79.2 -18.58 52.73 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.996 1.318 . . . . 1.0 112.306 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -94.74 -43.49 8.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.762 1.225 . . . . 1.0 112.097 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -134.41 146.94 50.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.98 1.312 . . . . 1.0 112.709 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -65.82 159.66 67.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.395 1.078 . . . . 1.0 111.329 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -54.59 151.58 30.66 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.491 3.461 . . . . 1.0 116.241 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 160.11 48.84 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.307 1.843 . . . . 1.0 111.109 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.11 126.02 10.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.987 3.125 . . . . 1.0 112.161 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.43 -33.51 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 113.239 0.829 . . . . 1.0 113.239 -174.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.44 -37.96 82.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.188 0.595 . . . . 1.0 111.909 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.77 -38.16 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 1.0 110.431 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.8 mt -61.55 -46.49 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.212 0.915 . . . . 1.0 110.518 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.35 -37.17 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.112 0.965 . . . . 1.0 111.764 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -63.6 -45.08 91.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.893 0.77 . . . . 1.0 111.363 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.6 m -58.68 -44.09 90.13 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.568 1.147 . . . . 1.0 111.746 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.01 63.09 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.533 0.733 . . . . 1.0 110.782 173.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.78 -39.74 85.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.018 0.927 . . . . 1.0 112.991 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -67.75 -33.92 75.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.112 0.965 . . . . 1.0 112.473 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 96.5 mtp -77.76 -33.21 52.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.845 -1.074 . . . . 1.0 112.857 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.8 t -48.62 128.83 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 120.33 1.423 . . . . 1.0 111.004 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.06 -15.3 62.74 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.628 1.585 . . . . 1.0 113.804 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -87.18 163.27 17.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.94 1.37 . . . . 1.0 111.494 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -125.57 157.7 36.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.393 1.477 . . . . 1.0 112.952 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.7 mtt -135.01 137.61 43.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.097 1.759 . . . . 1.0 110.258 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -60.42 131.79 51.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 118.79 0.723 . . . . 1.0 110.63 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -76.61 153.59 35.16 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.977 1.103 . . . . 1.0 113.977 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.4 t -138.55 139.87 38.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.982 1.713 . . . . 1.0 106.467 169.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -73.72 33.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 115.442 1.645 . . . . 1.0 115.442 -168.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.4 m -142.0 142.42 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.675 2.39 . . . . 1.0 109.846 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.8 p -80.67 -4.29 53.77 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.765 1.394 . . . . 1.0 114.765 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -58.37 -22.56 54.05 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.032 -1.042 . . . . 1.0 112.608 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -53.68 -29.71 40.04 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.792 -1.192 . . . . 1.0 113.073 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.9 -37.31 72.97 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 1.0 112.024 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -61.38 -52.09 66.09 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.447 0.699 . . . . 1.0 109.977 170.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -58.46 -37.67 75.95 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.816 -0.553 . . . . 1.0 111.881 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -59.82 -61.36 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.174 -0.917 . . . . 1.0 111.128 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.64 -24.81 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.799 1.181 . . . . 1.0 112.875 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -63.44 -49.36 73.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.449 1.1 . . . . 1.0 111.295 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -59.8 -28.24 67.28 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.425 0.69 . . . . 1.0 112.688 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -63.42 -36.11 82.63 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.107 0.78 . . . . 1.0 113.107 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -93.75 -44.04 8.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.812 0.845 . . . . 1.0 111.741 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.97 -46.24 88.66 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.001 -1.062 . . . . 1.0 112.349 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -90.82 30.81 5.92 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 126.566 2.031 . . . . 1.0 114.315 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.57 150.21 5.22 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.514 1.126 . . . . 1.0 113.131 175.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.254 1.341 0 C-N-CA 125.884 1.673 . . . . 1.0 114.0 -178.15 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 120.371 0.129 . . . . 1.0 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.89 158.67 32.97 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.131 0.972 . . . . 1.0 112.651 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.5 m -69.78 147.04 96.13 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.9 0.88 . . . . 1.0 112.904 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.08 -22.77 14.32 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.544 2.829 . . . . 1.0 113.804 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -160.52 175.52 12.63 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.872 1.669 . . . . 1.0 110.529 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -71.27 136.52 47.98 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.527 -0.733 . . . . 1.0 110.392 172.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -92.12 132.2 33.03 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.503 0.721 . . . . 1.0 109.482 170.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.08 143.16 22.5 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.35 2.7 . . . . 1.0 111.493 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -117.02 164.31 19.38 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.397 1.879 . . . . 1.0 111.323 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.64 128.46 10.72 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.855 3.036 . . . . 1.0 112.674 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.28 -3.4 87.25 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.368 -1.24 . . . . 1.0 115.429 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.3 142.24 57.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.647 1.723 . . . . 1.0 113.041 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 37.2 mt -89.22 118.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.039 -0.982 . . . . 1.0 108.984 174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.89 127.64 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.614 -1.624 . . . . 1.0 106.614 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -108.5 122.71 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.411 . . . . 1.0 107.696 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.9 mt -120.28 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 124.893 1.277 . . . . 1.0 109.254 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -86.15 56.95 4.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.537 1.535 . . . . 1.0 111.132 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -60.96 149.58 36.1 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.461 1.104 . . . . 1.0 110.855 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.46 146.75 47.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.668 1.187 . . . . 1.0 110.928 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.11 -61.92 4.3 Favored Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.84 1.21 . . . . 1.0 112.284 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -147.03 138.95 24.4 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.32 1.848 . . . . 1.0 111.78 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -66.56 159.13 28.08 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.056 1.342 . . . . 1.0 112.497 174.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -133.11 162.84 30.67 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.685 1.994 . . . . 1.0 110.928 -177.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -137.46 149.31 46.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.079 0.951 . . . . 1.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.58 151.65 38.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.196 0.998 . . . . 1.0 112.949 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -94.13 113.54 25.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.151 1.78 . . . . 1.0 108.778 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -82.32 129.56 34.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.086 -1.009 . . . . 1.0 112.425 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.7 pt -106.14 10.18 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.58 -35.48 4.48 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 124.665 1.126 . . . . 1.0 115.801 169.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.46 17.12 3.98 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.459 1.104 . . . . 1.0 113.706 -172.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 -4.89 85.43 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.905 1.241 . . . . 1.0 112.803 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -92.92 155.39 17.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.171 1.388 . . . . 1.0 113.131 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -126.94 151.31 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.247 1.419 . . . . 1.0 110.481 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.04 134.49 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 106.842 -1.54 . . . . 1.0 106.842 169.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -154.53 162.86 40.93 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.26 -0.9 . . . . 1.0 111.502 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -101.43 132.49 47.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.52 1.128 . . . . 1.0 109.156 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.19 152.14 90.32 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.161 0.985 . . . . 1.0 112.676 -174.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -66.5 -19.92 54.47 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 N-CA-C 121.265 3.525 . . . . 1.0 121.265 -172.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -53.24 139.15 63.82 Favored 'Trans proline' 0 C--N 1.359 1.125 0 CA-C-N 124.232 2.547 . . . . 1.0 115.021 -170.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -169.29 166.51 10.53 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.056 1.343 . . . . 1.0 112.505 -169.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 66.84 -156.2 0.23 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.869 1.668 . . . . 1.0 112.05 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -86.63 138.57 33.54 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.694 1.198 . . . . 1.0 111.802 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.17 175.32 11.41 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.982 3.121 . . . . 1.0 112.365 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.11 17.83 58.64 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.167 -0.796 . . . . 1.0 114.997 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.84 -17.35 63.38 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.462 1.282 . . . . 1.0 114.462 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.05 168.22 54.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.796 1.189 . . . . 1.0 113.229 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.9 p -63.68 -25.27 68.13 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -174.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.9 m -73.54 -12.22 60.7 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.312 1.045 . . . . 1.0 113.701 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t 70.96 -170.67 0.16 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.092 2.157 . . . . 1.0 113.976 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.31 -19.35 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.691 1.596 . . . . 1.0 113.38 -175.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -58.63 -26.61 63.92 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.03 0.932 . . . . 1.0 112.957 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.8 m -82.19 -17.83 44.82 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.919 1.081 . . . . 1.0 113.919 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.74 109.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.724 1.609 . . . . 1.0 110.522 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.6 -19.78 30.51 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.702 0.801 . . . . 1.0 112.944 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.8 m -144.02 165.17 28.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.718 1.607 . . . . 1.0 111.751 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.25 155.24 37.35 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.742 1.217 . . . . 1.0 112.777 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 m -152.42 151.87 31.32 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.158 1.383 . . . . 1.0 111.287 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.8 155.99 34.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.995 0.918 . . . . 1.0 109.303 169.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.64 135.64 35.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.823 1.249 . . . . 1.0 109.233 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.94 131.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.847 0.749 . . . . 1.0 109.268 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -135.05 162.19 33.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.58 1.552 . . . . 1.0 112.594 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -118.33 123.61 45.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.837 1.655 . . . . 1.0 109.946 171.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -145.52 172.08 13.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.715 1.206 . . . . 1.0 110.39 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -75.53 143.39 42.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.105 -0.997 . . . . 1.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.12 -51.92 64.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.172 -0.918 . . . . 1.0 111.702 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -54.33 -49.31 70.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.418 0.687 . . . . 1.0 111.299 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.64 -38.53 83.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.286 0.634 . . . . 1.0 111.846 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -44.79 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.405 1.082 . . . . 1.0 112.056 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -87.98 -7.58 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 114.354 1.242 . . . . 1.0 114.354 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.24 133.83 52.21 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.405 1.003 . . . . 1.0 113.192 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.08 80.87 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.822 1.201 . . . . 1.0 114.723 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.8 m -120.58 150.07 41.45 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.795 1.638 . . . . 1.0 111.204 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.8 m -81.41 158.87 24.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -161.18 168.02 25.02 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.429 . . . . 1.0 114.857 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -159.78 167.83 27.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.882 1.673 . . . . 1.0 112.205 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -87.25 126.57 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 168.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -131.67 57.66 1.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.336 1.065 . . . . 1.0 110.68 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.86 57.7 3.55 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.388 1.475 . . . . 1.0 111.667 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 p -78.64 -14.23 59.42 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.523 1.529 . . . . 1.0 114.72 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 mt -67.79 -11.83 59.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.135 1.161 . . . . 1.0 114.135 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.26 -26.69 67.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.946 0.794 . . . . 1.0 112.422 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -87.51 -5.37 58.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.123 1.369 . . . . 1.0 111.694 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -100.54 -47.24 4.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.549 1.54 . . . . 1.0 111.122 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -130.81 146.67 52.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.857 1.663 . . . . 1.0 112.338 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -64.52 155.13 82.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 1.0 111.864 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -48.78 141.23 21.46 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.569 3.513 . . . . 1.0 115.688 -170.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -121.21 146.45 44.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.724 1.61 . . . . 1.0 110.857 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.56 114.92 4.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.494 2.796 . . . . 1.0 110.398 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.06 -29.9 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 114.452 1.278 . . . . 1.0 114.452 -169.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.1 -35.72 75.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.926 0.49 . . . . 1.0 111.878 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.22 -32.61 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.254 0.622 . . . . 1.0 110.89 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.88 -49.24 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.289 0.949 . . . . 1.0 110.338 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.06 -38.6 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.086 0.954 . . . . 1.0 111.253 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.4 m -63.12 -41.77 99.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 1.0 112.127 173.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t -61.68 -44.45 96.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.101 0.96 . . . . 1.0 110.968 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.5 -52.42 65.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.164 0.986 . . . . 1.0 110.517 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.81 -39.09 87.64 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.138 0.975 . . . . 1.0 113.057 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.55 -34.71 77.63 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.921 0.888 . . . . 1.0 112.363 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 97.5 mtp -78.61 -31.64 47.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.711 -1.137 . . . . 1.0 113.305 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.6 t -47.61 126.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 120.264 1.393 . . . . 1.0 110.607 169.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.11 -12.43 65.43 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.741 1.639 . . . . 1.0 114.274 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.24 158.37 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.109 1.455 . . . . 1.0 111.45 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -118.53 159.54 23.35 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.338 1.455 . . . . 1.0 113.895 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.0 mtt -143.67 159.6 42.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.965 1.706 . . . . 1.0 112.091 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -96.43 -179.98 4.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.551 1.14 . . . . 1.0 111.666 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -94.37 158.85 15.38 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.742 1.217 . . . . 1.0 112.968 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.0 m 67.28 29.28 7.68 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.394 1.477 . . . . 1.0 112.747 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.6 pt -74.58 69.15 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.449 1.499 . . . . 1.0 112.628 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.5 t 78.55 -36.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 128.498 2.719 . . . . 1.0 111.663 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.6 t -152.25 -172.22 4.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.216 1.807 . . . . 1.0 110.166 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -57.44 120.66 8.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.465 1.106 . . . . 1.0 110.836 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -42.56 -65.31 0.48 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.948 1.699 . . . . 1.0 115.052 -169.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -69.6 -35.16 75.05 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.324 -0.86 . . . . 1.0 112.71 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.74 -51.79 66.89 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.729 0.812 . . . . 1.0 110.593 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -63.49 -34.63 78.2 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.254 -0.904 . . . . 1.0 111.261 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.38 -60.02 4.47 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.125 -0.985 . . . . 1.0 110.917 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.8 m -64.9 -22.76 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 120.634 1.561 . . . . 1.0 113.338 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.1 m -65.55 -52.87 49.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.788 1.235 . . . . 1.0 110.984 169.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -66.55 -24.96 66.44 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.391 0.885 . . . . 1.0 113.391 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.2 -37.55 75.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.911 0.884 . . . . 1.0 112.986 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -93.88 -46.74 7.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.118 0.967 . . . . 1.0 112.133 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -62.08 -44.68 96.15 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.153 -0.967 . . . . 1.0 111.747 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -93.6 33.65 5.05 Favored Glycine 0 N--CA 1.472 1.045 0 C-N-CA 126.424 1.964 . . . . 1.0 113.652 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.9 -49.03 63.82 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.614 1.166 . . . . 1.0 112.361 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.137 1.775 . . . . 1.0 113.216 -177.285 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 110.61 -0.145 . . . . 1.0 110.61 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.47 160.69 31.89 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.052 0.941 . . . . 1.0 112.901 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.0 p -74.93 151.33 86.4 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.862 0.865 . . . . 1.0 112.755 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.55 162.01 30.72 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.746 2.964 . . . . 1.0 111.694 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -76.12 -8.16 56.38 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.524 0.935 . . . . 1.0 113.524 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -142.09 129.36 21.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.777 1.631 . . . . 1.0 110.276 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.03 123.77 2.01 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.835 1.254 . . . . 1.0 109.614 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -86.33 158.62 9.63 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.68 3.587 . . . . 1.0 111.998 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -129.97 162.53 53.19 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.805 1.642 . . . . 1.0 112.027 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.77 128.01 8.51 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.253 3.302 . . . . 1.0 113.091 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.81 -9.42 76.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.999 1.285 . . . . 1.0 115.108 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.82 151.27 44.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.103 1.452 . . . . 1.0 113.71 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.31 125.45 35.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.087 0.955 . . . . 1.0 109.976 171.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.0 mm -95.0 132.93 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 106.757 -1.572 . . . . 1.0 106.757 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -111.68 130.88 55.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.776 1.63 . . . . 1.0 108.851 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.06 129.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.732 1.613 . . . . 1.0 109.355 -169.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -109.92 102.26 11.03 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.61 1.564 . . . . 1.0 109.274 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -99.61 162.3 13.1 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.86 2.064 . . . . 1.0 109.77 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.75 107.87 0.57 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.933 0.893 . . . . 1.0 109.956 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.07 14.47 82.58 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-O 118.489 -1.173 . . . . 1.0 115.472 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -156.89 143.31 18.23 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.583 1.692 . . . . 1.0 114.153 -172.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -109.15 135.27 50.54 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.24 1.416 . . . . 1.0 108.533 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -144.89 156.61 44.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.298 0.639 . . . . 1.0 111.944 -169.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -142.14 155.54 45.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.118 0.785 . . . . 1.0 113.118 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.12 153.33 42.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.462 1.105 . . . . 1.0 112.115 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.47 118.15 30.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.999 1.319 . . . . 1.0 108.52 171.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -83.39 132.55 34.98 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.236 -0.915 . . . . 1.0 112.156 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 pt -117.44 2.45 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 -170.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.43 163.71 27.33 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.742 1.163 . . . . 1.0 113.427 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 61.71 19.03 10.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.146 1.778 . . . . 1.0 114.116 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.78 2.93 81.0 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.602 1.572 . . . . 1.0 114.107 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -95.14 152.53 18.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.74 . . . . 1.0 114.151 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.8 160.53 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.034 1.733 . . . . 1.0 110.737 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.51 132.07 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.761 -1.57 . . . . 1.0 106.761 168.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.194 -0.941 . . . . 1.0 111.062 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.25 111.14 16.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 171.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.65 114.91 36.62 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.914 0.886 . . . . 1.0 111.326 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.7 139.61 15.97 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.739 2.292 . . . . 1.0 110.954 -172.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.73 137.97 28.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.477 2.785 . . . . 1.0 110.57 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.6 p -89.58 -31.99 17.33 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -172.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -147.85 151.02 35.24 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.121 1.768 . . . . 1.0 110.583 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -73.36 157.87 87.44 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.08 -30.71 75.89 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.017 3.145 . . . . 1.0 113.969 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.2 -176.88 15.39 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.077 1.322 . . . . 1.0 113.545 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.55 0.35 3.63 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.973 1.309 . . . . 1.0 114.262 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -87.1 -171.05 47.26 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.904 1.24 . . . . 1.0 113.333 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 m -70.81 -12.52 61.6 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.237 1.199 . . . . 1.0 114.237 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.3 m -74.48 45.94 0.25 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.044 1.737 . . . . 1.0 112.643 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 m -64.71 26.94 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 128.629 2.771 . . . . 1.0 116.931 -169.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -82.74 27.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 126.296 1.838 . . . . 1.0 112.545 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -55.23 -30.3 59.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.147 1.779 . . . . 1.0 113.754 -170.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m -66.19 -15.58 63.27 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.054 1.341 . . . . 1.0 114.269 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.36 17.44 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 125.251 1.421 . . . . 1.0 112.807 173.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -114.37 -154.19 0.54 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.363 1.465 . . . . 1.0 110.501 174.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 p -75.76 55.92 0.9 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.97 2.108 . . . . 1.0 113.006 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.84 22.96 0.98 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.912 1.449 . . . . 1.0 114.912 -173.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 m -73.95 158.45 34.37 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.849 -1.157 . . . . 1.0 112.442 171.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.21 149.97 21.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.138 1.375 . . . . 1.0 109.984 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.17 140.35 52.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.81 0.844 . . . . 1.0 109.837 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.36 123.32 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.3 153.71 51.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.987 1.315 . . . . 1.0 112.091 -175.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -100.96 125.11 47.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.967 1.707 . . . . 1.0 109.713 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -149.62 174.81 12.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.782 1.233 . . . . 1.0 110.372 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -75.54 144.57 41.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.008 -1.058 . . . . 1.0 111.71 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -48.99 -52.16 26.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.0 1.32 . . . . 1.0 110.942 173.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.66 -53.6 18.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.325 1.85 . . . . 1.0 111.248 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.32 -34.73 75.11 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.466 0.543 . . . . 1.0 112.466 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.8 t -71.25 -43.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.571 1.148 . . . . 1.0 112.303 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.2 m -73.87 -39.18 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 119.459 1.027 . . . . 1.0 112.697 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.39 -127.38 45.02 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.968 0.804 . . . . 1.0 112.191 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.01 3.16 84.54 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.102 1.334 . . . . 1.0 114.903 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.1 m -78.73 155.95 29.12 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.782 1.291 . . . . 1.0 111.579 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.59 150.91 37.94 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.659 0.384 . . . . 1.0 110.097 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -161.0 164.55 30.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -160.84 160.11 30.68 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.652 1.581 . . . . 1.0 111.556 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.11 133.38 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -155.87 87.3 1.07 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.596 0.758 . . . . 1.0 111.288 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.5 58.84 1.8 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.999 1.32 . . . . 1.0 112.353 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -61.19 -35.61 77.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.866 1.266 . . . . 1.0 112.988 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.47 -14.03 62.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.621 1.168 . . . . 1.0 113.487 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.97 -23.08 67.2 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.634 -0.666 . . . . 1.0 112.762 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.73 -2.67 55.81 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.141 1.376 . . . . 1.0 111.589 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -98.71 -46.2 5.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.633 1.573 . . . . 1.0 111.554 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -125.73 168.98 13.03 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.418 1.487 . . . . 1.0 114.079 -172.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -65.93 161.15 57.27 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.588 1.155 . . . . 1.0 111.204 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.78 131.82 28.66 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.867 2.378 . . . . 1.0 110.807 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -113.21 152.19 44.89 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.056 1.343 . . . . 1.0 110.989 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 118.07 5.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.404 2.736 . . . . 1.0 111.348 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.75 -36.6 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.899 1.28 . . . . 1.0 114.174 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.37 -35.53 79.43 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.944 0.498 . . . . 1.0 111.908 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.22 -37.92 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.334 0.654 . . . . 1.0 110.651 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -62.73 -47.13 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 118.95 0.796 . . . . 1.0 110.465 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.33 -36.84 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.821 0.849 . . . . 1.0 111.749 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -62.1 -44.13 97.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.146 0.885 . . . . 1.0 111.252 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 m -58.43 -44.73 89.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 1.0 111.72 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.66 -50.38 73.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.305 0.957 . . . . 1.0 110.89 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.54 -38.33 89.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.531 1.132 . . . . 1.0 113.322 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -69.32 -32.1 70.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.116 0.966 . . . . 1.0 112.155 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.36 -35.23 54.74 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.385 -0.817 . . . . 1.0 112.933 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -45.65 126.46 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.484 1.038 . . . . 1.0 111.359 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.14 59.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.22 1.867 . . . . 1.0 113.972 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -87.71 149.43 24.24 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.027 1.414 . . . . 1.0 111.078 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -106.4 153.15 22.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.397 1.479 . . . . 1.0 113.892 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.8 mtt -149.22 176.9 10.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.922 2.089 . . . . 1.0 110.811 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.39 176.21 9.98 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.182 -0.949 . . . . 1.0 111.939 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -87.86 -60.09 2.07 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.732 1.213 . . . . 1.0 112.94 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -156.11 131.87 9.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.474 1.51 . . . . 1.0 109.156 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.0 pt -127.7 10.84 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 114.493 1.294 . . . . 1.0 114.493 -169.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.4 p 132.63 -37.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 1 C-N-CA 133.017 4.527 . . . . 1.0 107.579 -169.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 t -114.83 149.59 36.83 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.884 1.673 . . . . 1.0 109.402 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -77.22 110.71 12.14 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.087 1.355 . . . . 1.0 108.467 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -59.71 -33.26 71.39 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 -169.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 27.3 p -58.43 -34.78 71.19 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.06 -1.025 . . . . 1.0 113.702 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -68.24 -55.28 12.76 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.74 1.616 . . . . 1.0 110.591 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -65.37 -33.19 75.38 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.164 -0.96 . . . . 1.0 111.415 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -56.75 -59.02 5.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.338 -0.839 . . . . 1.0 111.129 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.84 -24.38 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.729 1.15 . . . . 1.0 112.31 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -65.4 -48.35 73.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.036 0.934 . . . . 1.0 111.336 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -62.06 -26.47 68.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.267 1.027 . . . . 1.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.03 -32.87 74.33 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.339 0.972 . . . . 1.0 112.949 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -90.39 -48.87 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.275 1.03 . . . . 1.0 111.557 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.76 -30.45 68.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -93.81 16.47 60.75 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.147 1.832 . . . . 1.0 114.52 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.95 151.36 8.87 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 118.676 1.238 . . . . 1.0 112.833 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.346 1.858 . . . . 1.0 114.999 -175.636 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.91 160.22 31.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.251 1.02 . . . . 1.0 112.593 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 p -78.65 161.28 69.94 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.548 1.139 . . . . 1.0 113.19 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.78 153.37 50.53 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 124.002 3.135 . . . . 1.0 113.359 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -159.16 169.05 25.03 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.689 1.195 . . . . 1.0 111.734 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -70.61 136.84 49.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.182 0.993 . . . . 1.0 111.282 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -158.88 129.41 3.57 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.487 1.515 . . . . 1.0 109.402 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.07 144.96 12.16 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.663 2.908 . . . . 1.0 112.165 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -130.51 162.64 53.48 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.747 2.019 . . . . 1.0 111.678 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.15 129.23 15.19 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.559 2.839 . . . . 1.0 113.412 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.21 85.12 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.29 -1.284 . . . . 1.0 114.841 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.86 137.44 58.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.585 1.693 . . . . 1.0 112.758 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.39 117.88 24.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.785 1.234 . . . . 1.0 108.419 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.4 mm -99.67 121.81 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.46 1.504 . . . . 1.0 107.85 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.74 119.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.491 1.116 . . . . 1.0 109.505 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -88.52 63.28 6.95 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.192 1.397 . . . . 1.0 110.078 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -62.1 152.12 33.73 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.112 0.965 . . . . 1.0 110.688 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.07 134.76 49.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.74 0.816 . . . . 1.0 110.12 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.67 -125.1 6.72 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 109.612 -1.395 . . . . 1.0 109.612 -169.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -76.57 144.51 39.6 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.482 0.919 . . . . 1.0 113.482 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.92 156.04 21.95 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.557 1.543 . . . . 1.0 111.528 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.46 163.19 29.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.984 1.714 . . . . 1.0 110.854 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -139.69 153.32 47.23 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.267 1.027 . . . . 1.0 112.668 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 152.18 38.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.635 0.774 . . . . 1.0 112.693 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.27 115.43 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.084 1.754 . . . . 1.0 108.323 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -80.32 129.12 34.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.956 0.798 . . . . 1.0 112.099 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.5 pt -105.94 10.62 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 115.06 1.504 . . . . 1.0 115.06 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.86 -34.8 5.08 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.53 1.062 . . . . 1.0 115.743 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.96 16.59 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.371 1.068 . . . . 1.0 113.838 -172.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 -7.46 80.79 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.121 1.343 . . . . 1.0 113.202 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -91.89 156.64 17.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.051 1.341 . . . . 1.0 112.819 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -127.61 152.63 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.405 1.482 . . . . 1.0 110.309 172.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -110.91 135.03 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.061 1.345 . . . . 1.0 107.976 169.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -153.8 151.97 30.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.048 0.939 . . . . 1.0 112.294 -168.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.86 126.56 36.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.566 0.747 . . . . 1.0 109.406 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -88.77 136.47 30.9 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.841 -1.076 . . . . 1.0 109.518 173.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -79.73 170.16 17.29 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 123.446 2.764 . . . . 1.0 113.307 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.43 168.13 4.23 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.872 3.715 . . . . 1.0 113.178 169.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 t -169.35 172.38 7.24 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -172.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -74.22 156.27 37.43 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.567 1.547 . . . . 1.0 112.851 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.04 133.46 74.24 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 113.619 0.97 . . . . 1.0 113.619 -171.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.75 -21.14 7.31 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.385 2.723 . . . . 1.0 113.795 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.23 -135.65 6.59 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.658 1.123 . . . . 1.0 113.578 -176.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.38 -8.48 51.05 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.13 -156.33 28.29 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 124.789 1.185 . . . . 1.0 112.557 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -62.26 -13.6 29.95 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.492 1.293 . . . . 1.0 114.492 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 m -68.13 -8.53 39.2 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.931 1.292 . . . . 1.0 113.4 170.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 t -147.6 -164.89 2.11 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.225 1.81 . . . . 1.0 111.016 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.255 26.2 m 51.71 28.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 127.377 2.271 . . . . 1.0 115.042 174.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.43 -20.38 54.65 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.981 1.312 . . . . 1.0 113.828 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 p -65.9 -13.82 60.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.762 1.625 . . . . 1.0 114.322 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.05 153.35 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.815 1.646 . . . . 1.0 111.836 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.9 tp -104.26 -17.15 14.96 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.22 1.408 . . . . 1.0 113.095 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.0 t -166.99 174.07 8.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.908 1.683 . . . . 1.0 110.48 -173.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -78.5 151.01 32.79 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.01 0.924 . . . . 1.0 111.142 170.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 p -71.55 154.56 41.37 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.019 -1.051 . . . . 1.0 111.782 169.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.93 149.89 29.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.614 0.766 . . . . 1.0 109.633 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -136.96 137.46 39.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.541 0.736 . . . . 1.0 110.129 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.3 t -80.08 125.13 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.04 161.43 31.0 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.218 1.807 . . . . 1.0 111.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -120.52 124.59 45.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.753 1.621 . . . . 1.0 110.405 172.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -147.27 178.38 8.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.415 1.486 . . . . 1.0 110.219 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.02 143.19 32.69 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.952 -1.092 . . . . 1.0 111.78 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.77 -61.27 2.13 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.153 1.381 . . . . 1.0 111.319 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -56.19 -43.95 78.96 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.268 1.027 . . . . 1.0 111.36 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.39 -43.03 91.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.3 t -69.79 -42.1 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.451 1.1 . . . . 1.0 112.15 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -79.22 -5.47 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.91 132.96 51.21 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.616 1.103 . . . . 1.0 113.041 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.71 69.71 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.691 1.138 . . . . 1.0 114.785 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 m -126.04 154.22 43.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.307 1.843 . . . . 1.0 111.244 -175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.0 t -82.64 153.52 25.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 168.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -160.48 163.67 32.76 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -161.04 159.55 29.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.206 1.403 . . . . 1.0 112.813 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.2 t -82.75 133.06 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -153.77 80.47 1.15 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.885 0.85 . . . . 1.0 112.153 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.15 51.12 1.71 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.138 1.375 . . . . 1.0 113.049 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.8 m -59.0 -30.43 67.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.684 -1.26 . . . . 1.0 113.411 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.54 -16.07 63.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.88 1.067 . . . . 1.0 113.88 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.0 -20.66 65.5 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.038 0.755 . . . . 1.0 113.038 170.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -97.58 -3.2 40.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.596 1.558 . . . . 1.0 111.815 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -97.58 -48.11 5.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.657 1.583 . . . . 1.0 110.98 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.38 167.59 12.61 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.005 1.722 . . . . 1.0 112.795 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -67.45 163.36 48.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.756 0.822 . . . . 1.0 111.701 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.13 128.01 28.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.396 2.73 . . . . 1.0 111.527 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -113.26 152.65 45.32 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.318 1.447 . . . . 1.0 110.43 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.39 113.78 3.81 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.461 2.774 . . . . 1.0 110.783 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.19 -29.23 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -37.0 78.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.493 . . . . 1.0 111.887 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.02 -33.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.526 0.73 . . . . 1.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.17 -47.82 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.938 0.79 . . . . 1.0 110.121 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.81 -38.97 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.253 1.021 . . . . 1.0 111.729 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 t -63.03 -43.17 99.44 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.439 -0.788 . . . . 1.0 111.567 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.5 m -61.63 -42.38 98.8 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.342 1.057 . . . . 1.0 111.671 173.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 72.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.496 0.719 . . . . 1.0 110.456 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -60.95 -40.62 94.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.153 0.981 . . . . 1.0 112.865 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.79 -33.72 76.52 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.838 0.855 . . . . 1.0 112.554 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.5 mmm -73.48 -38.63 65.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.834 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.9 t -47.33 128.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.88 1.218 . . . . 1.0 111.507 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.76 62.95 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.788 1.661 . . . . 1.0 113.703 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -82.76 145.11 29.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 118.965 1.383 . . . . 1.0 111.19 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -114.9 147.38 40.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.83 1.652 . . . . 1.0 112.732 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.6 mmt -124.41 145.12 49.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.979 1.712 . . . . 1.0 110.237 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -75.23 146.97 40.71 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.517 -0.74 . . . . 1.0 112.787 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -70.91 -17.51 62.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.541 0.941 . . . . 1.0 113.541 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.6 m -71.26 -2.9 17.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.108 1.763 . . . . 1.0 114.89 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.9 tt -60.72 144.45 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.583 1.153 . . . . 1.0 111.808 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.03 -22.27 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 115.142 1.534 . . . . 1.0 115.142 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 t -160.51 178.72 9.25 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.145 0.978 . . . . 1.0 112.485 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -54.8 139.66 38.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.003 1.721 . . . . 1.0 111.831 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -122.79 -3.48 8.7 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.933 1.827 . . . . 1.0 115.933 -169.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.13 -43.91 81.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 121.446 1.93 . . . . 1.0 113.33 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -43.91 85.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.138 0.975 . . . . 1.0 110.88 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.23 -41.58 93.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.451 -0.781 . . . . 1.0 111.362 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -58.02 -58.92 6.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.139 0.976 . . . . 1.0 110.891 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.38 -22.52 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.61 1.095 . . . . 1.0 112.76 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 83.5 m -65.7 -49.91 66.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.615 1.166 . . . . 1.0 111.476 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.97 -29.02 64.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.555 1.142 . . . . 1.0 112.468 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.5 -34.54 77.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.219 0.822 . . . . 1.0 113.219 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -93.75 -47.86 6.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.164 0.986 . . . . 1.0 111.307 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.57 -30.48 71.5 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.547 1.139 . . . . 1.0 113.546 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -74.5 -9.75 82.08 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.599 1.095 . . . . 1.0 114.435 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -47.87 69.47 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.429 1.115 . . . . 1.0 111.034 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.253 1.271 0 C-N-CA 126.467 1.907 . . . . 1.0 113.773 -175.393 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.827 -0.064 . . . . 1.0 110.827 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.38 164.77 38.29 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.375 1.47 . . . . 1.0 111.931 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.2 p -75.98 149.98 83.12 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.423 1.089 . . . . 1.0 112.653 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.42 139.19 40.76 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.309 2.672 . . . . 1.0 112.061 -172.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -140.81 163.89 31.72 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.031 1.733 . . . . 1.0 111.592 -175.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -130.49 163.86 26.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.495 1.518 . . . . 1.0 111.274 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -130.44 128.19 22.57 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.567 1.147 . . . . 1.0 108.527 169.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 148.26 26.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.589 2.859 . . . . 1.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.88 164.27 41.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.246 1.818 . . . . 1.0 112.177 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.91 126.68 11.37 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.656 2.904 . . . . 1.0 113.235 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.66 -10.03 75.91 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.744 1.164 . . . . 1.0 115.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -66.87 137.78 56.83 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.457 1.628 . . . . 1.0 112.911 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.27 118.41 26.68 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.276 1.43 . . . . 1.0 108.45 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.3 mt -101.28 130.93 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -103.06 131.78 49.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.301 1.44 . . . . 1.0 108.364 170.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.5 mt -124.43 118.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.632 1.573 . . . . 1.0 108.431 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -88.39 52.25 2.4 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 1.0 112.034 -169.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -64.58 148.46 50.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.69 0.796 . . . . 1.0 111.017 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.14 149.38 47.84 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.226 1.01 . . . . 1.0 111.828 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.42 -42.62 2.62 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 125.382 1.467 . . . . 1.0 113.406 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -168.3 135.2 2.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.876 2.071 . . . . 1.0 111.519 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.13 151.68 42.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.175 1.79 . . . . 1.0 111.157 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.46 165.5 18.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.996 1.319 . . . . 1.0 110.433 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -141.41 154.43 45.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.091 0.557 . . . . 1.0 112.048 -175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.73 147.73 31.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.695 0.798 . . . . 1.0 112.356 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.35 118.72 32.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.091 1.756 . . . . 1.0 107.976 169.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.35 132.89 35.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.043 -1.035 . . . . 1.0 112.4 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.86 0.86 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 115.092 1.515 . . . . 1.0 115.092 -169.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.06 169.29 33.45 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.389 0.995 . . . . 1.0 112.917 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 64.1 15.49 9.32 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.239 1.816 . . . . 1.0 114.202 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.57 83.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.35 1.453 . . . . 1.0 114.059 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -101.53 154.52 18.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.21 1.505 . . . . 1.0 114.006 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.72 165.0 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.473 1.909 . . . . 1.0 110.769 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -121.91 135.53 61.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 168.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -154.81 166.02 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.073 -1.017 . . . . 1.0 110.808 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.3 tp -86.57 139.0 31.25 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.76 119.34 34.06 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.836 1.254 . . . . 1.0 109.371 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.49 161.99 27.98 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.01 2.473 . . . . 1.0 112.606 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.54 138.22 41.4 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.98 3.12 . . . . 1.0 110.47 170.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 p -88.18 -39.16 14.72 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.747 1.018 . . . . 1.0 113.747 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -169.92 149.13 3.62 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.537 1.935 . . . . 1.0 110.201 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -58.04 138.38 83.74 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 121.726 -0.609 . . . . 1.0 112.291 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.19 156.43 62.26 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.972 3.115 . . . . 1.0 112.581 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.79 -134.82 32.49 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.189 0.899 . . . . 1.0 112.549 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.69 1.64 33.32 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.243 1.417 . . . . 1.0 113.307 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.15 -120.92 5.87 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 124.944 1.259 . . . . 1.0 111.367 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -51.09 -38.11 49.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.515 1.526 . . . . 1.0 114.167 -172.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.2 m -73.29 -32.9 64.92 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.446 -0.784 . . . . 1.0 112.72 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 m -87.54 -35.31 18.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.83 0.852 . . . . 1.0 113.028 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -66.84 -14.01 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -59.84 -38.03 80.93 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.137 0.575 . . . . 1.0 110.802 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.2 m -94.87 -39.75 10.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.317 1.047 . . . . 1.0 112.572 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 t -103.02 68.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.445 1.498 . . . . 1.0 110.083 -175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.7 tp -69.65 -28.67 66.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.461 0.911 . . . . 1.0 113.461 -169.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.9 m -57.84 109.56 0.75 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.457 1.503 . . . . 1.0 113.856 -174.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -140.77 32.06 1.82 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.928 1.691 . . . . 1.0 111.361 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.3 m -84.88 161.63 19.8 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.769 -1.207 . . . . 1.0 113.589 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.38 159.08 23.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.718 1.207 . . . . 1.0 109.98 169.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -129.44 142.68 50.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.386 0.674 . . . . 1.0 111.195 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.0 t -75.41 125.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 169.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.94 151.48 51.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.709 1.204 . . . . 1.0 112.765 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -97.04 129.14 44.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.883 1.673 . . . . 1.0 108.394 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.15 163.06 37.93 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.029 0.532 . . . . 1.0 110.941 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -72.48 141.26 48.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.47 1.108 . . . . 1.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.69 -58.99 3.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.154 1.382 . . . . 1.0 111.167 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -55.77 -45.54 78.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.432 1.093 . . . . 1.0 111.393 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.42 -41.08 98.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.884 0.474 . . . . 1.0 111.671 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.23 -44.49 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.33 1.052 . . . . 1.0 112.325 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.94 -1.76 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 114.044 1.127 . . . . 1.0 114.044 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.27 50.81 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.377 0.989 . . . . 1.0 113.615 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 1.66 76.45 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.933 1.254 . . . . 1.0 114.56 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.4 m -126.27 155.75 41.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.148 1.779 . . . . 1.0 111.418 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.1 t -85.25 154.77 21.73 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -157.13 150.4 23.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.055 -1.028 . . . . 1.0 113.741 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -150.75 163.79 37.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.219 1.808 . . . . 1.0 110.58 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.6 t -83.64 137.46 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.085 0.954 . . . . 1.0 108.878 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -145.0 77.77 1.54 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.291 1.436 . . . . 1.0 110.845 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.08 62.69 2.89 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.929 1.292 . . . . 1.0 111.418 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.3 p -64.24 -40.18 95.5 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.806 1.242 . . . . 1.0 113.378 -170.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -71.48 -9.67 58.56 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.814 1.042 . . . . 1.0 113.814 -175.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.56 -27.06 68.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.873 0.844 . . . . 1.0 113.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -80.58 -14.73 57.96 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.295 1.438 . . . . 1.0 112.184 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -102.49 -39.89 6.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.654 1.581 . . . . 1.0 112.241 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -129.92 161.5 30.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.631 1.572 . . . . 1.0 113.11 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -65.85 159.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.413 1.085 . . . . 1.0 111.288 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.1 124.47 14.45 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.726 2.284 . . . . 1.0 110.817 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -94.23 154.94 40.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.076 1.35 . . . . 1.0 110.343 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.91 113.19 3.32 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.562 . . . . 1.0 110.89 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.45 -32.61 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.55 -36.29 78.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.875 0.47 . . . . 1.0 112.019 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.3 t -71.96 -36.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.912 0.885 . . . . 1.0 111.008 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.27 -47.72 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.858 0.754 . . . . 1.0 110.197 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.95 -38.81 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.945 0.898 . . . . 1.0 111.604 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -61.92 -41.52 98.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.305 0.957 . . . . 1.0 111.706 172.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -61.24 -45.3 95.1 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.2 -0.938 . . . . 1.0 111.055 173.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.94 73.36 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.394 -0.817 . . . . 1.0 110.717 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.69 -37.12 85.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.292 1.037 . . . . 1.0 113.43 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.76 -33.49 73.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.714 0.806 . . . . 1.0 112.507 173.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.9 mmm -74.65 -37.39 62.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.919 0.888 . . . . 1.0 112.654 176.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.9 t -46.11 128.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.268 0.94 . . . . 1.0 111.754 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.94 64.92 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.789 1.661 . . . . 1.0 113.56 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -84.06 146.05 28.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.004 1.402 . . . . 1.0 110.89 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -100.19 151.72 21.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.396 1.478 . . . . 1.0 112.56 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.6 mtt -150.74 169.35 21.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.586 1.554 . . . . 1.0 112.802 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -73.81 166.9 22.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.985 0.914 . . . . 1.0 111.408 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -156.12 171.49 20.06 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.639 1.576 . . . . 1.0 110.659 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 m -50.08 -19.0 0.64 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.439 2.696 . . . . 1.0 115.962 -172.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 tt -56.74 -23.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.793 1.237 . . . . 1.0 111.753 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.23 -45.29 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 126.863 2.065 . . . . 1.0 112.576 169.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.7 m -153.98 127.81 8.82 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.872 1.215 . . . . 1.0 111.528 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -57.88 132.39 53.23 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.326 -0.859 . . . . 1.0 111.283 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -144.45 -12.18 0.61 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.457 2.391 . . . . 1.0 117.457 -169.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 90.7 m -63.14 -41.53 99.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.463 1.938 . . . . 1.0 114.171 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.41 -47.05 77.61 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.754 -0.591 . . . . 1.0 110.881 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -59.54 -30.98 69.0 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.61 -0.681 . . . . 1.0 112.436 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.19 -61.16 2.55 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.376 -0.828 . . . . 1.0 111.01 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.41 -28.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 p -67.28 -39.08 85.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.959 0.904 . . . . 1.0 112.469 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -59.35 -24.41 63.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.804 0.842 . . . . 1.0 113.036 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -66.19 -35.7 81.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.091 0.86 . . . . 1.0 112.637 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -87.08 -42.79 12.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.064 0.946 . . . . 1.0 111.846 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -68.09 -30.86 70.14 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -79.09 -37.69 24.51 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.652 1.12 . . . . 1.0 113.298 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . 0.299 0.1 OUTLIER 38.01 -145.6 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 127.467 2.307 . . . . 1.0 115.805 174.777 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.419 1.888 . . . . 1.0 113.603 -179.64 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 110.717 -0.105 . . . . 1.0 110.717 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.55 158.6 35.38 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.036 0.934 . . . . 1.0 112.858 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 p -75.4 151.79 85.49 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.235 1.014 . . . . 1.0 112.989 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.76 159.49 38.53 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.666 2.911 . . . . 1.0 112.062 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.64 -15.95 60.27 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.412 0.893 . . . . 1.0 113.412 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -127.91 139.21 52.74 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.983 1.713 . . . . 1.0 109.215 174.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.54 150.21 43.1 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.128 0.971 . . . . 1.0 110.736 174.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.03 156.74 13.27 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.515 2.81 . . . . 1.0 113.197 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -126.85 162.14 49.2 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.587 1.955 . . . . 1.0 111.706 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -45.8 129.06 11.64 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.061 3.174 . . . . 1.0 113.289 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -7.36 73.94 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.251 1.405 . . . . 1.0 114.887 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -71.48 142.23 50.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.28 1.54 . . . . 1.0 113.839 -175.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.05 124.57 31.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.296 1.438 . . . . 1.0 108.814 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -105.25 128.47 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.124 -1.436 . . . . 1.0 107.124 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -109.6 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.364 1.466 . . . . 1.0 108.048 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mt -127.89 140.64 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.959 1.704 . . . . 1.0 108.911 -169.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -123.72 106.18 10.3 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 1.0 110.375 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -90.47 161.66 15.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.901 1.68 . . . . 1.0 108.437 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.94 108.93 0.5 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.669 0.788 . . . . 1.0 110.302 175.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.95 -2.76 87.17 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.518 1.532 . . . . 1.0 116.524 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -152.16 130.64 12.18 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 120.243 2.022 . . . . 1.0 114.544 -170.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -77.76 155.33 31.24 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.144 1.378 . . . . 1.0 112.151 169.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -151.16 165.7 33.09 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.566 1.547 . . . . 1.0 110.89 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -144.34 157.88 44.03 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.023 -1.048 . . . . 1.0 113.407 -173.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.91 40.11 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.781 1.232 . . . . 1.0 112.824 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.37 118.64 37.31 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.971 1.708 . . . . 1.0 108.37 171.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.092 -1.005 . . . . 1.0 112.496 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.06 2.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 115.155 1.539 . . . . 1.0 115.155 -170.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.15 166.84 31.5 Favored Glycine 0 N--CA 1.479 1.513 0 C-N-CA 124.593 1.092 . . . . 1.0 112.984 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 65.12 1.17 1.44 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.39 2.276 . . . . 1.0 114.321 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 6.09 59.31 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.112 1.339 . . . . 1.0 113.932 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -90.49 152.22 21.04 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.167 1.984 . . . . 1.0 113.573 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.68 154.76 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.695 1.598 . . . . 1.0 110.734 171.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -114.51 137.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.837 -1.542 . . . . 1.0 106.837 168.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -155.77 164.17 38.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 120.951 -1.093 . . . . 1.0 110.344 -170.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.7 tp -85.92 143.19 28.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.747 -1.205 . . . . 1.0 107.747 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.27 106.26 43.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.897 1.279 . . . . 1.0 110.692 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.52 139.18 80.4 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.464 2.776 . . . . 1.0 112.302 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -89.48 -172.32 0.62 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 124.43 3.42 . . . . 1.0 111.472 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 p -76.14 165.33 25.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.353 1.061 . . . . 1.0 113.066 169.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.52 146.34 40.61 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.284 1.033 . . . . 1.0 112.436 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.9 t80 88.0 129.28 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 129.1 2.96 . . . . 1.0 112.973 170.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -81.15 177.57 7.7 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.626 2.884 . . . . 1.0 111.655 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.57 171.28 55.1 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.357 0.979 . . . . 1.0 113.608 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 65.76 15.72 10.18 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.069 1.748 . . . . 1.0 114.649 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.43 170.4 23.3 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 126.084 1.802 . . . . 1.0 112.094 173.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.2 m -57.18 -31.1 65.08 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.279 1.214 . . . . 1.0 114.279 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.8 p -95.99 -2.16 47.52 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.987 1.315 . . . . 1.0 113.872 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.6 p -133.3 -9.06 2.94 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.489 2.033 . . . . 1.0 116.489 -170.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.0 -32.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 120.583 1.538 . . . . 1.0 114.71 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -84.91 -27.12 26.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.091 0.956 . . . . 1.0 113.397 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.5 p -100.17 -33.73 10.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.416 1.087 . . . . 1.0 113.374 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 t 63.91 72.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.712 2.005 . . . . 1.0 110.733 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.5 -178.98 5.52 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.54 1.536 . . . . 1.0 112.4 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -154.8 152.73 30.18 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.964 1.306 . . . . 1.0 110.824 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -114.62 5.92 15.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.907 0.883 . . . . 1.0 112.931 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.8 m -73.17 130.8 41.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.316 -1.49 . . . . 1.0 110.778 170.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.07 147.43 34.73 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.22 1.008 . . . . 1.0 110.608 173.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -113.39 141.6 46.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.64 0.776 . . . . 1.0 110.81 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.31 127.72 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 170.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.52 160.15 40.51 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.557 1.543 . . . . 1.0 112.636 -173.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -101.88 134.33 45.25 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.01 1.324 . . . . 1.0 110.059 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.49 172.9 12.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.505 1.522 . . . . 1.0 109.922 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -81.26 143.93 31.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.979 -1.076 . . . . 1.0 112.124 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 tp -50.85 -53.55 31.33 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.816 1.246 . . . . 1.0 111.226 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.77 -47.94 73.27 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 1.0 111.042 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.71 -36.53 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.5 -47.25 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.862 1.265 . . . . 1.0 112.292 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 m -79.78 -1.25 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 114.353 1.242 . . . . 1.0 114.353 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.32 127.42 44.86 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.974 0.797 . . . . 1.0 112.768 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 2.92 81.23 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.922 1.248 . . . . 1.0 114.781 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.2 m -125.38 160.46 29.32 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 1.0 111.909 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.9 m -89.18 157.8 18.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.806 0.842 . . . . 1.0 109.033 168.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.24 162.9 36.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -158.95 162.05 36.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.836 1.655 . . . . 1.0 112.001 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.1 t -83.23 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -148.5 74.8 1.29 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.278 1.037 . . . . 1.0 111.426 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -77.92 58.65 1.96 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.104 1.362 . . . . 1.0 111.555 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.5 p -63.56 -45.88 88.48 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.615 -1.303 . . . . 1.0 112.896 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 mt -72.49 -10.23 59.54 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.94 -25.36 57.57 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.708 0.803 . . . . 1.0 112.299 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.34 -4.61 53.64 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.45 1.5 . . . . 1.0 113.253 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -84.17 -65.44 1.01 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.431 1.093 . . . . 1.0 111.114 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -109.72 174.68 5.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.068 2.147 . . . . 1.0 113.148 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -66.48 140.21 96.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 121.271 -0.893 . . . . 1.0 110.791 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.21 148.37 91.17 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.887 3.058 . . . . 1.0 113.711 -169.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -99.26 153.83 37.59 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.832 1.253 . . . . 1.0 112.248 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.66 118.46 5.47 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.591 2.861 . . . . 1.0 110.341 170.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 t -55.8 -38.4 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.372 1.469 . . . . 1.0 112.851 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.01 -36.57 70.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.64 0.776 . . . . 1.0 111.616 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.29 -34.46 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.497 -0.764 . . . . 1.0 111.081 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.72 -46.66 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.535 1.062 . . . . 1.0 110.186 171.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.07 -36.68 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.48 1.112 . . . . 1.0 111.414 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 t -63.07 -44.39 95.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.061 0.846 . . . . 1.0 111.111 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.8 m -58.32 -44.44 88.64 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.483 1.113 . . . . 1.0 111.817 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.71 72.74 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.416 1.007 . . . . 1.0 111.135 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.368 1.067 . . . . 1.0 112.957 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.85 -32.89 74.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.978 0.911 . . . . 1.0 112.371 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 80.9 mmm -74.95 -36.35 62.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.703 -1.141 . . . . 1.0 113.086 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.8 t -46.42 125.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 120.277 1.398 . . . . 1.0 111.015 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.72 -17.13 57.9 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.151 1.834 . . . . 1.0 114.182 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -85.77 165.65 16.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.912 1.356 . . . . 1.0 110.961 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.6 156.32 44.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.4 mtt -144.15 177.21 8.75 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.797 2.039 . . . . 1.0 112.598 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.91 161.92 17.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 1.0 114.19 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -68.56 164.09 22.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.988 1.715 . . . . 1.0 113.948 -175.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 p -58.24 -16.91 15.71 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.71 1.604 . . . . 1.0 114.858 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.56 -29.76 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.91 0.884 . . . . 1.0 111.664 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.1 89.13 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 104.73 -2.322 . . . . 1.0 104.73 168.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.8 p -59.21 -32.76 70.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.617 1.34 . . . . 1.0 114.617 -169.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -84.93 2.77 41.33 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.29 1.218 . . . . 1.0 114.29 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -52.03 -42.49 63.13 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 120.698 1.59 . . . . 1.0 113.581 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.7 m -69.95 -36.64 75.42 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.075 -1.016 . . . . 1.0 113.366 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.4 -56.86 14.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.461 0.573 . . . . 1.0 109.942 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -55.58 -34.0 64.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 1.0 112.751 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -60.0 -59.73 4.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.074 -0.489 . . . . 1.0 110.737 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.22 -32.27 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 -170.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.75 -42.71 90.62 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.393 0.997 . . . . 1.0 111.553 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -61.41 -24.27 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.612 1.165 . . . . 1.0 112.773 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.95 -31.84 73.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.51 1.05 . . . . 1.0 112.846 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -94.89 -49.87 5.38 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.805 1.242 . . . . 1.0 111.352 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -62.26 -46.94 86.56 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.922 -1.111 . . . . 1.0 112.51 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.01 38.73 3.19 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.837 2.16 . . . . 1.0 112.969 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.41 150.42 3.58 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.824 0.85 . . . . 1.0 112.53 174.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 125.634 1.574 . . . . 1.0 114.866 -172.063 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 120.004 -0.046 . . . . 1.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.58 -10.9 38.87 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.546 1.313 . . . . 1.0 114.546 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -65.93 -39.04 27.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 116.212 1.93 . . . . 1.0 116.212 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -82.45 164.81 16.57 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.799 2.333 . . . . 1.0 111.946 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -87.99 164.32 15.86 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.786 0.834 . . . . 1.0 112.402 170.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -79.17 157.85 27.81 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.296 -0.877 . . . . 1.0 110.619 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.56 118.68 70.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.38 147.77 18.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.223 2.615 . . . . 1.0 112.722 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -129.81 159.48 69.64 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.219 1.807 . . . . 1.0 112.744 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -46.61 129.24 13.76 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 124.086 3.191 . . . . 1.0 112.907 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.99 79.05 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.584 -1.12 . . . . 1.0 114.863 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -64.85 144.12 57.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.323 1.561 . . . . 1.0 113.143 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -94.12 125.24 38.64 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.421 1.488 . . . . 1.0 108.523 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.57 132.35 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -103.89 133.75 48.33 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.578 1.551 . . . . 1.0 108.863 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.2 mt -127.81 119.92 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.929 1.692 . . . . 1.0 108.132 -171.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -88.68 62.74 6.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.899 1.679 . . . . 1.0 113.168 -168.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -66.57 149.04 51.06 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.725 -0.61 . . . . 1.0 110.401 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.67 138.91 58.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.967 0.907 . . . . 1.0 110.846 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.89 -126.89 7.61 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.972 -1.251 . . . . 1.0 109.972 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -67.22 141.27 57.35 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.334 0.588 . . . . 1.0 112.446 173.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -81.73 155.25 25.6 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.889 1.276 . . . . 1.0 111.177 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -108.76 156.0 20.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.459 1.104 . . . . 1.0 111.12 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.95 154.29 51.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.406 1.083 . . . . 1.0 111.259 174.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.8 146.84 28.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.16 115.41 27.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.972 1.709 . . . . 1.0 107.846 170.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -81.14 131.89 35.32 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.565 -0.71 . . . . 1.0 111.95 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.67 2.31 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.6 165.23 29.43 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 124.726 1.155 . . . . 1.0 112.759 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.58 17.31 9.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.109 1.764 . . . . 1.0 113.958 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 0.05 81.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.665 1.602 . . . . 1.0 114.195 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.83 154.2 17.37 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.448 1.624 . . . . 1.0 114.057 -175.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 m -137.25 158.38 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.98 1.712 . . . . 1.0 111.662 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.42 139.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.807 1.643 . . . . 1.0 108.326 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -156.43 150.02 24.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 1.0 111.661 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -97.06 124.79 41.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.863 0.865 . . . . 1.0 109.512 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.47 108.1 6.42 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.406 -1.283 . . . . 1.0 110.322 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -69.73 157.76 59.34 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.551 2.167 . . . . 1.0 114.44 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -56.95 -18.29 27.46 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.814 3.676 . . . . 1.0 116.183 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 p -80.36 -8.32 59.46 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.969 1.1 . . . . 1.0 113.969 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.12 137.57 34.02 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.684 0.794 . . . . 1.0 110.201 169.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -58.94 137.87 87.48 Favored Pre-proline 0 CA--C 1.55 0.944 0 O-C-N 121.59 -0.694 . . . . 1.0 112.76 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.43 160.41 38.76 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.258 2.639 . . . . 1.0 110.728 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.32 0.11 89.37 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.783 0.706 . . . . 1.0 114.834 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.27 -178.22 3.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.826 2.05 . . . . 1.0 111.671 -170.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.08 2.02 48.48 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 124.889 1.233 . . . . 1.0 115.471 172.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 t -165.0 -165.91 0.96 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.797 1.639 . . . . 1.0 111.065 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 p -67.46 -23.04 65.47 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.057 1.343 . . . . 1.0 114.104 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.1 t -165.91 169.53 14.72 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.34 1.856 . . . . 1.0 110.586 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.66 -31.13 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.788 0.835 . . . . 1.0 112.542 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -80.22 -13.3 59.34 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 1.0 113.248 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -80.88 -6.39 58.56 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.606 0.965 . . . . 1.0 113.606 -174.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.77 143.94 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 127.049 2.14 . . . . 1.0 109.705 176.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.8 mt -104.61 -78.17 0.57 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.938 0.895 . . . . 1.0 111.494 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.8 p -66.01 148.27 52.06 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.775 1.028 . . . . 1.0 113.775 -174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -169.67 169.44 8.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.977 1.711 . . . . 1.0 112.212 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.3 p -70.33 149.36 47.44 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.254 0.835 . . . . 1.0 113.254 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.82 154.36 17.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.226 1.01 . . . . 1.0 111.347 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -133.56 137.41 45.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.979 0.912 . . . . 1.0 109.98 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.45 127.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -132.27 160.98 34.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.984 1.714 . . . . 1.0 111.804 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -121.14 139.92 52.69 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.906 1.682 . . . . 1.0 109.84 172.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -164.86 -179.52 5.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.772 1.229 . . . . 1.0 111.076 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -70.09 142.92 52.56 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.943 0.897 . . . . 1.0 111.02 172.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.5 tp -51.57 -56.77 11.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.288 1.035 . . . . 1.0 112.152 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.51 -41.18 80.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.502 0.592 . . . . 1.0 111.187 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.37 -39.0 81.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.08 0.552 . . . . 1.0 112.137 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.0 -38.48 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.49 1.116 . . . . 1.0 111.972 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.56 -49.47 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.024 1.33 . . . . 1.0 111.056 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.38 -121.94 27.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.713 0.673 . . . . 1.0 111.677 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.31 -0.68 86.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.953 1.263 . . . . 1.0 114.854 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.6 m -79.43 175.27 10.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.076 1.35 . . . . 1.0 111.591 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 95.6 m -110.19 168.34 9.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.379 1.471 . . . . 1.0 108.884 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -158.05 162.56 38.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -149.39 155.15 40.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.024 1.73 . . . . 1.0 111.272 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.26 135.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -153.86 84.86 1.16 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.818 0.818 . . . . 1.0 111.866 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -81.11 50.13 1.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.187 1.395 . . . . 1.0 112.926 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 m -59.19 -33.46 70.98 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.501 -1.374 . . . . 1.0 113.144 -171.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.48 -12.37 60.13 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -26.69 68.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.962 0.801 . . . . 1.0 112.946 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -88.98 -5.1 58.2 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.893 1.277 . . . . 1.0 112.057 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -99.34 -50.26 4.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.17 1.388 . . . . 1.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -128.2 147.64 50.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.203 1.401 . . . . 1.0 112.774 -174.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -65.56 153.25 90.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 118.44 -0.79 . . . . 1.0 111.57 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.81 127.98 27.28 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.149 3.233 . . . . 1.0 114.765 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.32 155.62 46.45 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.003 1.321 . . . . 1.0 111.536 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.16 117.9 5.36 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.707 2.938 . . . . 1.0 110.063 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -57.3 -34.92 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.42 1.088 . . . . 1.0 113.017 -170.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.2 -36.37 75.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.953 0.501 . . . . 1.0 112.188 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.11 -36.1 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.97 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mt -59.99 -46.39 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 119.662 1.119 . . . . 1.0 110.337 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.44 -36.1 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.021 0.928 . . . . 1.0 111.288 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.7 m -64.56 -43.2 94.67 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.453 -0.779 . . . . 1.0 111.404 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.7 m -60.41 -43.97 96.17 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.658 1.183 . . . . 1.0 111.445 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.64 73.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.66 0.784 . . . . 1.0 110.458 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -60.92 -40.63 93.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.196 0.999 . . . . 1.0 113.002 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -65.25 -34.12 77.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.923 0.889 . . . . 1.0 112.334 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 75.3 mmm -73.73 -39.64 64.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.321 -0.847 . . . . 1.0 112.789 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -47.65 129.49 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.674 1.124 . . . . 1.0 111.707 172.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.37 -14.68 64.03 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.539 1.542 . . . . 1.0 113.464 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -82.69 143.2 31.09 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.122 1.461 . . . . 1.0 111.186 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.75 146.57 27.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.179 1.392 . . . . 1.0 111.633 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.3 mmt -124.57 142.92 51.0 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.809 1.643 . . . . 1.0 110.628 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.74 168.16 11.91 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -61.14 140.01 57.99 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.699 0.8 . . . . 1.0 111.843 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.6 t -87.27 139.17 30.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.55 -0.719 . . . . 1.0 112.031 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 pt -88.38 5.56 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 1.0 112.989 173.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 m -135.39 174.54 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.615 1.966 . . . . 1.0 110.681 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.8 p -67.23 -31.17 71.35 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -69.54 149.77 47.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.536 1.135 . . . . 1.0 112.497 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -165.69 -64.75 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.942 2.097 . . . . 1.0 111.867 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 6.9 t -85.04 -38.39 19.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.533 1.133 . . . . 1.0 113.504 -169.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -44.97 92.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.141 0.977 . . . . 1.0 110.385 169.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.31 -43.63 64.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.492 1.917 . . . . 1.0 111.381 170.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -64.12 -59.47 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.818 -0.611 . . . . 1.0 111.714 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.55 -22.36 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.481 1.037 . . . . 1.0 113.032 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 m -60.81 -51.41 69.42 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.791 1.236 . . . . 1.0 111.426 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -64.46 -26.51 68.47 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.979 0.733 . . . . 1.0 112.979 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.75 -34.97 76.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.035 0.834 . . . . 1.0 112.917 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -91.87 -49.71 6.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.23 1.012 . . . . 1.0 111.482 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -61.27 -45.86 92.73 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.257 -0.902 . . . . 1.0 112.288 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -115.01 52.17 0.67 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.38 1.943 . . . . 1.0 112.315 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 160.06 2.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.909 1.077 . . . . 1.0 113.909 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.255 1.363 0 C-N-CA 125.863 1.665 . . . . 1.0 114.221 -174.141 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 119.764 -0.16 . . . . 1.0 110.813 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.43 -25.9 54.92 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.699 1.37 . . . . 1.0 114.699 -173.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -62.72 143.36 96.77 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.179 0.992 . . . . 1.0 113.18 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.75 148.4 52.47 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.16 2.573 . . . . 1.0 111.645 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -140.2 153.69 46.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.725 1.61 . . . . 1.0 110.754 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -142.25 160.75 39.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.6 1.16 . . . . 1.0 111.833 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -150.48 129.97 6.52 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.617 1.567 . . . . 1.0 108.563 169.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.16 143.08 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.265 2.643 . . . . 1.0 111.591 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -129.48 163.44 46.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.094 1.757 . . . . 1.0 112.201 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -45.54 126.62 8.81 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 124.196 3.264 . . . . 1.0 113.095 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.75 82.6 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.44 1.495 . . . . 1.0 115.348 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.25 145.71 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.658 1.729 . . . . 1.0 113.782 -175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.94 123.05 30.06 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.54 1.136 . . . . 1.0 108.068 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.81 131.19 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.416 -1.328 . . . . 1.0 107.416 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.45 129.06 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.244 1.818 . . . . 1.0 108.27 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.75 128.95 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.005 1.722 . . . . 1.0 108.297 -170.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -109.91 137.52 47.58 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.384 1.474 . . . . 1.0 111.451 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -131.74 173.82 10.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.313 1.845 . . . . 1.0 110.119 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.89 101.68 1.13 Allowed 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.159 -0.963 . . . . 1.0 110.284 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.69 5.62 89.27 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.997 1.284 . . . . 1.0 115.701 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -148.92 163.51 37.23 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.464 1.505 . . . . 1.0 113.091 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -133.26 161.6 34.05 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.77 1.228 . . . . 1.0 110.619 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -147.38 169.25 19.87 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.835 1.254 . . . . 1.0 111.315 172.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -139.51 156.87 46.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.179 -0.951 . . . . 1.0 113.251 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.41 40.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.214 . . . . 1.0 112.546 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.08 119.08 38.21 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.901 1.681 . . . . 1.0 108.145 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -82.78 130.36 35.12 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.241 -0.912 . . . . 1.0 111.965 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 pt -113.05 3.3 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 114.744 1.387 . . . . 1.0 114.744 -170.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.37 168.05 35.63 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.4 1.0 . . . . 1.0 112.671 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.12 17.78 9.46 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.906 1.682 . . . . 1.0 113.999 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.63 85.37 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.002 1.287 . . . . 1.0 114.379 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.5 154.44 17.27 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.554 1.677 . . . . 1.0 114.204 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.27 157.11 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.283 1.833 . . . . 1.0 111.2 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.53 136.27 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.33 -1.73 . . . . 1.0 106.33 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -158.8 175.28 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.305 1.042 . . . . 1.0 110.32 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.6 mt -90.12 153.18 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.633 -0.667 . . . . 1.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.07 109.33 42.8 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.566 1.946 . . . . 1.0 107.86 169.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.11 157.54 23.41 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.224 2.616 . . . . 1.0 113.527 -169.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.25 -14.99 18.32 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.386 3.391 . . . . 1.0 113.363 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.3 m 70.93 8.32 6.49 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.226 1.81 . . . . 1.0 114.036 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -142.0 121.65 13.4 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.767 1.627 . . . . 1.0 110.013 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -69.86 -44.0 21.64 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.914 2.19 . . . . 1.0 116.914 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.73 164.1 35.6 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.538 2.825 . . . . 1.0 111.701 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.21 -23.13 76.34 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 119.047 -0.863 . . . . 1.0 114.323 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -167.28 -165.85 0.73 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.07 2.148 . . . . 1.0 110.895 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.03 177.6 31.4 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.81 1.195 . . . . 1.0 114.14 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.9 p -58.93 -30.46 67.87 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.944 1.461 . . . . 1.0 114.944 -169.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.3 m -83.93 -47.22 11.25 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.272 -0.893 . . . . 1.0 111.642 170.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.4 m -78.26 -15.91 58.31 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.167 1.173 . . . . 1.0 114.167 -170.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.98 -27.09 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 120.896 -1.127 . . . . 1.0 112.881 173.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -71.5 -34.37 70.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.559 0.744 . . . . 1.0 111.905 169.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 m -77.81 -30.77 51.38 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.429 1.492 . . . . 1.0 113.078 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.2 132.94 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.253 1.021 . . . . 1.0 112.557 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.0 mt -120.75 159.75 24.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.238 1.815 . . . . 1.0 111.458 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 t 72.48 169.8 0.32 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.293 1.837 . . . . 1.0 113.351 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 p30 179.48 158.17 0.64 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.864 2.065 . . . . 1.0 111.941 -170.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.9 m -143.45 152.02 41.03 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.089 0.956 . . . . 1.0 112.838 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.07 152.57 19.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.6 1.56 . . . . 1.0 110.13 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -98.24 138.77 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.093 0.861 . . . . 1.0 110.42 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.11 127.32 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 169.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -138.07 162.02 35.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.442 1.497 . . . . 1.0 112.276 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -109.22 140.28 43.05 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.227 1.811 . . . . 1.0 110.345 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.17 176.61 9.08 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.771 1.228 . . . . 1.0 110.909 172.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -74.28 142.07 45.27 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.705 1.202 . . . . 1.0 111.529 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.85 -51.94 64.34 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.977 -1.011 . . . . 1.0 111.844 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.19 -47.01 72.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.727 0.694 . . . . 1.0 111.22 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.74 -39.71 84.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.549 0.739 . . . . 1.0 112.025 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.55 -42.05 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.404 1.081 . . . . 1.0 112.401 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -0.63 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.536 1.535 . . . . 1.0 113.9 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.91 52.29 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.404 1.002 . . . . 1.0 112.993 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.48 1.87 77.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.725 1.155 . . . . 1.0 114.622 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 24.5 m -120.44 161.26 21.53 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.243 1.817 . . . . 1.0 111.127 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.1 t -97.14 163.19 13.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.015 0.926 . . . . 1.0 109.204 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -157.39 163.32 38.7 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.13 151.72 28.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 109.67 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.23 129.5 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -132.39 68.76 1.49 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.068 0.947 . . . . 1.0 111.531 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -75.58 73.2 2.59 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.873 1.269 . . . . 1.0 111.729 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 m -70.37 -38.76 74.82 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.124 -0.985 . . . . 1.0 113.305 -170.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -75.55 -10.47 59.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.473 1.286 . . . . 1.0 114.473 -169.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.95 -30.59 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.065 0.946 . . . . 1.0 112.693 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -79.21 -16.46 56.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.602 1.561 . . . . 1.0 112.538 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -100.0 -41.33 7.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.486 1.515 . . . . 1.0 112.365 -172.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -130.1 160.27 34.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.202 1.401 . . . . 1.0 113.299 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -66.08 162.86 42.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.706 1.203 . . . . 1.0 111.803 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.32 146.14 7.38 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 125.124 3.883 . . . . 1.0 115.255 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 151.71 63.0 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.486 1.514 . . . . 1.0 112.296 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.88 120.09 4.56 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.853 3.035 . . . . 1.0 112.446 -169.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.9 p -55.58 -33.25 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.208 1.188 . . . . 1.0 114.208 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.66 -35.4 79.51 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.677 0.391 . . . . 1.0 112.041 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.53 -35.47 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.202 0.601 . . . . 1.0 110.815 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.3 mt -62.52 -49.39 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.837 0.744 . . . . 1.0 110.059 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -68.65 -37.64 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.031 0.932 . . . . 1.0 111.709 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.1 m -62.11 -42.02 98.82 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.238 -0.914 . . . . 1.0 111.86 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 t -60.23 -45.44 93.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.559 0.744 . . . . 1.0 111.06 173.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.84 75.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.351 0.66 . . . . 1.0 110.95 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.55 -38.67 90.93 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.14 -0.975 . . . . 1.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.3 -35.58 80.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.766 0.827 . . . . 1.0 112.092 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mmm -73.75 -36.24 65.12 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 1.0 112.975 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.62 126.89 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.744 1.156 . . . . 1.0 111.417 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.27 -17.68 58.72 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.154 1.835 . . . . 1.0 113.981 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -88.14 158.07 18.65 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.872 1.336 . . . . 1.0 110.709 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.79 141.81 43.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.618 1.167 . . . . 1.0 112.335 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 mmt -127.43 146.48 50.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.381 1.872 . . . . 1.0 110.51 -175.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -58.31 132.63 54.22 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.7 -0.625 . . . . 1.0 111.891 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -74.36 168.47 19.61 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.072 0.767 . . . . 1.0 113.072 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.5 m -68.56 41.03 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 128.569 2.748 . . . . 1.0 115.644 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.02 139.56 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 O-C-N 120.488 -1.382 . . . . 1.0 109.857 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t 72.73 -44.81 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 127.232 2.213 . . . . 1.0 112.012 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -163.3 161.44 24.66 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.303 1.841 . . . . 1.0 111.397 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -66.57 132.89 49.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.576 0.75 . . . . 1.0 112.756 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -122.72 -2.59 8.81 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.0 m -74.79 -15.31 60.75 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.229 -1.544 . . . . 1.0 114.558 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -46.53 55.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.825 0.739 . . . . 1.0 110.391 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -53.12 -27.98 23.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.608 1.163 . . . . 1.0 113.654 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -65.07 -53.97 37.42 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.183 -0.948 . . . . 1.0 111.173 169.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.43 -26.6 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -64.56 -41.72 96.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.479 1.036 . . . . 1.0 111.815 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.6 -24.23 66.55 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.537 1.135 . . . . 1.0 112.923 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.16 -31.36 72.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.954 0.797 . . . . 1.0 112.557 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -94.16 -43.73 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.618 1.167 . . . . 1.0 111.723 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -67.81 -33.81 75.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.616 0.969 . . . . 1.0 113.616 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -84.3 10.76 60.3 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.8 1.667 . . . . 1.0 114.323 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -56.83 -39.54 74.39 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.419 1.488 . . . . 1.0 113.401 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.436 1.895 . . . . 1.0 112.641 178.786 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 119.067 -0.492 . . . . 1.0 111.133 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.17 163.48 27.03 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.139 0.881 . . . . 1.0 112.736 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 p -77.51 155.69 81.27 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.819 1.248 . . . . 1.0 112.955 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.18 161.1 43.92 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.368 2.712 . . . . 1.0 111.598 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -81.41 167.06 19.83 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.419 0.896 . . . . 1.0 113.419 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -71.89 146.71 47.69 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.1 0.96 . . . . 1.0 110.791 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -138.23 141.78 33.06 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 124.81 1.244 . . . . 1.0 110.717 173.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.37 148.6 16.55 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.689 2.926 . . . . 1.0 112.181 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -130.0 161.26 60.9 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.386 1.874 . . . . 1.0 112.915 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.43 128.17 12.16 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.182 3.255 . . . . 1.0 113.114 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.91 -7.64 78.86 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.122 1.344 . . . . 1.0 114.9 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.41 142.48 53.86 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.316 1.558 . . . . 1.0 113.689 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.85 123.96 31.8 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.132 1.373 . . . . 1.0 108.733 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 mm -105.64 127.17 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.783 -1.192 . . . . 1.0 107.783 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -102.49 125.67 49.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.498 1.519 . . . . 1.0 108.272 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.75 119.06 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.137 1.375 . . . . 1.0 109.317 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -85.39 62.32 7.41 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.444 1.498 . . . . 1.0 110.514 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -61.76 149.83 38.71 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.026 0.931 . . . . 1.0 110.651 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.31 129.62 32.35 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.473 1.109 . . . . 1.0 110.304 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.97 -123.02 5.93 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 -169.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -73.3 139.37 46.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.851 0.861 . . . . 1.0 113.046 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.0 mp0 -64.66 157.61 26.74 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.831 1.652 . . . . 1.0 111.374 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.09 163.04 28.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.791 1.636 . . . . 1.0 111.023 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -138.0 150.08 46.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.035 0.934 . . . . 1.0 112.868 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.28 155.82 42.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.468 1.107 . . . . 1.0 112.469 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.35 116.22 32.29 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.924 1.689 . . . . 1.0 107.733 172.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -82.29 131.09 35.23 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.241 -0.912 . . . . 1.0 111.872 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.2 pt -114.26 2.5 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.806 1.41 . . . . 1.0 114.806 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.73 168.67 36.73 Favored Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.448 1.023 . . . . 1.0 112.772 -175.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.74 17.8 9.07 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.983 1.713 . . . . 1.0 113.8 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.16 -0.35 85.79 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.143 1.354 . . . . 1.0 114.445 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -92.94 153.41 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.788 1.794 . . . . 1.0 114.646 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.85 156.52 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.274 1.83 . . . . 1.0 110.865 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.0 mt -115.09 134.84 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.659 1.584 . . . . 1.0 107.101 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.32 145.39 22.75 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.326 -0.859 . . . . 1.0 112.402 -168.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.71 93.31 8.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.491 0.716 . . . . 1.0 109.861 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.47 127.05 90.6 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.494 1.117 . . . . 1.0 111.374 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.87 161.75 42.88 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.357 2.705 . . . . 1.0 112.411 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.83 162.06 43.15 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.409 2.739 . . . . 1.0 111.421 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 52.0 p -74.21 -19.07 60.65 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -145.83 143.79 29.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.176 1.79 . . . . 1.0 110.738 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -76.39 -51.89 2.44 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 115.646 1.721 . . . . 1.0 115.646 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.85 151.54 16.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.449 2.766 . . . . 1.0 112.819 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.68 10.93 72.05 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.599 1.571 . . . . 1.0 113.001 173.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.51 144.03 48.4 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 1.0 111.641 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.41 -111.11 0.24 Allowed Glycine 0 N--CA 1.465 0.599 0 C-N-CA 123.707 0.67 . . . . 1.0 111.759 -171.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.1 p -66.02 -24.47 66.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.683 0.793 . . . . 1.0 112.599 170.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -122.12 147.16 46.48 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.661 1.584 . . . . 1.0 110.809 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.0 t -79.77 49.74 1.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 O-C-N 120.285 -1.509 . . . . 1.0 112.538 -174.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.14 46.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.823 1.649 . . . . 1.0 112.739 -175.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -54.47 -36.35 64.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.29 1.436 . . . . 1.0 113.236 -174.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -71.97 -10.54 59.92 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.79 1.033 . . . . 1.0 113.79 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.77 130.58 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.984 1.314 . . . . 1.0 108.773 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.5 -72.84 0.17 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.278 1.031 . . . . 1.0 112.126 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.7 m 66.17 -34.27 0.2 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 127.602 2.361 . . . . 1.0 114.968 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -83.23 150.87 25.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.182 1.793 . . . . 1.0 112.825 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.7 m -139.06 152.25 47.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.215 1.006 . . . . 1.0 111.781 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.08 155.7 20.7 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.266 1.026 . . . . 1.0 110.514 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.25 135.34 52.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.223 1.009 . . . . 1.0 110.929 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.44 122.35 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 170.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -128.04 161.03 30.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.536 1.534 . . . . 1.0 111.799 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -117.38 120.27 37.64 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.143 1.777 . . . . 1.0 109.994 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -147.19 177.53 9.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.694 1.198 . . . . 1.0 110.852 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.52 139.68 38.62 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.147 -0.97 . . . . 1.0 111.394 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.48 -49.97 68.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.063 0.945 . . . . 1.0 111.609 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.76 -46.21 74.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.426 0.69 . . . . 1.0 111.316 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -44.9 76.37 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.785 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.55 -41.56 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.825 1.25 . . . . 1.0 112.144 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.37 -2.08 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.502 1.521 . . . . 1.0 113.71 -171.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.1 128.65 47.91 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.228 0.918 . . . . 1.0 112.924 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.46 -1.17 83.08 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.942 1.258 . . . . 1.0 114.726 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 m -117.67 150.26 39.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.78 1.632 . . . . 1.0 111.283 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.74 159.64 20.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -160.71 168.46 24.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.484 1.29 . . . . 1.0 114.484 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -159.97 162.2 34.31 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.507 1.523 . . . . 1.0 112.098 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.02 134.31 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 107.146 -1.427 . . . . 1.0 107.146 168.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -145.25 75.64 1.45 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.087 0.946 . . . . 1.0 111.075 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.11 64.64 3.32 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.974 1.309 . . . . 1.0 110.71 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -62.89 -42.4 99.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.736 1.215 . . . . 1.0 113.036 -170.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.67 -7.43 50.37 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.53 -27.95 68.04 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.767 0.794 . . . . 1.0 112.841 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.33 -14.7 59.3 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.205 1.402 . . . . 1.0 112.391 175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -104.21 -40.42 6.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.544 1.538 . . . . 1.0 112.112 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -129.4 156.76 43.55 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.109 1.764 . . . . 1.0 112.75 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -65.95 160.3 63.88 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.951 0.9 . . . . 1.0 111.828 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.34 125.51 17.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.635 2.89 . . . . 1.0 112.28 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -96.99 154.49 38.19 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.955 1.302 . . . . 1.0 110.137 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.11 112.41 3.3 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.032 2.488 . . . . 1.0 111.061 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.67 -33.06 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 124.549 1.139 . . . . 1.0 113.133 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.83 -37.38 79.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.267 0.485 . . . . 1.0 112.034 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.4 -38.76 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.67 0.788 . . . . 1.0 110.646 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.0 mt -60.07 -50.26 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.7 0.682 . . . . 1.0 109.858 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.6 mt -66.67 -36.46 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.248 1.019 . . . . 1.0 112.077 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 t -63.77 -41.78 97.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.948 0.795 . . . . 1.0 110.745 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.4 p -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.67 0.788 . . . . 1.0 111.858 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.83 76.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.888 0.875 . . . . 1.0 110.469 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.59 -39.21 90.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.223 1.009 . . . . 1.0 112.974 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.99 -34.86 79.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.564 0.746 . . . . 1.0 112.358 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.5 mmm -74.63 -36.83 62.91 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.322 -0.847 . . . . 1.0 113.162 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.96 127.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.528 1.058 . . . . 1.0 111.389 170.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.18 -13.53 61.72 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.857 1.694 . . . . 1.0 113.782 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -88.16 155.89 19.53 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.062 1.431 . . . . 1.0 111.245 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.16 143.63 46.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.263 1.425 . . . . 1.0 113.187 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -140.15 174.25 10.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.385 1.874 . . . . 1.0 111.172 -172.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -60.24 145.85 45.84 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.297 -0.877 . . . . 1.0 112.241 172.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -51.33 140.52 16.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.504 1.922 . . . . 1.0 114.576 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.63 -24.15 27.23 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.689 1.366 . . . . 1.0 114.689 -170.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 pt -75.72 149.45 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.79 0.836 . . . . 1.0 111.032 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.6 t 71.75 -49.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 126.75 2.02 . . . . 1.0 111.907 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.8 p -76.81 -27.47 55.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.676 1.59 . . . . 1.0 113.737 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 62.31 22.54 13.27 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.107 1.763 . . . . 1.0 112.073 -169.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -53.42 -24.96 13.97 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.268 1.581 . . . . 1.0 115.268 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.34 -32.04 62.21 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.695 -1.253 . . . . 1.0 113.945 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.49 -50.94 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.789 1.177 . . . . 1.0 110.876 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -64.1 -28.87 70.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.637 0.775 . . . . 1.0 112.488 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.31 -56.11 19.15 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.746 -0.596 . . . . 1.0 110.112 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.64 -30.34 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.0 p -66.43 -41.24 89.49 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.809 1.186 . . . . 1.0 112.344 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -63.22 -21.87 66.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.134 0.974 . . . . 1.0 112.806 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.0 mt -65.14 -32.93 74.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.515 1.052 . . . . 1.0 112.14 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -84.26 -55.05 4.38 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.58 0.752 . . . . 1.0 111.055 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.95 -34.71 77.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 -170.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -101.25 25.32 28.66 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.2 1.857 . . . . 1.0 114.184 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.2 151.47 12.44 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 118.544 1.172 . . . . 1.0 113.126 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.316 1.846 . . . . 1.0 115.114 -175.69 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.545 0.761 0 CA-C-O 118.834 -0.603 . . . . 1.0 109.445 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.4 143.56 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.708 2.939 . . . . 1.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -125.0 160.41 54.54 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.61 1.964 . . . . 1.0 111.849 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.77 129.31 11.74 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 124.082 3.188 . . . . 1.0 112.786 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.5 -11.3 72.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.323 1.44 . . . . 1.0 114.924 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.77 137.64 57.91 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.125 1.463 . . . . 1.0 112.958 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.15 118.2 24.57 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.558 1.143 . . . . 1.0 108.348 171.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mm -93.95 127.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -108.29 117.14 33.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.246 2.219 . . . . 1.0 107.611 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mt -115.1 129.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.386 1.474 . . . . 1.0 109.052 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.442 1.497 . . . . 1.0 109.843 -179.316 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 119.669 -0.205 . . . . 1.0 111.512 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -136.54 154.95 50.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.422 1.267 . . . . 1.0 114.422 -173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.29 159.63 43.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.495 1.518 . . . . 1.0 112.744 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.43 114.88 29.5 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.076 1.75 . . . . 1.0 108.709 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -82.67 131.69 35.2 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.062 -1.024 . . . . 1.0 112.183 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 pt -112.86 -0.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -170.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.28 165.61 27.62 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 124.602 1.096 . . . . 1.0 113.164 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.3 t70 60.51 20.47 10.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.834 1.654 . . . . 1.0 114.079 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.54 0.27 79.47 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.637 1.589 . . . . 1.0 114.624 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.98 152.45 18.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.751 . . . . 1.0 114.16 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.3 155.09 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.664 1.586 . . . . 1.0 111.111 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.3 137.33 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.54 1.536 . . . . 1.0 107.219 169.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -153.07 159.34 42.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.143 0.977 . . . . 1.0 111.313 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -95.6 127.34 41.55 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 117.639 -1.172 . . . . 1.0 109.202 171.44 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -146.41 138.32 24.86 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.832 -0.542 . . . . 1.0 110.292 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -77.6 129.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.29 161.49 35.65 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.728 1.611 . . . . 1.0 112.004 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -117.4 129.47 55.87 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.104 1.762 . . . . 1.0 110.281 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -148.37 173.9 12.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.656 1.183 . . . . 1.0 111.291 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.79 142.66 49.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.624 0.77 . . . . 1.0 110.661 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.34 -51.0 61.2 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.389 1.076 . . . . 1.0 111.826 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.06 -48.01 71.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.168 0.987 . . . . 1.0 110.988 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.86 -39.21 93.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.982 0.513 . . . . 1.0 111.877 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.57 -46.44 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.432 1.093 . . . . 1.0 112.065 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.71 -35.36 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.389 0.995 . . . . 1.0 113.05 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.33 -124.14 35.01 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.421 1.009 . . . . 1.0 111.797 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.02 -7.2 84.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.383 0.992 . . . . 1.0 114.812 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.07 148.44 41.9 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 1.0 111.634 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -76.54 161.94 28.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.738 0.815 . . . . 1.0 110.978 171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -157.19 160.45 38.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -144.01 163.51 33.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.769 2.028 . . . . 1.0 110.844 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.99 129.94 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 168.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -147.85 83.69 1.52 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.91 0.862 . . . . 1.0 111.914 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -80.81 54.65 2.2 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.998 1.319 . . . . 1.0 112.66 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.1 m -60.54 -31.89 70.96 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.734 -1.229 . . . . 1.0 113.271 -171.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -68.57 -11.37 59.89 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.932 1.086 . . . . 1.0 113.932 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.07 -28.06 67.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.999 0.818 . . . . 1.0 112.968 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -80.35 -14.56 58.25 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.244 1.418 . . . . 1.0 112.185 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -101.33 -46.83 4.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.396 1.478 . . . . 1.0 111.863 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.02 167.09 13.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.499 1.519 . . . . 1.0 113.464 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -66.23 161.63 55.21 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.682 1.193 . . . . 1.0 111.87 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.9 87.96 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.174 2.582 . . . . 1.0 110.761 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.59 151.15 96.76 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.681 1.192 . . . . 1.0 111.428 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.37 116.42 4.69 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.567 2.845 . . . . 1.0 110.093 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.28 -31.81 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.34 -36.07 77.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.065 0.395 . . . . 1.0 112.065 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.0 t -76.57 -32.19 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.323 0.649 . . . . 1.0 111.211 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.91 -46.43 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 119.265 0.939 . . . . 1.0 110.155 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.15 -38.01 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 1.0 111.531 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.0 m -64.9 -38.28 90.45 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.92 0.782 . . . . 1.0 111.14 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.0 m -63.73 -43.71 95.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.941 0.897 . . . . 1.0 111.306 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.04 -50.41 72.81 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.294 0.637 . . . . 1.0 110.662 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.78 -40.7 96.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.219 1.008 . . . . 1.0 112.903 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -66.55 -32.97 74.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.855 0.862 . . . . 1.0 112.388 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.6 -39.21 64.78 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.187 -0.911 . . . . 1.0 112.595 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.2 127.24 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.674 1.125 . . . . 1.0 111.406 172.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.13 63.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.927 1.727 . . . . 1.0 114.017 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -84.89 143.3 29.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.024 1.412 . . . . 1.0 111.306 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -97.32 159.01 15.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.618 1.567 . . . . 1.0 113.501 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.476 0.861 0 C-N-CA 126.657 1.983 . . . . 1.0 110.347 172.426 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 115.723 1.749 . . . . 1.0 115.723 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 25.4 p -68.97 -38.75 79.56 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 121.199 1.818 . . . . 1.0 112.912 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -43.61 93.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.608 0.763 . . . . 1.0 111.018 170.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -61.37 -39.55 91.05 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.427 -0.796 . . . . 1.0 111.77 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.1 -59.78 4.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.196 0.999 . . . . 1.0 110.797 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.28 -21.19 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 119.769 1.168 . . . . 1.0 113.425 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.5 m -64.0 -49.69 71.47 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.818 1.247 . . . . 1.0 111.038 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -61.35 -25.2 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.521 0.728 . . . . 1.0 112.74 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.43 -35.16 80.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.996 0.816 . . . . 1.0 113.076 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -94.03 -40.77 9.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.117 0.967 . . . . 1.0 112.297 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.47 -44.65 78.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.894 0.877 . . . . 1.0 112.29 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.078 0 C-N-CA 126.229 1.871 . . . . 1.0 113.639 -179.51 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 118.855 -0.593 . . . . 1.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.02 153.23 22.03 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.828 3.019 . . . . 1.0 113.003 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.91 162.94 50.64 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.331 1.852 . . . . 1.0 112.841 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -45.36 128.51 10.14 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 124.387 3.392 . . . . 1.0 113.509 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 -3.74 85.66 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.232 1.396 . . . . 1.0 115.204 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -70.04 143.43 52.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.636 . . . . 1.0 113.382 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.57 127.48 34.91 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.612 1.165 . . . . 1.0 108.594 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mt -117.07 127.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.722 0.809 . . . . 1.0 109.523 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -89.46 134.24 34.18 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.936 1.294 . . . . 1.0 108.169 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.66 119.49 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.877 1.271 . . . . 1.0 108.375 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 125.009 1.324 . . . . 1.0 110.985 -171.667 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.3 m80 . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -133.86 148.63 51.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.313 -0.867 . . . . 1.0 112.841 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.36 151.49 40.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.235 1.014 . . . . 1.0 112.93 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.16 116.97 32.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.562 1.945 . . . . 1.0 108.306 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.3 133.04 35.22 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.135 -0.978 . . . . 1.0 112.356 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 pt -114.74 2.79 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 115.147 1.536 . . . . 1.0 115.147 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 166.63 32.86 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.353 0.978 . . . . 1.0 112.807 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.64 17.73 9.96 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.921 1.688 . . . . 1.0 114.143 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.57 80.95 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 125.11 1.338 . . . . 1.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -95.11 153.85 17.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.641 1.721 . . . . 1.0 114.672 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.59 158.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.031 1.732 . . . . 1.0 111.125 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.89 137.85 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 126.051 1.74 . . . . 1.0 106.718 168.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -154.38 149.31 26.72 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.215 -0.928 . . . . 1.0 111.625 -168.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.0 tp -86.12 130.1 34.64 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.505 1.122 . . . . 1.0 110.47 -175.694 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -132.36 140.98 48.73 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.433 -0.792 . . . . 1.0 110.813 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.12 126.89 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 170.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -132.66 163.28 29.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.38 1.472 . . . . 1.0 112.003 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -121.29 137.86 54.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.209 1.804 . . . . 1.0 110.393 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -163.46 178.69 7.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.079 1.351 . . . . 1.0 110.977 171.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.9 142.08 51.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.9 0.88 . . . . 1.0 111.115 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 tp -52.07 -52.0 54.02 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.371 1.068 . . . . 1.0 111.778 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -54.65 -47.92 72.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.074 0.95 . . . . 1.0 110.788 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.54 -39.21 93.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.985 0.514 . . . . 1.0 111.985 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.3 t -69.25 -44.99 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.724 1.21 . . . . 1.0 111.956 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.79 -36.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.48 1.036 . . . . 1.0 112.829 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.62 -119.55 18.72 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 119.499 1.045 . . . . 1.0 111.622 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.22 -3.86 86.9 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.543 1.068 . . . . 1.0 114.867 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.4 m -76.41 147.24 38.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.828 1.314 . . . . 1.0 111.429 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -78.84 166.28 22.6 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.175 0.59 . . . . 1.0 110.15 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -160.22 164.1 33.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.023 1.119 . . . . 1.0 114.023 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -156.38 158.54 37.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.956 1.303 . . . . 1.0 112.115 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.0 t -81.04 139.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.488 1.115 . . . . 1.0 108.657 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -150.88 80.55 1.33 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.22 1.008 . . . . 1.0 111.111 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.78 68.44 3.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.388 1.075 . . . . 1.0 111.124 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.3 p -64.65 -36.02 82.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.691 1.197 . . . . 1.0 113.331 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.57 -10.16 56.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.925 1.084 . . . . 1.0 113.925 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.15 -32.65 55.85 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.537 1.135 . . . . 1.0 112.181 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.13 -16.11 58.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.382 1.473 . . . . 1.0 112.877 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -103.79 -45.9 4.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.398 1.479 . . . . 1.0 112.185 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -128.67 162.55 27.08 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.133 1.373 . . . . 1.0 113.211 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -71.33 156.17 91.99 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.613 -0.68 . . . . 1.0 111.03 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -51.04 133.63 41.28 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.182 3.255 . . . . 1.0 113.508 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -98.66 153.8 37.76 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.359 1.464 . . . . 1.0 110.352 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.37 110.99 3.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.207 2.605 . . . . 1.0 110.749 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.42 -33.55 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.323 1.231 . . . . 1.0 114.323 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -37.98 84.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.134 0.425 . . . . 1.0 111.517 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.83 -36.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.523 0.729 . . . . 1.0 110.907 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -60.01 -48.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.589 0.631 . . . . 1.0 110.12 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.7 -39.47 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.083 0.953 . . . . 1.0 111.742 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -63.51 -38.28 90.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.567 1.076 . . . . 1.0 112.196 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -62.7 -45.6 92.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.501 -0.75 . . . . 1.0 111.021 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.26 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.434 0.693 . . . . 1.0 110.951 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.59 -39.48 91.35 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.925 0.89 . . . . 1.0 113.224 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.93 -34.01 77.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.785 0.834 . . . . 1.0 112.232 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.9 mmm -73.29 -40.64 64.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.349 -0.834 . . . . 1.0 112.649 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.07 128.36 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.483 1.038 . . . . 1.0 111.586 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.7 -14.06 63.38 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.569 1.556 . . . . 1.0 113.219 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -83.75 142.3 30.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.171 1.485 . . . . 1.0 111.242 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -95.32 147.2 23.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.164 1.385 . . . . 1.0 112.269 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 N--CA 1.472 0.628 0 C-N-CA 126.434 1.894 . . . . 1.0 110.237 179.446 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.6 t30 . . . . . 0 CA--C 1.552 1.03 0 N-CA-C 113.893 1.072 . . . . 1.0 113.893 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.3 m -59.59 -30.29 68.56 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.576 -1.328 . . . . 1.0 112.661 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -58.72 -56.76 17.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.462 0.573 . . . . 1.0 109.834 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -56.06 -32.21 63.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.756 0.822 . . . . 1.0 112.698 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -63.27 -57.84 9.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.64 -0.662 . . . . 1.0 110.491 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.74 -29.09 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.0 p -67.72 -41.98 82.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.656 1.116 . . . . 1.0 111.884 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -63.09 -23.26 67.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.987 0.915 . . . . 1.0 112.933 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.54 -30.21 71.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.399 0.999 . . . . 1.0 112.342 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -92.37 -53.72 4.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.27 1.428 . . . . 1.0 111.446 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -69.02 -35.3 76.48 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.881 1.067 . . . . 1.0 113.881 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.189 0 C-N-CA 126.142 1.829 . . . . 1.0 113.755 -177.627 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 118.677 -0.678 . . . . 1.0 109.929 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.45 147.97 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.634 2.889 . . . . 1.0 111.927 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -122.68 162.44 38.48 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.191 1.796 . . . . 1.0 111.728 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.57 127.09 11.23 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.822 3.014 . . . . 1.0 113.254 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.16 -8.51 77.62 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-O 118.495 -1.169 . . . . 1.0 115.303 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.28 143.38 57.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.326 1.563 . . . . 1.0 113.468 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.32 125.22 34.57 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.207 1.403 . . . . 1.0 109.341 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.3 mm -102.86 131.67 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.489 -1.3 . . . . 1.0 107.489 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -108.88 129.63 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.832 1.653 . . . . 1.0 108.231 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mt -126.81 118.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.9 1.28 . . . . 1.0 109.339 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 125.391 1.476 . . . . 1.0 110.539 -177.363 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -141.5 164.18 30.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.755 0.822 . . . . 1.0 112.537 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.98 154.45 35.0 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.74 115.19 27.51 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.029 1.732 . . . . 1.0 107.158 169.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -81.43 128.68 34.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.304 -0.873 . . . . 1.0 111.868 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.68 4.64 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.617 1.34 . . . . 1.0 114.617 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.71 169.82 40.15 Favored Glycine 0 N--CA 1.475 1.266 0 C-N-CA 124.292 0.949 . . . . 1.0 112.393 -173.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.78 16.14 8.77 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.004 1.722 . . . . 1.0 114.075 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 2.97 83.17 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.282 1.42 . . . . 1.0 114.205 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -98.66 154.34 18.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.749 1.775 . . . . 1.0 114.236 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.92 155.71 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.643 1.577 . . . . 1.0 111.309 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.5 mt -115.72 137.83 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.734 1.614 . . . . 1.0 107.327 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.34 147.41 24.64 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.982 -1.074 . . . . 1.0 111.636 -168.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.0 tp -87.48 128.55 35.23 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.392 -0.966 . . . . 1.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 124.721 1.208 . . . . 1.0 110.878 -170.374 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 119.512 -0.28 . . . . 1.0 110.837 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.7 139.04 54.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.499 1.12 . . . . 1.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.53 125.9 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.827 0.739 . . . . 1.0 109.013 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.98 162.93 29.52 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.93 1.692 . . . . 1.0 111.807 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.65 140.81 50.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.722 1.609 . . . . 1.0 110.227 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -162.09 179.7 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.018 1.327 . . . . 1.0 111.076 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.9 145.21 48.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.947 0.899 . . . . 1.0 111.413 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -52.16 -53.56 41.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.631 1.172 . . . . 1.0 111.227 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.1 -43.77 74.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.471 1.109 . . . . 1.0 111.627 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -44.04 91.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.317 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.56 -42.6 72.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.38 1.072 . . . . 1.0 112.207 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.27 -3.02 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.74 128.93 48.1 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.493 1.044 . . . . 1.0 113.555 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.04 1.23 79.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.864 1.221 . . . . 1.0 114.839 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.3 m -125.66 158.14 35.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.026 1.73 . . . . 1.0 111.561 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.9 m -86.08 156.17 20.5 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -158.97 164.52 35.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.565 1.321 . . . . 1.0 114.565 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -161.3 163.35 30.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.37 1.468 . . . . 1.0 112.169 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.0 t -82.11 135.47 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 107.329 -1.36 . . . . 1.0 107.329 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -146.97 74.79 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.269 1.033 . . . . 1.0 111.215 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -77.94 57.97 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.543 1.537 . . . . 1.0 111.486 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 t -60.78 -40.32 92.12 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.515 -1.366 . . . . 1.0 112.498 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.5 mt -70.82 -10.28 59.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.56 -28.74 70.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.273 0.942 . . . . 1.0 112.58 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -84.08 -4.82 59.04 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.313 1.445 . . . . 1.0 111.825 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -103.67 -47.29 4.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.379 1.472 . . . . 1.0 111.698 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -129.49 150.68 50.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.101 1.36 . . . . 1.0 113.497 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -65.32 152.29 92.27 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.346 1.058 . . . . 1.0 111.382 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.94 133.69 23.93 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.039 2.493 . . . . 1.0 112.784 -170.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -83.74 160.62 58.17 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.555 . . . . 1.0 112.024 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.6 115.52 3.77 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.691 2.928 . . . . 1.0 110.045 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.96 -30.49 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -169.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.74 -35.08 77.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.201 0.601 . . . . 1.0 112.112 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.81 -37.88 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.65 -0.656 . . . . 1.0 110.576 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.3 mt -64.07 -48.67 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.397 0.679 . . . . 1.0 110.235 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -71.68 -41.02 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.32 1.048 . . . . 1.0 112.27 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.4 p -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.878 1.217 . . . . 1.0 111.81 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.2 m -61.39 -45.0 96.19 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.683 -0.636 . . . . 1.0 111.767 169.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.31 -48.71 78.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.797 0.726 . . . . 1.0 110.585 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.16 -40.46 96.07 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.082 0.953 . . . . 1.0 112.972 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.59 -32.34 73.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.678 0.791 . . . . 1.0 112.475 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.8 mmm -73.7 -37.95 65.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.835 0.854 . . . . 1.0 112.89 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.5 t -47.21 126.96 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.594 1.088 . . . . 1.0 111.372 170.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.56 61.24 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.895 1.712 . . . . 1.0 113.929 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.6 162.97 17.7 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.034 1.417 . . . . 1.0 111.403 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.63 160.85 27.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.373 1.469 . . . . 1.0 113.046 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.9 mtt . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 125.278 1.431 . . . . 1.0 112.182 178.372 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 CA--C 1.546 0.8 0 N-CA-C 114.392 1.256 . . . . 1.0 114.392 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.25 -38.26 75.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.301 0.955 . . . . 1.0 113.352 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.63 -54.83 41.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 1.0 109.609 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -60.31 -29.08 68.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.643 0.777 . . . . 1.0 113.018 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.38 -59.88 3.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.39 -0.819 . . . . 1.0 109.928 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.63 -30.43 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.9 p -67.87 -44.48 76.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.577 1.081 . . . . 1.0 112.127 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.05 -25.16 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.068 0.947 . . . . 1.0 112.945 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.26 -29.14 67.34 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.216 0.916 . . . . 1.0 112.807 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -96.97 -53.71 3.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.629 1.172 . . . . 1.0 111.708 169.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -64.77 -28.85 69.86 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.207 1.188 . . . . 1.0 114.207 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.329 0 C-N-CA 123.944 0.783 . . . . 1.0 114.328 176.84 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.85 147.12 26.93 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.989 3.126 . . . . 1.0 111.376 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -127.29 156.11 75.33 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.187 1.795 . . . . 1.0 112.731 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.83 124.26 5.54 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.2 3.266 . . . . 1.0 113.677 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.11 -0.03 89.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.068 -1.407 . . . . 1.0 115.897 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.1 159.17 32.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.102 1.951 . . . . 1.0 114.241 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 124.67 34.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.615 1.166 . . . . 1.0 108.943 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.5 mt -100.34 124.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -88.68 116.33 26.86 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.52 129.86 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.165 0.986 . . . . 1.0 108.859 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 125.782 1.633 . . . . 1.0 108.997 179.041 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 110.108 -0.33 . . . . 1.0 110.108 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 144.87 25.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.818 -1.176 . . . . 1.0 110.48 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.5 154.0 44.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.423 1.489 . . . . 1.0 112.064 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.18 112.39 24.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.36 1.464 . . . . 1.0 108.426 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -83.67 133.86 34.8 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.007 -1.058 . . . . 1.0 112.091 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 38.7 pt -110.04 15.55 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -170.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -27.34 10.66 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 116.388 1.315 . . . . 1.0 116.388 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.44 13.13 26.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.359 1.063 . . . . 1.0 113.691 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.82 -4.6 83.5 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.704 1.145 . . . . 1.0 112.483 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -96.66 155.46 16.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.58 1.552 . . . . 1.0 112.906 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.82 152.69 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.601 1.56 . . . . 1.0 110.26 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.7 mt -117.83 138.11 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.14 1.376 . . . . 1.0 108.048 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -161.62 168.76 22.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.024 0.929 . . . . 1.0 110.463 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.3 tp -89.69 150.87 22.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 C-N-CA 124.871 1.268 . . . . 1.0 108.662 173.89 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.26 143.29 49.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.293 0.951 . . . . 1.0 111.646 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.49 124.21 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.65 157.42 42.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.13 1.372 . . . . 1.0 112.742 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -117.81 134.37 54.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.306 1.842 . . . . 1.0 110.215 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -159.38 174.89 14.05 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.993 0.917 . . . . 1.0 110.406 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.2 mtp85 -64.68 145.07 56.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.74 0.816 . . . . 1.0 110.893 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt -51.54 -52.31 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.032 0.933 . . . . 1.0 110.675 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -50.6 -50.56 53.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.004 1.322 . . . . 1.0 111.601 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.48 -43.79 89.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.256 0.623 . . . . 1.0 112.052 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.84 -40.89 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.248 1.019 . . . . 1.0 112.142 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 p -80.46 -35.29 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.947 0.794 . . . . 1.0 112.846 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.77 -130.37 47.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.877 0.762 . . . . 1.0 112.406 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.8 5.14 83.62 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.88 1.229 . . . . 1.0 114.734 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.2 m -79.19 160.13 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.611 1.206 . . . . 1.0 112.16 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.83 155.66 27.74 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.079 0.952 . . . . 1.0 111.124 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.02 163.67 33.84 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.319 1.229 . . . . 1.0 114.319 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -158.66 158.51 33.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.818 1.647 . . . . 1.0 111.283 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.4 t -86.13 134.45 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.193 0.997 . . . . 1.0 108.503 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -163.06 93.52 0.8 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.838 0.855 . . . . 1.0 111.804 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.33 109.05 10.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.37 0.668 . . . . 1.0 110.793 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.6 p -76.54 -51.5 11.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.545 1.138 . . . . 1.0 111.939 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.76 -14.18 62.86 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.463 1.105 . . . . 1.0 113.906 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.56 -30.1 62.74 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.285 1.034 . . . . 1.0 112.197 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -89.49 -6.34 56.52 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.09 1.356 . . . . 1.0 112.534 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -100.43 -49.27 4.28 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.367 1.467 . . . . 1.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.0 170.26 14.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.817 1.647 . . . . 1.0 112.505 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.64 139.75 83.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 121.317 -0.865 . . . . 1.0 108.861 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.27 143.45 77.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.473 2.782 . . . . 1.0 112.427 -170.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -86.0 162.09 47.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.368 0.667 . . . . 1.0 111.121 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.49 117.87 4.82 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.465 2.777 . . . . 1.0 111.535 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.77 -33.13 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.332 0.864 . . . . 1.0 113.332 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.06 -37.68 85.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.961 0.504 . . . . 1.0 111.37 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -34.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.535 0.734 . . . . 1.0 110.929 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.96 -43.06 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.362 0.983 . . . . 1.0 110.862 174.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.48 -36.83 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.885 -1.134 . . . . 1.0 111.599 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 t -69.58 -39.86 77.09 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.455 -0.778 . . . . 1.0 111.391 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.8 p -65.53 -40.23 92.69 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.89 0.876 . . . . 1.0 111.25 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.22 -53.5 57.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 1.0 110.808 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.75 -41.23 90.54 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.561 0.744 . . . . 1.0 112.847 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -65.9 -35.36 80.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.022 0.929 . . . . 1.0 112.559 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.76 -29.72 51.15 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.042 -0.98 . . . . 1.0 113.347 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.5 t -48.03 125.41 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.477 1.489 . . . . 1.0 111.17 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.64 -13.28 62.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.448 1.499 . . . . 1.0 114.318 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -75.81 155.88 35.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.197 1.499 . . . . 1.0 110.896 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.97 148.13 45.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.868 1.267 . . . . 1.0 112.604 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.471 0.582 0 C-N-CA 126.87 2.068 . . . . 1.0 110.499 179.042 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.4 p30 . . . . . 0 CA--C 1.554 1.099 0 N-CA-C 115.274 1.583 . . . . 1.0 115.274 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.0 m -59.25 -35.0 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.718 -1.239 . . . . 1.0 114.334 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -78.49 -49.19 13.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.149 1.379 . . . . 1.0 111.184 174.554 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -55.26 -35.04 64.58 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.244 1.017 . . . . 1.0 112.399 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -51.81 -51.5 55.99 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.641 -0.662 . . . . 1.0 112.494 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.35 -22.76 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.833 1.197 . . . . 1.0 113.557 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.5 p -74.79 -39.33 61.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.296 0.953 . . . . 1.0 110.922 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.97 -26.03 67.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.894 0.878 . . . . 1.0 113.127 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.05 -32.68 71.15 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 120.017 1.281 . . . . 1.0 113.247 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -89.62 -51.36 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.681 1.193 . . . . 1.0 110.978 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.21 -38.24 84.97 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.38 0.882 . . . . 1.0 113.38 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 126.962 2.22 . . . . 1.0 112.476 176.044 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 CA--C 1.545 0.781 0 CA-C-O 118.758 -0.639 . . . . 1.0 109.778 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.24 143.3 22.25 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.55 2.834 . . . . 1.0 111.387 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -115.27 160.07 35.63 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.939 1.696 . . . . 1.0 112.003 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -56.47 131.18 44.17 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.694 1.596 . . . . 1.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.97 -3.41 80.79 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.977 1.275 . . . . 1.0 114.348 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.29 149.83 38.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.101 1.45 . . . . 1.0 112.949 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.68 124.62 35.23 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.596 1.159 . . . . 1.0 109.379 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.57 130.5 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -110.66 129.5 55.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.389 2.276 . . . . 1.0 107.961 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.9 mt -125.26 120.34 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.1 1.36 . . . . 1.0 109.466 -169.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 125.377 1.471 . . . . 1.0 109.669 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 111.272 0.101 . . . . 1.0 111.272 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -141.71 153.66 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.257 -0.902 . . . . 1.0 113.286 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.07 154.87 39.9 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.751 1.22 . . . . 1.0 112.627 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.08 118.83 35.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.555 1.942 . . . . 1.0 108.443 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -82.06 130.56 35.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.186 -0.947 . . . . 1.0 112.156 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 pt -104.41 6.32 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 114.618 1.34 . . . . 1.0 114.618 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.99 -17.17 56.51 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 116.649 1.42 . . . . 1.0 116.649 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.13 13.67 26.49 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.813 1.245 . . . . 1.0 113.532 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -5.84 84.42 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.114 1.34 . . . . 1.0 112.305 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.61 156.53 16.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.867 1.667 . . . . 1.0 112.517 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -126.51 155.14 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.996 1.718 . . . . 1.0 109.888 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.54 138.47 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 168.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -159.86 175.55 12.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.324 1.05 . . . . 1.0 110.773 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.22 153.46 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.325 0.65 . . . . 1.0 109.263 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 168.721 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -141.78 142.57 33.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.014 0.926 . . . . 1.0 110.86 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.12 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -137.92 162.07 34.99 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.171 1.388 . . . . 1.0 112.595 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.6 ttp85 -112.69 136.44 52.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.287 1.835 . . . . 1.0 110.029 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.58 173.85 16.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.502 1.121 . . . . 1.0 110.557 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -66.17 143.62 57.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.763 1.625 . . . . 1.0 110.441 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 tt -52.8 -55.83 20.15 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.165 0.986 . . . . 1.0 110.478 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -52.58 -47.53 66.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.606 1.163 . . . . 1.0 111.635 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.77 -41.5 99.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.862 0.465 . . . . 1.0 111.687 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.49 -44.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.109 0.963 . . . . 1.0 112.356 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -74.6 -32.73 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 119.402 1.001 . . . . 1.0 112.768 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.54 -134.21 52.49 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.142 0.877 . . . . 1.0 112.904 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.47 0.99 87.25 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.78 1.181 . . . . 1.0 114.47 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.5 m -81.92 148.1 28.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.916 1.286 . . . . 1.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.82 156.18 39.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.387 0.675 . . . . 1.0 110.962 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -156.98 162.6 39.6 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.533 1.309 . . . . 1.0 114.533 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -160.12 165.58 31.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.262 1.825 . . . . 1.0 111.414 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.0 t -84.56 140.14 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.174 0.99 . . . . 1.0 108.836 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -146.24 74.21 1.36 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.423 1.089 . . . . 1.0 111.762 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -76.04 70.25 2.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.487 1.115 . . . . 1.0 111.312 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -60.37 -33.72 72.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.859 -1.151 . . . . 1.0 113.376 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.6 mt -71.47 -9.74 58.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.28 -34.56 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.467 1.107 . . . . 1.0 112.181 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.274 1.43 . . . . 1.0 112.741 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -104.43 -47.82 4.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.263 1.425 . . . . 1.0 112.576 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -131.15 156.33 45.46 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.899 1.28 . . . . 1.0 113.532 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.62 155.37 92.53 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.192 -0.909 . . . . 1.0 110.021 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.63 129.76 36.69 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.763 2.976 . . . . 1.0 114.926 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 159.33 85.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.48 1.112 . . . . 1.0 111.704 169.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.43 109.91 2.96 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.462 2.775 . . . . 1.0 110.151 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 p -52.89 -37.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.176 1.547 . . . . 1.0 115.176 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.524 0.602 . . . . 1.0 111.598 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 t -75.85 -31.67 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.706 0.802 . . . . 1.0 110.931 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.1 mt -64.46 -49.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.732 1.151 . . . . 1.0 109.976 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.44 -40.27 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.373 1.069 . . . . 1.0 110.667 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.2 m -68.56 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.523 -0.736 . . . . 1.0 111.981 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.4 m -63.26 -44.08 96.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.696 1.198 . . . . 1.0 110.763 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.64 77.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.433 0.693 . . . . 1.0 111.051 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -61.84 -38.36 87.91 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.147 -0.971 . . . . 1.0 113.173 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -66.09 -34.16 77.43 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.609 0.764 . . . . 1.0 112.307 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.4 mmm -74.83 -37.9 62.16 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.316 -0.85 . . . . 1.0 112.872 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.7 t -47.09 129.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.711 1.142 . . . . 1.0 111.684 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -16.43 60.57 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.934 1.73 . . . . 1.0 114.068 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -83.01 148.88 27.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.047 1.424 . . . . 1.0 111.267 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.1 156.61 17.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.151 1.38 . . . . 1.0 113.372 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.477 0.898 0 C-N-CA 125.934 1.694 . . . . 1.0 111.974 179.857 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 112.474 0.546 . . . . 1.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.8 m -69.56 -39.19 77.55 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.501 1.046 . . . . 1.0 112.85 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -57.57 -56.92 15.65 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.718 0.69 . . . . 1.0 109.255 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -58.61 -30.12 66.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.798 0.839 . . . . 1.0 113.128 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -67.23 -56.41 9.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.214 -0.928 . . . . 1.0 111.039 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.51 -26.12 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 -172.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.4 p -65.87 -44.65 84.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.703 1.138 . . . . 1.0 110.76 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.39 -24.57 66.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.339 0.866 . . . . 1.0 113.339 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.8 mt -61.77 -30.42 70.78 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.203 1.365 . . . . 1.0 112.835 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -94.06 -56.37 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.319 1.447 . . . . 1.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -65.98 -39.06 90.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.764 -1.21 . . . . 1.0 113.359 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.101 0 C-N-CA 126.404 1.954 . . . . 1.0 113.42 -179.269 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 CA--C 1.546 0.801 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.75 150.28 27.23 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.185 2.59 . . . . 1.0 112.441 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -126.44 158.92 65.62 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.138 1.775 . . . . 1.0 112.31 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -46.37 127.75 11.58 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.332 3.354 . . . . 1.0 113.083 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.56 -8.21 77.08 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.987 1.28 . . . . 1.0 115.126 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -67.55 143.55 56.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.251 1.525 . . . . 1.0 113.573 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.62 127.25 34.42 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.976 1.31 . . . . 1.0 108.155 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mt -112.63 131.19 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -102.85 138.77 39.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.558 1.143 . . . . 1.0 109.082 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.24 134.9 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.557 1.943 . . . . 1.0 108.396 -169.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.283 . . . . 1.0 109.243 -175.491 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -138.92 160.49 39.61 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.676 -1.265 . . . . 1.0 112.252 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.95 152.83 33.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.729 0.812 . . . . 1.0 112.756 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.9 116.06 31.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.672 1.989 . . . . 1.0 106.995 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -82.24 129.67 34.9 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.59 -0.694 . . . . 1.0 111.91 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.92 4.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 -170.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.01 163.73 31.11 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 124.598 1.094 . . . . 1.0 113.08 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 t70 60.8 20.06 10.22 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.02 1.728 . . . . 1.0 114.312 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.7 71.68 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.551 1.548 . . . . 1.0 114.625 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.42 153.8 18.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.585 1.693 . . . . 1.0 113.951 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.4 157.76 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.58 1.552 . . . . 1.0 111.58 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.8 mt -121.0 141.07 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.754 1.622 . . . . 1.0 108.183 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -154.52 163.19 40.57 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.063 -1.023 . . . . 1.0 110.92 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.8 tp -104.92 119.41 38.95 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 1.0 108.752 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 118.174 -0.917 . . . . 1.0 110.11 -175.455 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 110.37 -0.233 . . . . 1.0 110.37 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.39 138.49 34.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.823 0.849 . . . . 1.0 111.412 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.74 129.03 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -134.98 156.46 49.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.675 1.59 . . . . 1.0 112.025 -173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -117.8 140.11 50.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.062 1.745 . . . . 1.0 110.331 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -164.59 -179.97 6.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.561 1.144 . . . . 1.0 110.846 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.06 143.97 52.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.295 1.038 . . . . 1.0 110.476 170.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.7 tt -49.8 -56.87 8.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.912 1.285 . . . . 1.0 110.831 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.05 -49.17 63.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.509 1.124 . . . . 1.0 111.256 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.07 -34.05 76.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.33 0.652 . . . . 1.0 112.69 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.73 -45.58 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.903 0.881 . . . . 1.0 111.951 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -81.5 -32.97 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.516 1.053 . . . . 1.0 113.832 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.67 -123.64 32.37 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.54 1.063 . . . . 1.0 111.256 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.73 2.07 85.76 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.646 1.117 . . . . 1.0 114.719 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.12 147.49 34.6 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.723 1.261 . . . . 1.0 111.755 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 23.9 t -75.16 156.97 35.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.68 0.792 . . . . 1.0 110.952 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.93 161.82 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -161.06 160.17 30.16 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.708 1.603 . . . . 1.0 111.862 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.3 t -79.68 139.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.941 0.897 . . . . 1.0 109.334 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -149.26 79.06 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.439 1.096 . . . . 1.0 111.401 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.22 72.29 4.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.58 1.152 . . . . 1.0 110.89 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.9 p -67.85 -46.18 72.49 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.591 1.156 . . . . 1.0 112.79 -172.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.8 mt -75.58 -8.35 56.54 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -174.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.86 -27.46 68.14 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.96 0.886 . . . . 1.0 113.128 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -79.39 -15.4 57.91 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.429 1.492 . . . . 1.0 112.288 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -102.03 -39.93 7.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.556 1.543 . . . . 1.0 112.237 -174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -126.98 160.7 30.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.732 1.613 . . . . 1.0 113.159 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -66.06 159.19 72.52 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.545 1.138 . . . . 1.0 111.342 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.43 127.03 19.79 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.667 2.245 . . . . 1.0 110.796 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -95.34 157.38 36.4 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.134 1.374 . . . . 1.0 110.181 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.51 111.2 2.9 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.86 2.373 . . . . 1.0 110.674 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.93 -32.52 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.612 1.165 . . . . 1.0 112.815 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.18 -36.81 75.97 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.049 0.54 . . . . 1.0 112.237 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.58 -37.81 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.817 0.847 . . . . 1.0 110.776 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.83 -48.69 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 1.0 110.156 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.7 mt -68.33 -39.27 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.258 1.023 . . . . 1.0 111.836 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -61.17 -42.87 99.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.419 1.009 . . . . 1.0 111.42 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 -43.67 98.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 1.0 111.756 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.11 73.93 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.328 -0.857 . . . . 1.0 110.746 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.13 -38.29 88.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.311 1.044 . . . . 1.0 113.203 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.97 -36.34 83.06 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.585 0.754 . . . . 1.0 112.117 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.0 mmm -73.22 -38.36 66.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.881 0.873 . . . . 1.0 112.752 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.95 129.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.167 0.894 . . . . 1.0 111.606 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.52 66.51 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.711 1.624 . . . . 1.0 113.479 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -87.14 145.38 26.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.961 1.38 . . . . 1.0 111.477 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -95.32 148.27 22.61 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.761 1.224 . . . . 1.0 112.399 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.476 0.863 0 C-N-CA 125.522 1.529 . . . . 1.0 112.001 -173.429 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.6 t30 . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 120.51 0.195 . . . . 1.0 111.391 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.99 -40.04 60.91 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.914 1.079 . . . . 1.0 113.914 -169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -49.56 76.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.196 0.453 . . . . 1.0 110.18 170.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -61.52 -36.59 80.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.958 0.903 . . . . 1.0 111.814 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.05 -57.22 13.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.866 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.96 -28.13 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.828 1.194 . . . . 1.0 113.637 -173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.6 p -71.75 -39.72 69.82 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.846 1.203 . . . . 1.0 112.582 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -57.46 -26.62 61.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.812 0.845 . . . . 1.0 112.484 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.4 mt -62.31 -31.45 72.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.296 0.953 . . . . 1.0 112.719 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -88.75 -55.82 3.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.548 1.139 . . . . 1.0 111.18 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -65.37 -35.9 82.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -171.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 C-N-CA 126.923 2.201 . . . . 1.0 112.282 175.548 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -86.63 155.82 9.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.986 3.79 . . . . 1.0 112.471 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.09 168.3 17.24 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.812 2.045 . . . . 1.0 112.476 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -50.16 127.23 19.18 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.608 2.872 . . . . 1.0 113.402 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.5 -2.84 86.5 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.341 -1.255 . . . . 1.0 115.011 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -75.01 148.17 40.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.678 1.739 . . . . 1.0 113.011 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -93.96 129.89 40.26 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.203 1.401 . . . . 1.0 110.177 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.45 133.09 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.174 0.99 . . . . 1.0 108.94 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.49 128.34 52.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.683 1.593 . . . . 1.0 108.69 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.4 mt -130.29 124.17 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.65 1.18 . . . . 1.0 110.257 -169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 125.172 1.389 . . . . 1.0 108.6 173.417 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 . . . . . 0 CA--C 1.546 0.81 0 CA-C-O 120.523 0.201 . . . . 1.0 110.61 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -140.24 148.94 42.25 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.301 -0.874 . . . . 1.0 111.811 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.66 149.79 36.28 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.532 0.938 . . . . 1.0 113.532 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.28 119.2 38.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.524 2.33 . . . . 1.0 107.484 169.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -82.58 132.81 35.19 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.058 -1.026 . . . . 1.0 112.137 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.69 2.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.102 1.519 . . . . 1.0 115.102 -170.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 169.86 38.81 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.265 0.936 . . . . 1.0 112.756 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.99 16.04 7.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.204 1.802 . . . . 1.0 114.031 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.02 2.99 73.85 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 124.997 1.284 . . . . 1.0 114.717 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -101.89 154.32 19.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.812 1.806 . . . . 1.0 114.454 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.65 153.76 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.588 1.555 . . . . 1.0 111.36 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.64 138.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 168.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -153.53 176.3 12.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.615 1.166 . . . . 1.0 109.85 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -126.53 122.0 33.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.119 0.872 . . . . 1.0 108.78 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 118.075 -0.964 . . . . 1.0 109.775 -173.434 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -150.08 139.99 21.9 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.417 -0.802 . . . . 1.0 111.376 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.71 124.63 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.83 159.16 39.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.073 1.749 . . . . 1.0 112.77 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ttm105 -112.71 143.56 43.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.684 1.594 . . . . 1.0 110.245 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.86 176.77 9.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.351 1.46 . . . . 1.0 109.564 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -71.67 143.61 49.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.575 1.55 . . . . 1.0 110.008 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.91 -56.82 7.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.891 1.276 . . . . 1.0 110.275 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -53.56 -45.6 69.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.6 1.16 . . . . 1.0 111.812 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.99 -45.1 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.746 0.418 . . . . 1.0 111.297 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.63 -43.17 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.841 0.856 . . . . 1.0 111.745 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.47 -0.5 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.69 121.62 25.57 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.177 0.894 . . . . 1.0 111.306 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 10.99 85.92 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.294 0.95 . . . . 1.0 114.343 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 m -125.52 165.63 18.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.653 1.581 . . . . 1.0 112.413 -173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.6 m -111.98 150.94 29.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.193 1.397 . . . . 1.0 108.183 168.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.9 153.18 30.7 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.291 1.96 . . . . 1.0 116.291 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -132.31 151.51 51.81 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.379 2.271 . . . . 1.0 109.734 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.92 133.52 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.945 1.298 . . . . 1.0 107.625 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.94 85.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.058 0.932 . . . . 1.0 113.262 -169.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -79.11 46.99 0.75 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.203 1.401 . . . . 1.0 112.18 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.2 m -62.0 -24.43 67.04 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.593 -1.317 . . . . 1.0 113.293 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -61.99 -14.88 39.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.47 -33.81 46.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.917 1.287 . . . . 1.0 112.417 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -97.05 5.67 49.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.898 0.879 . . . . 1.0 113.222 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.32 -49.97 3.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.398 1.479 . . . . 1.0 111.204 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -126.52 167.46 15.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.802 1.641 . . . . 1.0 112.877 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -71.0 155.12 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 121.434 -0.791 . . . . 1.0 111.13 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.71 135.89 71.64 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.852 3.034 . . . . 1.0 113.075 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -113.39 148.28 39.29 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.27 1.428 . . . . 1.0 109.753 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.66 122.26 7.24 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.41 2.74 . . . . 1.0 111.536 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.28 -32.61 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.717 1.207 . . . . 1.0 113.198 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.39 -36.22 79.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.749 0.704 . . . . 1.0 112.061 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.27 -34.17 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.227 0.611 . . . . 1.0 111.065 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -64.66 -47.6 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.541 0.61 . . . . 1.0 110.049 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.02 -38.34 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.126 0.971 . . . . 1.0 111.399 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -41.38 96.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.928 0.786 . . . . 1.0 111.842 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.5 t -64.21 -42.36 96.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.738 0.815 . . . . 1.0 111.197 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.7 -48.39 77.81 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.212 -0.93 . . . . 1.0 110.855 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.91 -22.21 65.96 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.434 1.494 . . . . 1.0 114.529 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.5 -40.06 30.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.449 1.1 . . . . 1.0 111.621 170.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.6 mmm -75.45 -38.13 59.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.336 1.055 . . . . 1.0 112.688 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.71 135.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.186 0.81 . . . . 1.0 113.186 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.44 -16.17 61.68 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.806 1.67 . . . . 1.0 113.826 -174.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -84.04 146.9 27.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.154 1.477 . . . . 1.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.49 156.67 16.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.521 1.529 . . . . 1.0 112.271 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 125.264 1.426 . . . . 1.0 112.376 176.003 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 112.275 0.472 . . . . 1.0 112.275 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.3 m -55.26 -43.92 75.09 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.397 1.629 . . . . 1.0 115.397 -169.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.36 -41.2 96.85 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.552 0.614 . . . . 1.0 111.685 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -69.44 -37.05 77.2 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.257 -0.902 . . . . 1.0 110.851 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.11 -58.2 9.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.429 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.74 -25.35 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.914 1.234 . . . . 1.0 112.263 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -63.85 -48.76 75.46 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.157 0.983 . . . . 1.0 111.461 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -61.6 -27.59 68.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.583 1.153 . . . . 1.0 112.986 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.2 -34.41 72.13 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.598 1.09 . . . . 1.0 112.946 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.9 ttm105 -94.36 -51.15 4.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.605 1.162 . . . . 1.0 111.717 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.43 -29.96 70.21 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.115 -0.991 . . . . 1.0 113.665 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 C-N-CA 124.945 1.26 . . . . 1.0 114.3 176.062 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 118.753 -0.641 . . . . 1.0 110.042 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.84 148.3 25.16 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.072 2.514 . . . . 1.0 112.269 -177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -121.12 161.05 42.68 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.302 1.841 . . . . 1.0 111.346 171.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.59 132.07 49.91 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.431 2.088 . . . . 1.0 110.815 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.09 -1.39 73.76 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.322 -1.266 . . . . 1.0 114.835 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -76.53 149.38 36.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.442 1.621 . . . . 1.0 113.283 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.59 128.72 37.53 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.58 1.152 . . . . 1.0 108.93 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.4 mt -109.16 131.14 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -99.62 133.79 43.45 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.904 1.681 . . . . 1.0 108.231 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.8 mt -122.11 120.33 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.732 1.613 . . . . 1.0 108.322 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 125.152 1.381 . . . . 1.0 109.793 -179.421 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 119.637 -0.22 . . . . 1.0 111.492 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.12 158.3 44.27 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 154.89 39.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.973 1.309 . . . . 1.0 112.694 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.77 120.61 36.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.172 1.789 . . . . 1.0 108.135 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -82.97 134.92 35.04 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.903 -1.123 . . . . 1.0 112.229 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.1 pt -118.73 4.33 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 -171.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 168.34 37.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.348 0.975 . . . . 1.0 112.861 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t70 62.91 16.1 8.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.125 1.77 . . . . 1.0 113.899 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 -0.98 81.07 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.121 1.343 . . . . 1.0 114.478 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -96.43 154.56 17.2 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.396 1.598 . . . . 1.0 114.366 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.86 159.5 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.104 1.762 . . . . 1.0 111.02 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -120.18 137.4 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 106.651 -1.611 . . . . 1.0 106.651 168.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.57 174.95 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.214 1.006 . . . . 1.0 110.552 -169.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.14 151.92 20.78 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.965 -0.459 . . . . 1.0 110.033 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 168.564 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 120.352 0.12 . . . . 1.0 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.87 145.15 49.39 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.765 0.826 . . . . 1.0 110.973 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -75.72 127.93 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -137.62 161.69 35.79 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.669 1.188 . . . . 1.0 112.711 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -115.51 138.89 50.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.814 2.046 . . . . 1.0 110.138 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.09 176.93 8.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.991 1.316 . . . . 1.0 110.361 170.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -67.64 142.11 56.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.086 1.754 . . . . 1.0 110.377 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.7 tp -51.9 -52.54 49.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.975 0.91 . . . . 1.0 111.711 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -55.36 -47.51 75.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.165 0.986 . . . . 1.0 111.153 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.38 -39.61 94.99 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.783 0.433 . . . . 1.0 111.94 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.69 -45.39 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.545 1.138 . . . . 1.0 111.583 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.37 -35.36 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.716 1.144 . . . . 1.0 112.834 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.78 -124.16 32.13 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.331 0.969 . . . . 1.0 111.533 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.08 -0.19 87.25 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.601 1.096 . . . . 1.0 114.623 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.52 148.61 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.648 1.179 . . . . 1.0 110.974 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.95 165.92 23.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.438 0.695 . . . . 1.0 111.318 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -161.45 164.95 29.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -160.34 161.0 33.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.535 1.534 . . . . 1.0 112.015 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.03 131.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -140.68 60.3 1.53 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.744 1.259 . . . . 1.0 109.842 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.65 67.55 8.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.311 1.445 . . . . 1.0 111.577 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 p -68.48 -21.31 64.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.314 1.445 . . . . 1.0 114.463 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.1 mt -65.78 -14.07 60.65 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.674 0.99 . . . . 1.0 113.674 -172.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -33.33 53.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 1.0 112.255 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.17 -17.48 49.58 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.32 1.448 . . . . 1.0 112.622 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -98.19 -47.2 5.56 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.035 1.334 . . . . 1.0 111.996 -170.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -128.43 162.38 27.28 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.103 1.361 . . . . 1.0 113.458 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -69.97 159.77 82.94 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 118.377 -0.82 . . . . 1.0 110.358 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.45 156.5 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.285 3.323 . . . . 1.0 115.559 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 154.95 71.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.513 1.525 . . . . 1.0 112.182 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.24 123.27 5.5 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.046 3.164 . . . . 1.0 111.992 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.07 -35.42 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.454 1.102 . . . . 1.0 113.934 -170.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.9 -37.37 79.21 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.765 0.826 . . . . 1.0 111.788 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.94 -34.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.455 -0.778 . . . . 1.0 110.664 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mt -64.35 -48.21 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 118.813 0.733 . . . . 1.0 109.997 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -39.79 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.572 1.149 . . . . 1.0 111.108 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -66.18 -43.35 87.13 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.282 -0.886 . . . . 1.0 111.947 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.16 -44.44 92.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.598 1.159 . . . . 1.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.919 0.781 . . . . 1.0 110.672 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.16 -39.6 90.73 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.245 -0.91 . . . . 1.0 113.161 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.75 -34.22 77.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.79 0.836 . . . . 1.0 112.29 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.4 mmm -74.9 -36.07 62.23 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.383 -0.818 . . . . 1.0 112.934 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.4 t -46.33 129.67 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 1.0 112.008 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.54 -16.05 61.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.951 1.739 . . . . 1.0 114.041 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -84.47 143.69 29.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.081 1.441 . . . . 1.0 111.401 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -94.33 146.61 23.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.919 1.288 . . . . 1.0 112.393 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 125.591 1.556 . . . . 1.0 112.088 -170.331 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 113.78 1.029 . . . . 1.0 113.78 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.9 p -60.84 -61.22 2.74 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.333 1.453 . . . . 1.0 113.563 172.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.98 -46.71 87.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.772 0.829 . . . . 1.0 111.126 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -59.25 -46.53 88.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.107 0.412 . . . . 1.0 111.288 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -55.31 -59.21 5.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.493 0.717 . . . . 1.0 111.308 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.18 -26.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.997 0.817 . . . . 1.0 112.372 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.0 m -66.02 -49.45 67.7 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.344 1.057 . . . . 1.0 111.237 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.51 -29.77 68.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.904 0.882 . . . . 1.0 112.509 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.81 -33.82 74.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.295 0.85 . . . . 1.0 113.295 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -98.29 -42.78 7.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.777 1.231 . . . . 1.0 112.374 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -67.07 -50.82 60.46 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.856 -1.152 . . . . 1.0 112.092 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.199 0 C-N-CA 126.412 1.958 . . . . 1.0 114.222 -174.56 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 118.742 -0.647 . . . . 1.0 109.807 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.06 153.47 16.74 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.526 2.817 . . . . 1.0 112.728 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -128.61 162.65 49.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.54 1.936 . . . . 1.0 112.431 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -43.99 127.12 6.55 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 124.396 3.397 . . . . 1.0 113.093 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 2.33 87.95 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 118.354 -1.248 . . . . 1.0 115.422 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.71 146.14 42.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.739 1.77 . . . . 1.0 112.947 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.07 122.61 33.21 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.387 -1.338 . . . . 1.0 107.387 169.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -101.98 132.24 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -109.91 132.1 54.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.799 2.04 . . . . 1.0 107.951 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mt -127.42 123.77 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.78 1.232 . . . . 1.0 109.195 -169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 124.829 1.252 . . . . 1.0 110.172 174.801 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 119.701 -0.19 . . . . 1.0 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -138.56 155.32 48.47 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.088 -1.007 . . . . 1.0 113.206 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.1 153.4 40.65 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.424 1.489 . . . . 1.0 112.309 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.55 118.26 34.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.049 1.74 . . . . 1.0 108.205 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -84.19 130.9 34.81 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.449 1.022 . . . . 1.0 112.545 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -113.43 0.79 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 114.87 1.433 . . . . 1.0 114.87 -170.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.17 168.04 34.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.357 0.979 . . . . 1.0 112.881 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.74 16.3 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.212 1.805 . . . . 1.0 114.082 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.56 6.49 77.08 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.133 1.349 . . . . 1.0 114.274 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -103.83 154.5 19.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.352 1.576 . . . . 1.0 113.94 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.67 161.52 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.381 1.873 . . . . 1.0 111.229 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.59 137.61 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -161.98 169.96 20.18 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.208 -0.933 . . . . 1.0 110.537 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.9 mt -88.15 151.59 22.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.874 -0.516 . . . . 1.0 109.745 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.82 0 C-N-CA 125.685 1.594 . . . . 1.0 109.88 171.53 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 119.794 -0.146 . . . . 1.0 110.725 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.07 138.59 36.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.192 0.997 . . . . 1.0 110.595 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.1 t -77.63 123.2 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -127.38 155.01 44.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.417 1.487 . . . . 1.0 112.395 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -104.03 128.79 51.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.858 1.663 . . . . 1.0 108.291 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -157.24 166.07 34.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.45 0.568 . . . . 1.0 111.552 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -76.06 137.62 40.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.82 1.648 . . . . 1.0 110.743 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.32 -55.55 17.8 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.891 1.277 . . . . 1.0 110.952 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -55.01 -44.61 74.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.391 1.076 . . . . 1.0 111.721 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.14 -42.3 93.96 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.451 0.3 . . . . 1.0 111.521 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.92 -39.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.8 1.24 . . . . 1.0 112.244 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.6 m -85.58 -0.74 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.471 1.108 . . . . 1.0 113.776 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.28 126.72 36.51 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.322 0.963 . . . . 1.0 112.082 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.37 6.29 79.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.294 0.949 . . . . 1.0 114.194 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.9 m -122.52 -179.51 4.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.686 1.994 . . . . 1.0 110.783 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.07 156.99 39.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.392 1.477 . . . . 1.0 108.119 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -155.01 164.89 38.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.403 1.631 . . . . 1.0 115.403 -171.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -158.56 160.27 36.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.758 2.023 . . . . 1.0 110.944 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -88.14 129.05 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 168.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -131.66 54.58 1.92 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.502 1.144 . . . . 1.0 110.165 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.28 71.46 7.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.896 1.279 . . . . 1.0 111.329 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.2 p -73.56 -43.47 59.78 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.835 1.254 . . . . 1.0 113.681 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.79 -17.17 63.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.29 -28.13 51.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.126 1.37 . . . . 1.0 112.898 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -91.44 -20.44 21.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.375 1.47 . . . . 1.0 112.536 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -86.99 -36.24 18.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.412 1.085 . . . . 1.0 112.516 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -120.25 170.42 9.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.319 1.448 . . . . 1.0 112.355 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -66.35 144.8 98.86 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.437 -0.79 . . . . 1.0 109.557 171.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.41 134.16 46.81 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.86 2.373 . . . . 1.0 111.653 -169.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -93.81 151.65 40.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.069 1.348 . . . . 1.0 110.676 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.17 111.41 3.07 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.5 2.8 . . . . 1.0 110.858 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.72 -32.66 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.179 1.177 . . . . 1.0 114.179 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.73 -35.72 75.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.268 0.627 . . . . 1.0 112.16 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.6 -40.55 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.884 0.874 . . . . 1.0 110.722 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.3 mt -59.8 -46.74 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.762 0.71 . . . . 1.0 110.26 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.7 mt -69.18 -35.36 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.3 1.04 . . . . 1.0 111.627 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.3 m -64.34 -43.48 94.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.278 -0.889 . . . . 1.0 111.615 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.7 m -59.8 -43.77 94.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.303 1.041 . . . . 1.0 111.508 172.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.35 73.58 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.188 -0.945 . . . . 1.0 111.358 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -62.38 -38.11 88.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.301 1.041 . . . . 1.0 112.953 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.6 -35.3 79.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.84 0.856 . . . . 1.0 112.07 173.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.5 mmm -74.0 -37.54 64.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.376 -0.821 . . . . 1.0 112.85 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.9 t -46.68 130.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 119.359 0.981 . . . . 1.0 111.678 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.35 -14.04 65.73 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.567 1.556 . . . . 1.0 114.095 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -87.27 158.8 19.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.9 1.35 . . . . 1.0 111.413 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -120.25 148.61 43.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.148 1.379 . . . . 1.0 112.334 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 78.7 mtm . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 124.863 1.265 . . . . 1.0 112.161 179.777 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.3 m120 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.6 m -65.19 -40.68 94.54 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.31 0.959 . . . . 1.0 112.741 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -59.64 -53.11 61.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.111 0.964 . . . . 1.0 109.888 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.38 -45.75 87.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.813 0.445 . . . . 1.0 111.566 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -52.21 -60.09 3.61 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.861 0.865 . . . . 1.0 111.004 172.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -32.65 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.33 0.968 . . . . 1.0 113.017 -172.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -71.17 -38.87 72.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.647 0.779 . . . . 1.0 112.254 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -60.62 -26.55 67.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.997 0.817 . . . . 1.0 112.813 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.75 -26.54 68.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.868 1.213 . . . . 1.0 112.592 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -93.71 -53.31 4.08 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.657 1.583 . . . . 1.0 111.798 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -73.21 -38.94 65.92 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 C-N-CA 125.229 1.395 . . . . 1.0 112.292 175.524 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 118.588 -0.72 . . . . 1.0 110.089 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.23 144.58 26.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.562 2.841 . . . . 1.0 112.088 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -129.48 160.57 63.71 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.861 1.664 . . . . 1.0 112.846 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -47.59 129.03 16.3 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.815 3.01 . . . . 1.0 112.822 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -8.84 73.79 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.074 1.321 . . . . 1.0 114.172 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -68.59 139.34 55.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.968 1.384 . . . . 1.0 112.541 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.55 126.95 35.8 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.879 1.272 . . . . 1.0 108.905 170.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.3 131.93 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.44 138.45 39.34 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.187 1.395 . . . . 1.0 108.784 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mt -133.14 113.99 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.226 1.01 . . . . 1.0 109.174 -173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 125.474 1.51 . . . . 1.0 111.205 -169.58 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.034 0.445 . . . . 1.0 110.472 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -137.37 150.19 47.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.204 1.001 . . . . 1.0 110.546 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 152.1 44.37 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.312 1.045 . . . . 1.0 112.598 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.33 116.86 33.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.197 1.799 . . . . 1.0 107.921 170.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -79.89 132.24 36.04 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.326 -0.859 . . . . 1.0 111.716 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.2 pt -114.89 -3.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -171.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.57 166.31 24.48 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 124.717 1.151 . . . . 1.0 113.008 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 62.69 18.37 10.54 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.082 1.753 . . . . 1.0 113.867 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.75 85.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.446 1.498 . . . . 1.0 114.281 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -94.2 153.12 18.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.425 1.613 . . . . 1.0 114.252 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -133.54 157.87 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.004 1.721 . . . . 1.0 111.006 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -115.58 138.68 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.396 1.478 . . . . 1.0 107.13 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -155.43 150.95 27.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.723 0.809 . . . . 1.0 111.75 -168.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -84.38 121.49 27.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 124.492 1.117 . . . . 1.0 112.239 -169.987 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 110.579 -0.156 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.12 137.49 54.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.94 0.896 . . . . 1.0 109.989 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.77 124.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -132.05 163.81 27.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.414 1.486 . . . . 1.0 111.999 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -117.51 137.11 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.007 1.723 . . . . 1.0 110.077 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.05 177.74 10.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.822 1.249 . . . . 1.0 111.214 171.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.0 141.62 49.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.123 0.969 . . . . 1.0 111.604 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 tp -51.19 -52.82 40.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.308 1.043 . . . . 1.0 112.19 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.84 -48.22 73.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.086 0.954 . . . . 1.0 111.287 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.53 -35.02 79.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.083 0.553 . . . . 1.0 112.083 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.84 -45.23 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.17 0.988 . . . . 1.0 112.293 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.43 -34.47 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 119.585 1.084 . . . . 1.0 112.818 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.27 -131.11 49.68 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 119.151 0.887 . . . . 1.0 112.192 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.88 -3.73 85.38 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.652 1.12 . . . . 1.0 114.481 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.0 m -74.99 149.59 39.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.166 1.387 . . . . 1.0 111.433 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.5 t -72.05 154.43 41.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.007 0.523 . . . . 1.0 110.78 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -158.85 163.59 36.5 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.688 0.995 . . . . 1.0 113.688 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -159.81 157.46 29.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.83 1.252 . . . . 1.0 113.371 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.8 t -82.47 138.06 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.446 -1.316 . . . . 1.0 107.446 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -152.65 84.77 1.24 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 1.0 111.394 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.04 53.54 2.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.759 1.224 . . . . 1.0 111.847 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 p -58.73 -34.65 71.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.985 1.314 . . . . 1.0 113.159 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.65 -17.85 65.06 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.253 -0.905 . . . . 1.0 112.899 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.82 -25.9 68.38 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.126 0.876 . . . . 1.0 112.631 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.64 12.9 36.42 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.532 1.133 . . . . 1.0 111.949 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -109.8 -44.35 3.84 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.589 1.555 . . . . 1.0 111.754 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -131.41 168.32 17.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.593 1.557 . . . . 1.0 113.609 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -66.78 160.13 70.64 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.308 1.043 . . . . 1.0 112.471 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.77 152.33 35.71 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.405 3.403 . . . . 1.0 113.489 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -129.14 153.99 80.44 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.83 1.652 . . . . 1.0 111.042 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.75 111.45 3.25 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.205 2.604 . . . . 1.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.94 -31.86 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.193 0.997 . . . . 1.0 113.086 -169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.36 -36.98 76.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.731 0.696 . . . . 1.0 112.1 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 t -71.56 -34.41 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.057 0.943 . . . . 1.0 110.7 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.1 mt -66.13 -48.32 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.536 0.735 . . . . 1.0 109.982 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -42.62 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.702 1.201 . . . . 1.0 110.853 173.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -65.26 -40.92 94.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 1.0 111.384 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.8 m -63.48 -42.5 98.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.06 0.944 . . . . 1.0 111.804 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.4 77.98 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.559 -0.713 . . . . 1.0 110.29 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.47 -39.83 92.31 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.15 -0.969 . . . . 1.0 113.149 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.64 -32.9 74.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.905 0.882 . . . . 1.0 112.631 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -74.34 -37.25 63.6 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.33 -0.843 . . . . 1.0 112.815 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.8 t -47.57 127.54 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.726 1.148 . . . . 1.0 111.373 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.75 -16.47 59.58 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.006 1.765 . . . . 1.0 113.818 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -85.04 157.58 20.69 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.741 1.271 . . . . 1.0 111.067 176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.27 153.99 36.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.867 1.267 . . . . 1.0 113.214 -172.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.2 mtt . . . . . 0 N--CA 1.474 0.775 0 C-N-CA 126.243 1.817 . . . . 1.0 111.77 -178.814 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.7 t30 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -63.52 -36.71 84.68 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.325 -1.484 . . . . 1.0 113.022 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.46 -58.8 6.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.576 0.75 . . . . 1.0 109.963 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -52.83 -32.57 45.02 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.814 1.245 . . . . 1.0 113.419 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.91 -57.54 10.46 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.093 -1.004 . . . . 1.0 110.786 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.37 -28.29 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.902 1.075 . . . . 1.0 113.902 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.79 -42.5 90.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.539 1.063 . . . . 1.0 111.872 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -58.01 -29.37 65.25 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 1.0 112.813 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.21 -32.04 70.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.793 0.837 . . . . 1.0 112.652 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -94.42 -51.37 4.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 1.0 111.43 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -62.88 -32.07 73.25 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 -169.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.245 0 C-N-CA 123.883 0.754 . . . . 1.0 114.272 -179.543 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 CA--C 1.545 0.75 0 CA-C-O 118.668 -0.682 . . . . 1.0 109.638 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.22 146.53 17.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.817 3.012 . . . . 1.0 111.614 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.97 161.02 62.29 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.637 1.575 . . . . 1.0 112.583 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -46.74 128.58 13.33 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.942 3.095 . . . . 1.0 112.99 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.81 -7.88 80.59 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.265 -1.297 . . . . 1.0 115.18 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.05 143.91 54.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.666 1.733 . . . . 1.0 113.761 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.42 128.11 33.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.52 1.528 . . . . 1.0 107.922 169.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.56 129.38 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.629 1.171 . . . . 1.0 108.162 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -100.15 125.08 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.316 1.447 . . . . 1.0 107.676 170.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.3 mt -120.92 119.9 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.559 1.143 . . . . 1.0 109.167 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 125.741 1.616 . . . . 1.0 110.514 -175.888 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -136.39 145.2 45.07 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.738 0.815 . . . . 1.0 111.508 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 156.81 45.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.303 1.041 . . . . 1.0 112.515 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.95 116.32 32.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.538 1.935 . . . . 1.0 107.713 172.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -81.91 130.73 35.16 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.335 -0.853 . . . . 1.0 111.845 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.85 3.66 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.5 167.48 35.3 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.529 1.062 . . . . 1.0 112.584 -174.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 61.38 20.02 10.75 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.952 1.701 . . . . 1.0 113.813 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.99 -1.04 87.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.585 1.564 . . . . 1.0 114.458 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -91.68 151.72 20.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.595 1.698 . . . . 1.0 114.492 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.53 154.23 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.402 1.481 . . . . 1.0 111.155 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.8 mt -112.23 136.02 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -155.16 150.09 26.71 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.138 -0.977 . . . . 1.0 111.866 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.07 133.05 33.92 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.666 0 C-N-CA 125.114 1.366 . . . . 1.0 110.491 -175.97 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 119.552 -0.261 . . . . 1.0 110.675 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.23 139.44 53.78 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.272 1.029 . . . . 1.0 110.76 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.11 125.85 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.21 162.3 30.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.149 1.779 . . . . 1.0 111.986 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -120.69 126.28 49.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.819 1.648 . . . . 1.0 110.672 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -147.98 174.14 12.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.173 1.389 . . . . 1.0 110.681 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.74 137.37 38.43 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.109 -0.994 . . . . 1.0 110.744 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.79 -42.75 84.81 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.228 -0.92 . . . . 1.0 111.643 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.04 -46.42 75.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.774 . . . . 1.0 111.402 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.97 -42.94 80.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.671 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.15 -42.58 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 1.0 111.664 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.55 -2.31 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.813 1.245 . . . . 1.0 113.831 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.76 123.78 33.21 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.048 -1.033 . . . . 1.0 111.797 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.99 5.51 86.93 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.66 1.124 . . . . 1.0 114.757 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -126.31 -160.86 1.01 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.512 2.325 . . . . 1.0 110.436 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.2 t -148.87 171.8 15.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.266 1.826 . . . . 1.0 109.349 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -152.76 158.91 42.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.743 1.386 . . . . 1.0 114.743 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.98 150.29 39.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.362 1.865 . . . . 1.0 110.483 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.1 t -82.65 134.6 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -148.63 67.23 1.06 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.797 0.839 . . . . 1.0 112.197 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -72.61 82.62 1.12 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.37 1.068 . . . . 1.0 111.643 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -69.6 -38.33 77.25 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.148 0.795 . . . . 1.0 113.148 -170.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.7 mt -81.63 -8.89 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -172.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.56 -31.53 68.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 1.0 112.758 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -90.42 -5.71 55.79 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.925 1.29 . . . . 1.0 112.382 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -97.35 -47.76 5.58 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.033 1.333 . . . . 1.0 112.19 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -127.1 169.88 12.95 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.976 1.31 . . . . 1.0 113.717 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -66.21 148.59 98.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 110.067 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.38 144.72 62.84 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.364 2.709 . . . . 1.0 113.001 -170.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.92 151.72 37.94 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.45 1.5 . . . . 1.0 112.299 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.09 114.95 4.16 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.859 3.04 . . . . 1.0 110.991 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.81 -35.42 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.943 1.297 . . . . 1.0 114.154 -170.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.91 -35.4 78.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.827 0.451 . . . . 1.0 112.191 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.38 -36.71 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.468 0.707 . . . . 1.0 110.915 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.08 -49.5 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.472 0.578 . . . . 1.0 109.769 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.8 mt -67.68 -38.43 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.912 0.885 . . . . 1.0 111.904 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.9 m -62.42 -41.55 98.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.348 0.976 . . . . 1.0 111.71 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -62.46 -44.34 96.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.697 0.799 . . . . 1.0 111.079 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.63 72.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.618 0.767 . . . . 1.0 110.903 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.26 -40.36 93.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.234 1.014 . . . . 1.0 112.803 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.83 -33.47 75.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.565 0.746 . . . . 1.0 112.096 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.2 mmm -74.92 -38.24 61.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.195 -0.907 . . . . 1.0 112.975 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.54 127.95 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 120.017 1.281 . . . . 1.0 111.299 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.71 -15.42 62.72 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.722 1.629 . . . . 1.0 113.593 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -84.64 160.13 20.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.001 1.4 . . . . 1.0 111.314 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -123.86 157.81 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.368 1.467 . . . . 1.0 112.561 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.56 1.544 . . . . 1.0 110.283 177.772 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 . . . . . 0 CA--C 1.558 1.255 0 N-CA-C 117.072 2.249 . . . . 1.0 117.072 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 29.9 m -62.86 -29.94 71.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.024 1.329 . . . . 1.0 113.942 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.55 93.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.868 0.758 . . . . 1.0 111.674 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -58.68 -45.96 88.27 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.305 -0.872 . . . . 1.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -54.11 -57.1 12.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.569 -0.707 . . . . 1.0 111.349 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.47 -28.07 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.358 0.981 . . . . 1.0 113.489 -173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.4 p -72.47 -38.46 68.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.349 0.977 . . . . 1.0 112.276 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -57.6 -30.54 65.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.777 0.831 . . . . 1.0 112.53 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.26 -32.58 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.023 0.829 . . . . 1.0 112.928 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -93.58 -37.8 11.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 112.19 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -72.16 -46.27 57.1 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.605 -1.309 . . . . 1.0 112.908 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.059 0 C-N-CA 126.316 1.913 . . . . 1.0 114.006 -176.499 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 118.848 -0.596 . . . . 1.0 110.242 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.0 157.54 23.77 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.809 3.006 . . . . 1.0 113.263 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -124.82 162.56 42.44 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 127.188 2.195 . . . . 1.0 112.165 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.73 129.48 14.31 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.037 3.158 . . . . 1.0 113.059 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.78 -3.46 86.85 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.541 -1.144 . . . . 1.0 115.192 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.09 139.91 58.76 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.343 1.572 . . . . 1.0 113.027 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.69 120.95 26.98 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.88 124.75 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.401 -0.963 . . . . 1.0 108.401 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -87.57 135.31 33.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mt -124.57 116.6 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.899 1.28 . . . . 1.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.328 -0.363 0 C-N-CA 124.42 1.088 . . . . 1.0 109.678 -173.471 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.8 m80 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -135.99 145.16 45.82 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.108 0.963 . . . . 1.0 112.58 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 151.86 44.18 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 1.0 112.928 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.61 116.17 29.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.466 1.906 . . . . 1.0 109.223 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -83.03 129.89 35.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.14 -0.975 . . . . 1.0 112.502 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.0 pt -106.57 4.11 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.84 30.6 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 116.118 1.207 . . . . 1.0 116.118 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -88.36 9.11 24.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.747 1.219 . . . . 1.0 113.641 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.1 83.9 Favored Glycine 0 N--CA 1.476 1.355 0 C-N-CA 124.811 1.196 . . . . 1.0 112.142 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -95.09 157.03 16.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.913 1.685 . . . . 1.0 112.569 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.88 155.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.298 1.439 . . . . 1.0 110.105 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.2 mt -111.43 135.91 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -153.91 151.12 29.08 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.411 -0.805 . . . . 1.0 111.803 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -85.96 133.62 33.92 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 124.922 1.289 . . . . 1.0 110.254 -175.745 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 110.323 -0.251 . . . . 1.0 110.323 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -116.54 140.13 49.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.369 1.068 . . . . 1.0 110.195 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.79 125.39 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 169.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.69 163.13 27.89 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.412 1.485 . . . . 1.0 112.199 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -123.86 133.39 53.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.925 1.69 . . . . 1.0 110.058 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -158.14 174.65 14.87 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.063 0.945 . . . . 1.0 111.116 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.64 142.67 56.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.384 1.074 . . . . 1.0 111.453 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 tp -52.19 -53.96 36.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.764 0.826 . . . . 1.0 111.821 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.38 -48.59 71.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.213 1.005 . . . . 1.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.26 -36.18 83.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.222 0.609 . . . . 1.0 112.302 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.84 -42.54 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.228 1.011 . . . . 1.0 112.303 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.1 m -71.53 -36.76 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.031 1.287 . . . . 1.0 112.508 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.58 -130.84 46.48 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 119.033 0.833 . . . . 1.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.2 -6.79 87.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.415 1.007 . . . . 1.0 114.328 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -75.9 148.74 38.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.303 1.441 . . . . 1.0 111.35 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.8 t -73.35 160.44 31.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.051 0.54 . . . . 1.0 110.878 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -158.67 160.25 36.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.088 1.144 . . . . 1.0 114.088 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -160.89 158.69 28.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.26 1.424 . . . . 1.0 112.02 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.73 138.86 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -152.71 85.24 1.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 1.0 110.69 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.66 59.28 2.45 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.599 1.16 . . . . 1.0 112.141 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -65.01 -33.41 75.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.253 1.421 . . . . 1.0 113.56 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.94 -11.99 58.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.193 0.997 . . . . 1.0 113.58 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.73 -34.56 65.27 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.924 1.289 . . . . 1.0 112.136 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -79.2 -18.58 52.73 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.996 1.318 . . . . 1.0 112.306 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -94.74 -43.49 8.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.762 1.225 . . . . 1.0 112.097 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -134.41 146.94 50.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.98 1.312 . . . . 1.0 112.709 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -65.82 159.66 67.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.395 1.078 . . . . 1.0 111.329 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -54.59 151.58 30.66 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.491 3.461 . . . . 1.0 116.241 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 160.11 48.84 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.307 1.843 . . . . 1.0 111.109 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.11 126.02 10.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.987 3.125 . . . . 1.0 112.161 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.43 -33.51 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 113.239 0.829 . . . . 1.0 113.239 -174.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.44 -37.96 82.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.188 0.595 . . . . 1.0 111.909 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.77 -38.16 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 1.0 110.431 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.8 mt -61.55 -46.49 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.212 0.915 . . . . 1.0 110.518 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.35 -37.17 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.112 0.965 . . . . 1.0 111.764 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -63.6 -45.08 91.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.893 0.77 . . . . 1.0 111.363 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.6 m -58.68 -44.09 90.13 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.568 1.147 . . . . 1.0 111.746 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.01 63.09 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.533 0.733 . . . . 1.0 110.782 173.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.78 -39.74 85.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.018 0.927 . . . . 1.0 112.991 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -67.75 -33.92 75.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.112 0.965 . . . . 1.0 112.473 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 96.5 mtp -77.76 -33.21 52.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.845 -1.074 . . . . 1.0 112.857 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.8 t -48.62 128.83 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 120.33 1.423 . . . . 1.0 111.004 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.06 -15.3 62.74 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.628 1.585 . . . . 1.0 113.804 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -87.18 163.27 17.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.94 1.37 . . . . 1.0 111.494 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -125.57 157.7 36.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.393 1.477 . . . . 1.0 112.952 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.7 mtt . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 126.097 1.759 . . . . 1.0 110.258 177.951 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 . . . . . 0 CA--C 1.547 0.856 0 N-CA-C 113.073 0.768 . . . . 1.0 113.073 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.9 -37.31 72.97 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 1.0 112.024 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -61.38 -52.09 66.09 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.447 0.699 . . . . 1.0 109.977 170.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -58.46 -37.67 75.95 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.816 -0.553 . . . . 1.0 111.881 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -59.82 -61.36 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.174 -0.917 . . . . 1.0 111.128 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.64 -24.81 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.799 1.181 . . . . 1.0 112.875 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -63.44 -49.36 73.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.449 1.1 . . . . 1.0 111.295 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -59.8 -28.24 67.28 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.425 0.69 . . . . 1.0 112.688 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -63.42 -36.11 82.63 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.107 0.78 . . . . 1.0 113.107 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -93.75 -44.04 8.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.812 0.845 . . . . 1.0 111.741 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.97 -46.24 88.66 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.001 -1.062 . . . . 1.0 112.349 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.018 0 C-N-CA 126.566 2.031 . . . . 1.0 114.315 -176.821 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 118.659 -0.686 . . . . 1.0 109.482 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.08 143.16 22.5 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.35 2.7 . . . . 1.0 111.493 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -117.02 164.31 19.38 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.397 1.879 . . . . 1.0 111.323 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.64 128.46 10.72 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.855 3.036 . . . . 1.0 112.674 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.28 -3.4 87.25 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.368 -1.24 . . . . 1.0 115.429 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.3 142.24 57.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.647 1.723 . . . . 1.0 113.041 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 117' ' ' VAL . 37.2 mt -89.22 118.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.039 -0.982 . . . . 1.0 108.984 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.89 127.64 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.614 -1.624 . . . . 1.0 106.614 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -108.5 122.71 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.411 . . . . 1.0 107.696 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.9 mt -120.28 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 124.893 1.277 . . . . 1.0 109.254 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 125.537 1.535 . . . . 1.0 111.132 -176.859 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 120.357 0.122 . . . . 1.0 110.928 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -137.46 149.31 46.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.079 0.951 . . . . 1.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.58 151.65 38.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.196 0.998 . . . . 1.0 112.949 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -94.13 113.54 25.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.151 1.78 . . . . 1.0 108.778 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -82.32 129.56 34.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.086 -1.009 . . . . 1.0 112.425 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.7 pt -106.14 10.18 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.58 -35.48 4.48 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 124.665 1.126 . . . . 1.0 115.801 169.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.46 17.12 3.98 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.459 1.104 . . . . 1.0 113.706 -172.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 -4.89 85.43 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.905 1.241 . . . . 1.0 112.803 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -92.92 155.39 17.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.171 1.388 . . . . 1.0 113.131 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -126.94 151.31 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.247 1.419 . . . . 1.0 110.481 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.04 134.49 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 106.842 -1.54 . . . . 1.0 106.842 169.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -154.53 162.86 40.93 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.26 -0.9 . . . . 1.0 111.502 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -101.43 132.49 47.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.52 1.128 . . . . 1.0 109.156 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 124.161 0.985 . . . . 1.0 112.676 -174.911 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.64 135.64 35.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.823 1.249 . . . . 1.0 109.233 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.94 131.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.847 0.749 . . . . 1.0 109.268 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -135.05 162.19 33.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.58 1.552 . . . . 1.0 112.594 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -118.33 123.61 45.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.837 1.655 . . . . 1.0 109.946 171.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -145.52 172.08 13.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.715 1.206 . . . . 1.0 110.39 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -75.53 143.39 42.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.105 -0.997 . . . . 1.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.12 -51.92 64.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.172 -0.918 . . . . 1.0 111.702 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -54.33 -49.31 70.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.418 0.687 . . . . 1.0 111.299 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.64 -38.53 83.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.286 0.634 . . . . 1.0 111.846 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -44.79 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.405 1.082 . . . . 1.0 112.056 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -87.98 -7.58 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 114.354 1.242 . . . . 1.0 114.354 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.24 133.83 52.21 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.405 1.003 . . . . 1.0 113.192 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.08 80.87 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.822 1.201 . . . . 1.0 114.723 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.8 m -120.58 150.07 41.45 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.795 1.638 . . . . 1.0 111.204 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.8 m -81.41 158.87 24.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -161.18 168.02 25.02 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.429 . . . . 1.0 114.857 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -159.78 167.83 27.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.882 1.673 . . . . 1.0 112.205 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -87.25 126.57 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 168.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -131.67 57.66 1.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.336 1.065 . . . . 1.0 110.68 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.86 57.7 3.55 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.388 1.475 . . . . 1.0 111.667 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 p -78.64 -14.23 59.42 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.523 1.529 . . . . 1.0 114.72 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 mt -67.79 -11.83 59.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.135 1.161 . . . . 1.0 114.135 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.26 -26.69 67.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.946 0.794 . . . . 1.0 112.422 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -87.51 -5.37 58.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.123 1.369 . . . . 1.0 111.694 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -100.54 -47.24 4.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.549 1.54 . . . . 1.0 111.122 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -130.81 146.67 52.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.857 1.663 . . . . 1.0 112.338 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -64.52 155.13 82.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 1.0 111.864 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -48.78 141.23 21.46 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.569 3.513 . . . . 1.0 115.688 -170.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -121.21 146.45 44.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.724 1.61 . . . . 1.0 110.857 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.56 114.92 4.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.494 2.796 . . . . 1.0 110.398 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.06 -29.9 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 114.452 1.278 . . . . 1.0 114.452 -169.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.1 -35.72 75.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.926 0.49 . . . . 1.0 111.878 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.22 -32.61 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.254 0.622 . . . . 1.0 110.89 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.88 -49.24 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.289 0.949 . . . . 1.0 110.338 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.06 -38.6 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.086 0.954 . . . . 1.0 111.253 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.4 m -63.12 -41.77 99.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 1.0 112.127 173.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t -61.68 -44.45 96.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.101 0.96 . . . . 1.0 110.968 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.5 -52.42 65.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.164 0.986 . . . . 1.0 110.517 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.81 -39.09 87.64 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.138 0.975 . . . . 1.0 113.057 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.55 -34.71 77.63 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.921 0.888 . . . . 1.0 112.363 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 97.5 mtp -78.61 -31.64 47.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.711 -1.137 . . . . 1.0 113.305 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.6 t -47.61 126.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 120.264 1.393 . . . . 1.0 110.607 169.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.11 -12.43 65.43 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.741 1.639 . . . . 1.0 114.274 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.24 158.37 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.109 1.455 . . . . 1.0 111.45 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -118.53 159.54 23.35 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.338 1.455 . . . . 1.0 113.895 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 125.965 1.706 . . . . 1.0 112.091 -178.941 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -69.6 -35.16 75.05 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.324 -0.86 . . . . 1.0 112.71 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.74 -51.79 66.89 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.729 0.812 . . . . 1.0 110.593 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -63.49 -34.63 78.2 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.254 -0.904 . . . . 1.0 111.261 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.38 -60.02 4.47 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.125 -0.985 . . . . 1.0 110.917 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 13' ' ' LEU . 29.8 m -64.9 -22.76 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 120.634 1.561 . . . . 1.0 113.338 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.1 m -65.55 -52.87 49.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.788 1.235 . . . . 1.0 110.984 169.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -66.55 -24.96 66.44 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.391 0.885 . . . . 1.0 113.391 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.2 -37.55 75.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.911 0.884 . . . . 1.0 112.986 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -93.88 -46.74 7.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.118 0.967 . . . . 1.0 112.133 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -62.08 -44.68 96.15 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.153 -0.967 . . . . 1.0 111.747 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.045 0 C-N-CA 126.424 1.964 . . . . 1.0 113.652 179.148 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -86.33 158.62 9.63 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.68 3.587 . . . . 1.0 111.998 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -129.97 162.53 53.19 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.805 1.642 . . . . 1.0 112.027 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.77 128.01 8.51 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.253 3.302 . . . . 1.0 113.091 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.81 -9.42 76.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.999 1.285 . . . . 1.0 115.108 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.82 151.27 44.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.103 1.452 . . . . 1.0 113.71 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.31 125.45 35.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.087 0.955 . . . . 1.0 109.976 171.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.0 mm -95.0 132.93 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 106.757 -1.572 . . . . 1.0 106.757 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -111.68 130.88 55.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.776 1.63 . . . . 1.0 108.851 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.06 129.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.732 1.613 . . . . 1.0 109.355 -169.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 125.61 1.564 . . . . 1.0 109.274 178.694 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 111.944 0.35 . . . . 1.0 111.944 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -142.14 155.54 45.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.118 0.785 . . . . 1.0 113.118 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.12 153.33 42.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.462 1.105 . . . . 1.0 112.115 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.47 118.15 30.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.999 1.319 . . . . 1.0 108.52 171.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -83.39 132.55 34.98 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.236 -0.915 . . . . 1.0 112.156 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 pt -117.44 2.45 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 -170.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.43 163.71 27.33 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.742 1.163 . . . . 1.0 113.427 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 61.71 19.03 10.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.146 1.778 . . . . 1.0 114.116 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.78 2.93 81.0 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.602 1.572 . . . . 1.0 114.107 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -95.14 152.53 18.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.74 . . . . 1.0 114.151 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.8 160.53 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.034 1.733 . . . . 1.0 110.737 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.51 132.07 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.761 -1.57 . . . . 1.0 106.761 168.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.194 -0.941 . . . . 1.0 111.062 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.25 111.14 16.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 171.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 123.914 0.886 . . . . 1.0 111.326 -169.533 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.17 140.35 52.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.81 0.844 . . . . 1.0 109.837 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.36 123.32 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.3 153.71 51.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.987 1.315 . . . . 1.0 112.091 -175.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -100.96 125.11 47.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.967 1.707 . . . . 1.0 109.713 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -149.62 174.81 12.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.782 1.233 . . . . 1.0 110.372 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -75.54 144.57 41.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.008 -1.058 . . . . 1.0 111.71 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -48.99 -52.16 26.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.0 1.32 . . . . 1.0 110.942 173.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.66 -53.6 18.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.325 1.85 . . . . 1.0 111.248 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.32 -34.73 75.11 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.466 0.543 . . . . 1.0 112.466 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.8 t -71.25 -43.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.571 1.148 . . . . 1.0 112.303 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.2 m -73.87 -39.18 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 119.459 1.027 . . . . 1.0 112.697 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.39 -127.38 45.02 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.968 0.804 . . . . 1.0 112.191 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.01 3.16 84.54 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.102 1.334 . . . . 1.0 114.903 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.1 m -78.73 155.95 29.12 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.782 1.291 . . . . 1.0 111.579 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.59 150.91 37.94 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.659 0.384 . . . . 1.0 110.097 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -161.0 164.55 30.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -160.84 160.11 30.68 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.652 1.581 . . . . 1.0 111.556 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.11 133.38 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -155.87 87.3 1.07 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.596 0.758 . . . . 1.0 111.288 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.5 58.84 1.8 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.999 1.32 . . . . 1.0 112.353 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -61.19 -35.61 77.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.866 1.266 . . . . 1.0 112.988 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.47 -14.03 62.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.621 1.168 . . . . 1.0 113.487 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.97 -23.08 67.2 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.634 -0.666 . . . . 1.0 112.762 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.73 -2.67 55.81 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.141 1.376 . . . . 1.0 111.589 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -98.71 -46.2 5.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.633 1.573 . . . . 1.0 111.554 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -125.73 168.98 13.03 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.418 1.487 . . . . 1.0 114.079 -172.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -65.93 161.15 57.27 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.588 1.155 . . . . 1.0 111.204 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.78 131.82 28.66 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.867 2.378 . . . . 1.0 110.807 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -113.21 152.19 44.89 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.056 1.343 . . . . 1.0 110.989 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 118.07 5.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.404 2.736 . . . . 1.0 111.348 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.75 -36.6 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.899 1.28 . . . . 1.0 114.174 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.37 -35.53 79.43 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.944 0.498 . . . . 1.0 111.908 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.22 -37.92 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.334 0.654 . . . . 1.0 110.651 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -62.73 -47.13 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 118.95 0.796 . . . . 1.0 110.465 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.33 -36.84 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.821 0.849 . . . . 1.0 111.749 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -62.1 -44.13 97.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.146 0.885 . . . . 1.0 111.252 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 m -58.43 -44.73 89.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 1.0 111.72 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.66 -50.38 73.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.305 0.957 . . . . 1.0 110.89 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.54 -38.33 89.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.531 1.132 . . . . 1.0 113.322 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -69.32 -32.1 70.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.116 0.966 . . . . 1.0 112.155 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.36 -35.23 54.74 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.385 -0.817 . . . . 1.0 112.933 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -45.65 126.46 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.484 1.038 . . . . 1.0 111.359 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.14 59.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.22 1.867 . . . . 1.0 113.972 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -87.71 149.43 24.24 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.027 1.414 . . . . 1.0 111.078 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -106.4 153.15 22.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.397 1.479 . . . . 1.0 113.892 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.8 mtt . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 126.922 2.089 . . . . 1.0 110.811 174.111 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.9 m120 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 27.3 p -58.43 -34.78 71.19 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.06 -1.025 . . . . 1.0 113.702 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -68.24 -55.28 12.76 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.74 1.616 . . . . 1.0 110.591 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -65.37 -33.19 75.38 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.164 -0.96 . . . . 1.0 111.415 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -56.75 -59.02 5.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.338 -0.839 . . . . 1.0 111.129 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.84 -24.38 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.729 1.15 . . . . 1.0 112.31 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -65.4 -48.35 73.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.036 0.934 . . . . 1.0 111.336 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -62.06 -26.47 68.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.267 1.027 . . . . 1.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.03 -32.87 74.33 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.339 0.972 . . . . 1.0 112.949 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -90.39 -48.87 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.275 1.03 . . . . 1.0 111.557 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.76 -30.45 68.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.074 0 C-N-CA 126.147 1.832 . . . . 1.0 114.52 -179.832 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 CA--C 1.55 0.972 0 CA-C-O 118.739 -0.648 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.07 144.96 12.16 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.663 2.908 . . . . 1.0 112.165 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -130.51 162.64 53.48 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.747 2.019 . . . . 1.0 111.678 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.15 129.23 15.19 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.559 2.839 . . . . 1.0 113.412 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.21 85.12 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.29 -1.284 . . . . 1.0 114.841 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.86 137.44 58.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.585 1.693 . . . . 1.0 112.758 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.39 117.88 24.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.785 1.234 . . . . 1.0 108.419 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.4 mm -99.67 121.81 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.46 1.504 . . . . 1.0 107.85 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.74 119.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.491 1.116 . . . . 1.0 109.505 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 125.192 1.397 . . . . 1.0 110.078 -179.51 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 120.634 0.254 . . . . 1.0 110.854 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -139.69 153.32 47.23 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.267 1.027 . . . . 1.0 112.668 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 152.18 38.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.635 0.774 . . . . 1.0 112.693 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.27 115.43 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.084 1.754 . . . . 1.0 108.323 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -80.32 129.12 34.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.956 0.798 . . . . 1.0 112.099 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.5 pt -105.94 10.62 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 115.06 1.504 . . . . 1.0 115.06 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.86 -34.8 5.08 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.53 1.062 . . . . 1.0 115.743 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.96 16.59 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.371 1.068 . . . . 1.0 113.838 -172.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 -7.46 80.79 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.121 1.343 . . . . 1.0 113.202 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -91.89 156.64 17.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.051 1.341 . . . . 1.0 112.819 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -127.61 152.63 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.405 1.482 . . . . 1.0 110.309 172.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -110.91 135.03 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.061 1.345 . . . . 1.0 107.976 169.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -153.8 151.97 30.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.048 0.939 . . . . 1.0 112.294 -168.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.86 126.56 36.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.566 0.747 . . . . 1.0 109.406 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 117.841 -1.076 . . . . 1.0 109.518 173.681 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -136.96 137.46 39.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.541 0.736 . . . . 1.0 110.129 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.3 t -80.08 125.13 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.04 161.43 31.0 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.218 1.807 . . . . 1.0 111.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -120.52 124.59 45.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.753 1.621 . . . . 1.0 110.405 172.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -147.27 178.38 8.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.415 1.486 . . . . 1.0 110.219 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.02 143.19 32.69 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.952 -1.092 . . . . 1.0 111.78 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.77 -61.27 2.13 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.153 1.381 . . . . 1.0 111.319 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -56.19 -43.95 78.96 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.268 1.027 . . . . 1.0 111.36 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.39 -43.03 91.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.3 t -69.79 -42.1 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.451 1.1 . . . . 1.0 112.15 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -79.22 -5.47 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.91 132.96 51.21 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.616 1.103 . . . . 1.0 113.041 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.71 69.71 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.691 1.138 . . . . 1.0 114.785 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 m -126.04 154.22 43.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.307 1.843 . . . . 1.0 111.244 -175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.0 t -82.64 153.52 25.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 168.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -160.48 163.67 32.76 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -161.04 159.55 29.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.206 1.403 . . . . 1.0 112.813 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.2 t -82.75 133.06 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -153.77 80.47 1.15 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.885 0.85 . . . . 1.0 112.153 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.15 51.12 1.71 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.138 1.375 . . . . 1.0 113.049 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.8 m -59.0 -30.43 67.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.684 -1.26 . . . . 1.0 113.411 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.54 -16.07 63.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.88 1.067 . . . . 1.0 113.88 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.0 -20.66 65.5 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.038 0.755 . . . . 1.0 113.038 170.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -97.58 -3.2 40.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.596 1.558 . . . . 1.0 111.815 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -97.58 -48.11 5.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.657 1.583 . . . . 1.0 110.98 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.38 167.59 12.61 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.005 1.722 . . . . 1.0 112.795 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -67.45 163.36 48.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.756 0.822 . . . . 1.0 111.701 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.13 128.01 28.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.396 2.73 . . . . 1.0 111.527 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -113.26 152.65 45.32 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.318 1.447 . . . . 1.0 110.43 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.39 113.78 3.81 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.461 2.774 . . . . 1.0 110.783 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.19 -29.23 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -37.0 78.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.493 . . . . 1.0 111.887 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.02 -33.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.526 0.73 . . . . 1.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.17 -47.82 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.938 0.79 . . . . 1.0 110.121 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.81 -38.97 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.253 1.021 . . . . 1.0 111.729 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 t -63.03 -43.17 99.44 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.439 -0.788 . . . . 1.0 111.567 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.5 m -61.63 -42.38 98.8 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.342 1.057 . . . . 1.0 111.671 173.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 72.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.496 0.719 . . . . 1.0 110.456 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -60.95 -40.62 94.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.153 0.981 . . . . 1.0 112.865 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.79 -33.72 76.52 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.838 0.855 . . . . 1.0 112.554 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.5 mmm -73.48 -38.63 65.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.834 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.9 t -47.33 128.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.88 1.218 . . . . 1.0 111.507 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.76 62.95 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.788 1.661 . . . . 1.0 113.703 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -82.76 145.11 29.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 118.965 1.383 . . . . 1.0 111.19 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -114.9 147.38 40.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.83 1.652 . . . . 1.0 112.732 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 N--CA 1.472 0.669 0 C-N-CA 125.979 1.712 . . . . 1.0 110.237 -178.732 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 CA--C 1.546 0.809 0 N-CA-C 115.933 1.827 . . . . 1.0 115.933 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.13 -43.91 81.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 121.446 1.93 . . . . 1.0 113.33 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -43.91 85.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.138 0.975 . . . . 1.0 110.88 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.23 -41.58 93.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.451 -0.781 . . . . 1.0 111.362 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -58.02 -58.92 6.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.139 0.976 . . . . 1.0 110.891 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.38 -22.52 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.61 1.095 . . . . 1.0 112.76 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 83.5 m -65.7 -49.91 66.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.615 1.166 . . . . 1.0 111.476 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.97 -29.02 64.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.555 1.142 . . . . 1.0 112.468 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.5 -34.54 77.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.219 0.822 . . . . 1.0 113.219 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -93.75 -47.86 6.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.164 0.986 . . . . 1.0 111.307 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.57 -30.48 71.5 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.547 1.139 . . . . 1.0 113.546 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.219 0 C-N-CA 124.599 1.095 . . . . 1.0 114.435 177.823 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 CA--C 1.547 0.83 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 148.26 26.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.589 2.859 . . . . 1.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.88 164.27 41.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.246 1.818 . . . . 1.0 112.177 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.91 126.68 11.37 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.656 2.904 . . . . 1.0 113.235 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.66 -10.03 75.91 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.744 1.164 . . . . 1.0 115.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -66.87 137.78 56.83 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.457 1.628 . . . . 1.0 112.911 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.27 118.41 26.68 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.276 1.43 . . . . 1.0 108.45 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.3 mt -101.28 130.93 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -103.06 131.78 49.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.301 1.44 . . . . 1.0 108.364 170.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.5 mt -124.43 118.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.632 1.573 . . . . 1.0 108.431 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 1.0 112.034 -169.929 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 120.576 0.226 . . . . 1.0 110.433 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -141.41 154.43 45.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.091 0.557 . . . . 1.0 112.048 -175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.73 147.73 31.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.695 0.798 . . . . 1.0 112.356 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.35 118.72 32.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.091 1.756 . . . . 1.0 107.976 169.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.35 132.89 35.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.043 -1.035 . . . . 1.0 112.4 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.86 0.86 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 115.092 1.515 . . . . 1.0 115.092 -169.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.06 169.29 33.45 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.389 0.995 . . . . 1.0 112.917 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 64.1 15.49 9.32 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.239 1.816 . . . . 1.0 114.202 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.57 83.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.35 1.453 . . . . 1.0 114.059 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -101.53 154.52 18.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.21 1.505 . . . . 1.0 114.006 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.72 165.0 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.473 1.909 . . . . 1.0 110.769 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -121.91 135.53 61.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 168.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -154.81 166.02 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.073 -1.017 . . . . 1.0 110.808 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.3 tp -86.57 139.0 31.25 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 124.836 1.254 . . . . 1.0 109.371 -177.582 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -129.44 142.68 50.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.386 0.674 . . . . 1.0 111.195 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.0 t -75.41 125.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 169.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.94 151.48 51.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.709 1.204 . . . . 1.0 112.765 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -97.04 129.14 44.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.883 1.673 . . . . 1.0 108.394 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.15 163.06 37.93 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.029 0.532 . . . . 1.0 110.941 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -72.48 141.26 48.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.47 1.108 . . . . 1.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.69 -58.99 3.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.154 1.382 . . . . 1.0 111.167 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -55.77 -45.54 78.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.432 1.093 . . . . 1.0 111.393 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.42 -41.08 98.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.884 0.474 . . . . 1.0 111.671 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.23 -44.49 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.33 1.052 . . . . 1.0 112.325 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.94 -1.76 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 114.044 1.127 . . . . 1.0 114.044 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.27 50.81 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.377 0.989 . . . . 1.0 113.615 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 1.66 76.45 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.933 1.254 . . . . 1.0 114.56 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.4 m -126.27 155.75 41.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.148 1.779 . . . . 1.0 111.418 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.1 t -85.25 154.77 21.73 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -157.13 150.4 23.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.055 -1.028 . . . . 1.0 113.741 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -150.75 163.79 37.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.219 1.808 . . . . 1.0 110.58 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.6 t -83.64 137.46 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.085 0.954 . . . . 1.0 108.878 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -145.0 77.77 1.54 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.291 1.436 . . . . 1.0 110.845 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.08 62.69 2.89 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.929 1.292 . . . . 1.0 111.418 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.3 p -64.24 -40.18 95.5 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.806 1.242 . . . . 1.0 113.378 -170.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -71.48 -9.67 58.56 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.814 1.042 . . . . 1.0 113.814 -175.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.56 -27.06 68.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.873 0.844 . . . . 1.0 113.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -80.58 -14.73 57.96 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.295 1.438 . . . . 1.0 112.184 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -102.49 -39.89 6.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.654 1.581 . . . . 1.0 112.241 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -129.92 161.5 30.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.631 1.572 . . . . 1.0 113.11 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -65.85 159.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.413 1.085 . . . . 1.0 111.288 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.1 124.47 14.45 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.726 2.284 . . . . 1.0 110.817 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -94.23 154.94 40.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.076 1.35 . . . . 1.0 110.343 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.91 113.19 3.32 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.562 . . . . 1.0 110.89 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.45 -32.61 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.55 -36.29 78.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.875 0.47 . . . . 1.0 112.019 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.3 t -71.96 -36.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.912 0.885 . . . . 1.0 111.008 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.27 -47.72 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.858 0.754 . . . . 1.0 110.197 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.95 -38.81 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.945 0.898 . . . . 1.0 111.604 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -61.92 -41.52 98.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.305 0.957 . . . . 1.0 111.706 172.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -61.24 -45.3 95.1 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.2 -0.938 . . . . 1.0 111.055 173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.94 73.36 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.394 -0.817 . . . . 1.0 110.717 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.69 -37.12 85.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.292 1.037 . . . . 1.0 113.43 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.76 -33.49 73.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.714 0.806 . . . . 1.0 112.507 173.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.9 mmm -74.65 -37.39 62.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.919 0.888 . . . . 1.0 112.654 176.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.9 t -46.11 128.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.268 0.94 . . . . 1.0 111.754 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.94 64.92 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.789 1.661 . . . . 1.0 113.56 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -84.06 146.05 28.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.004 1.402 . . . . 1.0 110.89 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -100.19 151.72 21.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.396 1.478 . . . . 1.0 112.56 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 125.586 1.554 . . . . 1.0 112.802 -175.448 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 117.457 2.391 . . . . 1.0 117.457 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 90.7 m -63.14 -41.53 99.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.463 1.938 . . . . 1.0 114.171 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.41 -47.05 77.61 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.754 -0.591 . . . . 1.0 110.881 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -59.54 -30.98 69.0 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.61 -0.681 . . . . 1.0 112.436 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.19 -61.16 2.55 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.376 -0.828 . . . . 1.0 111.01 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.41 -28.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 p -67.28 -39.08 85.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.959 0.904 . . . . 1.0 112.469 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -59.35 -24.41 63.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.804 0.842 . . . . 1.0 113.036 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -66.19 -35.7 81.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.091 0.86 . . . . 1.0 112.637 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -87.08 -42.79 12.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.064 0.946 . . . . 1.0 111.846 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -68.09 -30.86 70.14 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.244 0 C-N-CA 124.652 1.12 . . . . 1.0 113.298 179.678 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 119.105 -0.474 . . . . 1.0 110.736 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.03 156.74 13.27 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.515 2.81 . . . . 1.0 113.197 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -126.85 162.14 49.2 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.587 1.955 . . . . 1.0 111.706 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -45.8 129.06 11.64 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.061 3.174 . . . . 1.0 113.289 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -7.36 73.94 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.251 1.405 . . . . 1.0 114.887 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -71.48 142.23 50.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.28 1.54 . . . . 1.0 113.839 -175.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.05 124.57 31.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.296 1.438 . . . . 1.0 108.814 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -105.25 128.47 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.124 -1.436 . . . . 1.0 107.124 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -109.6 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.364 1.466 . . . . 1.0 108.048 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mt -127.89 140.64 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.959 1.704 . . . . 1.0 108.911 -169.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 1.0 110.375 -179.559 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 110.89 -0.041 . . . . 1.0 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -144.34 157.88 44.03 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.023 -1.048 . . . . 1.0 113.407 -173.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.91 40.11 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.781 1.232 . . . . 1.0 112.824 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.37 118.64 37.31 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.971 1.708 . . . . 1.0 108.37 171.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.092 -1.005 . . . . 1.0 112.496 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.06 2.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 115.155 1.539 . . . . 1.0 115.155 -170.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.15 166.84 31.5 Favored Glycine 0 N--CA 1.479 1.513 0 C-N-CA 124.593 1.092 . . . . 1.0 112.984 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 65.12 1.17 1.44 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.39 2.276 . . . . 1.0 114.321 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 6.09 59.31 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.112 1.339 . . . . 1.0 113.932 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -90.49 152.22 21.04 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.167 1.984 . . . . 1.0 113.573 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.68 154.76 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.695 1.598 . . . . 1.0 110.734 171.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -114.51 137.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.837 -1.542 . . . . 1.0 106.837 168.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -155.77 164.17 38.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 120.951 -1.093 . . . . 1.0 110.344 -170.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.7 tp -85.92 143.19 28.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.747 -1.205 . . . . 1.0 107.747 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 124.897 1.279 . . . . 1.0 110.692 -176.695 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 119.164 -0.446 . . . . 1.0 110.608 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -113.39 141.6 46.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.64 0.776 . . . . 1.0 110.81 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.31 127.72 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 170.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.52 160.15 40.51 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.557 1.543 . . . . 1.0 112.636 -173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -101.88 134.33 45.25 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.01 1.324 . . . . 1.0 110.059 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.49 172.9 12.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.505 1.522 . . . . 1.0 109.922 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -81.26 143.93 31.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.979 -1.076 . . . . 1.0 112.124 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 tp -50.85 -53.55 31.33 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.816 1.246 . . . . 1.0 111.226 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.77 -47.94 73.27 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 1.0 111.042 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.71 -36.53 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.5 -47.25 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.862 1.265 . . . . 1.0 112.292 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 m -79.78 -1.25 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 114.353 1.242 . . . . 1.0 114.353 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.32 127.42 44.86 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.974 0.797 . . . . 1.0 112.768 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 2.92 81.23 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.922 1.248 . . . . 1.0 114.781 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.2 m -125.38 160.46 29.32 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 1.0 111.909 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.9 m -89.18 157.8 18.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.806 0.842 . . . . 1.0 109.033 168.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.24 162.9 36.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -158.95 162.05 36.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.836 1.655 . . . . 1.0 112.001 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.1 t -83.23 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -148.5 74.8 1.29 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.278 1.037 . . . . 1.0 111.426 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -77.92 58.65 1.96 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.104 1.362 . . . . 1.0 111.555 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.5 p -63.56 -45.88 88.48 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.615 -1.303 . . . . 1.0 112.896 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 mt -72.49 -10.23 59.54 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.94 -25.36 57.57 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.708 0.803 . . . . 1.0 112.299 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.34 -4.61 53.64 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.45 1.5 . . . . 1.0 113.253 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -84.17 -65.44 1.01 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.431 1.093 . . . . 1.0 111.114 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -109.72 174.68 5.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.068 2.147 . . . . 1.0 113.148 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -66.48 140.21 96.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 121.271 -0.893 . . . . 1.0 110.791 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.21 148.37 91.17 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.887 3.058 . . . . 1.0 113.711 -169.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -99.26 153.83 37.59 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.832 1.253 . . . . 1.0 112.248 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.66 118.46 5.47 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.591 2.861 . . . . 1.0 110.341 170.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 t -55.8 -38.4 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.372 1.469 . . . . 1.0 112.851 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.01 -36.57 70.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.64 0.776 . . . . 1.0 111.616 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.29 -34.46 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.497 -0.764 . . . . 1.0 111.081 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.72 -46.66 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.535 1.062 . . . . 1.0 110.186 171.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.07 -36.68 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.48 1.112 . . . . 1.0 111.414 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 t -63.07 -44.39 95.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.061 0.846 . . . . 1.0 111.111 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.8 m -58.32 -44.44 88.64 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.483 1.113 . . . . 1.0 111.817 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.71 72.74 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.416 1.007 . . . . 1.0 111.135 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.368 1.067 . . . . 1.0 112.957 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.85 -32.89 74.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.978 0.911 . . . . 1.0 112.371 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 80.9 mmm -74.95 -36.35 62.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.703 -1.141 . . . . 1.0 113.086 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.8 t -46.42 125.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 120.277 1.398 . . . . 1.0 111.015 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.72 -17.13 57.9 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.151 1.834 . . . . 1.0 114.182 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -85.77 165.65 16.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.912 1.356 . . . . 1.0 110.961 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.6 156.32 44.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.4 mtt . . . . . 0 N--CA 1.48 1.033 0 C-N-CA 126.797 2.039 . . . . 1.0 112.598 -177.559 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 113.581 0.956 . . . . 1.0 113.581 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.7 m -69.95 -36.64 75.42 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.075 -1.016 . . . . 1.0 113.366 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.4 -56.86 14.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.461 0.573 . . . . 1.0 109.942 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -55.58 -34.0 64.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 1.0 112.751 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -60.0 -59.73 4.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.074 -0.489 . . . . 1.0 110.737 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.22 -32.27 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 -170.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.75 -42.71 90.62 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.393 0.997 . . . . 1.0 111.553 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -61.41 -24.27 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.612 1.165 . . . . 1.0 112.773 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.95 -31.84 73.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.51 1.05 . . . . 1.0 112.846 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -94.89 -49.87 5.38 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.805 1.242 . . . . 1.0 111.352 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -62.26 -46.94 86.56 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.922 -1.111 . . . . 1.0 112.51 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 C-N-CA 126.837 2.16 . . . . 1.0 112.969 178.688 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.38 147.77 18.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.223 2.615 . . . . 1.0 112.722 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -129.81 159.48 69.64 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.219 1.807 . . . . 1.0 112.744 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -46.61 129.24 13.76 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 124.086 3.191 . . . . 1.0 112.907 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.99 79.05 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.584 -1.12 . . . . 1.0 114.863 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -64.85 144.12 57.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.323 1.561 . . . . 1.0 113.143 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -94.12 125.24 38.64 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.421 1.488 . . . . 1.0 108.523 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.57 132.35 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -103.89 133.75 48.33 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.578 1.551 . . . . 1.0 108.863 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.2 mt -127.81 119.92 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.929 1.692 . . . . 1.0 108.132 -171.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 125.899 1.679 . . . . 1.0 113.168 -168.65 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.0 m170 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 121.028 0.442 . . . . 1.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.95 154.29 51.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.406 1.083 . . . . 1.0 111.259 174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.8 146.84 28.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.16 115.41 27.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.972 1.709 . . . . 1.0 107.846 170.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -81.14 131.89 35.32 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.565 -0.71 . . . . 1.0 111.95 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.67 2.31 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.6 165.23 29.43 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 124.726 1.155 . . . . 1.0 112.759 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.58 17.31 9.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.109 1.764 . . . . 1.0 113.958 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 0.05 81.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.665 1.602 . . . . 1.0 114.195 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.83 154.2 17.37 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.448 1.624 . . . . 1.0 114.057 -175.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 m -137.25 158.38 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.98 1.712 . . . . 1.0 111.662 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.42 139.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.807 1.643 . . . . 1.0 108.326 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -156.43 150.02 24.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 1.0 111.661 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -97.06 124.79 41.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.863 0.865 . . . . 1.0 109.512 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.832 0 CA-C-O 117.406 -1.283 . . . . 1.0 110.322 -179.627 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 111.347 0.128 . . . . 1.0 111.347 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -133.56 137.41 45.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.979 0.912 . . . . 1.0 109.98 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.45 127.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -132.27 160.98 34.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.984 1.714 . . . . 1.0 111.804 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -121.14 139.92 52.69 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.906 1.682 . . . . 1.0 109.84 172.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -164.86 -179.52 5.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.772 1.229 . . . . 1.0 111.076 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -70.09 142.92 52.56 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.943 0.897 . . . . 1.0 111.02 172.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.5 tp -51.57 -56.77 11.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.288 1.035 . . . . 1.0 112.152 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.51 -41.18 80.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.502 0.592 . . . . 1.0 111.187 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.37 -39.0 81.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.08 0.552 . . . . 1.0 112.137 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.0 -38.48 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.49 1.116 . . . . 1.0 111.972 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.56 -49.47 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.024 1.33 . . . . 1.0 111.056 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.38 -121.94 27.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.713 0.673 . . . . 1.0 111.677 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.31 -0.68 86.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.953 1.263 . . . . 1.0 114.854 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.6 m -79.43 175.27 10.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.076 1.35 . . . . 1.0 111.591 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 95.6 m -110.19 168.34 9.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.379 1.471 . . . . 1.0 108.884 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -158.05 162.56 38.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -149.39 155.15 40.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.024 1.73 . . . . 1.0 111.272 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.26 135.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -153.86 84.86 1.16 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.818 0.818 . . . . 1.0 111.866 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -81.11 50.13 1.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.187 1.395 . . . . 1.0 112.926 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 m -59.19 -33.46 70.98 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.501 -1.374 . . . . 1.0 113.144 -171.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.48 -12.37 60.13 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -26.69 68.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.962 0.801 . . . . 1.0 112.946 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -88.98 -5.1 58.2 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.893 1.277 . . . . 1.0 112.057 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -99.34 -50.26 4.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.17 1.388 . . . . 1.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -128.2 147.64 50.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.203 1.401 . . . . 1.0 112.774 -174.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -65.56 153.25 90.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 118.44 -0.79 . . . . 1.0 111.57 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.81 127.98 27.28 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.149 3.233 . . . . 1.0 114.765 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.32 155.62 46.45 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.003 1.321 . . . . 1.0 111.536 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.16 117.9 5.36 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.707 2.938 . . . . 1.0 110.063 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -57.3 -34.92 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.42 1.088 . . . . 1.0 113.017 -170.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.2 -36.37 75.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.953 0.501 . . . . 1.0 112.188 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.11 -36.1 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.97 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mt -59.99 -46.39 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 119.662 1.119 . . . . 1.0 110.337 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.44 -36.1 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.021 0.928 . . . . 1.0 111.288 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.7 m -64.56 -43.2 94.67 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.453 -0.779 . . . . 1.0 111.404 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.7 m -60.41 -43.97 96.17 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.658 1.183 . . . . 1.0 111.445 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.64 73.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.66 0.784 . . . . 1.0 110.458 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -60.92 -40.63 93.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.196 0.999 . . . . 1.0 113.002 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -65.25 -34.12 77.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.923 0.889 . . . . 1.0 112.334 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 75.3 mmm -73.73 -39.64 64.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.321 -0.847 . . . . 1.0 112.789 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -47.65 129.49 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.674 1.124 . . . . 1.0 111.707 172.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.37 -14.68 64.03 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.539 1.542 . . . . 1.0 113.464 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -82.69 143.2 31.09 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.122 1.461 . . . . 1.0 111.186 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.75 146.57 27.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.179 1.392 . . . . 1.0 111.633 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.3 mmt . . . . . 0 N--CA 1.469 0.504 0 C-N-CA 125.809 1.643 . . . . 1.0 110.628 -178.031 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 111.867 0.321 . . . . 1.0 111.867 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 6.9 t -85.04 -38.39 19.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.533 1.133 . . . . 1.0 113.504 -169.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -44.97 92.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.141 0.977 . . . . 1.0 110.385 169.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.31 -43.63 64.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.492 1.917 . . . . 1.0 111.381 170.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -64.12 -59.47 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.818 -0.611 . . . . 1.0 111.714 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.55 -22.36 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.481 1.037 . . . . 1.0 113.032 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 m -60.81 -51.41 69.42 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.791 1.236 . . . . 1.0 111.426 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -64.46 -26.51 68.47 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.979 0.733 . . . . 1.0 112.979 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.75 -34.97 76.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.035 0.834 . . . . 1.0 112.917 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -91.87 -49.71 6.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.23 1.012 . . . . 1.0 111.482 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -61.27 -45.86 92.73 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.257 -0.902 . . . . 1.0 112.288 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 126.38 1.943 . . . . 1.0 112.315 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.16 143.08 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.265 2.643 . . . . 1.0 111.591 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -129.48 163.44 46.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.094 1.757 . . . . 1.0 112.201 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -45.54 126.62 8.81 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 124.196 3.264 . . . . 1.0 113.095 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.75 82.6 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.44 1.495 . . . . 1.0 115.348 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.25 145.71 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.658 1.729 . . . . 1.0 113.782 -175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.94 123.05 30.06 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.54 1.136 . . . . 1.0 108.068 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.81 131.19 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.416 -1.328 . . . . 1.0 107.416 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.45 129.06 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.244 1.818 . . . . 1.0 108.27 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.75 128.95 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.005 1.722 . . . . 1.0 108.297 -170.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 CA--C 1.533 0.321 0 C-N-CA 125.384 1.474 . . . . 1.0 111.451 -174.471 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 111.315 0.117 . . . . 1.0 111.315 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -139.51 156.87 46.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.179 -0.951 . . . . 1.0 113.251 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.41 40.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.214 . . . . 1.0 112.546 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.08 119.08 38.21 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.901 1.681 . . . . 1.0 108.145 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -82.78 130.36 35.12 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.241 -0.912 . . . . 1.0 111.965 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 pt -113.05 3.3 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 114.744 1.387 . . . . 1.0 114.744 -170.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.37 168.05 35.63 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.4 1.0 . . . . 1.0 112.671 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.12 17.78 9.46 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.906 1.682 . . . . 1.0 113.999 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.63 85.37 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.002 1.287 . . . . 1.0 114.379 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.5 154.44 17.27 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.554 1.677 . . . . 1.0 114.204 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.27 157.11 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.283 1.833 . . . . 1.0 111.2 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.53 136.27 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.33 -1.73 . . . . 1.0 106.33 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -158.8 175.28 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.305 1.042 . . . . 1.0 110.32 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.6 mt -90.12 153.18 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.633 -0.667 . . . . 1.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.911 0 C-N-CA 126.566 1.946 . . . . 1.0 107.86 169.386 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 119.255 -0.403 . . . . 1.0 110.13 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -98.24 138.77 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.093 0.861 . . . . 1.0 110.42 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.11 127.32 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 169.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -138.07 162.02 35.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.442 1.497 . . . . 1.0 112.276 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -109.22 140.28 43.05 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.227 1.811 . . . . 1.0 110.345 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.17 176.61 9.08 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.771 1.228 . . . . 1.0 110.909 172.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -74.28 142.07 45.27 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.705 1.202 . . . . 1.0 111.529 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.85 -51.94 64.34 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.977 -1.011 . . . . 1.0 111.844 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.19 -47.01 72.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.727 0.694 . . . . 1.0 111.22 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.74 -39.71 84.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.549 0.739 . . . . 1.0 112.025 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.55 -42.05 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.404 1.081 . . . . 1.0 112.401 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -0.63 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.536 1.535 . . . . 1.0 113.9 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.91 52.29 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.404 1.002 . . . . 1.0 112.993 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.48 1.87 77.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.725 1.155 . . . . 1.0 114.622 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 24.5 m -120.44 161.26 21.53 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.243 1.817 . . . . 1.0 111.127 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.1 t -97.14 163.19 13.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.015 0.926 . . . . 1.0 109.204 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -157.39 163.32 38.7 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.13 151.72 28.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 109.67 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.23 129.5 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -132.39 68.76 1.49 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.068 0.947 . . . . 1.0 111.531 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -75.58 73.2 2.59 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.873 1.269 . . . . 1.0 111.729 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 m -70.37 -38.76 74.82 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.124 -0.985 . . . . 1.0 113.305 -170.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -75.55 -10.47 59.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.473 1.286 . . . . 1.0 114.473 -169.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.95 -30.59 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.065 0.946 . . . . 1.0 112.693 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -79.21 -16.46 56.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.602 1.561 . . . . 1.0 112.538 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -100.0 -41.33 7.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.486 1.515 . . . . 1.0 112.365 -172.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -130.1 160.27 34.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.202 1.401 . . . . 1.0 113.299 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -66.08 162.86 42.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.706 1.203 . . . . 1.0 111.803 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.32 146.14 7.38 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 125.124 3.883 . . . . 1.0 115.255 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 151.71 63.0 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.486 1.514 . . . . 1.0 112.296 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.88 120.09 4.56 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.853 3.035 . . . . 1.0 112.446 -169.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.9 p -55.58 -33.25 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.208 1.188 . . . . 1.0 114.208 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.66 -35.4 79.51 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.677 0.391 . . . . 1.0 112.041 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.53 -35.47 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.202 0.601 . . . . 1.0 110.815 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.3 mt -62.52 -49.39 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.837 0.744 . . . . 1.0 110.059 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -68.65 -37.64 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.031 0.932 . . . . 1.0 111.709 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.1 m -62.11 -42.02 98.82 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.238 -0.914 . . . . 1.0 111.86 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 t -60.23 -45.44 93.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.559 0.744 . . . . 1.0 111.06 173.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.84 75.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.351 0.66 . . . . 1.0 110.95 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.55 -38.67 90.93 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.14 -0.975 . . . . 1.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.3 -35.58 80.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.766 0.827 . . . . 1.0 112.092 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mmm -73.75 -36.24 65.12 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 1.0 112.975 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.62 126.89 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.744 1.156 . . . . 1.0 111.417 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.27 -17.68 58.72 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.154 1.835 . . . . 1.0 113.981 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -88.14 158.07 18.65 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.872 1.336 . . . . 1.0 110.709 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.79 141.81 43.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.618 1.167 . . . . 1.0 112.335 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 126.381 1.872 . . . . 1.0 110.51 -175.52 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t30 . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.0 m -74.79 -15.31 60.75 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.229 -1.544 . . . . 1.0 114.558 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -46.53 55.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.825 0.739 . . . . 1.0 110.391 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -53.12 -27.98 23.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.608 1.163 . . . . 1.0 113.654 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -65.07 -53.97 37.42 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.183 -0.948 . . . . 1.0 111.173 169.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.43 -26.6 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -64.56 -41.72 96.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.479 1.036 . . . . 1.0 111.815 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.6 -24.23 66.55 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.537 1.135 . . . . 1.0 112.923 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.16 -31.36 72.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.954 0.797 . . . . 1.0 112.557 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -94.16 -43.73 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.618 1.167 . . . . 1.0 111.723 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -67.81 -33.81 75.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.616 0.969 . . . . 1.0 113.616 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 C-N-CA 125.8 1.667 . . . . 1.0 114.323 179.791 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 CA--C 1.547 0.835 0 CA-C-O 118.68 -0.676 . . . . 1.0 110.717 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.37 148.6 16.55 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.689 2.926 . . . . 1.0 112.181 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -130.0 161.26 60.9 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.386 1.874 . . . . 1.0 112.915 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.43 128.17 12.16 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.182 3.255 . . . . 1.0 113.114 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.91 -7.64 78.86 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.122 1.344 . . . . 1.0 114.9 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.41 142.48 53.86 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.316 1.558 . . . . 1.0 113.689 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.85 123.96 31.8 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.132 1.373 . . . . 1.0 108.733 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 mm -105.64 127.17 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.783 -1.192 . . . . 1.0 107.783 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -102.49 125.67 49.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.498 1.519 . . . . 1.0 108.272 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.75 119.06 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.137 1.375 . . . . 1.0 109.317 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 C--N 1.327 -0.393 0 C-N-CA 125.444 1.498 . . . . 1.0 110.514 -179.677 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 120.73 0.3 . . . . 1.0 111.023 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -138.0 150.08 46.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.035 0.934 . . . . 1.0 112.868 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.28 155.82 42.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.468 1.107 . . . . 1.0 112.469 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.35 116.22 32.29 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.924 1.689 . . . . 1.0 107.733 172.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -82.29 131.09 35.23 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.241 -0.912 . . . . 1.0 111.872 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.2 pt -114.26 2.5 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.806 1.41 . . . . 1.0 114.806 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.73 168.67 36.73 Favored Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.448 1.023 . . . . 1.0 112.772 -175.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.74 17.8 9.07 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.983 1.713 . . . . 1.0 113.8 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.16 -0.35 85.79 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.143 1.354 . . . . 1.0 114.445 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -92.94 153.41 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.788 1.794 . . . . 1.0 114.646 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.85 156.52 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.274 1.83 . . . . 1.0 110.865 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.0 mt -115.09 134.84 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.659 1.584 . . . . 1.0 107.101 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.32 145.39 22.75 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.326 -0.859 . . . . 1.0 112.402 -168.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.71 93.31 8.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.491 0.716 . . . . 1.0 109.861 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 124.494 1.117 . . . . 1.0 111.374 -176.74 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 119.48 -0.295 . . . . 1.0 110.514 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.25 135.34 52.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.223 1.009 . . . . 1.0 110.929 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.44 122.35 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 170.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -128.04 161.03 30.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.536 1.534 . . . . 1.0 111.799 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -117.38 120.27 37.64 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.143 1.777 . . . . 1.0 109.994 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -147.19 177.53 9.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.694 1.198 . . . . 1.0 110.852 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.52 139.68 38.62 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.147 -0.97 . . . . 1.0 111.394 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.48 -49.97 68.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.063 0.945 . . . . 1.0 111.609 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.76 -46.21 74.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.426 0.69 . . . . 1.0 111.316 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -44.9 76.37 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.785 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.55 -41.56 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.825 1.25 . . . . 1.0 112.144 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.37 -2.08 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.502 1.521 . . . . 1.0 113.71 -171.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.1 128.65 47.91 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.228 0.918 . . . . 1.0 112.924 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.46 -1.17 83.08 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.942 1.258 . . . . 1.0 114.726 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 m -117.67 150.26 39.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.78 1.632 . . . . 1.0 111.283 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.74 159.64 20.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -160.71 168.46 24.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.484 1.29 . . . . 1.0 114.484 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -159.97 162.2 34.31 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.507 1.523 . . . . 1.0 112.098 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.02 134.31 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 107.146 -1.427 . . . . 1.0 107.146 168.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -145.25 75.64 1.45 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.087 0.946 . . . . 1.0 111.075 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.11 64.64 3.32 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.974 1.309 . . . . 1.0 110.71 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -62.89 -42.4 99.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.736 1.215 . . . . 1.0 113.036 -170.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.67 -7.43 50.37 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.53 -27.95 68.04 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.767 0.794 . . . . 1.0 112.841 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.33 -14.7 59.3 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.205 1.402 . . . . 1.0 112.391 175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -104.21 -40.42 6.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.544 1.538 . . . . 1.0 112.112 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -129.4 156.76 43.55 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.109 1.764 . . . . 1.0 112.75 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -65.95 160.3 63.88 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.951 0.9 . . . . 1.0 111.828 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.34 125.51 17.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.635 2.89 . . . . 1.0 112.28 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -96.99 154.49 38.19 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.955 1.302 . . . . 1.0 110.137 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.11 112.41 3.3 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.032 2.488 . . . . 1.0 111.061 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.67 -33.06 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 124.549 1.139 . . . . 1.0 113.133 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.83 -37.38 79.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.267 0.485 . . . . 1.0 112.034 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.4 -38.76 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.67 0.788 . . . . 1.0 110.646 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.0 mt -60.07 -50.26 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.7 0.682 . . . . 1.0 109.858 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.6 mt -66.67 -36.46 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.248 1.019 . . . . 1.0 112.077 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 t -63.77 -41.78 97.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.948 0.795 . . . . 1.0 110.745 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.4 p -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.67 0.788 . . . . 1.0 111.858 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.83 76.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.888 0.875 . . . . 1.0 110.469 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.59 -39.21 90.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.223 1.009 . . . . 1.0 112.974 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.99 -34.86 79.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.564 0.746 . . . . 1.0 112.358 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.5 mmm -74.63 -36.83 62.91 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.322 -0.847 . . . . 1.0 113.162 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.96 127.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.528 1.058 . . . . 1.0 111.389 170.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.18 -13.53 61.72 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.857 1.694 . . . . 1.0 113.782 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -88.16 155.89 19.53 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.062 1.431 . . . . 1.0 111.245 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.16 143.63 46.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.263 1.425 . . . . 1.0 113.187 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 126.385 1.874 . . . . 1.0 111.172 -172.45 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.2 t30 . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 115.268 1.581 . . . . 1.0 115.268 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.34 -32.04 62.21 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.695 -1.253 . . . . 1.0 113.945 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.49 -50.94 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.789 1.177 . . . . 1.0 110.876 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -64.1 -28.87 70.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.637 0.775 . . . . 1.0 112.488 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.31 -56.11 19.15 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.746 -0.596 . . . . 1.0 110.112 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.64 -30.34 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.0 p -66.43 -41.24 89.49 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.809 1.186 . . . . 1.0 112.344 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -63.22 -21.87 66.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.134 0.974 . . . . 1.0 112.806 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.0 mt -65.14 -32.93 74.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.515 1.052 . . . . 1.0 112.14 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -84.26 -55.05 4.38 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.58 0.752 . . . . 1.0 111.055 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.95 -34.71 77.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 -170.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.085 0 C-N-CA 126.2 1.857 . . . . 1.0 114.184 -178.141 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 111.795 0.295 . . . . 1.0 111.795 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.31 162.39 28.46 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.162 0.985 . . . . 1.0 112.397 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -66.79 143.05 97.86 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.674 0.79 . . . . 1.0 112.678 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.23 -21.77 10.26 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.309 2.672 . . . . 1.0 113.538 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -128.94 162.87 26.56 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.606 1.562 . . . . 1.0 110.998 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -79.06 156.56 28.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.506 0.722 . . . . 1.0 111.389 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -134.75 131.3 20.07 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.7 1.2 . . . . 1.0 109.445 169.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.4 143.56 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.708 2.939 . . . . 1.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -125.0 160.41 54.54 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.61 1.964 . . . . 1.0 111.849 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.77 129.31 11.74 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 124.082 3.188 . . . . 1.0 112.786 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.5 -11.3 72.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.323 1.44 . . . . 1.0 114.924 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.77 137.64 57.91 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.125 1.463 . . . . 1.0 112.958 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.15 118.2 24.57 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.558 1.143 . . . . 1.0 108.348 171.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mm -93.95 127.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -108.29 117.14 33.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.246 2.219 . . . . 1.0 107.611 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mt -115.1 129.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.386 1.474 . . . . 1.0 109.052 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.82 105.0 14.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.442 1.497 . . . . 1.0 109.843 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -85.61 -178.88 6.77 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.59 1.556 . . . . 1.0 110.474 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -70.81 102.3 2.31 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.297 -0.877 . . . . 1.0 110.182 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.26 3.29 90.6 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.972 1.273 . . . . 1.0 115.837 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -150.77 160.83 43.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.645 1.578 . . . . 1.0 112.545 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -116.78 157.49 25.44 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.26 1.024 . . . . 1.0 111.669 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -147.66 161.31 41.43 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.075 1.35 . . . . 1.0 111.512 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -136.54 154.95 50.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.422 1.267 . . . . 1.0 114.422 -173.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.29 159.63 43.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.495 1.518 . . . . 1.0 112.744 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.43 114.88 29.5 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.076 1.75 . . . . 1.0 108.709 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -82.67 131.69 35.2 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.062 -1.024 . . . . 1.0 112.183 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 pt -112.86 -0.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -170.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.28 165.61 27.62 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 124.602 1.096 . . . . 1.0 113.164 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.3 t70 60.51 20.47 10.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.834 1.654 . . . . 1.0 114.079 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.54 0.27 79.47 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.637 1.589 . . . . 1.0 114.624 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.98 152.45 18.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.751 . . . . 1.0 114.16 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.3 155.09 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.664 1.586 . . . . 1.0 111.111 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.3 137.33 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.54 1.536 . . . . 1.0 107.219 169.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -153.07 159.34 42.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.143 0.977 . . . . 1.0 111.313 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -95.6 127.34 41.55 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.41 129.54 74.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 117.639 -1.172 . . . . 1.0 109.202 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.12 148.79 45.09 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.763 2.309 . . . . 1.0 111.944 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -89.52 -167.98 0.3 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.355 3.37 . . . . 1.0 111.622 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.9 t -148.4 -176.39 5.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.744 1.218 . . . . 1.0 112.002 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.47 7.46 44.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.682 1.993 . . . . 1.0 112.567 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . 0.333 1.8 t80 -37.29 -50.64 2.42 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 119.905 3.298 . . . . 1.0 119.905 -168.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.65 -14.59 42.44 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.226 2.617 . . . . 1.0 114.14 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.78 22.84 9.76 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.9 1.714 . . . . 1.0 113.099 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.3 146.41 23.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.529 1.165 . . . . 1.0 111.985 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.16 129.36 45.76 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.945 0.783 . . . . 1.0 113.794 -169.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t 76.78 -2.07 2.75 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.989 2.116 . . . . 1.0 113.441 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -123.08 174.09 7.44 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.614 1.566 . . . . 1.0 112.731 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -154.11 -174.17 4.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 1.0 110.395 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.39 -21.53 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.738 1.385 . . . . 1.0 114.738 -171.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -85.48 -21.54 28.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.619 1.167 . . . . 1.0 113.363 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 p -121.2 -13.27 8.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.683 1.593 . . . . 1.0 114.295 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.67 144.03 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.169 1.788 . . . . 1.0 109.881 170.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.6 mt -80.4 174.48 11.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.229 1.014 . . . . 1.0 112.811 -173.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.5 p -85.0 178.29 7.63 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.364 1.066 . . . . 1.0 113.713 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -148.73 176.09 10.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.692 1.597 . . . . 1.0 110.602 172.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.3 p -162.72 163.47 26.85 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.958 -1.089 . . . . 1.0 112.74 171.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.58 153.41 21.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.449 1.099 . . . . 1.0 109.445 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -146.41 138.32 24.86 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.832 -0.542 . . . . 1.0 110.292 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -77.6 129.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.29 161.49 35.65 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.728 1.611 . . . . 1.0 112.004 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -117.4 129.47 55.87 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.104 1.762 . . . . 1.0 110.281 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -148.37 173.9 12.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.656 1.183 . . . . 1.0 111.291 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.79 142.66 49.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.624 0.77 . . . . 1.0 110.661 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.34 -51.0 61.2 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.389 1.076 . . . . 1.0 111.826 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.06 -48.01 71.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.168 0.987 . . . . 1.0 110.988 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.86 -39.21 93.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.982 0.513 . . . . 1.0 111.877 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.57 -46.44 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.432 1.093 . . . . 1.0 112.065 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.71 -35.36 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.389 0.995 . . . . 1.0 113.05 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.33 -124.14 35.01 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.421 1.009 . . . . 1.0 111.797 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.02 -7.2 84.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.383 0.992 . . . . 1.0 114.812 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.07 148.44 41.9 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 1.0 111.634 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -76.54 161.94 28.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.738 0.815 . . . . 1.0 110.978 171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -157.19 160.45 38.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -144.01 163.51 33.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.769 2.028 . . . . 1.0 110.844 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.99 129.94 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 168.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -147.85 83.69 1.52 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.91 0.862 . . . . 1.0 111.914 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -80.81 54.65 2.2 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.998 1.319 . . . . 1.0 112.66 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.1 m -60.54 -31.89 70.96 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.734 -1.229 . . . . 1.0 113.271 -171.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -68.57 -11.37 59.89 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.932 1.086 . . . . 1.0 113.932 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.07 -28.06 67.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.999 0.818 . . . . 1.0 112.968 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -80.35 -14.56 58.25 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.244 1.418 . . . . 1.0 112.185 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -101.33 -46.83 4.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.396 1.478 . . . . 1.0 111.863 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.02 167.09 13.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.499 1.519 . . . . 1.0 113.464 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -66.23 161.63 55.21 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.682 1.193 . . . . 1.0 111.87 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.9 87.96 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.174 2.582 . . . . 1.0 110.761 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.59 151.15 96.76 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.681 1.192 . . . . 1.0 111.428 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.37 116.42 4.69 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.567 2.845 . . . . 1.0 110.093 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.28 -31.81 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.34 -36.07 77.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.065 0.395 . . . . 1.0 112.065 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.0 t -76.57 -32.19 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.323 0.649 . . . . 1.0 111.211 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.91 -46.43 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 119.265 0.939 . . . . 1.0 110.155 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.15 -38.01 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 1.0 111.531 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.0 m -64.9 -38.28 90.45 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.92 0.782 . . . . 1.0 111.14 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.0 m -63.73 -43.71 95.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.941 0.897 . . . . 1.0 111.306 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.04 -50.41 72.81 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.294 0.637 . . . . 1.0 110.662 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.78 -40.7 96.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.219 1.008 . . . . 1.0 112.903 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -66.55 -32.97 74.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.855 0.862 . . . . 1.0 112.388 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.6 -39.21 64.78 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.187 -0.911 . . . . 1.0 112.595 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.2 127.24 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.674 1.125 . . . . 1.0 111.406 172.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.13 63.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.927 1.727 . . . . 1.0 114.017 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -84.89 143.3 29.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.024 1.412 . . . . 1.0 111.306 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -97.32 159.01 15.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.618 1.567 . . . . 1.0 113.501 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.4 mtt -137.85 164.88 27.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.657 1.983 . . . . 1.0 110.347 172.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.29 -174.46 0.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 116.065 1.876 . . . . 1.0 116.065 -169.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -68.06 -172.37 0.29 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.627 1.971 . . . . 1.0 113.674 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.8 p -32.24 -42.18 0.06 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 127.091 2.156 . . . . 1.0 115.235 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 pp -56.07 -11.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 115.758 1.762 . . . . 1.0 115.758 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.3 m -67.22 -21.88 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 120.073 1.306 . . . . 1.0 112.443 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.8 t 57.32 -144.41 0.64 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.324 1.449 . . . . 1.0 111.743 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -60.84 112.59 2.1 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.84 -1.163 . . . . 1.0 109.728 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -142.57 -17.5 0.7 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.723 1.749 . . . . 1.0 115.723 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 25.4 p -68.97 -38.75 79.56 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 121.199 1.818 . . . . 1.0 112.912 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -43.61 93.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.608 0.763 . . . . 1.0 111.018 170.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -61.37 -39.55 91.05 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.427 -0.796 . . . . 1.0 111.77 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.1 -59.78 4.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.196 0.999 . . . . 1.0 110.797 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.28 -21.19 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 119.769 1.168 . . . . 1.0 113.425 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.5 m -64.0 -49.69 71.47 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.818 1.247 . . . . 1.0 111.038 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -61.35 -25.2 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.521 0.728 . . . . 1.0 112.74 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.43 -35.16 80.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.996 0.816 . . . . 1.0 113.076 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -94.03 -40.77 9.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.117 0.967 . . . . 1.0 112.297 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.47 -44.65 78.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.894 0.877 . . . . 1.0 112.29 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.9 32.33 6.45 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.229 1.871 . . . . 1.0 113.639 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.32 -48.62 71.14 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.528 1.131 . . . . 1.0 112.372 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.378 1.871 . . . . 1.0 113.09 -177.799 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 110.772 -0.085 . . . . 1.0 110.772 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.57 164.49 26.58 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.213 1.005 . . . . 1.0 113.14 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.9 m -65.45 147.93 98.35 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.116 0.966 . . . . 1.0 112.605 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.53 133.17 33.48 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.971 2.448 . . . . 1.0 110.726 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.54 -7.2 59.57 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.047 0.758 . . . . 1.0 113.047 -175.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -157.25 137.83 13.07 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.364 1.866 . . . . 1.0 109.121 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.12 138.57 27.75 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.484 1.113 . . . . 1.0 110.626 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.02 153.23 22.03 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.828 3.019 . . . . 1.0 113.003 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.91 162.94 50.64 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.331 1.852 . . . . 1.0 112.841 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -45.36 128.51 10.14 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 124.387 3.392 . . . . 1.0 113.509 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 -3.74 85.66 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.232 1.396 . . . . 1.0 115.204 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -70.04 143.43 52.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.636 . . . . 1.0 113.382 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.57 127.48 34.91 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.612 1.165 . . . . 1.0 108.594 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mt -117.07 127.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.722 0.809 . . . . 1.0 109.523 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -89.46 134.24 34.18 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.936 1.294 . . . . 1.0 108.169 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.66 119.49 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.877 1.271 . . . . 1.0 108.375 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -90.55 59.83 4.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.009 1.324 . . . . 1.0 110.985 -171.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -67.02 156.46 35.98 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.535 1.134 . . . . 1.0 111.396 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.0 tp -56.88 138.48 53.62 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.851 1.26 . . . . 1.0 111.565 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.42 -54.2 4.93 Favored Glycine 0 N--CA 1.473 1.144 0 C-N-CA 125.21 1.386 . . . . 1.0 112.996 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -147.28 142.63 27.38 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.724 1.61 . . . . 1.0 112.445 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.22 148.58 44.27 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.702 0.801 . . . . 1.0 110.99 170.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -124.18 165.42 17.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.169 1.788 . . . . 1.0 109.14 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -133.86 148.63 51.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.313 -0.867 . . . . 1.0 112.841 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.36 151.49 40.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.235 1.014 . . . . 1.0 112.93 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.16 116.97 32.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.562 1.945 . . . . 1.0 108.306 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.3 133.04 35.22 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.135 -0.978 . . . . 1.0 112.356 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 pt -114.74 2.79 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 115.147 1.536 . . . . 1.0 115.147 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 166.63 32.86 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.353 0.978 . . . . 1.0 112.807 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.64 17.73 9.96 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.921 1.688 . . . . 1.0 114.143 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.57 80.95 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 125.11 1.338 . . . . 1.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -95.11 153.85 17.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.641 1.721 . . . . 1.0 114.672 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.59 158.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.031 1.732 . . . . 1.0 111.125 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.89 137.85 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 126.051 1.74 . . . . 1.0 106.718 168.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -154.38 149.31 26.72 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.215 -0.928 . . . . 1.0 111.625 -168.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.0 tp -86.12 130.1 34.64 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.69 119.57 47.45 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 124.505 1.122 . . . . 1.0 110.47 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -60.28 168.72 5.92 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.151 3.234 . . . . 1.0 113.108 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.11 133.57 58.88 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.908 3.072 . . . . 1.0 112.588 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 p -83.63 -20.63 33.32 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.491 0.922 . . . . 1.0 113.491 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.6 159.61 3.62 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.604 2.362 . . . . 1.0 109.578 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 39.7 t80 -64.18 139.19 97.63 Favored Pre-proline 0 CA--C 1.559 1.29 0 O-C-N 121.401 -0.812 . . . . 1.0 112.135 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 42' ' ' TYR . 79.4 Cg_exo -60.42 -42.5 40.69 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.478 2.785 . . . . 1.0 115.303 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.15 -176.48 31.78 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 124.166 0.889 . . . . 1.0 113.519 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.53 60.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.645 0.609 . . . . 1.0 112.645 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.01 -141.52 15.63 Favored Glycine 0 C--N 1.344 1.023 0 C-N-CA 125.206 1.384 . . . . 1.0 112.421 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -63.31 -16.21 59.66 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.589 1.329 . . . . 1.0 114.589 -173.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -74.84 -27.46 60.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.134 0.974 . . . . 1.0 113.188 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.6 p -107.15 -50.04 3.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.609 1.164 . . . . 1.0 112.8 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t 73.09 -46.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 129.063 2.945 . . . . 1.0 112.426 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -72.55 -36.48 68.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.92 1.288 . . . . 1.0 113.666 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.8 p -87.16 1.0 54.4 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.517 1.302 . . . . 1.0 114.517 -170.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 m -68.25 147.13 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.147 0.979 . . . . 1.0 112.081 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.23 166.51 24.33 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.595 1.558 . . . . 1.0 110.929 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 m -68.91 148.04 50.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.865 0.866 . . . . 1.0 113.051 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -82.57 159.88 22.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.954 0.901 . . . . 1.0 112.135 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.9 p -158.28 151.0 22.35 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.314 1.046 . . . . 1.0 112.763 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -100.0 160.93 13.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.423 1.489 . . . . 1.0 110.06 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -132.36 140.98 48.73 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.433 -0.792 . . . . 1.0 110.813 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.12 126.89 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 170.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -132.66 163.28 29.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.38 1.472 . . . . 1.0 112.003 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -121.29 137.86 54.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.209 1.804 . . . . 1.0 110.393 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -163.46 178.69 7.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.079 1.351 . . . . 1.0 110.977 171.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.9 142.08 51.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.9 0.88 . . . . 1.0 111.115 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 tp -52.07 -52.0 54.02 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.371 1.068 . . . . 1.0 111.778 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -54.65 -47.92 72.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.074 0.95 . . . . 1.0 110.788 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.54 -39.21 93.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.985 0.514 . . . . 1.0 111.985 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.3 t -69.25 -44.99 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.724 1.21 . . . . 1.0 111.956 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.79 -36.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.48 1.036 . . . . 1.0 112.829 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.62 -119.55 18.72 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 119.499 1.045 . . . . 1.0 111.622 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.22 -3.86 86.9 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.543 1.068 . . . . 1.0 114.867 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.4 m -76.41 147.24 38.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.828 1.314 . . . . 1.0 111.429 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -78.84 166.28 22.6 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.175 0.59 . . . . 1.0 110.15 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -160.22 164.1 33.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.023 1.119 . . . . 1.0 114.023 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -156.38 158.54 37.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.956 1.303 . . . . 1.0 112.115 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.0 t -81.04 139.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.488 1.115 . . . . 1.0 108.657 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -150.88 80.55 1.33 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.22 1.008 . . . . 1.0 111.111 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.78 68.44 3.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.388 1.075 . . . . 1.0 111.124 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.3 p -64.65 -36.02 82.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.691 1.197 . . . . 1.0 113.331 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.57 -10.16 56.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.925 1.084 . . . . 1.0 113.925 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.15 -32.65 55.85 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.537 1.135 . . . . 1.0 112.181 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.13 -16.11 58.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.382 1.473 . . . . 1.0 112.877 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -103.79 -45.9 4.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.398 1.479 . . . . 1.0 112.185 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -128.67 162.55 27.08 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.133 1.373 . . . . 1.0 113.211 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -71.33 156.17 91.99 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.613 -0.68 . . . . 1.0 111.03 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -51.04 133.63 41.28 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.182 3.255 . . . . 1.0 113.508 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -98.66 153.8 37.76 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.359 1.464 . . . . 1.0 110.352 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.37 110.99 3.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.207 2.605 . . . . 1.0 110.749 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.42 -33.55 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.323 1.231 . . . . 1.0 114.323 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -37.98 84.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.134 0.425 . . . . 1.0 111.517 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.83 -36.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.523 0.729 . . . . 1.0 110.907 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -60.01 -48.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.589 0.631 . . . . 1.0 110.12 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.7 -39.47 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.083 0.953 . . . . 1.0 111.742 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -63.51 -38.28 90.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.567 1.076 . . . . 1.0 112.196 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -62.7 -45.6 92.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.501 -0.75 . . . . 1.0 111.021 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.26 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.434 0.693 . . . . 1.0 110.951 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.59 -39.48 91.35 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.925 0.89 . . . . 1.0 113.224 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.93 -34.01 77.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.785 0.834 . . . . 1.0 112.232 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.9 mmm -73.29 -40.64 64.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.349 -0.834 . . . . 1.0 112.649 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.07 128.36 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.483 1.038 . . . . 1.0 111.586 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.7 -14.06 63.38 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.569 1.556 . . . . 1.0 113.219 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -83.75 142.3 30.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.171 1.485 . . . . 1.0 111.242 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -95.32 147.2 23.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.164 1.385 . . . . 1.0 112.269 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 21.5 mmt -126.2 152.42 46.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.434 1.894 . . . . 1.0 110.237 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -61.77 157.76 17.25 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.709 -0.619 . . . . 1.0 112.668 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -61.61 135.62 57.71 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.469 -0.769 . . . . 1.0 112.258 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.6 m -106.93 -0.15 23.39 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -171.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.269 18.9 pt 58.1 -31.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 130.422 3.489 . . . . 1.0 116.382 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.18 150.43 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.942 2.497 . . . . 1.0 109.382 170.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.5 m -71.79 -7.79 50.34 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -53.52 -28.55 31.86 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -60.54 -18.48 52.64 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 113.893 1.072 . . . . 1.0 113.893 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.3 m -59.59 -30.29 68.56 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.576 -1.328 . . . . 1.0 112.661 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -58.72 -56.76 17.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.462 0.573 . . . . 1.0 109.834 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -56.06 -32.21 63.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.756 0.822 . . . . 1.0 112.698 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -63.27 -57.84 9.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.64 -0.662 . . . . 1.0 110.491 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.74 -29.09 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.0 p -67.72 -41.98 82.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.656 1.116 . . . . 1.0 111.884 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -63.09 -23.26 67.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.987 0.915 . . . . 1.0 112.933 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.54 -30.21 71.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.399 0.999 . . . . 1.0 112.342 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -92.37 -53.72 4.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.27 1.428 . . . . 1.0 111.446 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -69.02 -35.3 76.48 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.881 1.067 . . . . 1.0 113.881 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.23 23.22 37.2 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.142 1.829 . . . . 1.0 113.755 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.86 150.41 13.17 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 118.311 1.056 . . . . 1.0 112.719 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.512 1.925 . . . . 1.0 114.904 -175.115 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 119.024 -0.513 . . . . 1.0 110.993 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.64 167.62 29.91 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.459 1.503 . . . . 1.0 112.009 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 t -159.13 146.66 13.22 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.154 1.382 . . . . 1.0 111.101 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.02 150.25 65.76 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.554 2.836 . . . . 1.0 113.576 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -87.07 156.5 19.71 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.937 0.895 . . . . 1.0 112.37 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.24 140.96 56.05 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.194 -0.941 . . . . 1.0 110.528 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.75 133.04 20.88 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.331 1.053 . . . . 1.0 109.929 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.45 147.97 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.634 2.889 . . . . 1.0 111.927 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -122.68 162.44 38.48 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.191 1.796 . . . . 1.0 111.728 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.57 127.09 11.23 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.822 3.014 . . . . 1.0 113.254 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.16 -8.51 77.62 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-O 118.495 -1.169 . . . . 1.0 115.303 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.28 143.38 57.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.326 1.563 . . . . 1.0 113.468 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.32 125.22 34.57 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.207 1.403 . . . . 1.0 109.341 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.3 mm -102.86 131.67 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.489 -1.3 . . . . 1.0 107.489 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -108.88 129.63 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.832 1.653 . . . . 1.0 108.231 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mt -126.81 118.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.9 1.28 . . . . 1.0 109.339 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -88.7 64.68 7.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.391 1.476 . . . . 1.0 110.539 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -62.78 151.67 38.05 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.749 0.82 . . . . 1.0 110.488 169.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.4 tp -55.55 129.65 39.76 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.215 1.006 . . . . 1.0 110.729 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.17 -123.58 6.2 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -169.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -65.6 137.76 57.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.278 1.031 . . . . 1.0 112.852 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.67 161.17 18.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.702 0.801 . . . . 1.0 111.271 170.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.91 165.22 22.51 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.93 1.692 . . . . 1.0 109.668 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -141.5 164.18 30.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.755 0.822 . . . . 1.0 112.537 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.98 154.45 35.0 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.74 115.19 27.51 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.029 1.732 . . . . 1.0 107.158 169.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -81.43 128.68 34.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.304 -0.873 . . . . 1.0 111.868 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.68 4.64 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.617 1.34 . . . . 1.0 114.617 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.71 169.82 40.15 Favored Glycine 0 N--CA 1.475 1.266 0 C-N-CA 124.292 0.949 . . . . 1.0 112.393 -173.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.78 16.14 8.77 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.004 1.722 . . . . 1.0 114.075 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 2.97 83.17 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.282 1.42 . . . . 1.0 114.205 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -98.66 154.34 18.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.749 1.775 . . . . 1.0 114.236 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.92 155.71 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.643 1.577 . . . . 1.0 111.309 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.5 mt -115.72 137.83 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.734 1.614 . . . . 1.0 107.327 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.34 147.41 24.64 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.982 -1.074 . . . . 1.0 111.636 -168.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.0 tp -87.48 128.55 35.23 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.392 -0.966 . . . . 1.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.36 139.92 23.78 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.721 1.208 . . . . 1.0 110.878 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.13 161.06 45.74 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.07 2.514 . . . . 1.0 111.267 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.21 137.77 48.99 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.583 2.855 . . . . 1.0 111.416 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 p -82.92 -9.09 59.47 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -174.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -158.45 144.27 16.86 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.503 1.921 . . . . 1.0 109.253 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . 0.267 49.4 m-85 86.71 -9.82 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.264 0 N-CA-C 118.972 2.952 . . . . 1.0 118.972 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -70.28 148.85 62.58 Favored 'Trans proline' 0 C--N 1.362 1.258 0 CA-C-N 124.87 2.775 . . . . 1.0 110.961 176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.15 7.57 87.6 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.042 -0.865 . . . . 1.0 114.105 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.93 163.55 14.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.68 1.192 . . . . 1.0 113.12 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.7 -157.32 22.28 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.906 1.241 . . . . 1.0 112.645 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.5 m -74.33 -17.05 60.89 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.571 0.952 . . . . 1.0 113.571 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -86.11 -163.81 0.94 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.084 1.754 . . . . 1.0 112.298 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.9 t -147.79 176.7 9.91 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.325 -1.485 . . . . 1.0 111.215 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.5 m -59.57 -26.44 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.021 -1.049 . . . . 1.0 113.274 -173.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -75.59 -28.13 58.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.218 1.007 . . . . 1.0 112.713 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 p -107.42 -14.16 14.93 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.791 1.237 . . . . 1.0 114.114 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.25 149.46 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.921 1.288 . . . . 1.0 111.456 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.1 mt -124.88 151.84 44.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.744 1.218 . . . . 1.0 110.124 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.2 p -163.46 156.02 18.18 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.892 0.877 . . . . 1.0 112.099 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 78.77 157.0 0.16 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 128.133 2.573 . . . . 1.0 111.955 -172.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -77.41 149.01 35.18 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.429 1.27 . . . . 1.0 114.429 -171.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.1 153.43 19.37 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.738 1.615 . . . . 1.0 110.837 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.7 139.04 54.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.499 1.12 . . . . 1.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.53 125.9 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.827 0.739 . . . . 1.0 109.013 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.98 162.93 29.52 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.93 1.692 . . . . 1.0 111.807 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.65 140.81 50.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.722 1.609 . . . . 1.0 110.227 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -162.09 179.7 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.018 1.327 . . . . 1.0 111.076 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.9 145.21 48.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.947 0.899 . . . . 1.0 111.413 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -52.16 -53.56 41.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.631 1.172 . . . . 1.0 111.227 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.1 -43.77 74.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.471 1.109 . . . . 1.0 111.627 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -44.04 91.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.317 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.56 -42.6 72.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.38 1.072 . . . . 1.0 112.207 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.27 -3.02 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.74 128.93 48.1 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.493 1.044 . . . . 1.0 113.555 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.04 1.23 79.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.864 1.221 . . . . 1.0 114.839 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.3 m -125.66 158.14 35.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.026 1.73 . . . . 1.0 111.561 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.9 m -86.08 156.17 20.5 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -158.97 164.52 35.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.565 1.321 . . . . 1.0 114.565 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -161.3 163.35 30.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.37 1.468 . . . . 1.0 112.169 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.0 t -82.11 135.47 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 107.329 -1.36 . . . . 1.0 107.329 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -146.97 74.79 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.269 1.033 . . . . 1.0 111.215 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -77.94 57.97 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.543 1.537 . . . . 1.0 111.486 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 t -60.78 -40.32 92.12 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.515 -1.366 . . . . 1.0 112.498 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.5 mt -70.82 -10.28 59.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.56 -28.74 70.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.273 0.942 . . . . 1.0 112.58 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -84.08 -4.82 59.04 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.313 1.445 . . . . 1.0 111.825 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -103.67 -47.29 4.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.379 1.472 . . . . 1.0 111.698 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -129.49 150.68 50.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.101 1.36 . . . . 1.0 113.497 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -65.32 152.29 92.27 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.346 1.058 . . . . 1.0 111.382 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.94 133.69 23.93 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.039 2.493 . . . . 1.0 112.784 -170.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -83.74 160.62 58.17 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.555 . . . . 1.0 112.024 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.6 115.52 3.77 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.691 2.928 . . . . 1.0 110.045 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.96 -30.49 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -169.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.74 -35.08 77.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.201 0.601 . . . . 1.0 112.112 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.81 -37.88 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.65 -0.656 . . . . 1.0 110.576 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.3 mt -64.07 -48.67 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.397 0.679 . . . . 1.0 110.235 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -71.68 -41.02 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.32 1.048 . . . . 1.0 112.27 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.4 p -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.878 1.217 . . . . 1.0 111.81 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.2 m -61.39 -45.0 96.19 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.683 -0.636 . . . . 1.0 111.767 169.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.31 -48.71 78.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.797 0.726 . . . . 1.0 110.585 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.16 -40.46 96.07 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.082 0.953 . . . . 1.0 112.972 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.59 -32.34 73.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.678 0.791 . . . . 1.0 112.475 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.8 mmm -73.7 -37.95 65.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.835 0.854 . . . . 1.0 112.89 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.5 t -47.21 126.96 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.594 1.088 . . . . 1.0 111.372 170.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.56 61.24 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.895 1.712 . . . . 1.0 113.929 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.6 162.97 17.7 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.034 1.417 . . . . 1.0 111.403 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.63 160.85 27.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.373 1.469 . . . . 1.0 113.046 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.9 mtt -134.58 143.04 47.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.278 1.431 . . . . 1.0 112.182 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -77.71 166.79 22.54 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.894 1.277 . . . . 1.0 113.013 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -106.7 163.77 12.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.918 1.687 . . . . 1.0 112.718 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.6 m 71.01 -31.12 0.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 127.955 2.502 . . . . 1.0 114.071 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.6 tt -56.26 -34.9 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.771 2.028 . . . . 1.0 113.874 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.75 156.44 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 126.775 2.03 . . . . 1.0 109.723 172.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.7 p -83.39 -68.48 0.71 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.178 0.991 . . . . 1.0 112.758 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -83.31 51.87 2.08 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.629 1.572 . . . . 1.0 111.701 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -51.81 -40.0 59.69 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.641 1.576 . . . . 1.0 114.392 -170.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.25 -38.26 75.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.301 0.955 . . . . 1.0 113.352 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.63 -54.83 41.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 1.0 109.609 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -60.31 -29.08 68.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.643 0.777 . . . . 1.0 113.018 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.38 -59.88 3.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.39 -0.819 . . . . 1.0 109.928 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.63 -30.43 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.9 p -67.87 -44.48 76.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.577 1.081 . . . . 1.0 112.127 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.05 -25.16 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.068 0.947 . . . . 1.0 112.945 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.26 -29.14 67.34 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.216 0.916 . . . . 1.0 112.807 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -96.97 -53.71 3.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.629 1.172 . . . . 1.0 111.708 169.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -64.77 -28.85 69.86 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.207 1.188 . . . . 1.0 114.207 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.44 -4.21 86.96 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.944 0.783 . . . . 1.0 114.328 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -109.16 169.14 8.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.513 1.925 . . . . 1.0 111.859 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.389 1.876 . . . . 1.0 111.593 179.303 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 120.401 0.143 . . . . 1.0 110.975 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.5 160.76 30.51 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.199 1.0 . . . . 1.0 112.84 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 p -76.51 154.49 83.78 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.761 1.225 . . . . 1.0 112.762 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.7 162.81 37.05 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.502 2.801 . . . . 1.0 111.795 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -157.66 161.96 38.63 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.95 1.3 . . . . 1.0 111.323 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -72.01 151.33 43.27 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.56 -0.712 . . . . 1.0 111.699 171.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -116.81 130.28 24.68 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.552 1.141 . . . . 1.0 109.051 169.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.85 147.12 26.93 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.989 3.126 . . . . 1.0 111.376 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -127.29 156.11 75.33 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.187 1.795 . . . . 1.0 112.731 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.83 124.26 5.54 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.2 3.266 . . . . 1.0 113.677 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.11 -0.03 89.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.068 -1.407 . . . . 1.0 115.897 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.1 159.17 32.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.102 1.951 . . . . 1.0 114.241 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 124.67 34.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.615 1.166 . . . . 1.0 108.943 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.5 mt -100.34 124.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -88.68 116.33 26.86 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.52 129.86 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.165 0.986 . . . . 1.0 108.859 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -114.03 99.52 7.71 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.782 1.633 . . . . 1.0 108.997 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -84.92 175.06 9.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.212 1.405 . . . . 1.0 110.329 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.71 104.51 1.06 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.603 0.761 . . . . 1.0 109.877 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -0.32 89.28 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.112 1.339 . . . . 1.0 116.001 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -150.44 137.28 19.16 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.518 1.659 . . . . 1.0 113.762 -173.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.37 139.01 37.62 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.128 1.771 . . . . 1.0 110.77 172.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.19 127.52 18.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.494 1.517 . . . . 1.0 110.108 174.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 144.87 25.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.818 -1.176 . . . . 1.0 110.48 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.5 154.0 44.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.423 1.489 . . . . 1.0 112.064 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.18 112.39 24.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.36 1.464 . . . . 1.0 108.426 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -83.67 133.86 34.8 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.007 -1.058 . . . . 1.0 112.091 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 38.7 pt -110.04 15.55 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -170.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -27.34 10.66 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 116.388 1.315 . . . . 1.0 116.388 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.44 13.13 26.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.359 1.063 . . . . 1.0 113.691 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.82 -4.6 83.5 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.704 1.145 . . . . 1.0 112.483 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -96.66 155.46 16.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.58 1.552 . . . . 1.0 112.906 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.82 152.69 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.601 1.56 . . . . 1.0 110.26 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.7 mt -117.83 138.11 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.14 1.376 . . . . 1.0 108.048 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -161.62 168.76 22.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.024 0.929 . . . . 1.0 110.463 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.3 tp -89.69 150.87 22.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.67 119.64 28.08 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.871 1.268 . . . . 1.0 108.662 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.47 159.97 28.88 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.042 2.494 . . . . 1.0 111.753 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.81 116.42 4.56 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.456 2.771 . . . . 1.0 110.382 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.3 p -83.65 -20.88 32.82 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -94.18 20.52 7.93 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.651 1.58 . . . . 1.0 112.159 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -55.8 132.04 72.75 Favored Pre-proline 0 CA--C 1.555 1.136 0 O-C-N 120.692 -1.255 . . . . 1.0 112.421 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.11 131.31 15.25 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.195 2.597 . . . . 1.0 111.459 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.58 7.58 24.28 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-O 118.91 -0.939 . . . . 1.0 115.252 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.62 128.98 38.07 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.879 1.339 . . . . 1.0 112.432 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.04 -40.22 10.68 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 123.907 0.765 . . . . 1.0 113.735 -170.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 p -68.26 -30.88 70.02 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.207 1.003 . . . . 1.0 113.416 -175.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.6 p -93.15 -1.29 56.5 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.108 1.363 . . . . 1.0 113.13 172.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 m 66.59 8.26 5.71 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.657 1.983 . . . . 1.0 114.127 175.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.07 -12.58 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.665 -1.272 . . . . 1.0 114.325 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -67.58 -23.53 65.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.508 0.723 . . . . 1.0 111.997 169.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.3 p -121.83 -37.49 2.86 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.037 1.335 . . . . 1.0 113.74 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.52 155.75 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.512 1.051 . . . . 1.0 111.845 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.4 mt 66.44 -166.13 0.22 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.265 1.826 . . . . 1.0 111.724 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.6 p -166.75 165.2 16.5 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.265 1.426 . . . . 1.0 112.279 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -136.57 175.02 9.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.943 1.697 . . . . 1.0 110.595 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -105.88 130.99 53.73 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.945 -1.097 . . . . 1.0 113.822 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.49 149.5 22.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.241 1.817 . . . . 1.0 109.036 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.26 143.29 49.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.293 0.951 . . . . 1.0 111.646 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.49 124.21 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.65 157.42 42.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.13 1.372 . . . . 1.0 112.742 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -117.81 134.37 54.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.306 1.842 . . . . 1.0 110.215 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -159.38 174.89 14.05 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.993 0.917 . . . . 1.0 110.406 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.2 mtp85 -64.68 145.07 56.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.74 0.816 . . . . 1.0 110.893 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt -51.54 -52.31 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.032 0.933 . . . . 1.0 110.675 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -50.6 -50.56 53.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.004 1.322 . . . . 1.0 111.601 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.48 -43.79 89.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.256 0.623 . . . . 1.0 112.052 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.84 -40.89 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.248 1.019 . . . . 1.0 112.142 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 p -80.46 -35.29 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.947 0.794 . . . . 1.0 112.846 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.77 -130.37 47.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.877 0.762 . . . . 1.0 112.406 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.8 5.14 83.62 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.88 1.229 . . . . 1.0 114.734 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.2 m -79.19 160.13 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.611 1.206 . . . . 1.0 112.16 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.83 155.66 27.74 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.079 0.952 . . . . 1.0 111.124 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.02 163.67 33.84 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.319 1.229 . . . . 1.0 114.319 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -158.66 158.51 33.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.818 1.647 . . . . 1.0 111.283 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.4 t -86.13 134.45 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.193 0.997 . . . . 1.0 108.503 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -163.06 93.52 0.8 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.838 0.855 . . . . 1.0 111.804 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.33 109.05 10.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.37 0.668 . . . . 1.0 110.793 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.6 p -76.54 -51.5 11.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.545 1.138 . . . . 1.0 111.939 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.76 -14.18 62.86 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.463 1.105 . . . . 1.0 113.906 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.56 -30.1 62.74 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.285 1.034 . . . . 1.0 112.197 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -89.49 -6.34 56.52 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.09 1.356 . . . . 1.0 112.534 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -100.43 -49.27 4.28 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.367 1.467 . . . . 1.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.0 170.26 14.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.817 1.647 . . . . 1.0 112.505 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.64 139.75 83.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 121.317 -0.865 . . . . 1.0 108.861 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.27 143.45 77.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.473 2.782 . . . . 1.0 112.427 -170.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -86.0 162.09 47.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.368 0.667 . . . . 1.0 111.121 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.49 117.87 4.82 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.465 2.777 . . . . 1.0 111.535 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.77 -33.13 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.332 0.864 . . . . 1.0 113.332 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.06 -37.68 85.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.961 0.504 . . . . 1.0 111.37 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -34.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.535 0.734 . . . . 1.0 110.929 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.96 -43.06 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.362 0.983 . . . . 1.0 110.862 174.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.48 -36.83 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.885 -1.134 . . . . 1.0 111.599 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 t -69.58 -39.86 77.09 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.455 -0.778 . . . . 1.0 111.391 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.8 p -65.53 -40.23 92.69 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.89 0.876 . . . . 1.0 111.25 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.22 -53.5 57.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 1.0 110.808 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.75 -41.23 90.54 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.561 0.744 . . . . 1.0 112.847 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -65.9 -35.36 80.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.022 0.929 . . . . 1.0 112.559 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.76 -29.72 51.15 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.042 -0.98 . . . . 1.0 113.347 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.5 t -48.03 125.41 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.477 1.489 . . . . 1.0 111.17 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.64 -13.28 62.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.448 1.499 . . . . 1.0 114.318 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -75.81 155.88 35.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.197 1.499 . . . . 1.0 110.896 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.97 148.13 45.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.868 1.267 . . . . 1.0 112.604 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.1 mmt -124.97 151.2 45.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.87 2.068 . . . . 1.0 110.499 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -72.73 153.04 41.34 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.591 -0.693 . . . . 1.0 111.435 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -151.82 136.74 17.24 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.753 1.221 . . . . 1.0 111.387 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.2 p -130.64 1.94 4.48 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.817 1.414 . . . . 1.0 114.817 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.27 16.9 pt 57.63 -31.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 130.004 3.321 . . . . 1.0 115.063 -169.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 99.2 t -67.81 -37.45 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.862 2.065 . . . . 1.0 110.377 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t -119.49 162.16 19.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.844 1.258 . . . . 1.0 111.511 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -146.15 145.59 30.54 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.651 1.58 . . . . 1.0 111.382 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -139.74 5.74 2.2 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 115.274 1.583 . . . . 1.0 115.274 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.0 m -59.25 -35.0 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.718 -1.239 . . . . 1.0 114.334 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -78.49 -49.19 13.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.149 1.379 . . . . 1.0 111.184 174.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -55.26 -35.04 64.58 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.244 1.017 . . . . 1.0 112.399 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -51.81 -51.5 55.99 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.641 -0.662 . . . . 1.0 112.494 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.35 -22.76 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.833 1.197 . . . . 1.0 113.557 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.5 p -74.79 -39.33 61.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.296 0.953 . . . . 1.0 110.922 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.97 -26.03 67.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.894 0.878 . . . . 1.0 113.127 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.05 -32.68 71.15 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 120.017 1.281 . . . . 1.0 113.247 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -89.62 -51.36 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.681 1.193 . . . . 1.0 110.978 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.21 -38.24 84.97 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.38 0.882 . . . . 1.0 113.38 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.74 38.54 3.27 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 126.962 2.22 . . . . 1.0 112.476 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.18 152.33 3.34 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.382 1.073 . . . . 1.0 112.877 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.905 1.682 . . . . 1.0 114.964 -172.765 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 120.24 0.067 . . . . 1.0 110.932 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.73 163.55 27.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.274 1.03 . . . . 1.0 112.922 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 m -66.2 148.25 98.53 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.998 0.919 . . . . 1.0 112.814 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.57 160.46 44.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.632 2.888 . . . . 1.0 111.677 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -76.92 -8.68 57.8 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.898 1.073 . . . . 1.0 113.898 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -158.5 146.44 18.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.954 1.702 . . . . 1.0 109.82 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.17 134.91 13.85 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.509 1.124 . . . . 1.0 109.778 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.24 143.3 22.25 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.55 2.834 . . . . 1.0 111.387 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -115.27 160.07 35.63 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.939 1.696 . . . . 1.0 112.003 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -56.47 131.18 44.17 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.694 1.596 . . . . 1.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.97 -3.41 80.79 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.977 1.275 . . . . 1.0 114.348 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.29 149.83 38.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.101 1.45 . . . . 1.0 112.949 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.68 124.62 35.23 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.596 1.159 . . . . 1.0 109.379 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.57 130.5 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -110.66 129.5 55.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.389 2.276 . . . . 1.0 107.961 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.9 mt -125.26 120.34 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.1 1.36 . . . . 1.0 109.466 -169.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -90.65 76.35 6.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.377 1.471 . . . . 1.0 109.669 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -76.72 168.42 20.11 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.219 1.008 . . . . 1.0 111.49 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.9 tp -61.44 133.46 55.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.902 0.881 . . . . 1.0 110.203 169.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.86 -132.25 11.08 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.599 -1.0 . . . . 1.0 110.599 -170.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -67.04 151.19 48.1 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.563 0.745 . . . . 1.0 112.937 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -67.12 165.99 14.82 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.994 1.318 . . . . 1.0 111.028 169.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -138.36 164.0 30.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.912 1.285 . . . . 1.0 111.272 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -141.71 153.66 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.257 -0.902 . . . . 1.0 113.286 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.07 154.87 39.9 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.751 1.22 . . . . 1.0 112.627 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.08 118.83 35.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.555 1.942 . . . . 1.0 108.443 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -82.06 130.56 35.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.186 -0.947 . . . . 1.0 112.156 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 pt -104.41 6.32 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 114.618 1.34 . . . . 1.0 114.618 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.99 -17.17 56.51 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 116.649 1.42 . . . . 1.0 116.649 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.13 13.67 26.49 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.813 1.245 . . . . 1.0 113.532 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -5.84 84.42 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.114 1.34 . . . . 1.0 112.305 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.61 156.53 16.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.867 1.667 . . . . 1.0 112.517 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -126.51 155.14 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.996 1.718 . . . . 1.0 109.888 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.54 138.47 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 168.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -159.86 175.55 12.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.324 1.05 . . . . 1.0 110.773 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.22 153.46 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.325 0.65 . . . . 1.0 109.263 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.68 113.23 66.01 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 168.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.15 148.96 56.58 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.619 2.879 . . . . 1.0 113.885 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.76 173.68 12.61 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.878 3.052 . . . . 1.0 112.257 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 t -149.25 167.6 25.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.536 1.535 . . . . 1.0 111.024 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.22 126.04 26.47 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.705 0.802 . . . . 1.0 111.16 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -68.25 141.39 93.73 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 112.683 0.623 . . . . 1.0 112.683 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -82.79 -171.12 1.06 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.495 3.464 . . . . 1.0 111.627 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.5 -15.08 60.36 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.124 1.345 . . . . 1.0 114.523 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.29 -31.29 58.14 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.323 1.049 . . . . 1.0 112.864 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.33 -155.01 16.02 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.025 1.774 . . . . 1.0 112.548 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.1 m -71.66 -26.74 62.66 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -78.78 143.42 36.11 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.559 1.144 . . . . 1.0 112.017 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.5 t -132.1 -172.84 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.119 1.367 . . . . 1.0 112.304 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.48 -20.59 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 120.607 -1.308 . . . . 1.0 113.115 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -81.62 -23.22 37.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.458 1.103 . . . . 1.0 112.404 171.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 m -79.08 -32.23 44.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.716 1.206 . . . . 1.0 111.585 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.8 p -148.62 112.2 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.409 1.084 . . . . 1.0 111.028 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.39 -35.05 21.59 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.689 0.796 . . . . 1.0 112.521 -171.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 t -76.8 111.72 12.63 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.658 -0.651 . . . . 1.0 110.301 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -128.36 -77.42 0.56 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.417 1.087 . . . . 1.0 109.864 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 p -70.84 168.62 16.41 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.4 1.08 . . . . 1.0 112.65 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.82 155.49 25.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.441 -0.787 . . . . 1.0 112.001 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -141.78 142.57 33.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.014 0.926 . . . . 1.0 110.86 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.12 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -137.92 162.07 34.99 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.171 1.388 . . . . 1.0 112.595 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.6 ttp85 -112.69 136.44 52.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.287 1.835 . . . . 1.0 110.029 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.58 173.85 16.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.502 1.121 . . . . 1.0 110.557 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -66.17 143.62 57.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.763 1.625 . . . . 1.0 110.441 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 tt -52.8 -55.83 20.15 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.165 0.986 . . . . 1.0 110.478 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -52.58 -47.53 66.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.606 1.163 . . . . 1.0 111.635 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.77 -41.5 99.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.862 0.465 . . . . 1.0 111.687 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.49 -44.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.109 0.963 . . . . 1.0 112.356 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -74.6 -32.73 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 119.402 1.001 . . . . 1.0 112.768 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.54 -134.21 52.49 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.142 0.877 . . . . 1.0 112.904 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.47 0.99 87.25 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.78 1.181 . . . . 1.0 114.47 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.5 m -81.92 148.1 28.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.916 1.286 . . . . 1.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.82 156.18 39.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.387 0.675 . . . . 1.0 110.962 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -156.98 162.6 39.6 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.533 1.309 . . . . 1.0 114.533 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -160.12 165.58 31.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.262 1.825 . . . . 1.0 111.414 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.0 t -84.56 140.14 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.174 0.99 . . . . 1.0 108.836 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -146.24 74.21 1.36 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.423 1.089 . . . . 1.0 111.762 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -76.04 70.25 2.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.487 1.115 . . . . 1.0 111.312 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -60.37 -33.72 72.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.859 -1.151 . . . . 1.0 113.376 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.6 mt -71.47 -9.74 58.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.28 -34.56 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.467 1.107 . . . . 1.0 112.181 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.274 1.43 . . . . 1.0 112.741 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -104.43 -47.82 4.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.263 1.425 . . . . 1.0 112.576 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -131.15 156.33 45.46 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.899 1.28 . . . . 1.0 113.532 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.62 155.37 92.53 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.192 -0.909 . . . . 1.0 110.021 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.63 129.76 36.69 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.763 2.976 . . . . 1.0 114.926 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 159.33 85.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.48 1.112 . . . . 1.0 111.704 169.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.43 109.91 2.96 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.462 2.775 . . . . 1.0 110.151 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 p -52.89 -37.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.176 1.547 . . . . 1.0 115.176 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.524 0.602 . . . . 1.0 111.598 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 t -75.85 -31.67 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.706 0.802 . . . . 1.0 110.931 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.1 mt -64.46 -49.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.732 1.151 . . . . 1.0 109.976 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.44 -40.27 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.373 1.069 . . . . 1.0 110.667 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.2 m -68.56 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.523 -0.736 . . . . 1.0 111.981 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.4 m -63.26 -44.08 96.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.696 1.198 . . . . 1.0 110.763 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.64 77.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.433 0.693 . . . . 1.0 111.051 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -61.84 -38.36 87.91 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.147 -0.971 . . . . 1.0 113.173 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -66.09 -34.16 77.43 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.609 0.764 . . . . 1.0 112.307 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.4 mmm -74.83 -37.9 62.16 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.316 -0.85 . . . . 1.0 112.872 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.7 t -47.09 129.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.711 1.142 . . . . 1.0 111.684 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -16.43 60.57 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.934 1.73 . . . . 1.0 114.068 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -83.01 148.88 27.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.047 1.424 . . . . 1.0 111.267 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.1 156.61 17.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.151 1.38 . . . . 1.0 113.372 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtt -140.23 167.73 21.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.934 1.694 . . . . 1.0 111.974 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -67.48 177.09 2.06 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.203 1.557 . . . . 1.0 115.203 -170.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.37 0.87 39.85 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.885 1.674 . . . . 1.0 115.114 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -55.89 120.88 8.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.779 1.232 . . . . 1.0 112.803 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.28 -10.65 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 116.051 1.871 . . . . 1.0 116.051 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 63.7 t -79.39 108.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 119.072 0.851 . . . . 1.0 109.083 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.3 m -63.73 -8.95 11.86 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.405 2.002 . . . . 1.0 116.405 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -60.56 -19.31 57.03 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.588 -1.32 . . . . 1.0 112.561 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -56.39 -28.47 59.37 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 120.354 -1.466 . . . . 1.0 112.474 169.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.8 m -69.56 -39.19 77.55 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.501 1.046 . . . . 1.0 112.85 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -57.57 -56.92 15.65 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.718 0.69 . . . . 1.0 109.255 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -58.61 -30.12 66.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.798 0.839 . . . . 1.0 113.128 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -67.23 -56.41 9.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.214 -0.928 . . . . 1.0 111.039 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.51 -26.12 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 -172.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.4 p -65.87 -44.65 84.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.703 1.138 . . . . 1.0 110.76 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.39 -24.57 66.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.339 0.866 . . . . 1.0 113.339 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.8 mt -61.77 -30.42 70.78 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.203 1.365 . . . . 1.0 112.835 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -94.06 -56.37 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.319 1.447 . . . . 1.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -65.98 -39.06 90.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.764 -1.21 . . . . 1.0 113.359 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.18 24.3 32.62 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.404 1.954 . . . . 1.0 113.42 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 150.04 5.02 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.26 1.024 . . . . 1.0 112.34 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.596 1.958 . . . . 1.0 115.459 -175.784 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 120.184 0.04 . . . . 1.0 111.003 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.59 164.83 26.12 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.107 0.963 . . . . 1.0 112.616 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.3 p -75.2 159.21 82.94 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.199 1.0 . . . . 1.0 112.893 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.76 145.81 94.77 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.763 2.975 . . . . 1.0 113.473 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -162.73 169.77 19.45 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.76 1.624 . . . . 1.0 110.851 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -75.57 148.05 39.17 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.25 -0.906 . . . . 1.0 112.287 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -137.61 126.69 14.93 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.206 1.402 . . . . 1.0 108.745 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.75 150.28 27.23 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.185 2.59 . . . . 1.0 112.441 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -126.44 158.92 65.62 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.138 1.775 . . . . 1.0 112.31 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -46.37 127.75 11.58 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.332 3.354 . . . . 1.0 113.083 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.56 -8.21 77.08 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.987 1.28 . . . . 1.0 115.126 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -67.55 143.55 56.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.251 1.525 . . . . 1.0 113.573 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.62 127.25 34.42 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.976 1.31 . . . . 1.0 108.155 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mt -112.63 131.19 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -102.85 138.77 39.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.558 1.143 . . . . 1.0 109.082 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.24 134.9 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.557 1.943 . . . . 1.0 108.396 -169.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -114.21 93.69 4.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.283 . . . . 1.0 109.243 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.2 mtt-85 -81.12 167.18 19.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.705 0.802 . . . . 1.0 110.463 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.15 105.4 0.59 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.635 0.774 . . . . 1.0 110.917 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.27 -3.27 84.06 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.232 1.396 . . . . 1.0 116.176 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -165.61 144.02 6.05 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.874 1.837 . . . . 1.0 114.941 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.18 159.73 24.53 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.652 1.581 . . . . 1.0 113.047 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -151.1 159.38 44.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.1 2.16 . . . . 1.0 109.034 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -138.92 160.49 39.61 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.676 -1.265 . . . . 1.0 112.252 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.95 152.83 33.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.729 0.812 . . . . 1.0 112.756 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.9 116.06 31.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.672 1.989 . . . . 1.0 106.995 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -82.24 129.67 34.9 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.59 -0.694 . . . . 1.0 111.91 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.92 4.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 -170.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.01 163.73 31.11 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 124.598 1.094 . . . . 1.0 113.08 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 t70 60.8 20.06 10.22 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.02 1.728 . . . . 1.0 114.312 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.7 71.68 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.551 1.548 . . . . 1.0 114.625 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.42 153.8 18.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.585 1.693 . . . . 1.0 113.951 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.4 157.76 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.58 1.552 . . . . 1.0 111.58 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.8 mt -121.0 141.07 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.754 1.622 . . . . 1.0 108.183 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -154.52 163.19 40.57 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.063 -1.023 . . . . 1.0 110.92 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.8 tp -104.92 119.41 38.95 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 1.0 108.752 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.78 135.59 30.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.174 -0.917 . . . . 1.0 110.11 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.56 161.47 44.0 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.933 2.422 . . . . 1.0 111.425 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.82 151.17 85.01 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.01 2.473 . . . . 1.0 113.244 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m -66.48 -24.34 66.4 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.375 0.88 . . . . 1.0 113.375 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -160.57 92.37 0.96 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.228 1.811 . . . . 1.0 108.954 171.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -65.76 159.98 64.91 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.402 1.481 . . . . 1.0 114.622 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.67 156.32 64.46 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.066 2.511 . . . . 1.0 110.843 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.38 86.5 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.093 -0.837 . . . . 1.0 114.921 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.27 -25.33 66.82 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 118.699 1.25 . . . . 1.0 112.851 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.19 18.99 40.66 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.847 1.213 . . . . 1.0 115.017 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -158.44 -111.88 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.438 1.119 . . . . 1.0 110.726 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 m -54.64 -19.52 6.26 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.686 1.594 . . . . 1.0 113.332 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.0 p -49.83 -36.51 26.89 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.569 1.548 . . . . 1.0 112.46 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.62 -17.35 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.555 1.07 . . . . 1.0 113.505 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -100.36 -43.78 6.13 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.789 1.235 . . . . 1.0 110.111 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.6 m -65.52 -17.37 64.51 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.937 1.088 . . . . 1.0 113.937 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -54.64 -22.61 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 120.396 1.453 . . . . 1.0 113.455 169.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.13 -12.21 59.99 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.41 1.084 . . . . 1.0 113.525 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 m -131.99 -35.81 1.21 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.857 1.428 . . . . 1.0 114.857 -169.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -74.57 150.27 39.78 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.261 0.937 . . . . 1.0 113.414 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.1 p -166.23 156.5 12.39 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.824 1.25 . . . . 1.0 111.992 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.13 145.83 24.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.151 0.98 . . . . 1.0 110.37 170.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.39 138.49 34.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.823 0.849 . . . . 1.0 111.412 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.74 129.03 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -134.98 156.46 49.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.675 1.59 . . . . 1.0 112.025 -173.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -117.8 140.11 50.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.062 1.745 . . . . 1.0 110.331 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -164.59 -179.97 6.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.561 1.144 . . . . 1.0 110.846 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.06 143.97 52.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.295 1.038 . . . . 1.0 110.476 170.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.7 tt -49.8 -56.87 8.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.912 1.285 . . . . 1.0 110.831 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.05 -49.17 63.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.509 1.124 . . . . 1.0 111.256 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.07 -34.05 76.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.33 0.652 . . . . 1.0 112.69 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.73 -45.58 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.903 0.881 . . . . 1.0 111.951 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -81.5 -32.97 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.516 1.053 . . . . 1.0 113.832 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.67 -123.64 32.37 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.54 1.063 . . . . 1.0 111.256 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.73 2.07 85.76 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.646 1.117 . . . . 1.0 114.719 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.12 147.49 34.6 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.723 1.261 . . . . 1.0 111.755 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 23.9 t -75.16 156.97 35.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.68 0.792 . . . . 1.0 110.952 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.93 161.82 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -161.06 160.17 30.16 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.708 1.603 . . . . 1.0 111.862 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.3 t -79.68 139.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.941 0.897 . . . . 1.0 109.334 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -149.26 79.06 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.439 1.096 . . . . 1.0 111.401 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.22 72.29 4.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.58 1.152 . . . . 1.0 110.89 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.9 p -67.85 -46.18 72.49 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.591 1.156 . . . . 1.0 112.79 -172.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.8 mt -75.58 -8.35 56.54 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -174.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.86 -27.46 68.14 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.96 0.886 . . . . 1.0 113.128 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -79.39 -15.4 57.91 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.429 1.492 . . . . 1.0 112.288 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -102.03 -39.93 7.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.556 1.543 . . . . 1.0 112.237 -174.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -126.98 160.7 30.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.732 1.613 . . . . 1.0 113.159 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -66.06 159.19 72.52 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.545 1.138 . . . . 1.0 111.342 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.43 127.03 19.79 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.667 2.245 . . . . 1.0 110.796 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -95.34 157.38 36.4 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.134 1.374 . . . . 1.0 110.181 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.51 111.2 2.9 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.86 2.373 . . . . 1.0 110.674 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.93 -32.52 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.612 1.165 . . . . 1.0 112.815 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.18 -36.81 75.97 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.049 0.54 . . . . 1.0 112.237 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.58 -37.81 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.817 0.847 . . . . 1.0 110.776 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.83 -48.69 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 1.0 110.156 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.7 mt -68.33 -39.27 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.258 1.023 . . . . 1.0 111.836 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -61.17 -42.87 99.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.419 1.009 . . . . 1.0 111.42 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 -43.67 98.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 1.0 111.756 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.11 73.93 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.328 -0.857 . . . . 1.0 110.746 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.13 -38.29 88.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.311 1.044 . . . . 1.0 113.203 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.97 -36.34 83.06 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.585 0.754 . . . . 1.0 112.117 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.0 mmm -73.22 -38.36 66.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.881 0.873 . . . . 1.0 112.752 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.95 129.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.167 0.894 . . . . 1.0 111.606 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.52 66.51 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.711 1.624 . . . . 1.0 113.479 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -87.14 145.38 26.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.961 1.38 . . . . 1.0 111.477 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -95.32 148.27 22.61 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.761 1.224 . . . . 1.0 112.399 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.8 mmt -128.48 176.26 7.88 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.522 1.529 . . . . 1.0 112.001 -173.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.94 162.97 8.29 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.601 1.161 . . . . 1.0 112.887 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -71.93 168.33 18.2 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.64 1.176 . . . . 1.0 113.94 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.3 t -148.21 140.14 23.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.828 1.251 . . . . 1.0 109.767 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.7 tt -118.57 43.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 125.866 1.666 . . . . 1.0 107.497 169.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 t 64.02 47.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.943 1.697 . . . . 1.0 108.042 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.2 p -120.09 12.44 11.9 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.564 1.546 . . . . 1.0 114.402 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 82.07 133.52 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 129.596 3.158 . . . . 1.0 111.551 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -177.57 -58.8 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.119 2.168 . . . . 1.0 111.391 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.99 -40.04 60.91 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.914 1.079 . . . . 1.0 113.914 -169.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -49.56 76.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.196 0.453 . . . . 1.0 110.18 170.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -61.52 -36.59 80.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.958 0.903 . . . . 1.0 111.814 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.05 -57.22 13.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.866 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.96 -28.13 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.828 1.194 . . . . 1.0 113.637 -173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.6 p -71.75 -39.72 69.82 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.846 1.203 . . . . 1.0 112.582 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -57.46 -26.62 61.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.812 0.845 . . . . 1.0 112.484 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.4 mt -62.31 -31.45 72.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.296 0.953 . . . . 1.0 112.719 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -88.75 -55.82 3.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.548 1.139 . . . . 1.0 111.18 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -65.37 -35.9 82.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -171.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.47 39.73 2.79 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.923 2.201 . . . . 1.0 112.282 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -42.93 -54.95 3.96 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.712 1.605 . . . . 1.0 115.171 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.253 1.271 0 C-N-CA 128.13 2.572 . . . . 1.0 114.584 -172.266 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 ttp . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 110.489 -0.189 . . . . 1.0 110.489 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.44 157.42 35.64 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.275 1.03 . . . . 1.0 112.966 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 p -80.96 152.29 71.48 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.355 1.062 . . . . 1.0 112.51 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.83 -23.4 5.64 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.28 2.653 . . . . 1.0 113.734 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -149.37 166.51 28.82 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.472 1.509 . . . . 1.0 111.501 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -70.82 127.38 32.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.292 1.437 . . . . 1.0 110.958 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.35 129.16 56.54 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 121.572 -0.705 . . . . 1.0 112.457 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -86.63 155.82 9.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.986 3.79 . . . . 1.0 112.471 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.09 168.3 17.24 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.812 2.045 . . . . 1.0 112.476 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -50.16 127.23 19.18 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.608 2.872 . . . . 1.0 113.402 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.5 -2.84 86.5 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.341 -1.255 . . . . 1.0 115.011 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -75.01 148.17 40.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.678 1.739 . . . . 1.0 113.011 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -93.96 129.89 40.26 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.203 1.401 . . . . 1.0 110.177 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.45 133.09 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.174 0.99 . . . . 1.0 108.94 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.49 128.34 52.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.683 1.593 . . . . 1.0 108.69 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.4 mt -130.29 124.17 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.65 1.18 . . . . 1.0 110.257 -169.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -90.59 89.11 7.4 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.172 1.389 . . . . 1.0 108.6 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -94.33 155.31 17.06 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.449 1.5 . . . . 1.0 111.037 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.47 118.05 5.17 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.914 0.886 . . . . 1.0 111.031 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.99 -9.89 72.75 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.029 -1.429 . . . . 1.0 115.568 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -170.51 142.89 2.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.648 1.724 . . . . 1.0 114.532 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.45 144.04 54.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.967 0.907 . . . . 1.0 110.024 169.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -141.79 152.53 43.81 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.577 1.151 . . . . 1.0 110.61 -172.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -140.24 148.94 42.25 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.301 -0.874 . . . . 1.0 111.811 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.66 149.79 36.28 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.532 0.938 . . . . 1.0 113.532 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.28 119.2 38.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.524 2.33 . . . . 1.0 107.484 169.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -82.58 132.81 35.19 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.058 -1.026 . . . . 1.0 112.137 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.69 2.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.102 1.519 . . . . 1.0 115.102 -170.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 169.86 38.81 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.265 0.936 . . . . 1.0 112.756 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.99 16.04 7.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.204 1.802 . . . . 1.0 114.031 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.02 2.99 73.85 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 124.997 1.284 . . . . 1.0 114.717 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -101.89 154.32 19.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.812 1.806 . . . . 1.0 114.454 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.65 153.76 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.588 1.555 . . . . 1.0 111.36 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.64 138.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 168.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -153.53 176.3 12.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.615 1.166 . . . . 1.0 109.85 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -126.53 122.0 33.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.119 0.872 . . . . 1.0 108.78 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.18 124.5 55.7 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 118.075 -0.964 . . . . 1.0 109.775 -173.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.91 158.28 34.47 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.272 2.648 . . . . 1.0 111.891 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.79 -31.41 95.07 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.532 2.821 . . . . 1.0 115.756 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.5 m 70.8 -22.2 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.23 2.212 . . . . 1.0 114.383 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -129.72 130.78 45.9 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.114 2.166 . . . . 1.0 107.909 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -125.99 157.35 69.65 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.37 1.068 . . . . 1.0 113.207 -169.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.46 164.5 28.55 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.705 2.936 . . . . 1.0 112.985 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.37 -107.5 1.16 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.917 1.246 . . . . 1.0 111.193 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.51 -13.43 62.32 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.54 -129.82 9.42 Favored Glycine 0 N--CA 1.47 0.904 0 C-N-CA 124.709 1.147 . . . . 1.0 112.04 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.6 p -60.11 -23.68 64.05 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.825 1.046 . . . . 1.0 113.825 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -68.52 -35.22 77.17 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.919 0.888 . . . . 1.0 112.994 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -105.15 -25.16 12.6 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.341 14.4 m 59.13 18.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 128.653 2.781 . . . . 1.0 114.206 -169.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -68.05 120.44 14.29 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.608 0.763 . . . . 1.0 110.069 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.0 m 70.07 -26.55 0.16 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 127.315 2.246 . . . . 1.0 115.136 170.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.75 -23.26 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 120.094 1.315 . . . . 1.0 113.357 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.89 -3.86 52.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.807 1.243 . . . . 1.0 113.101 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -135.48 -49.45 0.72 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -72.18 144.84 48.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -172.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 p -165.0 156.13 14.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.585 1.154 . . . . 1.0 112.2 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.08 150.8 21.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.899 0.88 . . . . 1.0 109.525 169.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -150.08 139.99 21.9 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.417 -0.802 . . . . 1.0 111.376 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.71 124.63 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.83 159.16 39.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.073 1.749 . . . . 1.0 112.77 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ttm105 -112.71 143.56 43.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.684 1.594 . . . . 1.0 110.245 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.86 176.77 9.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.351 1.46 . . . . 1.0 109.564 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -71.67 143.61 49.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.575 1.55 . . . . 1.0 110.008 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.91 -56.82 7.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.891 1.276 . . . . 1.0 110.275 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -53.56 -45.6 69.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.6 1.16 . . . . 1.0 111.812 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.99 -45.1 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.746 0.418 . . . . 1.0 111.297 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.63 -43.17 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.841 0.856 . . . . 1.0 111.745 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.47 -0.5 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.69 121.62 25.57 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.177 0.894 . . . . 1.0 111.306 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 10.99 85.92 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.294 0.95 . . . . 1.0 114.343 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 m -125.52 165.63 18.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.653 1.581 . . . . 1.0 112.413 -173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.6 m -111.98 150.94 29.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.193 1.397 . . . . 1.0 108.183 168.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.9 153.18 30.7 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.291 1.96 . . . . 1.0 116.291 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -132.31 151.51 51.81 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.379 2.271 . . . . 1.0 109.734 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.92 133.52 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.945 1.298 . . . . 1.0 107.625 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.94 85.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.058 0.932 . . . . 1.0 113.262 -169.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -79.11 46.99 0.75 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.203 1.401 . . . . 1.0 112.18 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.2 m -62.0 -24.43 67.04 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.593 -1.317 . . . . 1.0 113.293 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -61.99 -14.88 39.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.47 -33.81 46.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.917 1.287 . . . . 1.0 112.417 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -97.05 5.67 49.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.898 0.879 . . . . 1.0 113.222 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.32 -49.97 3.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.398 1.479 . . . . 1.0 111.204 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -126.52 167.46 15.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.802 1.641 . . . . 1.0 112.877 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -71.0 155.12 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 121.434 -0.791 . . . . 1.0 111.13 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.71 135.89 71.64 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.852 3.034 . . . . 1.0 113.075 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -113.39 148.28 39.29 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.27 1.428 . . . . 1.0 109.753 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.66 122.26 7.24 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.41 2.74 . . . . 1.0 111.536 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.28 -32.61 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.717 1.207 . . . . 1.0 113.198 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.39 -36.22 79.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.749 0.704 . . . . 1.0 112.061 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.27 -34.17 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.227 0.611 . . . . 1.0 111.065 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -64.66 -47.6 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.541 0.61 . . . . 1.0 110.049 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.02 -38.34 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.126 0.971 . . . . 1.0 111.399 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -41.38 96.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.928 0.786 . . . . 1.0 111.842 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.5 t -64.21 -42.36 96.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.738 0.815 . . . . 1.0 111.197 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.7 -48.39 77.81 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.212 -0.93 . . . . 1.0 110.855 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.91 -22.21 65.96 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.434 1.494 . . . . 1.0 114.529 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.5 -40.06 30.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.449 1.1 . . . . 1.0 111.621 170.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.6 mmm -75.45 -38.13 59.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.336 1.055 . . . . 1.0 112.688 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.71 135.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.186 0.81 . . . . 1.0 113.186 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.44 -16.17 61.68 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.806 1.67 . . . . 1.0 113.826 -174.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -84.04 146.9 27.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.154 1.477 . . . . 1.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.49 156.67 16.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.521 1.529 . . . . 1.0 112.271 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 47.0 mtt -144.06 164.93 29.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.264 1.426 . . . . 1.0 112.376 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -72.75 162.53 29.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.447 1.099 . . . . 1.0 112.431 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -130.09 14.62 5.71 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.61 1.564 . . . . 1.0 113.965 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.8 m -57.83 124.66 19.97 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.355 1.062 . . . . 1.0 111.759 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.37 21.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 116.822 2.156 . . . . 1.0 116.822 -169.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.99 -34.73 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.33 1.452 . . . . 1.0 111.187 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.8 t -162.85 157.56 21.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.339 1.456 . . . . 1.0 110.549 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -76.52 113.79 14.52 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.709 0.804 . . . . 1.0 110.592 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -66.88 -48.84 67.52 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.549 -0.72 . . . . 1.0 112.275 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.3 m -55.26 -43.92 75.09 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.397 1.629 . . . . 1.0 115.397 -169.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.36 -41.2 96.85 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.552 0.614 . . . . 1.0 111.685 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -69.44 -37.05 77.2 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.257 -0.902 . . . . 1.0 110.851 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.11 -58.2 9.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.429 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.74 -25.35 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.914 1.234 . . . . 1.0 112.263 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -63.85 -48.76 75.46 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.157 0.983 . . . . 1.0 111.461 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -61.6 -27.59 68.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.583 1.153 . . . . 1.0 112.986 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.2 -34.41 72.13 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.598 1.09 . . . . 1.0 112.946 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.9 ttm105 -94.36 -51.15 4.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.605 1.162 . . . . 1.0 111.717 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.43 -29.96 70.21 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.115 -0.991 . . . . 1.0 113.665 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.59 -2.44 85.07 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.945 1.26 . . . . 1.0 114.3 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -63.1 -48.34 78.99 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.979 1.389 . . . . 1.0 111.252 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 C--O 1.255 1.352 0 C-N-CA 126.916 2.087 . . . . 1.0 113.773 -174.347 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 120.282 0.087 . . . . 1.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.51 160.48 31.63 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.171 0.989 . . . . 1.0 112.394 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 t -162.1 143.25 8.11 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.307 1.043 . . . . 1.0 111.882 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.46 172.45 16.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.56 2.84 . . . . 1.0 111.79 174.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 67.28 14.23 9.64 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.788 1.635 . . . . 1.0 114.449 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -65.87 133.98 52.07 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.219 -0.926 . . . . 1.0 110.825 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -80.04 130.63 65.74 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.753 -0.641 . . . . 1.0 110.042 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.84 148.3 25.16 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.072 2.514 . . . . 1.0 112.269 -177.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -121.12 161.05 42.68 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.302 1.841 . . . . 1.0 111.346 171.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.59 132.07 49.91 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.431 2.088 . . . . 1.0 110.815 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.09 -1.39 73.76 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.322 -1.266 . . . . 1.0 114.835 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -76.53 149.38 36.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.442 1.621 . . . . 1.0 113.283 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.59 128.72 37.53 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.58 1.152 . . . . 1.0 108.93 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.4 mt -109.16 131.14 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -99.62 133.79 43.45 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.904 1.681 . . . . 1.0 108.231 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.8 mt -122.11 120.33 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.732 1.613 . . . . 1.0 108.322 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -93.45 81.26 4.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.152 1.381 . . . . 1.0 109.793 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.1 mtt-85 -77.24 168.27 20.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.192 0.597 . . . . 1.0 111.048 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.66 144.41 56.32 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.57 0.748 . . . . 1.0 110.749 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.28 -66.03 3.88 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.854 1.216 . . . . 1.0 112.563 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -146.94 153.61 40.3 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.368 1.867 . . . . 1.0 112.836 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -72.34 163.94 27.13 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.614 1.566 . . . . 1.0 112.72 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -142.55 174.08 10.96 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.212 1.405 . . . . 1.0 111.492 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.12 158.3 44.27 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 154.89 39.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.973 1.309 . . . . 1.0 112.694 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.77 120.61 36.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.172 1.789 . . . . 1.0 108.135 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -82.97 134.92 35.04 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.903 -1.123 . . . . 1.0 112.229 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.1 pt -118.73 4.33 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 -171.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 168.34 37.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.348 0.975 . . . . 1.0 112.861 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t70 62.91 16.1 8.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.125 1.77 . . . . 1.0 113.899 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 -0.98 81.07 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.121 1.343 . . . . 1.0 114.478 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -96.43 154.56 17.2 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.396 1.598 . . . . 1.0 114.366 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.86 159.5 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.104 1.762 . . . . 1.0 111.02 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -120.18 137.4 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 106.651 -1.611 . . . . 1.0 106.651 168.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.57 174.95 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.214 1.006 . . . . 1.0 110.552 -169.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.14 151.92 20.78 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.965 -0.459 . . . . 1.0 110.033 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.93 106.86 58.67 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 168.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -59.69 162.01 16.58 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.712 2.941 . . . . 1.0 114.069 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.49 148.9 90.72 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.589 2.859 . . . . 1.0 111.972 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 p -78.56 -19.69 52.27 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.17 0.804 . . . . 1.0 113.17 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 74.26 -58.95 0.57 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.924 2.89 . . . . 1.0 110.838 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -117.83 99.36 52.13 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.959 1.703 . . . . 1.0 110.002 169.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.6 144.36 66.15 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.475 3.45 . . . . 1.0 113.043 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.02 -162.47 52.77 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.432 1.015 . . . . 1.0 115.214 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.65 11.86 35.6 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.446 1.498 . . . . 1.0 113.818 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.27 5.14 62.29 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.984 1.278 . . . . 1.0 114.403 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.9 t -80.0 -156.44 0.12 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.437 1.095 . . . . 1.0 110.994 170.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 m -51.22 -25.82 6.14 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.045 1.738 . . . . 1.0 115.208 -172.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 m -60.25 -19.44 54.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.988 1.315 . . . . 1.0 113.748 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 p -57.01 -23.62 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.168 1.387 . . . . 1.0 113.305 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -55.08 -31.31 61.09 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.395 1.078 . . . . 1.0 112.731 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.5 m -94.23 10.39 34.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.366 1.066 . . . . 1.0 113.762 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.8 t -54.73 125.8 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.567 1.147 . . . . 1.0 110.503 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.0 mt 65.14 -25.45 0.09 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.81 2.844 . . . . 1.0 114.634 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.5 m -73.88 -18.52 60.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.109 1.363 . . . . 1.0 113.657 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -64.72 156.41 30.52 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.291 1.436 . . . . 1.0 113.806 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -134.98 171.68 14.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.052 1.341 . . . . 1.0 112.223 -172.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.89 163.7 24.13 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.599 -0.688 . . . . 1.0 111.174 171.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.87 145.15 49.39 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.765 0.826 . . . . 1.0 110.973 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -75.72 127.93 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -137.62 161.69 35.79 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.669 1.188 . . . . 1.0 112.711 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -115.51 138.89 50.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.814 2.046 . . . . 1.0 110.138 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.09 176.93 8.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.991 1.316 . . . . 1.0 110.361 170.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -67.64 142.11 56.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.086 1.754 . . . . 1.0 110.377 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.7 tp -51.9 -52.54 49.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.975 0.91 . . . . 1.0 111.711 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -55.36 -47.51 75.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.165 0.986 . . . . 1.0 111.153 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.38 -39.61 94.99 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.783 0.433 . . . . 1.0 111.94 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.69 -45.39 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.545 1.138 . . . . 1.0 111.583 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.37 -35.36 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.716 1.144 . . . . 1.0 112.834 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.78 -124.16 32.13 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.331 0.969 . . . . 1.0 111.533 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.08 -0.19 87.25 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.601 1.096 . . . . 1.0 114.623 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.52 148.61 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.648 1.179 . . . . 1.0 110.974 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.95 165.92 23.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.438 0.695 . . . . 1.0 111.318 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -161.45 164.95 29.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -160.34 161.0 33.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.535 1.534 . . . . 1.0 112.015 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.03 131.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -140.68 60.3 1.53 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.744 1.259 . . . . 1.0 109.842 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.65 67.55 8.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.311 1.445 . . . . 1.0 111.577 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 p -68.48 -21.31 64.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.314 1.445 . . . . 1.0 114.463 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.1 mt -65.78 -14.07 60.65 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.674 0.99 . . . . 1.0 113.674 -172.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -33.33 53.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 1.0 112.255 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.17 -17.48 49.58 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.32 1.448 . . . . 1.0 112.622 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -98.19 -47.2 5.56 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.035 1.334 . . . . 1.0 111.996 -170.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -128.43 162.38 27.28 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.103 1.361 . . . . 1.0 113.458 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -69.97 159.77 82.94 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 118.377 -0.82 . . . . 1.0 110.358 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.45 156.5 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.285 3.323 . . . . 1.0 115.559 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 154.95 71.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.513 1.525 . . . . 1.0 112.182 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.24 123.27 5.5 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.046 3.164 . . . . 1.0 111.992 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.07 -35.42 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.454 1.102 . . . . 1.0 113.934 -170.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.9 -37.37 79.21 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.765 0.826 . . . . 1.0 111.788 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.94 -34.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.455 -0.778 . . . . 1.0 110.664 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mt -64.35 -48.21 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 118.813 0.733 . . . . 1.0 109.997 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -39.79 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.572 1.149 . . . . 1.0 111.108 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -66.18 -43.35 87.13 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.282 -0.886 . . . . 1.0 111.947 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.16 -44.44 92.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.598 1.159 . . . . 1.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.919 0.781 . . . . 1.0 110.672 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.16 -39.6 90.73 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.245 -0.91 . . . . 1.0 113.161 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.75 -34.22 77.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.79 0.836 . . . . 1.0 112.29 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.4 mmm -74.9 -36.07 62.23 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.383 -0.818 . . . . 1.0 112.934 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.4 t -46.33 129.67 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 1.0 112.008 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.54 -16.05 61.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.951 1.739 . . . . 1.0 114.041 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -84.47 143.69 29.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.081 1.441 . . . . 1.0 111.401 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -94.33 146.61 23.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.919 1.288 . . . . 1.0 112.393 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.7 mmt -134.83 141.54 46.42 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.591 1.556 . . . . 1.0 112.088 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -78.23 113.49 16.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.752 0.821 . . . . 1.0 109.544 170.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -93.37 -27.84 16.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -169.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 t -83.1 92.78 7.48 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.6 0.714 . . . . 1.0 110.489 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.1 tp -163.77 130.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.51 1.524 . . . . 1.0 109.789 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.81 -24.43 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 113.976 1.102 . . . . 1.0 113.976 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.5 m -67.43 -5.28 14.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.199 1.4 . . . . 1.0 114.413 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 66.64 86.14 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.568 2.347 . . . . 1.0 111.22 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -54.53 -34.56 61.95 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.78 1.029 . . . . 1.0 113.78 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.9 p -60.84 -61.22 2.74 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.333 1.453 . . . . 1.0 113.563 172.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.98 -46.71 87.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.772 0.829 . . . . 1.0 111.126 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -59.25 -46.53 88.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.107 0.412 . . . . 1.0 111.288 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -55.31 -59.21 5.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.493 0.717 . . . . 1.0 111.308 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.18 -26.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.997 0.817 . . . . 1.0 112.372 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.0 m -66.02 -49.45 67.7 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.344 1.057 . . . . 1.0 111.237 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.51 -29.77 68.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.904 0.882 . . . . 1.0 112.509 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.81 -33.82 74.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.295 0.85 . . . . 1.0 113.295 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -98.29 -42.78 7.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.777 1.231 . . . . 1.0 112.374 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -67.07 -50.82 60.46 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.856 -1.152 . . . . 1.0 112.092 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.79 35.77 3.69 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.412 1.958 . . . . 1.0 114.222 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 157.42 4.03 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.53 1.132 . . . . 1.0 113.15 172.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.738 1.615 . . . . 1.0 114.212 -176.67 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.2 mtp . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.385 0.136 . . . . 1.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.98 161.54 29.98 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.893 0.877 . . . . 1.0 112.434 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -67.7 144.3 97.41 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.662 0.785 . . . . 1.0 112.787 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.48 164.78 28.19 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.654 2.903 . . . . 1.0 112.133 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 80.13 160.69 0.17 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 127.496 2.318 . . . . 1.0 113.996 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -78.7 154.03 30.43 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.253 -0.904 . . . . 1.0 110.839 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -130.74 129.11 22.6 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.423 1.089 . . . . 1.0 109.807 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.06 153.47 16.74 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.526 2.817 . . . . 1.0 112.728 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -128.61 162.65 49.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.54 1.936 . . . . 1.0 112.431 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -43.99 127.12 6.55 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 124.396 3.397 . . . . 1.0 113.093 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 2.33 87.95 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 118.354 -1.248 . . . . 1.0 115.422 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.71 146.14 42.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.739 1.77 . . . . 1.0 112.947 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.07 122.61 33.21 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.387 -1.338 . . . . 1.0 107.387 169.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -101.98 132.24 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -109.91 132.1 54.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.799 2.04 . . . . 1.0 107.951 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mt -127.42 123.77 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.78 1.232 . . . . 1.0 109.195 -169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -86.56 131.14 34.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.829 1.252 . . . . 1.0 110.172 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -137.31 173.52 11.59 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.519 1.928 . . . . 1.0 110.2 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.23 122.27 13.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.958 0.903 . . . . 1.0 109.229 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.0 -130.55 9.77 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.215 0.912 . . . . 1.0 111.17 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -76.05 152.53 36.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.573 1.149 . . . . 1.0 113.438 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.07 168.47 8.29 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.935 1.694 . . . . 1.0 112.941 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -137.26 164.08 29.4 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.044 1.738 . . . . 1.0 111.146 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -138.56 155.32 48.47 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.088 -1.007 . . . . 1.0 113.206 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.1 153.4 40.65 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.424 1.489 . . . . 1.0 112.309 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.55 118.26 34.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.049 1.74 . . . . 1.0 108.205 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -84.19 130.9 34.81 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.449 1.022 . . . . 1.0 112.545 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -113.43 0.79 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 114.87 1.433 . . . . 1.0 114.87 -170.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.17 168.04 34.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.357 0.979 . . . . 1.0 112.881 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.74 16.3 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.212 1.805 . . . . 1.0 114.082 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.56 6.49 77.08 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.133 1.349 . . . . 1.0 114.274 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -103.83 154.5 19.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.352 1.576 . . . . 1.0 113.94 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.67 161.52 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.381 1.873 . . . . 1.0 111.229 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.59 137.61 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -161.98 169.96 20.18 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.208 -0.933 . . . . 1.0 110.537 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.9 mt -88.15 151.59 22.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.874 -0.516 . . . . 1.0 109.745 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.47 114.59 27.23 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.685 1.594 . . . . 1.0 109.88 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.52 164.79 25.82 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.346 2.697 . . . . 1.0 111.453 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.9 -19.23 18.3 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.977 3.118 . . . . 1.0 113.359 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.0 m 72.07 -18.99 0.29 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.434 2.294 . . . . 1.0 115.0 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -135.45 134.3 39.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.162 1.785 . . . . 1.0 110.164 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -72.38 144.62 86.96 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.962 0.905 . . . . 1.0 111.701 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.27 160.26 35.73 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.737 2.958 . . . . 1.0 113.703 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.68 142.23 9.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.718 1.627 . . . . 1.0 111.787 -170.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.19 -25.02 60.62 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -173.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.17 -134.94 1.84 Allowed Glycine 0 N--CA 1.471 1.013 0 C-N-CA 125.727 1.632 . . . . 1.0 111.043 175.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.7 m -57.77 -19.69 29.88 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.884 0.874 . . . . 1.0 112.749 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 p -53.36 -14.73 0.81 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.257 1.823 . . . . 1.0 113.631 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -52.62 -30.47 31.54 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.225 1.41 . . . . 1.0 113.298 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.91 -18.8 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.287 0.847 . . . . 1.0 113.287 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -106.05 -46.47 4.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.475 1.51 . . . . 1.0 111.225 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.7 m -75.12 42.7 0.19 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.333 1.853 . . . . 1.0 113.163 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.2 m -66.62 143.36 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.647 1.579 . . . . 1.0 112.469 -176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.3 tp -165.47 145.46 6.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.605 1.562 . . . . 1.0 110.329 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -63.01 128.07 34.15 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.367 -0.833 . . . . 1.0 111.811 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -91.28 150.91 21.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.701 0.8 . . . . 1.0 111.184 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.7 p -142.26 146.55 35.25 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.179 0.992 . . . . 1.0 112.837 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.68 150.16 27.25 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.557 1.543 . . . . 1.0 110.725 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.07 138.59 36.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.192 0.997 . . . . 1.0 110.595 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.1 t -77.63 123.2 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -127.38 155.01 44.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.417 1.487 . . . . 1.0 112.395 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -104.03 128.79 51.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.858 1.663 . . . . 1.0 108.291 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -157.24 166.07 34.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.45 0.568 . . . . 1.0 111.552 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -76.06 137.62 40.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.82 1.648 . . . . 1.0 110.743 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.32 -55.55 17.8 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.891 1.277 . . . . 1.0 110.952 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -55.01 -44.61 74.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.391 1.076 . . . . 1.0 111.721 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.14 -42.3 93.96 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.451 0.3 . . . . 1.0 111.521 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.92 -39.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.8 1.24 . . . . 1.0 112.244 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.6 m -85.58 -0.74 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.471 1.108 . . . . 1.0 113.776 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.28 126.72 36.51 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.322 0.963 . . . . 1.0 112.082 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.37 6.29 79.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.294 0.949 . . . . 1.0 114.194 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.9 m -122.52 -179.51 4.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.686 1.994 . . . . 1.0 110.783 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.07 156.99 39.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.392 1.477 . . . . 1.0 108.119 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -155.01 164.89 38.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.403 1.631 . . . . 1.0 115.403 -171.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -158.56 160.27 36.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.758 2.023 . . . . 1.0 110.944 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -88.14 129.05 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 168.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -131.66 54.58 1.92 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.502 1.144 . . . . 1.0 110.165 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.28 71.46 7.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.896 1.279 . . . . 1.0 111.329 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.2 p -73.56 -43.47 59.78 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.835 1.254 . . . . 1.0 113.681 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.79 -17.17 63.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.29 -28.13 51.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.126 1.37 . . . . 1.0 112.898 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -91.44 -20.44 21.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.375 1.47 . . . . 1.0 112.536 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -86.99 -36.24 18.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.412 1.085 . . . . 1.0 112.516 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -120.25 170.42 9.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.319 1.448 . . . . 1.0 112.355 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -66.35 144.8 98.86 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.437 -0.79 . . . . 1.0 109.557 171.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.41 134.16 46.81 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.86 2.373 . . . . 1.0 111.653 -169.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -93.81 151.65 40.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.069 1.348 . . . . 1.0 110.676 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.17 111.41 3.07 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.5 2.8 . . . . 1.0 110.858 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.72 -32.66 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.179 1.177 . . . . 1.0 114.179 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.73 -35.72 75.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.268 0.627 . . . . 1.0 112.16 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.6 -40.55 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.884 0.874 . . . . 1.0 110.722 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.3 mt -59.8 -46.74 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.762 0.71 . . . . 1.0 110.26 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.7 mt -69.18 -35.36 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.3 1.04 . . . . 1.0 111.627 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.3 m -64.34 -43.48 94.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.278 -0.889 . . . . 1.0 111.615 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.7 m -59.8 -43.77 94.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.303 1.041 . . . . 1.0 111.508 172.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.35 73.58 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.188 -0.945 . . . . 1.0 111.358 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -62.38 -38.11 88.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.301 1.041 . . . . 1.0 112.953 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.6 -35.3 79.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.84 0.856 . . . . 1.0 112.07 173.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.5 mmm -74.0 -37.54 64.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.376 -0.821 . . . . 1.0 112.85 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.9 t -46.68 130.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 119.359 0.981 . . . . 1.0 111.678 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.35 -14.04 65.73 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.567 1.556 . . . . 1.0 114.095 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -87.27 158.8 19.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.9 1.35 . . . . 1.0 111.413 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -120.25 148.61 43.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.148 1.379 . . . . 1.0 112.334 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 78.7 mtm -142.35 152.62 43.08 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.863 1.265 . . . . 1.0 112.161 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -74.33 162.34 28.98 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.012 0.925 . . . . 1.0 112.578 170.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -155.29 163.3 40.33 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.323 1.231 . . . . 1.0 114.323 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.0 t -145.14 130.64 18.8 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.891 1.677 . . . . 1.0 108.542 169.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.9 pt -64.64 -20.7 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 114.786 1.402 . . . . 1.0 114.786 -169.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.65 -14.35 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.099 0.959 . . . . 1.0 113.414 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.0 m -96.53 -5.8 38.52 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.55 0.944 . . . . 1.0 113.55 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.7 mtm-85 58.04 39.87 25.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.904 1.682 . . . . 1.0 112.875 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -53.6 -33.33 54.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -171.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.6 m -65.19 -40.68 94.54 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.31 0.959 . . . . 1.0 112.741 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -59.64 -53.11 61.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.111 0.964 . . . . 1.0 109.888 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.38 -45.75 87.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.813 0.445 . . . . 1.0 111.566 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -52.21 -60.09 3.61 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.861 0.865 . . . . 1.0 111.004 172.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -32.65 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.33 0.968 . . . . 1.0 113.017 -172.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -71.17 -38.87 72.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.647 0.779 . . . . 1.0 112.254 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -60.62 -26.55 67.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.997 0.817 . . . . 1.0 112.813 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.75 -26.54 68.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.868 1.213 . . . . 1.0 112.592 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -93.71 -53.31 4.08 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.657 1.583 . . . . 1.0 111.798 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -73.21 -38.94 65.92 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.45 -41.19 5.82 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.229 1.395 . . . . 1.0 112.292 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . 0.335 0.1 OUTLIER 43.6 -144.85 0.1 Allowed 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.971 2.108 . . . . 1.0 113.858 177.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.9 p . . . . . 0 C--O 1.253 1.277 0 C-N-CA 124.975 1.31 . . . . 1.0 114.228 174.641 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 110.866 -0.05 . . . . 1.0 110.866 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.96 162.64 41.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.398 1.479 . . . . 1.0 111.702 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.9 p -78.45 154.91 79.16 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.398 1.079 . . . . 1.0 112.734 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.49 162.76 39.3 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.753 2.969 . . . . 1.0 111.639 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -156.26 154.5 30.8 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.586 1.155 . . . . 1.0 111.771 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -157.93 141.7 15.64 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.565 1.546 . . . . 1.0 109.445 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.86 133.74 17.8 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.934 1.294 . . . . 1.0 110.089 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.23 144.58 26.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.562 2.841 . . . . 1.0 112.088 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -129.48 160.57 63.71 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.861 1.664 . . . . 1.0 112.846 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -47.59 129.03 16.3 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.815 3.01 . . . . 1.0 112.822 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -8.84 73.79 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.074 1.321 . . . . 1.0 114.172 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -68.59 139.34 55.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.968 1.384 . . . . 1.0 112.541 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.55 126.95 35.8 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.879 1.272 . . . . 1.0 108.905 170.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.3 131.93 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.44 138.45 39.34 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.187 1.395 . . . . 1.0 108.784 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mt -133.14 113.99 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.226 1.01 . . . . 1.0 109.174 -173.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -92.76 61.46 3.6 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.474 1.51 . . . . 1.0 111.205 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -66.89 158.87 29.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.173 0.989 . . . . 1.0 112.176 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.73 135.67 57.84 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.091 0.957 . . . . 1.0 110.13 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.82 -130.52 10.29 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -71.88 133.46 45.45 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.742 0.782 . . . . 1.0 112.607 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -66.23 163.28 18.2 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.594 1.958 . . . . 1.0 110.947 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.48 160.5 32.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.731 1.212 . . . . 1.0 110.472 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -137.37 150.19 47.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.204 1.001 . . . . 1.0 110.546 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 152.1 44.37 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.312 1.045 . . . . 1.0 112.598 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.33 116.86 33.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.197 1.799 . . . . 1.0 107.921 170.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -79.89 132.24 36.04 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.326 -0.859 . . . . 1.0 111.716 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.2 pt -114.89 -3.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -171.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.57 166.31 24.48 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 124.717 1.151 . . . . 1.0 113.008 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 62.69 18.37 10.54 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.082 1.753 . . . . 1.0 113.867 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.75 85.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.446 1.498 . . . . 1.0 114.281 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -94.2 153.12 18.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.425 1.613 . . . . 1.0 114.252 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -133.54 157.87 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.004 1.721 . . . . 1.0 111.006 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -115.58 138.68 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.396 1.478 . . . . 1.0 107.13 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -155.43 150.95 27.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.723 0.809 . . . . 1.0 111.75 -168.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -84.38 121.49 27.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.64 144.05 27.44 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.492 1.117 . . . . 1.0 112.239 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.23 144.44 29.52 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.233 2.622 . . . . 1.0 111.899 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.48 165.8 12.3 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.275 3.316 . . . . 1.0 112.614 174.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.3 m -71.57 140.3 49.76 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 169.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -59.88 -38.63 82.74 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -169.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -141.69 144.84 34.6 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.8 1.24 . . . . 1.0 112.241 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.76 -30.33 6.23 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.456 2.771 . . . . 1.0 112.41 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.23 -151.57 6.63 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.547 1.546 . . . . 1.0 112.732 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.57 159.28 17.97 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.482 1.113 . . . . 1.0 112.622 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.88 158.65 33.85 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.149 1.357 . . . . 1.0 114.018 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -76.17 -12.31 60.08 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.166 1.173 . . . . 1.0 114.166 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.2 p -90.79 -98.15 0.11 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.804 1.242 . . . . 1.0 109.459 169.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.6 t 65.9 -51.33 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 128.841 2.857 . . . . 1.0 115.759 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.98 -22.9 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.495 1.918 . . . . 1.0 114.756 -169.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.16 -13.72 62.58 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -171.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.2 p -85.75 -11.36 53.77 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.75 1.389 . . . . 1.0 114.75 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -157.47 143.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.294 0.952 . . . . 1.0 113.102 -169.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.1 tp -83.72 -13.33 54.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.17 1.388 . . . . 1.0 114.032 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 m -56.5 -25.23 50.82 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.746 1.388 . . . . 1.0 114.746 -173.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.11 41.05 0.16 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.062 1.745 . . . . 1.0 112.571 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.3 m -102.03 154.26 19.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.652 1.581 . . . . 1.0 111.47 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.49 147.11 42.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.012 0.925 . . . . 1.0 110.579 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.12 137.49 54.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.94 0.896 . . . . 1.0 109.989 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.77 124.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -132.05 163.81 27.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.414 1.486 . . . . 1.0 111.999 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -117.51 137.11 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.007 1.723 . . . . 1.0 110.077 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.05 177.74 10.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.822 1.249 . . . . 1.0 111.214 171.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.0 141.62 49.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.123 0.969 . . . . 1.0 111.604 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 tp -51.19 -52.82 40.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.308 1.043 . . . . 1.0 112.19 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.84 -48.22 73.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.086 0.954 . . . . 1.0 111.287 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.53 -35.02 79.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.083 0.553 . . . . 1.0 112.083 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.84 -45.23 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.17 0.988 . . . . 1.0 112.293 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.43 -34.47 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 119.585 1.084 . . . . 1.0 112.818 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.27 -131.11 49.68 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 119.151 0.887 . . . . 1.0 112.192 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.88 -3.73 85.38 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.652 1.12 . . . . 1.0 114.481 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.0 m -74.99 149.59 39.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.166 1.387 . . . . 1.0 111.433 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.5 t -72.05 154.43 41.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.007 0.523 . . . . 1.0 110.78 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -158.85 163.59 36.5 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.688 0.995 . . . . 1.0 113.688 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -159.81 157.46 29.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.83 1.252 . . . . 1.0 113.371 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.8 t -82.47 138.06 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.446 -1.316 . . . . 1.0 107.446 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -152.65 84.77 1.24 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 1.0 111.394 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.04 53.54 2.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.759 1.224 . . . . 1.0 111.847 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 p -58.73 -34.65 71.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.985 1.314 . . . . 1.0 113.159 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.65 -17.85 65.06 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.253 -0.905 . . . . 1.0 112.899 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.82 -25.9 68.38 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.126 0.876 . . . . 1.0 112.631 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.64 12.9 36.42 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.532 1.133 . . . . 1.0 111.949 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -109.8 -44.35 3.84 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.589 1.555 . . . . 1.0 111.754 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -131.41 168.32 17.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.593 1.557 . . . . 1.0 113.609 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -66.78 160.13 70.64 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.308 1.043 . . . . 1.0 112.471 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.77 152.33 35.71 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.405 3.403 . . . . 1.0 113.489 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -129.14 153.99 80.44 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.83 1.652 . . . . 1.0 111.042 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.75 111.45 3.25 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.205 2.604 . . . . 1.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.94 -31.86 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.193 0.997 . . . . 1.0 113.086 -169.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.36 -36.98 76.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.731 0.696 . . . . 1.0 112.1 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 t -71.56 -34.41 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.057 0.943 . . . . 1.0 110.7 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.1 mt -66.13 -48.32 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.536 0.735 . . . . 1.0 109.982 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -42.62 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.702 1.201 . . . . 1.0 110.853 173.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -65.26 -40.92 94.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 1.0 111.384 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.8 m -63.48 -42.5 98.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.06 0.944 . . . . 1.0 111.804 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.4 77.98 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.559 -0.713 . . . . 1.0 110.29 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.47 -39.83 92.31 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.15 -0.969 . . . . 1.0 113.149 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.64 -32.9 74.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.905 0.882 . . . . 1.0 112.631 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -74.34 -37.25 63.6 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.33 -0.843 . . . . 1.0 112.815 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.8 t -47.57 127.54 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.726 1.148 . . . . 1.0 111.373 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.75 -16.47 59.58 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.006 1.765 . . . . 1.0 113.818 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -85.04 157.58 20.69 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.741 1.271 . . . . 1.0 111.067 176.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.27 153.99 36.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.867 1.267 . . . . 1.0 113.214 -172.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.2 mtt -147.86 165.3 31.04 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.243 1.817 . . . . 1.0 111.77 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -69.89 142.17 53.04 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.494 -0.754 . . . . 1.0 109.949 169.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -78.75 164.37 24.61 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.251 -0.905 . . . . 1.0 113.065 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -55.73 140.94 40.1 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.627 1.171 . . . . 1.0 113.451 172.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.3 tt -167.06 97.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.189 1.795 . . . . 1.0 107.698 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 t 69.73 -61.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 127.498 2.319 . . . . 1.0 108.871 -169.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.6 m -82.56 143.13 31.26 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.687 1.595 . . . . 1.0 110.524 169.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -96.04 119.93 35.41 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.195 0.998 . . . . 1.0 110.791 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -91.06 -23.18 20.42 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -63.52 -36.71 84.68 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.325 -1.484 . . . . 1.0 113.022 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.46 -58.8 6.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.576 0.75 . . . . 1.0 109.963 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -52.83 -32.57 45.02 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.814 1.245 . . . . 1.0 113.419 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.91 -57.54 10.46 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.093 -1.004 . . . . 1.0 110.786 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.37 -28.29 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.902 1.075 . . . . 1.0 113.902 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.79 -42.5 90.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.539 1.063 . . . . 1.0 111.872 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -58.01 -29.37 65.25 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 1.0 112.813 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.21 -32.04 70.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.793 0.837 . . . . 1.0 112.652 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -94.42 -51.37 4.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 1.0 111.43 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -62.88 -32.07 73.25 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 -169.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.83 -9.02 87.46 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.883 0.754 . . . . 1.0 114.272 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -79.2 149.1 32.03 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.871 1.336 . . . . 1.0 112.211 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.618 1.567 . . . . 1.0 113.112 178.157 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 110.704 -0.109 . . . . 1.0 110.704 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.75 162.28 29.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.259 1.024 . . . . 1.0 113.11 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 m -66.37 149.06 98.29 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.787 0.835 . . . . 1.0 112.731 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.48 158.78 50.53 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.498 2.799 . . . . 1.0 111.834 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -160.25 146.79 15.73 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.87 1.268 . . . . 1.0 111.571 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -144.3 153.24 41.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.461 1.505 . . . . 1.0 110.049 175.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -136.1 129.72 18.1 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 124.539 1.136 . . . . 1.0 109.638 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.22 146.53 17.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.817 3.012 . . . . 1.0 111.614 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.97 161.02 62.29 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.637 1.575 . . . . 1.0 112.583 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -46.74 128.58 13.33 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.942 3.095 . . . . 1.0 112.99 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.81 -7.88 80.59 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.265 -1.297 . . . . 1.0 115.18 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.05 143.91 54.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.666 1.733 . . . . 1.0 113.761 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.42 128.11 33.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.52 1.528 . . . . 1.0 107.922 169.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.56 129.38 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.629 1.171 . . . . 1.0 108.162 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -100.15 125.08 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.316 1.447 . . . . 1.0 107.676 170.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.3 mt -120.92 119.9 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.559 1.143 . . . . 1.0 109.167 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -83.68 60.56 5.8 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.741 1.616 . . . . 1.0 110.514 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -65.85 147.16 53.81 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.355 1.062 . . . . 1.0 110.642 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.76 145.2 55.4 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.338 1.055 . . . . 1.0 111.428 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.43 -55.84 4.41 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.168 1.366 . . . . 1.0 112.678 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -147.41 132.1 17.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.308 1.843 . . . . 1.0 111.169 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.26 155.4 21.17 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.911 0.884 . . . . 1.0 111.423 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.3 166.9 20.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.979 1.712 . . . . 1.0 110.133 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -136.39 145.2 45.07 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.738 0.815 . . . . 1.0 111.508 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 156.81 45.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.303 1.041 . . . . 1.0 112.515 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.95 116.32 32.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.538 1.935 . . . . 1.0 107.713 172.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -81.91 130.73 35.16 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.335 -0.853 . . . . 1.0 111.845 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.85 3.66 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.5 167.48 35.3 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.529 1.062 . . . . 1.0 112.584 -174.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 61.38 20.02 10.75 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.952 1.701 . . . . 1.0 113.813 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.99 -1.04 87.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.585 1.564 . . . . 1.0 114.458 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -91.68 151.72 20.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.595 1.698 . . . . 1.0 114.492 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.53 154.23 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.402 1.481 . . . . 1.0 111.155 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.8 mt -112.23 136.02 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -155.16 150.09 26.71 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.138 -0.977 . . . . 1.0 111.866 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.07 133.05 33.92 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.26 130.69 23.74 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.114 1.366 . . . . 1.0 110.491 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.86 158.37 34.86 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.336 2.69 . . . . 1.0 112.343 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.41 171.85 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.424 3.416 . . . . 1.0 112.975 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.3 m -66.69 162.97 20.06 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.615 1.166 . . . . 1.0 113.064 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.93 -38.78 89.72 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.302 -0.874 . . . . 1.0 113.332 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -159.56 133.32 5.0 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.796 1.239 . . . . 1.0 112.143 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.18 157.12 26.33 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.515 2.81 . . . . 1.0 111.233 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.94 17.8 79.44 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 114.635 0.614 . . . . 1.0 114.635 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.1 64.06 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 118.332 1.066 . . . . 1.0 113.751 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.2 -158.72 34.95 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.406 1.479 . . . . 1.0 113.157 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.2 m -65.73 -27.59 68.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.6 m -77.5 54.63 1.19 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.459 1.503 . . . . 1.0 111.531 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.9 p -56.05 -33.06 64.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.74 1.616 . . . . 1.0 114.342 -169.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.9 m -55.8 -22.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.0 1.32 . . . . 1.0 113.855 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -63.63 -13.53 43.21 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.5 0.72 . . . . 1.0 112.899 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.7 m -56.64 -24.5 48.82 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.35 0.977 . . . . 1.0 113.232 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -71.29 -25.72 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.179 1.392 . . . . 1.0 112.595 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.37 156.75 27.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.835 1.254 . . . . 1.0 113.243 -169.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 p -84.23 167.71 16.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.682 1.193 . . . . 1.0 112.725 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -107.9 147.82 30.46 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.35 1.06 . . . . 1.0 112.374 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.1 m -145.62 140.1 27.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.452 1.101 . . . . 1.0 112.344 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.82 154.26 28.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.003 1.321 . . . . 1.0 110.675 169.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.23 139.44 53.78 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.272 1.029 . . . . 1.0 110.76 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.11 125.85 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.21 162.3 30.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.149 1.779 . . . . 1.0 111.986 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -120.69 126.28 49.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.819 1.648 . . . . 1.0 110.672 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -147.98 174.14 12.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.173 1.389 . . . . 1.0 110.681 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.74 137.37 38.43 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.109 -0.994 . . . . 1.0 110.744 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.79 -42.75 84.81 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.228 -0.92 . . . . 1.0 111.643 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.04 -46.42 75.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.774 . . . . 1.0 111.402 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.97 -42.94 80.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.671 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.15 -42.58 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 1.0 111.664 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.55 -2.31 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.813 1.245 . . . . 1.0 113.831 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.76 123.78 33.21 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.048 -1.033 . . . . 1.0 111.797 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.99 5.51 86.93 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.66 1.124 . . . . 1.0 114.757 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -126.31 -160.86 1.01 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.512 2.325 . . . . 1.0 110.436 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.2 t -148.87 171.8 15.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.266 1.826 . . . . 1.0 109.349 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -152.76 158.91 42.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.743 1.386 . . . . 1.0 114.743 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.98 150.29 39.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.362 1.865 . . . . 1.0 110.483 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.1 t -82.65 134.6 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -148.63 67.23 1.06 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.797 0.839 . . . . 1.0 112.197 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -72.61 82.62 1.12 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.37 1.068 . . . . 1.0 111.643 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -69.6 -38.33 77.25 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.148 0.795 . . . . 1.0 113.148 -170.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.7 mt -81.63 -8.89 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -172.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.56 -31.53 68.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 1.0 112.758 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -90.42 -5.71 55.79 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.925 1.29 . . . . 1.0 112.382 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -97.35 -47.76 5.58 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.033 1.333 . . . . 1.0 112.19 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -127.1 169.88 12.95 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.976 1.31 . . . . 1.0 113.717 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -66.21 148.59 98.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 110.067 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.38 144.72 62.84 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.364 2.709 . . . . 1.0 113.001 -170.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.92 151.72 37.94 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.45 1.5 . . . . 1.0 112.299 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.09 114.95 4.16 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.859 3.04 . . . . 1.0 110.991 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.81 -35.42 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.943 1.297 . . . . 1.0 114.154 -170.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.91 -35.4 78.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.827 0.451 . . . . 1.0 112.191 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.38 -36.71 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.468 0.707 . . . . 1.0 110.915 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.08 -49.5 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.472 0.578 . . . . 1.0 109.769 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.8 mt -67.68 -38.43 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.912 0.885 . . . . 1.0 111.904 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.9 m -62.42 -41.55 98.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.348 0.976 . . . . 1.0 111.71 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -62.46 -44.34 96.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.697 0.799 . . . . 1.0 111.079 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.63 72.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.618 0.767 . . . . 1.0 110.903 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.26 -40.36 93.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.234 1.014 . . . . 1.0 112.803 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.83 -33.47 75.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.565 0.746 . . . . 1.0 112.096 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.2 mmm -74.92 -38.24 61.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.195 -0.907 . . . . 1.0 112.975 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.54 127.95 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 120.017 1.281 . . . . 1.0 111.299 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.71 -15.42 62.72 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.722 1.629 . . . . 1.0 113.593 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -84.64 160.13 20.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.001 1.4 . . . . 1.0 111.314 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -123.86 157.81 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.368 1.467 . . . . 1.0 112.561 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.2 mtt -133.11 136.05 45.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.56 1.544 . . . . 1.0 110.283 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -59.09 133.88 56.49 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.775 -0.578 . . . . 1.0 110.936 174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -68.29 126.91 31.05 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.853 0.686 . . . . 1.0 112.853 -170.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.2 m -76.79 36.28 0.16 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.236 1.814 . . . . 1.0 113.192 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.1 pt 55.54 -14.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 130.755 3.622 . . . . 1.0 117.181 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.46 151.05 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 128.449 2.7 . . . . 1.0 109.038 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.2 m -59.56 168.03 1.77 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.196 1.399 . . . . 1.0 113.979 174.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 117.05 -20.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 131.328 3.851 . . . . 1.0 113.563 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -59.14 -6.96 1.0 Allowed 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 117.072 2.249 . . . . 1.0 117.072 -174.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 29.9 m -62.86 -29.94 71.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.024 1.329 . . . . 1.0 113.942 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.55 93.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.868 0.758 . . . . 1.0 111.674 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -58.68 -45.96 88.27 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.305 -0.872 . . . . 1.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -54.11 -57.1 12.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.569 -0.707 . . . . 1.0 111.349 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.47 -28.07 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.358 0.981 . . . . 1.0 113.489 -173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.4 p -72.47 -38.46 68.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.349 0.977 . . . . 1.0 112.276 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -57.6 -30.54 65.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.777 0.831 . . . . 1.0 112.53 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.26 -32.58 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.023 0.829 . . . . 1.0 112.928 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -93.58 -37.8 11.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 112.19 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -72.16 -46.27 57.1 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.605 -1.309 . . . . 1.0 112.908 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.53 30.71 8.77 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.316 1.913 . . . . 1.0 114.006 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.97 152.0 10.91 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.291 1.036 . . . . 1.0 112.458 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.271 1.829 . . . . 1.0 114.946 -175.277 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 110.542 -0.17 . . . . 1.0 110.542 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.43 158.24 31.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.962 0.905 . . . . 1.0 112.624 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 p -79.21 -31.67 0.72 Allowed Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 117.805 2.52 . . . . 1.0 117.805 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -81.5 156.82 19.1 Favored 'Trans proline' 0 C--N 1.357 1.023 0 CA-C-N 123.007 2.11 . . . . 1.0 112.136 -175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -86.45 4.6 38.94 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.999 0.92 . . . . 1.0 112.722 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -153.66 140.92 19.56 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.037 1.735 . . . . 1.0 109.687 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -135.55 139.86 32.36 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.699 1.199 . . . . 1.0 110.242 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.0 157.54 23.77 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.809 3.006 . . . . 1.0 113.263 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -124.82 162.56 42.44 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 127.188 2.195 . . . . 1.0 112.165 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.73 129.48 14.31 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.037 3.158 . . . . 1.0 113.059 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.78 -3.46 86.85 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.541 -1.144 . . . . 1.0 115.192 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.09 139.91 58.76 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.343 1.572 . . . . 1.0 113.027 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.69 120.95 26.98 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.88 124.75 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.401 -0.963 . . . . 1.0 108.401 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -87.57 135.31 33.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mt -124.57 116.6 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.899 1.28 . . . . 1.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.28 85.97 4.1 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.42 1.088 . . . . 1.0 109.678 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -78.29 165.97 23.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.77 0.828 . . . . 1.0 110.485 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.13 112.44 1.9 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.88 0.872 . . . . 1.0 110.625 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.34 -5.27 60.46 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.25 1.405 . . . . 1.0 115.934 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -154.09 115.39 4.11 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.417 1.608 . . . . 1.0 113.881 -170.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -73.19 137.72 45.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.031 0.932 . . . . 1.0 110.234 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -125.01 170.01 11.56 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.365 1.866 . . . . 1.0 110.073 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -135.99 145.16 45.82 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.108 0.963 . . . . 1.0 112.58 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 151.86 44.18 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 1.0 112.928 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.61 116.17 29.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.466 1.906 . . . . 1.0 109.223 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -83.03 129.89 35.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.14 -0.975 . . . . 1.0 112.502 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.0 pt -106.57 4.11 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.84 30.6 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 116.118 1.207 . . . . 1.0 116.118 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -88.36 9.11 24.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.747 1.219 . . . . 1.0 113.641 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.1 83.9 Favored Glycine 0 N--CA 1.476 1.355 0 C-N-CA 124.811 1.196 . . . . 1.0 112.142 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -95.09 157.03 16.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.913 1.685 . . . . 1.0 112.569 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.88 155.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.298 1.439 . . . . 1.0 110.105 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.2 mt -111.43 135.91 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -153.91 151.12 29.08 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.411 -0.805 . . . . 1.0 111.803 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -85.96 133.62 33.92 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.57 121.71 35.39 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.922 1.289 . . . . 1.0 110.254 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.09 158.25 11.99 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 124.381 3.387 . . . . 1.0 113.667 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.25 152.9 77.5 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.221 3.281 . . . . 1.0 112.794 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.4 p -75.86 -19.91 58.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.265 1.209 . . . . 1.0 114.265 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -157.67 111.71 2.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.832 1.253 . . . . 1.0 111.143 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -81.98 136.2 47.57 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 118.642 -0.695 . . . . 1.0 110.567 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.98 122.97 11.44 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.083 2.522 . . . . 1.0 112.299 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.35 7.51 78.25 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.974 1.273 . . . . 1.0 116.135 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.18 86.68 2.42 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.978 1.389 . . . . 1.0 112.531 -177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.55 -111.17 3.96 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.133 0.873 . . . . 1.0 111.638 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.4 m -69.99 -17.46 63.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.989 0.916 . . . . 1.0 113.397 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.5 m -70.86 140.75 51.2 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.062 -1.024 . . . . 1.0 112.647 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.1 t -98.29 -147.2 0.32 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.315 1.446 . . . . 1.0 111.743 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.28 26.2 m 56.62 32.26 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 127.706 2.402 . . . . 1.0 114.288 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -42.13 -43.03 3.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.342 2.257 . . . . 1.0 114.349 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.6 m -82.66 -8.95 59.57 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.167 1.173 . . . . 1.0 114.167 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.77 120.03 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.655 1.182 . . . . 1.0 109.467 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.29 -18.76 26.33 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.709 1.003 . . . . 1.0 113.709 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.3 t -73.76 135.74 43.59 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.388 -0.82 . . . . 1.0 112.36 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.61 123.92 1.11 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.868 1.267 . . . . 1.0 110.715 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.0 m -146.9 142.36 27.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.035 0.754 . . . . 1.0 113.035 -169.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.28 152.16 26.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.83 1.252 . . . . 1.0 110.323 169.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -116.54 140.13 49.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.369 1.068 . . . . 1.0 110.195 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.79 125.39 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 169.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.69 163.13 27.89 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.412 1.485 . . . . 1.0 112.199 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -123.86 133.39 53.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.925 1.69 . . . . 1.0 110.058 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -158.14 174.65 14.87 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.063 0.945 . . . . 1.0 111.116 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.64 142.67 56.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.384 1.074 . . . . 1.0 111.453 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 tp -52.19 -53.96 36.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.764 0.826 . . . . 1.0 111.821 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.38 -48.59 71.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.213 1.005 . . . . 1.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.26 -36.18 83.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.222 0.609 . . . . 1.0 112.302 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.84 -42.54 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.228 1.011 . . . . 1.0 112.303 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.1 m -71.53 -36.76 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.031 1.287 . . . . 1.0 112.508 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.58 -130.84 46.48 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 119.033 0.833 . . . . 1.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.2 -6.79 87.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.415 1.007 . . . . 1.0 114.328 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -75.9 148.74 38.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.303 1.441 . . . . 1.0 111.35 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.8 t -73.35 160.44 31.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.051 0.54 . . . . 1.0 110.878 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -158.67 160.25 36.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.088 1.144 . . . . 1.0 114.088 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -160.89 158.69 28.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.26 1.424 . . . . 1.0 112.02 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.73 138.86 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -152.71 85.24 1.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 1.0 110.69 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.66 59.28 2.45 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.599 1.16 . . . . 1.0 112.141 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -65.01 -33.41 75.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.253 1.421 . . . . 1.0 113.56 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.94 -11.99 58.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.193 0.997 . . . . 1.0 113.58 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.73 -34.56 65.27 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.924 1.289 . . . . 1.0 112.136 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -79.2 -18.58 52.73 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.996 1.318 . . . . 1.0 112.306 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -94.74 -43.49 8.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.762 1.225 . . . . 1.0 112.097 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -134.41 146.94 50.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.98 1.312 . . . . 1.0 112.709 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -65.82 159.66 67.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.395 1.078 . . . . 1.0 111.329 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -54.59 151.58 30.66 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.491 3.461 . . . . 1.0 116.241 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 160.11 48.84 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.307 1.843 . . . . 1.0 111.109 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.11 126.02 10.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.987 3.125 . . . . 1.0 112.161 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.43 -33.51 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 113.239 0.829 . . . . 1.0 113.239 -174.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.44 -37.96 82.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.188 0.595 . . . . 1.0 111.909 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.77 -38.16 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 1.0 110.431 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.8 mt -61.55 -46.49 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.212 0.915 . . . . 1.0 110.518 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.35 -37.17 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.112 0.965 . . . . 1.0 111.764 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -63.6 -45.08 91.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.893 0.77 . . . . 1.0 111.363 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.6 m -58.68 -44.09 90.13 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.568 1.147 . . . . 1.0 111.746 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.01 63.09 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.533 0.733 . . . . 1.0 110.782 173.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.78 -39.74 85.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.018 0.927 . . . . 1.0 112.991 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -67.75 -33.92 75.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.112 0.965 . . . . 1.0 112.473 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 96.5 mtp -77.76 -33.21 52.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.845 -1.074 . . . . 1.0 112.857 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.8 t -48.62 128.83 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 120.33 1.423 . . . . 1.0 111.004 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.06 -15.3 62.74 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.628 1.585 . . . . 1.0 113.804 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -87.18 163.27 17.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.94 1.37 . . . . 1.0 111.494 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -125.57 157.7 36.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.393 1.477 . . . . 1.0 112.952 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.7 mtt -135.01 137.61 43.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.097 1.759 . . . . 1.0 110.258 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -60.42 131.79 51.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 118.79 0.723 . . . . 1.0 110.63 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -76.61 153.59 35.16 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.977 1.103 . . . . 1.0 113.977 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.4 t -138.55 139.87 38.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.982 1.713 . . . . 1.0 106.467 169.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -73.72 33.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 115.442 1.645 . . . . 1.0 115.442 -168.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.4 m -142.0 142.42 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.675 2.39 . . . . 1.0 109.846 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.8 p -80.67 -4.29 53.77 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.765 1.394 . . . . 1.0 114.765 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -58.37 -22.56 54.05 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.032 -1.042 . . . . 1.0 112.608 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -53.68 -29.71 40.04 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.792 -1.192 . . . . 1.0 113.073 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.9 -37.31 72.97 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 1.0 112.024 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -61.38 -52.09 66.09 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.447 0.699 . . . . 1.0 109.977 170.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -58.46 -37.67 75.95 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.816 -0.553 . . . . 1.0 111.881 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -59.82 -61.36 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.174 -0.917 . . . . 1.0 111.128 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.64 -24.81 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.799 1.181 . . . . 1.0 112.875 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -63.44 -49.36 73.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.449 1.1 . . . . 1.0 111.295 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -59.8 -28.24 67.28 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.425 0.69 . . . . 1.0 112.688 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -63.42 -36.11 82.63 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.107 0.78 . . . . 1.0 113.107 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -93.75 -44.04 8.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.812 0.845 . . . . 1.0 111.741 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.97 -46.24 88.66 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.001 -1.062 . . . . 1.0 112.349 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -90.82 30.81 5.92 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 126.566 2.031 . . . . 1.0 114.315 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.57 150.21 5.22 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.514 1.126 . . . . 1.0 113.131 175.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.254 1.341 0 C-N-CA 125.884 1.673 . . . . 1.0 114.0 -178.15 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 120.371 0.129 . . . . 1.0 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.89 158.67 32.97 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.131 0.972 . . . . 1.0 112.651 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.5 m -69.78 147.04 96.13 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.9 0.88 . . . . 1.0 112.904 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.08 -22.77 14.32 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.544 2.829 . . . . 1.0 113.804 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -160.52 175.52 12.63 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.872 1.669 . . . . 1.0 110.529 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -71.27 136.52 47.98 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.527 -0.733 . . . . 1.0 110.392 172.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -92.12 132.2 33.03 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.503 0.721 . . . . 1.0 109.482 170.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.08 143.16 22.5 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.35 2.7 . . . . 1.0 111.493 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -117.02 164.31 19.38 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.397 1.879 . . . . 1.0 111.323 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.64 128.46 10.72 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.855 3.036 . . . . 1.0 112.674 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.28 -3.4 87.25 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.368 -1.24 . . . . 1.0 115.429 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.3 142.24 57.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.647 1.723 . . . . 1.0 113.041 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 117' ' ' VAL . 37.2 mt -89.22 118.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.039 -0.982 . . . . 1.0 108.984 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.89 127.64 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.614 -1.624 . . . . 1.0 106.614 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -108.5 122.71 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.411 . . . . 1.0 107.696 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.9 mt -120.28 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 124.893 1.277 . . . . 1.0 109.254 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -86.15 56.95 4.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.537 1.535 . . . . 1.0 111.132 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -60.96 149.58 36.1 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.461 1.104 . . . . 1.0 110.855 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.46 146.75 47.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.668 1.187 . . . . 1.0 110.928 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.11 -61.92 4.3 Favored Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.84 1.21 . . . . 1.0 112.284 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -147.03 138.95 24.4 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.32 1.848 . . . . 1.0 111.78 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -66.56 159.13 28.08 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.056 1.342 . . . . 1.0 112.497 174.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -133.11 162.84 30.67 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.685 1.994 . . . . 1.0 110.928 -177.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -137.46 149.31 46.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.079 0.951 . . . . 1.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.58 151.65 38.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.196 0.998 . . . . 1.0 112.949 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -94.13 113.54 25.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.151 1.78 . . . . 1.0 108.778 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -82.32 129.56 34.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.086 -1.009 . . . . 1.0 112.425 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.7 pt -106.14 10.18 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.58 -35.48 4.48 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 124.665 1.126 . . . . 1.0 115.801 169.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.46 17.12 3.98 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.459 1.104 . . . . 1.0 113.706 -172.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 -4.89 85.43 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.905 1.241 . . . . 1.0 112.803 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -92.92 155.39 17.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.171 1.388 . . . . 1.0 113.131 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -126.94 151.31 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.247 1.419 . . . . 1.0 110.481 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.04 134.49 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 106.842 -1.54 . . . . 1.0 106.842 169.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -154.53 162.86 40.93 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.26 -0.9 . . . . 1.0 111.502 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -101.43 132.49 47.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.52 1.128 . . . . 1.0 109.156 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -73.19 152.14 90.32 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.161 0.985 . . . . 1.0 112.676 -174.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 49.3 Cg_exo -66.5 -19.92 54.47 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 N-CA-C 121.265 3.525 . . . . 1.0 121.265 -172.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -53.24 139.15 63.82 Favored 'Trans proline' 0 C--N 1.359 1.125 0 CA-C-N 124.232 2.547 . . . . 1.0 115.021 -170.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -169.29 166.51 10.53 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.056 1.343 . . . . 1.0 112.505 -169.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 66.84 -156.2 0.23 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.869 1.668 . . . . 1.0 112.05 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -86.63 138.57 33.54 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.694 1.198 . . . . 1.0 111.802 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.17 175.32 11.41 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.982 3.121 . . . . 1.0 112.365 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.11 17.83 58.64 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.167 -0.796 . . . . 1.0 114.997 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.84 -17.35 63.38 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.462 1.282 . . . . 1.0 114.462 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.05 168.22 54.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.796 1.189 . . . . 1.0 113.229 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.9 p -63.68 -25.27 68.13 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -174.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.9 m -73.54 -12.22 60.7 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.312 1.045 . . . . 1.0 113.701 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t 70.96 -170.67 0.16 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.092 2.157 . . . . 1.0 113.976 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.31 -19.35 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.691 1.596 . . . . 1.0 113.38 -175.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -58.63 -26.61 63.92 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.03 0.932 . . . . 1.0 112.957 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.8 m -82.19 -17.83 44.82 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.919 1.081 . . . . 1.0 113.919 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.74 109.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.724 1.609 . . . . 1.0 110.522 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.6 -19.78 30.51 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.702 0.801 . . . . 1.0 112.944 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.8 m -144.02 165.17 28.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.718 1.607 . . . . 1.0 111.751 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.25 155.24 37.35 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.742 1.217 . . . . 1.0 112.777 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 m -152.42 151.87 31.32 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.158 1.383 . . . . 1.0 111.287 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.8 155.99 34.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.995 0.918 . . . . 1.0 109.303 169.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.64 135.64 35.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.823 1.249 . . . . 1.0 109.233 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.94 131.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.847 0.749 . . . . 1.0 109.268 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -135.05 162.19 33.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.58 1.552 . . . . 1.0 112.594 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -118.33 123.61 45.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.837 1.655 . . . . 1.0 109.946 171.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -145.52 172.08 13.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.715 1.206 . . . . 1.0 110.39 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -75.53 143.39 42.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.105 -0.997 . . . . 1.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.12 -51.92 64.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.172 -0.918 . . . . 1.0 111.702 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -54.33 -49.31 70.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.418 0.687 . . . . 1.0 111.299 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.64 -38.53 83.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.286 0.634 . . . . 1.0 111.846 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -44.79 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.405 1.082 . . . . 1.0 112.056 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -87.98 -7.58 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 114.354 1.242 . . . . 1.0 114.354 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.24 133.83 52.21 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.405 1.003 . . . . 1.0 113.192 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.08 80.87 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.822 1.201 . . . . 1.0 114.723 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.8 m -120.58 150.07 41.45 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.795 1.638 . . . . 1.0 111.204 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.8 m -81.41 158.87 24.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -161.18 168.02 25.02 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.429 . . . . 1.0 114.857 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -159.78 167.83 27.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.882 1.673 . . . . 1.0 112.205 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -87.25 126.57 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 168.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -131.67 57.66 1.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.336 1.065 . . . . 1.0 110.68 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.86 57.7 3.55 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.388 1.475 . . . . 1.0 111.667 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 p -78.64 -14.23 59.42 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.523 1.529 . . . . 1.0 114.72 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 mt -67.79 -11.83 59.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.135 1.161 . . . . 1.0 114.135 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.26 -26.69 67.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.946 0.794 . . . . 1.0 112.422 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -87.51 -5.37 58.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.123 1.369 . . . . 1.0 111.694 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -100.54 -47.24 4.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.549 1.54 . . . . 1.0 111.122 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -130.81 146.67 52.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.857 1.663 . . . . 1.0 112.338 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -64.52 155.13 82.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 1.0 111.864 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -48.78 141.23 21.46 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.569 3.513 . . . . 1.0 115.688 -170.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -121.21 146.45 44.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.724 1.61 . . . . 1.0 110.857 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.56 114.92 4.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.494 2.796 . . . . 1.0 110.398 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.06 -29.9 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 114.452 1.278 . . . . 1.0 114.452 -169.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.1 -35.72 75.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.926 0.49 . . . . 1.0 111.878 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.22 -32.61 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.254 0.622 . . . . 1.0 110.89 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.88 -49.24 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.289 0.949 . . . . 1.0 110.338 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.06 -38.6 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.086 0.954 . . . . 1.0 111.253 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.4 m -63.12 -41.77 99.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 1.0 112.127 173.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t -61.68 -44.45 96.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.101 0.96 . . . . 1.0 110.968 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.5 -52.42 65.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.164 0.986 . . . . 1.0 110.517 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.81 -39.09 87.64 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.138 0.975 . . . . 1.0 113.057 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.55 -34.71 77.63 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.921 0.888 . . . . 1.0 112.363 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 97.5 mtp -78.61 -31.64 47.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.711 -1.137 . . . . 1.0 113.305 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.6 t -47.61 126.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 120.264 1.393 . . . . 1.0 110.607 169.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.11 -12.43 65.43 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.741 1.639 . . . . 1.0 114.274 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.24 158.37 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.109 1.455 . . . . 1.0 111.45 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -118.53 159.54 23.35 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.338 1.455 . . . . 1.0 113.895 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.0 mtt -143.67 159.6 42.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.965 1.706 . . . . 1.0 112.091 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -96.43 -179.98 4.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.551 1.14 . . . . 1.0 111.666 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -94.37 158.85 15.38 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.742 1.217 . . . . 1.0 112.968 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.0 m 67.28 29.28 7.68 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.394 1.477 . . . . 1.0 112.747 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.6 pt -74.58 69.15 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.449 1.499 . . . . 1.0 112.628 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.5 t 78.55 -36.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 128.498 2.719 . . . . 1.0 111.663 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.6 t -152.25 -172.22 4.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.216 1.807 . . . . 1.0 110.166 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -57.44 120.66 8.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.465 1.106 . . . . 1.0 110.836 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -42.56 -65.31 0.48 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.948 1.699 . . . . 1.0 115.052 -169.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -69.6 -35.16 75.05 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.324 -0.86 . . . . 1.0 112.71 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.74 -51.79 66.89 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.729 0.812 . . . . 1.0 110.593 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -63.49 -34.63 78.2 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.254 -0.904 . . . . 1.0 111.261 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.38 -60.02 4.47 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.125 -0.985 . . . . 1.0 110.917 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 13' ' ' LEU . 29.8 m -64.9 -22.76 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 120.634 1.561 . . . . 1.0 113.338 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.1 m -65.55 -52.87 49.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.788 1.235 . . . . 1.0 110.984 169.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -66.55 -24.96 66.44 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.391 0.885 . . . . 1.0 113.391 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.2 -37.55 75.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.911 0.884 . . . . 1.0 112.986 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -93.88 -46.74 7.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.118 0.967 . . . . 1.0 112.133 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -62.08 -44.68 96.15 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.153 -0.967 . . . . 1.0 111.747 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -93.6 33.65 5.05 Favored Glycine 0 N--CA 1.472 1.045 0 C-N-CA 126.424 1.964 . . . . 1.0 113.652 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.9 -49.03 63.82 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.614 1.166 . . . . 1.0 112.361 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.137 1.775 . . . . 1.0 113.216 -177.285 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 110.61 -0.145 . . . . 1.0 110.61 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.47 160.69 31.89 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.052 0.941 . . . . 1.0 112.901 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.0 p -74.93 151.33 86.4 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.862 0.865 . . . . 1.0 112.755 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.55 162.01 30.72 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.746 2.964 . . . . 1.0 111.694 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -76.12 -8.16 56.38 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.524 0.935 . . . . 1.0 113.524 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -142.09 129.36 21.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.777 1.631 . . . . 1.0 110.276 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.03 123.77 2.01 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.835 1.254 . . . . 1.0 109.614 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -86.33 158.62 9.63 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.68 3.587 . . . . 1.0 111.998 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -129.97 162.53 53.19 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.805 1.642 . . . . 1.0 112.027 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.77 128.01 8.51 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.253 3.302 . . . . 1.0 113.091 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.81 -9.42 76.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.999 1.285 . . . . 1.0 115.108 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.82 151.27 44.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.103 1.452 . . . . 1.0 113.71 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.31 125.45 35.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.087 0.955 . . . . 1.0 109.976 171.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.0 mm -95.0 132.93 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 106.757 -1.572 . . . . 1.0 106.757 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -111.68 130.88 55.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.776 1.63 . . . . 1.0 108.851 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.06 129.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.732 1.613 . . . . 1.0 109.355 -169.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -109.92 102.26 11.03 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.61 1.564 . . . . 1.0 109.274 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -99.61 162.3 13.1 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.86 2.064 . . . . 1.0 109.77 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.75 107.87 0.57 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.933 0.893 . . . . 1.0 109.956 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.07 14.47 82.58 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-O 118.489 -1.173 . . . . 1.0 115.472 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -156.89 143.31 18.23 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.583 1.692 . . . . 1.0 114.153 -172.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -109.15 135.27 50.54 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.24 1.416 . . . . 1.0 108.533 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -144.89 156.61 44.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.298 0.639 . . . . 1.0 111.944 -169.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -142.14 155.54 45.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.118 0.785 . . . . 1.0 113.118 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.12 153.33 42.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.462 1.105 . . . . 1.0 112.115 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.47 118.15 30.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.999 1.319 . . . . 1.0 108.52 171.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -83.39 132.55 34.98 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.236 -0.915 . . . . 1.0 112.156 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 pt -117.44 2.45 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 -170.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.43 163.71 27.33 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.742 1.163 . . . . 1.0 113.427 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 61.71 19.03 10.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.146 1.778 . . . . 1.0 114.116 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.78 2.93 81.0 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.602 1.572 . . . . 1.0 114.107 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -95.14 152.53 18.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.74 . . . . 1.0 114.151 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.8 160.53 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.034 1.733 . . . . 1.0 110.737 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.51 132.07 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.761 -1.57 . . . . 1.0 106.761 168.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.194 -0.941 . . . . 1.0 111.062 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.25 111.14 16.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 171.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.65 114.91 36.62 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.914 0.886 . . . . 1.0 111.326 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.7 139.61 15.97 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.739 2.292 . . . . 1.0 110.954 -172.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.73 137.97 28.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.477 2.785 . . . . 1.0 110.57 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.6 p -89.58 -31.99 17.33 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -172.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -147.85 151.02 35.24 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.121 1.768 . . . . 1.0 110.583 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -73.36 157.87 87.44 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.08 -30.71 75.89 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.017 3.145 . . . . 1.0 113.969 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.2 -176.88 15.39 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.077 1.322 . . . . 1.0 113.545 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.55 0.35 3.63 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.973 1.309 . . . . 1.0 114.262 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -87.1 -171.05 47.26 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.904 1.24 . . . . 1.0 113.333 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 m -70.81 -12.52 61.6 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.237 1.199 . . . . 1.0 114.237 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.3 m -74.48 45.94 0.25 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.044 1.737 . . . . 1.0 112.643 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 m -64.71 26.94 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 128.629 2.771 . . . . 1.0 116.931 -169.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -82.74 27.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 126.296 1.838 . . . . 1.0 112.545 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -55.23 -30.3 59.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.147 1.779 . . . . 1.0 113.754 -170.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m -66.19 -15.58 63.27 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.054 1.341 . . . . 1.0 114.269 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.36 17.44 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 125.251 1.421 . . . . 1.0 112.807 173.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -114.37 -154.19 0.54 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.363 1.465 . . . . 1.0 110.501 174.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 p -75.76 55.92 0.9 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.97 2.108 . . . . 1.0 113.006 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.84 22.96 0.98 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.912 1.449 . . . . 1.0 114.912 -173.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 m -73.95 158.45 34.37 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.849 -1.157 . . . . 1.0 112.442 171.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.21 149.97 21.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.138 1.375 . . . . 1.0 109.984 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.17 140.35 52.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.81 0.844 . . . . 1.0 109.837 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.36 123.32 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.3 153.71 51.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.987 1.315 . . . . 1.0 112.091 -175.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -100.96 125.11 47.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.967 1.707 . . . . 1.0 109.713 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -149.62 174.81 12.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.782 1.233 . . . . 1.0 110.372 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -75.54 144.57 41.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.008 -1.058 . . . . 1.0 111.71 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -48.99 -52.16 26.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.0 1.32 . . . . 1.0 110.942 173.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.66 -53.6 18.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.325 1.85 . . . . 1.0 111.248 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.32 -34.73 75.11 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.466 0.543 . . . . 1.0 112.466 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.8 t -71.25 -43.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.571 1.148 . . . . 1.0 112.303 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.2 m -73.87 -39.18 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 119.459 1.027 . . . . 1.0 112.697 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.39 -127.38 45.02 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.968 0.804 . . . . 1.0 112.191 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.01 3.16 84.54 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.102 1.334 . . . . 1.0 114.903 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.1 m -78.73 155.95 29.12 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.782 1.291 . . . . 1.0 111.579 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.59 150.91 37.94 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.659 0.384 . . . . 1.0 110.097 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -161.0 164.55 30.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -160.84 160.11 30.68 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.652 1.581 . . . . 1.0 111.556 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.11 133.38 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -155.87 87.3 1.07 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.596 0.758 . . . . 1.0 111.288 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.5 58.84 1.8 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.999 1.32 . . . . 1.0 112.353 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -61.19 -35.61 77.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.866 1.266 . . . . 1.0 112.988 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.47 -14.03 62.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.621 1.168 . . . . 1.0 113.487 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.97 -23.08 67.2 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.634 -0.666 . . . . 1.0 112.762 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.73 -2.67 55.81 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.141 1.376 . . . . 1.0 111.589 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -98.71 -46.2 5.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.633 1.573 . . . . 1.0 111.554 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -125.73 168.98 13.03 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.418 1.487 . . . . 1.0 114.079 -172.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -65.93 161.15 57.27 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.588 1.155 . . . . 1.0 111.204 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.78 131.82 28.66 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.867 2.378 . . . . 1.0 110.807 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -113.21 152.19 44.89 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.056 1.343 . . . . 1.0 110.989 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 118.07 5.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.404 2.736 . . . . 1.0 111.348 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.75 -36.6 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.899 1.28 . . . . 1.0 114.174 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.37 -35.53 79.43 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.944 0.498 . . . . 1.0 111.908 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.22 -37.92 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.334 0.654 . . . . 1.0 110.651 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -62.73 -47.13 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 118.95 0.796 . . . . 1.0 110.465 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.33 -36.84 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.821 0.849 . . . . 1.0 111.749 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -62.1 -44.13 97.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.146 0.885 . . . . 1.0 111.252 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 m -58.43 -44.73 89.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 1.0 111.72 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.66 -50.38 73.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.305 0.957 . . . . 1.0 110.89 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.54 -38.33 89.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.531 1.132 . . . . 1.0 113.322 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -69.32 -32.1 70.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.116 0.966 . . . . 1.0 112.155 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.36 -35.23 54.74 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.385 -0.817 . . . . 1.0 112.933 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -45.65 126.46 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.484 1.038 . . . . 1.0 111.359 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.14 59.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.22 1.867 . . . . 1.0 113.972 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -87.71 149.43 24.24 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.027 1.414 . . . . 1.0 111.078 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -106.4 153.15 22.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.397 1.479 . . . . 1.0 113.892 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.8 mtt -149.22 176.9 10.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.922 2.089 . . . . 1.0 110.811 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.39 176.21 9.98 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.182 -0.949 . . . . 1.0 111.939 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -87.86 -60.09 2.07 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.732 1.213 . . . . 1.0 112.94 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -156.11 131.87 9.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.474 1.51 . . . . 1.0 109.156 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.0 pt -127.7 10.84 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 114.493 1.294 . . . . 1.0 114.493 -169.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.4 p 132.63 -37.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 1 C-N-CA 133.017 4.527 . . . . 1.0 107.579 -169.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 t -114.83 149.59 36.83 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.884 1.673 . . . . 1.0 109.402 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -77.22 110.71 12.14 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.087 1.355 . . . . 1.0 108.467 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -59.71 -33.26 71.39 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 -169.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 27.3 p -58.43 -34.78 71.19 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.06 -1.025 . . . . 1.0 113.702 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -68.24 -55.28 12.76 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.74 1.616 . . . . 1.0 110.591 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -65.37 -33.19 75.38 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.164 -0.96 . . . . 1.0 111.415 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -56.75 -59.02 5.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.338 -0.839 . . . . 1.0 111.129 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.84 -24.38 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.729 1.15 . . . . 1.0 112.31 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -65.4 -48.35 73.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.036 0.934 . . . . 1.0 111.336 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -62.06 -26.47 68.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.267 1.027 . . . . 1.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.03 -32.87 74.33 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.339 0.972 . . . . 1.0 112.949 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -90.39 -48.87 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.275 1.03 . . . . 1.0 111.557 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.76 -30.45 68.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -93.81 16.47 60.75 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.147 1.832 . . . . 1.0 114.52 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.95 151.36 8.87 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 118.676 1.238 . . . . 1.0 112.833 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.346 1.858 . . . . 1.0 114.999 -175.636 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.91 160.22 31.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.251 1.02 . . . . 1.0 112.593 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 p -78.65 161.28 69.94 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.548 1.139 . . . . 1.0 113.19 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.78 153.37 50.53 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 124.002 3.135 . . . . 1.0 113.359 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -159.16 169.05 25.03 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.689 1.195 . . . . 1.0 111.734 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -70.61 136.84 49.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.182 0.993 . . . . 1.0 111.282 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -158.88 129.41 3.57 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.487 1.515 . . . . 1.0 109.402 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.07 144.96 12.16 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.663 2.908 . . . . 1.0 112.165 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -130.51 162.64 53.48 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.747 2.019 . . . . 1.0 111.678 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.15 129.23 15.19 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.559 2.839 . . . . 1.0 113.412 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.21 85.12 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.29 -1.284 . . . . 1.0 114.841 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.86 137.44 58.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.585 1.693 . . . . 1.0 112.758 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.39 117.88 24.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.785 1.234 . . . . 1.0 108.419 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.4 mm -99.67 121.81 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.46 1.504 . . . . 1.0 107.85 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.74 119.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.491 1.116 . . . . 1.0 109.505 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -88.52 63.28 6.95 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.192 1.397 . . . . 1.0 110.078 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -62.1 152.12 33.73 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.112 0.965 . . . . 1.0 110.688 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.07 134.76 49.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.74 0.816 . . . . 1.0 110.12 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.67 -125.1 6.72 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 109.612 -1.395 . . . . 1.0 109.612 -169.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -76.57 144.51 39.6 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.482 0.919 . . . . 1.0 113.482 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.92 156.04 21.95 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.557 1.543 . . . . 1.0 111.528 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.46 163.19 29.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.984 1.714 . . . . 1.0 110.854 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -139.69 153.32 47.23 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.267 1.027 . . . . 1.0 112.668 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 152.18 38.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.635 0.774 . . . . 1.0 112.693 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.27 115.43 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.084 1.754 . . . . 1.0 108.323 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -80.32 129.12 34.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.956 0.798 . . . . 1.0 112.099 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.5 pt -105.94 10.62 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 115.06 1.504 . . . . 1.0 115.06 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.86 -34.8 5.08 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.53 1.062 . . . . 1.0 115.743 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.96 16.59 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.371 1.068 . . . . 1.0 113.838 -172.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 -7.46 80.79 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.121 1.343 . . . . 1.0 113.202 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -91.89 156.64 17.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.051 1.341 . . . . 1.0 112.819 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -127.61 152.63 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.405 1.482 . . . . 1.0 110.309 172.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -110.91 135.03 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.061 1.345 . . . . 1.0 107.976 169.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -153.8 151.97 30.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.048 0.939 . . . . 1.0 112.294 -168.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.86 126.56 36.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.566 0.747 . . . . 1.0 109.406 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -88.77 136.47 30.9 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.841 -1.076 . . . . 1.0 109.518 173.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -79.73 170.16 17.29 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 123.446 2.764 . . . . 1.0 113.307 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.43 168.13 4.23 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.872 3.715 . . . . 1.0 113.178 169.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 t -169.35 172.38 7.24 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -172.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -74.22 156.27 37.43 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.567 1.547 . . . . 1.0 112.851 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.04 133.46 74.24 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 113.619 0.97 . . . . 1.0 113.619 -171.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.75 -21.14 7.31 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.385 2.723 . . . . 1.0 113.795 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.23 -135.65 6.59 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.658 1.123 . . . . 1.0 113.578 -176.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.38 -8.48 51.05 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.13 -156.33 28.29 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 124.789 1.185 . . . . 1.0 112.557 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -62.26 -13.6 29.95 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.492 1.293 . . . . 1.0 114.492 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 m -68.13 -8.53 39.2 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.931 1.292 . . . . 1.0 113.4 170.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 t -147.6 -164.89 2.11 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.225 1.81 . . . . 1.0 111.016 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.255 26.2 m 51.71 28.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 127.377 2.271 . . . . 1.0 115.042 174.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.43 -20.38 54.65 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.981 1.312 . . . . 1.0 113.828 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 p -65.9 -13.82 60.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.762 1.625 . . . . 1.0 114.322 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.05 153.35 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.815 1.646 . . . . 1.0 111.836 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.9 tp -104.26 -17.15 14.96 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.22 1.408 . . . . 1.0 113.095 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.0 t -166.99 174.07 8.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.908 1.683 . . . . 1.0 110.48 -173.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -78.5 151.01 32.79 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.01 0.924 . . . . 1.0 111.142 170.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 p -71.55 154.56 41.37 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.019 -1.051 . . . . 1.0 111.782 169.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.93 149.89 29.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.614 0.766 . . . . 1.0 109.633 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -136.96 137.46 39.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.541 0.736 . . . . 1.0 110.129 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.3 t -80.08 125.13 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.04 161.43 31.0 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.218 1.807 . . . . 1.0 111.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -120.52 124.59 45.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.753 1.621 . . . . 1.0 110.405 172.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -147.27 178.38 8.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.415 1.486 . . . . 1.0 110.219 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.02 143.19 32.69 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.952 -1.092 . . . . 1.0 111.78 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.77 -61.27 2.13 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.153 1.381 . . . . 1.0 111.319 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -56.19 -43.95 78.96 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.268 1.027 . . . . 1.0 111.36 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.39 -43.03 91.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.3 t -69.79 -42.1 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.451 1.1 . . . . 1.0 112.15 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -79.22 -5.47 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.91 132.96 51.21 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.616 1.103 . . . . 1.0 113.041 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.71 69.71 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.691 1.138 . . . . 1.0 114.785 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 m -126.04 154.22 43.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.307 1.843 . . . . 1.0 111.244 -175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.0 t -82.64 153.52 25.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 168.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -160.48 163.67 32.76 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -161.04 159.55 29.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.206 1.403 . . . . 1.0 112.813 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.2 t -82.75 133.06 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -153.77 80.47 1.15 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.885 0.85 . . . . 1.0 112.153 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.15 51.12 1.71 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.138 1.375 . . . . 1.0 113.049 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.8 m -59.0 -30.43 67.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.684 -1.26 . . . . 1.0 113.411 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.54 -16.07 63.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.88 1.067 . . . . 1.0 113.88 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.0 -20.66 65.5 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.038 0.755 . . . . 1.0 113.038 170.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -97.58 -3.2 40.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.596 1.558 . . . . 1.0 111.815 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -97.58 -48.11 5.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.657 1.583 . . . . 1.0 110.98 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.38 167.59 12.61 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.005 1.722 . . . . 1.0 112.795 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -67.45 163.36 48.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.756 0.822 . . . . 1.0 111.701 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.13 128.01 28.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.396 2.73 . . . . 1.0 111.527 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -113.26 152.65 45.32 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.318 1.447 . . . . 1.0 110.43 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.39 113.78 3.81 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.461 2.774 . . . . 1.0 110.783 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.19 -29.23 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -37.0 78.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.493 . . . . 1.0 111.887 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.02 -33.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.526 0.73 . . . . 1.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.17 -47.82 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.938 0.79 . . . . 1.0 110.121 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.81 -38.97 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.253 1.021 . . . . 1.0 111.729 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 t -63.03 -43.17 99.44 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.439 -0.788 . . . . 1.0 111.567 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.5 m -61.63 -42.38 98.8 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.342 1.057 . . . . 1.0 111.671 173.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 72.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.496 0.719 . . . . 1.0 110.456 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -60.95 -40.62 94.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.153 0.981 . . . . 1.0 112.865 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.79 -33.72 76.52 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.838 0.855 . . . . 1.0 112.554 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.5 mmm -73.48 -38.63 65.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.834 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.9 t -47.33 128.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.88 1.218 . . . . 1.0 111.507 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.76 62.95 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.788 1.661 . . . . 1.0 113.703 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -82.76 145.11 29.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 118.965 1.383 . . . . 1.0 111.19 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -114.9 147.38 40.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.83 1.652 . . . . 1.0 112.732 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.6 mmt -124.41 145.12 49.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.979 1.712 . . . . 1.0 110.237 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -75.23 146.97 40.71 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.517 -0.74 . . . . 1.0 112.787 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -70.91 -17.51 62.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.541 0.941 . . . . 1.0 113.541 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.6 m -71.26 -2.9 17.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.108 1.763 . . . . 1.0 114.89 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.9 tt -60.72 144.45 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.583 1.153 . . . . 1.0 111.808 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.03 -22.27 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 115.142 1.534 . . . . 1.0 115.142 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 t -160.51 178.72 9.25 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.145 0.978 . . . . 1.0 112.485 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -54.8 139.66 38.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.003 1.721 . . . . 1.0 111.831 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -122.79 -3.48 8.7 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.933 1.827 . . . . 1.0 115.933 -169.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.13 -43.91 81.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 121.446 1.93 . . . . 1.0 113.33 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -43.91 85.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.138 0.975 . . . . 1.0 110.88 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.23 -41.58 93.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.451 -0.781 . . . . 1.0 111.362 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -58.02 -58.92 6.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.139 0.976 . . . . 1.0 110.891 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.38 -22.52 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.61 1.095 . . . . 1.0 112.76 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 83.5 m -65.7 -49.91 66.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.615 1.166 . . . . 1.0 111.476 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.97 -29.02 64.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.555 1.142 . . . . 1.0 112.468 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.5 -34.54 77.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.219 0.822 . . . . 1.0 113.219 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -93.75 -47.86 6.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.164 0.986 . . . . 1.0 111.307 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.57 -30.48 71.5 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.547 1.139 . . . . 1.0 113.546 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -74.5 -9.75 82.08 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.599 1.095 . . . . 1.0 114.435 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -47.87 69.47 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.429 1.115 . . . . 1.0 111.034 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.253 1.271 0 C-N-CA 126.467 1.907 . . . . 1.0 113.773 -175.393 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.827 -0.064 . . . . 1.0 110.827 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.38 164.77 38.29 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.375 1.47 . . . . 1.0 111.931 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.2 p -75.98 149.98 83.12 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.423 1.089 . . . . 1.0 112.653 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.42 139.19 40.76 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.309 2.672 . . . . 1.0 112.061 -172.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -140.81 163.89 31.72 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.031 1.733 . . . . 1.0 111.592 -175.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -130.49 163.86 26.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.495 1.518 . . . . 1.0 111.274 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -130.44 128.19 22.57 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.567 1.147 . . . . 1.0 108.527 169.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 148.26 26.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.589 2.859 . . . . 1.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.88 164.27 41.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.246 1.818 . . . . 1.0 112.177 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.91 126.68 11.37 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.656 2.904 . . . . 1.0 113.235 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.66 -10.03 75.91 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.744 1.164 . . . . 1.0 115.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -66.87 137.78 56.83 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.457 1.628 . . . . 1.0 112.911 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.27 118.41 26.68 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.276 1.43 . . . . 1.0 108.45 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.3 mt -101.28 130.93 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -103.06 131.78 49.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.301 1.44 . . . . 1.0 108.364 170.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.5 mt -124.43 118.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.632 1.573 . . . . 1.0 108.431 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -88.39 52.25 2.4 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 1.0 112.034 -169.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -64.58 148.46 50.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.69 0.796 . . . . 1.0 111.017 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.14 149.38 47.84 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.226 1.01 . . . . 1.0 111.828 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.42 -42.62 2.62 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 125.382 1.467 . . . . 1.0 113.406 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -168.3 135.2 2.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.876 2.071 . . . . 1.0 111.519 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.13 151.68 42.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.175 1.79 . . . . 1.0 111.157 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.46 165.5 18.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.996 1.319 . . . . 1.0 110.433 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -141.41 154.43 45.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.091 0.557 . . . . 1.0 112.048 -175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.73 147.73 31.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.695 0.798 . . . . 1.0 112.356 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.35 118.72 32.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.091 1.756 . . . . 1.0 107.976 169.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.35 132.89 35.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.043 -1.035 . . . . 1.0 112.4 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.86 0.86 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 115.092 1.515 . . . . 1.0 115.092 -169.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.06 169.29 33.45 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.389 0.995 . . . . 1.0 112.917 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 64.1 15.49 9.32 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.239 1.816 . . . . 1.0 114.202 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.57 83.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.35 1.453 . . . . 1.0 114.059 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -101.53 154.52 18.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.21 1.505 . . . . 1.0 114.006 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.72 165.0 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.473 1.909 . . . . 1.0 110.769 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -121.91 135.53 61.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 168.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -154.81 166.02 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.073 -1.017 . . . . 1.0 110.808 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.3 tp -86.57 139.0 31.25 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.76 119.34 34.06 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.836 1.254 . . . . 1.0 109.371 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.49 161.99 27.98 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.01 2.473 . . . . 1.0 112.606 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.54 138.22 41.4 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.98 3.12 . . . . 1.0 110.47 170.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 p -88.18 -39.16 14.72 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.747 1.018 . . . . 1.0 113.747 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -169.92 149.13 3.62 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.537 1.935 . . . . 1.0 110.201 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -58.04 138.38 83.74 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 121.726 -0.609 . . . . 1.0 112.291 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.19 156.43 62.26 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.972 3.115 . . . . 1.0 112.581 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.79 -134.82 32.49 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.189 0.899 . . . . 1.0 112.549 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.69 1.64 33.32 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.243 1.417 . . . . 1.0 113.307 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.15 -120.92 5.87 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 124.944 1.259 . . . . 1.0 111.367 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -51.09 -38.11 49.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.515 1.526 . . . . 1.0 114.167 -172.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.2 m -73.29 -32.9 64.92 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.446 -0.784 . . . . 1.0 112.72 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 m -87.54 -35.31 18.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.83 0.852 . . . . 1.0 113.028 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -66.84 -14.01 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -59.84 -38.03 80.93 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.137 0.575 . . . . 1.0 110.802 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.2 m -94.87 -39.75 10.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.317 1.047 . . . . 1.0 112.572 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 t -103.02 68.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.445 1.498 . . . . 1.0 110.083 -175.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.7 tp -69.65 -28.67 66.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.461 0.911 . . . . 1.0 113.461 -169.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.9 m -57.84 109.56 0.75 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.457 1.503 . . . . 1.0 113.856 -174.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -140.77 32.06 1.82 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.928 1.691 . . . . 1.0 111.361 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.3 m -84.88 161.63 19.8 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.769 -1.207 . . . . 1.0 113.589 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.38 159.08 23.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.718 1.207 . . . . 1.0 109.98 169.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -129.44 142.68 50.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.386 0.674 . . . . 1.0 111.195 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.0 t -75.41 125.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 169.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.94 151.48 51.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.709 1.204 . . . . 1.0 112.765 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -97.04 129.14 44.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.883 1.673 . . . . 1.0 108.394 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.15 163.06 37.93 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.029 0.532 . . . . 1.0 110.941 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -72.48 141.26 48.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.47 1.108 . . . . 1.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.69 -58.99 3.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.154 1.382 . . . . 1.0 111.167 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -55.77 -45.54 78.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.432 1.093 . . . . 1.0 111.393 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.42 -41.08 98.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.884 0.474 . . . . 1.0 111.671 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.23 -44.49 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.33 1.052 . . . . 1.0 112.325 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.94 -1.76 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 114.044 1.127 . . . . 1.0 114.044 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.27 50.81 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.377 0.989 . . . . 1.0 113.615 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 1.66 76.45 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.933 1.254 . . . . 1.0 114.56 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.4 m -126.27 155.75 41.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.148 1.779 . . . . 1.0 111.418 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.1 t -85.25 154.77 21.73 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -157.13 150.4 23.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.055 -1.028 . . . . 1.0 113.741 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -150.75 163.79 37.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.219 1.808 . . . . 1.0 110.58 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.6 t -83.64 137.46 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.085 0.954 . . . . 1.0 108.878 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -145.0 77.77 1.54 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.291 1.436 . . . . 1.0 110.845 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.08 62.69 2.89 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.929 1.292 . . . . 1.0 111.418 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.3 p -64.24 -40.18 95.5 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.806 1.242 . . . . 1.0 113.378 -170.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -71.48 -9.67 58.56 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.814 1.042 . . . . 1.0 113.814 -175.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.56 -27.06 68.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.873 0.844 . . . . 1.0 113.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -80.58 -14.73 57.96 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.295 1.438 . . . . 1.0 112.184 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -102.49 -39.89 6.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.654 1.581 . . . . 1.0 112.241 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -129.92 161.5 30.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.631 1.572 . . . . 1.0 113.11 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -65.85 159.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.413 1.085 . . . . 1.0 111.288 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.1 124.47 14.45 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.726 2.284 . . . . 1.0 110.817 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -94.23 154.94 40.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.076 1.35 . . . . 1.0 110.343 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.91 113.19 3.32 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.562 . . . . 1.0 110.89 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.45 -32.61 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.55 -36.29 78.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.875 0.47 . . . . 1.0 112.019 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.3 t -71.96 -36.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.912 0.885 . . . . 1.0 111.008 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.27 -47.72 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.858 0.754 . . . . 1.0 110.197 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.95 -38.81 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.945 0.898 . . . . 1.0 111.604 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -61.92 -41.52 98.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.305 0.957 . . . . 1.0 111.706 172.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -61.24 -45.3 95.1 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.2 -0.938 . . . . 1.0 111.055 173.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.94 73.36 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.394 -0.817 . . . . 1.0 110.717 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.69 -37.12 85.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.292 1.037 . . . . 1.0 113.43 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.76 -33.49 73.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.714 0.806 . . . . 1.0 112.507 173.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.9 mmm -74.65 -37.39 62.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.919 0.888 . . . . 1.0 112.654 176.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.9 t -46.11 128.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.268 0.94 . . . . 1.0 111.754 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.94 64.92 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.789 1.661 . . . . 1.0 113.56 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -84.06 146.05 28.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.004 1.402 . . . . 1.0 110.89 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -100.19 151.72 21.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.396 1.478 . . . . 1.0 112.56 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.6 mtt -150.74 169.35 21.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.586 1.554 . . . . 1.0 112.802 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -73.81 166.9 22.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.985 0.914 . . . . 1.0 111.408 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -156.12 171.49 20.06 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.639 1.576 . . . . 1.0 110.659 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 m -50.08 -19.0 0.64 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.439 2.696 . . . . 1.0 115.962 -172.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 tt -56.74 -23.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.793 1.237 . . . . 1.0 111.753 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.23 -45.29 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 126.863 2.065 . . . . 1.0 112.576 169.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.7 m -153.98 127.81 8.82 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.872 1.215 . . . . 1.0 111.528 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -57.88 132.39 53.23 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.326 -0.859 . . . . 1.0 111.283 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -144.45 -12.18 0.61 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.457 2.391 . . . . 1.0 117.457 -169.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 90.7 m -63.14 -41.53 99.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.463 1.938 . . . . 1.0 114.171 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.41 -47.05 77.61 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.754 -0.591 . . . . 1.0 110.881 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -59.54 -30.98 69.0 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.61 -0.681 . . . . 1.0 112.436 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.19 -61.16 2.55 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.376 -0.828 . . . . 1.0 111.01 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.41 -28.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 p -67.28 -39.08 85.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.959 0.904 . . . . 1.0 112.469 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -59.35 -24.41 63.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.804 0.842 . . . . 1.0 113.036 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -66.19 -35.7 81.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.091 0.86 . . . . 1.0 112.637 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -87.08 -42.79 12.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.064 0.946 . . . . 1.0 111.846 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -68.09 -30.86 70.14 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -79.09 -37.69 24.51 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.652 1.12 . . . . 1.0 113.298 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . 0.299 0.1 OUTLIER 38.01 -145.6 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 127.467 2.307 . . . . 1.0 115.805 174.777 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.419 1.888 . . . . 1.0 113.603 -179.64 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 110.717 -0.105 . . . . 1.0 110.717 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.55 158.6 35.38 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.036 0.934 . . . . 1.0 112.858 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 p -75.4 151.79 85.49 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.235 1.014 . . . . 1.0 112.989 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.76 159.49 38.53 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.666 2.911 . . . . 1.0 112.062 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.64 -15.95 60.27 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.412 0.893 . . . . 1.0 113.412 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -127.91 139.21 52.74 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.983 1.713 . . . . 1.0 109.215 174.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.54 150.21 43.1 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.128 0.971 . . . . 1.0 110.736 174.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.03 156.74 13.27 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.515 2.81 . . . . 1.0 113.197 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -126.85 162.14 49.2 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.587 1.955 . . . . 1.0 111.706 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -45.8 129.06 11.64 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.061 3.174 . . . . 1.0 113.289 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -7.36 73.94 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.251 1.405 . . . . 1.0 114.887 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -71.48 142.23 50.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.28 1.54 . . . . 1.0 113.839 -175.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.05 124.57 31.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.296 1.438 . . . . 1.0 108.814 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -105.25 128.47 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.124 -1.436 . . . . 1.0 107.124 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -109.6 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.364 1.466 . . . . 1.0 108.048 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mt -127.89 140.64 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.959 1.704 . . . . 1.0 108.911 -169.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -123.72 106.18 10.3 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 1.0 110.375 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -90.47 161.66 15.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.901 1.68 . . . . 1.0 108.437 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.94 108.93 0.5 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.669 0.788 . . . . 1.0 110.302 175.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.95 -2.76 87.17 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.518 1.532 . . . . 1.0 116.524 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -152.16 130.64 12.18 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 120.243 2.022 . . . . 1.0 114.544 -170.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -77.76 155.33 31.24 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.144 1.378 . . . . 1.0 112.151 169.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -151.16 165.7 33.09 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.566 1.547 . . . . 1.0 110.89 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -144.34 157.88 44.03 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.023 -1.048 . . . . 1.0 113.407 -173.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.91 40.11 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.781 1.232 . . . . 1.0 112.824 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.37 118.64 37.31 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.971 1.708 . . . . 1.0 108.37 171.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.092 -1.005 . . . . 1.0 112.496 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.06 2.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 115.155 1.539 . . . . 1.0 115.155 -170.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.15 166.84 31.5 Favored Glycine 0 N--CA 1.479 1.513 0 C-N-CA 124.593 1.092 . . . . 1.0 112.984 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 65.12 1.17 1.44 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.39 2.276 . . . . 1.0 114.321 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 6.09 59.31 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.112 1.339 . . . . 1.0 113.932 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -90.49 152.22 21.04 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.167 1.984 . . . . 1.0 113.573 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.68 154.76 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.695 1.598 . . . . 1.0 110.734 171.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -114.51 137.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.837 -1.542 . . . . 1.0 106.837 168.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -155.77 164.17 38.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 120.951 -1.093 . . . . 1.0 110.344 -170.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.7 tp -85.92 143.19 28.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.747 -1.205 . . . . 1.0 107.747 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.27 106.26 43.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.897 1.279 . . . . 1.0 110.692 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.52 139.18 80.4 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.464 2.776 . . . . 1.0 112.302 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -89.48 -172.32 0.62 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 124.43 3.42 . . . . 1.0 111.472 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 p -76.14 165.33 25.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.353 1.061 . . . . 1.0 113.066 169.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.52 146.34 40.61 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.284 1.033 . . . . 1.0 112.436 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.9 t80 88.0 129.28 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 129.1 2.96 . . . . 1.0 112.973 170.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -81.15 177.57 7.7 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.626 2.884 . . . . 1.0 111.655 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.57 171.28 55.1 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.357 0.979 . . . . 1.0 113.608 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 65.76 15.72 10.18 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.069 1.748 . . . . 1.0 114.649 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.43 170.4 23.3 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 126.084 1.802 . . . . 1.0 112.094 173.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.2 m -57.18 -31.1 65.08 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.279 1.214 . . . . 1.0 114.279 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.8 p -95.99 -2.16 47.52 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.987 1.315 . . . . 1.0 113.872 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.6 p -133.3 -9.06 2.94 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.489 2.033 . . . . 1.0 116.489 -170.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.0 -32.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 120.583 1.538 . . . . 1.0 114.71 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -84.91 -27.12 26.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.091 0.956 . . . . 1.0 113.397 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.5 p -100.17 -33.73 10.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.416 1.087 . . . . 1.0 113.374 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 t 63.91 72.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.712 2.005 . . . . 1.0 110.733 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.5 -178.98 5.52 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.54 1.536 . . . . 1.0 112.4 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -154.8 152.73 30.18 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.964 1.306 . . . . 1.0 110.824 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -114.62 5.92 15.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.907 0.883 . . . . 1.0 112.931 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.8 m -73.17 130.8 41.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.316 -1.49 . . . . 1.0 110.778 170.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.07 147.43 34.73 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.22 1.008 . . . . 1.0 110.608 173.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -113.39 141.6 46.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.64 0.776 . . . . 1.0 110.81 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.31 127.72 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 170.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.52 160.15 40.51 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.557 1.543 . . . . 1.0 112.636 -173.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -101.88 134.33 45.25 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.01 1.324 . . . . 1.0 110.059 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.49 172.9 12.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.505 1.522 . . . . 1.0 109.922 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -81.26 143.93 31.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.979 -1.076 . . . . 1.0 112.124 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 tp -50.85 -53.55 31.33 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.816 1.246 . . . . 1.0 111.226 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.77 -47.94 73.27 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 1.0 111.042 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.71 -36.53 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.5 -47.25 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.862 1.265 . . . . 1.0 112.292 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 m -79.78 -1.25 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 114.353 1.242 . . . . 1.0 114.353 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.32 127.42 44.86 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.974 0.797 . . . . 1.0 112.768 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 2.92 81.23 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.922 1.248 . . . . 1.0 114.781 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.2 m -125.38 160.46 29.32 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 1.0 111.909 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.9 m -89.18 157.8 18.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.806 0.842 . . . . 1.0 109.033 168.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.24 162.9 36.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -158.95 162.05 36.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.836 1.655 . . . . 1.0 112.001 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.1 t -83.23 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -148.5 74.8 1.29 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.278 1.037 . . . . 1.0 111.426 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -77.92 58.65 1.96 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.104 1.362 . . . . 1.0 111.555 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.5 p -63.56 -45.88 88.48 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.615 -1.303 . . . . 1.0 112.896 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 mt -72.49 -10.23 59.54 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.94 -25.36 57.57 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.708 0.803 . . . . 1.0 112.299 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.34 -4.61 53.64 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.45 1.5 . . . . 1.0 113.253 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -84.17 -65.44 1.01 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.431 1.093 . . . . 1.0 111.114 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -109.72 174.68 5.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.068 2.147 . . . . 1.0 113.148 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -66.48 140.21 96.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 121.271 -0.893 . . . . 1.0 110.791 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.21 148.37 91.17 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.887 3.058 . . . . 1.0 113.711 -169.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -99.26 153.83 37.59 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.832 1.253 . . . . 1.0 112.248 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.66 118.46 5.47 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.591 2.861 . . . . 1.0 110.341 170.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 t -55.8 -38.4 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.372 1.469 . . . . 1.0 112.851 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.01 -36.57 70.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.64 0.776 . . . . 1.0 111.616 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.29 -34.46 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.497 -0.764 . . . . 1.0 111.081 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.72 -46.66 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.535 1.062 . . . . 1.0 110.186 171.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.07 -36.68 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.48 1.112 . . . . 1.0 111.414 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 t -63.07 -44.39 95.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.061 0.846 . . . . 1.0 111.111 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.8 m -58.32 -44.44 88.64 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.483 1.113 . . . . 1.0 111.817 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.71 72.74 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.416 1.007 . . . . 1.0 111.135 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.368 1.067 . . . . 1.0 112.957 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.85 -32.89 74.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.978 0.911 . . . . 1.0 112.371 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 80.9 mmm -74.95 -36.35 62.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.703 -1.141 . . . . 1.0 113.086 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.8 t -46.42 125.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 120.277 1.398 . . . . 1.0 111.015 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.72 -17.13 57.9 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.151 1.834 . . . . 1.0 114.182 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -85.77 165.65 16.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.912 1.356 . . . . 1.0 110.961 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.6 156.32 44.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.4 mtt -144.15 177.21 8.75 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.797 2.039 . . . . 1.0 112.598 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.91 161.92 17.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 1.0 114.19 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -68.56 164.09 22.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.988 1.715 . . . . 1.0 113.948 -175.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 p -58.24 -16.91 15.71 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.71 1.604 . . . . 1.0 114.858 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.56 -29.76 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.91 0.884 . . . . 1.0 111.664 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.1 89.13 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 104.73 -2.322 . . . . 1.0 104.73 168.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.8 p -59.21 -32.76 70.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.617 1.34 . . . . 1.0 114.617 -169.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -84.93 2.77 41.33 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.29 1.218 . . . . 1.0 114.29 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -52.03 -42.49 63.13 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 120.698 1.59 . . . . 1.0 113.581 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.7 m -69.95 -36.64 75.42 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.075 -1.016 . . . . 1.0 113.366 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.4 -56.86 14.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.461 0.573 . . . . 1.0 109.942 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -55.58 -34.0 64.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 1.0 112.751 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -60.0 -59.73 4.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.074 -0.489 . . . . 1.0 110.737 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.22 -32.27 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 -170.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.75 -42.71 90.62 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.393 0.997 . . . . 1.0 111.553 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -61.41 -24.27 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.612 1.165 . . . . 1.0 112.773 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.95 -31.84 73.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.51 1.05 . . . . 1.0 112.846 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -94.89 -49.87 5.38 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.805 1.242 . . . . 1.0 111.352 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -62.26 -46.94 86.56 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.922 -1.111 . . . . 1.0 112.51 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.01 38.73 3.19 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.837 2.16 . . . . 1.0 112.969 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.41 150.42 3.58 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.824 0.85 . . . . 1.0 112.53 174.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 125.634 1.574 . . . . 1.0 114.866 -172.063 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 120.004 -0.046 . . . . 1.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.58 -10.9 38.87 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.546 1.313 . . . . 1.0 114.546 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -65.93 -39.04 27.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 116.212 1.93 . . . . 1.0 116.212 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -82.45 164.81 16.57 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.799 2.333 . . . . 1.0 111.946 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -87.99 164.32 15.86 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.786 0.834 . . . . 1.0 112.402 170.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -79.17 157.85 27.81 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.296 -0.877 . . . . 1.0 110.619 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.56 118.68 70.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.38 147.77 18.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.223 2.615 . . . . 1.0 112.722 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -129.81 159.48 69.64 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.219 1.807 . . . . 1.0 112.744 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -46.61 129.24 13.76 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 124.086 3.191 . . . . 1.0 112.907 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.99 79.05 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.584 -1.12 . . . . 1.0 114.863 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -64.85 144.12 57.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.323 1.561 . . . . 1.0 113.143 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -94.12 125.24 38.64 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.421 1.488 . . . . 1.0 108.523 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.57 132.35 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -103.89 133.75 48.33 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.578 1.551 . . . . 1.0 108.863 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.2 mt -127.81 119.92 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.929 1.692 . . . . 1.0 108.132 -171.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -88.68 62.74 6.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.899 1.679 . . . . 1.0 113.168 -168.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -66.57 149.04 51.06 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.725 -0.61 . . . . 1.0 110.401 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.67 138.91 58.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.967 0.907 . . . . 1.0 110.846 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.89 -126.89 7.61 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.972 -1.251 . . . . 1.0 109.972 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -67.22 141.27 57.35 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.334 0.588 . . . . 1.0 112.446 173.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -81.73 155.25 25.6 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.889 1.276 . . . . 1.0 111.177 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -108.76 156.0 20.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.459 1.104 . . . . 1.0 111.12 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.95 154.29 51.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.406 1.083 . . . . 1.0 111.259 174.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.8 146.84 28.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.16 115.41 27.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.972 1.709 . . . . 1.0 107.846 170.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -81.14 131.89 35.32 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.565 -0.71 . . . . 1.0 111.95 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.67 2.31 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.6 165.23 29.43 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 124.726 1.155 . . . . 1.0 112.759 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.58 17.31 9.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.109 1.764 . . . . 1.0 113.958 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 0.05 81.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.665 1.602 . . . . 1.0 114.195 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.83 154.2 17.37 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.448 1.624 . . . . 1.0 114.057 -175.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 m -137.25 158.38 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.98 1.712 . . . . 1.0 111.662 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.42 139.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.807 1.643 . . . . 1.0 108.326 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -156.43 150.02 24.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 1.0 111.661 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -97.06 124.79 41.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.863 0.865 . . . . 1.0 109.512 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.47 108.1 6.42 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.406 -1.283 . . . . 1.0 110.322 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -69.73 157.76 59.34 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.551 2.167 . . . . 1.0 114.44 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -56.95 -18.29 27.46 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.814 3.676 . . . . 1.0 116.183 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 p -80.36 -8.32 59.46 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.969 1.1 . . . . 1.0 113.969 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.12 137.57 34.02 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.684 0.794 . . . . 1.0 110.201 169.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -58.94 137.87 87.48 Favored Pre-proline 0 CA--C 1.55 0.944 0 O-C-N 121.59 -0.694 . . . . 1.0 112.76 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.43 160.41 38.76 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.258 2.639 . . . . 1.0 110.728 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.32 0.11 89.37 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.783 0.706 . . . . 1.0 114.834 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.27 -178.22 3.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.826 2.05 . . . . 1.0 111.671 -170.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.08 2.02 48.48 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 124.889 1.233 . . . . 1.0 115.471 172.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 t -165.0 -165.91 0.96 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.797 1.639 . . . . 1.0 111.065 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 p -67.46 -23.04 65.47 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.057 1.343 . . . . 1.0 114.104 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.1 t -165.91 169.53 14.72 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.34 1.856 . . . . 1.0 110.586 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.66 -31.13 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.788 0.835 . . . . 1.0 112.542 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -80.22 -13.3 59.34 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 1.0 113.248 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -80.88 -6.39 58.56 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.606 0.965 . . . . 1.0 113.606 -174.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.77 143.94 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 127.049 2.14 . . . . 1.0 109.705 176.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.8 mt -104.61 -78.17 0.57 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.938 0.895 . . . . 1.0 111.494 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.8 p -66.01 148.27 52.06 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.775 1.028 . . . . 1.0 113.775 -174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -169.67 169.44 8.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.977 1.711 . . . . 1.0 112.212 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.3 p -70.33 149.36 47.44 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.254 0.835 . . . . 1.0 113.254 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.82 154.36 17.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.226 1.01 . . . . 1.0 111.347 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -133.56 137.41 45.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.979 0.912 . . . . 1.0 109.98 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.45 127.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -132.27 160.98 34.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.984 1.714 . . . . 1.0 111.804 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -121.14 139.92 52.69 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.906 1.682 . . . . 1.0 109.84 172.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -164.86 -179.52 5.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.772 1.229 . . . . 1.0 111.076 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -70.09 142.92 52.56 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.943 0.897 . . . . 1.0 111.02 172.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.5 tp -51.57 -56.77 11.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.288 1.035 . . . . 1.0 112.152 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.51 -41.18 80.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.502 0.592 . . . . 1.0 111.187 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.37 -39.0 81.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.08 0.552 . . . . 1.0 112.137 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.0 -38.48 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.49 1.116 . . . . 1.0 111.972 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.56 -49.47 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.024 1.33 . . . . 1.0 111.056 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.38 -121.94 27.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.713 0.673 . . . . 1.0 111.677 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.31 -0.68 86.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.953 1.263 . . . . 1.0 114.854 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.6 m -79.43 175.27 10.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.076 1.35 . . . . 1.0 111.591 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 95.6 m -110.19 168.34 9.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.379 1.471 . . . . 1.0 108.884 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -158.05 162.56 38.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -149.39 155.15 40.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.024 1.73 . . . . 1.0 111.272 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.26 135.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -153.86 84.86 1.16 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.818 0.818 . . . . 1.0 111.866 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -81.11 50.13 1.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.187 1.395 . . . . 1.0 112.926 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 m -59.19 -33.46 70.98 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.501 -1.374 . . . . 1.0 113.144 -171.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.48 -12.37 60.13 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -26.69 68.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.962 0.801 . . . . 1.0 112.946 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -88.98 -5.1 58.2 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.893 1.277 . . . . 1.0 112.057 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -99.34 -50.26 4.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.17 1.388 . . . . 1.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -128.2 147.64 50.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.203 1.401 . . . . 1.0 112.774 -174.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -65.56 153.25 90.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 118.44 -0.79 . . . . 1.0 111.57 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.81 127.98 27.28 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.149 3.233 . . . . 1.0 114.765 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.32 155.62 46.45 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.003 1.321 . . . . 1.0 111.536 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.16 117.9 5.36 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.707 2.938 . . . . 1.0 110.063 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -57.3 -34.92 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.42 1.088 . . . . 1.0 113.017 -170.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.2 -36.37 75.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.953 0.501 . . . . 1.0 112.188 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.11 -36.1 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.97 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mt -59.99 -46.39 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 119.662 1.119 . . . . 1.0 110.337 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.44 -36.1 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.021 0.928 . . . . 1.0 111.288 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.7 m -64.56 -43.2 94.67 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.453 -0.779 . . . . 1.0 111.404 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.7 m -60.41 -43.97 96.17 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.658 1.183 . . . . 1.0 111.445 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.64 73.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.66 0.784 . . . . 1.0 110.458 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -60.92 -40.63 93.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.196 0.999 . . . . 1.0 113.002 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -65.25 -34.12 77.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.923 0.889 . . . . 1.0 112.334 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 75.3 mmm -73.73 -39.64 64.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.321 -0.847 . . . . 1.0 112.789 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -47.65 129.49 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.674 1.124 . . . . 1.0 111.707 172.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.37 -14.68 64.03 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.539 1.542 . . . . 1.0 113.464 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -82.69 143.2 31.09 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.122 1.461 . . . . 1.0 111.186 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.75 146.57 27.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.179 1.392 . . . . 1.0 111.633 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.3 mmt -124.57 142.92 51.0 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.809 1.643 . . . . 1.0 110.628 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.74 168.16 11.91 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -61.14 140.01 57.99 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.699 0.8 . . . . 1.0 111.843 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.6 t -87.27 139.17 30.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.55 -0.719 . . . . 1.0 112.031 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 pt -88.38 5.56 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 1.0 112.989 173.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 m -135.39 174.54 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.615 1.966 . . . . 1.0 110.681 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.8 p -67.23 -31.17 71.35 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -69.54 149.77 47.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.536 1.135 . . . . 1.0 112.497 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -165.69 -64.75 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.942 2.097 . . . . 1.0 111.867 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 6.9 t -85.04 -38.39 19.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.533 1.133 . . . . 1.0 113.504 -169.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -44.97 92.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.141 0.977 . . . . 1.0 110.385 169.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.31 -43.63 64.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.492 1.917 . . . . 1.0 111.381 170.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -64.12 -59.47 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.818 -0.611 . . . . 1.0 111.714 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.55 -22.36 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.481 1.037 . . . . 1.0 113.032 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 m -60.81 -51.41 69.42 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.791 1.236 . . . . 1.0 111.426 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -64.46 -26.51 68.47 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.979 0.733 . . . . 1.0 112.979 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.75 -34.97 76.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.035 0.834 . . . . 1.0 112.917 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -91.87 -49.71 6.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.23 1.012 . . . . 1.0 111.482 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -61.27 -45.86 92.73 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.257 -0.902 . . . . 1.0 112.288 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -115.01 52.17 0.67 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.38 1.943 . . . . 1.0 112.315 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 160.06 2.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.909 1.077 . . . . 1.0 113.909 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.255 1.363 0 C-N-CA 125.863 1.665 . . . . 1.0 114.221 -174.141 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 119.764 -0.16 . . . . 1.0 110.813 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.43 -25.9 54.92 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.699 1.37 . . . . 1.0 114.699 -173.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -62.72 143.36 96.77 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.179 0.992 . . . . 1.0 113.18 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.75 148.4 52.47 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.16 2.573 . . . . 1.0 111.645 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -140.2 153.69 46.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.725 1.61 . . . . 1.0 110.754 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -142.25 160.75 39.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.6 1.16 . . . . 1.0 111.833 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -150.48 129.97 6.52 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.617 1.567 . . . . 1.0 108.563 169.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.16 143.08 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.265 2.643 . . . . 1.0 111.591 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -129.48 163.44 46.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.094 1.757 . . . . 1.0 112.201 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -45.54 126.62 8.81 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 124.196 3.264 . . . . 1.0 113.095 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.75 82.6 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.44 1.495 . . . . 1.0 115.348 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.25 145.71 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.658 1.729 . . . . 1.0 113.782 -175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.94 123.05 30.06 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.54 1.136 . . . . 1.0 108.068 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.81 131.19 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.416 -1.328 . . . . 1.0 107.416 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.45 129.06 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.244 1.818 . . . . 1.0 108.27 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.75 128.95 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.005 1.722 . . . . 1.0 108.297 -170.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -109.91 137.52 47.58 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.384 1.474 . . . . 1.0 111.451 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -131.74 173.82 10.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.313 1.845 . . . . 1.0 110.119 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.89 101.68 1.13 Allowed 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.159 -0.963 . . . . 1.0 110.284 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.69 5.62 89.27 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.997 1.284 . . . . 1.0 115.701 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -148.92 163.51 37.23 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.464 1.505 . . . . 1.0 113.091 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -133.26 161.6 34.05 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.77 1.228 . . . . 1.0 110.619 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -147.38 169.25 19.87 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.835 1.254 . . . . 1.0 111.315 172.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -139.51 156.87 46.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.179 -0.951 . . . . 1.0 113.251 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.41 40.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.214 . . . . 1.0 112.546 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.08 119.08 38.21 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.901 1.681 . . . . 1.0 108.145 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -82.78 130.36 35.12 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.241 -0.912 . . . . 1.0 111.965 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 pt -113.05 3.3 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 114.744 1.387 . . . . 1.0 114.744 -170.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.37 168.05 35.63 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.4 1.0 . . . . 1.0 112.671 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.12 17.78 9.46 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.906 1.682 . . . . 1.0 113.999 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.63 85.37 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.002 1.287 . . . . 1.0 114.379 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.5 154.44 17.27 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.554 1.677 . . . . 1.0 114.204 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.27 157.11 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.283 1.833 . . . . 1.0 111.2 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.53 136.27 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.33 -1.73 . . . . 1.0 106.33 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -158.8 175.28 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.305 1.042 . . . . 1.0 110.32 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.6 mt -90.12 153.18 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.633 -0.667 . . . . 1.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.07 109.33 42.8 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.566 1.946 . . . . 1.0 107.86 169.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.11 157.54 23.41 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.224 2.616 . . . . 1.0 113.527 -169.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.25 -14.99 18.32 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.386 3.391 . . . . 1.0 113.363 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.3 m 70.93 8.32 6.49 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.226 1.81 . . . . 1.0 114.036 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -142.0 121.65 13.4 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.767 1.627 . . . . 1.0 110.013 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -69.86 -44.0 21.64 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.914 2.19 . . . . 1.0 116.914 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.73 164.1 35.6 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.538 2.825 . . . . 1.0 111.701 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.21 -23.13 76.34 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 119.047 -0.863 . . . . 1.0 114.323 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -167.28 -165.85 0.73 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.07 2.148 . . . . 1.0 110.895 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.03 177.6 31.4 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.81 1.195 . . . . 1.0 114.14 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.9 p -58.93 -30.46 67.87 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.944 1.461 . . . . 1.0 114.944 -169.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.3 m -83.93 -47.22 11.25 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.272 -0.893 . . . . 1.0 111.642 170.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.4 m -78.26 -15.91 58.31 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.167 1.173 . . . . 1.0 114.167 -170.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.98 -27.09 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 120.896 -1.127 . . . . 1.0 112.881 173.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -71.5 -34.37 70.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.559 0.744 . . . . 1.0 111.905 169.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 m -77.81 -30.77 51.38 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.429 1.492 . . . . 1.0 113.078 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.2 132.94 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.253 1.021 . . . . 1.0 112.557 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.0 mt -120.75 159.75 24.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.238 1.815 . . . . 1.0 111.458 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 t 72.48 169.8 0.32 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.293 1.837 . . . . 1.0 113.351 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 p30 179.48 158.17 0.64 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.864 2.065 . . . . 1.0 111.941 -170.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.9 m -143.45 152.02 41.03 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.089 0.956 . . . . 1.0 112.838 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.07 152.57 19.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.6 1.56 . . . . 1.0 110.13 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -98.24 138.77 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.093 0.861 . . . . 1.0 110.42 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.11 127.32 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 169.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -138.07 162.02 35.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.442 1.497 . . . . 1.0 112.276 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -109.22 140.28 43.05 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.227 1.811 . . . . 1.0 110.345 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.17 176.61 9.08 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.771 1.228 . . . . 1.0 110.909 172.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -74.28 142.07 45.27 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.705 1.202 . . . . 1.0 111.529 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.85 -51.94 64.34 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.977 -1.011 . . . . 1.0 111.844 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.19 -47.01 72.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.727 0.694 . . . . 1.0 111.22 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.74 -39.71 84.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.549 0.739 . . . . 1.0 112.025 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.55 -42.05 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.404 1.081 . . . . 1.0 112.401 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -0.63 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.536 1.535 . . . . 1.0 113.9 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.91 52.29 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.404 1.002 . . . . 1.0 112.993 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.48 1.87 77.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.725 1.155 . . . . 1.0 114.622 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 24.5 m -120.44 161.26 21.53 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.243 1.817 . . . . 1.0 111.127 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.1 t -97.14 163.19 13.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.015 0.926 . . . . 1.0 109.204 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -157.39 163.32 38.7 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.13 151.72 28.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 109.67 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.23 129.5 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -132.39 68.76 1.49 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.068 0.947 . . . . 1.0 111.531 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -75.58 73.2 2.59 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.873 1.269 . . . . 1.0 111.729 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 m -70.37 -38.76 74.82 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.124 -0.985 . . . . 1.0 113.305 -170.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -75.55 -10.47 59.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.473 1.286 . . . . 1.0 114.473 -169.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.95 -30.59 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.065 0.946 . . . . 1.0 112.693 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -79.21 -16.46 56.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.602 1.561 . . . . 1.0 112.538 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -100.0 -41.33 7.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.486 1.515 . . . . 1.0 112.365 -172.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -130.1 160.27 34.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.202 1.401 . . . . 1.0 113.299 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -66.08 162.86 42.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.706 1.203 . . . . 1.0 111.803 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.32 146.14 7.38 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 125.124 3.883 . . . . 1.0 115.255 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 151.71 63.0 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.486 1.514 . . . . 1.0 112.296 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.88 120.09 4.56 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.853 3.035 . . . . 1.0 112.446 -169.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.9 p -55.58 -33.25 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.208 1.188 . . . . 1.0 114.208 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.66 -35.4 79.51 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.677 0.391 . . . . 1.0 112.041 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.53 -35.47 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.202 0.601 . . . . 1.0 110.815 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.3 mt -62.52 -49.39 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.837 0.744 . . . . 1.0 110.059 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -68.65 -37.64 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.031 0.932 . . . . 1.0 111.709 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.1 m -62.11 -42.02 98.82 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.238 -0.914 . . . . 1.0 111.86 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 t -60.23 -45.44 93.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.559 0.744 . . . . 1.0 111.06 173.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.84 75.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.351 0.66 . . . . 1.0 110.95 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.55 -38.67 90.93 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.14 -0.975 . . . . 1.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.3 -35.58 80.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.766 0.827 . . . . 1.0 112.092 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mmm -73.75 -36.24 65.12 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 1.0 112.975 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.62 126.89 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.744 1.156 . . . . 1.0 111.417 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.27 -17.68 58.72 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.154 1.835 . . . . 1.0 113.981 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -88.14 158.07 18.65 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.872 1.336 . . . . 1.0 110.709 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.79 141.81 43.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.618 1.167 . . . . 1.0 112.335 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 mmt -127.43 146.48 50.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.381 1.872 . . . . 1.0 110.51 -175.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -58.31 132.63 54.22 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.7 -0.625 . . . . 1.0 111.891 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -74.36 168.47 19.61 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.072 0.767 . . . . 1.0 113.072 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.5 m -68.56 41.03 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 128.569 2.748 . . . . 1.0 115.644 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.02 139.56 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 O-C-N 120.488 -1.382 . . . . 1.0 109.857 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t 72.73 -44.81 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 127.232 2.213 . . . . 1.0 112.012 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -163.3 161.44 24.66 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.303 1.841 . . . . 1.0 111.397 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -66.57 132.89 49.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.576 0.75 . . . . 1.0 112.756 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -122.72 -2.59 8.81 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.0 m -74.79 -15.31 60.75 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.229 -1.544 . . . . 1.0 114.558 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -46.53 55.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.825 0.739 . . . . 1.0 110.391 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -53.12 -27.98 23.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.608 1.163 . . . . 1.0 113.654 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -65.07 -53.97 37.42 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.183 -0.948 . . . . 1.0 111.173 169.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.43 -26.6 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -64.56 -41.72 96.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.479 1.036 . . . . 1.0 111.815 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.6 -24.23 66.55 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.537 1.135 . . . . 1.0 112.923 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.16 -31.36 72.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.954 0.797 . . . . 1.0 112.557 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -94.16 -43.73 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.618 1.167 . . . . 1.0 111.723 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -67.81 -33.81 75.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.616 0.969 . . . . 1.0 113.616 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -84.3 10.76 60.3 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.8 1.667 . . . . 1.0 114.323 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -56.83 -39.54 74.39 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.419 1.488 . . . . 1.0 113.401 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.436 1.895 . . . . 1.0 112.641 178.786 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 119.067 -0.492 . . . . 1.0 111.133 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.17 163.48 27.03 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.139 0.881 . . . . 1.0 112.736 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 p -77.51 155.69 81.27 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.819 1.248 . . . . 1.0 112.955 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.18 161.1 43.92 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.368 2.712 . . . . 1.0 111.598 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -81.41 167.06 19.83 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.419 0.896 . . . . 1.0 113.419 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -71.89 146.71 47.69 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.1 0.96 . . . . 1.0 110.791 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -138.23 141.78 33.06 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 124.81 1.244 . . . . 1.0 110.717 173.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.37 148.6 16.55 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.689 2.926 . . . . 1.0 112.181 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -130.0 161.26 60.9 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.386 1.874 . . . . 1.0 112.915 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.43 128.17 12.16 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.182 3.255 . . . . 1.0 113.114 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.91 -7.64 78.86 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.122 1.344 . . . . 1.0 114.9 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.41 142.48 53.86 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.316 1.558 . . . . 1.0 113.689 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.85 123.96 31.8 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.132 1.373 . . . . 1.0 108.733 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 mm -105.64 127.17 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.783 -1.192 . . . . 1.0 107.783 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -102.49 125.67 49.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.498 1.519 . . . . 1.0 108.272 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.75 119.06 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.137 1.375 . . . . 1.0 109.317 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -85.39 62.32 7.41 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.444 1.498 . . . . 1.0 110.514 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -61.76 149.83 38.71 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.026 0.931 . . . . 1.0 110.651 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.31 129.62 32.35 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.473 1.109 . . . . 1.0 110.304 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.97 -123.02 5.93 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 -169.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -73.3 139.37 46.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.851 0.861 . . . . 1.0 113.046 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.0 mp0 -64.66 157.61 26.74 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.831 1.652 . . . . 1.0 111.374 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.09 163.04 28.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.791 1.636 . . . . 1.0 111.023 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -138.0 150.08 46.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.035 0.934 . . . . 1.0 112.868 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.28 155.82 42.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.468 1.107 . . . . 1.0 112.469 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.35 116.22 32.29 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.924 1.689 . . . . 1.0 107.733 172.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -82.29 131.09 35.23 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.241 -0.912 . . . . 1.0 111.872 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.2 pt -114.26 2.5 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.806 1.41 . . . . 1.0 114.806 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.73 168.67 36.73 Favored Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.448 1.023 . . . . 1.0 112.772 -175.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.74 17.8 9.07 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.983 1.713 . . . . 1.0 113.8 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.16 -0.35 85.79 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.143 1.354 . . . . 1.0 114.445 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -92.94 153.41 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.788 1.794 . . . . 1.0 114.646 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.85 156.52 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.274 1.83 . . . . 1.0 110.865 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.0 mt -115.09 134.84 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.659 1.584 . . . . 1.0 107.101 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.32 145.39 22.75 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.326 -0.859 . . . . 1.0 112.402 -168.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.71 93.31 8.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.491 0.716 . . . . 1.0 109.861 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.47 127.05 90.6 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.494 1.117 . . . . 1.0 111.374 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.87 161.75 42.88 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.357 2.705 . . . . 1.0 112.411 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.83 162.06 43.15 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.409 2.739 . . . . 1.0 111.421 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 52.0 p -74.21 -19.07 60.65 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -145.83 143.79 29.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.176 1.79 . . . . 1.0 110.738 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -76.39 -51.89 2.44 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 115.646 1.721 . . . . 1.0 115.646 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.85 151.54 16.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.449 2.766 . . . . 1.0 112.819 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.68 10.93 72.05 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.599 1.571 . . . . 1.0 113.001 173.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.51 144.03 48.4 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 1.0 111.641 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.41 -111.11 0.24 Allowed Glycine 0 N--CA 1.465 0.599 0 C-N-CA 123.707 0.67 . . . . 1.0 111.759 -171.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.1 p -66.02 -24.47 66.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.683 0.793 . . . . 1.0 112.599 170.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -122.12 147.16 46.48 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.661 1.584 . . . . 1.0 110.809 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.0 t -79.77 49.74 1.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 O-C-N 120.285 -1.509 . . . . 1.0 112.538 -174.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.14 46.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.823 1.649 . . . . 1.0 112.739 -175.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -54.47 -36.35 64.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.29 1.436 . . . . 1.0 113.236 -174.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -71.97 -10.54 59.92 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.79 1.033 . . . . 1.0 113.79 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.77 130.58 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.984 1.314 . . . . 1.0 108.773 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.5 -72.84 0.17 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.278 1.031 . . . . 1.0 112.126 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.7 m 66.17 -34.27 0.2 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 127.602 2.361 . . . . 1.0 114.968 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -83.23 150.87 25.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.182 1.793 . . . . 1.0 112.825 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.7 m -139.06 152.25 47.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.215 1.006 . . . . 1.0 111.781 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.08 155.7 20.7 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.266 1.026 . . . . 1.0 110.514 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.25 135.34 52.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.223 1.009 . . . . 1.0 110.929 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.44 122.35 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 170.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -128.04 161.03 30.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.536 1.534 . . . . 1.0 111.799 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -117.38 120.27 37.64 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.143 1.777 . . . . 1.0 109.994 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -147.19 177.53 9.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.694 1.198 . . . . 1.0 110.852 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.52 139.68 38.62 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.147 -0.97 . . . . 1.0 111.394 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.48 -49.97 68.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.063 0.945 . . . . 1.0 111.609 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.76 -46.21 74.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.426 0.69 . . . . 1.0 111.316 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -44.9 76.37 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.785 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.55 -41.56 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.825 1.25 . . . . 1.0 112.144 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.37 -2.08 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.502 1.521 . . . . 1.0 113.71 -171.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.1 128.65 47.91 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.228 0.918 . . . . 1.0 112.924 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.46 -1.17 83.08 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.942 1.258 . . . . 1.0 114.726 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 m -117.67 150.26 39.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.78 1.632 . . . . 1.0 111.283 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.74 159.64 20.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -160.71 168.46 24.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.484 1.29 . . . . 1.0 114.484 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -159.97 162.2 34.31 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.507 1.523 . . . . 1.0 112.098 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.02 134.31 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 107.146 -1.427 . . . . 1.0 107.146 168.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -145.25 75.64 1.45 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.087 0.946 . . . . 1.0 111.075 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.11 64.64 3.32 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.974 1.309 . . . . 1.0 110.71 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -62.89 -42.4 99.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.736 1.215 . . . . 1.0 113.036 -170.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.67 -7.43 50.37 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.53 -27.95 68.04 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.767 0.794 . . . . 1.0 112.841 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.33 -14.7 59.3 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.205 1.402 . . . . 1.0 112.391 175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -104.21 -40.42 6.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.544 1.538 . . . . 1.0 112.112 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -129.4 156.76 43.55 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.109 1.764 . . . . 1.0 112.75 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -65.95 160.3 63.88 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.951 0.9 . . . . 1.0 111.828 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.34 125.51 17.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.635 2.89 . . . . 1.0 112.28 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -96.99 154.49 38.19 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.955 1.302 . . . . 1.0 110.137 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.11 112.41 3.3 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.032 2.488 . . . . 1.0 111.061 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.67 -33.06 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 124.549 1.139 . . . . 1.0 113.133 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.83 -37.38 79.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.267 0.485 . . . . 1.0 112.034 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.4 -38.76 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.67 0.788 . . . . 1.0 110.646 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.0 mt -60.07 -50.26 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.7 0.682 . . . . 1.0 109.858 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.6 mt -66.67 -36.46 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.248 1.019 . . . . 1.0 112.077 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 t -63.77 -41.78 97.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.948 0.795 . . . . 1.0 110.745 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.4 p -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.67 0.788 . . . . 1.0 111.858 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.83 76.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.888 0.875 . . . . 1.0 110.469 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.59 -39.21 90.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.223 1.009 . . . . 1.0 112.974 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.99 -34.86 79.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.564 0.746 . . . . 1.0 112.358 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.5 mmm -74.63 -36.83 62.91 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.322 -0.847 . . . . 1.0 113.162 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.96 127.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.528 1.058 . . . . 1.0 111.389 170.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.18 -13.53 61.72 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.857 1.694 . . . . 1.0 113.782 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -88.16 155.89 19.53 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.062 1.431 . . . . 1.0 111.245 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.16 143.63 46.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.263 1.425 . . . . 1.0 113.187 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -140.15 174.25 10.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.385 1.874 . . . . 1.0 111.172 -172.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -60.24 145.85 45.84 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.297 -0.877 . . . . 1.0 112.241 172.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -51.33 140.52 16.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.504 1.922 . . . . 1.0 114.576 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.63 -24.15 27.23 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.689 1.366 . . . . 1.0 114.689 -170.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 pt -75.72 149.45 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.79 0.836 . . . . 1.0 111.032 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.6 t 71.75 -49.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 126.75 2.02 . . . . 1.0 111.907 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.8 p -76.81 -27.47 55.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.676 1.59 . . . . 1.0 113.737 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 62.31 22.54 13.27 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.107 1.763 . . . . 1.0 112.073 -169.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -53.42 -24.96 13.97 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.268 1.581 . . . . 1.0 115.268 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.34 -32.04 62.21 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.695 -1.253 . . . . 1.0 113.945 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.49 -50.94 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.789 1.177 . . . . 1.0 110.876 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -64.1 -28.87 70.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.637 0.775 . . . . 1.0 112.488 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.31 -56.11 19.15 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.746 -0.596 . . . . 1.0 110.112 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.64 -30.34 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.0 p -66.43 -41.24 89.49 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.809 1.186 . . . . 1.0 112.344 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -63.22 -21.87 66.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.134 0.974 . . . . 1.0 112.806 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.0 mt -65.14 -32.93 74.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.515 1.052 . . . . 1.0 112.14 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -84.26 -55.05 4.38 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.58 0.752 . . . . 1.0 111.055 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.95 -34.71 77.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 -170.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -101.25 25.32 28.66 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.2 1.857 . . . . 1.0 114.184 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.2 151.47 12.44 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 118.544 1.172 . . . . 1.0 113.126 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.316 1.846 . . . . 1.0 115.114 -175.69 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 . . . . . 0 CA--C 1.545 0.761 0 CA-C-O 118.834 -0.603 . . . . 1.0 109.445 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.4 143.56 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.708 2.939 . . . . 1.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -125.0 160.41 54.54 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.61 1.964 . . . . 1.0 111.849 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.77 129.31 11.74 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 124.082 3.188 . . . . 1.0 112.786 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.5 -11.3 72.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.323 1.44 . . . . 1.0 114.924 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.77 137.64 57.91 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.125 1.463 . . . . 1.0 112.958 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.15 118.2 24.57 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.558 1.143 . . . . 1.0 108.348 171.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mm -93.95 127.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -108.29 117.14 33.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.246 2.219 . . . . 1.0 107.611 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mt -115.1 129.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.386 1.474 . . . . 1.0 109.052 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.442 1.497 . . . . 1.0 109.843 -179.316 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 119.669 -0.205 . . . . 1.0 111.512 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -136.54 154.95 50.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.422 1.267 . . . . 1.0 114.422 -173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.29 159.63 43.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.495 1.518 . . . . 1.0 112.744 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.43 114.88 29.5 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.076 1.75 . . . . 1.0 108.709 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -82.67 131.69 35.2 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.062 -1.024 . . . . 1.0 112.183 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 pt -112.86 -0.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -170.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.28 165.61 27.62 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 124.602 1.096 . . . . 1.0 113.164 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.3 t70 60.51 20.47 10.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.834 1.654 . . . . 1.0 114.079 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.54 0.27 79.47 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.637 1.589 . . . . 1.0 114.624 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.98 152.45 18.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.751 . . . . 1.0 114.16 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.3 155.09 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.664 1.586 . . . . 1.0 111.111 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.3 137.33 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.54 1.536 . . . . 1.0 107.219 169.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -153.07 159.34 42.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.143 0.977 . . . . 1.0 111.313 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -95.6 127.34 41.55 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.786 0 CA-C-O 117.639 -1.172 . . . . 1.0 109.202 171.44 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 109.445 -0.576 . . . . 1.0 109.445 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -146.41 138.32 24.86 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.832 -0.542 . . . . 1.0 110.292 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -77.6 129.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.29 161.49 35.65 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.728 1.611 . . . . 1.0 112.004 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -117.4 129.47 55.87 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.104 1.762 . . . . 1.0 110.281 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -148.37 173.9 12.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.656 1.183 . . . . 1.0 111.291 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.79 142.66 49.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.624 0.77 . . . . 1.0 110.661 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.34 -51.0 61.2 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.389 1.076 . . . . 1.0 111.826 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.06 -48.01 71.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.168 0.987 . . . . 1.0 110.988 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.86 -39.21 93.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.982 0.513 . . . . 1.0 111.877 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.57 -46.44 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.432 1.093 . . . . 1.0 112.065 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.71 -35.36 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.389 0.995 . . . . 1.0 113.05 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.33 -124.14 35.01 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.421 1.009 . . . . 1.0 111.797 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.02 -7.2 84.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.383 0.992 . . . . 1.0 114.812 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.07 148.44 41.9 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 1.0 111.634 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -76.54 161.94 28.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.738 0.815 . . . . 1.0 110.978 171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -157.19 160.45 38.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -144.01 163.51 33.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.769 2.028 . . . . 1.0 110.844 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.99 129.94 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 168.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -147.85 83.69 1.52 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.91 0.862 . . . . 1.0 111.914 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -80.81 54.65 2.2 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.998 1.319 . . . . 1.0 112.66 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.1 m -60.54 -31.89 70.96 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.734 -1.229 . . . . 1.0 113.271 -171.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -68.57 -11.37 59.89 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.932 1.086 . . . . 1.0 113.932 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.07 -28.06 67.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.999 0.818 . . . . 1.0 112.968 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -80.35 -14.56 58.25 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.244 1.418 . . . . 1.0 112.185 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -101.33 -46.83 4.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.396 1.478 . . . . 1.0 111.863 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.02 167.09 13.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.499 1.519 . . . . 1.0 113.464 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -66.23 161.63 55.21 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.682 1.193 . . . . 1.0 111.87 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.9 87.96 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.174 2.582 . . . . 1.0 110.761 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.59 151.15 96.76 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.681 1.192 . . . . 1.0 111.428 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.37 116.42 4.69 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.567 2.845 . . . . 1.0 110.093 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.28 -31.81 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.34 -36.07 77.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.065 0.395 . . . . 1.0 112.065 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.0 t -76.57 -32.19 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.323 0.649 . . . . 1.0 111.211 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.91 -46.43 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 119.265 0.939 . . . . 1.0 110.155 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.15 -38.01 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 1.0 111.531 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.0 m -64.9 -38.28 90.45 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.92 0.782 . . . . 1.0 111.14 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.0 m -63.73 -43.71 95.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.941 0.897 . . . . 1.0 111.306 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.04 -50.41 72.81 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.294 0.637 . . . . 1.0 110.662 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.78 -40.7 96.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.219 1.008 . . . . 1.0 112.903 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -66.55 -32.97 74.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.855 0.862 . . . . 1.0 112.388 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.6 -39.21 64.78 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.187 -0.911 . . . . 1.0 112.595 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.2 127.24 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.674 1.125 . . . . 1.0 111.406 172.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.13 63.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.927 1.727 . . . . 1.0 114.017 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -84.89 143.3 29.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.024 1.412 . . . . 1.0 111.306 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -97.32 159.01 15.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.618 1.567 . . . . 1.0 113.501 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.476 0.861 0 C-N-CA 126.657 1.983 . . . . 1.0 110.347 172.426 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 115.723 1.749 . . . . 1.0 115.723 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 25.4 p -68.97 -38.75 79.56 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 121.199 1.818 . . . . 1.0 112.912 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -43.61 93.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.608 0.763 . . . . 1.0 111.018 170.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -61.37 -39.55 91.05 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.427 -0.796 . . . . 1.0 111.77 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.1 -59.78 4.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.196 0.999 . . . . 1.0 110.797 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.28 -21.19 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 119.769 1.168 . . . . 1.0 113.425 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.5 m -64.0 -49.69 71.47 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.818 1.247 . . . . 1.0 111.038 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -61.35 -25.2 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.521 0.728 . . . . 1.0 112.74 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.43 -35.16 80.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.996 0.816 . . . . 1.0 113.076 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -94.03 -40.77 9.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.117 0.967 . . . . 1.0 112.297 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.47 -44.65 78.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.894 0.877 . . . . 1.0 112.29 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.078 0 C-N-CA 126.229 1.871 . . . . 1.0 113.639 -179.51 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 118.855 -0.593 . . . . 1.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.02 153.23 22.03 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.828 3.019 . . . . 1.0 113.003 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.91 162.94 50.64 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.331 1.852 . . . . 1.0 112.841 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -45.36 128.51 10.14 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 124.387 3.392 . . . . 1.0 113.509 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 -3.74 85.66 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.232 1.396 . . . . 1.0 115.204 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -70.04 143.43 52.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.636 . . . . 1.0 113.382 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.57 127.48 34.91 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.612 1.165 . . . . 1.0 108.594 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mt -117.07 127.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.722 0.809 . . . . 1.0 109.523 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -89.46 134.24 34.18 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.936 1.294 . . . . 1.0 108.169 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.66 119.49 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.877 1.271 . . . . 1.0 108.375 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 . . . . . 0 CA--C 1.536 0.421 0 C-N-CA 125.009 1.324 . . . . 1.0 110.985 -171.667 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.3 m80 . . . . . 0 CA--C 1.549 0.932 0 N-CA-C 109.14 -0.689 . . . . 1.0 109.14 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -133.86 148.63 51.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.313 -0.867 . . . . 1.0 112.841 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.36 151.49 40.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.235 1.014 . . . . 1.0 112.93 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.16 116.97 32.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.562 1.945 . . . . 1.0 108.306 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.3 133.04 35.22 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.135 -0.978 . . . . 1.0 112.356 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 pt -114.74 2.79 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 115.147 1.536 . . . . 1.0 115.147 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 166.63 32.86 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.353 0.978 . . . . 1.0 112.807 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.64 17.73 9.96 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.921 1.688 . . . . 1.0 114.143 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.57 80.95 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 125.11 1.338 . . . . 1.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -95.11 153.85 17.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.641 1.721 . . . . 1.0 114.672 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.59 158.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.031 1.732 . . . . 1.0 111.125 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.89 137.85 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 126.051 1.74 . . . . 1.0 106.718 168.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -154.38 149.31 26.72 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.215 -0.928 . . . . 1.0 111.625 -168.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.0 tp -86.12 130.1 34.64 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.757 0 C-N-CA 124.505 1.122 . . . . 1.0 110.47 -175.694 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 110.06 -0.348 . . . . 1.0 110.06 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -132.36 140.98 48.73 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.433 -0.792 . . . . 1.0 110.813 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.12 126.89 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 170.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -132.66 163.28 29.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.38 1.472 . . . . 1.0 112.003 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -121.29 137.86 54.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.209 1.804 . . . . 1.0 110.393 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -163.46 178.69 7.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.079 1.351 . . . . 1.0 110.977 171.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.9 142.08 51.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.9 0.88 . . . . 1.0 111.115 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 tp -52.07 -52.0 54.02 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.371 1.068 . . . . 1.0 111.778 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -54.65 -47.92 72.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.074 0.95 . . . . 1.0 110.788 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.54 -39.21 93.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.985 0.514 . . . . 1.0 111.985 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.3 t -69.25 -44.99 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.724 1.21 . . . . 1.0 111.956 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.79 -36.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.48 1.036 . . . . 1.0 112.829 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.62 -119.55 18.72 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 119.499 1.045 . . . . 1.0 111.622 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.22 -3.86 86.9 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.543 1.068 . . . . 1.0 114.867 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.4 m -76.41 147.24 38.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.828 1.314 . . . . 1.0 111.429 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -78.84 166.28 22.6 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.175 0.59 . . . . 1.0 110.15 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -160.22 164.1 33.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.023 1.119 . . . . 1.0 114.023 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -156.38 158.54 37.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.956 1.303 . . . . 1.0 112.115 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.0 t -81.04 139.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.488 1.115 . . . . 1.0 108.657 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -150.88 80.55 1.33 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.22 1.008 . . . . 1.0 111.111 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.78 68.44 3.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.388 1.075 . . . . 1.0 111.124 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.3 p -64.65 -36.02 82.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.691 1.197 . . . . 1.0 113.331 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.57 -10.16 56.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.925 1.084 . . . . 1.0 113.925 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.15 -32.65 55.85 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.537 1.135 . . . . 1.0 112.181 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.13 -16.11 58.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.382 1.473 . . . . 1.0 112.877 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -103.79 -45.9 4.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.398 1.479 . . . . 1.0 112.185 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -128.67 162.55 27.08 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.133 1.373 . . . . 1.0 113.211 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -71.33 156.17 91.99 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.613 -0.68 . . . . 1.0 111.03 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -51.04 133.63 41.28 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.182 3.255 . . . . 1.0 113.508 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -98.66 153.8 37.76 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.359 1.464 . . . . 1.0 110.352 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.37 110.99 3.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.207 2.605 . . . . 1.0 110.749 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.42 -33.55 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.323 1.231 . . . . 1.0 114.323 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -37.98 84.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.134 0.425 . . . . 1.0 111.517 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.83 -36.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.523 0.729 . . . . 1.0 110.907 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -60.01 -48.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.589 0.631 . . . . 1.0 110.12 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.7 -39.47 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.083 0.953 . . . . 1.0 111.742 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -63.51 -38.28 90.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.567 1.076 . . . . 1.0 112.196 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -62.7 -45.6 92.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.501 -0.75 . . . . 1.0 111.021 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.26 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.434 0.693 . . . . 1.0 110.951 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.59 -39.48 91.35 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.925 0.89 . . . . 1.0 113.224 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.93 -34.01 77.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.785 0.834 . . . . 1.0 112.232 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.9 mmm -73.29 -40.64 64.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.349 -0.834 . . . . 1.0 112.649 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.07 128.36 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.483 1.038 . . . . 1.0 111.586 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.7 -14.06 63.38 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.569 1.556 . . . . 1.0 113.219 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -83.75 142.3 30.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.171 1.485 . . . . 1.0 111.242 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -95.32 147.2 23.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.164 1.385 . . . . 1.0 112.269 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 21.5 mmt . . . . . 0 N--CA 1.472 0.628 0 C-N-CA 126.434 1.894 . . . . 1.0 110.237 179.446 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.6 t30 . . . . . 0 CA--C 1.552 1.03 0 N-CA-C 113.893 1.072 . . . . 1.0 113.893 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.3 m -59.59 -30.29 68.56 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.576 -1.328 . . . . 1.0 112.661 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -58.72 -56.76 17.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.462 0.573 . . . . 1.0 109.834 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -56.06 -32.21 63.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.756 0.822 . . . . 1.0 112.698 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -63.27 -57.84 9.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.64 -0.662 . . . . 1.0 110.491 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.74 -29.09 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.0 p -67.72 -41.98 82.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.656 1.116 . . . . 1.0 111.884 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -63.09 -23.26 67.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.987 0.915 . . . . 1.0 112.933 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.54 -30.21 71.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.399 0.999 . . . . 1.0 112.342 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -92.37 -53.72 4.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.27 1.428 . . . . 1.0 111.446 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -69.02 -35.3 76.48 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.881 1.067 . . . . 1.0 113.881 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.189 0 C-N-CA 126.142 1.829 . . . . 1.0 113.755 -177.627 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 . . . . . 0 CA--C 1.545 0.772 0 CA-C-O 118.677 -0.678 . . . . 1.0 109.929 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.45 147.97 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.634 2.889 . . . . 1.0 111.927 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -122.68 162.44 38.48 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.191 1.796 . . . . 1.0 111.728 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.57 127.09 11.23 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.822 3.014 . . . . 1.0 113.254 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.16 -8.51 77.62 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-O 118.495 -1.169 . . . . 1.0 115.303 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.28 143.38 57.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.326 1.563 . . . . 1.0 113.468 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.32 125.22 34.57 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.207 1.403 . . . . 1.0 109.341 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.3 mm -102.86 131.67 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.489 -1.3 . . . . 1.0 107.489 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -108.88 129.63 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.832 1.653 . . . . 1.0 108.231 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mt -126.81 118.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.9 1.28 . . . . 1.0 109.339 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 . . . . . 0 CA--C 1.538 0.512 0 C-N-CA 125.391 1.476 . . . . 1.0 110.539 -177.363 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.774 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -141.5 164.18 30.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.755 0.822 . . . . 1.0 112.537 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.98 154.45 35.0 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.74 115.19 27.51 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.029 1.732 . . . . 1.0 107.158 169.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -81.43 128.68 34.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.304 -0.873 . . . . 1.0 111.868 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.68 4.64 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.617 1.34 . . . . 1.0 114.617 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.71 169.82 40.15 Favored Glycine 0 N--CA 1.475 1.266 0 C-N-CA 124.292 0.949 . . . . 1.0 112.393 -173.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.78 16.14 8.77 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.004 1.722 . . . . 1.0 114.075 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 2.97 83.17 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.282 1.42 . . . . 1.0 114.205 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -98.66 154.34 18.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.749 1.775 . . . . 1.0 114.236 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.92 155.71 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.643 1.577 . . . . 1.0 111.309 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.5 mt -115.72 137.83 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.734 1.614 . . . . 1.0 107.327 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.34 147.41 24.64 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.982 -1.074 . . . . 1.0 111.636 -168.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.0 tp -87.48 128.55 35.23 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.392 -0.966 . . . . 1.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.696 0 C-N-CA 124.721 1.208 . . . . 1.0 110.878 -170.374 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 119.512 -0.28 . . . . 1.0 110.837 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.7 139.04 54.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.499 1.12 . . . . 1.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.53 125.9 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.827 0.739 . . . . 1.0 109.013 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.98 162.93 29.52 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.93 1.692 . . . . 1.0 111.807 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.65 140.81 50.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.722 1.609 . . . . 1.0 110.227 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -162.09 179.7 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.018 1.327 . . . . 1.0 111.076 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.9 145.21 48.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.947 0.899 . . . . 1.0 111.413 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -52.16 -53.56 41.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.631 1.172 . . . . 1.0 111.227 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.1 -43.77 74.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.471 1.109 . . . . 1.0 111.627 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -44.04 91.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.317 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.56 -42.6 72.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.38 1.072 . . . . 1.0 112.207 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.27 -3.02 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.74 128.93 48.1 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.493 1.044 . . . . 1.0 113.555 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.04 1.23 79.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.864 1.221 . . . . 1.0 114.839 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.3 m -125.66 158.14 35.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.026 1.73 . . . . 1.0 111.561 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.9 m -86.08 156.17 20.5 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -158.97 164.52 35.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.565 1.321 . . . . 1.0 114.565 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -161.3 163.35 30.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.37 1.468 . . . . 1.0 112.169 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.0 t -82.11 135.47 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 107.329 -1.36 . . . . 1.0 107.329 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -146.97 74.79 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.269 1.033 . . . . 1.0 111.215 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -77.94 57.97 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.543 1.537 . . . . 1.0 111.486 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 t -60.78 -40.32 92.12 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.515 -1.366 . . . . 1.0 112.498 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.5 mt -70.82 -10.28 59.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.56 -28.74 70.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.273 0.942 . . . . 1.0 112.58 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -84.08 -4.82 59.04 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.313 1.445 . . . . 1.0 111.825 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -103.67 -47.29 4.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.379 1.472 . . . . 1.0 111.698 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -129.49 150.68 50.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.101 1.36 . . . . 1.0 113.497 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -65.32 152.29 92.27 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.346 1.058 . . . . 1.0 111.382 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.94 133.69 23.93 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.039 2.493 . . . . 1.0 112.784 -170.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -83.74 160.62 58.17 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.555 . . . . 1.0 112.024 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.6 115.52 3.77 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.691 2.928 . . . . 1.0 110.045 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.96 -30.49 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -169.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.74 -35.08 77.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.201 0.601 . . . . 1.0 112.112 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.81 -37.88 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.65 -0.656 . . . . 1.0 110.576 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.3 mt -64.07 -48.67 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.397 0.679 . . . . 1.0 110.235 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -71.68 -41.02 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.32 1.048 . . . . 1.0 112.27 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.4 p -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.878 1.217 . . . . 1.0 111.81 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.2 m -61.39 -45.0 96.19 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.683 -0.636 . . . . 1.0 111.767 169.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.31 -48.71 78.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.797 0.726 . . . . 1.0 110.585 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.16 -40.46 96.07 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.082 0.953 . . . . 1.0 112.972 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.59 -32.34 73.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.678 0.791 . . . . 1.0 112.475 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.8 mmm -73.7 -37.95 65.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.835 0.854 . . . . 1.0 112.89 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.5 t -47.21 126.96 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.594 1.088 . . . . 1.0 111.372 170.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.56 61.24 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.895 1.712 . . . . 1.0 113.929 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.6 162.97 17.7 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.034 1.417 . . . . 1.0 111.403 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.63 160.85 27.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.373 1.469 . . . . 1.0 113.046 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.9 mtt . . . . . 0 N--CA 1.477 0.908 0 C-N-CA 125.278 1.431 . . . . 1.0 112.182 178.372 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 CA--C 1.546 0.8 0 N-CA-C 114.392 1.256 . . . . 1.0 114.392 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.25 -38.26 75.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.301 0.955 . . . . 1.0 113.352 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.63 -54.83 41.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 1.0 109.609 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -60.31 -29.08 68.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.643 0.777 . . . . 1.0 113.018 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.38 -59.88 3.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.39 -0.819 . . . . 1.0 109.928 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.63 -30.43 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.9 p -67.87 -44.48 76.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.577 1.081 . . . . 1.0 112.127 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.05 -25.16 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.068 0.947 . . . . 1.0 112.945 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.26 -29.14 67.34 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.216 0.916 . . . . 1.0 112.807 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -96.97 -53.71 3.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.629 1.172 . . . . 1.0 111.708 169.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -64.77 -28.85 69.86 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.207 1.188 . . . . 1.0 114.207 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.329 0 C-N-CA 123.944 0.783 . . . . 1.0 114.328 176.84 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 109.051 -0.722 . . . . 1.0 109.051 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.85 147.12 26.93 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.989 3.126 . . . . 1.0 111.376 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -127.29 156.11 75.33 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.187 1.795 . . . . 1.0 112.731 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.83 124.26 5.54 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.2 3.266 . . . . 1.0 113.677 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.11 -0.03 89.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.068 -1.407 . . . . 1.0 115.897 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.1 159.17 32.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.102 1.951 . . . . 1.0 114.241 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 124.67 34.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.615 1.166 . . . . 1.0 108.943 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.5 mt -100.34 124.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -88.68 116.33 26.86 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.52 129.86 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.165 0.986 . . . . 1.0 108.859 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 125.782 1.633 . . . . 1.0 108.997 179.041 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 110.108 -0.33 . . . . 1.0 110.108 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 144.87 25.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.818 -1.176 . . . . 1.0 110.48 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.5 154.0 44.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.423 1.489 . . . . 1.0 112.064 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.18 112.39 24.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.36 1.464 . . . . 1.0 108.426 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -83.67 133.86 34.8 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.007 -1.058 . . . . 1.0 112.091 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 38.7 pt -110.04 15.55 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -170.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -27.34 10.66 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 116.388 1.315 . . . . 1.0 116.388 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.44 13.13 26.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.359 1.063 . . . . 1.0 113.691 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.82 -4.6 83.5 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.704 1.145 . . . . 1.0 112.483 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -96.66 155.46 16.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.58 1.552 . . . . 1.0 112.906 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.82 152.69 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.601 1.56 . . . . 1.0 110.26 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.7 mt -117.83 138.11 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.14 1.376 . . . . 1.0 108.048 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -161.62 168.76 22.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.024 0.929 . . . . 1.0 110.463 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.3 tp -89.69 150.87 22.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 C-N-CA 124.871 1.268 . . . . 1.0 108.662 173.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 109.036 -0.727 . . . . 1.0 109.036 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.26 143.29 49.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.293 0.951 . . . . 1.0 111.646 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.49 124.21 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.65 157.42 42.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.13 1.372 . . . . 1.0 112.742 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -117.81 134.37 54.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.306 1.842 . . . . 1.0 110.215 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -159.38 174.89 14.05 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.993 0.917 . . . . 1.0 110.406 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.2 mtp85 -64.68 145.07 56.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.74 0.816 . . . . 1.0 110.893 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt -51.54 -52.31 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.032 0.933 . . . . 1.0 110.675 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -50.6 -50.56 53.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.004 1.322 . . . . 1.0 111.601 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.48 -43.79 89.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.256 0.623 . . . . 1.0 112.052 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.84 -40.89 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.248 1.019 . . . . 1.0 112.142 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 p -80.46 -35.29 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.947 0.794 . . . . 1.0 112.846 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.77 -130.37 47.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.877 0.762 . . . . 1.0 112.406 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.8 5.14 83.62 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.88 1.229 . . . . 1.0 114.734 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.2 m -79.19 160.13 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.611 1.206 . . . . 1.0 112.16 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.83 155.66 27.74 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.079 0.952 . . . . 1.0 111.124 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.02 163.67 33.84 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.319 1.229 . . . . 1.0 114.319 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -158.66 158.51 33.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.818 1.647 . . . . 1.0 111.283 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.4 t -86.13 134.45 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.193 0.997 . . . . 1.0 108.503 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -163.06 93.52 0.8 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.838 0.855 . . . . 1.0 111.804 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.33 109.05 10.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.37 0.668 . . . . 1.0 110.793 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.6 p -76.54 -51.5 11.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.545 1.138 . . . . 1.0 111.939 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.76 -14.18 62.86 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.463 1.105 . . . . 1.0 113.906 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.56 -30.1 62.74 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.285 1.034 . . . . 1.0 112.197 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -89.49 -6.34 56.52 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.09 1.356 . . . . 1.0 112.534 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -100.43 -49.27 4.28 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.367 1.467 . . . . 1.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.0 170.26 14.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.817 1.647 . . . . 1.0 112.505 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.64 139.75 83.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 121.317 -0.865 . . . . 1.0 108.861 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.27 143.45 77.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.473 2.782 . . . . 1.0 112.427 -170.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -86.0 162.09 47.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.368 0.667 . . . . 1.0 111.121 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.49 117.87 4.82 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.465 2.777 . . . . 1.0 111.535 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.77 -33.13 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.332 0.864 . . . . 1.0 113.332 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.06 -37.68 85.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.961 0.504 . . . . 1.0 111.37 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -34.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.535 0.734 . . . . 1.0 110.929 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.96 -43.06 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.362 0.983 . . . . 1.0 110.862 174.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.48 -36.83 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.885 -1.134 . . . . 1.0 111.599 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 t -69.58 -39.86 77.09 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.455 -0.778 . . . . 1.0 111.391 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.8 p -65.53 -40.23 92.69 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.89 0.876 . . . . 1.0 111.25 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.22 -53.5 57.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 1.0 110.808 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.75 -41.23 90.54 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.561 0.744 . . . . 1.0 112.847 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -65.9 -35.36 80.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.022 0.929 . . . . 1.0 112.559 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.76 -29.72 51.15 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.042 -0.98 . . . . 1.0 113.347 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.5 t -48.03 125.41 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.477 1.489 . . . . 1.0 111.17 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.64 -13.28 62.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.448 1.499 . . . . 1.0 114.318 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -75.81 155.88 35.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.197 1.499 . . . . 1.0 110.896 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.97 148.13 45.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.868 1.267 . . . . 1.0 112.604 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.1 mmt . . . . . 0 N--CA 1.471 0.582 0 C-N-CA 126.87 2.068 . . . . 1.0 110.499 179.042 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.4 p30 . . . . . 0 CA--C 1.554 1.099 0 N-CA-C 115.274 1.583 . . . . 1.0 115.274 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.0 m -59.25 -35.0 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.718 -1.239 . . . . 1.0 114.334 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -78.49 -49.19 13.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.149 1.379 . . . . 1.0 111.184 174.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -55.26 -35.04 64.58 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.244 1.017 . . . . 1.0 112.399 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -51.81 -51.5 55.99 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.641 -0.662 . . . . 1.0 112.494 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.35 -22.76 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.833 1.197 . . . . 1.0 113.557 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.5 p -74.79 -39.33 61.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.296 0.953 . . . . 1.0 110.922 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.97 -26.03 67.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.894 0.878 . . . . 1.0 113.127 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.05 -32.68 71.15 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 120.017 1.281 . . . . 1.0 113.247 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -89.62 -51.36 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.681 1.193 . . . . 1.0 110.978 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.21 -38.24 84.97 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.38 0.882 . . . . 1.0 113.38 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 126.962 2.22 . . . . 1.0 112.476 176.044 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 . . . . . 0 CA--C 1.545 0.781 0 CA-C-O 118.758 -0.639 . . . . 1.0 109.778 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.24 143.3 22.25 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.55 2.834 . . . . 1.0 111.387 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -115.27 160.07 35.63 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.939 1.696 . . . . 1.0 112.003 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -56.47 131.18 44.17 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.694 1.596 . . . . 1.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.97 -3.41 80.79 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.977 1.275 . . . . 1.0 114.348 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.29 149.83 38.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.101 1.45 . . . . 1.0 112.949 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.68 124.62 35.23 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.596 1.159 . . . . 1.0 109.379 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.57 130.5 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -110.66 129.5 55.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.389 2.276 . . . . 1.0 107.961 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.9 mt -125.26 120.34 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.1 1.36 . . . . 1.0 109.466 -169.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 CA--C 1.535 0.392 0 C-N-CA 125.377 1.471 . . . . 1.0 109.669 -179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 . . . . . 0 CA--C 1.545 0.752 0 N-CA-C 111.272 0.101 . . . . 1.0 111.272 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -141.71 153.66 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.257 -0.902 . . . . 1.0 113.286 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.07 154.87 39.9 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.751 1.22 . . . . 1.0 112.627 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.08 118.83 35.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.555 1.942 . . . . 1.0 108.443 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -82.06 130.56 35.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.186 -0.947 . . . . 1.0 112.156 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 pt -104.41 6.32 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 114.618 1.34 . . . . 1.0 114.618 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.99 -17.17 56.51 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 116.649 1.42 . . . . 1.0 116.649 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.13 13.67 26.49 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.813 1.245 . . . . 1.0 113.532 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -5.84 84.42 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.114 1.34 . . . . 1.0 112.305 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.61 156.53 16.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.867 1.667 . . . . 1.0 112.517 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -126.51 155.14 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.996 1.718 . . . . 1.0 109.888 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.54 138.47 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 168.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -159.86 175.55 12.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.324 1.05 . . . . 1.0 110.773 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.22 153.46 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.325 0.65 . . . . 1.0 109.263 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 168.721 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.615 0 N-CA-C 112.001 0.371 . . . . 1.0 112.001 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -141.78 142.57 33.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.014 0.926 . . . . 1.0 110.86 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.12 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -137.92 162.07 34.99 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.171 1.388 . . . . 1.0 112.595 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.6 ttp85 -112.69 136.44 52.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.287 1.835 . . . . 1.0 110.029 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.58 173.85 16.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.502 1.121 . . . . 1.0 110.557 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -66.17 143.62 57.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.763 1.625 . . . . 1.0 110.441 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 tt -52.8 -55.83 20.15 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.165 0.986 . . . . 1.0 110.478 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -52.58 -47.53 66.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.606 1.163 . . . . 1.0 111.635 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.77 -41.5 99.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.862 0.465 . . . . 1.0 111.687 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.49 -44.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.109 0.963 . . . . 1.0 112.356 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -74.6 -32.73 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 119.402 1.001 . . . . 1.0 112.768 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.54 -134.21 52.49 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.142 0.877 . . . . 1.0 112.904 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.47 0.99 87.25 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.78 1.181 . . . . 1.0 114.47 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.5 m -81.92 148.1 28.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.916 1.286 . . . . 1.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.82 156.18 39.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.387 0.675 . . . . 1.0 110.962 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -156.98 162.6 39.6 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.533 1.309 . . . . 1.0 114.533 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -160.12 165.58 31.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.262 1.825 . . . . 1.0 111.414 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.0 t -84.56 140.14 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.174 0.99 . . . . 1.0 108.836 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -146.24 74.21 1.36 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.423 1.089 . . . . 1.0 111.762 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -76.04 70.25 2.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.487 1.115 . . . . 1.0 111.312 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -60.37 -33.72 72.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.859 -1.151 . . . . 1.0 113.376 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.6 mt -71.47 -9.74 58.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.28 -34.56 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.467 1.107 . . . . 1.0 112.181 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.274 1.43 . . . . 1.0 112.741 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -104.43 -47.82 4.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.263 1.425 . . . . 1.0 112.576 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -131.15 156.33 45.46 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.899 1.28 . . . . 1.0 113.532 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.62 155.37 92.53 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.192 -0.909 . . . . 1.0 110.021 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.63 129.76 36.69 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.763 2.976 . . . . 1.0 114.926 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 159.33 85.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.48 1.112 . . . . 1.0 111.704 169.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.43 109.91 2.96 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.462 2.775 . . . . 1.0 110.151 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 p -52.89 -37.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.176 1.547 . . . . 1.0 115.176 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.524 0.602 . . . . 1.0 111.598 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 t -75.85 -31.67 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.706 0.802 . . . . 1.0 110.931 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.1 mt -64.46 -49.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.732 1.151 . . . . 1.0 109.976 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.44 -40.27 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.373 1.069 . . . . 1.0 110.667 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.2 m -68.56 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.523 -0.736 . . . . 1.0 111.981 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.4 m -63.26 -44.08 96.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.696 1.198 . . . . 1.0 110.763 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.64 77.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.433 0.693 . . . . 1.0 111.051 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -61.84 -38.36 87.91 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.147 -0.971 . . . . 1.0 113.173 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -66.09 -34.16 77.43 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.609 0.764 . . . . 1.0 112.307 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.4 mmm -74.83 -37.9 62.16 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.316 -0.85 . . . . 1.0 112.872 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.7 t -47.09 129.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.711 1.142 . . . . 1.0 111.684 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -16.43 60.57 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.934 1.73 . . . . 1.0 114.068 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -83.01 148.88 27.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.047 1.424 . . . . 1.0 111.267 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.1 156.61 17.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.151 1.38 . . . . 1.0 113.372 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtt . . . . . 0 N--CA 1.477 0.898 0 C-N-CA 125.934 1.694 . . . . 1.0 111.974 179.857 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 112.474 0.546 . . . . 1.0 112.474 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.8 m -69.56 -39.19 77.55 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.501 1.046 . . . . 1.0 112.85 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -57.57 -56.92 15.65 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.718 0.69 . . . . 1.0 109.255 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -58.61 -30.12 66.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.798 0.839 . . . . 1.0 113.128 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -67.23 -56.41 9.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.214 -0.928 . . . . 1.0 111.039 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.51 -26.12 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 -172.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.4 p -65.87 -44.65 84.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.703 1.138 . . . . 1.0 110.76 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.39 -24.57 66.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.339 0.866 . . . . 1.0 113.339 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.8 mt -61.77 -30.42 70.78 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.203 1.365 . . . . 1.0 112.835 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -94.06 -56.37 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.319 1.447 . . . . 1.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -65.98 -39.06 90.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.764 -1.21 . . . . 1.0 113.359 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.101 0 C-N-CA 126.404 1.954 . . . . 1.0 113.42 -179.269 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 CA--C 1.546 0.801 0 N-CA-C 108.745 -0.835 . . . . 1.0 108.745 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.75 150.28 27.23 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.185 2.59 . . . . 1.0 112.441 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -126.44 158.92 65.62 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.138 1.775 . . . . 1.0 112.31 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -46.37 127.75 11.58 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.332 3.354 . . . . 1.0 113.083 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.56 -8.21 77.08 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.987 1.28 . . . . 1.0 115.126 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -67.55 143.55 56.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.251 1.525 . . . . 1.0 113.573 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.62 127.25 34.42 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.976 1.31 . . . . 1.0 108.155 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mt -112.63 131.19 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -102.85 138.77 39.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.558 1.143 . . . . 1.0 109.082 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.24 134.9 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.557 1.943 . . . . 1.0 108.396 -169.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.283 . . . . 1.0 109.243 -175.491 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 109.034 -0.728 . . . . 1.0 109.034 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -138.92 160.49 39.61 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.676 -1.265 . . . . 1.0 112.252 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.95 152.83 33.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.729 0.812 . . . . 1.0 112.756 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.9 116.06 31.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.672 1.989 . . . . 1.0 106.995 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -82.24 129.67 34.9 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.59 -0.694 . . . . 1.0 111.91 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.92 4.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 -170.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.01 163.73 31.11 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 124.598 1.094 . . . . 1.0 113.08 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 t70 60.8 20.06 10.22 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.02 1.728 . . . . 1.0 114.312 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.7 71.68 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.551 1.548 . . . . 1.0 114.625 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.42 153.8 18.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.585 1.693 . . . . 1.0 113.951 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.4 157.76 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.58 1.552 . . . . 1.0 111.58 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.8 mt -121.0 141.07 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.754 1.622 . . . . 1.0 108.183 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -154.52 163.19 40.57 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.063 -1.023 . . . . 1.0 110.92 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.8 tp -104.92 119.41 38.95 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 1.0 108.752 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.71 0 CA-C-O 118.174 -0.917 . . . . 1.0 110.11 -175.455 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.503 0 N-CA-C 110.37 -0.233 . . . . 1.0 110.37 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.39 138.49 34.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.823 0.849 . . . . 1.0 111.412 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.74 129.03 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -134.98 156.46 49.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.675 1.59 . . . . 1.0 112.025 -173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -117.8 140.11 50.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.062 1.745 . . . . 1.0 110.331 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -164.59 -179.97 6.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.561 1.144 . . . . 1.0 110.846 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.06 143.97 52.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.295 1.038 . . . . 1.0 110.476 170.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.7 tt -49.8 -56.87 8.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.912 1.285 . . . . 1.0 110.831 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.05 -49.17 63.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.509 1.124 . . . . 1.0 111.256 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.07 -34.05 76.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.33 0.652 . . . . 1.0 112.69 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.73 -45.58 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.903 0.881 . . . . 1.0 111.951 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -81.5 -32.97 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.516 1.053 . . . . 1.0 113.832 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.67 -123.64 32.37 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.54 1.063 . . . . 1.0 111.256 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.73 2.07 85.76 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.646 1.117 . . . . 1.0 114.719 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.12 147.49 34.6 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.723 1.261 . . . . 1.0 111.755 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 23.9 t -75.16 156.97 35.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.68 0.792 . . . . 1.0 110.952 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.93 161.82 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -161.06 160.17 30.16 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.708 1.603 . . . . 1.0 111.862 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.3 t -79.68 139.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.941 0.897 . . . . 1.0 109.334 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -149.26 79.06 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.439 1.096 . . . . 1.0 111.401 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.22 72.29 4.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.58 1.152 . . . . 1.0 110.89 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.9 p -67.85 -46.18 72.49 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.591 1.156 . . . . 1.0 112.79 -172.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.8 mt -75.58 -8.35 56.54 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -174.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.86 -27.46 68.14 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.96 0.886 . . . . 1.0 113.128 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -79.39 -15.4 57.91 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.429 1.492 . . . . 1.0 112.288 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -102.03 -39.93 7.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.556 1.543 . . . . 1.0 112.237 -174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -126.98 160.7 30.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.732 1.613 . . . . 1.0 113.159 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -66.06 159.19 72.52 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.545 1.138 . . . . 1.0 111.342 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.43 127.03 19.79 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.667 2.245 . . . . 1.0 110.796 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -95.34 157.38 36.4 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.134 1.374 . . . . 1.0 110.181 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.51 111.2 2.9 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.86 2.373 . . . . 1.0 110.674 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.93 -32.52 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.612 1.165 . . . . 1.0 112.815 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.18 -36.81 75.97 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.049 0.54 . . . . 1.0 112.237 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.58 -37.81 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.817 0.847 . . . . 1.0 110.776 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.83 -48.69 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 1.0 110.156 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.7 mt -68.33 -39.27 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.258 1.023 . . . . 1.0 111.836 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -61.17 -42.87 99.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.419 1.009 . . . . 1.0 111.42 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 -43.67 98.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 1.0 111.756 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.11 73.93 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.328 -0.857 . . . . 1.0 110.746 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.13 -38.29 88.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.311 1.044 . . . . 1.0 113.203 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.97 -36.34 83.06 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.585 0.754 . . . . 1.0 112.117 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.0 mmm -73.22 -38.36 66.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.881 0.873 . . . . 1.0 112.752 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.95 129.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.167 0.894 . . . . 1.0 111.606 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.52 66.51 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.711 1.624 . . . . 1.0 113.479 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -87.14 145.38 26.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.961 1.38 . . . . 1.0 111.477 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -95.32 148.27 22.61 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.761 1.224 . . . . 1.0 112.399 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.476 0.863 0 C-N-CA 125.522 1.529 . . . . 1.0 112.001 -173.429 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.6 t30 . . . . . 0 CA--C 1.546 0.799 0 CA-C-O 120.51 0.195 . . . . 1.0 111.391 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.99 -40.04 60.91 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.914 1.079 . . . . 1.0 113.914 -169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -49.56 76.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.196 0.453 . . . . 1.0 110.18 170.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -61.52 -36.59 80.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.958 0.903 . . . . 1.0 111.814 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.05 -57.22 13.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.866 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.96 -28.13 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.828 1.194 . . . . 1.0 113.637 -173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.6 p -71.75 -39.72 69.82 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.846 1.203 . . . . 1.0 112.582 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -57.46 -26.62 61.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.812 0.845 . . . . 1.0 112.484 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.4 mt -62.31 -31.45 72.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.296 0.953 . . . . 1.0 112.719 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -88.75 -55.82 3.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.548 1.139 . . . . 1.0 111.18 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -65.37 -35.9 82.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -171.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 C-N-CA 126.923 2.201 . . . . 1.0 112.282 175.548 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 CA--C 1.551 1.013 0 N-CA-C 112.457 0.54 . . . . 1.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -86.63 155.82 9.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.986 3.79 . . . . 1.0 112.471 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.09 168.3 17.24 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.812 2.045 . . . . 1.0 112.476 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -50.16 127.23 19.18 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.608 2.872 . . . . 1.0 113.402 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.5 -2.84 86.5 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.341 -1.255 . . . . 1.0 115.011 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -75.01 148.17 40.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.678 1.739 . . . . 1.0 113.011 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -93.96 129.89 40.26 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.203 1.401 . . . . 1.0 110.177 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.45 133.09 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.174 0.99 . . . . 1.0 108.94 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.49 128.34 52.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.683 1.593 . . . . 1.0 108.69 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.4 mt -130.29 124.17 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.65 1.18 . . . . 1.0 110.257 -169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 . . . . . 0 CA--C 1.537 0.457 0 C-N-CA 125.172 1.389 . . . . 1.0 108.6 173.417 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 . . . . . 0 CA--C 1.546 0.81 0 CA-C-O 120.523 0.201 . . . . 1.0 110.61 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -140.24 148.94 42.25 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.301 -0.874 . . . . 1.0 111.811 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.66 149.79 36.28 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.532 0.938 . . . . 1.0 113.532 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.28 119.2 38.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.524 2.33 . . . . 1.0 107.484 169.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -82.58 132.81 35.19 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.058 -1.026 . . . . 1.0 112.137 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.69 2.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.102 1.519 . . . . 1.0 115.102 -170.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 169.86 38.81 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.265 0.936 . . . . 1.0 112.756 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.99 16.04 7.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.204 1.802 . . . . 1.0 114.031 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.02 2.99 73.85 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 124.997 1.284 . . . . 1.0 114.717 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -101.89 154.32 19.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.812 1.806 . . . . 1.0 114.454 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.65 153.76 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.588 1.555 . . . . 1.0 111.36 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.64 138.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 168.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -153.53 176.3 12.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.615 1.166 . . . . 1.0 109.85 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -126.53 122.0 33.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.119 0.872 . . . . 1.0 108.78 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.588 0 CA-C-O 118.075 -0.964 . . . . 1.0 109.775 -173.434 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 109.525 -0.546 . . . . 1.0 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -150.08 139.99 21.9 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.417 -0.802 . . . . 1.0 111.376 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.71 124.63 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.83 159.16 39.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.073 1.749 . . . . 1.0 112.77 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ttm105 -112.71 143.56 43.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.684 1.594 . . . . 1.0 110.245 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.86 176.77 9.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.351 1.46 . . . . 1.0 109.564 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -71.67 143.61 49.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.575 1.55 . . . . 1.0 110.008 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.91 -56.82 7.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.891 1.276 . . . . 1.0 110.275 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -53.56 -45.6 69.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.6 1.16 . . . . 1.0 111.812 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.99 -45.1 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.746 0.418 . . . . 1.0 111.297 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.63 -43.17 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.841 0.856 . . . . 1.0 111.745 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.47 -0.5 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.69 121.62 25.57 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.177 0.894 . . . . 1.0 111.306 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 10.99 85.92 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.294 0.95 . . . . 1.0 114.343 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 m -125.52 165.63 18.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.653 1.581 . . . . 1.0 112.413 -173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.6 m -111.98 150.94 29.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.193 1.397 . . . . 1.0 108.183 168.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.9 153.18 30.7 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.291 1.96 . . . . 1.0 116.291 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -132.31 151.51 51.81 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.379 2.271 . . . . 1.0 109.734 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.92 133.52 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.945 1.298 . . . . 1.0 107.625 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.94 85.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.058 0.932 . . . . 1.0 113.262 -169.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -79.11 46.99 0.75 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.203 1.401 . . . . 1.0 112.18 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.2 m -62.0 -24.43 67.04 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.593 -1.317 . . . . 1.0 113.293 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -61.99 -14.88 39.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.47 -33.81 46.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.917 1.287 . . . . 1.0 112.417 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -97.05 5.67 49.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.898 0.879 . . . . 1.0 113.222 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.32 -49.97 3.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.398 1.479 . . . . 1.0 111.204 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -126.52 167.46 15.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.802 1.641 . . . . 1.0 112.877 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -71.0 155.12 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 121.434 -0.791 . . . . 1.0 111.13 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.71 135.89 71.64 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.852 3.034 . . . . 1.0 113.075 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -113.39 148.28 39.29 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.27 1.428 . . . . 1.0 109.753 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.66 122.26 7.24 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.41 2.74 . . . . 1.0 111.536 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.28 -32.61 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.717 1.207 . . . . 1.0 113.198 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.39 -36.22 79.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.749 0.704 . . . . 1.0 112.061 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.27 -34.17 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.227 0.611 . . . . 1.0 111.065 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -64.66 -47.6 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.541 0.61 . . . . 1.0 110.049 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.02 -38.34 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.126 0.971 . . . . 1.0 111.399 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -41.38 96.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.928 0.786 . . . . 1.0 111.842 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.5 t -64.21 -42.36 96.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.738 0.815 . . . . 1.0 111.197 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.7 -48.39 77.81 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.212 -0.93 . . . . 1.0 110.855 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.91 -22.21 65.96 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.434 1.494 . . . . 1.0 114.529 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.5 -40.06 30.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.449 1.1 . . . . 1.0 111.621 170.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.6 mmm -75.45 -38.13 59.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.336 1.055 . . . . 1.0 112.688 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.71 135.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.186 0.81 . . . . 1.0 113.186 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.44 -16.17 61.68 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.806 1.67 . . . . 1.0 113.826 -174.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -84.04 146.9 27.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.154 1.477 . . . . 1.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.49 156.67 16.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.521 1.529 . . . . 1.0 112.271 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 47.0 mtt . . . . . 0 N--CA 1.474 0.763 0 C-N-CA 125.264 1.426 . . . . 1.0 112.376 176.003 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 . . . . . 0 CA--C 1.542 0.652 0 N-CA-C 112.275 0.472 . . . . 1.0 112.275 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.3 m -55.26 -43.92 75.09 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.397 1.629 . . . . 1.0 115.397 -169.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.36 -41.2 96.85 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.552 0.614 . . . . 1.0 111.685 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -69.44 -37.05 77.2 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.257 -0.902 . . . . 1.0 110.851 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.11 -58.2 9.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.429 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.74 -25.35 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.914 1.234 . . . . 1.0 112.263 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -63.85 -48.76 75.46 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.157 0.983 . . . . 1.0 111.461 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -61.6 -27.59 68.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.583 1.153 . . . . 1.0 112.986 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.2 -34.41 72.13 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.598 1.09 . . . . 1.0 112.946 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.9 ttm105 -94.36 -51.15 4.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.605 1.162 . . . . 1.0 111.717 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.43 -29.96 70.21 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.115 -0.991 . . . . 1.0 113.665 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.332 0 C-N-CA 124.945 1.26 . . . . 1.0 114.3 176.062 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.546 0.806 0 CA-C-O 118.753 -0.641 . . . . 1.0 110.042 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.84 148.3 25.16 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.072 2.514 . . . . 1.0 112.269 -177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -121.12 161.05 42.68 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.302 1.841 . . . . 1.0 111.346 171.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.59 132.07 49.91 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.431 2.088 . . . . 1.0 110.815 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.09 -1.39 73.76 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.322 -1.266 . . . . 1.0 114.835 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -76.53 149.38 36.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.442 1.621 . . . . 1.0 113.283 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.59 128.72 37.53 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.58 1.152 . . . . 1.0 108.93 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.4 mt -109.16 131.14 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -99.62 133.79 43.45 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.904 1.681 . . . . 1.0 108.231 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.8 mt -122.11 120.33 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.732 1.613 . . . . 1.0 108.322 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 . . . . . 0 CA--C 1.533 0.303 0 C-N-CA 125.152 1.381 . . . . 1.0 109.793 -179.421 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 . . . . . 0 CA--C 1.548 0.901 0 CA-C-O 119.637 -0.22 . . . . 1.0 111.492 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.12 158.3 44.27 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 154.89 39.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.973 1.309 . . . . 1.0 112.694 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.77 120.61 36.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.172 1.789 . . . . 1.0 108.135 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -82.97 134.92 35.04 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.903 -1.123 . . . . 1.0 112.229 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.1 pt -118.73 4.33 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 -171.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 168.34 37.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.348 0.975 . . . . 1.0 112.861 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t70 62.91 16.1 8.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.125 1.77 . . . . 1.0 113.899 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 -0.98 81.07 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.121 1.343 . . . . 1.0 114.478 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -96.43 154.56 17.2 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.396 1.598 . . . . 1.0 114.366 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.86 159.5 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.104 1.762 . . . . 1.0 111.02 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -120.18 137.4 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 106.651 -1.611 . . . . 1.0 106.651 168.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.57 174.95 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.214 1.006 . . . . 1.0 110.552 -169.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.14 151.92 20.78 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.965 -0.459 . . . . 1.0 110.033 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.788 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 168.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 120.352 0.12 . . . . 1.0 111.174 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.87 145.15 49.39 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.765 0.826 . . . . 1.0 110.973 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -75.72 127.93 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -137.62 161.69 35.79 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.669 1.188 . . . . 1.0 112.711 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -115.51 138.89 50.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.814 2.046 . . . . 1.0 110.138 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.09 176.93 8.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.991 1.316 . . . . 1.0 110.361 170.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -67.64 142.11 56.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.086 1.754 . . . . 1.0 110.377 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.7 tp -51.9 -52.54 49.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.975 0.91 . . . . 1.0 111.711 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -55.36 -47.51 75.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.165 0.986 . . . . 1.0 111.153 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.38 -39.61 94.99 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.783 0.433 . . . . 1.0 111.94 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.69 -45.39 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.545 1.138 . . . . 1.0 111.583 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.37 -35.36 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.716 1.144 . . . . 1.0 112.834 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.78 -124.16 32.13 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.331 0.969 . . . . 1.0 111.533 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.08 -0.19 87.25 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.601 1.096 . . . . 1.0 114.623 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.52 148.61 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.648 1.179 . . . . 1.0 110.974 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.95 165.92 23.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.438 0.695 . . . . 1.0 111.318 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -161.45 164.95 29.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -160.34 161.0 33.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.535 1.534 . . . . 1.0 112.015 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.03 131.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -140.68 60.3 1.53 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.744 1.259 . . . . 1.0 109.842 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.65 67.55 8.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.311 1.445 . . . . 1.0 111.577 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 p -68.48 -21.31 64.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.314 1.445 . . . . 1.0 114.463 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.1 mt -65.78 -14.07 60.65 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.674 0.99 . . . . 1.0 113.674 -172.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -33.33 53.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 1.0 112.255 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.17 -17.48 49.58 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.32 1.448 . . . . 1.0 112.622 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -98.19 -47.2 5.56 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.035 1.334 . . . . 1.0 111.996 -170.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -128.43 162.38 27.28 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.103 1.361 . . . . 1.0 113.458 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -69.97 159.77 82.94 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 118.377 -0.82 . . . . 1.0 110.358 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.45 156.5 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.285 3.323 . . . . 1.0 115.559 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 154.95 71.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.513 1.525 . . . . 1.0 112.182 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.24 123.27 5.5 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.046 3.164 . . . . 1.0 111.992 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.07 -35.42 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.454 1.102 . . . . 1.0 113.934 -170.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.9 -37.37 79.21 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.765 0.826 . . . . 1.0 111.788 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.94 -34.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.455 -0.778 . . . . 1.0 110.664 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mt -64.35 -48.21 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 118.813 0.733 . . . . 1.0 109.997 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -39.79 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.572 1.149 . . . . 1.0 111.108 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -66.18 -43.35 87.13 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.282 -0.886 . . . . 1.0 111.947 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.16 -44.44 92.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.598 1.159 . . . . 1.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.919 0.781 . . . . 1.0 110.672 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.16 -39.6 90.73 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.245 -0.91 . . . . 1.0 113.161 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.75 -34.22 77.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.79 0.836 . . . . 1.0 112.29 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.4 mmm -74.9 -36.07 62.23 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.383 -0.818 . . . . 1.0 112.934 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.4 t -46.33 129.67 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 1.0 112.008 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.54 -16.05 61.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.951 1.739 . . . . 1.0 114.041 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -84.47 143.69 29.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.081 1.441 . . . . 1.0 111.401 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -94.33 146.61 23.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.919 1.288 . . . . 1.0 112.393 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.7 mmt . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 125.591 1.556 . . . . 1.0 112.088 -170.331 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 113.78 1.029 . . . . 1.0 113.78 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.9 p -60.84 -61.22 2.74 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.333 1.453 . . . . 1.0 113.563 172.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.98 -46.71 87.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.772 0.829 . . . . 1.0 111.126 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -59.25 -46.53 88.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.107 0.412 . . . . 1.0 111.288 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -55.31 -59.21 5.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.493 0.717 . . . . 1.0 111.308 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.18 -26.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.997 0.817 . . . . 1.0 112.372 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.0 m -66.02 -49.45 67.7 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.344 1.057 . . . . 1.0 111.237 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.51 -29.77 68.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.904 0.882 . . . . 1.0 112.509 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.81 -33.82 74.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.295 0.85 . . . . 1.0 113.295 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -98.29 -42.78 7.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.777 1.231 . . . . 1.0 112.374 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -67.07 -50.82 60.46 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.856 -1.152 . . . . 1.0 112.092 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.199 0 C-N-CA 126.412 1.958 . . . . 1.0 114.222 -174.56 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 118.742 -0.647 . . . . 1.0 109.807 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.06 153.47 16.74 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.526 2.817 . . . . 1.0 112.728 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -128.61 162.65 49.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.54 1.936 . . . . 1.0 112.431 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -43.99 127.12 6.55 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 124.396 3.397 . . . . 1.0 113.093 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 2.33 87.95 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 118.354 -1.248 . . . . 1.0 115.422 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.71 146.14 42.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.739 1.77 . . . . 1.0 112.947 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.07 122.61 33.21 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.387 -1.338 . . . . 1.0 107.387 169.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -101.98 132.24 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -109.91 132.1 54.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.799 2.04 . . . . 1.0 107.951 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mt -127.42 123.77 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.78 1.232 . . . . 1.0 109.195 -169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 . . . . . 0 CA--C 1.535 0.395 0 C-N-CA 124.829 1.252 . . . . 1.0 110.172 174.801 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 . . . . . 0 CA--C 1.548 0.878 0 CA-C-O 119.701 -0.19 . . . . 1.0 111.146 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -138.56 155.32 48.47 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.088 -1.007 . . . . 1.0 113.206 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.1 153.4 40.65 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.424 1.489 . . . . 1.0 112.309 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.55 118.26 34.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.049 1.74 . . . . 1.0 108.205 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -84.19 130.9 34.81 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.449 1.022 . . . . 1.0 112.545 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -113.43 0.79 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 114.87 1.433 . . . . 1.0 114.87 -170.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.17 168.04 34.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.357 0.979 . . . . 1.0 112.881 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.74 16.3 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.212 1.805 . . . . 1.0 114.082 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.56 6.49 77.08 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.133 1.349 . . . . 1.0 114.274 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -103.83 154.5 19.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.352 1.576 . . . . 1.0 113.94 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.67 161.52 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.381 1.873 . . . . 1.0 111.229 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.59 137.61 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -161.98 169.96 20.18 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.208 -0.933 . . . . 1.0 110.537 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.9 mt -88.15 151.59 22.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.874 -0.516 . . . . 1.0 109.745 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.82 0 C-N-CA 125.685 1.594 . . . . 1.0 109.88 171.53 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 119.794 -0.146 . . . . 1.0 110.725 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.07 138.59 36.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.192 0.997 . . . . 1.0 110.595 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.1 t -77.63 123.2 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -127.38 155.01 44.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.417 1.487 . . . . 1.0 112.395 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -104.03 128.79 51.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.858 1.663 . . . . 1.0 108.291 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -157.24 166.07 34.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.45 0.568 . . . . 1.0 111.552 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -76.06 137.62 40.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.82 1.648 . . . . 1.0 110.743 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.32 -55.55 17.8 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.891 1.277 . . . . 1.0 110.952 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -55.01 -44.61 74.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.391 1.076 . . . . 1.0 111.721 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.14 -42.3 93.96 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.451 0.3 . . . . 1.0 111.521 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.92 -39.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.8 1.24 . . . . 1.0 112.244 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.6 m -85.58 -0.74 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.471 1.108 . . . . 1.0 113.776 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.28 126.72 36.51 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.322 0.963 . . . . 1.0 112.082 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.37 6.29 79.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.294 0.949 . . . . 1.0 114.194 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.9 m -122.52 -179.51 4.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.686 1.994 . . . . 1.0 110.783 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.07 156.99 39.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.392 1.477 . . . . 1.0 108.119 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -155.01 164.89 38.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.403 1.631 . . . . 1.0 115.403 -171.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -158.56 160.27 36.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.758 2.023 . . . . 1.0 110.944 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -88.14 129.05 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 168.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -131.66 54.58 1.92 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.502 1.144 . . . . 1.0 110.165 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.28 71.46 7.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.896 1.279 . . . . 1.0 111.329 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.2 p -73.56 -43.47 59.78 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.835 1.254 . . . . 1.0 113.681 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.79 -17.17 63.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.29 -28.13 51.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.126 1.37 . . . . 1.0 112.898 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -91.44 -20.44 21.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.375 1.47 . . . . 1.0 112.536 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -86.99 -36.24 18.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.412 1.085 . . . . 1.0 112.516 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -120.25 170.42 9.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.319 1.448 . . . . 1.0 112.355 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -66.35 144.8 98.86 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.437 -0.79 . . . . 1.0 109.557 171.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.41 134.16 46.81 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.86 2.373 . . . . 1.0 111.653 -169.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -93.81 151.65 40.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.069 1.348 . . . . 1.0 110.676 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.17 111.41 3.07 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.5 2.8 . . . . 1.0 110.858 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.72 -32.66 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.179 1.177 . . . . 1.0 114.179 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.73 -35.72 75.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.268 0.627 . . . . 1.0 112.16 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.6 -40.55 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.884 0.874 . . . . 1.0 110.722 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.3 mt -59.8 -46.74 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.762 0.71 . . . . 1.0 110.26 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.7 mt -69.18 -35.36 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.3 1.04 . . . . 1.0 111.627 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.3 m -64.34 -43.48 94.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.278 -0.889 . . . . 1.0 111.615 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.7 m -59.8 -43.77 94.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.303 1.041 . . . . 1.0 111.508 172.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.35 73.58 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.188 -0.945 . . . . 1.0 111.358 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -62.38 -38.11 88.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.301 1.041 . . . . 1.0 112.953 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.6 -35.3 79.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.84 0.856 . . . . 1.0 112.07 173.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.5 mmm -74.0 -37.54 64.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.376 -0.821 . . . . 1.0 112.85 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.9 t -46.68 130.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 119.359 0.981 . . . . 1.0 111.678 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.35 -14.04 65.73 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.567 1.556 . . . . 1.0 114.095 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -87.27 158.8 19.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.9 1.35 . . . . 1.0 111.413 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -120.25 148.61 43.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.148 1.379 . . . . 1.0 112.334 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 78.7 mtm . . . . . 0 N--CA 1.482 1.138 0 C-N-CA 124.863 1.265 . . . . 1.0 112.161 179.777 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.3 m120 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.6 m -65.19 -40.68 94.54 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.31 0.959 . . . . 1.0 112.741 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -59.64 -53.11 61.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.111 0.964 . . . . 1.0 109.888 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.38 -45.75 87.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.813 0.445 . . . . 1.0 111.566 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -52.21 -60.09 3.61 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.861 0.865 . . . . 1.0 111.004 172.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -32.65 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.33 0.968 . . . . 1.0 113.017 -172.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -71.17 -38.87 72.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.647 0.779 . . . . 1.0 112.254 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -60.62 -26.55 67.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.997 0.817 . . . . 1.0 112.813 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.75 -26.54 68.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.868 1.213 . . . . 1.0 112.592 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -93.71 -53.31 4.08 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.657 1.583 . . . . 1.0 111.798 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -73.21 -38.94 65.92 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 C-N-CA 125.229 1.395 . . . . 1.0 112.292 175.524 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 118.588 -0.72 . . . . 1.0 110.089 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.23 144.58 26.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.562 2.841 . . . . 1.0 112.088 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -129.48 160.57 63.71 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.861 1.664 . . . . 1.0 112.846 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -47.59 129.03 16.3 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.815 3.01 . . . . 1.0 112.822 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -8.84 73.79 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.074 1.321 . . . . 1.0 114.172 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -68.59 139.34 55.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.968 1.384 . . . . 1.0 112.541 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.55 126.95 35.8 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.879 1.272 . . . . 1.0 108.905 170.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.3 131.93 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.44 138.45 39.34 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.187 1.395 . . . . 1.0 108.784 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mt -133.14 113.99 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.226 1.01 . . . . 1.0 109.174 -173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 . . . . . 0 CA--C 1.535 0.403 0 C-N-CA 125.474 1.51 . . . . 1.0 111.205 -169.58 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 121.034 0.445 . . . . 1.0 110.472 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -137.37 150.19 47.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.204 1.001 . . . . 1.0 110.546 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 152.1 44.37 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.312 1.045 . . . . 1.0 112.598 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.33 116.86 33.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.197 1.799 . . . . 1.0 107.921 170.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -79.89 132.24 36.04 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.326 -0.859 . . . . 1.0 111.716 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.2 pt -114.89 -3.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -171.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.57 166.31 24.48 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 124.717 1.151 . . . . 1.0 113.008 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 62.69 18.37 10.54 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.082 1.753 . . . . 1.0 113.867 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.75 85.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.446 1.498 . . . . 1.0 114.281 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -94.2 153.12 18.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.425 1.613 . . . . 1.0 114.252 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -133.54 157.87 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.004 1.721 . . . . 1.0 111.006 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -115.58 138.68 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.396 1.478 . . . . 1.0 107.13 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -155.43 150.95 27.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.723 0.809 . . . . 1.0 111.75 -168.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -84.38 121.49 27.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 124.492 1.117 . . . . 1.0 112.239 -169.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 110.579 -0.156 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.12 137.49 54.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.94 0.896 . . . . 1.0 109.989 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.77 124.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -132.05 163.81 27.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.414 1.486 . . . . 1.0 111.999 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -117.51 137.11 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.007 1.723 . . . . 1.0 110.077 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.05 177.74 10.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.822 1.249 . . . . 1.0 111.214 171.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.0 141.62 49.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.123 0.969 . . . . 1.0 111.604 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 tp -51.19 -52.82 40.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.308 1.043 . . . . 1.0 112.19 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.84 -48.22 73.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.086 0.954 . . . . 1.0 111.287 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.53 -35.02 79.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.083 0.553 . . . . 1.0 112.083 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.84 -45.23 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.17 0.988 . . . . 1.0 112.293 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.43 -34.47 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 119.585 1.084 . . . . 1.0 112.818 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.27 -131.11 49.68 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 119.151 0.887 . . . . 1.0 112.192 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.88 -3.73 85.38 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.652 1.12 . . . . 1.0 114.481 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.0 m -74.99 149.59 39.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.166 1.387 . . . . 1.0 111.433 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.5 t -72.05 154.43 41.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.007 0.523 . . . . 1.0 110.78 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -158.85 163.59 36.5 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.688 0.995 . . . . 1.0 113.688 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -159.81 157.46 29.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.83 1.252 . . . . 1.0 113.371 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.8 t -82.47 138.06 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.446 -1.316 . . . . 1.0 107.446 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -152.65 84.77 1.24 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 1.0 111.394 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.04 53.54 2.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.759 1.224 . . . . 1.0 111.847 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 p -58.73 -34.65 71.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.985 1.314 . . . . 1.0 113.159 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.65 -17.85 65.06 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.253 -0.905 . . . . 1.0 112.899 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.82 -25.9 68.38 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.126 0.876 . . . . 1.0 112.631 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.64 12.9 36.42 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.532 1.133 . . . . 1.0 111.949 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -109.8 -44.35 3.84 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.589 1.555 . . . . 1.0 111.754 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -131.41 168.32 17.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.593 1.557 . . . . 1.0 113.609 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -66.78 160.13 70.64 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.308 1.043 . . . . 1.0 112.471 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.77 152.33 35.71 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.405 3.403 . . . . 1.0 113.489 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -129.14 153.99 80.44 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.83 1.652 . . . . 1.0 111.042 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.75 111.45 3.25 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.205 2.604 . . . . 1.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.94 -31.86 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.193 0.997 . . . . 1.0 113.086 -169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.36 -36.98 76.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.731 0.696 . . . . 1.0 112.1 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 t -71.56 -34.41 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.057 0.943 . . . . 1.0 110.7 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.1 mt -66.13 -48.32 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.536 0.735 . . . . 1.0 109.982 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -42.62 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.702 1.201 . . . . 1.0 110.853 173.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -65.26 -40.92 94.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 1.0 111.384 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.8 m -63.48 -42.5 98.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.06 0.944 . . . . 1.0 111.804 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.4 77.98 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.559 -0.713 . . . . 1.0 110.29 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.47 -39.83 92.31 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.15 -0.969 . . . . 1.0 113.149 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.64 -32.9 74.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.905 0.882 . . . . 1.0 112.631 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -74.34 -37.25 63.6 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.33 -0.843 . . . . 1.0 112.815 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.8 t -47.57 127.54 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.726 1.148 . . . . 1.0 111.373 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.75 -16.47 59.58 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.006 1.765 . . . . 1.0 113.818 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -85.04 157.58 20.69 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.741 1.271 . . . . 1.0 111.067 176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.27 153.99 36.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.867 1.267 . . . . 1.0 113.214 -172.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.2 mtt . . . . . 0 N--CA 1.474 0.775 0 C-N-CA 126.243 1.817 . . . . 1.0 111.77 -178.814 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.7 t30 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -63.52 -36.71 84.68 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.325 -1.484 . . . . 1.0 113.022 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.46 -58.8 6.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.576 0.75 . . . . 1.0 109.963 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -52.83 -32.57 45.02 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.814 1.245 . . . . 1.0 113.419 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.91 -57.54 10.46 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.093 -1.004 . . . . 1.0 110.786 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.37 -28.29 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.902 1.075 . . . . 1.0 113.902 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.79 -42.5 90.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.539 1.063 . . . . 1.0 111.872 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -58.01 -29.37 65.25 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 1.0 112.813 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.21 -32.04 70.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.793 0.837 . . . . 1.0 112.652 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -94.42 -51.37 4.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 1.0 111.43 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -62.88 -32.07 73.25 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 -169.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.245 0 C-N-CA 123.883 0.754 . . . . 1.0 114.272 -179.543 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 CA--C 1.545 0.75 0 CA-C-O 118.668 -0.682 . . . . 1.0 109.638 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.22 146.53 17.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.817 3.012 . . . . 1.0 111.614 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.97 161.02 62.29 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.637 1.575 . . . . 1.0 112.583 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -46.74 128.58 13.33 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.942 3.095 . . . . 1.0 112.99 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.81 -7.88 80.59 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.265 -1.297 . . . . 1.0 115.18 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.05 143.91 54.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.666 1.733 . . . . 1.0 113.761 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.42 128.11 33.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.52 1.528 . . . . 1.0 107.922 169.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.56 129.38 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.629 1.171 . . . . 1.0 108.162 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -100.15 125.08 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.316 1.447 . . . . 1.0 107.676 170.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.3 mt -120.92 119.9 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.559 1.143 . . . . 1.0 109.167 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 CA--C 1.537 0.447 0 C-N-CA 125.741 1.616 . . . . 1.0 110.514 -175.888 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.542 0.67 0 N-CA-C 110.133 -0.321 . . . . 1.0 110.133 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -136.39 145.2 45.07 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.738 0.815 . . . . 1.0 111.508 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 156.81 45.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.303 1.041 . . . . 1.0 112.515 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.95 116.32 32.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.538 1.935 . . . . 1.0 107.713 172.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -81.91 130.73 35.16 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.335 -0.853 . . . . 1.0 111.845 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.85 3.66 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.5 167.48 35.3 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.529 1.062 . . . . 1.0 112.584 -174.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 61.38 20.02 10.75 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.952 1.701 . . . . 1.0 113.813 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.99 -1.04 87.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.585 1.564 . . . . 1.0 114.458 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -91.68 151.72 20.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.595 1.698 . . . . 1.0 114.492 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.53 154.23 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.402 1.481 . . . . 1.0 111.155 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.8 mt -112.23 136.02 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -155.16 150.09 26.71 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.138 -0.977 . . . . 1.0 111.866 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.07 133.05 33.92 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.666 0 C-N-CA 125.114 1.366 . . . . 1.0 110.491 -175.97 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 119.552 -0.261 . . . . 1.0 110.675 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.23 139.44 53.78 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.272 1.029 . . . . 1.0 110.76 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.11 125.85 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.21 162.3 30.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.149 1.779 . . . . 1.0 111.986 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -120.69 126.28 49.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.819 1.648 . . . . 1.0 110.672 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -147.98 174.14 12.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.173 1.389 . . . . 1.0 110.681 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.74 137.37 38.43 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.109 -0.994 . . . . 1.0 110.744 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.79 -42.75 84.81 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.228 -0.92 . . . . 1.0 111.643 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.04 -46.42 75.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.774 . . . . 1.0 111.402 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.97 -42.94 80.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.671 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.15 -42.58 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 1.0 111.664 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.55 -2.31 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.813 1.245 . . . . 1.0 113.831 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.76 123.78 33.21 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.048 -1.033 . . . . 1.0 111.797 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.99 5.51 86.93 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.66 1.124 . . . . 1.0 114.757 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -126.31 -160.86 1.01 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.512 2.325 . . . . 1.0 110.436 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.2 t -148.87 171.8 15.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.266 1.826 . . . . 1.0 109.349 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -152.76 158.91 42.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.743 1.386 . . . . 1.0 114.743 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.98 150.29 39.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.362 1.865 . . . . 1.0 110.483 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.1 t -82.65 134.6 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -148.63 67.23 1.06 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.797 0.839 . . . . 1.0 112.197 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -72.61 82.62 1.12 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.37 1.068 . . . . 1.0 111.643 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -69.6 -38.33 77.25 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.148 0.795 . . . . 1.0 113.148 -170.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.7 mt -81.63 -8.89 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -172.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.56 -31.53 68.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 1.0 112.758 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -90.42 -5.71 55.79 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.925 1.29 . . . . 1.0 112.382 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -97.35 -47.76 5.58 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.033 1.333 . . . . 1.0 112.19 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -127.1 169.88 12.95 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.976 1.31 . . . . 1.0 113.717 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -66.21 148.59 98.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 110.067 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.38 144.72 62.84 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.364 2.709 . . . . 1.0 113.001 -170.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.92 151.72 37.94 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.45 1.5 . . . . 1.0 112.299 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.09 114.95 4.16 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.859 3.04 . . . . 1.0 110.991 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.81 -35.42 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.943 1.297 . . . . 1.0 114.154 -170.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.91 -35.4 78.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.827 0.451 . . . . 1.0 112.191 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.38 -36.71 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.468 0.707 . . . . 1.0 110.915 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.08 -49.5 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.472 0.578 . . . . 1.0 109.769 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.8 mt -67.68 -38.43 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.912 0.885 . . . . 1.0 111.904 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.9 m -62.42 -41.55 98.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.348 0.976 . . . . 1.0 111.71 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -62.46 -44.34 96.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.697 0.799 . . . . 1.0 111.079 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.63 72.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.618 0.767 . . . . 1.0 110.903 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.26 -40.36 93.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.234 1.014 . . . . 1.0 112.803 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.83 -33.47 75.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.565 0.746 . . . . 1.0 112.096 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.2 mmm -74.92 -38.24 61.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.195 -0.907 . . . . 1.0 112.975 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.54 127.95 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 120.017 1.281 . . . . 1.0 111.299 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.71 -15.42 62.72 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.722 1.629 . . . . 1.0 113.593 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -84.64 160.13 20.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.001 1.4 . . . . 1.0 111.314 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -123.86 157.81 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.368 1.467 . . . . 1.0 112.561 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.2 mtt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.56 1.544 . . . . 1.0 110.283 177.772 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 . . . . . 0 CA--C 1.558 1.255 0 N-CA-C 117.072 2.249 . . . . 1.0 117.072 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 29.9 m -62.86 -29.94 71.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.024 1.329 . . . . 1.0 113.942 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.55 93.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.868 0.758 . . . . 1.0 111.674 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -58.68 -45.96 88.27 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.305 -0.872 . . . . 1.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -54.11 -57.1 12.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.569 -0.707 . . . . 1.0 111.349 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.47 -28.07 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.358 0.981 . . . . 1.0 113.489 -173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.4 p -72.47 -38.46 68.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.349 0.977 . . . . 1.0 112.276 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -57.6 -30.54 65.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.777 0.831 . . . . 1.0 112.53 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.26 -32.58 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.023 0.829 . . . . 1.0 112.928 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -93.58 -37.8 11.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 112.19 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -72.16 -46.27 57.1 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.605 -1.309 . . . . 1.0 112.908 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.059 0 C-N-CA 126.316 1.913 . . . . 1.0 114.006 -176.499 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 . . . . . 0 CA--C 1.547 0.844 0 CA-C-O 118.848 -0.596 . . . . 1.0 110.242 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.0 157.54 23.77 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.809 3.006 . . . . 1.0 113.263 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -124.82 162.56 42.44 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 127.188 2.195 . . . . 1.0 112.165 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.73 129.48 14.31 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.037 3.158 . . . . 1.0 113.059 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.78 -3.46 86.85 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.541 -1.144 . . . . 1.0 115.192 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.09 139.91 58.76 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.343 1.572 . . . . 1.0 113.027 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.69 120.95 26.98 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.88 124.75 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.401 -0.963 . . . . 1.0 108.401 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -87.57 135.31 33.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mt -124.57 116.6 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.899 1.28 . . . . 1.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--N 1.328 -0.363 0 C-N-CA 124.42 1.088 . . . . 1.0 109.678 -173.471 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.8 m80 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -135.99 145.16 45.82 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.108 0.963 . . . . 1.0 112.58 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 151.86 44.18 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 1.0 112.928 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.61 116.17 29.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.466 1.906 . . . . 1.0 109.223 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -83.03 129.89 35.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.14 -0.975 . . . . 1.0 112.502 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.0 pt -106.57 4.11 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.84 30.6 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 116.118 1.207 . . . . 1.0 116.118 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -88.36 9.11 24.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.747 1.219 . . . . 1.0 113.641 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.1 83.9 Favored Glycine 0 N--CA 1.476 1.355 0 C-N-CA 124.811 1.196 . . . . 1.0 112.142 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -95.09 157.03 16.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.913 1.685 . . . . 1.0 112.569 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.88 155.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.298 1.439 . . . . 1.0 110.105 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.2 mt -111.43 135.91 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -153.91 151.12 29.08 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.411 -0.805 . . . . 1.0 111.803 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -85.96 133.62 33.92 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 124.922 1.289 . . . . 1.0 110.254 -175.745 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 110.323 -0.251 . . . . 1.0 110.323 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -116.54 140.13 49.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.369 1.068 . . . . 1.0 110.195 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.79 125.39 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 169.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.69 163.13 27.89 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.412 1.485 . . . . 1.0 112.199 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -123.86 133.39 53.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.925 1.69 . . . . 1.0 110.058 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -158.14 174.65 14.87 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.063 0.945 . . . . 1.0 111.116 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.64 142.67 56.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.384 1.074 . . . . 1.0 111.453 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 tp -52.19 -53.96 36.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.764 0.826 . . . . 1.0 111.821 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.38 -48.59 71.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.213 1.005 . . . . 1.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.26 -36.18 83.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.222 0.609 . . . . 1.0 112.302 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.84 -42.54 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.228 1.011 . . . . 1.0 112.303 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.1 m -71.53 -36.76 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.031 1.287 . . . . 1.0 112.508 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.58 -130.84 46.48 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 119.033 0.833 . . . . 1.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.2 -6.79 87.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.415 1.007 . . . . 1.0 114.328 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -75.9 148.74 38.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.303 1.441 . . . . 1.0 111.35 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.8 t -73.35 160.44 31.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.051 0.54 . . . . 1.0 110.878 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -158.67 160.25 36.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.088 1.144 . . . . 1.0 114.088 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -160.89 158.69 28.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.26 1.424 . . . . 1.0 112.02 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.73 138.86 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -152.71 85.24 1.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 1.0 110.69 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.66 59.28 2.45 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.599 1.16 . . . . 1.0 112.141 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -65.01 -33.41 75.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.253 1.421 . . . . 1.0 113.56 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.94 -11.99 58.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.193 0.997 . . . . 1.0 113.58 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.73 -34.56 65.27 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.924 1.289 . . . . 1.0 112.136 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -79.2 -18.58 52.73 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.996 1.318 . . . . 1.0 112.306 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -94.74 -43.49 8.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.762 1.225 . . . . 1.0 112.097 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -134.41 146.94 50.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.98 1.312 . . . . 1.0 112.709 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -65.82 159.66 67.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.395 1.078 . . . . 1.0 111.329 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -54.59 151.58 30.66 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.491 3.461 . . . . 1.0 116.241 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 160.11 48.84 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.307 1.843 . . . . 1.0 111.109 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.11 126.02 10.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.987 3.125 . . . . 1.0 112.161 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.43 -33.51 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 113.239 0.829 . . . . 1.0 113.239 -174.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.44 -37.96 82.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.188 0.595 . . . . 1.0 111.909 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.77 -38.16 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 1.0 110.431 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.8 mt -61.55 -46.49 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.212 0.915 . . . . 1.0 110.518 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.35 -37.17 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.112 0.965 . . . . 1.0 111.764 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -63.6 -45.08 91.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.893 0.77 . . . . 1.0 111.363 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.6 m -58.68 -44.09 90.13 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.568 1.147 . . . . 1.0 111.746 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.01 63.09 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.533 0.733 . . . . 1.0 110.782 173.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.78 -39.74 85.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.018 0.927 . . . . 1.0 112.991 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -67.75 -33.92 75.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.112 0.965 . . . . 1.0 112.473 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 96.5 mtp -77.76 -33.21 52.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.845 -1.074 . . . . 1.0 112.857 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.8 t -48.62 128.83 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 120.33 1.423 . . . . 1.0 111.004 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.06 -15.3 62.74 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.628 1.585 . . . . 1.0 113.804 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -87.18 163.27 17.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.94 1.37 . . . . 1.0 111.494 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -125.57 157.7 36.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.393 1.477 . . . . 1.0 112.952 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.7 mtt . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 126.097 1.759 . . . . 1.0 110.258 177.951 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 . . . . . 0 CA--C 1.547 0.856 0 N-CA-C 113.073 0.768 . . . . 1.0 113.073 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.9 -37.31 72.97 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 1.0 112.024 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -61.38 -52.09 66.09 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.447 0.699 . . . . 1.0 109.977 170.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -58.46 -37.67 75.95 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.816 -0.553 . . . . 1.0 111.881 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -59.82 -61.36 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.174 -0.917 . . . . 1.0 111.128 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.64 -24.81 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.799 1.181 . . . . 1.0 112.875 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -63.44 -49.36 73.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.449 1.1 . . . . 1.0 111.295 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -59.8 -28.24 67.28 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.425 0.69 . . . . 1.0 112.688 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -63.42 -36.11 82.63 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.107 0.78 . . . . 1.0 113.107 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -93.75 -44.04 8.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.812 0.845 . . . . 1.0 111.741 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.97 -46.24 88.66 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.001 -1.062 . . . . 1.0 112.349 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.018 0 C-N-CA 126.566 2.031 . . . . 1.0 114.315 -176.821 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 . . . . . 0 CA--C 1.548 0.894 0 CA-C-O 118.659 -0.686 . . . . 1.0 109.482 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.08 143.16 22.5 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.35 2.7 . . . . 1.0 111.493 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -117.02 164.31 19.38 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.397 1.879 . . . . 1.0 111.323 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.64 128.46 10.72 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.855 3.036 . . . . 1.0 112.674 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.28 -3.4 87.25 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.368 -1.24 . . . . 1.0 115.429 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.3 142.24 57.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.647 1.723 . . . . 1.0 113.041 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 117' ' ' VAL . 37.2 mt -89.22 118.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.039 -0.982 . . . . 1.0 108.984 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.89 127.64 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.614 -1.624 . . . . 1.0 106.614 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -108.5 122.71 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.411 . . . . 1.0 107.696 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.9 mt -120.28 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 124.893 1.277 . . . . 1.0 109.254 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 . . . . . 0 CA--C 1.538 0.508 0 C-N-CA 125.537 1.535 . . . . 1.0 111.132 -176.859 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 120.357 0.122 . . . . 1.0 110.928 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -137.46 149.31 46.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.079 0.951 . . . . 1.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.58 151.65 38.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.196 0.998 . . . . 1.0 112.949 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -94.13 113.54 25.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.151 1.78 . . . . 1.0 108.778 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -82.32 129.56 34.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.086 -1.009 . . . . 1.0 112.425 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.7 pt -106.14 10.18 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.58 -35.48 4.48 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 124.665 1.126 . . . . 1.0 115.801 169.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.46 17.12 3.98 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.459 1.104 . . . . 1.0 113.706 -172.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 -4.89 85.43 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.905 1.241 . . . . 1.0 112.803 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -92.92 155.39 17.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.171 1.388 . . . . 1.0 113.131 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -126.94 151.31 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.247 1.419 . . . . 1.0 110.481 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.04 134.49 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 106.842 -1.54 . . . . 1.0 106.842 169.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -154.53 162.86 40.93 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.26 -0.9 . . . . 1.0 111.502 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -101.43 132.49 47.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.52 1.128 . . . . 1.0 109.156 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 C-N-CA 124.161 0.985 . . . . 1.0 112.676 -174.911 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.718 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.64 135.64 35.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.823 1.249 . . . . 1.0 109.233 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.94 131.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.847 0.749 . . . . 1.0 109.268 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -135.05 162.19 33.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.58 1.552 . . . . 1.0 112.594 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -118.33 123.61 45.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.837 1.655 . . . . 1.0 109.946 171.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -145.52 172.08 13.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.715 1.206 . . . . 1.0 110.39 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -75.53 143.39 42.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.105 -0.997 . . . . 1.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.12 -51.92 64.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.172 -0.918 . . . . 1.0 111.702 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -54.33 -49.31 70.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.418 0.687 . . . . 1.0 111.299 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.64 -38.53 83.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.286 0.634 . . . . 1.0 111.846 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -44.79 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.405 1.082 . . . . 1.0 112.056 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -87.98 -7.58 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 114.354 1.242 . . . . 1.0 114.354 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.24 133.83 52.21 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.405 1.003 . . . . 1.0 113.192 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.08 80.87 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.822 1.201 . . . . 1.0 114.723 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.8 m -120.58 150.07 41.45 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.795 1.638 . . . . 1.0 111.204 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.8 m -81.41 158.87 24.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -161.18 168.02 25.02 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.429 . . . . 1.0 114.857 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -159.78 167.83 27.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.882 1.673 . . . . 1.0 112.205 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -87.25 126.57 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 168.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -131.67 57.66 1.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.336 1.065 . . . . 1.0 110.68 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.86 57.7 3.55 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.388 1.475 . . . . 1.0 111.667 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 p -78.64 -14.23 59.42 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.523 1.529 . . . . 1.0 114.72 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 mt -67.79 -11.83 59.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.135 1.161 . . . . 1.0 114.135 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.26 -26.69 67.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.946 0.794 . . . . 1.0 112.422 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -87.51 -5.37 58.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.123 1.369 . . . . 1.0 111.694 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -100.54 -47.24 4.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.549 1.54 . . . . 1.0 111.122 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -130.81 146.67 52.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.857 1.663 . . . . 1.0 112.338 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -64.52 155.13 82.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 1.0 111.864 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -48.78 141.23 21.46 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.569 3.513 . . . . 1.0 115.688 -170.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -121.21 146.45 44.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.724 1.61 . . . . 1.0 110.857 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.56 114.92 4.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.494 2.796 . . . . 1.0 110.398 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.06 -29.9 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 114.452 1.278 . . . . 1.0 114.452 -169.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.1 -35.72 75.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.926 0.49 . . . . 1.0 111.878 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.22 -32.61 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.254 0.622 . . . . 1.0 110.89 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.88 -49.24 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.289 0.949 . . . . 1.0 110.338 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.06 -38.6 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.086 0.954 . . . . 1.0 111.253 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.4 m -63.12 -41.77 99.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 1.0 112.127 173.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t -61.68 -44.45 96.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.101 0.96 . . . . 1.0 110.968 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.5 -52.42 65.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.164 0.986 . . . . 1.0 110.517 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.81 -39.09 87.64 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.138 0.975 . . . . 1.0 113.057 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.55 -34.71 77.63 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.921 0.888 . . . . 1.0 112.363 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 97.5 mtp -78.61 -31.64 47.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.711 -1.137 . . . . 1.0 113.305 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.6 t -47.61 126.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 120.264 1.393 . . . . 1.0 110.607 169.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.11 -12.43 65.43 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.741 1.639 . . . . 1.0 114.274 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.24 158.37 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.109 1.455 . . . . 1.0 111.45 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -118.53 159.54 23.35 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.338 1.455 . . . . 1.0 113.895 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 125.965 1.706 . . . . 1.0 112.091 -178.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 115.052 1.501 . . . . 1.0 115.052 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -69.6 -35.16 75.05 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.324 -0.86 . . . . 1.0 112.71 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.74 -51.79 66.89 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.729 0.812 . . . . 1.0 110.593 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -63.49 -34.63 78.2 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.254 -0.904 . . . . 1.0 111.261 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.38 -60.02 4.47 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.125 -0.985 . . . . 1.0 110.917 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 13' ' ' LEU . 29.8 m -64.9 -22.76 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 120.634 1.561 . . . . 1.0 113.338 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.1 m -65.55 -52.87 49.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.788 1.235 . . . . 1.0 110.984 169.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -66.55 -24.96 66.44 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.391 0.885 . . . . 1.0 113.391 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.2 -37.55 75.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.911 0.884 . . . . 1.0 112.986 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -93.88 -46.74 7.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.118 0.967 . . . . 1.0 112.133 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -62.08 -44.68 96.15 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.153 -0.967 . . . . 1.0 111.747 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.045 0 C-N-CA 126.424 1.964 . . . . 1.0 113.652 179.148 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.546 0.808 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -86.33 158.62 9.63 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.68 3.587 . . . . 1.0 111.998 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -129.97 162.53 53.19 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.805 1.642 . . . . 1.0 112.027 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.77 128.01 8.51 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.253 3.302 . . . . 1.0 113.091 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.81 -9.42 76.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.999 1.285 . . . . 1.0 115.108 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.82 151.27 44.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.103 1.452 . . . . 1.0 113.71 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.31 125.45 35.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.087 0.955 . . . . 1.0 109.976 171.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.0 mm -95.0 132.93 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 106.757 -1.572 . . . . 1.0 106.757 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -111.68 130.88 55.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.776 1.63 . . . . 1.0 108.851 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.06 129.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.732 1.613 . . . . 1.0 109.355 -169.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 CA--C 1.535 0.381 0 C-N-CA 125.61 1.564 . . . . 1.0 109.274 178.694 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 111.944 0.35 . . . . 1.0 111.944 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -142.14 155.54 45.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.118 0.785 . . . . 1.0 113.118 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.12 153.33 42.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.462 1.105 . . . . 1.0 112.115 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.47 118.15 30.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.999 1.319 . . . . 1.0 108.52 171.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -83.39 132.55 34.98 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.236 -0.915 . . . . 1.0 112.156 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 pt -117.44 2.45 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 -170.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.43 163.71 27.33 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.742 1.163 . . . . 1.0 113.427 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 61.71 19.03 10.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.146 1.778 . . . . 1.0 114.116 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.78 2.93 81.0 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.602 1.572 . . . . 1.0 114.107 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -95.14 152.53 18.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.74 . . . . 1.0 114.151 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.8 160.53 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.034 1.733 . . . . 1.0 110.737 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.51 132.07 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.761 -1.57 . . . . 1.0 106.761 168.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.194 -0.941 . . . . 1.0 111.062 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.25 111.14 16.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 171.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.708 0 C-N-CA 123.914 0.886 . . . . 1.0 111.326 -169.533 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 109.984 -0.376 . . . . 1.0 109.984 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.17 140.35 52.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.81 0.844 . . . . 1.0 109.837 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.36 123.32 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.3 153.71 51.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.987 1.315 . . . . 1.0 112.091 -175.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -100.96 125.11 47.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.967 1.707 . . . . 1.0 109.713 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -149.62 174.81 12.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.782 1.233 . . . . 1.0 110.372 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -75.54 144.57 41.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.008 -1.058 . . . . 1.0 111.71 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -48.99 -52.16 26.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.0 1.32 . . . . 1.0 110.942 173.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.66 -53.6 18.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.325 1.85 . . . . 1.0 111.248 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.32 -34.73 75.11 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.466 0.543 . . . . 1.0 112.466 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.8 t -71.25 -43.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.571 1.148 . . . . 1.0 112.303 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.2 m -73.87 -39.18 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 119.459 1.027 . . . . 1.0 112.697 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.39 -127.38 45.02 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.968 0.804 . . . . 1.0 112.191 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.01 3.16 84.54 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.102 1.334 . . . . 1.0 114.903 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.1 m -78.73 155.95 29.12 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.782 1.291 . . . . 1.0 111.579 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.59 150.91 37.94 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.659 0.384 . . . . 1.0 110.097 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -161.0 164.55 30.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -160.84 160.11 30.68 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.652 1.581 . . . . 1.0 111.556 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.11 133.38 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -155.87 87.3 1.07 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.596 0.758 . . . . 1.0 111.288 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.5 58.84 1.8 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.999 1.32 . . . . 1.0 112.353 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -61.19 -35.61 77.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.866 1.266 . . . . 1.0 112.988 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.47 -14.03 62.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.621 1.168 . . . . 1.0 113.487 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.97 -23.08 67.2 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.634 -0.666 . . . . 1.0 112.762 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.73 -2.67 55.81 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.141 1.376 . . . . 1.0 111.589 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -98.71 -46.2 5.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.633 1.573 . . . . 1.0 111.554 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -125.73 168.98 13.03 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.418 1.487 . . . . 1.0 114.079 -172.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -65.93 161.15 57.27 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.588 1.155 . . . . 1.0 111.204 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.78 131.82 28.66 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.867 2.378 . . . . 1.0 110.807 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -113.21 152.19 44.89 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.056 1.343 . . . . 1.0 110.989 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 118.07 5.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.404 2.736 . . . . 1.0 111.348 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.75 -36.6 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.899 1.28 . . . . 1.0 114.174 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.37 -35.53 79.43 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.944 0.498 . . . . 1.0 111.908 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.22 -37.92 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.334 0.654 . . . . 1.0 110.651 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -62.73 -47.13 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 118.95 0.796 . . . . 1.0 110.465 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.33 -36.84 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.821 0.849 . . . . 1.0 111.749 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -62.1 -44.13 97.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.146 0.885 . . . . 1.0 111.252 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 m -58.43 -44.73 89.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 1.0 111.72 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.66 -50.38 73.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.305 0.957 . . . . 1.0 110.89 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.54 -38.33 89.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.531 1.132 . . . . 1.0 113.322 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -69.32 -32.1 70.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.116 0.966 . . . . 1.0 112.155 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.36 -35.23 54.74 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.385 -0.817 . . . . 1.0 112.933 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -45.65 126.46 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.484 1.038 . . . . 1.0 111.359 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.14 59.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.22 1.867 . . . . 1.0 113.972 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -87.71 149.43 24.24 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.027 1.414 . . . . 1.0 111.078 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -106.4 153.15 22.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.397 1.479 . . . . 1.0 113.892 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.8 mtt . . . . . 0 N--CA 1.479 0.977 0 C-N-CA 126.922 2.089 . . . . 1.0 110.811 174.111 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.9 m120 . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 27.3 p -58.43 -34.78 71.19 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.06 -1.025 . . . . 1.0 113.702 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -68.24 -55.28 12.76 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.74 1.616 . . . . 1.0 110.591 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -65.37 -33.19 75.38 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.164 -0.96 . . . . 1.0 111.415 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -56.75 -59.02 5.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.338 -0.839 . . . . 1.0 111.129 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.84 -24.38 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.729 1.15 . . . . 1.0 112.31 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -65.4 -48.35 73.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.036 0.934 . . . . 1.0 111.336 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -62.06 -26.47 68.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.267 1.027 . . . . 1.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.03 -32.87 74.33 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.339 0.972 . . . . 1.0 112.949 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -90.39 -48.87 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.275 1.03 . . . . 1.0 111.557 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.76 -30.45 68.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.074 0 C-N-CA 126.147 1.832 . . . . 1.0 114.52 -179.832 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 CA--C 1.55 0.972 0 CA-C-O 118.739 -0.648 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.07 144.96 12.16 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.663 2.908 . . . . 1.0 112.165 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -130.51 162.64 53.48 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.747 2.019 . . . . 1.0 111.678 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.15 129.23 15.19 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.559 2.839 . . . . 1.0 113.412 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.21 85.12 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.29 -1.284 . . . . 1.0 114.841 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.86 137.44 58.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.585 1.693 . . . . 1.0 112.758 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.39 117.88 24.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.785 1.234 . . . . 1.0 108.419 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.4 mm -99.67 121.81 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.46 1.504 . . . . 1.0 107.85 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.74 119.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.491 1.116 . . . . 1.0 109.505 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 125.192 1.397 . . . . 1.0 110.078 -179.51 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.544 0.717 0 CA-C-O 120.634 0.254 . . . . 1.0 110.854 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -139.69 153.32 47.23 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.267 1.027 . . . . 1.0 112.668 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 152.18 38.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.635 0.774 . . . . 1.0 112.693 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.27 115.43 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.084 1.754 . . . . 1.0 108.323 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -80.32 129.12 34.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.956 0.798 . . . . 1.0 112.099 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.5 pt -105.94 10.62 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 115.06 1.504 . . . . 1.0 115.06 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.86 -34.8 5.08 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.53 1.062 . . . . 1.0 115.743 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.96 16.59 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.371 1.068 . . . . 1.0 113.838 -172.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 -7.46 80.79 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.121 1.343 . . . . 1.0 113.202 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -91.89 156.64 17.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.051 1.341 . . . . 1.0 112.819 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -127.61 152.63 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.405 1.482 . . . . 1.0 110.309 172.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -110.91 135.03 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.061 1.345 . . . . 1.0 107.976 169.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -153.8 151.97 30.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.048 0.939 . . . . 1.0 112.294 -168.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.86 126.56 36.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.566 0.747 . . . . 1.0 109.406 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.732 0 CA-C-O 117.841 -1.076 . . . . 1.0 109.518 173.681 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.499 0 N-CA-C 109.633 -0.506 . . . . 1.0 109.633 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -136.96 137.46 39.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.541 0.736 . . . . 1.0 110.129 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.3 t -80.08 125.13 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.04 161.43 31.0 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.218 1.807 . . . . 1.0 111.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -120.52 124.59 45.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.753 1.621 . . . . 1.0 110.405 172.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -147.27 178.38 8.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.415 1.486 . . . . 1.0 110.219 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.02 143.19 32.69 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.952 -1.092 . . . . 1.0 111.78 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.77 -61.27 2.13 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.153 1.381 . . . . 1.0 111.319 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -56.19 -43.95 78.96 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.268 1.027 . . . . 1.0 111.36 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.39 -43.03 91.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.3 t -69.79 -42.1 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.451 1.1 . . . . 1.0 112.15 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -79.22 -5.47 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.91 132.96 51.21 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.616 1.103 . . . . 1.0 113.041 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.71 69.71 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.691 1.138 . . . . 1.0 114.785 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 m -126.04 154.22 43.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.307 1.843 . . . . 1.0 111.244 -175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.0 t -82.64 153.52 25.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 168.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -160.48 163.67 32.76 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -161.04 159.55 29.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.206 1.403 . . . . 1.0 112.813 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.2 t -82.75 133.06 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -153.77 80.47 1.15 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.885 0.85 . . . . 1.0 112.153 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.15 51.12 1.71 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.138 1.375 . . . . 1.0 113.049 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.8 m -59.0 -30.43 67.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.684 -1.26 . . . . 1.0 113.411 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.54 -16.07 63.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.88 1.067 . . . . 1.0 113.88 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.0 -20.66 65.5 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.038 0.755 . . . . 1.0 113.038 170.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -97.58 -3.2 40.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.596 1.558 . . . . 1.0 111.815 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -97.58 -48.11 5.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.657 1.583 . . . . 1.0 110.98 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.38 167.59 12.61 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.005 1.722 . . . . 1.0 112.795 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -67.45 163.36 48.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.756 0.822 . . . . 1.0 111.701 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.13 128.01 28.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.396 2.73 . . . . 1.0 111.527 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -113.26 152.65 45.32 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.318 1.447 . . . . 1.0 110.43 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.39 113.78 3.81 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.461 2.774 . . . . 1.0 110.783 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.19 -29.23 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -37.0 78.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.493 . . . . 1.0 111.887 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.02 -33.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.526 0.73 . . . . 1.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.17 -47.82 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.938 0.79 . . . . 1.0 110.121 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.81 -38.97 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.253 1.021 . . . . 1.0 111.729 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 t -63.03 -43.17 99.44 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.439 -0.788 . . . . 1.0 111.567 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.5 m -61.63 -42.38 98.8 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.342 1.057 . . . . 1.0 111.671 173.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 72.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.496 0.719 . . . . 1.0 110.456 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -60.95 -40.62 94.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.153 0.981 . . . . 1.0 112.865 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.79 -33.72 76.52 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.838 0.855 . . . . 1.0 112.554 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.5 mmm -73.48 -38.63 65.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.834 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.9 t -47.33 128.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.88 1.218 . . . . 1.0 111.507 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.76 62.95 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.788 1.661 . . . . 1.0 113.703 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -82.76 145.11 29.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 118.965 1.383 . . . . 1.0 111.19 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -114.9 147.38 40.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.83 1.652 . . . . 1.0 112.732 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.6 mmt . . . . . 0 N--CA 1.472 0.669 0 C-N-CA 125.979 1.712 . . . . 1.0 110.237 -178.732 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 63.9 t30 . . . . . 0 CA--C 1.546 0.809 0 N-CA-C 115.933 1.827 . . . . 1.0 115.933 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.13 -43.91 81.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 121.446 1.93 . . . . 1.0 113.33 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -43.91 85.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.138 0.975 . . . . 1.0 110.88 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.23 -41.58 93.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.451 -0.781 . . . . 1.0 111.362 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -58.02 -58.92 6.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.139 0.976 . . . . 1.0 110.891 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.38 -22.52 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.61 1.095 . . . . 1.0 112.76 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 83.5 m -65.7 -49.91 66.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.615 1.166 . . . . 1.0 111.476 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.97 -29.02 64.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.555 1.142 . . . . 1.0 112.468 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.5 -34.54 77.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.219 0.822 . . . . 1.0 113.219 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -93.75 -47.86 6.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.164 0.986 . . . . 1.0 111.307 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.57 -30.48 71.5 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.547 1.139 . . . . 1.0 113.546 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.219 0 C-N-CA 124.599 1.095 . . . . 1.0 114.435 177.823 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 CA--C 1.547 0.83 0 N-CA-C 108.527 -0.916 . . . . 1.0 108.527 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 148.26 26.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.589 2.859 . . . . 1.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.88 164.27 41.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.246 1.818 . . . . 1.0 112.177 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.91 126.68 11.37 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.656 2.904 . . . . 1.0 113.235 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.66 -10.03 75.91 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.744 1.164 . . . . 1.0 115.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -66.87 137.78 56.83 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.457 1.628 . . . . 1.0 112.911 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.27 118.41 26.68 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.276 1.43 . . . . 1.0 108.45 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.3 mt -101.28 130.93 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -103.06 131.78 49.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.301 1.44 . . . . 1.0 108.364 170.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.5 mt -124.43 118.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.632 1.573 . . . . 1.0 108.431 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 1.0 112.034 -169.929 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.487 0 CA-C-O 120.576 0.226 . . . . 1.0 110.433 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -141.41 154.43 45.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.091 0.557 . . . . 1.0 112.048 -175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.73 147.73 31.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.695 0.798 . . . . 1.0 112.356 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.35 118.72 32.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.091 1.756 . . . . 1.0 107.976 169.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.35 132.89 35.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.043 -1.035 . . . . 1.0 112.4 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.86 0.86 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 115.092 1.515 . . . . 1.0 115.092 -169.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.06 169.29 33.45 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.389 0.995 . . . . 1.0 112.917 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 64.1 15.49 9.32 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.239 1.816 . . . . 1.0 114.202 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.57 83.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.35 1.453 . . . . 1.0 114.059 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -101.53 154.52 18.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.21 1.505 . . . . 1.0 114.006 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.72 165.0 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.473 1.909 . . . . 1.0 110.769 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -121.91 135.53 61.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 168.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -154.81 166.02 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.073 -1.017 . . . . 1.0 110.808 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.3 tp -86.57 139.0 31.25 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.641 0 C-N-CA 124.836 1.254 . . . . 1.0 109.371 -177.582 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 109.98 -0.378 . . . . 1.0 109.98 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -129.44 142.68 50.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.386 0.674 . . . . 1.0 111.195 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.0 t -75.41 125.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 169.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.94 151.48 51.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.709 1.204 . . . . 1.0 112.765 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -97.04 129.14 44.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.883 1.673 . . . . 1.0 108.394 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.15 163.06 37.93 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.029 0.532 . . . . 1.0 110.941 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -72.48 141.26 48.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.47 1.108 . . . . 1.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.69 -58.99 3.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.154 1.382 . . . . 1.0 111.167 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -55.77 -45.54 78.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.432 1.093 . . . . 1.0 111.393 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.42 -41.08 98.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.884 0.474 . . . . 1.0 111.671 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.23 -44.49 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.33 1.052 . . . . 1.0 112.325 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.94 -1.76 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 114.044 1.127 . . . . 1.0 114.044 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.27 50.81 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.377 0.989 . . . . 1.0 113.615 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 1.66 76.45 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.933 1.254 . . . . 1.0 114.56 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.4 m -126.27 155.75 41.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.148 1.779 . . . . 1.0 111.418 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.1 t -85.25 154.77 21.73 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -157.13 150.4 23.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.055 -1.028 . . . . 1.0 113.741 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -150.75 163.79 37.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.219 1.808 . . . . 1.0 110.58 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.6 t -83.64 137.46 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.085 0.954 . . . . 1.0 108.878 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -145.0 77.77 1.54 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.291 1.436 . . . . 1.0 110.845 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.08 62.69 2.89 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.929 1.292 . . . . 1.0 111.418 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.3 p -64.24 -40.18 95.5 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.806 1.242 . . . . 1.0 113.378 -170.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -71.48 -9.67 58.56 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.814 1.042 . . . . 1.0 113.814 -175.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.56 -27.06 68.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.873 0.844 . . . . 1.0 113.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -80.58 -14.73 57.96 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.295 1.438 . . . . 1.0 112.184 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -102.49 -39.89 6.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.654 1.581 . . . . 1.0 112.241 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -129.92 161.5 30.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.631 1.572 . . . . 1.0 113.11 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -65.85 159.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.413 1.085 . . . . 1.0 111.288 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.1 124.47 14.45 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.726 2.284 . . . . 1.0 110.817 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -94.23 154.94 40.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.076 1.35 . . . . 1.0 110.343 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.91 113.19 3.32 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.562 . . . . 1.0 110.89 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.45 -32.61 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.55 -36.29 78.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.875 0.47 . . . . 1.0 112.019 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.3 t -71.96 -36.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.912 0.885 . . . . 1.0 111.008 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.27 -47.72 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.858 0.754 . . . . 1.0 110.197 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.95 -38.81 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.945 0.898 . . . . 1.0 111.604 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -61.92 -41.52 98.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.305 0.957 . . . . 1.0 111.706 172.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -61.24 -45.3 95.1 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.2 -0.938 . . . . 1.0 111.055 173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.94 73.36 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.394 -0.817 . . . . 1.0 110.717 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.69 -37.12 85.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.292 1.037 . . . . 1.0 113.43 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.76 -33.49 73.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.714 0.806 . . . . 1.0 112.507 173.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.9 mmm -74.65 -37.39 62.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.919 0.888 . . . . 1.0 112.654 176.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.9 t -46.11 128.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.268 0.94 . . . . 1.0 111.754 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.94 64.92 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.789 1.661 . . . . 1.0 113.56 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -84.06 146.05 28.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.004 1.402 . . . . 1.0 110.89 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -100.19 151.72 21.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.396 1.478 . . . . 1.0 112.56 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.6 mtt . . . . . 0 N--CA 1.477 0.895 0 C-N-CA 125.586 1.554 . . . . 1.0 112.802 -175.448 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.8 t30 . . . . . 0 CA--C 1.552 1.049 0 N-CA-C 117.457 2.391 . . . . 1.0 117.457 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 90.7 m -63.14 -41.53 99.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.463 1.938 . . . . 1.0 114.171 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.41 -47.05 77.61 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.754 -0.591 . . . . 1.0 110.881 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -59.54 -30.98 69.0 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.61 -0.681 . . . . 1.0 112.436 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.19 -61.16 2.55 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.376 -0.828 . . . . 1.0 111.01 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.41 -28.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 p -67.28 -39.08 85.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.959 0.904 . . . . 1.0 112.469 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -59.35 -24.41 63.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.804 0.842 . . . . 1.0 113.036 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -66.19 -35.7 81.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.091 0.86 . . . . 1.0 112.637 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -87.08 -42.79 12.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.064 0.946 . . . . 1.0 111.846 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -68.09 -30.86 70.14 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.244 0 C-N-CA 124.652 1.12 . . . . 1.0 113.298 179.678 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 . . . . . 0 CA--C 1.545 0.758 0 CA-C-O 119.105 -0.474 . . . . 1.0 110.736 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.03 156.74 13.27 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.515 2.81 . . . . 1.0 113.197 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -126.85 162.14 49.2 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.587 1.955 . . . . 1.0 111.706 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -45.8 129.06 11.64 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.061 3.174 . . . . 1.0 113.289 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -7.36 73.94 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.251 1.405 . . . . 1.0 114.887 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -71.48 142.23 50.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.28 1.54 . . . . 1.0 113.839 -175.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.05 124.57 31.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.296 1.438 . . . . 1.0 108.814 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -105.25 128.47 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.124 -1.436 . . . . 1.0 107.124 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -109.6 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.364 1.466 . . . . 1.0 108.048 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mt -127.89 140.64 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.959 1.704 . . . . 1.0 108.911 -169.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 1.0 110.375 -179.559 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 . . . . . 0 CA--C 1.552 1.043 0 N-CA-C 110.89 -0.041 . . . . 1.0 110.89 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -144.34 157.88 44.03 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.023 -1.048 . . . . 1.0 113.407 -173.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.91 40.11 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.781 1.232 . . . . 1.0 112.824 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.37 118.64 37.31 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.971 1.708 . . . . 1.0 108.37 171.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.092 -1.005 . . . . 1.0 112.496 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.06 2.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 115.155 1.539 . . . . 1.0 115.155 -170.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.15 166.84 31.5 Favored Glycine 0 N--CA 1.479 1.513 0 C-N-CA 124.593 1.092 . . . . 1.0 112.984 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 65.12 1.17 1.44 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.39 2.276 . . . . 1.0 114.321 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 6.09 59.31 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.112 1.339 . . . . 1.0 113.932 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -90.49 152.22 21.04 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.167 1.984 . . . . 1.0 113.573 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.68 154.76 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.695 1.598 . . . . 1.0 110.734 171.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -114.51 137.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.837 -1.542 . . . . 1.0 106.837 168.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -155.77 164.17 38.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 120.951 -1.093 . . . . 1.0 110.344 -170.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.7 tp -85.92 143.19 28.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.747 -1.205 . . . . 1.0 107.747 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 124.897 1.279 . . . . 1.0 110.692 -176.695 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 119.164 -0.446 . . . . 1.0 110.608 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -113.39 141.6 46.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.64 0.776 . . . . 1.0 110.81 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.31 127.72 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 170.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.52 160.15 40.51 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.557 1.543 . . . . 1.0 112.636 -173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -101.88 134.33 45.25 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.01 1.324 . . . . 1.0 110.059 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.49 172.9 12.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.505 1.522 . . . . 1.0 109.922 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -81.26 143.93 31.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.979 -1.076 . . . . 1.0 112.124 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 tp -50.85 -53.55 31.33 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.816 1.246 . . . . 1.0 111.226 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.77 -47.94 73.27 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 1.0 111.042 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.71 -36.53 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.5 -47.25 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.862 1.265 . . . . 1.0 112.292 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 m -79.78 -1.25 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 114.353 1.242 . . . . 1.0 114.353 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.32 127.42 44.86 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.974 0.797 . . . . 1.0 112.768 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 2.92 81.23 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.922 1.248 . . . . 1.0 114.781 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.2 m -125.38 160.46 29.32 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 1.0 111.909 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.9 m -89.18 157.8 18.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.806 0.842 . . . . 1.0 109.033 168.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.24 162.9 36.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -158.95 162.05 36.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.836 1.655 . . . . 1.0 112.001 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.1 t -83.23 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -148.5 74.8 1.29 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.278 1.037 . . . . 1.0 111.426 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -77.92 58.65 1.96 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.104 1.362 . . . . 1.0 111.555 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.5 p -63.56 -45.88 88.48 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.615 -1.303 . . . . 1.0 112.896 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 mt -72.49 -10.23 59.54 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.94 -25.36 57.57 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.708 0.803 . . . . 1.0 112.299 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.34 -4.61 53.64 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.45 1.5 . . . . 1.0 113.253 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -84.17 -65.44 1.01 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.431 1.093 . . . . 1.0 111.114 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -109.72 174.68 5.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.068 2.147 . . . . 1.0 113.148 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -66.48 140.21 96.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 121.271 -0.893 . . . . 1.0 110.791 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.21 148.37 91.17 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.887 3.058 . . . . 1.0 113.711 -169.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -99.26 153.83 37.59 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.832 1.253 . . . . 1.0 112.248 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.66 118.46 5.47 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.591 2.861 . . . . 1.0 110.341 170.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 t -55.8 -38.4 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.372 1.469 . . . . 1.0 112.851 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.01 -36.57 70.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.64 0.776 . . . . 1.0 111.616 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.29 -34.46 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.497 -0.764 . . . . 1.0 111.081 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.72 -46.66 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.535 1.062 . . . . 1.0 110.186 171.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.07 -36.68 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.48 1.112 . . . . 1.0 111.414 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 t -63.07 -44.39 95.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.061 0.846 . . . . 1.0 111.111 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.8 m -58.32 -44.44 88.64 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.483 1.113 . . . . 1.0 111.817 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.71 72.74 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.416 1.007 . . . . 1.0 111.135 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.368 1.067 . . . . 1.0 112.957 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.85 -32.89 74.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.978 0.911 . . . . 1.0 112.371 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 80.9 mmm -74.95 -36.35 62.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.703 -1.141 . . . . 1.0 113.086 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.8 t -46.42 125.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 120.277 1.398 . . . . 1.0 111.015 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.72 -17.13 57.9 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.151 1.834 . . . . 1.0 114.182 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -85.77 165.65 16.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.912 1.356 . . . . 1.0 110.961 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.6 156.32 44.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.4 mtt . . . . . 0 N--CA 1.48 1.033 0 C-N-CA 126.797 2.039 . . . . 1.0 112.598 -177.559 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 113.581 0.956 . . . . 1.0 113.581 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.7 m -69.95 -36.64 75.42 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.075 -1.016 . . . . 1.0 113.366 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.4 -56.86 14.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.461 0.573 . . . . 1.0 109.942 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -55.58 -34.0 64.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 1.0 112.751 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -60.0 -59.73 4.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.074 -0.489 . . . . 1.0 110.737 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.22 -32.27 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 -170.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.75 -42.71 90.62 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.393 0.997 . . . . 1.0 111.553 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -61.41 -24.27 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.612 1.165 . . . . 1.0 112.773 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.95 -31.84 73.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.51 1.05 . . . . 1.0 112.846 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -94.89 -49.87 5.38 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.805 1.242 . . . . 1.0 111.352 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -62.26 -46.94 86.56 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.922 -1.111 . . . . 1.0 112.51 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 C-N-CA 126.837 2.16 . . . . 1.0 112.969 178.688 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.38 147.77 18.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.223 2.615 . . . . 1.0 112.722 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -129.81 159.48 69.64 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.219 1.807 . . . . 1.0 112.744 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -46.61 129.24 13.76 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 124.086 3.191 . . . . 1.0 112.907 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.99 79.05 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.584 -1.12 . . . . 1.0 114.863 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -64.85 144.12 57.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.323 1.561 . . . . 1.0 113.143 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -94.12 125.24 38.64 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.421 1.488 . . . . 1.0 108.523 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.57 132.35 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -103.89 133.75 48.33 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.578 1.551 . . . . 1.0 108.863 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.2 mt -127.81 119.92 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.929 1.692 . . . . 1.0 108.132 -171.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 125.899 1.679 . . . . 1.0 113.168 -168.65 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.0 m170 . . . . . 0 CA--C 1.539 0.529 0 CA-C-O 121.028 0.442 . . . . 1.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.95 154.29 51.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.406 1.083 . . . . 1.0 111.259 174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.8 146.84 28.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.16 115.41 27.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.972 1.709 . . . . 1.0 107.846 170.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -81.14 131.89 35.32 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.565 -0.71 . . . . 1.0 111.95 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.67 2.31 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.6 165.23 29.43 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 124.726 1.155 . . . . 1.0 112.759 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.58 17.31 9.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.109 1.764 . . . . 1.0 113.958 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 0.05 81.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.665 1.602 . . . . 1.0 114.195 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.83 154.2 17.37 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.448 1.624 . . . . 1.0 114.057 -175.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 m -137.25 158.38 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.98 1.712 . . . . 1.0 111.662 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.42 139.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.807 1.643 . . . . 1.0 108.326 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -156.43 150.02 24.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 1.0 111.661 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -97.06 124.79 41.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.863 0.865 . . . . 1.0 109.512 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.832 0 CA-C-O 117.406 -1.283 . . . . 1.0 110.322 -179.627 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.668 0 N-CA-C 111.347 0.128 . . . . 1.0 111.347 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -133.56 137.41 45.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.979 0.912 . . . . 1.0 109.98 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.45 127.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -132.27 160.98 34.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.984 1.714 . . . . 1.0 111.804 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -121.14 139.92 52.69 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.906 1.682 . . . . 1.0 109.84 172.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -164.86 -179.52 5.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.772 1.229 . . . . 1.0 111.076 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -70.09 142.92 52.56 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.943 0.897 . . . . 1.0 111.02 172.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.5 tp -51.57 -56.77 11.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.288 1.035 . . . . 1.0 112.152 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.51 -41.18 80.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.502 0.592 . . . . 1.0 111.187 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.37 -39.0 81.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.08 0.552 . . . . 1.0 112.137 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.0 -38.48 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.49 1.116 . . . . 1.0 111.972 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.56 -49.47 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.024 1.33 . . . . 1.0 111.056 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.38 -121.94 27.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.713 0.673 . . . . 1.0 111.677 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.31 -0.68 86.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.953 1.263 . . . . 1.0 114.854 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.6 m -79.43 175.27 10.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.076 1.35 . . . . 1.0 111.591 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 95.6 m -110.19 168.34 9.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.379 1.471 . . . . 1.0 108.884 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -158.05 162.56 38.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -149.39 155.15 40.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.024 1.73 . . . . 1.0 111.272 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.26 135.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -153.86 84.86 1.16 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.818 0.818 . . . . 1.0 111.866 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -81.11 50.13 1.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.187 1.395 . . . . 1.0 112.926 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 m -59.19 -33.46 70.98 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.501 -1.374 . . . . 1.0 113.144 -171.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.48 -12.37 60.13 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -26.69 68.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.962 0.801 . . . . 1.0 112.946 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -88.98 -5.1 58.2 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.893 1.277 . . . . 1.0 112.057 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -99.34 -50.26 4.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.17 1.388 . . . . 1.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -128.2 147.64 50.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.203 1.401 . . . . 1.0 112.774 -174.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -65.56 153.25 90.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 118.44 -0.79 . . . . 1.0 111.57 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.81 127.98 27.28 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.149 3.233 . . . . 1.0 114.765 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.32 155.62 46.45 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.003 1.321 . . . . 1.0 111.536 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.16 117.9 5.36 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.707 2.938 . . . . 1.0 110.063 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -57.3 -34.92 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.42 1.088 . . . . 1.0 113.017 -170.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.2 -36.37 75.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.953 0.501 . . . . 1.0 112.188 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.11 -36.1 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.97 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mt -59.99 -46.39 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 119.662 1.119 . . . . 1.0 110.337 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.44 -36.1 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.021 0.928 . . . . 1.0 111.288 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.7 m -64.56 -43.2 94.67 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.453 -0.779 . . . . 1.0 111.404 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.7 m -60.41 -43.97 96.17 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.658 1.183 . . . . 1.0 111.445 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.64 73.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.66 0.784 . . . . 1.0 110.458 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -60.92 -40.63 93.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.196 0.999 . . . . 1.0 113.002 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -65.25 -34.12 77.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.923 0.889 . . . . 1.0 112.334 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 75.3 mmm -73.73 -39.64 64.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.321 -0.847 . . . . 1.0 112.789 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -47.65 129.49 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.674 1.124 . . . . 1.0 111.707 172.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.37 -14.68 64.03 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.539 1.542 . . . . 1.0 113.464 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -82.69 143.2 31.09 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.122 1.461 . . . . 1.0 111.186 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.75 146.57 27.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.179 1.392 . . . . 1.0 111.633 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.3 mmt . . . . . 0 N--CA 1.469 0.504 0 C-N-CA 125.809 1.643 . . . . 1.0 110.628 -178.031 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 . . . . . 0 CA--C 1.544 0.732 0 N-CA-C 111.867 0.321 . . . . 1.0 111.867 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 6.9 t -85.04 -38.39 19.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.533 1.133 . . . . 1.0 113.504 -169.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -44.97 92.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.141 0.977 . . . . 1.0 110.385 169.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.31 -43.63 64.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.492 1.917 . . . . 1.0 111.381 170.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -64.12 -59.47 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.818 -0.611 . . . . 1.0 111.714 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.55 -22.36 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.481 1.037 . . . . 1.0 113.032 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 m -60.81 -51.41 69.42 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.791 1.236 . . . . 1.0 111.426 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -64.46 -26.51 68.47 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.979 0.733 . . . . 1.0 112.979 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.75 -34.97 76.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.035 0.834 . . . . 1.0 112.917 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -91.87 -49.71 6.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.23 1.012 . . . . 1.0 111.482 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -61.27 -45.86 92.73 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.257 -0.902 . . . . 1.0 112.288 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 C-N-CA 126.38 1.943 . . . . 1.0 112.315 179.795 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 108.563 -0.903 . . . . 1.0 108.563 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.16 143.08 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.265 2.643 . . . . 1.0 111.591 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -129.48 163.44 46.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.094 1.757 . . . . 1.0 112.201 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -45.54 126.62 8.81 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 124.196 3.264 . . . . 1.0 113.095 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.75 82.6 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.44 1.495 . . . . 1.0 115.348 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.25 145.71 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.658 1.729 . . . . 1.0 113.782 -175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.94 123.05 30.06 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.54 1.136 . . . . 1.0 108.068 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.81 131.19 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.416 -1.328 . . . . 1.0 107.416 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.45 129.06 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.244 1.818 . . . . 1.0 108.27 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.75 128.95 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.005 1.722 . . . . 1.0 108.297 -170.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 . . . . . 0 CA--C 1.533 0.321 0 C-N-CA 125.384 1.474 . . . . 1.0 111.451 -174.471 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 111.315 0.117 . . . . 1.0 111.315 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -139.51 156.87 46.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.179 -0.951 . . . . 1.0 113.251 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.41 40.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.214 . . . . 1.0 112.546 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.08 119.08 38.21 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.901 1.681 . . . . 1.0 108.145 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -82.78 130.36 35.12 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.241 -0.912 . . . . 1.0 111.965 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 pt -113.05 3.3 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 114.744 1.387 . . . . 1.0 114.744 -170.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.37 168.05 35.63 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.4 1.0 . . . . 1.0 112.671 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.12 17.78 9.46 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.906 1.682 . . . . 1.0 113.999 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.63 85.37 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.002 1.287 . . . . 1.0 114.379 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.5 154.44 17.27 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.554 1.677 . . . . 1.0 114.204 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.27 157.11 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.283 1.833 . . . . 1.0 111.2 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.53 136.27 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.33 -1.73 . . . . 1.0 106.33 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -158.8 175.28 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.305 1.042 . . . . 1.0 110.32 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.6 mt -90.12 153.18 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.633 -0.667 . . . . 1.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.911 0 C-N-CA 126.566 1.946 . . . . 1.0 107.86 169.386 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 CA-C-O 119.255 -0.403 . . . . 1.0 110.13 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -98.24 138.77 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.093 0.861 . . . . 1.0 110.42 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.11 127.32 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 169.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -138.07 162.02 35.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.442 1.497 . . . . 1.0 112.276 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -109.22 140.28 43.05 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.227 1.811 . . . . 1.0 110.345 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.17 176.61 9.08 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.771 1.228 . . . . 1.0 110.909 172.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -74.28 142.07 45.27 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.705 1.202 . . . . 1.0 111.529 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.85 -51.94 64.34 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.977 -1.011 . . . . 1.0 111.844 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.19 -47.01 72.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.727 0.694 . . . . 1.0 111.22 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.74 -39.71 84.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.549 0.739 . . . . 1.0 112.025 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.55 -42.05 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.404 1.081 . . . . 1.0 112.401 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -0.63 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.536 1.535 . . . . 1.0 113.9 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.91 52.29 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.404 1.002 . . . . 1.0 112.993 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.48 1.87 77.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.725 1.155 . . . . 1.0 114.622 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 24.5 m -120.44 161.26 21.53 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.243 1.817 . . . . 1.0 111.127 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.1 t -97.14 163.19 13.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.015 0.926 . . . . 1.0 109.204 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -157.39 163.32 38.7 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.13 151.72 28.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 109.67 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.23 129.5 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -132.39 68.76 1.49 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.068 0.947 . . . . 1.0 111.531 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -75.58 73.2 2.59 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.873 1.269 . . . . 1.0 111.729 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 m -70.37 -38.76 74.82 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.124 -0.985 . . . . 1.0 113.305 -170.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -75.55 -10.47 59.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.473 1.286 . . . . 1.0 114.473 -169.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.95 -30.59 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.065 0.946 . . . . 1.0 112.693 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -79.21 -16.46 56.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.602 1.561 . . . . 1.0 112.538 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -100.0 -41.33 7.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.486 1.515 . . . . 1.0 112.365 -172.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -130.1 160.27 34.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.202 1.401 . . . . 1.0 113.299 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -66.08 162.86 42.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.706 1.203 . . . . 1.0 111.803 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.32 146.14 7.38 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 125.124 3.883 . . . . 1.0 115.255 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 151.71 63.0 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.486 1.514 . . . . 1.0 112.296 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.88 120.09 4.56 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.853 3.035 . . . . 1.0 112.446 -169.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.9 p -55.58 -33.25 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.208 1.188 . . . . 1.0 114.208 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.66 -35.4 79.51 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.677 0.391 . . . . 1.0 112.041 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.53 -35.47 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.202 0.601 . . . . 1.0 110.815 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.3 mt -62.52 -49.39 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.837 0.744 . . . . 1.0 110.059 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -68.65 -37.64 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.031 0.932 . . . . 1.0 111.709 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.1 m -62.11 -42.02 98.82 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.238 -0.914 . . . . 1.0 111.86 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 t -60.23 -45.44 93.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.559 0.744 . . . . 1.0 111.06 173.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.84 75.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.351 0.66 . . . . 1.0 110.95 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.55 -38.67 90.93 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.14 -0.975 . . . . 1.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.3 -35.58 80.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.766 0.827 . . . . 1.0 112.092 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mmm -73.75 -36.24 65.12 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 1.0 112.975 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.62 126.89 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.744 1.156 . . . . 1.0 111.417 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.27 -17.68 58.72 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.154 1.835 . . . . 1.0 113.981 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -88.14 158.07 18.65 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.872 1.336 . . . . 1.0 110.709 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.79 141.81 43.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.618 1.167 . . . . 1.0 112.335 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.478 0.928 0 C-N-CA 126.381 1.872 . . . . 1.0 110.51 -175.52 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t30 . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.0 m -74.79 -15.31 60.75 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.229 -1.544 . . . . 1.0 114.558 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -46.53 55.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.825 0.739 . . . . 1.0 110.391 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -53.12 -27.98 23.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.608 1.163 . . . . 1.0 113.654 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -65.07 -53.97 37.42 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.183 -0.948 . . . . 1.0 111.173 169.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.43 -26.6 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -64.56 -41.72 96.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.479 1.036 . . . . 1.0 111.815 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.6 -24.23 66.55 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.537 1.135 . . . . 1.0 112.923 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.16 -31.36 72.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.954 0.797 . . . . 1.0 112.557 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -94.16 -43.73 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.618 1.167 . . . . 1.0 111.723 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -67.81 -33.81 75.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.616 0.969 . . . . 1.0 113.616 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 C-N-CA 125.8 1.667 . . . . 1.0 114.323 179.791 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 . . . . . 0 CA--C 1.547 0.835 0 CA-C-O 118.68 -0.676 . . . . 1.0 110.717 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.37 148.6 16.55 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.689 2.926 . . . . 1.0 112.181 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -130.0 161.26 60.9 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.386 1.874 . . . . 1.0 112.915 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.43 128.17 12.16 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.182 3.255 . . . . 1.0 113.114 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.91 -7.64 78.86 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.122 1.344 . . . . 1.0 114.9 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.41 142.48 53.86 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.316 1.558 . . . . 1.0 113.689 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.85 123.96 31.8 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.132 1.373 . . . . 1.0 108.733 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 mm -105.64 127.17 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.783 -1.192 . . . . 1.0 107.783 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -102.49 125.67 49.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.498 1.519 . . . . 1.0 108.272 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.75 119.06 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.137 1.375 . . . . 1.0 109.317 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 . . . . . 0 C--N 1.327 -0.393 0 C-N-CA 125.444 1.498 . . . . 1.0 110.514 -179.677 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.755 0 CA-C-O 120.73 0.3 . . . . 1.0 111.023 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -138.0 150.08 46.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.035 0.934 . . . . 1.0 112.868 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.28 155.82 42.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.468 1.107 . . . . 1.0 112.469 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.35 116.22 32.29 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.924 1.689 . . . . 1.0 107.733 172.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -82.29 131.09 35.23 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.241 -0.912 . . . . 1.0 111.872 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.2 pt -114.26 2.5 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.806 1.41 . . . . 1.0 114.806 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.73 168.67 36.73 Favored Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.448 1.023 . . . . 1.0 112.772 -175.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.74 17.8 9.07 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.983 1.713 . . . . 1.0 113.8 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.16 -0.35 85.79 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.143 1.354 . . . . 1.0 114.445 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -92.94 153.41 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.788 1.794 . . . . 1.0 114.646 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.85 156.52 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.274 1.83 . . . . 1.0 110.865 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.0 mt -115.09 134.84 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.659 1.584 . . . . 1.0 107.101 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.32 145.39 22.75 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.326 -0.859 . . . . 1.0 112.402 -168.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.71 93.31 8.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.491 0.716 . . . . 1.0 109.861 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 124.494 1.117 . . . . 1.0 111.374 -176.74 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 119.48 -0.295 . . . . 1.0 110.514 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.25 135.34 52.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.223 1.009 . . . . 1.0 110.929 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.44 122.35 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 170.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -128.04 161.03 30.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.536 1.534 . . . . 1.0 111.799 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -117.38 120.27 37.64 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.143 1.777 . . . . 1.0 109.994 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -147.19 177.53 9.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.694 1.198 . . . . 1.0 110.852 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.52 139.68 38.62 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.147 -0.97 . . . . 1.0 111.394 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.48 -49.97 68.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.063 0.945 . . . . 1.0 111.609 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.76 -46.21 74.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.426 0.69 . . . . 1.0 111.316 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -44.9 76.37 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.785 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.55 -41.56 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.825 1.25 . . . . 1.0 112.144 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.37 -2.08 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.502 1.521 . . . . 1.0 113.71 -171.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.1 128.65 47.91 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.228 0.918 . . . . 1.0 112.924 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.46 -1.17 83.08 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.942 1.258 . . . . 1.0 114.726 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 m -117.67 150.26 39.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.78 1.632 . . . . 1.0 111.283 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.74 159.64 20.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -160.71 168.46 24.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.484 1.29 . . . . 1.0 114.484 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -159.97 162.2 34.31 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.507 1.523 . . . . 1.0 112.098 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.02 134.31 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 107.146 -1.427 . . . . 1.0 107.146 168.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -145.25 75.64 1.45 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.087 0.946 . . . . 1.0 111.075 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.11 64.64 3.32 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.974 1.309 . . . . 1.0 110.71 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -62.89 -42.4 99.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.736 1.215 . . . . 1.0 113.036 -170.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.67 -7.43 50.37 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.53 -27.95 68.04 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.767 0.794 . . . . 1.0 112.841 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.33 -14.7 59.3 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.205 1.402 . . . . 1.0 112.391 175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -104.21 -40.42 6.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.544 1.538 . . . . 1.0 112.112 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -129.4 156.76 43.55 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.109 1.764 . . . . 1.0 112.75 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -65.95 160.3 63.88 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.951 0.9 . . . . 1.0 111.828 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.34 125.51 17.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.635 2.89 . . . . 1.0 112.28 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -96.99 154.49 38.19 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.955 1.302 . . . . 1.0 110.137 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.11 112.41 3.3 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.032 2.488 . . . . 1.0 111.061 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.67 -33.06 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 124.549 1.139 . . . . 1.0 113.133 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.83 -37.38 79.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.267 0.485 . . . . 1.0 112.034 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.4 -38.76 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.67 0.788 . . . . 1.0 110.646 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.0 mt -60.07 -50.26 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.7 0.682 . . . . 1.0 109.858 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.6 mt -66.67 -36.46 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.248 1.019 . . . . 1.0 112.077 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 t -63.77 -41.78 97.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.948 0.795 . . . . 1.0 110.745 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.4 p -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.67 0.788 . . . . 1.0 111.858 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.83 76.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.888 0.875 . . . . 1.0 110.469 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.59 -39.21 90.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.223 1.009 . . . . 1.0 112.974 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.99 -34.86 79.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.564 0.746 . . . . 1.0 112.358 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.5 mmm -74.63 -36.83 62.91 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.322 -0.847 . . . . 1.0 113.162 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.96 127.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.528 1.058 . . . . 1.0 111.389 170.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.18 -13.53 61.72 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.857 1.694 . . . . 1.0 113.782 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -88.16 155.89 19.53 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.062 1.431 . . . . 1.0 111.245 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.16 143.63 46.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.263 1.425 . . . . 1.0 113.187 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 126.385 1.874 . . . . 1.0 111.172 -172.45 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.2 t30 . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 115.268 1.581 . . . . 1.0 115.268 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.34 -32.04 62.21 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.695 -1.253 . . . . 1.0 113.945 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.49 -50.94 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.789 1.177 . . . . 1.0 110.876 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -64.1 -28.87 70.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.637 0.775 . . . . 1.0 112.488 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.31 -56.11 19.15 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.746 -0.596 . . . . 1.0 110.112 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.64 -30.34 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.0 p -66.43 -41.24 89.49 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.809 1.186 . . . . 1.0 112.344 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -63.22 -21.87 66.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.134 0.974 . . . . 1.0 112.806 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.0 mt -65.14 -32.93 74.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.515 1.052 . . . . 1.0 112.14 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -84.26 -55.05 4.38 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.58 0.752 . . . . 1.0 111.055 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.95 -34.71 77.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 -170.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.085 0 C-N-CA 126.2 1.857 . . . . 1.0 114.184 -178.141 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 111.795 0.295 . . . . 1.0 111.795 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.31 162.39 28.46 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.162 0.985 . . . . 1.0 112.397 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 m -66.79 143.05 97.86 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 123.674 0.79 . . . . 1.0 112.678 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.23 -21.77 10.26 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.309 2.672 . . . . 1.0 113.538 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -128.94 162.87 26.56 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.606 1.562 . . . . 1.0 110.998 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -79.06 156.56 28.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.506 0.722 . . . . 1.0 111.389 173.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -134.75 131.3 20.07 Favored Pre-proline 0 CA--C 1.545 0.761 0 C-N-CA 124.7 1.2 . . . . 1.0 109.445 169.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.4 143.56 17.39 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.708 2.939 . . . . 1.0 112.225 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -125.0 160.41 54.54 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 126.61 1.964 . . . . 1.0 111.849 174.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.77 129.31 11.74 Favored 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 124.082 3.188 . . . . 1.0 112.786 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.5 -11.3 72.43 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.323 1.44 . . . . 1.0 114.924 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.77 137.64 57.91 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 119.125 1.463 . . . . 1.0 112.958 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -85.15 118.2 24.57 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.558 1.143 . . . . 1.0 108.348 171.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.2 mm -93.95 127.36 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 -179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -108.29 117.14 33.39 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.246 2.219 . . . . 1.0 107.611 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.7 mt -115.1 129.6 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.386 1.474 . . . . 1.0 109.052 -170.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -106.82 105.0 14.81 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.442 1.497 . . . . 1.0 109.843 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -85.61 -178.88 6.77 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.59 1.556 . . . . 1.0 110.474 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.6 mt -70.81 102.3 2.31 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.297 -0.877 . . . . 1.0 110.182 170.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.26 3.29 90.6 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 124.972 1.273 . . . . 1.0 115.837 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -150.77 160.83 43.6 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.645 1.578 . . . . 1.0 112.545 -175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 mp0 -116.78 157.49 25.44 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.26 1.024 . . . . 1.0 111.669 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.9 t-80 -147.66 161.31 41.43 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.075 1.35 . . . . 1.0 111.512 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 26.2 m-90 -136.54 154.95 50.57 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 114.422 1.267 . . . . 1.0 114.422 -173.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.29 159.63 43.47 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.495 1.518 . . . . 1.0 112.744 179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.43 114.88 29.5 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.076 1.75 . . . . 1.0 108.709 177.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -82.67 131.69 35.2 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.062 -1.024 . . . . 1.0 112.183 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.5 pt -112.86 -0.35 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 114.816 1.413 . . . . 1.0 114.816 -170.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.28 165.61 27.62 Favored Glycine 0 N--CA 1.473 1.154 0 C-N-CA 124.602 1.096 . . . . 1.0 113.164 -175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.3 t70 60.51 20.47 10.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.834 1.654 . . . . 1.0 114.079 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.54 0.27 79.47 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.637 1.589 . . . . 1.0 114.624 -177.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -96.98 152.45 18.71 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 119.701 1.751 . . . . 1.0 114.16 -175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.3 155.09 41.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.664 1.586 . . . . 1.0 111.111 175.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -112.3 137.33 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.54 1.536 . . . . 1.0 107.219 169.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -153.07 159.34 42.81 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.143 0.977 . . . . 1.0 111.313 -168.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 39.3 tp -95.6 127.34 41.55 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.719 -0.845 . . . . 1.0 108.719 170.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.41 129.54 74.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-O 117.639 -1.172 . . . . 1.0 109.202 171.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.12 148.79 45.09 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 122.763 2.309 . . . . 1.0 111.944 -173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -89.52 -167.98 0.3 Allowed 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 124.355 3.37 . . . . 1.0 111.622 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.9 t -148.4 -176.39 5.28 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.744 1.218 . . . . 1.0 112.002 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -93.47 7.46 44.46 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.682 1.993 . . . . 1.0 112.567 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . 0.333 1.8 t80 -37.29 -50.64 2.42 Favored Pre-proline 0 CA--C 1.552 1.027 0 N-CA-C 119.905 3.298 . . . . 1.0 119.905 -168.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.65 -14.59 42.44 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.226 2.617 . . . . 1.0 114.14 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -117.78 22.84 9.76 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.9 1.714 . . . . 1.0 113.099 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -56.3 146.41 23.97 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.529 1.165 . . . . 1.0 111.985 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.16 129.36 45.76 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.945 0.783 . . . . 1.0 113.794 -169.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.3 t 76.78 -2.07 2.75 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.989 2.116 . . . . 1.0 113.441 -179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.5 m -123.08 174.09 7.44 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.614 1.566 . . . . 1.0 112.731 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 t -154.11 -174.17 4.86 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.187 1.395 . . . . 1.0 110.395 173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.39 -21.53 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 114.738 1.385 . . . . 1.0 114.738 -171.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -85.48 -21.54 28.62 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.619 1.167 . . . . 1.0 113.363 176.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.9 p -121.2 -13.27 8.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.683 1.593 . . . . 1.0 114.295 -174.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 p -140.67 144.03 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 126.169 1.788 . . . . 1.0 109.881 170.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.6 mt -80.4 174.48 11.56 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 122.229 1.014 . . . . 1.0 112.811 -173.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.5 p -85.0 178.29 7.63 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.364 1.066 . . . . 1.0 113.713 175.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -148.73 176.09 10.67 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.692 1.597 . . . . 1.0 110.602 172.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.3 p -162.72 163.47 26.85 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 120.958 -1.089 . . . . 1.0 112.74 171.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.58 153.41 21.42 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.449 1.099 . . . . 1.0 109.445 169.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -146.41 138.32 24.86 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 121.832 -0.542 . . . . 1.0 110.292 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -77.6 129.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.725 -0.843 . . . . 1.0 108.725 171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.29 161.49 35.65 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.728 1.611 . . . . 1.0 112.004 -172.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.4 ttp85 -117.4 129.47 55.87 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 126.104 1.762 . . . . 1.0 110.281 173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -148.37 173.9 12.6 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.656 1.183 . . . . 1.0 111.291 174.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -71.79 142.66 49.67 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.624 0.77 . . . . 1.0 110.661 171.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.34 -51.0 61.2 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.389 1.076 . . . . 1.0 111.826 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -54.06 -48.01 71.04 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.168 0.987 . . . . 1.0 110.988 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.86 -39.21 93.67 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 122.982 0.513 . . . . 1.0 111.877 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 44.9 t -69.57 -46.44 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 C-N-CA 124.432 1.093 . . . . 1.0 112.065 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.4 m -74.71 -35.36 36.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.389 0.995 . . . . 1.0 113.05 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.33 -124.14 35.01 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-N 119.421 1.009 . . . . 1.0 111.797 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.02 -7.2 84.02 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.383 0.992 . . . . 1.0 114.812 174.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.07 148.44 41.9 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.765 1.226 . . . . 1.0 111.634 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -76.54 161.94 28.2 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.738 0.815 . . . . 1.0 110.978 171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -157.19 160.45 38.73 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.4 mtm180 -144.01 163.51 33.29 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.769 2.028 . . . . 1.0 110.844 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 55.1 t -92.99 129.94 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 N-CA-C 105.995 -1.854 . . . . 1.0 105.995 168.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -147.85 83.69 1.52 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.91 0.862 . . . . 1.0 111.914 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -80.81 54.65 2.2 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.998 1.319 . . . . 1.0 112.66 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 13.1 m -60.54 -31.89 70.96 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.734 -1.229 . . . . 1.0 113.271 -171.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.8 mt -68.57 -11.37 59.89 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 113.932 1.086 . . . . 1.0 113.932 -175.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -60.07 -28.06 67.49 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.999 0.818 . . . . 1.0 112.968 172.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -80.35 -14.56 58.25 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 125.244 1.418 . . . . 1.0 112.185 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -101.33 -46.83 4.9 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.396 1.478 . . . . 1.0 111.863 -174.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -122.02 167.09 13.51 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.499 1.519 . . . . 1.0 113.464 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -66.23 161.63 55.21 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.682 1.193 . . . . 1.0 111.87 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.9 87.96 0.68 Allowed 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.174 2.582 . . . . 1.0 110.761 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.59 151.15 96.76 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.681 1.192 . . . . 1.0 111.428 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -71.37 116.42 4.69 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 123.567 2.845 . . . . 1.0 110.093 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -57.28 -31.81 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 114.556 1.317 . . . . 1.0 114.556 -169.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.34 -36.07 77.12 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.065 0.395 . . . . 1.0 112.065 175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 17.0 t -76.57 -32.19 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.323 0.649 . . . . 1.0 111.211 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 45.4 mt -64.91 -46.43 91.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 CA-C-N 119.265 0.939 . . . . 1.0 110.155 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.4 mt -66.15 -38.01 81.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 123.974 0.91 . . . . 1.0 111.531 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.0 m -64.9 -38.28 90.45 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.92 0.782 . . . . 1.0 111.14 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.0 m -63.73 -43.71 95.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.941 0.897 . . . . 1.0 111.306 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.04 -50.41 72.81 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 123.294 0.637 . . . . 1.0 110.662 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -61.78 -40.7 96.11 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.219 1.008 . . . . 1.0 112.903 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -66.55 -32.97 74.65 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.855 0.862 . . . . 1.0 112.388 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.3 mmm -73.6 -39.21 64.78 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.187 -0.911 . . . . 1.0 112.595 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 75.7 t -47.2 127.24 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.674 1.125 . . . . 1.0 111.406 172.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.15 -13.13 63.54 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.927 1.727 . . . . 1.0 114.017 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -84.89 143.3 29.11 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 119.024 1.412 . . . . 1.0 111.306 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.6 mttp -97.32 159.01 15.17 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.618 1.567 . . . . 1.0 113.501 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.4 mtt -137.85 164.88 27.84 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.657 1.983 . . . . 1.0 110.347 172.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.29 -174.46 0.38 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 116.065 1.876 . . . . 1.0 116.065 -169.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -68.06 -172.37 0.29 Allowed 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.627 1.971 . . . . 1.0 113.674 -175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.8 p -32.24 -42.18 0.06 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 127.091 2.156 . . . . 1.0 115.235 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.6 pp -56.07 -11.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 N-CA-C 115.758 1.762 . . . . 1.0 115.758 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.3 m -67.22 -21.88 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 120.073 1.306 . . . . 1.0 112.443 169.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.8 t 57.32 -144.41 0.64 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.324 1.449 . . . . 1.0 111.743 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -60.84 112.59 2.1 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.84 -1.163 . . . . 1.0 109.728 169.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -142.57 -17.5 0.7 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.723 1.749 . . . . 1.0 115.723 -170.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 25.4 p -68.97 -38.75 79.56 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 121.199 1.818 . . . . 1.0 112.912 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.62 -43.61 93.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.608 0.763 . . . . 1.0 111.018 170.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -61.37 -39.55 91.05 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.427 -0.796 . . . . 1.0 111.77 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -59.1 -59.78 4.92 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.196 0.999 . . . . 1.0 110.797 171.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.9 m -66.28 -21.19 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 119.769 1.168 . . . . 1.0 113.425 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 53.5 m -64.0 -49.69 71.47 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.818 1.247 . . . . 1.0 111.038 169.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -61.35 -25.2 66.99 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.521 0.728 . . . . 1.0 112.74 -178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 76.9 mt -64.43 -35.16 80.01 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 118.996 0.816 . . . . 1.0 113.076 176.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -94.03 -40.77 9.91 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.117 0.967 . . . . 1.0 112.297 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -67.47 -44.65 78.04 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.894 0.877 . . . . 1.0 112.29 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.9 32.33 6.45 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.229 1.871 . . . . 1.0 113.639 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.32 -48.62 71.14 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.528 1.131 . . . . 1.0 112.372 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 44.4 m . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.378 1.871 . . . . 1.0 113.09 -177.799 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 tpt . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 110.772 -0.085 . . . . 1.0 110.772 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.57 164.49 26.58 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.213 1.005 . . . . 1.0 113.14 178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.9 m -65.45 147.93 98.35 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.116 0.966 . . . . 1.0 112.605 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -65.53 133.17 33.48 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.971 2.448 . . . . 1.0 110.726 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -83.54 -7.2 59.57 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.047 0.758 . . . . 1.0 113.047 -175.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -157.25 137.83 13.07 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.364 1.866 . . . . 1.0 109.121 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.12 138.57 27.75 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.484 1.113 . . . . 1.0 110.626 176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.02 153.23 22.03 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.828 3.019 . . . . 1.0 113.003 -177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.91 162.94 50.64 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.331 1.852 . . . . 1.0 112.841 177.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -45.36 128.51 10.14 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 124.387 3.392 . . . . 1.0 113.509 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 88.07 -3.74 85.66 Favored Glycine 0 CA--C 1.531 1.072 0 C-N-CA 125.232 1.396 . . . . 1.0 115.204 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -70.04 143.43 52.5 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.472 1.636 . . . . 1.0 113.382 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -86.57 127.48 34.91 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.612 1.165 . . . . 1.0 108.594 169.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.4 mt -117.07 127.96 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.722 0.809 . . . . 1.0 109.523 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -89.46 134.24 34.18 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.936 1.294 . . . . 1.0 108.169 169.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.9 mt -122.66 119.49 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.877 1.271 . . . . 1.0 108.375 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -90.55 59.83 4.39 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.009 1.324 . . . . 1.0 110.985 -171.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -67.02 156.46 35.98 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.535 1.134 . . . . 1.0 111.396 174.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.0 tp -56.88 138.48 53.62 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.851 1.26 . . . . 1.0 111.565 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.42 -54.2 4.93 Favored Glycine 0 N--CA 1.473 1.144 0 C-N-CA 125.21 1.386 . . . . 1.0 112.996 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -147.28 142.63 27.38 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.724 1.61 . . . . 1.0 112.445 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.22 148.58 44.27 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.702 0.801 . . . . 1.0 110.99 170.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 8.3 m80 -124.18 165.42 17.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.169 1.788 . . . . 1.0 109.14 175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 10.6 m-90 -133.86 148.63 51.3 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 121.313 -0.867 . . . . 1.0 112.841 -173.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.36 151.49 40.51 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.235 1.014 . . . . 1.0 112.93 176.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.16 116.97 32.6 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.562 1.945 . . . . 1.0 108.306 170.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.3 133.04 35.22 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.135 -0.978 . . . . 1.0 112.356 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.8 pt -114.74 2.79 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 N-CA-C 115.147 1.536 . . . . 1.0 115.147 -171.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.1 166.63 32.86 Favored Glycine 0 N--CA 1.475 1.254 0 C-N-CA 124.353 0.978 . . . . 1.0 112.807 -175.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.0 t70 62.64 17.73 9.96 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.921 1.688 . . . . 1.0 114.143 174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.88 -1.57 80.95 Favored Glycine 0 C--N 1.342 0.901 0 C-N-CA 125.11 1.338 . . . . 1.0 114.395 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -95.11 153.85 17.46 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 119.641 1.721 . . . . 1.0 114.672 -175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -134.59 158.05 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 126.031 1.732 . . . . 1.0 111.125 176.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.6 mt -115.89 137.85 48.23 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 126.051 1.74 . . . . 1.0 106.718 168.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -154.38 149.31 26.72 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.215 -0.928 . . . . 1.0 111.625 -168.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 63.0 tp -86.12 130.1 34.64 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.69 119.57 47.45 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 124.505 1.122 . . . . 1.0 110.47 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -60.28 168.72 5.92 Favored 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 124.151 3.234 . . . . 1.0 113.108 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -55.11 133.57 58.88 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.908 3.072 . . . . 1.0 112.588 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 p -83.63 -20.63 33.32 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.491 0.922 . . . . 1.0 113.491 178.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.6 159.61 3.62 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.604 2.362 . . . . 1.0 109.578 -178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 39.7 t80 -64.18 139.19 97.63 Favored Pre-proline 0 CA--C 1.559 1.29 0 O-C-N 121.401 -0.812 . . . . 1.0 112.135 178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 42' ' ' TYR . 79.4 Cg_exo -60.42 -42.5 40.69 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 123.478 2.785 . . . . 1.0 115.303 -173.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -99.15 -176.48 31.78 Favored Glycine 0 N--CA 1.474 1.181 0 C-N-CA 124.166 0.889 . . . . 1.0 113.519 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.23 -24.53 60.5 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 112.645 0.609 . . . . 1.0 112.645 171.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.01 -141.52 15.63 Favored Glycine 0 C--N 1.344 1.023 0 C-N-CA 125.206 1.384 . . . . 1.0 112.421 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -63.31 -16.21 59.66 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.589 1.329 . . . . 1.0 114.589 -173.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -74.84 -27.46 60.29 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.134 0.974 . . . . 1.0 113.188 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 88.6 p -107.15 -50.04 3.16 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.609 1.164 . . . . 1.0 112.8 177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t 73.09 -46.58 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 129.063 2.945 . . . . 1.0 112.426 -177.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -72.55 -36.48 68.26 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.92 1.288 . . . . 1.0 113.666 -174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 81.8 p -87.16 1.0 54.4 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 114.517 1.302 . . . . 1.0 114.517 -170.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.5 m -68.25 147.13 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.147 0.979 . . . . 1.0 112.081 -178.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.7 mt -139.23 166.51 24.33 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.595 1.558 . . . . 1.0 110.929 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.9 m -68.91 148.04 50.78 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.865 0.866 . . . . 1.0 113.051 177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 -82.57 159.88 22.67 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.954 0.901 . . . . 1.0 112.135 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.9 p -158.28 151.0 22.35 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.314 1.046 . . . . 1.0 112.763 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -100.0 160.93 13.93 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.423 1.489 . . . . 1.0 110.06 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -132.36 140.98 48.73 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.433 -0.792 . . . . 1.0 110.813 175.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.8 t -78.12 126.89 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 170.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -132.66 163.28 29.29 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.38 1.472 . . . . 1.0 112.003 -174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -121.29 137.86 54.5 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.209 1.804 . . . . 1.0 110.393 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -163.46 178.69 7.85 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.079 1.351 . . . . 1.0 110.977 171.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -70.9 142.08 51.16 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.9 0.88 . . . . 1.0 111.115 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 54.0 tp -52.07 -52.0 54.02 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.371 1.068 . . . . 1.0 111.778 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -54.65 -47.92 72.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.074 0.95 . . . . 1.0 110.788 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -64.54 -39.21 93.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 122.985 0.514 . . . . 1.0 111.985 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.3 t -69.25 -44.99 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 C-N-CA 124.724 1.21 . . . . 1.0 111.956 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 28.3 m -74.79 -36.3 39.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 119.48 1.036 . . . . 1.0 112.829 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 59.62 -119.55 18.72 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-N 119.499 1.045 . . . . 1.0 111.622 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.22 -3.86 86.9 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 124.543 1.068 . . . . 1.0 114.867 174.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 32.4 m -76.41 147.24 38.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 118.828 1.314 . . . . 1.0 111.429 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.2 m -78.84 166.28 22.6 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.175 0.59 . . . . 1.0 110.15 169.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -160.22 164.1 33.02 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.023 1.119 . . . . 1.0 114.023 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -156.38 158.54 37.54 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.956 1.303 . . . . 1.0 112.115 173.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.0 t -81.04 139.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.488 1.115 . . . . 1.0 108.657 169.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -150.88 80.55 1.33 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.22 1.008 . . . . 1.0 111.111 176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -77.78 68.44 3.85 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.388 1.075 . . . . 1.0 111.124 176.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.3 p -64.65 -36.02 82.89 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.691 1.197 . . . . 1.0 113.331 -172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.9 mt -69.57 -10.16 56.99 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.925 1.084 . . . . 1.0 113.925 -175.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.15 -32.65 55.85 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.537 1.135 . . . . 1.0 112.181 169.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -78.13 -16.11 58.25 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.382 1.473 . . . . 1.0 112.877 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -103.79 -45.9 4.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.398 1.479 . . . . 1.0 112.185 -170.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -128.67 162.55 27.08 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.133 1.373 . . . . 1.0 113.211 -175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -71.33 156.17 91.99 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 121.613 -0.68 . . . . 1.0 111.03 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -51.04 133.63 41.28 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 124.182 3.255 . . . . 1.0 113.508 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -98.66 153.8 37.76 Favored Pre-proline 0 CA--C 1.554 1.115 0 C-N-CA 125.359 1.464 . . . . 1.0 110.352 178.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.37 110.99 3.18 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 123.207 2.605 . . . . 1.0 110.749 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -55.42 -33.55 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 114.323 1.231 . . . . 1.0 114.323 -169.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.95 -37.98 84.26 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.134 0.425 . . . . 1.0 111.517 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.9 t -70.83 -36.51 64.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.523 0.729 . . . . 1.0 110.907 178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.7 mt -60.01 -48.81 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 118.589 0.631 . . . . 1.0 110.12 173.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.7 -39.47 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 124.083 0.953 . . . . 1.0 111.742 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 36.6 m -63.51 -38.28 90.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.567 1.076 . . . . 1.0 112.196 172.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.9 t -62.7 -45.6 92.01 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.501 -0.75 . . . . 1.0 111.021 173.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.7 -49.82 75.26 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.434 0.693 . . . . 1.0 110.951 174.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.59 -39.48 91.35 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.925 0.89 . . . . 1.0 113.224 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -65.93 -34.01 77.13 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.785 0.834 . . . . 1.0 112.232 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.9 mmm -73.29 -40.64 64.39 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 118.349 -0.834 . . . . 1.0 112.649 175.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.6 t -47.07 128.36 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 CA-C-N 119.483 1.038 . . . . 1.0 111.586 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.7 -14.06 63.38 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 125.569 1.556 . . . . 1.0 113.219 -177.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -83.75 142.3 30.8 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.171 1.485 . . . . 1.0 111.242 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.3 mttp -95.32 147.2 23.75 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.164 1.385 . . . . 1.0 112.269 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 21.5 mmt -126.2 152.42 46.05 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.434 1.894 . . . . 1.0 110.237 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -61.77 157.76 17.25 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.709 -0.619 . . . . 1.0 112.668 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -61.61 135.62 57.71 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 121.469 -0.769 . . . . 1.0 112.258 178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.6 m -106.93 -0.15 23.39 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.129 1.159 . . . . 1.0 114.129 -171.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.269 18.9 pt 58.1 -31.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 130.422 3.489 . . . . 1.0 116.382 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.2 m -139.18 150.43 23.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 127.942 2.497 . . . . 1.0 109.382 170.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.5 m -71.79 -7.79 50.34 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 -172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -53.52 -28.55 31.86 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -60.54 -18.48 52.64 Favored 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 113.893 1.072 . . . . 1.0 113.893 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.3 m -59.59 -30.29 68.56 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 120.576 -1.328 . . . . 1.0 112.661 171.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -58.72 -56.76 17.98 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.462 0.573 . . . . 1.0 109.834 171.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -56.06 -32.21 63.89 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.756 0.822 . . . . 1.0 112.698 177.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -63.27 -57.84 9.1 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.64 -0.662 . . . . 1.0 110.491 170.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -70.74 -29.09 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 113.989 1.107 . . . . 1.0 113.989 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 36.0 p -67.72 -41.98 82.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.656 1.116 . . . . 1.0 111.884 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -63.09 -23.26 67.36 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.987 0.915 . . . . 1.0 112.933 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 66.8 mt -64.54 -30.21 71.24 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.399 0.999 . . . . 1.0 112.342 173.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -92.37 -53.72 4.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.27 1.428 . . . . 1.0 111.446 175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -69.02 -35.3 76.48 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.881 1.067 . . . . 1.0 113.881 -175.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -99.23 23.22 37.2 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.142 1.829 . . . . 1.0 113.755 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.86 150.41 13.17 Favored 'General case' 0 CA--C 1.556 1.175 0 CA-C-N 118.311 1.056 . . . . 1.0 112.719 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.512 1.925 . . . . 1.0 114.904 -175.115 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 ttm . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 119.024 -0.513 . . . . 1.0 110.993 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.64 167.62 29.91 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.459 1.503 . . . . 1.0 112.009 -176.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.0 t -159.13 146.66 13.22 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.154 1.382 . . . . 1.0 111.101 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -58.02 150.25 65.76 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 123.554 2.836 . . . . 1.0 113.576 177.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -87.07 156.5 19.71 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.937 0.895 . . . . 1.0 112.37 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -68.24 140.96 56.05 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.194 -0.941 . . . . 1.0 110.528 172.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.75 133.04 20.88 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 124.331 1.053 . . . . 1.0 109.929 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.45 147.97 26.0 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.634 2.889 . . . . 1.0 111.927 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -122.68 162.44 38.48 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 126.191 1.796 . . . . 1.0 111.728 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.57 127.09 11.23 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 123.822 3.014 . . . . 1.0 113.254 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.16 -8.51 77.62 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-O 118.495 -1.169 . . . . 1.0 115.303 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -66.28 143.38 57.24 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.326 1.563 . . . . 1.0 113.468 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.8 mt -88.32 125.22 34.57 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.207 1.403 . . . . 1.0 109.341 172.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.3 mm -102.86 131.67 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 107.489 -1.3 . . . . 1.0 107.489 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -108.88 129.63 55.41 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.832 1.653 . . . . 1.0 108.231 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 37.0 mt -126.81 118.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.9 1.28 . . . . 1.0 109.339 -171.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -88.7 64.68 7.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.391 1.476 . . . . 1.0 110.539 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -62.78 151.67 38.05 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.749 0.82 . . . . 1.0 110.488 169.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.4 tp -55.55 129.65 39.76 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.215 1.006 . . . . 1.0 110.729 176.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.17 -123.58 6.2 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 110.476 -1.05 . . . . 1.0 110.476 -169.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -65.6 137.76 57.58 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.278 1.031 . . . . 1.0 112.852 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -64.67 161.17 18.29 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.702 0.801 . . . . 1.0 111.271 170.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.91 165.22 22.51 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.93 1.692 . . . . 1.0 109.668 173.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 25.8 m-90 -141.5 164.18 30.91 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.755 0.822 . . . . 1.0 112.537 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -152.98 154.45 35.0 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.103 0.779 . . . . 1.0 113.103 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -97.74 115.19 27.51 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.029 1.732 . . . . 1.0 107.158 169.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 66.5 t80 -81.43 128.68 34.13 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.304 -0.873 . . . . 1.0 111.868 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.4 pt -109.68 4.64 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.617 1.34 . . . . 1.0 114.617 -169.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.71 169.82 40.15 Favored Glycine 0 N--CA 1.475 1.266 0 C-N-CA 124.292 0.949 . . . . 1.0 112.393 -173.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 62.78 16.14 8.77 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.004 1.722 . . . . 1.0 114.075 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.07 2.97 83.17 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.282 1.42 . . . . 1.0 114.205 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -98.66 154.34 18.03 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.749 1.775 . . . . 1.0 114.236 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -135.92 155.71 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.643 1.577 . . . . 1.0 111.309 178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.5 mt -115.72 137.83 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 125.734 1.614 . . . . 1.0 107.327 169.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -154.34 147.41 24.64 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 120.982 -1.074 . . . . 1.0 111.636 -168.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.0 tp -87.48 128.55 35.23 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 108.392 -0.966 . . . . 1.0 108.392 169.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -113.36 139.92 23.78 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.721 1.208 . . . . 1.0 110.878 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.13 161.06 45.74 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.07 2.514 . . . . 1.0 111.267 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.21 137.77 48.99 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.583 2.855 . . . . 1.0 111.416 176.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.1 p -82.92 -9.09 59.47 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -174.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -158.45 144.27 16.86 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.503 1.921 . . . . 1.0 109.253 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . 0.267 49.4 m-85 86.71 -9.82 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.264 0 N-CA-C 118.972 2.952 . . . . 1.0 118.972 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -70.28 148.85 62.58 Favored 'Trans proline' 0 C--N 1.362 1.258 0 CA-C-N 124.87 2.775 . . . . 1.0 110.961 176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.15 7.57 87.6 Favored Glycine 0 CA--C 1.533 1.171 0 CA-C-O 119.042 -0.865 . . . . 1.0 114.105 173.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.93 163.55 14.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.68 1.192 . . . . 1.0 113.12 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.7 -157.32 22.28 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.906 1.241 . . . . 1.0 112.645 -175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.5 m -74.33 -17.05 60.89 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.571 0.952 . . . . 1.0 113.571 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 49.9 m -86.11 -163.81 0.94 Allowed 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 126.084 1.754 . . . . 1.0 112.298 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.9 t -147.79 176.7 9.91 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 120.325 -1.485 . . . . 1.0 111.215 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.5 m -59.57 -26.44 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 O-C-N 121.021 -1.049 . . . . 1.0 113.274 -173.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -75.59 -28.13 58.8 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.218 1.007 . . . . 1.0 112.713 176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 p -107.42 -14.16 14.93 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.791 1.237 . . . . 1.0 114.114 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.0 p -153.25 149.46 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.921 1.288 . . . . 1.0 111.456 173.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 91.1 mt -124.88 151.84 44.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.744 1.218 . . . . 1.0 110.124 169.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.2 p -163.46 156.02 18.18 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.892 0.877 . . . . 1.0 112.099 -171.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 78.77 157.0 0.16 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 128.133 2.573 . . . . 1.0 111.955 -172.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.4 m -77.41 149.01 35.18 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.429 1.27 . . . . 1.0 114.429 -171.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.1 153.43 19.37 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.738 1.615 . . . . 1.0 110.837 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.7 139.04 54.07 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.499 1.12 . . . . 1.0 110.845 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.9 t -80.53 125.9 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 118.827 0.739 . . . . 1.0 109.013 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -131.98 162.93 29.52 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.93 1.692 . . . . 1.0 111.807 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.4 ttp180 -119.65 140.81 50.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.722 1.609 . . . . 1.0 110.227 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -162.09 179.7 7.76 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.018 1.327 . . . . 1.0 111.076 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.9 145.21 48.65 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.947 0.899 . . . . 1.0 111.413 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -52.16 -53.56 41.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.631 1.172 . . . . 1.0 111.227 178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -55.1 -43.77 74.32 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.471 1.109 . . . . 1.0 111.627 -178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.81 -44.04 91.17 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.284 -0.417 . . . . 1.0 111.317 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.0 t -71.56 -42.6 72.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 124.38 1.072 . . . . 1.0 112.207 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 m -78.27 -3.02 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 N-CA-C 113.992 1.108 . . . . 1.0 113.992 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.74 128.93 48.1 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.493 1.044 . . . . 1.0 113.555 -173.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 78.04 1.23 79.0 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.864 1.221 . . . . 1.0 114.839 -177.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.3 m -125.66 158.14 35.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.026 1.73 . . . . 1.0 111.561 -175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 89.9 m -86.08 156.17 20.5 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.988 -0.745 . . . . 1.0 108.988 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.6 p90 -158.97 164.52 35.51 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 114.565 1.321 . . . . 1.0 114.565 -176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.7 ptt180 -161.3 163.35 30.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.37 1.468 . . . . 1.0 112.169 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 97.0 t -82.11 135.47 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 N-CA-C 107.329 -1.36 . . . . 1.0 107.329 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -146.97 74.79 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 122.269 1.033 . . . . 1.0 111.215 -178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -77.94 57.97 1.84 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 125.543 1.537 . . . . 1.0 111.486 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.4 t -60.78 -40.32 92.12 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 120.515 -1.366 . . . . 1.0 112.498 -169.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.5 mt -70.82 -10.28 59.23 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 114.097 1.147 . . . . 1.0 114.097 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -62.56 -28.74 70.08 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 119.273 0.942 . . . . 1.0 112.58 172.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -84.08 -4.82 59.04 Favored 'General case' 0 CA--C 1.557 1.246 0 C-N-CA 125.313 1.445 . . . . 1.0 111.825 175.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -103.67 -47.29 4.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.379 1.472 . . . . 1.0 111.698 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -129.49 150.68 50.73 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.101 1.36 . . . . 1.0 113.497 -173.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 88.2 mm-40 -65.32 152.29 92.27 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.346 1.058 . . . . 1.0 111.382 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -70.94 133.69 23.93 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.039 2.493 . . . . 1.0 112.784 -170.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -83.74 160.62 58.17 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.589 1.555 . . . . 1.0 112.024 175.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.6 115.52 3.77 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.691 2.928 . . . . 1.0 110.045 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.96 -30.49 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 N-CA-C 114.225 1.195 . . . . 1.0 114.225 -169.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.74 -35.08 77.07 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.201 0.601 . . . . 1.0 112.112 175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 73.3 t -70.81 -37.88 70.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 O-C-N 121.65 -0.656 . . . . 1.0 110.576 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 34.3 mt -64.07 -48.67 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.397 0.679 . . . . 1.0 110.235 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.2 mt -71.68 -41.02 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 124.32 1.048 . . . . 1.0 112.27 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.4 p -65.57 -36.4 83.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.878 1.217 . . . . 1.0 111.81 175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.2 m -61.39 -45.0 96.19 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.683 -0.636 . . . . 1.0 111.767 169.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.31 -48.71 78.24 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 118.797 0.726 . . . . 1.0 110.585 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -62.16 -40.46 96.07 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.082 0.953 . . . . 1.0 112.972 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -66.59 -32.34 73.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.678 0.791 . . . . 1.0 112.475 173.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.8 mmm -73.7 -37.95 65.01 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.835 0.854 . . . . 1.0 112.89 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 87.5 t -47.21 126.96 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-N 119.594 1.088 . . . . 1.0 111.372 170.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.19 -15.56 61.24 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 125.895 1.712 . . . . 1.0 113.929 -175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -86.6 162.97 17.7 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 119.034 1.417 . . . . 1.0 111.403 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -124.63 160.85 27.55 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.373 1.469 . . . . 1.0 113.046 -175.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.9 mtt -134.58 143.04 47.13 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.278 1.431 . . . . 1.0 112.182 178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -77.71 166.79 22.54 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.894 1.277 . . . . 1.0 113.013 178.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -106.7 163.77 12.64 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.918 1.687 . . . . 1.0 112.718 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 62.6 m 71.01 -31.12 0.22 Allowed 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 127.955 2.502 . . . . 1.0 114.071 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.6 tt -56.26 -34.9 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 126.771 2.028 . . . . 1.0 113.874 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 28.9 m -148.75 156.44 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 126.775 2.03 . . . . 1.0 109.723 172.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 29.7 p -83.39 -68.48 0.71 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.178 0.991 . . . . 1.0 112.758 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -83.31 51.87 2.08 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.629 1.572 . . . . 1.0 111.701 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -51.81 -40.0 59.69 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.641 1.576 . . . . 1.0 114.392 -170.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 52.6 t -70.25 -38.26 75.11 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.301 0.955 . . . . 1.0 113.352 176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -59.63 -54.83 41.84 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.655 0.782 . . . . 1.0 109.609 170.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -60.31 -29.08 68.63 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.643 0.777 . . . . 1.0 113.018 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -64.38 -59.88 3.83 Favored 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.39 -0.819 . . . . 1.0 109.928 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.63 -30.43 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 113.622 0.971 . . . . 1.0 113.622 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.9 p -67.87 -44.48 76.98 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 119.577 1.081 . . . . 1.0 112.127 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.05 -25.16 67.52 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.068 0.947 . . . . 1.0 112.945 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 89.8 mt -59.26 -29.14 67.34 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 119.216 0.916 . . . . 1.0 112.807 173.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -96.97 -53.71 3.42 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.629 1.172 . . . . 1.0 111.708 169.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -64.77 -28.85 69.86 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.207 1.188 . . . . 1.0 114.207 -169.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.44 -4.21 86.96 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 123.944 0.783 . . . . 1.0 114.328 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -109.16 169.14 8.88 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.513 1.925 . . . . 1.0 111.859 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 12.9 t . . . . . 0 C--O 1.253 1.289 0 C-N-CA 126.389 1.876 . . . . 1.0 111.593 179.303 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 120.401 0.143 . . . . 1.0 110.975 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.5 160.76 30.51 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.199 1.0 . . . . 1.0 112.84 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.0 p -76.51 154.49 83.78 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.761 1.225 . . . . 1.0 112.762 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.7 162.81 37.05 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.502 2.801 . . . . 1.0 111.795 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -157.66 161.96 38.63 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.95 1.3 . . . . 1.0 111.323 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -72.01 151.33 43.27 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 121.56 -0.712 . . . . 1.0 111.699 171.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -116.81 130.28 24.68 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.552 1.141 . . . . 1.0 109.051 169.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.85 147.12 26.93 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.989 3.126 . . . . 1.0 111.376 178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -127.29 156.11 75.33 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.187 1.795 . . . . 1.0 112.731 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -44.83 124.26 5.54 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.2 3.266 . . . . 1.0 113.677 -176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.11 -0.03 89.12 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-O 118.068 -1.407 . . . . 1.0 115.897 171.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.6 p30 -74.1 159.17 32.98 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.102 1.951 . . . . 1.0 114.241 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.14 124.67 34.55 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.615 1.166 . . . . 1.0 108.943 171.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 48.5 mt -100.34 124.42 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 N-CA-C 106.892 -1.521 . . . . 1.0 106.892 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -88.68 116.33 26.86 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 108.616 -0.883 . . . . 1.0 108.616 171.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 63.9 mt -104.52 129.86 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.165 0.986 . . . . 1.0 108.859 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -114.03 99.52 7.71 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.782 1.633 . . . . 1.0 108.997 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -84.92 175.06 9.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.212 1.405 . . . . 1.0 110.329 173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.71 104.51 1.06 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.603 0.761 . . . . 1.0 109.877 174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 84.46 -0.32 89.28 Favored Glycine 0 CA--C 1.537 1.407 0 C-N-CA 125.112 1.339 . . . . 1.0 116.001 176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -150.44 137.28 19.16 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.518 1.659 . . . . 1.0 113.762 -173.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.37 139.01 37.62 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.128 1.771 . . . . 1.0 110.77 172.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -142.19 127.52 18.77 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.494 1.517 . . . . 1.0 110.108 174.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -95.12 144.87 25.41 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.818 -1.176 . . . . 1.0 110.48 178.014 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.5 154.0 44.37 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.423 1.489 . . . . 1.0 112.064 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.18 112.39 24.71 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.36 1.464 . . . . 1.0 108.426 175.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -83.67 133.86 34.8 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.007 -1.058 . . . . 1.0 112.091 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.261 38.7 pt -110.04 15.55 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 115.478 1.659 . . . . 1.0 115.478 -170.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.32 -27.34 10.66 Favored Glycine 0 N--CA 1.479 1.525 0 N-CA-C 116.388 1.315 . . . . 1.0 116.388 169.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -95.44 13.13 26.92 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.359 1.063 . . . . 1.0 113.691 -170.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.82 -4.6 83.5 Favored Glycine 0 N--CA 1.475 1.271 0 C-N-CA 124.704 1.145 . . . . 1.0 112.483 -169.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -96.66 155.46 16.76 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.58 1.552 . . . . 1.0 112.906 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.82 152.69 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 125.601 1.56 . . . . 1.0 110.26 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 56.7 mt -117.83 138.11 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 C-N-CA 125.14 1.376 . . . . 1.0 108.048 169.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -161.62 168.76 22.86 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.024 0.929 . . . . 1.0 110.463 -170.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.3 tp -89.69 150.87 22.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.869 -0.789 . . . . 1.0 108.869 169.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.67 119.64 28.08 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.871 1.268 . . . . 1.0 108.662 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.47 159.97 28.88 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 123.042 2.494 . . . . 1.0 111.753 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.81 116.42 4.56 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.456 2.771 . . . . 1.0 110.382 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.3 p -83.65 -20.88 32.82 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.759 1.022 . . . . 1.0 113.759 -177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -94.18 20.52 7.93 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 125.651 1.58 . . . . 1.0 112.159 -179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -55.8 132.04 72.75 Favored Pre-proline 0 CA--C 1.555 1.136 0 O-C-N 120.692 -1.255 . . . . 1.0 112.421 -177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.11 131.31 15.25 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.195 2.597 . . . . 1.0 111.459 -174.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.58 7.58 24.28 Favored Glycine 0 N--CA 1.474 1.183 0 CA-C-O 118.91 -0.939 . . . . 1.0 115.252 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.62 128.98 38.07 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 118.879 1.339 . . . . 1.0 112.432 -174.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.04 -40.22 10.68 Favored Glycine 0 N--CA 1.468 0.806 0 C-N-CA 123.907 0.765 . . . . 1.0 113.735 -170.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.0 p -68.26 -30.88 70.02 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.207 1.003 . . . . 1.0 113.416 -175.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.6 p -93.15 -1.29 56.5 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.108 1.363 . . . . 1.0 113.13 172.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.7 m 66.59 8.26 5.71 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.657 1.983 . . . . 1.0 114.127 175.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -64.07 -12.58 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 O-C-N 120.665 -1.272 . . . . 1.0 114.325 -172.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -67.58 -23.53 65.41 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 123.508 0.723 . . . . 1.0 111.997 169.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 91.3 p -121.83 -37.49 2.86 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.037 1.335 . . . . 1.0 113.74 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.8 m -82.52 155.75 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 119.512 1.051 . . . . 1.0 111.845 172.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.4 mt 66.44 -166.13 0.22 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.265 1.826 . . . . 1.0 111.724 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.6 p -166.75 165.2 16.5 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.265 1.426 . . . . 1.0 112.279 -174.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -136.57 175.02 9.99 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.943 1.697 . . . . 1.0 110.595 177.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.7 m -105.88 130.99 53.73 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.945 -1.097 . . . . 1.0 113.822 -171.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -97.49 149.5 22.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.241 1.817 . . . . 1.0 109.036 169.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -122.26 143.29 49.69 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.293 0.951 . . . . 1.0 111.646 -174.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.49 124.21 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 169.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -130.65 157.42 42.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.13 1.372 . . . . 1.0 112.742 -176.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -117.81 134.37 54.99 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.306 1.842 . . . . 1.0 110.215 173.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -159.38 174.89 14.05 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.993 0.917 . . . . 1.0 110.406 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 74.2 mtp85 -64.68 145.07 56.73 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.74 0.816 . . . . 1.0 110.893 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.4 tt -51.54 -52.31 48.15 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.032 0.933 . . . . 1.0 110.675 175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -50.6 -50.56 53.66 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.004 1.322 . . . . 1.0 111.601 176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -65.48 -43.79 89.13 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.256 0.623 . . . . 1.0 112.052 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.6 t -69.84 -40.89 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 124.248 1.019 . . . . 1.0 112.142 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.3 p -80.46 -35.29 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 118.947 0.794 . . . . 1.0 112.846 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.77 -130.37 47.93 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 118.877 0.762 . . . . 1.0 112.406 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.8 5.14 83.62 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.88 1.229 . . . . 1.0 114.734 175.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 86.2 m -79.19 160.13 27.07 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 118.611 1.206 . . . . 1.0 112.16 -177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 71.6 m -79.83 155.66 27.74 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.079 0.952 . . . . 1.0 111.124 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -160.02 163.67 33.84 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.319 1.229 . . . . 1.0 114.319 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -158.66 158.51 33.91 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.818 1.647 . . . . 1.0 111.283 176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 95.4 t -86.13 134.45 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.193 0.997 . . . . 1.0 108.503 169.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -163.06 93.52 0.8 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.838 0.855 . . . . 1.0 111.804 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -77.33 109.05 10.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.37 0.668 . . . . 1.0 110.793 171.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.6 p -76.54 -51.5 11.56 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.545 1.138 . . . . 1.0 111.939 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.2 mt -68.76 -14.18 62.86 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.463 1.105 . . . . 1.0 113.906 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -56.56 -30.1 62.74 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.285 1.034 . . . . 1.0 112.197 169.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -89.49 -6.34 56.52 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 125.09 1.356 . . . . 1.0 112.534 176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -100.43 -49.27 4.28 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.367 1.467 . . . . 1.0 111.831 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -131.0 170.26 14.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.817 1.647 . . . . 1.0 112.505 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -71.64 139.75 83.77 Favored Pre-proline 0 CA--C 1.543 0.707 0 O-C-N 121.317 -0.865 . . . . 1.0 108.861 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -65.27 143.45 77.21 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.473 2.782 . . . . 1.0 112.427 -170.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -86.0 162.09 47.8 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.368 0.667 . . . . 1.0 111.121 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.49 117.87 4.82 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 123.465 2.777 . . . . 1.0 111.535 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.7 p -57.77 -33.13 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 113.332 0.864 . . . . 1.0 113.332 -170.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.06 -37.68 85.88 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.961 0.504 . . . . 1.0 111.37 177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.57 -34.23 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.535 0.734 . . . . 1.0 110.929 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 44.0 mt -64.96 -43.06 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 CA-C-N 119.362 0.983 . . . . 1.0 110.862 174.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 80.6 mt -68.48 -36.83 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 O-C-N 120.885 -1.134 . . . . 1.0 111.599 174.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.6 t -69.58 -39.86 77.09 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 121.455 -0.778 . . . . 1.0 111.391 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.8 p -65.53 -40.23 92.69 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 123.89 0.876 . . . . 1.0 111.25 176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.22 -53.5 57.55 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.703 0.801 . . . . 1.0 110.808 171.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -59.75 -41.23 90.54 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.561 0.744 . . . . 1.0 112.847 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -65.9 -35.36 80.43 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.022 0.929 . . . . 1.0 112.559 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.76 -29.72 51.15 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 118.042 -0.98 . . . . 1.0 113.347 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.5 t -48.03 125.41 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 CA-C-N 120.477 1.489 . . . . 1.0 111.17 169.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.64 -13.28 62.69 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.448 1.499 . . . . 1.0 114.318 -173.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -75.81 155.88 35.0 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 119.197 1.499 . . . . 1.0 110.896 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.97 148.13 45.18 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.868 1.267 . . . . 1.0 112.604 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.1 mmt -124.97 151.2 45.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.87 2.068 . . . . 1.0 110.499 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -72.73 153.04 41.34 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.591 -0.693 . . . . 1.0 111.435 171.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -151.82 136.74 17.24 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.753 1.221 . . . . 1.0 111.387 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 93.2 p -130.64 1.94 4.48 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.817 1.414 . . . . 1.0 114.817 -171.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.27 16.9 pt 57.63 -31.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 130.004 3.321 . . . . 1.0 115.063 -169.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 99.2 t -67.81 -37.45 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 126.862 2.065 . . . . 1.0 110.377 169.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.0 t -119.49 162.16 19.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.844 1.258 . . . . 1.0 111.511 170.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -146.15 145.59 30.54 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.651 1.58 . . . . 1.0 111.382 -172.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -139.74 5.74 2.2 Favored 'General case' 0 CA--C 1.554 1.099 0 N-CA-C 115.274 1.583 . . . . 1.0 115.274 -176.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 82.0 m -59.25 -35.0 72.9 Favored 'General case' 0 N--CA 1.479 0.996 0 O-C-N 120.718 -1.239 . . . . 1.0 114.334 -177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -78.49 -49.19 13.85 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.149 1.379 . . . . 1.0 111.184 174.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -55.26 -35.04 64.58 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.244 1.017 . . . . 1.0 112.399 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -51.81 -51.5 55.99 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.641 -0.662 . . . . 1.0 112.494 170.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.5 m -79.35 -22.76 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.833 1.197 . . . . 1.0 113.557 -171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.5 p -74.79 -39.33 61.78 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.296 0.953 . . . . 1.0 110.922 169.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -61.97 -26.03 67.97 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.894 0.878 . . . . 1.0 113.127 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.05 -32.68 71.15 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 120.017 1.281 . . . . 1.0 113.247 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -89.62 -51.36 5.57 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.681 1.193 . . . . 1.0 110.978 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -67.21 -38.24 84.97 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.38 0.882 . . . . 1.0 113.38 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -106.74 38.54 3.27 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 126.962 2.22 . . . . 1.0 112.476 176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.18 152.33 3.34 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.382 1.073 . . . . 1.0 112.877 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.905 1.682 . . . . 1.0 114.964 -172.765 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 120.24 0.067 . . . . 1.0 110.932 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.73 163.55 27.57 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.274 1.03 . . . . 1.0 112.922 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.3 m -66.2 148.25 98.53 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 123.998 0.919 . . . . 1.0 112.814 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.57 160.46 44.19 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 123.632 2.888 . . . . 1.0 111.677 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -76.92 -8.68 57.8 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.898 1.073 . . . . 1.0 113.898 -176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -158.5 146.44 18.25 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.954 1.702 . . . . 1.0 109.82 -176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -142.17 134.91 13.85 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.509 1.124 . . . . 1.0 109.778 176.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -77.24 143.3 22.25 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.55 2.834 . . . . 1.0 111.387 176.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -115.27 160.07 35.63 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 125.939 1.696 . . . . 1.0 112.003 174.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -56.47 131.18 44.17 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 121.694 1.596 . . . . 1.0 110.386 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.97 -3.41 80.79 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.977 1.275 . . . . 1.0 114.348 -177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -75.29 149.83 38.67 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.101 1.45 . . . . 1.0 112.949 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 42.2 mt -90.68 124.62 35.23 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 124.596 1.159 . . . . 1.0 109.379 172.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.57 130.5 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 107.29 -1.374 . . . . 1.0 107.29 174.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -110.66 129.5 55.81 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 127.389 2.276 . . . . 1.0 107.961 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 32.9 mt -125.26 120.34 57.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 125.1 1.36 . . . . 1.0 109.466 -169.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -90.65 76.35 6.5 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.377 1.471 . . . . 1.0 109.669 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 25.3 mtp-105 -76.72 168.42 20.11 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.219 1.008 . . . . 1.0 111.49 173.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.9 tp -61.44 133.46 55.79 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.902 0.881 . . . . 1.0 110.203 169.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.86 -132.25 11.08 Favored Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.599 -1.0 . . . . 1.0 110.599 -170.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -67.04 151.19 48.1 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.563 0.745 . . . . 1.0 112.937 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.4 mp0 -67.12 165.99 14.82 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.994 1.318 . . . . 1.0 111.028 169.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -138.36 164.0 30.42 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.912 1.285 . . . . 1.0 111.272 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 31.3 m-90 -141.71 153.66 44.79 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.257 -0.902 . . . . 1.0 113.286 -172.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.07 154.87 39.9 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.751 1.22 . . . . 1.0 112.627 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.08 118.83 35.56 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.555 1.942 . . . . 1.0 108.443 171.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -82.06 130.56 35.12 Favored 'General case' 0 N--CA 1.473 0.724 0 O-C-N 121.186 -0.947 . . . . 1.0 112.156 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 pt -104.41 6.32 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 N-CA-C 114.618 1.34 . . . . 1.0 114.618 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.99 -17.17 56.51 Favored Glycine 0 N--CA 1.478 1.499 0 N-CA-C 116.649 1.42 . . . . 1.0 116.649 169.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.13 13.67 26.49 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.813 1.245 . . . . 1.0 113.532 -174.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.12 -5.84 84.42 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.114 1.34 . . . . 1.0 112.305 -169.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -98.61 156.53 16.76 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.867 1.667 . . . . 1.0 112.517 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.4 m -126.51 155.14 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.996 1.718 . . . . 1.0 109.888 172.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.3 mt -112.54 138.47 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 N-CA-C 107.633 -1.247 . . . . 1.0 107.633 168.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -159.86 175.55 12.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.324 1.05 . . . . 1.0 110.773 -169.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.7 mt -95.22 153.46 17.65 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.325 0.65 . . . . 1.0 109.263 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -102.68 113.23 66.01 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 107.066 -1.457 . . . . 1.0 107.066 168.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.15 148.96 56.58 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.619 2.879 . . . . 1.0 113.885 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.76 173.68 12.61 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.878 3.052 . . . . 1.0 112.257 -177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.4 t -149.25 167.6 25.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.536 1.535 . . . . 1.0 111.024 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.22 126.04 26.47 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.705 0.802 . . . . 1.0 111.16 -176.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 48.7 p90 -68.25 141.39 93.73 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 112.683 0.623 . . . . 1.0 112.683 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -82.79 -171.12 1.06 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 124.495 3.464 . . . . 1.0 111.627 -178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 99.5 -15.08 60.36 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.124 1.345 . . . . 1.0 114.523 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.29 -31.29 58.14 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.323 1.049 . . . . 1.0 112.864 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.33 -155.01 16.02 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 126.025 1.774 . . . . 1.0 112.548 174.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 33.1 m -71.66 -26.74 62.66 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.206 0.817 . . . . 1.0 113.206 178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 57.9 m -78.78 143.42 36.11 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.559 1.144 . . . . 1.0 112.017 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.5 t -132.1 -172.84 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.119 1.367 . . . . 1.0 112.304 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 m -64.48 -20.59 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 O-C-N 120.607 -1.308 . . . . 1.0 113.115 -176.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -81.62 -23.22 37.14 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.458 1.103 . . . . 1.0 112.404 171.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 m -79.08 -32.23 44.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.716 1.206 . . . . 1.0 111.585 173.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.8 p -148.62 112.2 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.409 1.084 . . . . 1.0 111.028 173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.39 -35.05 21.59 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.689 0.796 . . . . 1.0 112.521 -171.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.5 t -76.8 111.72 12.63 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.658 -0.651 . . . . 1.0 110.301 178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -128.36 -77.42 0.56 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.417 1.087 . . . . 1.0 109.864 -175.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.9 p -70.84 168.62 16.41 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.4 1.08 . . . . 1.0 112.65 169.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.82 155.49 25.38 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.441 -0.787 . . . . 1.0 112.001 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -141.78 142.57 33.22 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.014 0.926 . . . . 1.0 110.86 176.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -77.12 128.81 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -137.92 162.07 34.99 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.171 1.388 . . . . 1.0 112.595 -175.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.6 ttp85 -112.69 136.44 52.26 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.287 1.835 . . . . 1.0 110.029 173.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.58 173.85 16.31 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.502 1.121 . . . . 1.0 110.557 170.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -66.17 143.62 57.16 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.763 1.625 . . . . 1.0 110.441 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 5.6 tt -52.8 -55.83 20.15 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.165 0.986 . . . . 1.0 110.478 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -52.58 -47.53 66.8 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.606 1.163 . . . . 1.0 111.635 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -62.77 -41.5 99.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 122.862 0.465 . . . . 1.0 111.687 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.9 t -72.49 -44.32 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 124.109 0.963 . . . . 1.0 112.356 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.5 m -74.6 -32.73 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 119.402 1.001 . . . . 1.0 112.768 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.54 -134.21 52.49 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.142 0.877 . . . . 1.0 112.904 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.47 0.99 87.25 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.78 1.181 . . . . 1.0 114.47 174.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 60.5 m -81.92 148.1 28.92 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.916 1.286 . . . . 1.0 110.781 177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.8 m -72.82 156.18 39.16 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.387 0.675 . . . . 1.0 110.962 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -156.98 162.6 39.6 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 114.533 1.309 . . . . 1.0 114.533 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -160.12 165.58 31.44 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.262 1.825 . . . . 1.0 111.414 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.0 t -84.56 140.14 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.174 0.99 . . . . 1.0 108.836 169.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -146.24 74.21 1.36 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.423 1.089 . . . . 1.0 111.762 176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -76.04 70.25 2.71 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.487 1.115 . . . . 1.0 111.312 175.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -60.37 -33.72 72.85 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.859 -1.151 . . . . 1.0 113.376 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 33.6 mt -71.47 -9.74 58.66 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.076 1.139 . . . . 1.0 114.076 -177.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -54.28 -34.56 61.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.467 1.107 . . . . 1.0 112.181 170.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -76.21 -15.09 60.11 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 125.274 1.43 . . . . 1.0 112.741 177.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -104.43 -47.82 4.0 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.263 1.425 . . . . 1.0 112.576 -170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -131.15 156.33 45.46 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.899 1.28 . . . . 1.0 113.532 -173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -71.62 155.37 92.53 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-O 118.192 -0.909 . . . . 1.0 110.021 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.63 129.76 36.69 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.763 2.976 . . . . 1.0 114.926 -169.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.3 159.33 85.68 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.48 1.112 . . . . 1.0 111.704 169.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.43 109.91 2.96 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.462 2.775 . . . . 1.0 110.151 175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.7 p -52.89 -37.29 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 115.176 1.547 . . . . 1.0 115.176 -169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.85 -35.43 76.55 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 118.524 0.602 . . . . 1.0 111.598 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.0 t -75.85 -31.67 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.706 0.802 . . . . 1.0 110.931 178.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.1 mt -64.46 -49.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.732 1.151 . . . . 1.0 109.976 173.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.44 -40.27 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.373 1.069 . . . . 1.0 110.667 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 51.2 m -68.56 -38.75 81.01 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.523 -0.736 . . . . 1.0 111.981 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 58.4 m -63.26 -44.08 96.15 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.696 1.198 . . . . 1.0 110.763 175.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.27 -49.64 77.05 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.433 0.693 . . . . 1.0 111.051 173.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -61.84 -38.36 87.91 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 121.147 -0.971 . . . . 1.0 113.173 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -66.09 -34.16 77.43 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.609 0.764 . . . . 1.0 112.307 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 88.4 mmm -74.83 -37.9 62.16 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 118.316 -0.85 . . . . 1.0 112.872 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 74.7 t -47.09 129.31 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 CA-C-N 119.711 1.142 . . . . 1.0 111.684 170.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -16.43 60.57 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.934 1.73 . . . . 1.0 114.068 -176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -83.01 148.88 27.3 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 119.047 1.424 . . . . 1.0 111.267 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -105.1 156.61 17.91 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.151 1.38 . . . . 1.0 113.372 -176.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.9 mtt -140.23 167.73 21.47 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.934 1.694 . . . . 1.0 111.974 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -67.48 177.09 2.06 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.203 1.557 . . . . 1.0 115.203 -170.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.37 0.87 39.85 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 125.885 1.674 . . . . 1.0 115.114 -174.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.3 m -55.89 120.88 8.09 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.779 1.232 . . . . 1.0 112.803 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -86.28 -10.65 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 N-CA-C 116.051 1.871 . . . . 1.0 116.051 -169.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 63.7 t -79.39 108.98 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 119.072 0.851 . . . . 1.0 109.083 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.3 m -63.73 -8.95 11.86 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.405 2.002 . . . . 1.0 116.405 -169.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -60.56 -19.31 57.03 Favored 'General case' 0 N--CA 1.478 0.954 0 O-C-N 120.588 -1.32 . . . . 1.0 112.561 171.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 48.7 p-10 -56.39 -28.47 59.37 Favored 'General case' 0 CA--C 1.55 0.943 0 O-C-N 120.354 -1.466 . . . . 1.0 112.474 169.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.8 m -69.56 -39.19 77.55 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.501 1.046 . . . . 1.0 112.85 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -57.57 -56.92 15.65 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.718 0.69 . . . . 1.0 109.255 169.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 45.5 m170 -58.61 -30.12 66.99 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.798 0.839 . . . . 1.0 113.128 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -67.23 -56.41 9.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.214 -0.928 . . . . 1.0 111.039 169.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.0 m -70.51 -26.12 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 113.883 1.068 . . . . 1.0 113.883 -172.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 37.4 p -65.87 -44.65 84.74 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 119.703 1.138 . . . . 1.0 110.76 169.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -66.39 -24.57 66.5 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.339 0.866 . . . . 1.0 113.339 177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 73.8 mt -61.77 -30.42 70.78 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 120.203 1.365 . . . . 1.0 112.835 170.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -94.06 -56.37 2.88 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.319 1.447 . . . . 1.0 111.17 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 44.0 t80 -65.98 -39.06 90.01 Favored 'General case' 0 N--CA 1.476 0.84 0 O-C-N 120.764 -1.21 . . . . 1.0 113.359 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -100.18 24.3 32.62 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 126.404 1.954 . . . . 1.0 113.42 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.3 150.04 5.02 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.26 1.024 . . . . 1.0 112.34 174.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.596 1.958 . . . . 1.0 115.459 -175.784 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.1 mmm . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 120.184 0.04 . . . . 1.0 111.003 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.59 164.83 26.12 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.107 0.963 . . . . 1.0 112.616 176.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.3 p -75.2 159.21 82.94 Favored Pre-proline 0 CA--C 1.554 1.112 0 C-N-CA 124.199 1.0 . . . . 1.0 112.893 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -58.76 145.81 94.77 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 123.763 2.975 . . . . 1.0 113.473 177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -162.73 169.77 19.45 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.76 1.624 . . . . 1.0 110.851 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -75.57 148.05 39.17 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.25 -0.906 . . . . 1.0 112.287 177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -137.61 126.69 14.93 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 125.206 1.402 . . . . 1.0 108.745 169.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.75 150.28 27.23 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.185 2.59 . . . . 1.0 112.441 -174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -126.44 158.92 65.62 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 126.138 1.775 . . . . 1.0 112.31 175.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -46.37 127.75 11.58 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 124.332 3.354 . . . . 1.0 113.083 -177.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.56 -8.21 77.08 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 124.987 1.28 . . . . 1.0 115.126 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -67.55 143.55 56.06 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.251 1.525 . . . . 1.0 113.573 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -85.62 127.25 34.42 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.976 1.31 . . . . 1.0 108.155 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 43.0 mt -112.63 131.19 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 107.454 -1.313 . . . . 1.0 107.454 174.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -102.85 138.77 39.29 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.558 1.143 . . . . 1.0 109.082 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.3 mt -131.24 134.9 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 126.557 1.943 . . . . 1.0 108.396 -169.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -114.21 93.69 4.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.906 1.283 . . . . 1.0 109.243 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.2 mtt-85 -81.12 167.18 19.97 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.705 0.802 . . . . 1.0 110.463 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.5 tp -62.15 105.4 0.59 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.635 0.774 . . . . 1.0 110.917 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 89.27 -3.27 84.06 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.232 1.396 . . . . 1.0 116.176 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -165.61 144.02 6.05 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.874 1.837 . . . . 1.0 114.941 -176.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.18 159.73 24.53 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.652 1.581 . . . . 1.0 113.047 177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -151.1 159.38 44.53 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 127.1 2.16 . . . . 1.0 109.034 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.6 m-90 -138.92 160.49 39.61 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 120.676 -1.265 . . . . 1.0 112.252 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.95 152.83 33.01 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.729 0.812 . . . . 1.0 112.756 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.9 116.06 31.08 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.672 1.989 . . . . 1.0 106.995 169.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -82.24 129.67 34.9 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.59 -0.694 . . . . 1.0 111.91 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.8 pt -110.92 4.62 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 114.519 1.303 . . . . 1.0 114.519 -170.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.01 163.73 31.11 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 124.598 1.094 . . . . 1.0 113.08 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.8 t70 60.8 20.06 10.22 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.02 1.728 . . . . 1.0 114.312 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.32 1.7 71.68 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.551 1.548 . . . . 1.0 114.625 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -98.42 153.8 18.32 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.585 1.693 . . . . 1.0 113.951 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.4 157.76 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.58 1.552 . . . . 1.0 111.58 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 52.8 mt -121.0 141.07 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 125.754 1.622 . . . . 1.0 108.183 169.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -154.52 163.19 40.57 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.063 -1.023 . . . . 1.0 110.92 -173.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 29.8 tp -104.92 119.41 38.95 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 1.0 108.752 172.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.78 135.59 30.33 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-O 118.174 -0.917 . . . . 1.0 110.11 -175.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.56 161.47 44.0 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.933 2.422 . . . . 1.0 111.425 178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.82 151.17 85.01 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.01 2.473 . . . . 1.0 113.244 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.4 m -66.48 -24.34 66.4 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.375 0.88 . . . . 1.0 113.375 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -160.57 92.37 0.96 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.228 1.811 . . . . 1.0 108.954 171.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -65.76 159.98 64.91 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.402 1.481 . . . . 1.0 114.622 -176.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.67 156.32 64.46 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 123.066 2.511 . . . . 1.0 110.843 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.15 1.38 86.5 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.093 -0.837 . . . . 1.0 114.921 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.27 -25.33 66.82 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 118.699 1.25 . . . . 1.0 112.851 174.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.19 18.99 40.66 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.847 1.213 . . . . 1.0 115.017 170.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 86.4 p -158.44 -111.88 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 118.438 1.119 . . . . 1.0 110.726 -176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 44.5 m -54.64 -19.52 6.26 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.686 1.594 . . . . 1.0 113.332 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.0 p -49.83 -36.51 26.89 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.569 1.548 . . . . 1.0 112.46 169.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.62 -17.35 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 CA-C-N 119.555 1.07 . . . . 1.0 113.505 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -100.36 -43.78 6.13 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.789 1.235 . . . . 1.0 110.111 169.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.6 m -65.52 -17.37 64.51 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.937 1.088 . . . . 1.0 113.937 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.7 m -54.64 -22.61 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-N 120.396 1.453 . . . . 1.0 113.455 169.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.3 mt -79.13 -12.21 59.99 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.41 1.084 . . . . 1.0 113.525 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 m -131.99 -35.81 1.21 Allowed 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.857 1.428 . . . . 1.0 114.857 -169.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -74.57 150.27 39.78 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 119.261 0.937 . . . . 1.0 113.414 -172.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.1 p -166.23 156.5 12.39 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.824 1.25 . . . . 1.0 111.992 176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.13 145.83 24.12 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.151 0.98 . . . . 1.0 110.37 170.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -140.39 138.49 34.83 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.823 0.849 . . . . 1.0 111.412 -174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.74 129.03 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.302 -0.629 . . . . 1.0 109.302 171.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -134.98 156.46 49.0 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.675 1.59 . . . . 1.0 112.025 -173.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -117.8 140.11 50.15 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.062 1.745 . . . . 1.0 110.331 175.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -164.59 -179.97 6.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.561 1.144 . . . . 1.0 110.846 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.06 143.97 52.32 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.295 1.038 . . . . 1.0 110.476 170.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.7 tt -49.8 -56.87 8.7 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.912 1.285 . . . . 1.0 110.831 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -52.05 -49.17 63.98 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.509 1.124 . . . . 1.0 111.256 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -67.07 -34.05 76.83 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.33 0.652 . . . . 1.0 112.69 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 53.2 t -68.73 -45.58 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 123.903 0.881 . . . . 1.0 111.951 173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.0 m -81.5 -32.97 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 119.516 1.053 . . . . 1.0 113.832 -175.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.67 -123.64 32.37 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.54 1.063 . . . . 1.0 111.256 -175.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.73 2.07 85.76 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 124.646 1.117 . . . . 1.0 114.719 174.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 57.6 m -78.12 147.49 34.6 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 118.723 1.261 . . . . 1.0 111.755 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 23.9 t -75.16 156.97 35.34 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.68 0.792 . . . . 1.0 110.952 175.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -159.93 161.82 34.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.799 1.037 . . . . 1.0 113.799 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -161.06 160.17 30.16 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.708 1.603 . . . . 1.0 111.862 176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 92.3 t -79.68 139.48 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.941 0.897 . . . . 1.0 109.334 171.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -149.26 79.06 1.4 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.439 1.096 . . . . 1.0 111.401 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -78.22 72.29 4.74 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.58 1.152 . . . . 1.0 110.89 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.9 p -67.85 -46.18 72.49 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.591 1.156 . . . . 1.0 112.79 -172.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.8 mt -75.58 -8.35 56.54 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -174.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.86 -27.46 68.14 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.96 0.886 . . . . 1.0 113.128 172.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -79.39 -15.4 57.91 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.429 1.492 . . . . 1.0 112.288 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -102.03 -39.93 7.09 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.556 1.543 . . . . 1.0 112.237 -174.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -126.98 160.7 30.29 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.732 1.613 . . . . 1.0 113.159 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.4 mm-40 -66.06 159.19 72.52 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 124.545 1.138 . . . . 1.0 111.342 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -62.43 127.03 19.79 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.667 2.245 . . . . 1.0 110.796 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -95.34 157.38 36.4 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.134 1.374 . . . . 1.0 110.181 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.51 111.2 2.9 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.86 2.373 . . . . 1.0 110.674 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.93 -32.52 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.612 1.165 . . . . 1.0 112.815 -169.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.18 -36.81 75.97 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.049 0.54 . . . . 1.0 112.237 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.3 t -71.58 -37.81 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 123.817 0.847 . . . . 1.0 110.776 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -61.83 -48.69 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 123.188 0.595 . . . . 1.0 110.156 175.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 85.7 mt -68.33 -39.27 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.258 1.023 . . . . 1.0 111.836 178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.0 t -61.17 -42.87 99.33 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.419 1.009 . . . . 1.0 111.42 173.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 t -61.58 -43.67 98.44 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 1.0 111.756 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.11 73.93 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.328 -0.857 . . . . 1.0 110.746 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.13 -38.29 88.38 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.311 1.044 . . . . 1.0 113.203 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -65.97 -36.34 83.06 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.585 0.754 . . . . 1.0 112.117 173.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 71.0 mmm -73.22 -38.36 66.1 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.881 0.873 . . . . 1.0 112.752 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.6 t -46.95 129.5 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.167 0.894 . . . . 1.0 111.606 171.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.43 -13.52 66.51 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.711 1.624 . . . . 1.0 113.479 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -87.14 145.38 26.45 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.961 1.38 . . . . 1.0 111.477 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -95.32 148.27 22.61 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.761 1.224 . . . . 1.0 112.399 174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 22.8 mmt -128.48 176.26 7.88 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.522 1.529 . . . . 1.0 112.001 -173.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -61.94 162.97 8.29 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.601 1.161 . . . . 1.0 112.887 174.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -71.93 168.33 18.2 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.64 1.176 . . . . 1.0 113.94 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.3 t -148.21 140.14 23.96 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.828 1.251 . . . . 1.0 109.767 169.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 9.7 tt -118.57 43.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 C-N-CA 125.866 1.666 . . . . 1.0 107.497 169.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 t 64.02 47.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.943 1.697 . . . . 1.0 108.042 -169.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 35.2 p -120.09 12.44 11.9 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.564 1.546 . . . . 1.0 114.402 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 82.07 133.52 0.06 Allowed 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 129.596 3.158 . . . . 1.0 111.551 -175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -177.57 -58.8 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 127.119 2.168 . . . . 1.0 111.391 -174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -74.99 -40.04 60.91 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 113.914 1.079 . . . . 1.0 113.914 -169.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -49.56 76.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.196 0.453 . . . . 1.0 110.18 170.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -61.52 -36.59 80.96 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.958 0.903 . . . . 1.0 111.814 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -60.05 -57.22 13.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 118.372 -0.823 . . . . 1.0 110.866 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -67.96 -28.13 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-N 119.828 1.194 . . . . 1.0 113.637 -173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 33.6 p -71.75 -39.72 69.82 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.846 1.203 . . . . 1.0 112.582 173.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -57.46 -26.62 61.49 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.812 0.845 . . . . 1.0 112.484 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.4 mt -62.31 -31.45 72.06 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.296 0.953 . . . . 1.0 112.719 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 54.8 ttt180 -88.75 -55.82 3.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.548 1.139 . . . . 1.0 111.18 171.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -65.37 -35.9 82.38 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.456 0.91 . . . . 1.0 113.456 -171.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.47 39.73 2.79 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 126.923 2.201 . . . . 1.0 112.282 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ptmm? -42.93 -54.95 3.96 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.712 1.605 . . . . 1.0 115.171 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.253 1.271 0 C-N-CA 128.13 2.572 . . . . 1.0 114.584 -172.266 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.0 ttp . . . . . 0 N--CA 1.496 1.865 0 N-CA-C 110.489 -0.189 . . . . 1.0 110.489 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.44 157.42 35.64 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.275 1.03 . . . . 1.0 112.966 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.4 p -80.96 152.29 71.48 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 124.355 1.062 . . . . 1.0 112.51 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.83 -23.4 5.64 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.28 2.653 . . . . 1.0 113.734 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -149.37 166.51 28.82 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.472 1.509 . . . . 1.0 111.501 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -70.82 127.38 32.44 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.292 1.437 . . . . 1.0 110.958 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.35 129.16 56.54 Favored Pre-proline 0 CA--C 1.551 1.013 0 O-C-N 121.572 -0.705 . . . . 1.0 112.457 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -86.63 155.82 9.02 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.986 3.79 . . . . 1.0 112.471 176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.09 168.3 17.24 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 126.812 2.045 . . . . 1.0 112.476 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -50.16 127.23 19.18 Favored 'Trans proline' 0 C--N 1.359 1.117 0 C-N-CA 123.608 2.872 . . . . 1.0 113.402 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.5 -2.84 86.5 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-O 118.341 -1.255 . . . . 1.0 115.011 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -75.01 148.17 40.11 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.678 1.739 . . . . 1.0 113.011 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.0 mt -93.96 129.89 40.26 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.203 1.401 . . . . 1.0 110.177 172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 15.1 mt -117.45 133.09 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.174 0.99 . . . . 1.0 108.94 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -104.49 128.34 52.4 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 125.683 1.593 . . . . 1.0 108.69 169.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.4 mt -130.29 124.17 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.65 1.18 . . . . 1.0 110.257 -169.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -90.59 89.11 7.4 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.172 1.389 . . . . 1.0 108.6 173.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 45.2 ttt85 -94.33 155.31 17.06 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.449 1.5 . . . . 1.0 111.037 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 61.3 tp -58.47 118.05 5.17 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.914 0.886 . . . . 1.0 111.031 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.99 -9.89 72.75 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.029 -1.429 . . . . 1.0 115.568 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.4 p90 -170.51 142.89 2.16 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.648 1.724 . . . . 1.0 114.532 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -68.45 144.04 54.82 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.967 0.907 . . . . 1.0 110.024 169.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -141.79 152.53 43.81 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.577 1.151 . . . . 1.0 110.61 -172.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -140.24 148.94 42.25 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.301 -0.874 . . . . 1.0 111.811 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.66 149.79 36.28 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.532 0.938 . . . . 1.0 113.532 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.28 119.2 38.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.524 2.33 . . . . 1.0 107.484 169.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -82.58 132.81 35.19 Favored 'General case' 0 N--CA 1.472 0.625 0 O-C-N 121.058 -1.026 . . . . 1.0 112.137 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.3 pt -113.69 2.4 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 N-CA-C 115.102 1.519 . . . . 1.0 115.102 -170.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.6 169.86 38.81 Favored Glycine 0 N--CA 1.474 1.18 0 C-N-CA 124.265 0.936 . . . . 1.0 112.756 -175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.99 16.04 7.78 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.204 1.802 . . . . 1.0 114.031 177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.02 2.99 73.85 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 124.997 1.284 . . . . 1.0 114.717 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -101.89 154.32 19.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 119.812 1.806 . . . . 1.0 114.454 -174.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.3 m -133.65 153.76 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.588 1.555 . . . . 1.0 111.36 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.5 mt -114.64 138.57 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 106.344 -1.725 . . . . 1.0 106.344 168.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -153.53 176.3 12.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.615 1.166 . . . . 1.0 109.85 -169.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.4 tt -126.53 122.0 33.9 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.119 0.872 . . . . 1.0 108.78 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.18 124.5 55.7 Favored Pre-proline 0 CA--C 1.54 0.588 0 CA-C-O 118.075 -0.964 . . . . 1.0 109.775 -173.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -60.91 158.28 34.47 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.272 2.648 . . . . 1.0 111.891 169.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.79 -31.41 95.07 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.532 2.821 . . . . 1.0 115.756 -176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 35.5 m 70.8 -22.2 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.23 2.212 . . . . 1.0 114.383 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -129.72 130.78 45.9 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.114 2.166 . . . . 1.0 107.909 169.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -125.99 157.35 69.65 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 124.37 1.068 . . . . 1.0 113.207 -169.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.46 164.5 28.55 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.705 2.936 . . . . 1.0 112.985 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -89.37 -107.5 1.16 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.917 1.246 . . . . 1.0 111.193 172.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.51 -13.43 62.32 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.377 1.251 . . . . 1.0 114.377 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.54 -129.82 9.42 Favored Glycine 0 N--CA 1.47 0.904 0 C-N-CA 124.709 1.147 . . . . 1.0 112.04 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 39.6 p -60.11 -23.68 64.05 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.825 1.046 . . . . 1.0 113.825 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -68.52 -35.22 77.17 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.919 0.888 . . . . 1.0 112.994 175.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 80.1 p -105.15 -25.16 12.6 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.834 1.05 . . . . 1.0 113.834 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.341 14.4 m 59.13 18.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 128.653 2.781 . . . . 1.0 114.206 -169.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 17.9 m-30 -68.05 120.44 14.29 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.608 0.763 . . . . 1.0 110.069 173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 22.0 m 70.07 -26.55 0.16 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 127.315 2.246 . . . . 1.0 115.136 170.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.1 m -58.75 -23.26 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-N 120.094 1.315 . . . . 1.0 113.357 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.89 -3.86 52.82 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.807 1.243 . . . . 1.0 113.101 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.7 t -135.48 -49.45 0.72 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -173.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -72.18 144.84 48.4 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 113.537 0.94 . . . . 1.0 113.537 -172.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 p -165.0 156.13 14.62 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.585 1.154 . . . . 1.0 112.2 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -91.08 150.8 21.26 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.899 0.88 . . . . 1.0 109.525 169.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -150.08 139.99 21.9 Favored 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.417 -0.802 . . . . 1.0 111.376 -170.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.71 124.63 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 108.565 -0.902 . . . . 1.0 108.565 170.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.83 159.16 39.34 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.073 1.749 . . . . 1.0 112.77 -173.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.7 ttm105 -112.71 143.56 43.71 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.684 1.594 . . . . 1.0 110.245 171.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -162.86 176.77 9.88 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.351 1.46 . . . . 1.0 109.564 169.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -71.67 143.61 49.66 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.575 1.55 . . . . 1.0 110.008 174.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.91 -56.82 7.67 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.891 1.276 . . . . 1.0 110.275 173.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -53.56 -45.6 69.95 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.6 1.16 . . . . 1.0 111.812 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -63.99 -45.1 90.52 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 122.746 0.418 . . . . 1.0 111.297 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.5 t -66.63 -43.17 90.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 C-N-CA 123.841 0.856 . . . . 1.0 111.745 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -82.47 -0.5 4.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 N-CA-C 113.833 1.049 . . . . 1.0 113.833 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -62.69 121.62 25.57 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.177 0.894 . . . . 1.0 111.306 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.41 10.99 85.92 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.294 0.95 . . . . 1.0 114.343 -173.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 14.4 m -125.52 165.63 18.14 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.653 1.581 . . . . 1.0 112.413 -173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 75.6 m -111.98 150.94 29.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.193 1.397 . . . . 1.0 108.183 168.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -154.9 153.18 30.7 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 116.291 1.96 . . . . 1.0 116.291 -174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -132.31 151.51 51.81 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 127.379 2.271 . . . . 1.0 109.734 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.92 133.52 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.945 1.298 . . . . 1.0 107.625 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -154.94 85.41 1.09 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.058 0.932 . . . . 1.0 113.262 -169.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -79.11 46.99 0.75 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 125.203 1.401 . . . . 1.0 112.18 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.2 m -62.0 -24.43 67.04 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.593 -1.317 . . . . 1.0 113.293 -169.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 29.2 mt -61.99 -14.88 39.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 113.487 0.921 . . . . 1.0 113.487 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -52.47 -33.81 46.24 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.917 1.287 . . . . 1.0 112.417 169.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -97.05 5.67 49.94 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.898 0.879 . . . . 1.0 113.222 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.32 -49.97 3.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.398 1.479 . . . . 1.0 111.204 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -126.52 167.46 15.59 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.802 1.641 . . . . 1.0 112.877 -174.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -71.0 155.12 93.77 Favored Pre-proline 0 CA--C 1.549 0.92 0 O-C-N 121.434 -0.791 . . . . 1.0 111.13 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -55.71 135.89 71.64 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.852 3.034 . . . . 1.0 113.075 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -113.39 148.28 39.29 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 125.27 1.428 . . . . 1.0 109.753 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.66 122.26 7.24 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.41 2.74 . . . . 1.0 111.536 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 20.9 t -59.28 -32.61 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 124.717 1.207 . . . . 1.0 113.198 -169.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.39 -36.22 79.66 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.749 0.704 . . . . 1.0 112.061 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 47.2 t -74.27 -34.17 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.227 0.611 . . . . 1.0 111.065 177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.5 mt -64.66 -47.6 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 118.541 0.61 . . . . 1.0 110.049 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -66.02 -38.34 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 124.126 0.971 . . . . 1.0 111.399 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -61.19 -41.38 96.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.928 0.786 . . . . 1.0 111.842 172.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.5 t -64.21 -42.36 96.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.738 0.815 . . . . 1.0 111.197 175.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.7 -48.39 77.81 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.212 -0.93 . . . . 1.0 110.855 172.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.91 -22.21 65.96 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.434 1.494 . . . . 1.0 114.529 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.5 -40.06 30.58 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.449 1.1 . . . . 1.0 111.621 170.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 82.6 mmm -75.45 -38.13 59.9 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.336 1.055 . . . . 1.0 112.688 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.4 p -52.71 135.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 113.186 0.81 . . . . 1.0 113.186 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.44 -16.17 61.68 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.806 1.67 . . . . 1.0 113.826 -174.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -84.04 146.9 27.7 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.154 1.477 . . . . 1.0 111.953 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -94.49 156.67 16.35 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.521 1.529 . . . . 1.0 112.271 175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 47.0 mtt -144.06 164.93 29.23 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.264 1.426 . . . . 1.0 112.376 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 62.7 mtpt -72.75 162.53 29.37 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.447 1.099 . . . . 1.0 112.431 173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -130.09 14.62 5.71 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.61 1.564 . . . . 1.0 113.965 -171.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 17.8 m -57.83 124.66 19.97 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.355 1.062 . . . . 1.0 111.759 -177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -68.37 21.42 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 116.822 2.156 . . . . 1.0 116.822 -169.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 67.8 t -70.99 -34.73 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 125.33 1.452 . . . . 1.0 111.187 178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 20.8 t -162.85 157.56 21.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.339 1.456 . . . . 1.0 110.549 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -76.52 113.79 14.52 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.709 0.804 . . . . 1.0 110.592 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.4 t-20 -66.88 -48.84 67.52 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.549 -0.72 . . . . 1.0 112.275 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 34.3 m -55.26 -43.92 75.09 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.397 1.629 . . . . 1.0 115.397 -169.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -64.36 -41.2 96.85 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 118.552 0.614 . . . . 1.0 111.685 177.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -69.44 -37.05 77.2 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.257 -0.902 . . . . 1.0 110.851 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -57.11 -58.2 9.22 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.371 -0.823 . . . . 1.0 111.429 171.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.6 m -65.74 -25.35 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.914 1.234 . . . . 1.0 112.263 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 54.6 m -63.85 -48.76 75.46 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.157 0.983 . . . . 1.0 111.461 169.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -61.6 -27.59 68.75 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.583 1.153 . . . . 1.0 112.986 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.2 -34.41 72.13 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 119.598 1.09 . . . . 1.0 112.946 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 14.9 ttm105 -94.36 -51.15 4.92 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.605 1.162 . . . . 1.0 111.717 173.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -66.43 -29.96 70.21 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.115 -0.991 . . . . 1.0 113.665 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.59 -2.44 85.07 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.945 1.26 . . . . 1.0 114.3 176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 7.8 tmtt? -63.1 -48.34 78.99 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 118.979 1.389 . . . . 1.0 111.252 174.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.7 m . . . . . 0 C--O 1.255 1.352 0 C-N-CA 126.916 2.087 . . . . 1.0 113.773 -174.347 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.499 1.985 0 CA-C-O 120.282 0.087 . . . . 1.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.51 160.48 31.63 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.171 0.989 . . . . 1.0 112.394 175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.1 t -162.1 143.25 8.11 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.307 1.043 . . . . 1.0 111.882 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.46 172.45 16.21 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.56 2.84 . . . . 1.0 111.79 174.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 67.28 14.23 9.64 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.788 1.635 . . . . 1.0 114.449 171.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -65.87 133.98 52.07 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.219 -0.926 . . . . 1.0 110.825 175.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -80.04 130.63 65.74 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.753 -0.641 . . . . 1.0 110.042 173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.84 148.3 25.16 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.072 2.514 . . . . 1.0 112.269 -177.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -121.12 161.05 42.68 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 126.302 1.841 . . . . 1.0 111.346 171.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -55.59 132.07 49.91 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.431 2.088 . . . . 1.0 110.815 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.09 -1.39 73.76 Favored Glycine 0 CA--C 1.534 1.245 0 CA-C-O 118.322 -1.266 . . . . 1.0 114.835 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -76.53 149.38 36.7 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 119.442 1.621 . . . . 1.0 113.283 173.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.9 mt -91.59 128.72 37.53 Favored 'General case' 0 N--CA 1.461 0.102 0 C-N-CA 124.58 1.152 . . . . 1.0 108.93 169.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 46.4 mt -109.16 131.14 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 107.644 -1.243 . . . . 1.0 107.644 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -99.62 133.79 43.45 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.904 1.681 . . . . 1.0 108.231 171.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.8 mt -122.11 120.33 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.732 1.613 . . . . 1.0 108.322 -173.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -93.45 81.26 4.37 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.152 1.381 . . . . 1.0 109.793 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 71.1 mtt-85 -77.24 168.27 20.34 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.192 0.597 . . . . 1.0 111.048 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -62.66 144.41 56.32 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.57 0.748 . . . . 1.0 110.749 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.28 -66.03 3.88 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.854 1.216 . . . . 1.0 112.563 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -146.94 153.61 40.3 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.368 1.867 . . . . 1.0 112.836 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -72.34 163.94 27.13 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.614 1.566 . . . . 1.0 112.72 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -142.55 174.08 10.96 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.212 1.405 . . . . 1.0 111.492 170.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.12 158.3 44.27 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.565 0.95 . . . . 1.0 113.565 -173.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.66 154.89 39.32 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.973 1.309 . . . . 1.0 112.694 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.77 120.61 36.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.172 1.789 . . . . 1.0 108.135 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -82.97 134.92 35.04 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 120.903 -1.123 . . . . 1.0 112.229 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.1 pt -118.73 4.33 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 115.039 1.496 . . . . 1.0 115.039 -171.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.23 168.34 37.39 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 124.348 0.975 . . . . 1.0 112.861 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 t70 62.91 16.1 8.89 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 126.125 1.77 . . . . 1.0 113.899 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.58 -0.98 81.07 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.121 1.343 . . . . 1.0 114.478 -174.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -96.43 154.56 17.2 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.396 1.598 . . . . 1.0 114.366 -175.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.86 159.5 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 126.104 1.762 . . . . 1.0 111.02 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -120.18 137.4 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 106.651 -1.611 . . . . 1.0 106.651 168.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -158.57 174.95 14.29 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.214 1.006 . . . . 1.0 110.552 -169.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 52.5 mt -91.14 151.92 20.78 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.965 -0.459 . . . . 1.0 110.033 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.93 106.86 58.67 Favored Pre-proline 0 CA--C 1.545 0.788 0 N-CA-C 105.898 -1.89 . . . . 1.0 105.898 168.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -59.69 162.01 16.58 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.712 2.941 . . . . 1.0 114.069 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -64.49 148.9 90.72 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.589 2.859 . . . . 1.0 111.972 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 47.4 p -78.56 -19.69 52.27 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.17 0.804 . . . . 1.0 113.17 176.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 74.26 -58.95 0.57 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 128.924 2.89 . . . . 1.0 110.838 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -117.83 99.36 52.13 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 125.959 1.703 . . . . 1.0 110.002 169.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -67.6 144.36 66.15 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.475 3.45 . . . . 1.0 113.043 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.02 -162.47 52.77 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.432 1.015 . . . . 1.0 115.214 171.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -97.65 11.86 35.6 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.446 1.498 . . . . 1.0 113.818 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.27 5.14 62.29 Favored Glycine 0 N--CA 1.477 1.401 0 C-N-CA 124.984 1.278 . . . . 1.0 114.403 -175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.9 t -80.0 -156.44 0.12 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.437 1.095 . . . . 1.0 110.994 170.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 m -51.22 -25.82 6.14 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 126.045 1.738 . . . . 1.0 115.208 -172.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.5 m -60.25 -19.44 54.63 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.988 1.315 . . . . 1.0 113.748 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.2 p -57.01 -23.62 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.168 1.387 . . . . 1.0 113.305 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -55.08 -31.31 61.09 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.395 1.078 . . . . 1.0 112.731 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 66.5 m -94.23 10.39 34.21 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.366 1.066 . . . . 1.0 113.762 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.8 t -54.73 125.8 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 C-N-CA 124.567 1.147 . . . . 1.0 110.503 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.0 mt 65.14 -25.45 0.09 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 128.81 2.844 . . . . 1.0 114.634 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.5 m -73.88 -18.52 60.91 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.109 1.363 . . . . 1.0 113.657 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -64.72 156.41 30.52 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.291 1.436 . . . . 1.0 113.806 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.8 m -134.98 171.68 14.07 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.052 1.341 . . . . 1.0 112.223 -172.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.89 163.7 24.13 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.599 -0.688 . . . . 1.0 111.174 171.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -133.87 145.15 49.39 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.765 0.826 . . . . 1.0 110.973 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.1 t -75.72 127.93 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 108.501 -0.926 . . . . 1.0 108.501 169.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -137.62 161.69 35.79 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.669 1.188 . . . . 1.0 112.711 -178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.7 ttt-85 -115.51 138.89 50.57 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.814 2.046 . . . . 1.0 110.138 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.09 176.93 8.1 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.991 1.316 . . . . 1.0 110.361 170.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -67.64 142.11 56.5 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.086 1.754 . . . . 1.0 110.377 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.7 tp -51.9 -52.54 49.16 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.975 0.91 . . . . 1.0 111.711 177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -55.36 -47.51 75.66 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.165 0.986 . . . . 1.0 111.153 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -63.38 -39.61 94.99 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 122.783 0.433 . . . . 1.0 111.94 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.69 -45.39 74.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.545 1.138 . . . . 1.0 111.583 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.9 m -75.37 -35.36 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.716 1.144 . . . . 1.0 112.834 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 62.78 -124.16 32.13 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 119.331 0.969 . . . . 1.0 111.533 -178.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.08 -0.19 87.25 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.601 1.096 . . . . 1.0 114.623 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 58.6 m -82.52 148.61 28.0 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.648 1.179 . . . . 1.0 110.974 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 76.8 m -77.95 165.92 23.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.438 0.695 . . . . 1.0 111.318 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -161.45 164.95 29.45 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -160.34 161.0 33.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.535 1.534 . . . . 1.0 112.015 176.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.1 t -79.03 131.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.821 -1.177 . . . . 1.0 107.821 169.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -140.68 60.3 1.53 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.744 1.259 . . . . 1.0 109.842 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 51.9 t-20 -82.65 67.55 8.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.311 1.445 . . . . 1.0 111.577 -175.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 45.2 p -68.48 -21.31 64.62 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.314 1.445 . . . . 1.0 114.463 -173.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 37.1 mt -65.78 -14.07 60.65 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.674 0.99 . . . . 1.0 113.674 -172.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -53.45 -33.33 53.75 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 1.0 112.255 169.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -81.17 -17.48 49.58 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.32 1.448 . . . . 1.0 112.622 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -98.19 -47.2 5.56 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.035 1.334 . . . . 1.0 111.996 -170.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -128.43 162.38 27.28 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.103 1.361 . . . . 1.0 113.458 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -69.97 159.77 82.94 Favored Pre-proline 0 CA--C 1.548 0.898 0 CA-C-O 118.377 -0.82 . . . . 1.0 110.358 169.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.45 156.5 13.95 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 124.285 3.323 . . . . 1.0 115.559 -177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 154.95 71.04 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 125.513 1.525 . . . . 1.0 112.182 176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -79.24 123.27 5.5 Favored 'Trans proline' 0 C--N 1.356 0.943 0 C-N-CA 124.046 3.164 . . . . 1.0 111.992 -169.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.8 p -57.07 -35.42 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.454 1.102 . . . . 1.0 113.934 -170.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -59.9 -37.37 79.21 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.765 0.826 . . . . 1.0 111.788 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 77.0 t -73.94 -34.65 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 O-C-N 121.455 -0.778 . . . . 1.0 110.664 178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.1 mt -64.35 -48.21 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 118.813 0.733 . . . . 1.0 109.997 177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -39.79 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.572 1.149 . . . . 1.0 111.108 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 65.2 m -66.18 -43.35 87.13 Favored 'General case' 0 N--CA 1.471 0.591 0 O-C-N 121.282 -0.886 . . . . 1.0 111.947 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.8 m -59.16 -44.44 92.13 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.598 1.159 . . . . 1.0 111.233 172.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.66 -51.41 70.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 118.919 0.781 . . . . 1.0 110.672 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.16 -39.6 90.73 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.245 -0.91 . . . . 1.0 113.161 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.75 -34.22 77.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.79 0.836 . . . . 1.0 112.29 174.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.4 mmm -74.9 -36.07 62.23 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 118.383 -0.818 . . . . 1.0 112.934 177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 62.4 t -46.33 129.67 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 119.448 1.022 . . . . 1.0 112.008 171.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.54 -16.05 61.71 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.951 1.739 . . . . 1.0 114.041 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -84.47 143.69 29.22 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.081 1.441 . . . . 1.0 111.401 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -94.33 146.61 23.92 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.919 1.288 . . . . 1.0 112.393 178.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.7 mmt -134.83 141.54 46.42 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.591 1.556 . . . . 1.0 112.088 -170.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -78.23 113.49 16.24 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.752 0.821 . . . . 1.0 109.544 170.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.2 t80 -93.37 -27.84 16.52 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.01 1.485 . . . . 1.0 115.01 -169.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.4 t -83.1 92.78 7.48 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.6 0.714 . . . . 1.0 110.489 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.1 tp -163.77 130.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.51 1.524 . . . . 1.0 109.789 -173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.81 -24.43 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 113.976 1.102 . . . . 1.0 113.976 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.5 m -67.43 -5.28 14.05 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.199 1.4 . . . . 1.0 114.413 176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 66.64 86.14 0.13 Allowed 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.568 2.347 . . . . 1.0 111.22 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -54.53 -34.56 61.95 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.78 1.029 . . . . 1.0 113.78 -173.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.9 p -60.84 -61.22 2.74 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.333 1.453 . . . . 1.0 113.563 172.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.98 -46.71 87.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.772 0.829 . . . . 1.0 111.126 177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -59.25 -46.53 88.26 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.107 0.412 . . . . 1.0 111.288 177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -55.31 -59.21 5.11 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.493 0.717 . . . . 1.0 111.308 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.2 m -65.18 -26.2 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-N 118.997 0.817 . . . . 1.0 112.372 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.0 m -66.02 -49.45 67.7 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.344 1.057 . . . . 1.0 111.237 170.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -59.51 -29.77 68.1 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.904 0.882 . . . . 1.0 112.509 -176.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.81 -33.82 74.82 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.295 0.85 . . . . 1.0 113.295 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -98.29 -42.78 7.24 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.777 1.231 . . . . 1.0 112.374 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -67.07 -50.82 60.46 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 120.856 -1.152 . . . . 1.0 112.092 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.79 35.77 3.69 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 126.412 1.958 . . . . 1.0 114.222 -174.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.6 157.42 4.03 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.53 1.132 . . . . 1.0 113.15 172.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.738 1.615 . . . . 1.0 114.212 -176.67 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.2 mtp . . . . . 0 N--CA 1.498 1.925 0 CA-C-O 120.385 0.136 . . . . 1.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.98 161.54 29.98 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.893 0.877 . . . . 1.0 112.434 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.3 m -67.7 144.3 97.41 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.662 0.785 . . . . 1.0 112.787 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.48 164.78 28.19 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.654 2.903 . . . . 1.0 112.133 177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 80.13 160.69 0.17 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 127.496 2.318 . . . . 1.0 113.996 172.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -78.7 154.03 30.43 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.253 -0.904 . . . . 1.0 110.839 169.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -130.74 129.11 22.6 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.423 1.089 . . . . 1.0 109.807 171.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.06 153.47 16.74 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 123.526 2.817 . . . . 1.0 112.728 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -128.61 162.65 49.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 126.54 1.936 . . . . 1.0 112.431 174.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_exo -43.99 127.12 6.55 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 124.396 3.397 . . . . 1.0 113.093 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.21 2.33 87.95 Favored Glycine 0 N--CA 1.473 1.124 0 CA-C-O 118.354 -1.248 . . . . 1.0 115.422 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -74.71 146.14 42.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.739 1.77 . . . . 1.0 112.947 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -90.07 122.61 33.21 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.387 -1.338 . . . . 1.0 107.387 169.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 45.9 mt -101.98 132.24 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 N-CA-C 106.86 -1.533 . . . . 1.0 106.86 175.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -109.91 132.1 54.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.799 2.04 . . . . 1.0 107.951 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.6 mt -127.42 123.77 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 C-N-CA 124.78 1.232 . . . . 1.0 109.195 -169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -86.56 131.14 34.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.829 1.252 . . . . 1.0 110.172 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -137.31 173.52 11.59 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.519 1.928 . . . . 1.0 110.2 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.23 122.27 13.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.958 0.903 . . . . 1.0 109.229 170.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.0 -130.55 9.77 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 124.215 0.912 . . . . 1.0 111.17 -171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -76.05 152.53 36.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.573 1.149 . . . . 1.0 113.438 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.07 168.47 8.29 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.935 1.694 . . . . 1.0 112.941 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -137.26 164.08 29.4 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.044 1.738 . . . . 1.0 111.146 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.5 m-90 -138.56 155.32 48.47 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 121.088 -1.007 . . . . 1.0 113.206 -175.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.1 153.4 40.65 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.424 1.489 . . . . 1.0 112.309 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.55 118.26 34.83 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.049 1.74 . . . . 1.0 108.205 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -84.19 130.9 34.81 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.449 1.022 . . . . 1.0 112.545 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.6 pt -113.43 0.79 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 N-CA-C 114.87 1.433 . . . . 1.0 114.87 -170.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.17 168.04 34.47 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.357 0.979 . . . . 1.0 112.881 -175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.2 t70 63.74 16.3 9.65 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 126.212 1.805 . . . . 1.0 114.082 174.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.56 6.49 77.08 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.133 1.349 . . . . 1.0 114.274 -175.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -103.83 154.5 19.52 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 119.352 1.576 . . . . 1.0 113.94 -178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.67 161.52 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 126.381 1.873 . . . . 1.0 111.229 175.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.7 mt -118.59 137.61 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 N-CA-C 106.982 -1.488 . . . . 1.0 106.982 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -161.98 169.96 20.18 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.208 -0.933 . . . . 1.0 110.537 -169.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.9 mt -88.15 151.59 22.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 121.874 -0.516 . . . . 1.0 109.745 169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -124.47 114.59 27.23 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.685 1.594 . . . . 1.0 109.88 171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.52 164.79 25.82 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 123.346 2.697 . . . . 1.0 111.453 178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.9 -19.23 18.3 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 123.977 3.118 . . . . 1.0 113.359 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 70.0 m 72.07 -18.99 0.29 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 127.434 2.294 . . . . 1.0 115.0 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -135.45 134.3 39.46 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.162 1.785 . . . . 1.0 110.164 176.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -72.38 144.62 86.96 Favored Pre-proline 0 CA--C 1.553 1.085 0 C-N-CA 123.962 0.905 . . . . 1.0 111.701 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.27 160.26 35.73 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.737 2.958 . . . . 1.0 113.703 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.68 142.23 9.1 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 125.718 1.627 . . . . 1.0 111.787 -170.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.19 -25.02 60.62 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.802 1.038 . . . . 1.0 113.802 -173.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -157.17 -134.94 1.84 Allowed Glycine 0 N--CA 1.471 1.013 0 C-N-CA 125.727 1.632 . . . . 1.0 111.043 175.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.7 m -57.77 -19.69 29.88 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.884 0.874 . . . . 1.0 112.749 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 20.2 p -53.36 -14.73 0.81 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.257 1.823 . . . . 1.0 113.631 169.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -52.62 -30.47 31.54 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.225 1.41 . . . . 1.0 113.298 169.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.9 m -68.91 -18.8 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 113.287 0.847 . . . . 1.0 113.287 176.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -106.05 -46.47 4.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.475 1.51 . . . . 1.0 111.225 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.7 m -75.12 42.7 0.19 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.333 1.853 . . . . 1.0 113.163 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.2 m -66.62 143.36 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.647 1.579 . . . . 1.0 112.469 -176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 53.3 tp -165.47 145.46 6.75 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.605 1.562 . . . . 1.0 110.329 -173.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -63.01 128.07 34.15 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.367 -0.833 . . . . 1.0 111.811 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -91.28 150.91 21.11 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.701 0.8 . . . . 1.0 111.184 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.7 p -142.26 146.55 35.25 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.179 0.992 . . . . 1.0 112.837 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -107.68 150.16 27.25 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.557 1.543 . . . . 1.0 110.725 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -100.07 138.59 36.94 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.192 0.997 . . . . 1.0 110.595 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.1 t -77.63 123.2 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 170.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -127.38 155.01 44.29 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.417 1.487 . . . . 1.0 112.395 -177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.6 ttp180 -104.03 128.79 51.64 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.858 1.663 . . . . 1.0 108.291 169.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -157.24 166.07 34.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.45 0.568 . . . . 1.0 111.552 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -76.06 137.62 40.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.82 1.648 . . . . 1.0 110.743 -176.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.32 -55.55 17.8 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.891 1.277 . . . . 1.0 110.952 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -55.01 -44.61 74.7 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.391 1.076 . . . . 1.0 111.721 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -65.14 -42.3 93.96 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.451 0.3 . . . . 1.0 111.521 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.92 -39.27 77.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 124.8 1.24 . . . . 1.0 112.244 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.6 m -85.58 -0.74 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 C-N-CA 124.471 1.108 . . . . 1.0 113.776 175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -63.28 126.72 36.51 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.322 0.963 . . . . 1.0 112.082 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.37 6.29 79.92 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.294 0.949 . . . . 1.0 114.194 -173.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 13.9 m -122.52 -179.51 4.23 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.686 1.994 . . . . 1.0 110.783 -176.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.6 t -126.07 156.99 39.12 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.392 1.477 . . . . 1.0 108.119 168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -155.01 164.89 38.26 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 115.403 1.631 . . . . 1.0 115.403 -171.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -158.56 160.27 36.44 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.758 2.023 . . . . 1.0 110.944 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -88.14 129.05 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 106.978 -1.49 . . . . 1.0 106.978 168.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -131.66 54.58 1.92 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 122.502 1.144 . . . . 1.0 110.165 177.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.28 71.46 7.07 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.896 1.279 . . . . 1.0 111.329 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 28.2 p -73.56 -43.47 59.78 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.835 1.254 . . . . 1.0 113.681 -174.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -68.79 -17.17 63.98 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.995 1.109 . . . . 1.0 113.995 -169.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.29 -28.13 51.49 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.126 1.37 . . . . 1.0 112.898 169.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -91.44 -20.44 21.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.375 1.47 . . . . 1.0 112.536 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -86.99 -36.24 18.37 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.412 1.085 . . . . 1.0 112.516 -173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -120.25 170.42 9.35 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.319 1.448 . . . . 1.0 112.355 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -66.35 144.8 98.86 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.437 -0.79 . . . . 1.0 109.557 171.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.41 134.16 46.81 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.86 2.373 . . . . 1.0 111.653 -169.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -93.81 151.65 40.04 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.069 1.348 . . . . 1.0 110.676 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.17 111.41 3.07 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.5 2.8 . . . . 1.0 110.858 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.7 p -56.72 -32.66 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 N-CA-C 114.179 1.177 . . . . 1.0 114.179 -169.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.73 -35.72 75.12 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.268 0.627 . . . . 1.0 112.16 175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.6 -40.55 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 123.884 0.874 . . . . 1.0 110.722 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 41.3 mt -59.8 -46.74 93.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 118.762 0.71 . . . . 1.0 110.26 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 93.7 mt -69.18 -35.36 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 124.3 1.04 . . . . 1.0 111.627 177.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.3 m -64.34 -43.48 94.49 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 121.278 -0.889 . . . . 1.0 111.615 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.7 m -59.8 -43.77 94.3 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.303 1.041 . . . . 1.0 111.508 172.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.35 73.58 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.188 -0.945 . . . . 1.0 111.358 173.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -62.38 -38.11 88.33 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.301 1.041 . . . . 1.0 112.953 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -66.6 -35.3 79.86 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.84 0.856 . . . . 1.0 112.07 173.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.5 mmm -74.0 -37.54 64.38 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 118.376 -0.821 . . . . 1.0 112.85 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 54.9 t -46.68 130.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 CA-C-N 119.359 0.981 . . . . 1.0 111.678 170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 95.35 -14.04 65.73 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 125.567 1.556 . . . . 1.0 114.095 -177.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -87.27 158.8 19.0 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.9 1.35 . . . . 1.0 111.413 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -120.25 148.61 43.48 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.148 1.379 . . . . 1.0 112.334 175.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 78.7 mtm -142.35 152.62 43.08 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 124.863 1.265 . . . . 1.0 112.161 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -74.33 162.34 28.98 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.012 0.925 . . . . 1.0 112.578 170.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -155.29 163.3 40.33 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.323 1.231 . . . . 1.0 114.323 -177.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 38.0 t -145.14 130.64 18.8 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.891 1.677 . . . . 1.0 108.542 169.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.9 pt -64.64 -20.7 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 114.786 1.402 . . . . 1.0 114.786 -169.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 35.3 m -82.65 -14.35 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 124.099 0.959 . . . . 1.0 113.414 173.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.0 m -96.53 -5.8 38.52 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.55 0.944 . . . . 1.0 113.55 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 55.7 mtm-85 58.04 39.87 25.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.904 1.682 . . . . 1.0 112.875 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -53.6 -33.33 54.58 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.988 1.107 . . . . 1.0 113.988 -171.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 59.6 m -65.19 -40.68 94.54 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.31 0.959 . . . . 1.0 112.741 175.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -59.64 -53.11 61.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.111 0.964 . . . . 1.0 109.888 173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 40.9 t-80 -58.38 -45.75 87.71 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 122.813 0.445 . . . . 1.0 111.566 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -52.21 -60.09 3.61 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.861 0.865 . . . . 1.0 111.004 172.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -32.65 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 119.33 0.968 . . . . 1.0 113.017 -172.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.4 p -71.17 -38.87 72.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.647 0.779 . . . . 1.0 112.254 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -60.62 -26.55 67.1 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.997 0.817 . . . . 1.0 112.813 174.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 57.5 mt -61.75 -26.54 68.13 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.868 1.213 . . . . 1.0 112.592 173.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 31.5 ttm-85 -93.71 -53.31 4.08 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.657 1.583 . . . . 1.0 111.798 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -73.21 -38.94 65.92 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 113.455 0.909 . . . . 1.0 113.455 -172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -89.45 -41.19 5.82 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.229 1.395 . . . . 1.0 112.292 175.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . 0.335 0.1 OUTLIER 43.6 -144.85 0.1 Allowed 'General case' 0 CA--C 1.559 1.313 0 C-N-CA 126.971 2.108 . . . . 1.0 113.858 177.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.9 p . . . . . 0 C--O 1.253 1.277 0 C-N-CA 124.975 1.31 . . . . 1.0 114.228 174.641 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 110.866 -0.05 . . . . 1.0 110.866 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.96 162.64 41.06 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.398 1.479 . . . . 1.0 111.702 178.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.9 p -78.45 154.91 79.16 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.398 1.079 . . . . 1.0 112.734 175.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.49 162.76 39.3 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.753 2.969 . . . . 1.0 111.639 176.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -156.26 154.5 30.8 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 124.586 1.155 . . . . 1.0 111.771 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -157.93 141.7 15.64 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.565 1.546 . . . . 1.0 109.445 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -137.86 133.74 17.8 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 124.934 1.294 . . . . 1.0 110.089 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -76.23 144.58 26.51 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.562 2.841 . . . . 1.0 112.088 -177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -129.48 160.57 63.71 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.861 1.664 . . . . 1.0 112.846 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -47.59 129.03 16.3 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 123.815 3.01 . . . . 1.0 112.822 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -8.84 73.79 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.074 1.321 . . . . 1.0 114.172 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -68.59 139.34 55.54 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.968 1.384 . . . . 1.0 112.541 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.2 mt -89.55 126.95 35.8 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.879 1.272 . . . . 1.0 108.905 170.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.1 mt -116.3 131.93 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 108.029 -1.1 . . . . 1.0 108.029 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -102.44 138.45 39.34 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.187 1.395 . . . . 1.0 108.784 175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.9 mt -133.14 113.99 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 124.226 1.01 . . . . 1.0 109.174 -173.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -92.76 61.46 3.6 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.474 1.51 . . . . 1.0 111.205 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -66.89 158.87 29.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.173 0.989 . . . . 1.0 112.176 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.73 135.67 57.84 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.091 0.957 . . . . 1.0 110.13 169.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.82 -130.52 10.29 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 109.943 -1.263 . . . . 1.0 109.943 -169.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -71.88 133.46 45.45 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.742 0.782 . . . . 1.0 112.607 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 39.4 mp0 -66.23 163.28 18.2 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.594 1.958 . . . . 1.0 110.947 173.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -129.48 160.5 32.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.731 1.212 . . . . 1.0 110.472 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.5 m-90 -137.37 150.19 47.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.204 1.001 . . . . 1.0 110.546 175.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 152.1 44.37 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.312 1.045 . . . . 1.0 112.598 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.33 116.86 33.77 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.197 1.799 . . . . 1.0 107.921 170.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -79.89 132.24 36.04 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.326 -0.859 . . . . 1.0 111.716 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.2 pt -114.89 -3.18 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 N-CA-C 114.948 1.462 . . . . 1.0 114.948 -171.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.57 166.31 24.48 Favored Glycine 0 N--CA 1.476 1.347 0 C-N-CA 124.717 1.151 . . . . 1.0 113.008 -176.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 62.69 18.37 10.54 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 126.082 1.753 . . . . 1.0 113.867 176.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.65 -0.75 85.11 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 125.446 1.498 . . . . 1.0 114.281 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -94.2 153.12 18.24 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.425 1.613 . . . . 1.0 114.252 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.0 m -133.54 157.87 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 126.004 1.721 . . . . 1.0 111.006 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mt -115.58 138.68 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.396 1.478 . . . . 1.0 107.13 169.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -155.43 150.95 27.22 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.723 0.809 . . . . 1.0 111.75 -168.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 58.0 tp -84.38 121.49 27.62 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.662 -0.866 . . . . 1.0 108.662 170.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -98.64 144.05 27.44 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.492 1.117 . . . . 1.0 112.239 -169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -75.23 144.44 29.52 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.233 2.622 . . . . 1.0 111.899 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.48 165.8 12.3 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 124.275 3.316 . . . . 1.0 112.614 174.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.3 m -71.57 140.3 49.76 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.763 -0.458 . . . . 1.0 109.763 169.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -59.88 -38.63 82.74 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 114.211 1.189 . . . . 1.0 114.211 -169.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -141.69 144.84 34.6 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.8 1.24 . . . . 1.0 112.241 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.76 -30.33 6.23 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.456 2.771 . . . . 1.0 112.41 172.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.23 -151.57 6.63 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.547 1.546 . . . . 1.0 112.732 174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.57 159.28 17.97 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.482 1.113 . . . . 1.0 112.622 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.88 158.65 33.85 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 125.149 1.357 . . . . 1.0 114.018 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 19.7 m -76.17 -12.31 60.08 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 114.166 1.173 . . . . 1.0 114.166 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.2 p -90.79 -98.15 0.11 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.804 1.242 . . . . 1.0 109.459 169.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.6 t 65.9 -51.33 0.4 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 128.841 2.857 . . . . 1.0 115.759 169.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.98 -22.9 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.495 1.918 . . . . 1.0 114.756 -169.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -69.16 -13.72 62.58 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 114.282 1.216 . . . . 1.0 114.282 -171.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 94.2 p -85.75 -11.36 53.77 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 114.75 1.389 . . . . 1.0 114.75 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.9 p -157.47 143.0 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 119.294 0.952 . . . . 1.0 113.102 -169.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 30.1 tp -83.72 -13.33 54.26 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.17 1.388 . . . . 1.0 114.032 -175.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.4 m -56.5 -25.23 50.82 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.746 1.388 . . . . 1.0 114.746 -173.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.11 41.05 0.16 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.062 1.745 . . . . 1.0 112.571 175.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 71.3 m -102.03 154.26 19.14 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.652 1.581 . . . . 1.0 111.47 177.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.49 147.11 42.19 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.012 0.925 . . . . 1.0 110.579 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.12 137.49 54.8 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.94 0.896 . . . . 1.0 109.989 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 47.5 t -72.77 124.67 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 108.396 -0.965 . . . . 1.0 108.396 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -132.05 163.81 27.63 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.414 1.486 . . . . 1.0 111.999 -176.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -117.51 137.11 52.77 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.007 1.723 . . . . 1.0 110.077 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -161.05 177.74 10.02 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.822 1.249 . . . . 1.0 111.214 171.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.0 141.62 49.35 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.123 0.969 . . . . 1.0 111.604 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.6 tp -51.19 -52.82 40.7 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.308 1.043 . . . . 1.0 112.19 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -54.84 -48.22 73.14 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.086 0.954 . . . . 1.0 111.287 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.53 -35.02 79.22 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.083 0.553 . . . . 1.0 112.083 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.0 t -71.84 -45.23 66.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.17 0.988 . . . . 1.0 112.293 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 33.1 m -74.43 -34.47 36.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 119.585 1.084 . . . . 1.0 112.818 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 60.27 -131.11 49.68 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-N 119.151 0.887 . . . . 1.0 112.192 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.88 -3.73 85.38 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.652 1.12 . . . . 1.0 114.481 174.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 31.0 m -74.99 149.59 39.25 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.166 1.387 . . . . 1.0 111.433 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 32.5 t -72.05 154.43 41.13 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.007 0.523 . . . . 1.0 110.78 172.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -158.85 163.59 36.5 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.688 0.995 . . . . 1.0 113.688 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -159.81 157.46 29.29 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.83 1.252 . . . . 1.0 113.371 177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 63.8 t -82.47 138.06 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.446 -1.316 . . . . 1.0 107.446 168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -152.65 84.77 1.24 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.033 0.933 . . . . 1.0 111.394 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.04 53.54 2.01 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.759 1.224 . . . . 1.0 111.847 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.6 p -58.73 -34.65 71.61 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.985 1.314 . . . . 1.0 113.159 -173.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 11.1 mt -66.65 -17.85 65.06 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.253 -0.905 . . . . 1.0 112.899 -178.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -63.82 -25.9 68.38 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 119.126 0.876 . . . . 1.0 112.631 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -100.64 12.9 36.42 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.532 1.133 . . . . 1.0 111.949 174.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -109.8 -44.35 3.84 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.589 1.555 . . . . 1.0 111.754 169.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -131.41 168.32 17.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.593 1.557 . . . . 1.0 113.609 -176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 -66.78 160.13 70.64 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.308 1.043 . . . . 1.0 112.471 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -55.77 152.33 35.71 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.405 3.403 . . . . 1.0 113.489 173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 44.6 mmt-85 -129.14 153.99 80.44 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 125.83 1.652 . . . . 1.0 111.042 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.75 111.45 3.25 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 123.205 2.604 . . . . 1.0 110.482 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 41.5 t -58.94 -31.86 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.193 0.997 . . . . 1.0 113.086 -169.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.36 -36.98 76.73 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.731 0.696 . . . . 1.0 112.1 175.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.8 t -71.56 -34.41 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.057 0.943 . . . . 1.0 110.7 177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 37.1 mt -66.13 -48.32 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.536 0.735 . . . . 1.0 109.982 175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -59.43 -42.62 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.702 1.201 . . . . 1.0 110.853 173.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.3 t -65.26 -40.92 94.57 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.41 0.624 . . . . 1.0 111.384 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 36.8 m -63.48 -42.5 98.57 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.06 0.944 . . . . 1.0 111.804 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.4 77.98 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 121.559 -0.713 . . . . 1.0 110.29 174.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.47 -39.83 92.31 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.15 -0.969 . . . . 1.0 113.149 177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -66.64 -32.9 74.52 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.905 0.882 . . . . 1.0 112.631 174.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 84.3 mmm -74.34 -37.25 63.6 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.33 -0.843 . . . . 1.0 112.815 175.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 79.8 t -47.57 127.54 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.726 1.148 . . . . 1.0 111.373 170.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 98.75 -16.47 59.58 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.006 1.765 . . . . 1.0 113.818 -175.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -85.04 157.58 20.69 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 118.741 1.271 . . . . 1.0 111.067 176.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -121.27 153.99 36.94 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.867 1.267 . . . . 1.0 113.214 -172.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 57.2 mtt -147.86 165.3 31.04 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.243 1.817 . . . . 1.0 111.77 -178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.9 mtmt -69.89 142.17 53.04 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 121.494 -0.754 . . . . 1.0 109.949 169.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -78.75 164.37 24.61 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.251 -0.905 . . . . 1.0 113.065 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.8 m -55.73 140.94 40.1 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.627 1.171 . . . . 1.0 113.451 172.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.3 tt -167.06 97.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.189 1.795 . . . . 1.0 107.698 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 27.0 t 69.73 -61.85 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 127.498 2.319 . . . . 1.0 108.871 -169.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.6 m -82.56 143.13 31.26 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.687 1.595 . . . . 1.0 110.524 169.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -96.04 119.93 35.41 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.195 0.998 . . . . 1.0 110.791 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -91.06 -23.18 20.42 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -63.52 -36.71 84.68 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 120.325 -1.484 . . . . 1.0 113.022 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -58.46 -58.8 6.94 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.576 0.75 . . . . 1.0 109.963 169.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 19.3 t-80 -52.83 -32.57 45.02 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.814 1.245 . . . . 1.0 113.419 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.91 -57.54 10.46 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.093 -1.004 . . . . 1.0 110.786 169.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.9 m -71.37 -28.29 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.902 1.075 . . . . 1.0 113.902 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.79 -42.5 90.67 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.539 1.063 . . . . 1.0 111.872 178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -58.01 -29.37 65.25 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.423 1.089 . . . . 1.0 112.813 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.21 -32.04 70.72 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.793 0.837 . . . . 1.0 112.652 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -94.42 -51.37 4.8 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 1.0 111.43 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -62.88 -32.07 73.25 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 114.273 1.212 . . . . 1.0 114.273 -169.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.83 -9.02 87.46 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 123.883 0.754 . . . . 1.0 114.272 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 10.5 mmpt? -79.2 149.1 32.03 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 118.871 1.336 . . . . 1.0 112.211 -178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.618 1.567 . . . . 1.0 113.112 178.157 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.495 1.783 0 N-CA-C 110.704 -0.109 . . . . 1.0 110.704 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.75 162.28 29.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.259 1.024 . . . . 1.0 113.11 179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 m -66.37 149.06 98.29 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 123.787 0.835 . . . . 1.0 112.731 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -72.48 158.78 50.53 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.498 2.799 . . . . 1.0 111.834 177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -160.25 146.79 15.73 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.87 1.268 . . . . 1.0 111.571 -176.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -144.3 153.24 41.8 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.461 1.505 . . . . 1.0 110.049 175.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -136.1 129.72 18.1 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 124.539 1.136 . . . . 1.0 109.638 170.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -80.22 146.53 17.83 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.817 3.012 . . . . 1.0 111.614 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.97 161.02 62.29 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.637 1.575 . . . . 1.0 112.583 177.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -46.74 128.58 13.33 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.942 3.095 . . . . 1.0 112.99 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.81 -7.88 80.59 Favored Glycine 0 CA--C 1.531 1.086 0 CA-C-O 118.265 -1.297 . . . . 1.0 115.18 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -69.05 143.91 54.16 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 119.666 1.733 . . . . 1.0 113.761 -176.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -82.42 128.11 33.94 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.52 1.528 . . . . 1.0 107.922 169.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.5 mm -115.56 129.38 71.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.629 1.171 . . . . 1.0 108.162 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.9 tt0 -100.15 125.08 46.22 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 125.316 1.447 . . . . 1.0 107.676 170.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.3 mt -120.92 119.9 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.559 1.143 . . . . 1.0 109.167 -172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -83.68 60.56 5.8 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.741 1.616 . . . . 1.0 110.514 -175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.5 ttt180 -65.85 147.16 53.81 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.355 1.062 . . . . 1.0 110.642 174.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.76 145.2 55.4 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.338 1.055 . . . . 1.0 111.428 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.43 -55.84 4.41 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.168 1.366 . . . . 1.0 112.678 -176.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -147.41 132.1 17.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.308 1.843 . . . . 1.0 111.169 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -61.26 155.4 21.17 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.911 0.884 . . . . 1.0 111.423 173.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.3 166.9 20.19 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.979 1.712 . . . . 1.0 110.133 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.4 m-90 -136.39 145.2 45.07 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.738 0.815 . . . . 1.0 111.508 -177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 156.81 45.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.303 1.041 . . . . 1.0 112.515 -173.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -103.95 116.32 32.04 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.538 1.935 . . . . 1.0 107.713 172.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -81.91 130.73 35.16 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.335 -0.853 . . . . 1.0 111.845 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.6 pt -112.85 3.66 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 114.488 1.292 . . . . 1.0 114.488 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.5 167.48 35.3 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.529 1.062 . . . . 1.0 112.584 -174.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.4 t70 61.38 20.02 10.75 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.952 1.701 . . . . 1.0 113.813 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.99 -1.04 87.86 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 125.585 1.564 . . . . 1.0 114.458 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -91.68 151.72 20.54 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.595 1.698 . . . . 1.0 114.492 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -132.53 154.23 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.402 1.481 . . . . 1.0 111.155 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.8 mt -112.23 136.02 49.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 106.726 -1.583 . . . . 1.0 106.726 169.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -155.16 150.09 26.71 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.138 -0.977 . . . . 1.0 111.866 -168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.07 133.05 33.92 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.682 -0.859 . . . . 1.0 108.682 169.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.26 130.69 23.74 Favored Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 125.114 1.366 . . . . 1.0 110.491 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -76.86 158.37 34.86 Favored 'Trans proline' 0 CA--C 1.546 1.111 0 C-N-CA 123.336 2.69 . . . . 1.0 112.343 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -77.41 171.85 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 124.424 3.416 . . . . 1.0 112.975 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 41.3 m -66.69 162.97 20.06 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 124.615 1.166 . . . . 1.0 113.064 169.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.93 -38.78 89.72 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 121.302 -0.874 . . . . 1.0 113.332 -175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -159.56 133.32 5.0 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 124.796 1.239 . . . . 1.0 112.143 178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.18 157.12 26.33 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.515 2.81 . . . . 1.0 111.233 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.94 17.8 79.44 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 114.635 0.614 . . . . 1.0 114.635 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.0 -23.1 64.06 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 118.332 1.066 . . . . 1.0 113.751 177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.2 -158.72 34.95 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.406 1.479 . . . . 1.0 113.157 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 22.2 m -65.73 -27.59 68.43 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.545 0.942 . . . . 1.0 113.545 -177.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 38.6 m -77.5 54.63 1.19 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.459 1.503 . . . . 1.0 111.531 175.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.9 p -56.05 -33.06 64.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.74 1.616 . . . . 1.0 114.342 -169.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.9 m -55.8 -22.94 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.0 1.32 . . . . 1.0 113.855 177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -63.63 -13.53 43.21 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.5 0.72 . . . . 1.0 112.899 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 27.7 m -56.64 -24.5 48.82 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 119.35 0.977 . . . . 1.0 113.232 171.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -71.29 -25.72 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.179 1.392 . . . . 1.0 112.595 177.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 73.5 mt -79.37 156.75 27.82 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.835 1.254 . . . . 1.0 113.243 -169.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 57.7 p -84.23 167.71 16.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.682 1.193 . . . . 1.0 112.725 171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -107.9 147.82 30.46 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.35 1.06 . . . . 1.0 112.374 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.1 m -145.62 140.1 27.11 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.452 1.101 . . . . 1.0 112.344 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.82 154.26 28.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.003 1.321 . . . . 1.0 110.675 169.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -122.23 139.44 53.78 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.272 1.029 . . . . 1.0 110.76 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 40.6 t -81.11 125.85 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 109.057 -0.72 . . . . 1.0 109.057 170.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -131.21 162.3 30.27 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.149 1.779 . . . . 1.0 111.986 -174.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -120.69 126.28 49.8 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.819 1.648 . . . . 1.0 110.672 173.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -147.98 174.14 12.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.173 1.389 . . . . 1.0 110.681 176.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -77.74 137.37 38.43 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.109 -0.994 . . . . 1.0 110.744 174.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.79 -42.75 84.81 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.228 -0.92 . . . . 1.0 111.643 178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.04 -46.42 75.32 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.634 0.774 . . . . 1.0 111.402 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.97 -42.94 80.08 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.671 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.15 -42.58 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.664 1.186 . . . . 1.0 111.664 176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 p -85.55 -2.31 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 124.813 1.245 . . . . 1.0 113.831 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -56.76 123.78 33.21 Favored Glycine 0 CA--C 1.535 1.336 0 O-C-N 121.048 -1.033 . . . . 1.0 111.797 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.99 5.51 86.93 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.66 1.124 . . . . 1.0 114.757 -173.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -126.31 -160.86 1.01 Allowed 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 127.512 2.325 . . . . 1.0 110.436 -175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 13.2 t -148.87 171.8 15.7 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.266 1.826 . . . . 1.0 109.349 169.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -152.76 158.91 42.97 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 114.743 1.386 . . . . 1.0 114.743 -178.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.98 150.29 39.47 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.362 1.865 . . . . 1.0 110.483 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 85.1 t -82.65 134.6 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.731 -1.211 . . . . 1.0 107.731 169.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -148.63 67.23 1.06 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.797 0.839 . . . . 1.0 112.197 -170.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -72.61 82.62 1.12 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.37 1.068 . . . . 1.0 111.643 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -69.6 -38.33 77.25 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.148 0.795 . . . . 1.0 113.148 -170.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.7 mt -81.63 -8.89 59.76 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 114.366 1.247 . . . . 1.0 114.366 -172.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -58.56 -31.53 68.08 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.378 1.071 . . . . 1.0 112.758 -179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -90.42 -5.71 55.79 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.925 1.29 . . . . 1.0 112.382 177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 -97.35 -47.76 5.58 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.033 1.333 . . . . 1.0 112.19 -175.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -127.1 169.88 12.95 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.976 1.31 . . . . 1.0 113.717 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -66.21 148.59 98.4 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.618 0.767 . . . . 1.0 110.067 169.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -68.38 144.72 62.84 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.364 2.709 . . . . 1.0 113.001 -170.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.92 151.72 37.94 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.45 1.5 . . . . 1.0 112.299 -176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.09 114.95 4.16 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 123.859 3.04 . . . . 1.0 110.991 176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -53.81 -35.42 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 124.943 1.297 . . . . 1.0 114.154 -170.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.91 -35.4 78.27 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 122.827 0.451 . . . . 1.0 112.191 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 44.8 t -73.38 -36.71 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.468 0.707 . . . . 1.0 110.915 177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 35.6 mt -62.08 -49.5 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 CA-C-N 118.472 0.578 . . . . 1.0 109.769 175.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 88.8 mt -67.68 -38.43 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 123.912 0.885 . . . . 1.0 111.904 178.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 53.9 m -62.42 -41.55 98.78 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.348 0.976 . . . . 1.0 111.71 173.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 t -62.46 -44.34 96.64 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.697 0.799 . . . . 1.0 111.079 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.64 -50.63 72.52 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.618 0.767 . . . . 1.0 110.903 174.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -61.26 -40.36 93.78 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.234 1.014 . . . . 1.0 112.803 178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -65.83 -33.47 75.92 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.565 0.746 . . . . 1.0 112.096 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 81.2 mmm -74.92 -38.24 61.86 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 118.195 -0.907 . . . . 1.0 112.975 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 84.0 t -47.54 127.95 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-N 120.017 1.281 . . . . 1.0 111.299 170.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.71 -15.42 62.72 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.722 1.629 . . . . 1.0 113.593 -176.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -84.64 160.13 20.45 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.001 1.4 . . . . 1.0 111.314 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -123.86 157.81 33.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.368 1.467 . . . . 1.0 112.561 -177.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.2 mtt -133.11 136.05 45.59 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.56 1.544 . . . . 1.0 110.283 177.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -59.09 133.88 56.49 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.775 -0.578 . . . . 1.0 110.936 174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -68.29 126.91 31.05 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.853 0.686 . . . . 1.0 112.853 -170.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 10.2 m -76.79 36.28 0.16 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.236 1.814 . . . . 1.0 113.192 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 23.1 pt 55.54 -14.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 C-N-CA 130.755 3.622 . . . . 1.0 117.181 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.0 p -154.46 151.05 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 128.449 2.7 . . . . 1.0 109.038 175.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.2 m -59.56 168.03 1.77 Allowed 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 125.196 1.399 . . . . 1.0 113.979 174.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 117.05 -20.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 131.328 3.851 . . . . 1.0 113.563 173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -59.14 -6.96 1.0 Allowed 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 117.072 2.249 . . . . 1.0 117.072 -174.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 29.9 m -62.86 -29.94 71.14 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.024 1.329 . . . . 1.0 113.942 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -45.55 93.38 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.868 0.758 . . . . 1.0 111.674 177.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -58.68 -45.96 88.27 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.305 -0.872 . . . . 1.0 111.129 174.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -54.11 -57.1 12.39 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.569 -0.707 . . . . 1.0 111.349 173.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.47 -28.07 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 CA-C-N 119.358 0.981 . . . . 1.0 113.489 -173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.4 p -72.47 -38.46 68.2 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.349 0.977 . . . . 1.0 112.276 173.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -57.6 -30.54 65.4 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.777 0.831 . . . . 1.0 112.53 173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 84.4 mt -61.26 -32.58 72.39 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-N 119.023 0.829 . . . . 1.0 112.928 175.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -93.58 -37.8 11.7 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.954 1.302 . . . . 1.0 112.19 177.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -72.16 -46.27 57.1 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 120.605 -1.309 . . . . 1.0 112.908 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -97.53 30.71 8.77 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.316 1.913 . . . . 1.0 114.006 -176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.97 152.0 10.91 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.291 1.036 . . . . 1.0 112.458 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 C--O 1.252 1.193 0 C-N-CA 126.271 1.829 . . . . 1.0 114.946 -175.277 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 110.542 -0.17 . . . . 1.0 110.542 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.43 158.24 31.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.962 0.905 . . . . 1.0 112.624 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 p -79.21 -31.67 0.72 Allowed Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 117.805 2.52 . . . . 1.0 117.805 -175.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -81.5 156.82 19.1 Favored 'Trans proline' 0 C--N 1.357 1.023 0 CA-C-N 123.007 2.11 . . . . 1.0 112.136 -175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -86.45 4.6 38.94 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.999 0.92 . . . . 1.0 112.722 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -153.66 140.92 19.56 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.037 1.735 . . . . 1.0 109.687 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -135.55 139.86 32.36 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.699 1.199 . . . . 1.0 110.242 175.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.0 157.54 23.77 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.809 3.006 . . . . 1.0 113.263 -176.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -124.82 162.56 42.44 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 127.188 2.195 . . . . 1.0 112.165 176.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.73 129.48 14.31 Favored 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 124.037 3.158 . . . . 1.0 113.059 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.78 -3.46 86.85 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.541 -1.144 . . . . 1.0 115.192 177.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.09 139.91 58.76 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.343 1.572 . . . . 1.0 113.027 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -84.69 120.95 26.98 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 108.124 -1.065 . . . . 1.0 108.124 169.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.88 124.75 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 108.401 -0.963 . . . . 1.0 108.401 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -87.57 135.31 33.41 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.692 -1.225 . . . . 1.0 107.692 169.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.8 mt -124.57 116.6 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 124.899 1.28 . . . . 1.0 108.043 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -96.28 85.97 4.1 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.42 1.088 . . . . 1.0 109.678 -173.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.0 mtt-85 -78.29 165.97 23.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.77 0.828 . . . . 1.0 110.485 172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.13 112.44 1.9 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.88 0.872 . . . . 1.0 110.625 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.34 -5.27 60.46 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 125.25 1.405 . . . . 1.0 115.934 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -154.09 115.39 4.11 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 119.417 1.608 . . . . 1.0 113.881 -170.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -73.19 137.72 45.22 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.031 0.932 . . . . 1.0 110.234 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 52.8 m80 -125.01 170.01 11.56 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.365 1.866 . . . . 1.0 110.073 177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 22.4 m-90 -135.99 145.16 45.82 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.108 0.963 . . . . 1.0 112.58 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.18 151.86 44.18 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.808 1.243 . . . . 1.0 112.928 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -97.61 116.17 29.3 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.466 1.906 . . . . 1.0 109.223 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -83.03 129.89 35.08 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 121.14 -0.975 . . . . 1.0 112.502 178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.0 pt -106.57 4.11 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 115.893 1.812 . . . . 1.0 115.893 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.15 -24.84 30.6 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 116.118 1.207 . . . . 1.0 116.118 169.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -88.36 9.11 24.48 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.747 1.219 . . . . 1.0 113.641 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.48 -4.1 83.9 Favored Glycine 0 N--CA 1.476 1.355 0 C-N-CA 124.811 1.196 . . . . 1.0 112.142 -169.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -95.09 157.03 16.07 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.913 1.685 . . . . 1.0 112.569 177.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.5 m -126.88 155.55 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 125.298 1.439 . . . . 1.0 110.105 170.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.2 mt -111.43 135.91 49.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 107.033 -1.469 . . . . 1.0 107.033 169.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -153.91 151.12 29.08 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.411 -0.805 . . . . 1.0 111.803 -168.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.6 tp -85.96 133.62 33.92 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 108.641 -0.874 . . . . 1.0 108.641 169.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.57 121.71 35.39 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.922 1.289 . . . . 1.0 110.254 -175.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.09 158.25 11.99 Favored 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 124.381 3.387 . . . . 1.0 113.667 175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.25 152.9 77.5 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 124.221 3.281 . . . . 1.0 112.794 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 51.4 p -75.86 -19.91 58.52 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.265 1.209 . . . . 1.0 114.265 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -157.67 111.71 2.59 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.832 1.253 . . . . 1.0 111.143 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -81.98 136.2 47.57 Favored Pre-proline 0 CA--C 1.546 0.823 0 CA-C-O 118.642 -0.695 . . . . 1.0 110.567 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.98 122.97 11.44 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.083 2.522 . . . . 1.0 112.299 -172.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.35 7.51 78.25 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.974 1.273 . . . . 1.0 116.135 171.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.18 86.68 2.42 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 118.978 1.389 . . . . 1.0 112.531 -177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.55 -111.17 3.96 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.133 0.873 . . . . 1.0 111.638 175.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 31.4 m -69.99 -17.46 63.29 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.989 0.916 . . . . 1.0 113.397 174.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.5 m -70.86 140.75 51.2 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.062 -1.024 . . . . 1.0 112.647 175.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.1 t -98.29 -147.2 0.32 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.315 1.446 . . . . 1.0 111.743 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.28 26.2 m 56.62 32.26 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 127.706 2.402 . . . . 1.0 114.288 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -42.13 -43.03 3.15 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.342 2.257 . . . . 1.0 114.349 -176.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.6 m -82.66 -8.95 59.57 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.167 1.173 . . . . 1.0 114.167 -175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.77 120.03 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.655 1.182 . . . . 1.0 109.467 -177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -89.29 -18.76 26.33 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.709 1.003 . . . . 1.0 113.709 -177.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.3 t -73.76 135.74 43.59 Favored 'General case' 0 CA--C 1.543 0.683 0 O-C-N 121.388 -0.82 . . . . 1.0 112.36 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -167.61 123.92 1.11 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.868 1.267 . . . . 1.0 110.715 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.0 m -146.9 142.36 27.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.035 0.754 . . . . 1.0 113.035 -169.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.28 152.16 26.46 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.83 1.252 . . . . 1.0 110.323 169.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -116.54 140.13 49.72 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.369 1.068 . . . . 1.0 110.195 177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.79 125.39 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 108.545 -0.909 . . . . 1.0 108.545 169.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.69 163.13 27.89 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.412 1.485 . . . . 1.0 112.199 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.8 ttp85 -123.86 133.39 53.78 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.925 1.69 . . . . 1.0 110.058 173.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -158.14 174.65 14.87 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.063 0.945 . . . . 1.0 111.116 172.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.64 142.67 56.33 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.384 1.074 . . . . 1.0 111.453 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.8 tp -52.19 -53.96 36.79 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.764 0.826 . . . . 1.0 111.821 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.38 -48.59 71.36 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.213 1.005 . . . . 1.0 111.182 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -65.26 -36.18 83.31 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.222 0.609 . . . . 1.0 112.302 -179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.84 -42.54 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 124.228 1.011 . . . . 1.0 112.303 178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 30.1 m -71.53 -36.76 61.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.031 1.287 . . . . 1.0 112.508 176.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.58 -130.84 46.48 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-N 119.033 0.833 . . . . 1.0 112.065 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -83.2 -6.79 87.65 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.415 1.007 . . . . 1.0 114.328 173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 21.7 m -75.9 148.74 38.04 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.303 1.441 . . . . 1.0 111.35 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 17.8 t -73.35 160.44 31.81 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.051 0.54 . . . . 1.0 110.878 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -158.67 160.25 36.25 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.088 1.144 . . . . 1.0 114.088 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -160.89 158.69 28.67 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.26 1.424 . . . . 1.0 112.02 178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 69.0 t -81.73 138.86 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 108.637 -0.875 . . . . 1.0 108.637 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -152.71 85.24 1.24 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.507 1.123 . . . . 1.0 110.69 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -78.66 59.28 2.45 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.599 1.16 . . . . 1.0 112.141 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 p -65.01 -33.41 75.97 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.253 1.421 . . . . 1.0 113.56 -175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.94 -11.99 58.15 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.193 0.997 . . . . 1.0 113.58 -174.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -55.73 -34.56 65.27 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.924 1.289 . . . . 1.0 112.136 169.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -79.2 -18.58 52.73 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.996 1.318 . . . . 1.0 112.306 176.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -94.74 -43.49 8.22 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.762 1.225 . . . . 1.0 112.097 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -134.41 146.94 50.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.98 1.312 . . . . 1.0 112.709 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 -65.82 159.66 67.68 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 124.395 1.078 . . . . 1.0 111.329 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -54.59 151.58 30.66 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 124.491 3.461 . . . . 1.0 116.241 -172.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 160.11 48.84 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 126.307 1.843 . . . . 1.0 111.109 172.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.11 126.02 10.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.987 3.125 . . . . 1.0 112.161 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.0 p -59.43 -33.51 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 113.239 0.829 . . . . 1.0 113.239 -174.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -60.44 -37.96 82.59 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.188 0.595 . . . . 1.0 111.909 174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 81.7 t -71.77 -38.16 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 123.768 0.827 . . . . 1.0 110.431 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 57.8 mt -61.55 -46.49 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-N 119.212 0.915 . . . . 1.0 110.518 175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.9 mt -67.35 -37.17 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.112 0.965 . . . . 1.0 111.764 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.0 t -63.6 -45.08 91.98 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 118.893 0.77 . . . . 1.0 111.363 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 38.6 m -58.68 -44.09 90.13 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.568 1.147 . . . . 1.0 111.746 172.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.89 -53.01 63.09 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.533 0.733 . . . . 1.0 110.782 173.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -59.78 -39.74 85.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.018 0.927 . . . . 1.0 112.991 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -67.75 -33.92 75.82 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.112 0.965 . . . . 1.0 112.473 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 96.5 mtp -77.76 -33.21 52.85 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.845 -1.074 . . . . 1.0 112.857 176.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 69.8 t -48.62 128.83 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 CA-C-N 120.33 1.423 . . . . 1.0 111.004 169.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.06 -15.3 62.74 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.628 1.585 . . . . 1.0 113.804 -175.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -87.18 163.27 17.02 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.94 1.37 . . . . 1.0 111.494 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -125.57 157.7 36.46 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.393 1.477 . . . . 1.0 112.952 -175.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.7 mtt -135.01 137.61 43.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.097 1.759 . . . . 1.0 110.258 177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 59.6 mtmt -60.42 131.79 51.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 118.79 0.723 . . . . 1.0 110.63 175.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -76.61 153.59 35.16 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 113.977 1.103 . . . . 1.0 113.977 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.4 t -138.55 139.87 38.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.982 1.713 . . . . 1.0 106.467 169.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . 0.251 0.1 OUTLIER -73.72 33.52 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 115.442 1.645 . . . . 1.0 115.442 -168.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 17.4 m -142.0 142.42 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.675 2.39 . . . . 1.0 109.846 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 43.8 p -80.67 -4.29 53.77 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 114.765 1.394 . . . . 1.0 114.765 -172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.5 ttp180 -58.37 -22.56 54.05 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 121.032 -1.042 . . . . 1.0 112.608 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -53.68 -29.71 40.04 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 120.792 -1.192 . . . . 1.0 113.073 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 83.9 m -70.9 -37.31 72.97 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.211 -0.931 . . . . 1.0 112.024 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -61.38 -52.09 66.09 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.447 0.699 . . . . 1.0 109.977 170.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 41.3 m-70 -58.46 -37.67 75.95 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 121.816 -0.553 . . . . 1.0 111.881 177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -59.82 -61.36 2.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.174 -0.917 . . . . 1.0 111.128 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 32.8 m -64.64 -24.81 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 CA-C-N 119.799 1.181 . . . . 1.0 112.875 -175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.5 m -63.44 -49.36 73.98 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.449 1.1 . . . . 1.0 111.295 171.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -59.8 -28.24 67.28 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.425 0.69 . . . . 1.0 112.688 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 54.9 mt -63.42 -36.11 82.63 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.107 0.78 . . . . 1.0 113.107 178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -93.75 -44.04 8.34 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.812 0.845 . . . . 1.0 111.741 175.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.97 -46.24 88.66 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.001 -1.062 . . . . 1.0 112.349 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -90.82 30.81 5.92 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 126.566 2.031 . . . . 1.0 114.315 -176.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.57 150.21 5.22 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.514 1.126 . . . . 1.0 113.131 175.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.7 m . . . . . 0 C--O 1.254 1.341 0 C-N-CA 125.884 1.673 . . . . 1.0 114.0 -178.15 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 120.371 0.129 . . . . 1.0 110.671 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.89 158.67 32.97 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.131 0.972 . . . . 1.0 112.651 177.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.5 m -69.78 147.04 96.13 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 123.9 0.88 . . . . 1.0 112.904 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.08 -22.77 14.32 Favored 'Trans proline' 0 C--N 1.354 0.859 0 C-N-CA 123.544 2.829 . . . . 1.0 113.804 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -160.52 175.52 12.63 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 125.872 1.669 . . . . 1.0 110.529 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -71.27 136.52 47.98 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.527 -0.733 . . . . 1.0 110.392 172.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -92.12 132.2 33.03 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 123.503 0.721 . . . . 1.0 109.482 170.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.08 143.16 22.5 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.35 2.7 . . . . 1.0 111.493 177.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -117.02 164.31 19.38 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 126.397 1.879 . . . . 1.0 111.323 174.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -45.64 128.46 10.72 Favored 'Trans proline' 0 C--N 1.355 0.921 0 C-N-CA 123.855 3.036 . . . . 1.0 112.674 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.28 -3.4 87.25 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-O 118.368 -1.24 . . . . 1.0 115.429 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -66.3 142.24 57.73 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.647 1.723 . . . . 1.0 113.041 178.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 117' ' ' VAL . 37.2 mt -89.22 118.68 29.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 115.039 -0.982 . . . . 1.0 108.984 174.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -91.89 127.64 44.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 106.614 -1.624 . . . . 1.0 106.614 177.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -108.5 122.71 47.6 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.229 1.411 . . . . 1.0 107.696 174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.9 mt -120.28 118.59 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 124.893 1.277 . . . . 1.0 109.254 -169.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -86.15 56.95 4.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.537 1.535 . . . . 1.0 111.132 -176.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -60.96 149.58 36.1 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.461 1.104 . . . . 1.0 110.855 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.7 mp -61.46 146.75 47.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.668 1.187 . . . . 1.0 110.928 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.11 -61.92 4.3 Favored Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.84 1.21 . . . . 1.0 112.284 -175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -147.03 138.95 24.4 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.32 1.848 . . . . 1.0 111.78 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -66.56 159.13 28.08 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.056 1.342 . . . . 1.0 112.497 174.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -133.11 162.84 30.67 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.685 1.994 . . . . 1.0 110.928 -177.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 29.1 m-90 -137.46 149.31 46.75 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.079 0.951 . . . . 1.0 112.345 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -145.58 151.65 38.45 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.196 0.998 . . . . 1.0 112.949 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -94.13 113.54 25.51 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 126.151 1.78 . . . . 1.0 108.778 174.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -82.32 129.56 34.9 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.086 -1.009 . . . . 1.0 112.425 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 29.7 pt -106.14 10.18 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 115.012 1.486 . . . . 1.0 115.012 -169.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.58 -35.48 4.48 Favored Glycine 0 N--CA 1.476 1.359 0 C-N-CA 124.665 1.126 . . . . 1.0 115.801 169.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.46 17.12 3.98 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 124.459 1.104 . . . . 1.0 113.706 -172.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.07 -4.89 85.43 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 124.905 1.241 . . . . 1.0 112.803 -169.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -92.92 155.39 17.61 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.171 1.388 . . . . 1.0 113.131 178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.0 m -126.94 151.31 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.247 1.419 . . . . 1.0 110.481 171.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.6 mt -110.04 134.49 52.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 106.842 -1.54 . . . . 1.0 106.842 169.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -154.53 162.86 40.93 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.26 -0.9 . . . . 1.0 111.502 -168.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 42.6 tp -101.43 132.49 47.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.52 1.128 . . . . 1.0 109.156 176.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -73.19 152.14 90.32 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.161 0.985 . . . . 1.0 112.676 -174.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 49.3 Cg_exo -66.5 -19.92 54.47 Favored 'Trans proline' 0 CA--C 1.551 1.34 0 N-CA-C 121.265 3.525 . . . . 1.0 121.265 -172.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -53.24 139.15 63.82 Favored 'Trans proline' 0 C--N 1.359 1.125 0 CA-C-N 124.232 2.547 . . . . 1.0 115.021 -170.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 60.2 p -169.29 166.51 10.53 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.056 1.343 . . . . 1.0 112.505 -169.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 66.84 -156.2 0.23 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.869 1.668 . . . . 1.0 112.05 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -86.63 138.57 33.54 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.694 1.198 . . . . 1.0 111.802 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -75.17 175.32 11.41 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.982 3.121 . . . . 1.0 112.365 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.11 17.83 58.64 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-O 119.167 -0.796 . . . . 1.0 114.997 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.84 -17.35 63.38 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 114.462 1.282 . . . . 1.0 114.462 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.05 168.22 54.75 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.796 1.189 . . . . 1.0 113.229 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.9 p -63.68 -25.27 68.13 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.256 1.206 . . . . 1.0 114.256 -174.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.9 m -73.54 -12.22 60.7 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.312 1.045 . . . . 1.0 113.701 173.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t 70.96 -170.67 0.16 Allowed 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.092 2.157 . . . . 1.0 113.976 177.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.4 p -63.31 -19.35 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.691 1.596 . . . . 1.0 113.38 -175.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -58.63 -26.61 63.92 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.03 0.932 . . . . 1.0 112.957 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.8 m -82.19 -17.83 44.82 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.919 1.081 . . . . 1.0 113.919 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.74 109.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.724 1.609 . . . . 1.0 110.522 -176.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.6 -19.78 30.51 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.702 0.801 . . . . 1.0 112.944 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 73.8 m -144.02 165.17 28.54 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.718 1.607 . . . . 1.0 111.751 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.25 155.24 37.35 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.742 1.217 . . . . 1.0 112.777 171.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 67.3 m -152.42 151.87 31.32 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.158 1.383 . . . . 1.0 111.287 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.8 155.99 34.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.995 0.918 . . . . 1.0 109.303 169.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -138.64 135.64 35.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.823 1.249 . . . . 1.0 109.233 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.0 t -79.94 131.12 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.847 0.749 . . . . 1.0 109.268 174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -135.05 162.19 33.18 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.58 1.552 . . . . 1.0 112.594 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -118.33 123.61 45.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.837 1.655 . . . . 1.0 109.946 171.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -145.52 172.08 13.74 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.715 1.206 . . . . 1.0 110.39 175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -75.53 143.39 42.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.105 -0.997 . . . . 1.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.5 tp -55.12 -51.92 64.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 118.172 -0.918 . . . . 1.0 111.702 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -54.33 -49.31 70.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.418 0.687 . . . . 1.0 111.299 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.64 -38.53 83.97 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.286 0.634 . . . . 1.0 111.846 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -68.73 -44.79 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.405 1.082 . . . . 1.0 112.056 175.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 p -87.98 -7.58 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 114.354 1.242 . . . . 1.0 114.354 -169.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.24 133.83 52.21 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.405 1.003 . . . . 1.0 113.192 -175.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.75 -2.08 80.87 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 124.822 1.201 . . . . 1.0 114.723 -177.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.8 m -120.58 150.07 41.45 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.795 1.638 . . . . 1.0 111.204 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 77.8 m -81.41 158.87 24.46 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.142 -0.688 . . . . 1.0 109.142 169.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -161.18 168.02 25.02 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.857 1.429 . . . . 1.0 114.857 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -159.78 167.83 27.31 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.882 1.673 . . . . 1.0 112.205 174.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 71.8 t -87.25 126.57 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 106.781 -1.562 . . . . 1.0 106.781 168.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -131.67 57.66 1.76 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 122.336 1.065 . . . . 1.0 110.68 177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -81.86 57.7 3.55 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.388 1.475 . . . . 1.0 111.667 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.0 p -78.64 -14.23 59.42 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.523 1.529 . . . . 1.0 114.72 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.0 mt -67.79 -11.83 59.31 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.135 1.161 . . . . 1.0 114.135 -169.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -61.26 -26.69 67.94 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.946 0.794 . . . . 1.0 112.422 169.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -87.51 -5.37 58.82 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.123 1.369 . . . . 1.0 111.694 175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -100.54 -47.24 4.94 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.549 1.54 . . . . 1.0 111.122 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -130.81 146.67 52.32 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.857 1.663 . . . . 1.0 112.338 -176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 -64.52 155.13 82.29 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 123.921 0.888 . . . . 1.0 111.864 -175.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -48.78 141.23 21.46 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 124.569 3.513 . . . . 1.0 115.688 -170.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 -121.21 146.45 44.52 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 125.724 1.61 . . . . 1.0 110.857 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.56 114.92 4.14 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 123.494 2.796 . . . . 1.0 110.398 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.06 -29.9 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 114.452 1.278 . . . . 1.0 114.452 -169.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.1 -35.72 75.83 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 122.926 0.49 . . . . 1.0 111.878 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 t -75.22 -32.61 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 123.254 0.622 . . . . 1.0 110.89 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 32.2 mt -64.88 -49.24 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.289 0.949 . . . . 1.0 110.338 173.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 68.1 mt -64.06 -38.6 82.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.086 0.954 . . . . 1.0 111.253 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.4 m -63.12 -41.77 99.4 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.889 0.768 . . . . 1.0 112.127 173.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.0 t -61.68 -44.45 96.92 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.101 0.96 . . . . 1.0 110.968 175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.5 -52.42 65.46 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.164 0.986 . . . . 1.0 110.517 174.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -60.81 -39.09 87.64 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.138 0.975 . . . . 1.0 113.057 178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -67.55 -34.71 77.63 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.921 0.888 . . . . 1.0 112.363 174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 97.5 mtp -78.61 -31.64 47.16 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 117.711 -1.137 . . . . 1.0 113.305 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 57.6 t -47.61 126.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 CA-C-N 120.264 1.393 . . . . 1.0 110.607 169.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.11 -12.43 65.43 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.741 1.639 . . . . 1.0 114.274 -175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -91.24 158.37 16.63 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.109 1.455 . . . . 1.0 111.45 176.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -118.53 159.54 23.35 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.338 1.455 . . . . 1.0 113.895 -172.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 59.0 mtt -143.67 159.6 42.19 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.965 1.706 . . . . 1.0 112.091 -178.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -96.43 -179.98 4.82 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.551 1.14 . . . . 1.0 111.666 169.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -94.37 158.85 15.38 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.742 1.217 . . . . 1.0 112.968 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.0 m 67.28 29.28 7.68 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.394 1.477 . . . . 1.0 112.747 176.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 27.6 pt -74.58 69.15 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 125.449 1.499 . . . . 1.0 112.628 -170.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 23.5 t 78.55 -36.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 128.498 2.719 . . . . 1.0 111.663 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.6 t -152.25 -172.22 4.16 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.216 1.807 . . . . 1.0 110.166 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -57.44 120.66 8.62 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.465 1.106 . . . . 1.0 110.836 -176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -42.56 -65.31 0.48 Allowed 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.948 1.699 . . . . 1.0 115.052 -169.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.0 m -69.6 -35.16 75.05 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 121.324 -0.86 . . . . 1.0 112.71 -174.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.74 -51.79 66.89 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.729 0.812 . . . . 1.0 110.593 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -63.49 -34.63 78.2 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.254 -0.904 . . . . 1.0 111.261 178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -60.38 -60.02 4.47 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.125 -0.985 . . . . 1.0 110.917 169.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 13' ' ' LEU . 29.8 m -64.9 -22.76 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-N 120.634 1.561 . . . . 1.0 113.338 -177.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 98.1 m -65.55 -52.87 49.23 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.788 1.235 . . . . 1.0 110.984 169.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -66.55 -24.96 66.44 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 113.391 0.885 . . . . 1.0 113.391 -171.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.2 -37.55 75.01 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.911 0.884 . . . . 1.0 112.986 170.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -93.88 -46.74 7.05 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.118 0.967 . . . . 1.0 112.133 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -62.08 -44.68 96.15 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.153 -0.967 . . . . 1.0 111.747 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -93.6 33.65 5.05 Favored Glycine 0 N--CA 1.472 1.045 0 C-N-CA 126.424 1.964 . . . . 1.0 113.652 179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.9 -49.03 63.82 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.614 1.166 . . . . 1.0 112.361 177.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 126.137 1.775 . . . . 1.0 113.216 -177.285 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.4 ttp . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 110.61 -0.145 . . . . 1.0 110.61 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.47 160.69 31.89 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.052 0.941 . . . . 1.0 112.901 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.0 p -74.93 151.33 86.4 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.862 0.865 . . . . 1.0 112.755 175.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.55 162.01 30.72 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.746 2.964 . . . . 1.0 111.694 179.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -76.12 -8.16 56.38 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 113.524 0.935 . . . . 1.0 113.524 179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -142.09 129.36 21.08 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.777 1.631 . . . . 1.0 110.276 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -160.03 123.77 2.01 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.835 1.254 . . . . 1.0 109.614 169.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -86.33 158.62 9.63 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.68 3.587 . . . . 1.0 111.998 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.1 mmtp -129.97 162.53 53.19 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.805 1.642 . . . . 1.0 112.027 175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.77 128.01 8.51 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 124.253 3.302 . . . . 1.0 113.091 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.81 -9.42 76.84 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.999 1.285 . . . . 1.0 115.108 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -70.82 151.27 44.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 119.103 1.452 . . . . 1.0 113.71 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.31 125.45 35.12 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.087 0.955 . . . . 1.0 109.976 171.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.0 mm -95.0 132.93 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 N-CA-C 106.757 -1.572 . . . . 1.0 106.757 169.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -111.68 130.88 55.63 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.776 1.63 . . . . 1.0 108.851 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.4 mt -130.06 129.33 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.732 1.613 . . . . 1.0 109.355 -169.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -109.92 102.26 11.03 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.61 1.564 . . . . 1.0 109.274 178.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -99.61 162.3 13.1 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.86 2.064 . . . . 1.0 109.77 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.75 107.87 0.57 Allowed 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.933 0.893 . . . . 1.0 109.956 178.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 77.07 14.47 82.58 Favored Glycine 0 CA--C 1.537 1.468 0 CA-C-O 118.489 -1.173 . . . . 1.0 115.472 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -156.89 143.31 18.23 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.583 1.692 . . . . 1.0 114.153 -172.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -109.15 135.27 50.54 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.24 1.416 . . . . 1.0 108.533 174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -144.89 156.61 44.09 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.298 0.639 . . . . 1.0 111.944 -169.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.0 m-90 -142.14 155.54 45.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.118 0.785 . . . . 1.0 113.118 -174.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -143.12 153.33 42.79 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.462 1.105 . . . . 1.0 112.115 175.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.47 118.15 30.97 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.999 1.319 . . . . 1.0 108.52 171.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -83.39 132.55 34.98 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.236 -0.915 . . . . 1.0 112.156 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.3 pt -117.44 2.45 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.77 1.396 . . . . 1.0 114.77 -170.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.43 163.71 27.33 Favored Glycine 0 N--CA 1.478 1.452 0 C-N-CA 124.742 1.163 . . . . 1.0 113.427 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t70 61.71 19.03 10.16 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.146 1.778 . . . . 1.0 114.116 175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.78 2.93 81.0 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 125.602 1.572 . . . . 1.0 114.107 -175.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -95.14 152.53 18.26 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.679 1.74 . . . . 1.0 114.151 -178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 m -135.8 160.53 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 126.034 1.733 . . . . 1.0 110.737 177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.7 mt -120.51 132.07 71.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 106.761 -1.57 . . . . 1.0 106.761 168.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -151.02 160.58 43.83 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.194 -0.941 . . . . 1.0 111.062 -178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 55.5 tp -80.25 111.14 16.35 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 107.903 -1.147 . . . . 1.0 107.903 171.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.65 114.91 36.62 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 123.914 0.886 . . . . 1.0 111.326 -169.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -78.7 139.61 15.97 Favored 'Trans proline' 0 CA--C 1.545 1.038 0 C-N-CA 122.739 2.292 . . . . 1.0 110.954 -172.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.73 137.97 28.26 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.477 2.785 . . . . 1.0 110.57 174.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 48.6 p -89.58 -31.99 17.33 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.261 1.208 . . . . 1.0 114.261 -172.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -147.85 151.02 35.24 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.121 1.768 . . . . 1.0 110.583 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 51.0 m-85 -73.36 157.87 87.44 Favored Pre-proline 0 CA--C 1.552 1.057 0 N-CA-C 113.255 0.835 . . . . 1.0 113.255 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -63.08 -30.71 75.89 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.017 3.145 . . . . 1.0 113.969 176.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.2 -176.88 15.39 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 125.077 1.322 . . . . 1.0 113.545 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -132.55 0.35 3.63 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.973 1.309 . . . . 1.0 114.262 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -87.1 -171.05 47.26 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.904 1.24 . . . . 1.0 113.333 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 m -70.81 -12.52 61.6 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 114.237 1.199 . . . . 1.0 114.237 -176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.3 m -74.48 45.94 0.25 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 126.044 1.737 . . . . 1.0 112.643 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 m -64.71 26.94 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 128.629 2.771 . . . . 1.0 116.931 -169.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -82.74 27.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 C-N-CA 126.296 1.838 . . . . 1.0 112.545 -178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -55.23 -30.3 59.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 126.147 1.779 . . . . 1.0 113.754 -170.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.5 m -66.19 -15.58 63.27 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.054 1.341 . . . . 1.0 114.269 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.0 m -116.36 17.44 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 125.251 1.421 . . . . 1.0 112.807 173.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 97.5 mt -114.37 -154.19 0.54 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.363 1.465 . . . . 1.0 110.501 174.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.3 p -75.76 55.92 0.9 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.97 2.108 . . . . 1.0 113.006 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -148.84 22.96 0.98 Allowed 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 114.912 1.449 . . . . 1.0 114.912 -173.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 m -73.95 158.45 34.37 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.849 -1.157 . . . . 1.0 112.442 171.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.21 149.97 21.16 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.138 1.375 . . . . 1.0 109.984 169.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -127.17 140.35 52.31 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.81 0.844 . . . . 1.0 109.837 176.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -69.36 123.32 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 108.737 -0.838 . . . . 1.0 108.737 171.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.3 153.71 51.09 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.987 1.315 . . . . 1.0 112.091 -175.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -100.96 125.11 47.53 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.967 1.707 . . . . 1.0 109.713 174.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -149.62 174.81 12.14 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.782 1.233 . . . . 1.0 110.372 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 62.2 mtp85 -75.54 144.57 41.86 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.008 -1.058 . . . . 1.0 111.71 173.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 56.6 tp -48.99 -52.16 26.52 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.0 1.32 . . . . 1.0 110.942 173.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -48.66 -53.6 18.04 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.325 1.85 . . . . 1.0 111.248 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -69.32 -34.73 75.11 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.466 0.543 . . . . 1.0 112.466 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.8 t -71.25 -43.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.571 1.148 . . . . 1.0 112.303 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.2 m -73.87 -39.18 51.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 119.459 1.027 . . . . 1.0 112.697 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 58.39 -127.38 45.02 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 118.968 0.804 . . . . 1.0 112.191 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.01 3.16 84.54 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.102 1.334 . . . . 1.0 114.903 175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 70.1 m -78.73 155.95 29.12 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.782 1.291 . . . . 1.0 111.579 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.59 150.91 37.94 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.659 0.384 . . . . 1.0 110.097 169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -161.0 164.55 30.9 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.642 0.979 . . . . 1.0 113.642 -178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.5 ptt180 -160.84 160.11 30.68 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.652 1.581 . . . . 1.0 111.556 178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -88.11 133.38 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.704 -0.85 . . . . 1.0 108.704 169.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -155.87 87.3 1.07 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.596 0.758 . . . . 1.0 111.288 -170.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -77.5 58.84 1.8 Allowed 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.999 1.32 . . . . 1.0 112.353 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 36.8 p -61.19 -35.61 77.62 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.866 1.266 . . . . 1.0 112.988 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.4 mt -67.47 -14.03 62.56 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.621 1.168 . . . . 1.0 113.487 -178.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -63.97 -23.08 67.2 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.634 -0.666 . . . . 1.0 112.762 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -92.73 -2.67 55.81 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 125.141 1.376 . . . . 1.0 111.589 174.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -98.71 -46.2 5.77 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.633 1.573 . . . . 1.0 111.554 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -125.73 168.98 13.03 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.418 1.487 . . . . 1.0 114.079 -172.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 93.8 mm-40 -65.93 161.15 57.27 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.588 1.155 . . . . 1.0 111.204 171.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -65.78 131.82 28.66 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.867 2.378 . . . . 1.0 110.807 173.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -113.21 152.19 44.89 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 125.056 1.343 . . . . 1.0 110.989 -178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.01 118.07 5.45 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.404 2.736 . . . . 1.0 111.348 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.3 p -52.75 -36.6 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.899 1.28 . . . . 1.0 114.174 -171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.37 -35.53 79.43 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.944 0.498 . . . . 1.0 111.908 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.6 t -72.22 -37.92 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.334 0.654 . . . . 1.0 110.651 176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -62.73 -47.13 94.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-N 118.95 0.796 . . . . 1.0 110.465 176.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.33 -36.84 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.821 0.849 . . . . 1.0 111.749 176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 67.6 m -62.1 -44.13 97.32 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.146 0.885 . . . . 1.0 111.252 173.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.8 m -58.43 -44.73 89.23 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.087 0.955 . . . . 1.0 111.72 171.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -57.66 -50.38 73.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.305 0.957 . . . . 1.0 110.89 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.54 -38.33 89.61 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.531 1.132 . . . . 1.0 113.322 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -69.32 -32.1 70.99 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.116 0.966 . . . . 1.0 112.155 174.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.2 mmm -77.36 -35.23 54.74 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 118.385 -0.817 . . . . 1.0 112.933 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.0 t -45.65 126.46 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 119.484 1.038 . . . . 1.0 111.359 169.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.14 59.39 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 126.22 1.867 . . . . 1.0 113.972 -176.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -87.71 149.43 24.24 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 119.027 1.414 . . . . 1.0 111.078 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.1 mttp -106.4 153.15 22.65 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.397 1.479 . . . . 1.0 113.892 -176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.8 mtt -149.22 176.9 10.11 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.922 2.089 . . . . 1.0 110.811 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -80.39 176.21 9.98 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.182 -0.949 . . . . 1.0 111.939 169.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -87.86 -60.09 2.07 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.732 1.213 . . . . 1.0 112.94 -176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.4 t -156.11 131.87 9.71 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.474 1.51 . . . . 1.0 109.156 173.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.0 pt -127.7 10.84 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 114.493 1.294 . . . . 1.0 114.493 -169.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 8.4 p 132.63 -37.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 1 C-N-CA 133.017 4.527 . . . . 1.0 107.579 -169.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 t -114.83 149.59 36.83 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.884 1.673 . . . . 1.0 109.402 169.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -77.22 110.71 12.14 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.087 1.355 . . . . 1.0 108.467 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -59.71 -33.26 71.39 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.44 1.274 . . . . 1.0 114.44 -169.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 27.3 p -58.43 -34.78 71.19 Favored 'General case' 0 N--CA 1.478 0.956 0 O-C-N 121.06 -1.025 . . . . 1.0 113.702 173.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -68.24 -55.28 12.76 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 125.74 1.616 . . . . 1.0 110.591 -176.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 11.4 p80 -65.37 -33.19 75.38 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.164 -0.96 . . . . 1.0 111.415 174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -56.75 -59.02 5.63 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 118.338 -0.839 . . . . 1.0 111.129 174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.9 m -64.84 -24.38 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 119.729 1.15 . . . . 1.0 112.31 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 87.8 m -65.4 -48.35 73.15 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.036 0.934 . . . . 1.0 111.336 171.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -62.06 -26.47 68.28 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.267 1.027 . . . . 1.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 75.4 mt -63.03 -32.87 74.33 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 119.339 0.972 . . . . 1.0 112.949 175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -90.39 -48.87 6.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.275 1.03 . . . . 1.0 111.557 173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -69.76 -30.45 68.04 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -93.81 16.47 60.75 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.147 1.832 . . . . 1.0 114.52 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.95 151.36 8.87 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 118.676 1.238 . . . . 1.0 112.833 176.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.6 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.346 1.858 . . . . 1.0 114.999 -175.636 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 111.95 0.352 . . . . 1.0 111.95 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.91 160.22 31.7 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.251 1.02 . . . . 1.0 112.593 176.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 p -78.65 161.28 69.94 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.548 1.139 . . . . 1.0 113.19 175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.78 153.37 50.53 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 124.002 3.135 . . . . 1.0 113.359 174.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 45.7 t60 -159.16 169.05 25.03 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.689 1.195 . . . . 1.0 111.734 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -70.61 136.84 49.48 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.182 0.993 . . . . 1.0 111.282 177.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -158.88 129.41 3.57 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.487 1.515 . . . . 1.0 109.402 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.07 144.96 12.16 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.663 2.908 . . . . 1.0 112.165 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.9 mmtp -130.51 162.64 53.48 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 126.747 2.019 . . . . 1.0 111.678 176.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.15 129.23 15.19 Favored 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 123.559 2.839 . . . . 1.0 113.412 -175.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.47 -5.21 85.12 Favored Glycine 0 CA--C 1.531 1.051 0 CA-C-O 118.29 -1.284 . . . . 1.0 114.841 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 -62.86 137.44 58.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.585 1.693 . . . . 1.0 112.758 -177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.39 117.88 24.58 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.785 1.234 . . . . 1.0 108.419 171.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.4 mm -99.67 121.81 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 106.75 -1.574 . . . . 1.0 106.75 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -99.56 127.88 45.65 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 125.46 1.504 . . . . 1.0 107.85 174.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.6 mt -126.74 119.28 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.491 1.116 . . . . 1.0 109.505 -171.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -88.52 63.28 6.95 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.192 1.397 . . . . 1.0 110.078 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.9 ttt180 -62.1 152.12 33.73 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.112 0.965 . . . . 1.0 110.688 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 97.0 mt -55.07 134.76 49.36 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.74 0.816 . . . . 1.0 110.12 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.67 -125.1 6.72 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 109.612 -1.395 . . . . 1.0 109.612 -169.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -76.57 144.51 39.6 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.482 0.919 . . . . 1.0 113.482 177.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.92 156.04 21.95 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.557 1.543 . . . . 1.0 111.528 171.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.46 163.19 29.34 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.984 1.714 . . . . 1.0 110.854 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 20.7 m-90 -139.69 153.32 47.23 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.267 1.027 . . . . 1.0 112.668 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.09 152.18 38.09 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.635 0.774 . . . . 1.0 112.693 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.27 115.43 27.62 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.084 1.754 . . . . 1.0 108.323 172.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -80.32 129.12 34.29 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.956 0.798 . . . . 1.0 112.099 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.5 pt -105.94 10.62 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 N-CA-C 115.06 1.504 . . . . 1.0 115.06 -169.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.86 -34.8 5.08 Favored Glycine 0 N--CA 1.478 1.461 0 C-N-CA 124.53 1.062 . . . . 1.0 115.743 169.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -88.96 16.59 6.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.371 1.068 . . . . 1.0 113.838 -172.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.45 -7.46 80.79 Favored Glycine 0 N--CA 1.475 1.267 0 C-N-CA 125.121 1.343 . . . . 1.0 113.202 -169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -91.89 156.64 17.34 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.051 1.341 . . . . 1.0 112.819 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.6 m -127.61 152.63 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.405 1.482 . . . . 1.0 110.309 172.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.4 mt -110.91 135.03 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 125.061 1.345 . . . . 1.0 107.976 169.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -153.8 151.97 30.17 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.048 0.939 . . . . 1.0 112.294 -168.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 21.1 tp -90.86 126.56 36.08 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.566 0.747 . . . . 1.0 109.406 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -88.77 136.47 30.9 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.841 -1.076 . . . . 1.0 109.518 173.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -79.73 170.16 17.29 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 123.446 2.764 . . . . 1.0 113.307 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.43 168.13 4.23 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 124.872 3.715 . . . . 1.0 113.178 169.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.6 t -169.35 172.38 7.24 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.366 0.876 . . . . 1.0 113.366 -172.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -74.22 156.27 37.43 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.567 1.547 . . . . 1.0 112.851 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -56.04 133.46 74.24 Favored Pre-proline 0 CA--C 1.556 1.195 0 N-CA-C 113.619 0.97 . . . . 1.0 113.619 -171.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.75 -21.14 7.31 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.385 2.723 . . . . 1.0 113.795 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -91.23 -135.65 6.59 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.658 1.123 . . . . 1.0 113.578 -176.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -70.38 -8.48 51.05 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.078 1.51 . . . . 1.0 115.078 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.13 -156.33 28.29 Favored Glycine 0 N--CA 1.47 0.954 0 C-N-CA 124.789 1.185 . . . . 1.0 112.557 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 18.7 m -62.26 -13.6 29.95 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.492 1.293 . . . . 1.0 114.492 -174.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.7 m -68.13 -8.53 39.2 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.931 1.292 . . . . 1.0 113.4 170.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.8 t -147.6 -164.89 2.11 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 126.225 1.81 . . . . 1.0 111.016 176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . 0.255 26.2 m 51.71 28.98 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 127.377 2.271 . . . . 1.0 115.042 174.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -59.43 -20.38 54.65 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.981 1.312 . . . . 1.0 113.828 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 46.6 p -65.9 -13.82 60.38 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.762 1.625 . . . . 1.0 114.322 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.05 153.35 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.815 1.646 . . . . 1.0 111.836 177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.9 tp -104.26 -17.15 14.96 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.22 1.408 . . . . 1.0 113.095 178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.0 t -166.99 174.07 8.73 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.908 1.683 . . . . 1.0 110.48 -173.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -78.5 151.01 32.79 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.01 0.924 . . . . 1.0 111.142 170.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.0 p -71.55 154.56 41.37 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.019 -1.051 . . . . 1.0 111.782 169.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.93 149.89 29.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.614 0.766 . . . . 1.0 109.633 169.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -136.96 137.46 39.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.541 0.736 . . . . 1.0 110.129 -177.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 37.3 t -80.08 125.13 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 108.794 -0.817 . . . . 1.0 108.794 169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.04 161.43 31.0 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.218 1.807 . . . . 1.0 111.866 -174.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 72.2 ttp85 -120.52 124.59 45.74 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.753 1.621 . . . . 1.0 110.405 172.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -147.27 178.38 8.45 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.415 1.486 . . . . 1.0 110.219 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.02 143.19 32.69 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 120.952 -1.092 . . . . 1.0 111.78 -175.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.77 -61.27 2.13 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 125.153 1.381 . . . . 1.0 111.319 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -56.19 -43.95 78.96 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.268 1.027 . . . . 1.0 111.36 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -65.39 -43.03 91.97 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 116.409 -0.359 . . . . 1.0 111.881 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 43.3 t -69.79 -42.1 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 124.451 1.1 . . . . 1.0 112.15 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.9 m -79.22 -5.47 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 N-CA-C 113.322 0.86 . . . . 1.0 113.322 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -59.91 132.96 51.21 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.616 1.103 . . . . 1.0 113.041 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.81 0.71 69.71 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.691 1.138 . . . . 1.0 114.785 -177.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 39.3 m -126.04 154.22 43.31 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.307 1.843 . . . . 1.0 111.244 -175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 35.0 t -82.64 153.52 25.37 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.33 -0.989 . . . . 1.0 108.33 168.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 21.4 p90 -160.48 163.67 32.76 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.993 1.109 . . . . 1.0 113.993 -175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -161.04 159.55 29.44 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.206 1.403 . . . . 1.0 112.813 177.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 65.2 t -82.75 133.06 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.807 -1.553 . . . . 1.0 106.807 168.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -153.77 80.47 1.15 Allowed 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.885 0.85 . . . . 1.0 112.153 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.15 51.12 1.71 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.138 1.375 . . . . 1.0 113.049 -173.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.8 m -59.0 -30.43 67.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 120.684 -1.26 . . . . 1.0 113.411 -172.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 35.7 mt -65.54 -16.07 63.31 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.88 1.067 . . . . 1.0 113.88 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -63.0 -20.66 65.5 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.038 0.755 . . . . 1.0 113.038 170.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.1 t-80 -97.58 -3.2 40.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 125.596 1.558 . . . . 1.0 111.815 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -97.58 -48.11 5.38 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.657 1.583 . . . . 1.0 110.98 174.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -121.38 167.59 12.61 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.005 1.722 . . . . 1.0 112.795 -175.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -67.45 163.36 48.03 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 123.756 0.822 . . . . 1.0 111.701 174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.13 128.01 28.43 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.396 2.73 . . . . 1.0 111.527 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -113.26 152.65 45.32 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 125.318 1.447 . . . . 1.0 110.43 177.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.39 113.78 3.81 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.461 2.774 . . . . 1.0 110.783 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -59.19 -29.23 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 114.34 1.237 . . . . 1.0 114.34 -169.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.9 -37.0 78.15 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 122.934 0.493 . . . . 1.0 111.887 174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.02 -33.85 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.526 0.73 . . . . 1.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.17 -47.82 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 118.938 0.79 . . . . 1.0 110.121 174.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.0 mt -64.81 -38.97 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.253 1.021 . . . . 1.0 111.729 175.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.1 t -63.03 -43.17 99.44 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.439 -0.788 . . . . 1.0 111.567 174.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.5 m -61.63 -42.38 98.8 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.342 1.057 . . . . 1.0 111.671 173.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.44 -50.78 72.49 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.496 0.719 . . . . 1.0 110.456 174.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -60.95 -40.62 94.01 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.153 0.981 . . . . 1.0 112.865 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -65.79 -33.72 76.52 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.838 0.855 . . . . 1.0 112.554 174.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 77.5 mmm -73.48 -38.63 65.34 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 118.228 -0.891 . . . . 1.0 112.834 175.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 83.9 t -47.33 128.05 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-N 119.88 1.218 . . . . 1.0 111.507 172.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.76 62.95 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 125.788 1.661 . . . . 1.0 113.703 -176.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -82.76 145.11 29.73 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 118.965 1.383 . . . . 1.0 111.19 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -114.9 147.38 40.03 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.83 1.652 . . . . 1.0 112.732 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.6 mmt -124.41 145.12 49.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.979 1.712 . . . . 1.0 110.237 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -75.23 146.97 40.71 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 121.517 -0.74 . . . . 1.0 112.787 -176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -70.91 -17.51 62.69 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.541 0.941 . . . . 1.0 113.541 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.6 m -71.26 -2.9 17.7 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 126.108 1.763 . . . . 1.0 114.89 -177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 20.9 tt -60.72 144.45 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 124.583 1.153 . . . . 1.0 111.808 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.8 p -65.03 -22.27 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 115.142 1.534 . . . . 1.0 115.142 -169.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.9 t -160.51 178.72 9.25 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.145 0.978 . . . . 1.0 112.485 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -54.8 139.66 38.95 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.003 1.721 . . . . 1.0 111.831 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -122.79 -3.48 8.7 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 115.933 1.827 . . . . 1.0 115.933 -169.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.13 -43.91 81.18 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 121.446 1.93 . . . . 1.0 113.33 -174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -43.91 85.35 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.138 0.975 . . . . 1.0 110.88 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -60.23 -41.58 93.43 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.451 -0.781 . . . . 1.0 111.362 175.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -58.02 -58.92 6.31 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.139 0.976 . . . . 1.0 110.891 173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.38 -22.52 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 CA-C-N 119.61 1.095 . . . . 1.0 112.76 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 83.5 m -65.7 -49.91 66.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.615 1.166 . . . . 1.0 111.476 169.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -57.97 -29.02 64.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.555 1.142 . . . . 1.0 112.468 -179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.5 -34.54 77.07 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.219 0.822 . . . . 1.0 113.219 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -93.75 -47.86 6.58 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.164 0.986 . . . . 1.0 111.307 174.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -64.57 -30.48 71.5 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.547 1.139 . . . . 1.0 113.546 -175.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -74.5 -9.75 82.08 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.599 1.095 . . . . 1.0 114.435 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.24 -47.87 69.47 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 118.429 1.115 . . . . 1.0 111.034 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--O 1.253 1.271 0 C-N-CA 126.467 1.907 . . . . 1.0 113.773 -175.393 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.827 -0.064 . . . . 1.0 110.827 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.38 164.77 38.29 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.375 1.47 . . . . 1.0 111.931 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.2 p -75.98 149.98 83.12 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.423 1.089 . . . . 1.0 112.653 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.42 139.19 40.76 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.309 2.672 . . . . 1.0 112.061 -172.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -140.81 163.89 31.72 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.031 1.733 . . . . 1.0 111.592 -175.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -130.49 163.86 26.09 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.495 1.518 . . . . 1.0 111.274 -175.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -130.44 128.19 22.57 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.567 1.147 . . . . 1.0 108.527 169.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.46 148.26 26.25 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.589 2.859 . . . . 1.0 111.68 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -129.88 164.27 41.54 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.246 1.818 . . . . 1.0 112.177 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -46.91 126.68 11.37 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 123.656 2.904 . . . . 1.0 113.235 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.66 -10.03 75.91 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 124.744 1.164 . . . . 1.0 115.154 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -66.87 137.78 56.83 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.457 1.628 . . . . 1.0 112.911 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.3 mt -87.27 118.41 26.68 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.276 1.43 . . . . 1.0 108.45 169.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 50.3 mt -101.28 130.93 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -103.06 131.78 49.8 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.301 1.44 . . . . 1.0 108.364 170.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.5 mt -124.43 118.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 125.632 1.573 . . . . 1.0 108.431 -172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -88.39 52.25 2.4 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.839 1.256 . . . . 1.0 112.034 -169.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -64.58 148.46 50.77 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.69 0.796 . . . . 1.0 111.017 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.4 mt -64.14 149.38 47.84 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.226 1.01 . . . . 1.0 111.828 178.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.42 -42.62 2.62 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 125.382 1.467 . . . . 1.0 113.406 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -168.3 135.2 2.03 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.876 2.071 . . . . 1.0 111.519 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -64.13 151.68 42.59 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.175 1.79 . . . . 1.0 111.157 177.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.46 165.5 18.97 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.996 1.319 . . . . 1.0 110.433 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 19.4 m-90 -141.41 154.43 45.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.091 0.557 . . . . 1.0 112.048 -175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.73 147.73 31.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.695 0.798 . . . . 1.0 112.356 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.35 118.72 32.6 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.091 1.756 . . . . 1.0 107.976 169.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -82.35 132.89 35.22 Favored 'General case' 0 N--CA 1.473 0.719 0 O-C-N 121.043 -1.035 . . . . 1.0 112.4 178.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.6 pt -116.86 0.86 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 115.092 1.515 . . . . 1.0 115.092 -169.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.06 169.29 33.45 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.389 0.995 . . . . 1.0 112.917 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.4 t70 64.1 15.49 9.32 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 126.239 1.816 . . . . 1.0 114.202 175.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.41 4.57 83.32 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.35 1.453 . . . . 1.0 114.059 -173.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -101.53 154.52 18.77 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 119.21 1.505 . . . . 1.0 114.006 -178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.72 165.0 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 126.473 1.909 . . . . 1.0 110.769 175.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mt -121.91 135.53 61.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.075 -1.454 . . . . 1.0 107.075 168.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -154.81 166.02 34.8 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 121.073 -1.017 . . . . 1.0 110.808 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.3 tp -86.57 139.0 31.25 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.435 -0.95 . . . . 1.0 108.435 169.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.76 119.34 34.06 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.836 1.254 . . . . 1.0 109.371 -177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -78.49 161.99 27.98 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.01 2.473 . . . . 1.0 112.606 -173.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -68.54 138.22 41.4 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.98 3.12 . . . . 1.0 110.47 170.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 40.9 p -88.18 -39.16 14.72 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.747 1.018 . . . . 1.0 113.747 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -169.92 149.13 3.62 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.537 1.935 . . . . 1.0 110.201 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -58.04 138.38 83.74 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 121.726 -0.609 . . . . 1.0 112.291 175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.19 156.43 62.26 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.972 3.115 . . . . 1.0 112.581 -178.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.79 -134.82 32.49 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.189 0.899 . . . . 1.0 112.549 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.69 1.64 33.32 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.243 1.417 . . . . 1.0 113.307 173.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.15 -120.92 5.87 Favored Glycine 0 C--N 1.343 0.928 0 C-N-CA 124.944 1.259 . . . . 1.0 111.367 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.3 m -51.09 -38.11 49.79 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.515 1.526 . . . . 1.0 114.167 -172.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.2 m -73.29 -32.9 64.92 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 121.446 -0.784 . . . . 1.0 112.72 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.7 m -87.54 -35.31 18.23 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.83 0.852 . . . . 1.0 113.028 -177.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.3 m -66.84 -14.01 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 114.065 1.135 . . . . 1.0 114.065 -175.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -59.84 -38.03 80.93 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.137 0.575 . . . . 1.0 110.802 169.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.2 m -94.87 -39.75 10.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.317 1.047 . . . . 1.0 112.572 172.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 t -103.02 68.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.445 1.498 . . . . 1.0 110.083 -175.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 34.7 tp -69.65 -28.67 66.09 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.461 0.911 . . . . 1.0 113.461 -169.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.9 m -57.84 109.56 0.75 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.457 1.503 . . . . 1.0 113.856 -174.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -140.77 32.06 1.82 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.928 1.691 . . . . 1.0 111.361 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.3 m -84.88 161.63 19.8 Favored 'General case' 0 N--CA 1.475 0.817 0 O-C-N 120.769 -1.207 . . . . 1.0 113.589 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.38 159.08 23.11 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.718 1.207 . . . . 1.0 109.98 169.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -129.44 142.68 50.73 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.386 0.674 . . . . 1.0 111.195 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 53.0 t -75.41 125.08 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 108.557 -0.905 . . . . 1.0 108.557 169.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -130.94 151.48 51.3 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.709 1.204 . . . . 1.0 112.765 -175.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -97.04 129.14 44.52 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.883 1.673 . . . . 1.0 108.394 169.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -158.15 163.06 37.93 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.029 0.532 . . . . 1.0 110.941 -170.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -72.48 141.26 48.57 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.47 1.108 . . . . 1.0 110.761 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -48.69 -58.99 3.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.154 1.382 . . . . 1.0 111.167 176.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -55.77 -45.54 78.12 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.432 1.093 . . . . 1.0 111.393 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -63.42 -41.08 98.7 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 122.884 0.474 . . . . 1.0 111.671 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.23 -44.49 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 124.33 1.052 . . . . 1.0 112.325 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.5 m -82.94 -1.76 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 114.044 1.127 . . . . 1.0 114.044 -177.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.77 130.27 50.81 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.377 0.989 . . . . 1.0 113.615 -173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 1.66 76.45 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.933 1.254 . . . . 1.0 114.56 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.4 m -126.27 155.75 41.43 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.148 1.779 . . . . 1.0 111.418 -174.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 34.1 t -85.25 154.77 21.73 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.41 -0.959 . . . . 1.0 108.41 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -157.13 150.4 23.95 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 121.055 -1.028 . . . . 1.0 113.741 -178.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 83.1 mmt-85 -150.75 163.79 37.75 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.219 1.808 . . . . 1.0 110.58 176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 82.6 t -83.64 137.46 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.085 0.954 . . . . 1.0 108.878 172.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.1 t-20 -145.0 77.77 1.54 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.291 1.436 . . . . 1.0 110.845 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -78.08 62.69 2.89 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 124.929 1.292 . . . . 1.0 111.418 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.3 p -64.24 -40.18 95.5 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.806 1.242 . . . . 1.0 113.378 -170.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.0 mt -71.48 -9.67 58.56 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.814 1.042 . . . . 1.0 113.814 -175.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -61.56 -27.06 68.35 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.873 0.844 . . . . 1.0 113.006 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -80.58 -14.73 57.96 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.295 1.438 . . . . 1.0 112.184 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -102.49 -39.89 6.92 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.654 1.581 . . . . 1.0 112.241 -174.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -129.92 161.5 30.72 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.631 1.572 . . . . 1.0 113.11 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.1 mm-40 -65.85 159.49 69.06 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 124.413 1.085 . . . . 1.0 111.288 178.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.1 124.47 14.45 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.726 2.284 . . . . 1.0 110.817 177.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -94.23 154.94 40.39 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.076 1.35 . . . . 1.0 110.343 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.91 113.19 3.32 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.142 2.562 . . . . 1.0 110.89 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.9 p -56.45 -32.61 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 N-CA-C 114.159 1.17 . . . . 1.0 114.159 -169.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.55 -36.29 78.08 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.875 0.47 . . . . 1.0 112.019 176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 58.3 t -71.96 -36.41 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 123.912 0.885 . . . . 1.0 111.008 177.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.2 mt -64.27 -47.72 88.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-N 118.858 0.754 . . . . 1.0 110.197 175.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 84.4 mt -66.95 -38.81 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 123.945 0.898 . . . . 1.0 111.604 176.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.3 t -61.92 -41.52 98.04 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 119.305 0.957 . . . . 1.0 111.706 172.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 11.7 t -61.24 -45.3 95.1 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.2 -0.938 . . . . 1.0 111.055 173.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.94 73.36 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.394 -0.817 . . . . 1.0 110.717 174.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -62.69 -37.12 85.22 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.292 1.037 . . . . 1.0 113.43 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -68.76 -33.49 73.99 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.714 0.806 . . . . 1.0 112.507 173.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 79.9 mmm -74.65 -37.39 62.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.919 0.888 . . . . 1.0 112.654 176.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 51.9 t -46.11 128.92 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 119.268 0.94 . . . . 1.0 111.754 169.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.45 -13.94 64.92 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.789 1.661 . . . . 1.0 113.56 -177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -84.06 146.05 28.14 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.004 1.402 . . . . 1.0 110.89 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -100.19 151.72 21.1 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.396 1.478 . . . . 1.0 112.56 179.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.6 mtt -150.74 169.35 21.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.586 1.554 . . . . 1.0 112.802 -175.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -73.81 166.9 22.48 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.985 0.914 . . . . 1.0 111.408 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -156.12 171.49 20.06 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.639 1.576 . . . . 1.0 110.659 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 m -50.08 -19.0 0.64 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.439 2.696 . . . . 1.0 115.962 -172.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.6 tt -56.74 -23.11 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.793 1.237 . . . . 1.0 111.753 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.6 p -131.23 -45.29 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 126.863 2.065 . . . . 1.0 112.576 169.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 75.7 m -153.98 127.81 8.82 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 119.872 1.215 . . . . 1.0 111.528 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -57.88 132.39 53.23 Favored 'General case' 0 N--CA 1.481 1.086 0 O-C-N 121.326 -0.859 . . . . 1.0 111.283 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -144.45 -12.18 0.61 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 117.457 2.391 . . . . 1.0 117.457 -169.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 90.7 m -63.14 -41.53 99.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 121.463 1.938 . . . . 1.0 114.171 -170.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -65.41 -47.05 77.61 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.754 -0.591 . . . . 1.0 110.881 173.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -59.54 -30.98 69.0 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.61 -0.681 . . . . 1.0 112.436 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -63.19 -61.16 2.55 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.376 -0.828 . . . . 1.0 111.01 169.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 30.0 m -69.41 -28.66 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 113.713 1.005 . . . . 1.0 113.713 -170.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.3 p -67.28 -39.08 85.98 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.959 0.904 . . . . 1.0 112.469 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -59.35 -24.41 63.35 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.804 0.842 . . . . 1.0 113.036 175.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 70.8 mt -66.19 -35.7 81.14 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 119.091 0.86 . . . . 1.0 112.637 179.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 -87.08 -42.79 12.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.064 0.946 . . . . 1.0 111.846 170.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -68.09 -30.86 70.14 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.669 0.989 . . . . 1.0 113.669 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -79.09 -37.69 24.51 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.652 1.12 . . . . 1.0 113.298 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . 0.299 0.1 OUTLIER 38.01 -145.6 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 127.467 2.307 . . . . 1.0 115.805 174.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 126.419 1.888 . . . . 1.0 113.603 -179.64 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.493 1.711 0 N-CA-C 110.717 -0.105 . . . . 1.0 110.717 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.55 158.6 35.38 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.036 0.934 . . . . 1.0 112.858 178.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.1 p -75.4 151.79 85.49 Favored Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.235 1.014 . . . . 1.0 112.989 176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.76 159.49 38.53 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 123.666 2.911 . . . . 1.0 112.062 178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -75.64 -15.95 60.27 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 113.412 0.893 . . . . 1.0 113.412 -178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -127.91 139.21 52.74 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.983 1.713 . . . . 1.0 109.215 174.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.54 150.21 43.1 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 124.128 0.971 . . . . 1.0 110.736 174.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -84.03 156.74 13.27 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.515 2.81 . . . . 1.0 113.197 -172.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -126.85 162.14 49.2 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 126.587 1.955 . . . . 1.0 111.706 171.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -45.8 129.06 11.64 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 124.061 3.174 . . . . 1.0 113.289 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.78 -7.36 73.94 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.251 1.405 . . . . 1.0 114.887 179.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -71.48 142.23 50.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.28 1.54 . . . . 1.0 113.839 -175.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.05 124.57 31.23 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.296 1.438 . . . . 1.0 108.814 169.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 32.6 mm -105.25 128.47 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 107.124 -1.436 . . . . 1.0 107.124 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -109.6 130.81 55.48 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.364 1.466 . . . . 1.0 108.048 173.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.9 mt -127.89 140.64 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 125.959 1.704 . . . . 1.0 108.911 -169.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -123.72 106.18 10.3 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.872 1.269 . . . . 1.0 110.375 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -90.47 161.66 15.42 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.901 1.68 . . . . 1.0 108.437 169.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 10.8 mp -55.94 108.93 0.5 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.669 0.788 . . . . 1.0 110.302 175.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 83.95 -2.76 87.17 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.518 1.532 . . . . 1.0 116.524 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -152.16 130.64 12.18 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 120.243 2.022 . . . . 1.0 114.544 -170.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -77.76 155.33 31.24 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.144 1.378 . . . . 1.0 112.151 169.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -151.16 165.7 33.09 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.566 1.547 . . . . 1.0 110.89 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 28.2 m-90 -144.34 157.88 44.03 Favored 'General case' 0 N--CA 1.479 0.977 0 O-C-N 121.023 -1.048 . . . . 1.0 113.407 -173.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.91 40.11 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.781 1.232 . . . . 1.0 112.824 175.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -102.37 118.64 37.31 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 125.971 1.708 . . . . 1.0 108.37 171.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -84.93 133.74 34.27 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.092 -1.005 . . . . 1.0 112.496 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.6 pt -117.06 2.49 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 N-CA-C 115.155 1.539 . . . . 1.0 115.155 -170.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.15 166.84 31.5 Favored Glycine 0 N--CA 1.479 1.513 0 C-N-CA 124.593 1.092 . . . . 1.0 112.984 -175.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.7 t70 65.12 1.17 1.44 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.39 2.276 . . . . 1.0 114.321 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.0 6.09 59.31 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.112 1.339 . . . . 1.0 113.932 -169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -90.49 152.22 21.04 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.167 1.984 . . . . 1.0 113.573 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -132.68 154.76 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.695 1.598 . . . . 1.0 110.734 171.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.8 mt -114.51 137.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 106.837 -1.542 . . . . 1.0 106.837 168.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 19.7 p80 -155.77 164.17 38.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 120.951 -1.093 . . . . 1.0 110.344 -170.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 36.7 tp -85.92 143.19 28.33 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.747 -1.205 . . . . 1.0 107.747 169.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.27 106.26 43.15 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.897 1.279 . . . . 1.0 110.692 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.52 139.18 80.4 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.464 2.776 . . . . 1.0 112.302 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -89.48 -172.32 0.62 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 124.43 3.42 . . . . 1.0 111.472 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.7 p -76.14 165.33 25.07 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 124.353 1.061 . . . . 1.0 113.066 169.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -75.52 146.34 40.61 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.284 1.033 . . . . 1.0 112.436 -179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 28.9 t80 88.0 129.28 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 129.1 2.96 . . . . 1.0 112.973 170.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -81.15 177.57 7.7 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.626 2.884 . . . . 1.0 111.655 -175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.57 171.28 55.1 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 124.357 0.979 . . . . 1.0 113.608 174.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . 65.76 15.72 10.18 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.069 1.748 . . . . 1.0 114.649 176.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.43 170.4 23.3 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 126.084 1.802 . . . . 1.0 112.094 173.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.2 m -57.18 -31.1 65.08 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.279 1.214 . . . . 1.0 114.279 -170.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 55.8 p -95.99 -2.16 47.52 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.987 1.315 . . . . 1.0 113.872 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 91.6 p -133.3 -9.06 2.94 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 116.489 2.033 . . . . 1.0 116.489 -170.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -49.0 -32.91 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 120.583 1.538 . . . . 1.0 114.71 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -84.91 -27.12 26.83 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.091 0.956 . . . . 1.0 113.397 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 37.5 p -100.17 -33.73 10.32 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.416 1.087 . . . . 1.0 113.374 -176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 9.2 t 63.91 72.91 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 126.712 2.005 . . . . 1.0 110.733 176.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.0 mt -77.5 -178.98 5.52 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.54 1.536 . . . . 1.0 112.4 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.1 t -154.8 152.73 30.18 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.964 1.306 . . . . 1.0 110.824 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -114.62 5.92 15.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.907 0.883 . . . . 1.0 112.931 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.8 m -73.17 130.8 41.05 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 120.316 -1.49 . . . . 1.0 110.778 170.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.07 147.43 34.73 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.22 1.008 . . . . 1.0 110.608 173.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -113.39 141.6 46.87 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.64 0.776 . . . . 1.0 110.81 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -77.31 127.72 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 N-CA-C 109.133 -0.692 . . . . 1.0 109.133 170.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -139.52 160.15 40.51 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.557 1.543 . . . . 1.0 112.636 -173.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -101.88 134.33 45.25 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.01 1.324 . . . . 1.0 110.059 169.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -144.49 172.9 12.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.505 1.522 . . . . 1.0 109.922 171.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 76.4 mtt-85 -81.26 143.93 31.92 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 120.979 -1.076 . . . . 1.0 112.124 171.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 63.6 tp -50.85 -53.55 31.33 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.816 1.246 . . . . 1.0 111.226 178.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -54.77 -47.94 73.27 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 1.0 111.042 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -64.71 -36.53 84.58 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.375 0.509 . . . . 1.0 112.375 179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.5 t -72.5 -47.25 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 124.862 1.265 . . . . 1.0 112.292 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.5 m -79.78 -1.25 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 114.353 1.242 . . . . 1.0 114.353 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.32 127.42 44.86 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 123.974 0.797 . . . . 1.0 112.768 -177.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.36 2.92 81.23 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 124.922 1.248 . . . . 1.0 114.781 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 59.2 m -125.38 160.46 29.32 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.056 1.742 . . . . 1.0 111.909 -175.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 82.9 m -89.18 157.8 18.14 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.806 0.842 . . . . 1.0 109.033 168.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -159.24 162.9 36.23 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.379 1.251 . . . . 1.0 114.379 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -158.95 162.05 36.78 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.836 1.655 . . . . 1.0 112.001 179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 98.1 t -83.23 136.43 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 N-CA-C 107.831 -1.174 . . . . 1.0 107.831 169.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -148.5 74.8 1.29 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 122.278 1.037 . . . . 1.0 111.426 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -77.92 58.65 1.96 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.104 1.362 . . . . 1.0 111.555 176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 25.5 p -63.56 -45.88 88.48 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.615 -1.303 . . . . 1.0 112.896 -173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 mt -72.49 -10.23 59.54 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 113.93 1.085 . . . . 1.0 113.93 -174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.94 -25.36 57.57 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.708 0.803 . . . . 1.0 112.299 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 42.6 t60 -92.34 -4.61 53.64 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.45 1.5 . . . . 1.0 113.253 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -84.17 -65.44 1.01 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.431 1.093 . . . . 1.0 111.114 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -109.72 174.68 5.75 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.068 2.147 . . . . 1.0 113.148 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -66.48 140.21 96.49 Favored Pre-proline 0 CA--C 1.547 0.864 0 O-C-N 121.271 -0.893 . . . . 1.0 110.791 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.21 148.37 91.17 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.887 3.058 . . . . 1.0 113.711 -169.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.2 mmt180 -99.26 153.83 37.59 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.832 1.253 . . . . 1.0 112.248 -172.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -73.66 118.46 5.47 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 123.591 2.861 . . . . 1.0 110.341 170.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 t -55.8 -38.4 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 125.372 1.469 . . . . 1.0 112.851 -171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -57.01 -36.57 70.58 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.64 0.776 . . . . 1.0 111.616 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.6 t -77.29 -34.46 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-O 118.497 -0.764 . . . . 1.0 111.081 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.72 -46.66 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 119.535 1.062 . . . . 1.0 110.186 171.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.07 -36.68 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 124.48 1.112 . . . . 1.0 111.414 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.2 t -63.07 -44.39 95.91 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 119.061 0.846 . . . . 1.0 111.111 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 74.8 m -58.32 -44.44 88.64 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.483 1.113 . . . . 1.0 111.817 171.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.71 72.74 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.416 1.007 . . . . 1.0 111.135 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -61.86 -40.36 95.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.368 1.067 . . . . 1.0 112.957 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -66.85 -32.89 74.46 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.978 0.911 . . . . 1.0 112.371 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 80.9 mmm -74.95 -36.35 62.1 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 117.703 -1.141 . . . . 1.0 113.086 175.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 76.8 t -46.42 125.3 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-N 120.277 1.398 . . . . 1.0 111.015 169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.72 -17.13 57.9 Favored Glycine 0 CA--C 1.537 1.414 0 C-N-CA 126.151 1.834 . . . . 1.0 114.182 -174.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -85.77 165.65 16.72 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 118.912 1.356 . . . . 1.0 110.961 175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -129.6 156.32 44.39 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 114.424 1.268 . . . . 1.0 114.424 -169.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 48.4 mtt -144.15 177.21 8.75 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.797 2.039 . . . . 1.0 112.598 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.91 161.92 17.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.013 1.325 . . . . 1.0 114.19 -178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -68.56 164.09 22.11 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.988 1.715 . . . . 1.0 113.948 -175.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 26.1 p -58.24 -16.91 15.71 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 125.71 1.604 . . . . 1.0 114.858 -178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.56 -29.76 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 123.91 0.884 . . . . 1.0 111.664 169.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 58.4 t -87.1 89.13 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 104.73 -2.322 . . . . 1.0 104.73 168.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 62.8 p -59.21 -32.76 70.24 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 114.617 1.34 . . . . 1.0 114.617 -169.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -84.93 2.77 41.33 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 114.29 1.218 . . . . 1.0 114.29 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -52.03 -42.49 63.13 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 120.698 1.59 . . . . 1.0 113.581 -176.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.7 m -69.95 -36.64 75.42 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 121.075 -1.016 . . . . 1.0 113.366 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.4 -56.86 14.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 118.461 0.573 . . . . 1.0 109.942 171.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -55.58 -34.0 64.4 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.316 1.046 . . . . 1.0 112.751 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -60.0 -59.73 4.95 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 119.074 -0.489 . . . . 1.0 110.737 169.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -70.22 -32.27 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 N-CA-C 113.87 1.063 . . . . 1.0 113.87 -170.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 35.6 p -65.75 -42.71 90.62 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.393 0.997 . . . . 1.0 111.553 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -61.41 -24.27 66.4 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.612 1.165 . . . . 1.0 112.773 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.95 -31.84 73.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.51 1.05 . . . . 1.0 112.846 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.0 ttm180 -94.89 -49.87 5.38 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.805 1.242 . . . . 1.0 111.352 174.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -62.26 -46.94 86.56 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 120.922 -1.111 . . . . 1.0 112.51 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -109.01 38.73 3.19 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 126.837 2.16 . . . . 1.0 112.969 178.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.41 150.42 3.58 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.824 0.85 . . . . 1.0 112.53 174.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 125.634 1.574 . . . . 1.0 114.866 -172.063 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 N--CA 1.501 2.093 0 CA-C-O 120.004 -0.046 . . . . 1.0 111.061 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.58 -10.9 38.87 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 114.546 1.313 . . . . 1.0 114.546 -176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 p -65.93 -39.04 27.03 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 116.212 1.93 . . . . 1.0 116.212 -178.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -82.45 164.81 16.57 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 122.799 2.333 . . . . 1.0 111.946 173.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -87.99 164.32 15.86 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.786 0.834 . . . . 1.0 112.402 170.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -79.17 157.85 27.81 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.296 -0.877 . . . . 1.0 110.619 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.56 118.68 70.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 108.961 -0.755 . . . . 1.0 108.961 169.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -80.38 147.77 18.23 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.223 2.615 . . . . 1.0 112.722 -173.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -129.81 159.48 69.64 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 126.219 1.807 . . . . 1.0 112.744 176.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -46.61 129.24 13.76 Favored 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 124.086 3.191 . . . . 1.0 112.907 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.95 -8.99 79.05 Favored Glycine 0 CA--C 1.535 1.327 0 CA-C-O 118.584 -1.12 . . . . 1.0 114.863 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -64.85 144.12 57.48 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.323 1.561 . . . . 1.0 113.143 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 75.4 mt -94.12 125.24 38.64 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 125.421 1.488 . . . . 1.0 108.523 171.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.57 132.35 63.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 107.771 -1.196 . . . . 1.0 107.771 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -103.89 133.75 48.33 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.578 1.551 . . . . 1.0 108.863 171.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.2 mt -127.81 119.92 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 C-N-CA 125.929 1.692 . . . . 1.0 108.132 -171.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -88.68 62.74 6.61 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.899 1.679 . . . . 1.0 113.168 -168.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -66.57 149.04 51.06 Favored 'General case' 0 CA--C 1.546 0.807 0 O-C-N 121.725 -0.61 . . . . 1.0 110.401 169.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 90.7 mt -62.67 138.91 58.61 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.967 0.907 . . . . 1.0 110.846 173.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 80.89 -126.89 7.61 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 109.972 -1.251 . . . . 1.0 109.972 -169.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -67.22 141.27 57.35 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 121.334 0.588 . . . . 1.0 112.446 173.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -81.73 155.25 25.6 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.889 1.276 . . . . 1.0 111.177 178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 6.0 m170 -108.76 156.0 20.11 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.459 1.104 . . . . 1.0 111.12 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.7 m-90 -134.95 154.29 51.76 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.406 1.083 . . . . 1.0 111.259 174.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.8 146.84 28.19 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.915 0.709 . . . . 1.0 112.915 179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.16 115.41 27.69 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.972 1.709 . . . . 1.0 107.846 170.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -81.14 131.89 35.32 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 121.565 -0.71 . . . . 1.0 111.95 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.9 pt -114.67 2.31 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 N-CA-C 114.748 1.388 . . . . 1.0 114.748 -169.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 99.6 165.23 29.43 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 124.726 1.155 . . . . 1.0 112.759 -176.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.5 t70 62.58 17.31 9.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.109 1.764 . . . . 1.0 113.958 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.99 0.05 81.5 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.665 1.602 . . . . 1.0 114.195 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -94.83 154.2 17.37 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.448 1.624 . . . . 1.0 114.057 -175.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.6 m -137.25 158.38 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 125.98 1.712 . . . . 1.0 111.662 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.1 mt -117.42 139.39 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.807 1.643 . . . . 1.0 108.326 169.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -156.43 150.02 24.7 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.185 0.994 . . . . 1.0 111.661 -168.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 61.1 tp -97.06 124.79 41.16 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.863 0.865 . . . . 1.0 109.512 172.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.47 108.1 6.42 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-O 117.406 -1.283 . . . . 1.0 110.322 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -69.73 157.76 59.34 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.551 2.167 . . . . 1.0 114.44 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -56.95 -18.29 27.46 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 124.814 3.676 . . . . 1.0 116.183 175.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 p -80.36 -8.32 59.46 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.969 1.1 . . . . 1.0 113.969 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -83.12 137.57 34.02 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.684 0.794 . . . . 1.0 110.201 169.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -58.94 137.87 87.48 Favored Pre-proline 0 CA--C 1.55 0.944 0 O-C-N 121.59 -0.694 . . . . 1.0 112.76 -177.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -75.43 160.41 38.76 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.258 2.639 . . . . 1.0 110.728 174.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.32 0.11 89.37 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.783 0.706 . . . . 1.0 114.834 -178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -168.27 -178.22 3.54 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.826 2.05 . . . . 1.0 111.671 -170.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.08 2.02 48.48 Favored Glycine 0 N--CA 1.477 1.377 0 C-N-CA 124.889 1.233 . . . . 1.0 115.471 172.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.6 t -165.0 -165.91 0.96 Allowed 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 125.797 1.639 . . . . 1.0 111.065 178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 58.5 p -67.46 -23.04 65.47 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.057 1.343 . . . . 1.0 114.104 -176.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.1 t -165.91 169.53 14.72 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.34 1.856 . . . . 1.0 110.586 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.7 m -61.66 -31.13 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.788 0.835 . . . . 1.0 112.542 -174.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -80.22 -13.3 59.34 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.64 1.176 . . . . 1.0 113.248 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.0 m -80.88 -6.39 58.56 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.606 0.965 . . . . 1.0 113.606 -174.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -142.77 143.94 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 127.049 2.14 . . . . 1.0 109.705 176.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.8 mt -104.61 -78.17 0.57 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.938 0.895 . . . . 1.0 111.494 -173.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 21.8 p -66.01 148.27 52.06 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.775 1.028 . . . . 1.0 113.775 -174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -169.67 169.44 8.58 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.977 1.711 . . . . 1.0 112.212 -176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.3 p -70.33 149.36 47.44 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.254 0.835 . . . . 1.0 113.254 176.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -95.82 154.36 17.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.226 1.01 . . . . 1.0 111.347 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -133.56 137.41 45.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.979 0.912 . . . . 1.0 109.98 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 t -79.45 127.57 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.844 -0.798 . . . . 1.0 108.844 170.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -132.27 160.98 34.64 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.984 1.714 . . . . 1.0 111.804 -173.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.5 ttp180 -121.14 139.92 52.69 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.906 1.682 . . . . 1.0 109.84 172.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -164.86 -179.52 5.85 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.772 1.229 . . . . 1.0 111.076 170.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.6 mtp-105 -70.09 142.92 52.56 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.943 0.897 . . . . 1.0 111.02 172.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 37.5 tp -51.57 -56.77 11.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.288 1.035 . . . . 1.0 112.152 178.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -57.51 -41.18 80.29 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 118.502 0.592 . . . . 1.0 111.187 -177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.37 -39.0 81.91 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.08 0.552 . . . . 1.0 112.137 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 64.7 t -67.0 -38.48 81.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 124.49 1.116 . . . . 1.0 111.972 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.9 t -62.56 -49.47 83.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 C-N-CA 125.024 1.33 . . . . 1.0 111.056 173.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 61.38 -121.94 27.77 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 123.713 0.673 . . . . 1.0 111.677 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -86.31 -0.68 86.62 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 124.953 1.263 . . . . 1.0 114.854 175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.6 m -79.43 175.27 10.75 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.076 1.35 . . . . 1.0 111.591 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 95.6 m -110.19 168.34 9.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.379 1.471 . . . . 1.0 108.884 168.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -158.05 162.56 38.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 114.994 1.479 . . . . 1.0 114.994 -177.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 87.3 mmt-85 -149.39 155.15 40.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.024 1.73 . . . . 1.0 111.272 172.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.9 t -84.26 135.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 106.953 -1.499 . . . . 1.0 106.953 168.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -153.86 84.86 1.16 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.818 0.818 . . . . 1.0 111.866 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -81.11 50.13 1.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.187 1.395 . . . . 1.0 112.926 -174.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 9.7 m -59.19 -33.46 70.98 Favored 'General case' 0 N--CA 1.482 1.128 0 O-C-N 120.501 -1.374 . . . . 1.0 113.144 -171.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.5 mt -67.48 -12.37 60.13 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.727 1.01 . . . . 1.0 113.727 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.74 -26.69 68.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.962 0.801 . . . . 1.0 112.946 170.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -88.98 -5.1 58.2 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.893 1.277 . . . . 1.0 112.057 174.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -99.34 -50.26 4.17 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.17 1.388 . . . . 1.0 111.638 176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -128.2 147.64 50.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.203 1.401 . . . . 1.0 112.774 -174.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -65.56 153.25 90.86 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 118.44 -0.79 . . . . 1.0 111.57 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.81 127.98 27.28 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.149 3.233 . . . . 1.0 114.765 -170.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -90.32 155.62 46.45 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.003 1.321 . . . . 1.0 111.536 169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.16 117.9 5.36 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.707 2.938 . . . . 1.0 110.063 171.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.1 t -57.3 -34.92 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 124.42 1.088 . . . . 1.0 113.017 -170.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -59.2 -36.37 75.26 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.953 0.501 . . . . 1.0 112.188 176.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 21.6 t -76.11 -36.1 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 118.604 -0.712 . . . . 1.0 110.97 177.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 38.7 mt -59.99 -46.39 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 CA-C-N 119.662 1.119 . . . . 1.0 110.337 173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.44 -36.1 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.021 0.928 . . . . 1.0 111.288 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 54.7 m -64.56 -43.2 94.67 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 121.453 -0.779 . . . . 1.0 111.404 174.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 70.7 m -60.41 -43.97 96.17 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.658 1.183 . . . . 1.0 111.445 172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.58 -50.64 73.08 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.66 0.784 . . . . 1.0 110.458 175.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -60.92 -40.63 93.91 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.196 0.999 . . . . 1.0 113.002 178.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -65.25 -34.12 77.59 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.923 0.889 . . . . 1.0 112.334 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 75.3 mmm -73.73 -39.64 64.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.321 -0.847 . . . . 1.0 112.789 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 71.5 t -47.65 129.49 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-N 119.674 1.124 . . . . 1.0 111.707 172.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 96.37 -14.68 64.03 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.539 1.542 . . . . 1.0 113.464 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -82.69 143.2 31.09 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 119.122 1.461 . . . . 1.0 111.186 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -101.75 146.57 27.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.179 1.392 . . . . 1.0 111.633 174.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 19.3 mmt -124.57 142.92 51.0 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.809 1.643 . . . . 1.0 110.628 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.74 168.16 11.91 Favored 'General case' 0 CA--C 1.547 0.861 0 N-CA-C 113.657 0.984 . . . . 1.0 113.657 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -61.14 140.01 57.99 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.699 0.8 . . . . 1.0 111.843 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.6 t -87.27 139.17 30.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.55 -0.719 . . . . 1.0 112.031 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 48.3 pt -88.38 5.56 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 123.804 0.842 . . . . 1.0 112.989 173.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.6 m -135.39 174.54 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.615 1.966 . . . . 1.0 110.681 177.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 41.8 p -67.23 -31.17 71.35 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 113.521 0.934 . . . . 1.0 113.521 177.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 86.0 mtt85 -69.54 149.77 47.85 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.536 1.135 . . . . 1.0 112.497 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -165.69 -64.75 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.942 2.097 . . . . 1.0 111.867 178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 6.9 t -85.04 -38.39 19.23 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.533 1.133 . . . . 1.0 113.504 -169.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.66 -44.97 92.2 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.141 0.977 . . . . 1.0 110.385 169.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -52.31 -43.63 64.63 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.492 1.917 . . . . 1.0 111.381 170.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -64.12 -59.47 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.818 -0.611 . . . . 1.0 111.714 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.0 m -65.55 -22.36 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 119.481 1.037 . . . . 1.0 113.032 -175.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 m -60.81 -51.41 69.42 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.791 1.236 . . . . 1.0 111.426 169.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -64.46 -26.51 68.47 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.979 0.733 . . . . 1.0 112.979 -175.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.75 -34.97 76.78 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 119.035 0.834 . . . . 1.0 112.917 176.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -91.87 -49.71 6.1 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.23 1.012 . . . . 1.0 111.482 173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -61.27 -45.86 92.73 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.257 -0.902 . . . . 1.0 112.288 -174.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -115.01 52.17 0.67 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.38 1.943 . . . . 1.0 112.315 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.73 160.06 2.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 113.909 1.077 . . . . 1.0 113.909 176.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 C--O 1.255 1.363 0 C-N-CA 125.863 1.665 . . . . 1.0 114.221 -174.141 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 tpt . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 119.764 -0.16 . . . . 1.0 110.813 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.43 -25.9 54.92 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.699 1.37 . . . . 1.0 114.699 -173.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.7 m -62.72 143.36 96.77 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.179 0.992 . . . . 1.0 113.18 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.75 148.4 52.47 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.16 2.573 . . . . 1.0 111.645 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -140.2 153.69 46.67 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.725 1.61 . . . . 1.0 110.754 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -142.25 160.75 39.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.6 1.16 . . . . 1.0 111.833 178.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -150.48 129.97 6.52 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.617 1.567 . . . . 1.0 108.563 169.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -76.16 143.08 25.13 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.265 2.643 . . . . 1.0 111.591 -175.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -129.48 163.44 46.49 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 126.094 1.757 . . . . 1.0 112.201 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -45.54 126.62 8.81 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 124.196 3.264 . . . . 1.0 113.095 -177.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.37 -5.75 82.6 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.44 1.495 . . . . 1.0 115.348 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -72.25 145.71 47.74 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.658 1.729 . . . . 1.0 113.782 -175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.94 123.05 30.06 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.54 1.136 . . . . 1.0 108.068 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 58.8 mt -105.81 131.19 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 107.416 -1.328 . . . . 1.0 107.416 173.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.45 129.06 54.99 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.244 1.818 . . . . 1.0 108.27 173.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.75 128.95 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 126.005 1.722 . . . . 1.0 108.297 -170.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -109.91 137.52 47.58 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.384 1.474 . . . . 1.0 111.451 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -131.74 173.82 10.76 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.313 1.845 . . . . 1.0 110.119 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.89 101.68 1.13 Allowed 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.159 -0.963 . . . . 1.0 110.284 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.69 5.62 89.27 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.997 1.284 . . . . 1.0 115.701 177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -148.92 163.51 37.23 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.464 1.505 . . . . 1.0 113.091 -175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -133.26 161.6 34.05 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.77 1.228 . . . . 1.0 110.619 171.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -147.38 169.25 19.87 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.835 1.254 . . . . 1.0 111.315 172.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 30.6 m-90 -139.51 156.87 46.65 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.179 -0.951 . . . . 1.0 113.251 -173.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.39 156.41 40.65 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.736 1.214 . . . . 1.0 112.546 178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -102.08 119.08 38.21 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.901 1.681 . . . . 1.0 108.145 170.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -82.78 130.36 35.12 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 121.241 -0.912 . . . . 1.0 111.965 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.5 pt -113.05 3.3 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 N-CA-C 114.744 1.387 . . . . 1.0 114.744 -170.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.37 168.05 35.63 Favored Glycine 0 N--CA 1.472 1.073 0 C-N-CA 124.4 1.0 . . . . 1.0 112.671 -175.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.1 t70 62.12 17.78 9.46 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.906 1.682 . . . . 1.0 113.999 176.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.62 1.63 85.37 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.002 1.287 . . . . 1.0 114.379 -174.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.6 m-85 -96.5 154.44 17.27 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.554 1.677 . . . . 1.0 114.204 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.3 m -135.27 157.11 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 126.283 1.833 . . . . 1.0 111.2 177.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 mt -115.53 136.27 52.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 106.33 -1.73 . . . . 1.0 106.33 168.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -158.8 175.28 13.79 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.305 1.042 . . . . 1.0 110.32 -168.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 66.6 mt -90.12 153.18 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.633 -0.667 . . . . 1.0 111.553 169.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.07 109.33 42.8 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.566 1.946 . . . . 1.0 107.86 169.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.11 157.54 23.41 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.224 2.616 . . . . 1.0 113.527 -169.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.25 -14.99 18.32 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 124.386 3.391 . . . . 1.0 113.363 174.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 24.3 m 70.93 8.32 6.49 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.226 1.81 . . . . 1.0 114.036 173.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -142.0 121.65 13.4 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.767 1.627 . . . . 1.0 110.013 -178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -69.86 -44.0 21.64 Favored Pre-proline 0 CA--C 1.55 0.959 0 N-CA-C 116.914 2.19 . . . . 1.0 116.914 -176.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.73 164.1 35.6 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 123.538 2.825 . . . . 1.0 111.701 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.21 -23.13 76.34 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-O 119.047 -0.863 . . . . 1.0 114.323 -176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -167.28 -165.85 0.73 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.07 2.148 . . . . 1.0 110.895 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.03 177.6 31.4 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.81 1.195 . . . . 1.0 114.14 178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 43.9 p -58.93 -30.46 67.87 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 114.944 1.461 . . . . 1.0 114.944 -169.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.3 m -83.93 -47.22 11.25 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.272 -0.893 . . . . 1.0 111.642 170.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.4 m -78.26 -15.91 58.31 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 114.167 1.173 . . . . 1.0 114.167 -170.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.98 -27.09 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 O-C-N 120.896 -1.127 . . . . 1.0 112.881 173.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -71.5 -34.37 70.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.559 0.744 . . . . 1.0 111.905 169.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 m -77.81 -30.77 51.38 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.429 1.492 . . . . 1.0 113.078 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.7 p -149.2 132.94 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.253 1.021 . . . . 1.0 112.557 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.0 mt -120.75 159.75 24.75 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.238 1.815 . . . . 1.0 111.458 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.5 t 72.48 169.8 0.32 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 126.293 1.837 . . . . 1.0 113.351 -178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 p30 179.48 158.17 0.64 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.864 2.065 . . . . 1.0 111.941 -170.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.9 m -143.45 152.02 41.03 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.089 0.956 . . . . 1.0 112.838 -170.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.07 152.57 19.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.6 1.56 . . . . 1.0 110.13 170.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -98.24 138.77 35.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.093 0.861 . . . . 1.0 110.42 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.0 t -75.11 127.32 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 109.1 -0.704 . . . . 1.0 109.1 169.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -138.07 162.02 35.24 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.442 1.497 . . . . 1.0 112.276 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.5 ttp85 -109.22 140.28 43.05 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.227 1.811 . . . . 1.0 110.345 174.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.17 176.61 9.08 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.771 1.228 . . . . 1.0 110.909 172.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -74.28 142.07 45.27 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.705 1.202 . . . . 1.0 111.529 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.85 -51.94 64.34 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.977 -1.011 . . . . 1.0 111.844 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -54.19 -47.01 72.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.727 0.694 . . . . 1.0 111.22 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -67.74 -39.71 84.2 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.549 0.739 . . . . 1.0 112.025 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.2 t -68.55 -42.05 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.404 1.081 . . . . 1.0 112.401 175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -91.27 -0.63 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 C-N-CA 125.536 1.535 . . . . 1.0 113.9 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.91 52.29 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.404 1.002 . . . . 1.0 112.993 -175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.48 1.87 77.87 Favored Glycine 0 CA--C 1.538 1.476 0 C-N-CA 124.725 1.155 . . . . 1.0 114.622 -175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 24.5 m -120.44 161.26 21.53 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 126.243 1.817 . . . . 1.0 111.127 -176.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 25.1 t -97.14 163.19 13.03 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.015 0.926 . . . . 1.0 109.204 169.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -157.39 163.32 38.7 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 115.014 1.487 . . . . 1.0 115.014 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -155.13 151.72 28.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.637 1.975 . . . . 1.0 109.67 -177.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.23 129.5 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 108.572 -0.899 . . . . 1.0 108.572 169.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -132.39 68.76 1.49 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.068 0.947 . . . . 1.0 111.531 -177.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -75.58 73.2 2.59 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.873 1.269 . . . . 1.0 111.729 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 m -70.37 -38.76 74.82 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.124 -0.985 . . . . 1.0 113.305 -170.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.3 mt -75.55 -10.47 59.47 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.473 1.286 . . . . 1.0 114.473 -169.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.95 -30.59 68.0 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.065 0.946 . . . . 1.0 112.693 173.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -79.21 -16.46 56.48 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.602 1.561 . . . . 1.0 112.538 175.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -100.0 -41.33 7.22 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.486 1.515 . . . . 1.0 112.365 -172.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -130.1 160.27 34.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.202 1.401 . . . . 1.0 113.299 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -66.08 162.86 42.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.706 1.203 . . . . 1.0 111.803 176.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.32 146.14 7.38 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 125.124 3.883 . . . . 1.0 115.255 175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.04 151.71 63.0 Favored Pre-proline 0 CA--C 1.553 1.064 0 C-N-CA 125.486 1.514 . . . . 1.0 112.296 -176.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -78.88 120.09 4.56 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.853 3.035 . . . . 1.0 112.446 -169.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 13.9 p -55.58 -33.25 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 114.208 1.188 . . . . 1.0 114.208 -174.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.66 -35.4 79.51 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 122.677 0.391 . . . . 1.0 112.041 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.53 -35.47 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.202 0.601 . . . . 1.0 110.815 176.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.3 mt -62.52 -49.39 84.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 CA-C-N 118.837 0.744 . . . . 1.0 110.059 175.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -68.65 -37.64 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.031 0.932 . . . . 1.0 111.709 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.1 m -62.11 -42.02 98.82 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 121.238 -0.914 . . . . 1.0 111.86 172.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 22.6 t -60.23 -45.44 93.23 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.559 0.744 . . . . 1.0 111.06 173.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -58.15 -49.84 75.58 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.351 0.66 . . . . 1.0 110.95 175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.55 -38.67 90.93 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.14 -0.975 . . . . 1.0 113.114 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -66.3 -35.58 80.76 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.766 0.827 . . . . 1.0 112.092 173.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 66.4 mmm -73.75 -36.24 65.12 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 117.982 -1.008 . . . . 1.0 112.975 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.62 126.89 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-N 119.744 1.156 . . . . 1.0 111.417 170.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 97.27 -17.68 58.72 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 126.154 1.835 . . . . 1.0 113.981 -174.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -88.14 158.07 18.65 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.872 1.336 . . . . 1.0 110.709 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -110.79 141.81 43.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.618 1.167 . . . . 1.0 112.335 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.8 mmt -127.43 146.48 50.47 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.381 1.872 . . . . 1.0 110.51 -175.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -58.31 132.63 54.22 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.7 -0.625 . . . . 1.0 111.891 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -74.36 168.47 19.61 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 113.072 0.767 . . . . 1.0 113.072 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 74.5 m -68.56 41.03 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 128.569 2.748 . . . . 1.0 115.644 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 38.2 pt -69.02 139.56 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 O-C-N 120.488 -1.382 . . . . 1.0 109.857 169.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 21.5 t 72.73 -44.81 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 127.232 2.213 . . . . 1.0 112.012 -177.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.3 t -163.3 161.44 24.66 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.303 1.841 . . . . 1.0 111.397 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 72.4 mtm-85 -66.57 132.89 49.17 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.576 0.75 . . . . 1.0 112.756 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -122.72 -2.59 8.81 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 114.661 1.356 . . . . 1.0 114.661 -170.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.0 m -74.79 -15.31 60.75 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.229 -1.544 . . . . 1.0 114.558 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -46.53 55.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.825 0.739 . . . . 1.0 110.391 170.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -53.12 -27.98 23.32 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.608 1.163 . . . . 1.0 113.654 176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -65.07 -53.97 37.42 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.183 -0.948 . . . . 1.0 111.173 169.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.43 -26.6 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 113.511 0.93 . . . . 1.0 113.511 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 34.6 p -64.56 -41.72 96.13 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.479 1.036 . . . . 1.0 111.815 175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -61.6 -24.23 66.55 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.537 1.135 . . . . 1.0 112.923 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.16 -31.36 72.51 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 118.954 0.797 . . . . 1.0 112.557 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 20.3 ttm180 -94.16 -43.73 8.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.618 1.167 . . . . 1.0 111.723 173.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -67.81 -33.81 75.53 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.616 0.969 . . . . 1.0 113.616 -178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -84.3 10.76 60.3 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.8 1.667 . . . . 1.0 114.323 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -56.83 -39.54 74.39 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.419 1.488 . . . . 1.0 113.401 178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.436 1.895 . . . . 1.0 112.641 178.786 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.9 ttp . . . . . 0 N--CA 1.493 1.697 0 CA-C-O 119.067 -0.492 . . . . 1.0 111.133 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.17 163.48 27.03 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 119.139 0.881 . . . . 1.0 112.736 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.4 p -77.51 155.69 81.27 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.819 1.248 . . . . 1.0 112.955 175.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.18 161.1 43.92 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.368 2.712 . . . . 1.0 111.598 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.0 p80 -81.41 167.06 19.83 Favored 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 113.419 0.896 . . . . 1.0 113.419 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -71.89 146.71 47.69 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.1 0.96 . . . . 1.0 110.791 173.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -138.23 141.78 33.06 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 124.81 1.244 . . . . 1.0 110.717 173.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -81.37 148.6 16.55 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.689 2.926 . . . . 1.0 112.181 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -130.0 161.26 60.9 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 126.386 1.874 . . . . 1.0 112.915 176.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.43 128.17 12.16 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 124.182 3.255 . . . . 1.0 113.114 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 91.91 -7.64 78.86 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.122 1.344 . . . . 1.0 114.9 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -69.41 142.48 53.86 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 119.316 1.558 . . . . 1.0 113.689 -177.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.3 mt -85.85 123.96 31.8 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 125.132 1.373 . . . . 1.0 108.733 169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.2 mm -105.64 127.17 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 107.783 -1.192 . . . . 1.0 107.783 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -102.49 125.67 49.29 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.498 1.519 . . . . 1.0 108.272 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.75 119.06 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 125.137 1.375 . . . . 1.0 109.317 -173.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -85.39 62.32 7.41 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.444 1.498 . . . . 1.0 110.514 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 -61.76 149.83 38.71 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.026 0.931 . . . . 1.0 110.651 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.31 129.62 32.35 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.473 1.109 . . . . 1.0 110.304 176.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 79.97 -123.02 5.93 Favored Glycine 0 CA--C 1.532 1.122 0 N-CA-C 109.992 -1.243 . . . . 1.0 109.992 -169.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -73.3 139.37 46.05 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.851 0.861 . . . . 1.0 113.046 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.0 mp0 -64.66 157.61 26.74 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.831 1.652 . . . . 1.0 111.374 173.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -131.09 163.04 28.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.791 1.636 . . . . 1.0 111.023 178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -138.0 150.08 46.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.035 0.934 . . . . 1.0 112.868 -176.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.28 155.82 42.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.468 1.107 . . . . 1.0 112.469 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.35 116.22 32.29 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.924 1.689 . . . . 1.0 107.733 172.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -82.29 131.09 35.23 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.241 -0.912 . . . . 1.0 111.872 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.2 pt -114.26 2.5 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 N-CA-C 114.806 1.41 . . . . 1.0 114.806 -169.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.73 168.67 36.73 Favored Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.448 1.023 . . . . 1.0 112.772 -175.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 61.74 17.8 9.07 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.983 1.713 . . . . 1.0 113.8 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.16 -0.35 85.79 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.143 1.354 . . . . 1.0 114.445 -174.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -92.94 153.41 18.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 119.788 1.794 . . . . 1.0 114.646 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -132.85 156.52 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 126.274 1.83 . . . . 1.0 110.865 174.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.0 mt -115.09 134.84 56.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.659 1.584 . . . . 1.0 107.101 169.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -154.32 145.39 22.75 Favored 'General case' 0 CA--C 1.539 0.536 0 O-C-N 121.326 -0.859 . . . . 1.0 112.402 -168.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.1 tp -85.71 93.31 8.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.491 0.716 . . . . 1.0 109.861 175.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.47 127.05 90.6 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.494 1.117 . . . . 1.0 111.374 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.87 161.75 42.88 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.357 2.705 . . . . 1.0 112.411 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -71.83 162.06 43.15 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.409 2.739 . . . . 1.0 111.421 170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 52.0 p -74.21 -19.07 60.65 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.774 1.027 . . . . 1.0 113.774 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -145.83 143.79 29.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.176 1.79 . . . . 1.0 110.738 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -76.39 -51.89 2.44 Favored Pre-proline 0 CA--C 1.549 0.915 0 N-CA-C 115.646 1.721 . . . . 1.0 115.646 172.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.85 151.54 16.64 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.449 2.766 . . . . 1.0 112.819 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.68 10.93 72.05 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.599 1.571 . . . . 1.0 113.001 173.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.51 144.03 48.4 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.733 1.213 . . . . 1.0 111.641 176.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -164.41 -111.11 0.24 Allowed Glycine 0 N--CA 1.465 0.599 0 C-N-CA 123.707 0.67 . . . . 1.0 111.759 -171.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.1 p -66.02 -24.47 66.76 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.683 0.793 . . . . 1.0 112.599 170.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 68.1 m -122.12 147.16 46.48 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.661 1.584 . . . . 1.0 110.809 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.0 t -79.77 49.74 1.08 Allowed 'General case' 0 CA--C 1.552 1.055 0 O-C-N 120.285 -1.509 . . . . 1.0 112.538 -174.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.6 m -80.14 46.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 125.823 1.649 . . . . 1.0 112.739 -175.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -54.47 -36.35 64.03 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.29 1.436 . . . . 1.0 113.236 -174.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 19.3 m -71.97 -10.54 59.92 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.79 1.033 . . . . 1.0 113.79 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.9 t -90.77 130.58 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.984 1.314 . . . . 1.0 108.773 174.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.5 -72.84 0.17 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.278 1.031 . . . . 1.0 112.126 -176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 54.7 m 66.17 -34.27 0.2 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 127.602 2.361 . . . . 1.0 114.968 -175.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 -83.23 150.87 25.93 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 126.182 1.793 . . . . 1.0 112.825 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.7 m -139.06 152.25 47.41 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.215 1.006 . . . . 1.0 111.781 -178.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.08 155.7 20.7 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.266 1.026 . . . . 1.0 110.514 169.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -125.25 135.34 52.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.223 1.009 . . . . 1.0 110.929 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.9 t -73.44 122.35 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 108.726 -0.842 . . . . 1.0 108.726 170.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -128.04 161.03 30.13 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.536 1.534 . . . . 1.0 111.799 -177.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 73.1 ttt-85 -117.38 120.27 37.64 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 126.143 1.777 . . . . 1.0 109.994 174.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -147.19 177.53 9.11 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.694 1.198 . . . . 1.0 110.852 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.52 139.68 38.62 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 121.147 -0.97 . . . . 1.0 111.394 178.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.1 tp -54.48 -49.97 68.85 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.063 0.945 . . . . 1.0 111.609 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -54.76 -46.21 74.33 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.426 0.69 . . . . 1.0 111.316 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -67.77 -44.9 76.37 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.785 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 41.8 t -63.55 -41.56 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.825 1.25 . . . . 1.0 112.144 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.37 -2.08 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 125.502 1.521 . . . . 1.0 113.71 -171.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -57.1 128.65 47.91 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 124.228 0.918 . . . . 1.0 112.924 -176.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.46 -1.17 83.08 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.942 1.258 . . . . 1.0 114.726 -176.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 m -117.67 150.26 39.35 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.78 1.632 . . . . 1.0 111.283 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 72.5 m -84.74 159.64 20.45 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.356 -0.609 . . . . 1.0 109.356 169.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -160.71 168.46 24.8 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.484 1.29 . . . . 1.0 114.484 -177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 40.9 ptt180 -159.97 162.2 34.31 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.507 1.523 . . . . 1.0 112.098 174.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 88.4 t -81.02 134.31 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 107.146 -1.427 . . . . 1.0 107.146 168.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -145.25 75.64 1.45 Allowed 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 122.087 0.946 . . . . 1.0 111.075 -178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -78.11 64.64 3.32 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.974 1.309 . . . . 1.0 110.71 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -62.89 -42.4 99.76 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.736 1.215 . . . . 1.0 113.036 -170.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.7 mt -72.67 -7.43 50.37 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 113.778 1.029 . . . . 1.0 113.778 -176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -60.53 -27.95 68.04 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.767 0.794 . . . . 1.0 112.841 170.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -78.33 -14.7 59.3 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.205 1.402 . . . . 1.0 112.391 175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -104.21 -40.42 6.14 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.544 1.538 . . . . 1.0 112.112 -174.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -129.4 156.76 43.55 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.109 1.764 . . . . 1.0 112.75 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -65.95 160.3 63.88 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.951 0.9 . . . . 1.0 111.828 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.34 125.51 17.82 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.635 2.89 . . . . 1.0 112.28 175.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -96.99 154.49 38.19 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.955 1.302 . . . . 1.0 110.137 177.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.11 112.41 3.3 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.032 2.488 . . . . 1.0 111.061 -177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.0 t -57.67 -33.06 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 C-N-CA 124.549 1.139 . . . . 1.0 113.133 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -59.83 -37.38 79.05 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.267 0.485 . . . . 1.0 112.034 175.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.8 t -71.4 -38.76 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 123.67 0.788 . . . . 1.0 110.646 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.0 mt -60.07 -50.26 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-N 118.7 0.682 . . . . 1.0 109.858 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 86.6 mt -66.67 -36.46 77.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 C-N-CA 124.248 1.019 . . . . 1.0 112.077 178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 t -63.77 -41.78 97.91 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.948 0.795 . . . . 1.0 110.745 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 10.4 p -63.2 -41.33 99.15 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.67 0.788 . . . . 1.0 111.858 174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -59.7 -49.83 76.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.888 0.875 . . . . 1.0 110.469 173.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -61.59 -39.21 90.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.223 1.009 . . . . 1.0 112.974 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -65.99 -34.86 79.05 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.564 0.746 . . . . 1.0 112.358 173.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 69.5 mmm -74.63 -36.83 62.91 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 118.322 -0.847 . . . . 1.0 113.162 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.96 127.0 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.528 1.058 . . . . 1.0 111.389 170.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 99.18 -13.53 61.72 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.857 1.694 . . . . 1.0 113.782 -177.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -88.16 155.89 19.53 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 119.062 1.431 . . . . 1.0 111.245 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.16 143.63 46.35 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.263 1.425 . . . . 1.0 113.187 -176.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -140.15 174.25 10.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.385 1.874 . . . . 1.0 111.172 -172.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -60.24 145.85 45.84 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.297 -0.877 . . . . 1.0 112.241 172.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -51.33 140.52 16.98 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.504 1.922 . . . . 1.0 114.576 -172.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.63 -24.15 27.23 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 114.689 1.366 . . . . 1.0 114.689 -170.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 pt -75.72 149.45 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.79 0.836 . . . . 1.0 111.032 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.6 t 71.75 -49.44 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 126.75 2.02 . . . . 1.0 111.907 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 88.8 p -76.81 -27.47 55.22 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.676 1.59 . . . . 1.0 113.737 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 81.8 mtt85 62.31 22.54 13.27 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.107 1.763 . . . . 1.0 112.073 -169.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -53.42 -24.96 13.97 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 115.268 1.581 . . . . 1.0 115.268 -170.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 9.2 p -55.34 -32.04 62.21 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 120.695 -1.253 . . . . 1.0 113.945 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -62.49 -50.94 69.42 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.789 1.177 . . . . 1.0 110.876 172.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 43.9 m-70 -64.1 -28.87 70.07 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.637 0.775 . . . . 1.0 112.488 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -63.31 -56.11 19.15 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.746 -0.596 . . . . 1.0 110.112 169.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.64 -30.34 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 N-CA-C 114.174 1.176 . . . . 1.0 114.174 -171.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 28.0 p -66.43 -41.24 89.49 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 119.809 1.186 . . . . 1.0 112.344 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -63.22 -21.87 66.5 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.134 0.974 . . . . 1.0 112.806 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 74.0 mt -65.14 -32.93 74.87 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.515 1.052 . . . . 1.0 112.14 173.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -84.26 -55.05 4.38 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.58 0.752 . . . . 1.0 111.055 170.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.95 -34.71 77.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.754 1.02 . . . . 1.0 113.754 -170.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -101.25 25.32 28.66 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 126.2 1.857 . . . . 1.0 114.184 -178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.2 151.47 12.44 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 118.544 1.172 . . . . 1.0 113.126 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.253 1.272 0 C-N-CA 126.316 1.846 . . . . 1.0 115.114 -175.69 . . . . . . . . 0 0 . 1 stop_ save_